PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Donovan, LM; Patel, SR				Donovan, Lucas M.; Patel, Sanjay R.			Making the Most of Simplified Sleep Apnea Testing	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DIAGNOSIS; POLYSOMNOGRAPHY; AUTOTITRATION; HOME		[Donovan, Lucas M.] Univ Washington, Div Pulm & Crit Care, 1959 NE Pacific St,Campus Box 356522, Seattle, WA 98116 USA; [Patel, Sanjay R.] Univ Pittsburgh, Pittsburgh, PA USA; [Patel, Sanjay R.] UPMC Montefiore Hosp, NW628,3459 Fifth Ave, Pittsburgh, PA 15213 USA	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian	Patel, SR (corresponding author), UPMC Montefiore Hosp, NW628,3459 Fifth Ave, Pittsburgh, PA 15213 USA.	patelsr2@upmc.edu		Patel, Sanjay/0000-0002-9142-5172	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL127307, T32HL007287] Funding Source: NIH RePORTER; NHLBI NIH HHS [K24 HL127307, T32 HL007287] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Berry RB, 2008, SLEEP, V31, P1423; Chai-Coetzer CL, 2017, ANN INTERN MED, V166, P332, DOI 10.7326/M16-1301; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; Kim RD, 2015, SLEEP, V38, P1027, DOI 10.5665/sleep.4804; Kuna ST, 2011, AM J RESP CRIT CARE, V183, P1238, DOI 10.1164/rccm.201011-1770OC; Mulgrew AT, 2007, ANN INTERN MED, V146, P157, DOI 10.7326/0003-4819-146-3-200702060-00004; Pack AI, 2015, J CLIN SLEEP MED, V11, P925, DOI 10.5664/jcsm.4948; Rosen CL, 2012, SLEEP, V35, P757, DOI 10.5665/sleep.1870; Skomro RP, 2010, CHEST, V138, P257, DOI 10.1378/chest.09-0577	9	4	5	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					366	+		10.7326/M16-2902	http://dx.doi.org/10.7326/M16-2902			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28114686	Green Accepted			2022-12-28	WOS:000396432800011
J	Wang, T; Yu, HY; Hughes, NW; Liu, BX; Kendirli, A; Klein, K; Chen, WW; Lander, ES; Sabatini, DM				Wang, Tim; Yu, Haiyan; Hughes, Nicholas W.; Liu, Bingxu; Kendirli, Arek; Klein, Klara; Chen, Walter W.; Lander, Eric S.; Sabatini, David M.			Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras	CELL			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; ACUTE MYELOID-LEUKEMIA; LUNG-CANCER; CELL-LINES; SYSTEMATIC IDENTIFICATION; EXPRESSION PROFILES; DRUG-SENSITIVITY; C-RAF; N-RAS; GENOME	The genetic dependencies of human cancers widely vary. Here, we catalog this heterogeneity and use it to identify functional gene interactions and genotype-dependent liabilities in cancer. By using genome-wide CRISPR-based screens, we generate a gene essentiality dataset across 14 human acute myeloid leukemia (AML) cell lines. Sets of genes with correlated patterns of essentiality across the lines reveal new gene relationships, the essential substrates of enzymes, and the molecular functions of uncharacterized proteins. Comparisons of differentially essential genes between Ras-dependent and -independent lines uncover synthetic lethal partners of oncogenic Ras. Screens in both human AML and engineered mouse pro-B cells converge on a surprisingly small number of genes in the Ras processing and MAPK pathways and pinpoint PREX1 as an AML-specific activator of MAPK signaling. Our findings suggest general strategies for definingmammalian gene networks and synthetic lethal interactions by exploiting the natural genetic and epigenetic diversity of human cancer cells.	[Wang, Tim; Chen, Walter W.; Lander, Eric S.; Sabatini, David M.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Wang, Tim; Yu, Haiyan; Hughes, Nicholas W.; Liu, Bingxu; Kendirli, Arek; Klein, Klara; Chen, Walter W.; Lander, Eric S.; Sabatini, David M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Wang, Tim; Hughes, Nicholas W.; Liu, Bingxu; Chen, Walter W.; Sabatini, David M.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Wang, Tim; Hughes, Nicholas W.; Liu, Bingxu; Chen, Walter W.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Wang, Tim; Hughes, Nicholas W.; Liu, Bingxu; Chen, Walter W.; Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kendirli, Arek; Klein, Klara] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Lander, Eric S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Harvard Medical School	Lander, ES; Sabatini, DM (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lander, ES; Sabatini, DM (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lander, ES (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	lander@broadinstitute.org; sabatini@wi.mit.edu		Wang, Timothy/0000-0001-5730-3019; /0000-0002-1446-7256; Chen, Walter/0000-0002-7752-9581	NIH [CA103866, F31 CA189437]; National Human Genome Research Institute [2U54HG003067-10]; MIT Whitaker Health Sciences Fund; NATIONAL CANCER INSTITUTE [F31CA189437, R01CA103866] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MIT Whitaker Health Sciences Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank W.C. Comb, M.L. Valenstein, and K.M. Krupczak for assistance and L. Chantranupong, R.A. Saxton, and C.H. Adelmann for manuscript review. This work was supported by the NIH (CA103866 to D.M.S.; F31 CA189437 to T.W), the National Human Genome Research Institute (2U54HG003067-10) (to E.S.L.), and the MIT Whitaker Health Sciences Fund (to T.W.). D.M.S. is an investigator of the Howard Hughes Medical Institute. E.S.L. directs The Broad Institute, which holds patents and has filed patent applications on technologies related to CRISPR-Cas 9. E.S.L. has no personal financial interest in the work in the paper. D.M.S. and T.W. are co-founders of and D.M.S is a consultant to KSQ Therapeutics, Inc., which is using CRISPR-based genetic screens to identify to drug targets. T.W., D.M.S., and E.S.L. are inventors on a patent for functional genomics using CRISPR-Cas (US 15/141,348).	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Berger AH, 2016, CANCER CELL, V30, P214, DOI 10.1016/j.ccell.2016.06.022; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Boehm JS, 2011, NAT REV GENET, V12, P487, DOI 10.1038/nrg3013; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chen C., 2014, CONT ANAL APPL MATH, V2, P1, DOI DOI 10.1088/2053-1583/1/3/034001; Chow HY, 2012, CANCER RES, V72, P5966, DOI 10.1158/0008-5472.CAN-12-2246; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; FEIG LA, 1988, MOL CELL BIOL, V8, P2472, DOI 10.1128/MCB.8.6.2472; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; Kim HS, 2013, CELL, V155, P552, DOI 10.1016/j.cell.2013.09.041; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lehrbach NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.17721; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; Radhakrishnan SK, 2014, ELIFE, V3, DOI [10.7554/elife.01856, 10.7554/eLife.01856]; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Starita LM, 2015, GENETICS, V200, P413, DOI 10.1534/genetics.115.175802; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Toledo CM, 2015, CELL REP, V13, P2425, DOI 10.1016/j.celrep.2015.11.021; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsang YH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10500; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459	61	351	359	1	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					890	+		10.1016/j.cell.2017.01.013	http://dx.doi.org/10.1016/j.cell.2017.01.013			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28162770	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000396284800017
J	Marouli, E; Graff, M; Medina-Gomez, C; Lo, KS; Wood, AR; Kjaer, TR; Fine, RS; Lu, YC; Schurmann, C; Highland, HM; Rueger, S; Thorleifsson, G; Justice, AE; Lamparter, D; Stirrups, KE; Turcot, V; Young, KL; Winkler, TW; Esko, T; Karaderi, T; Locke, AE; Masca, NGD; Ng, MCY; Mudgal, P; Rivas, MA; Vedantam, S; Mahajan, A; Guo, XQ; Abecasis, G; Aben, KK; Adair, LS; Alam, DS; Albrecht, E; Allin, KH; Allison, M; Amouyel, P; Appel, EV; Arveiler, D; Asselbergs, FW; Auer, PL; Balkau, B; Banas, B; Bang, LE; Benn, M; Bergmann, S; Bielak, LF; Bluher, M; Boeing, H; Boerwinkle, E; Boger, CA; Bonnycastle, LL; Bork-Jensen, J; Bots, ML; Bottinger, EP; Bowden, DW; Brandslund, I; Breen, G; Brilliant, MH; Broer, L; Burt, AA; Butterworth, AS; Carey, DJ; Caulfield, MJ; Chambers, JC; Chasman, DI; Chen, YDI; Chowdhury, R; Christensen, C; Chu, AY; Cocca, M; Collins, FS; Cook, JP; Corley, J; Galbany, JC; Cox, AJ; Cuellar-Partida, G; Danesh, J; Davies, G; de Bakker, PIW; de Borst, GJ; de Denus, S; de Groot, MCH; de Mutsert, R; Deary, IJ; Dedoussis, G; Demerath, EW; den Hollander, AI; Dennis, JG; Di Angelantonio, E; Drenos, F; Du, MM; Dunning, AM; Easton, DF; Ebeling, T; Edwards, TL; Ellinor, PT; Elliott, P; Evangelou, E; Farmaki, AE; Faul, JD; Feitosa, MF; Feng, S; Ferrannini, E; Ferrario, MM; Ferrieres, J; Florez, JC; Ford, I; Fornage, M; Franks, PW; Frikke-Schmidt, R; Galesloot, TE; Gan, W; Gandin, I; Gasparini, P; Giedraitis, V; Giri, A; Girotto, G; Gordon, SD; Gordon-Larsen, P; Gorski, M; Grarup, N; Grove, ML; Gudnason, V; Gustafsson, S; Hansen, T; Harris, KM; Harris, TB; Hattersley, AT; Hayward, C; He, L; Heid, IM; Heikkila, K; Helgeland, O; Hernesniemi, J; Hewitt, AW; Hocking, LJ; Hollensted, M; Holmen, OL; Hovingh, GK; Howson, JMM; Hoyng, CB; Huang, PL; Hveem, K; Ikram, MA; Ingelsson, E; Jackson, AU; Jansson, JH; Jarvik, GP; Jensen, GB; Jhun, MA; Jia, YC; Jiang, XJ; Johansson, S; Jorgensen, ME; Jorgensen, T; Jousilahti, P; Jukema, JW; Kahali, B; Kahn, RS; Kahonen, M; Kamstrup, PR; Kanoni, S; Kaprio, J; Karaleftheri, M; Kardia, SLR; Karpe, F; Kee, F; Keeman, R; Kiemeney, LA; Kitajima, H; Kluivers, KB; Kocher, T; Komulainen, P; Kontto, J; Kooner, JS; Kooperberg, C; Kovacs, P; Kriebel, J; Kuivaniemi, H; Kury, S; Kuusisto, J; La Bianca, M; Laakso, M; Lakka, TA; Lange, EM; Lange, LA; Langefeld, CD; Langenberg, C; Larson, EB; Lee, IT; Lehtimaki, T; Lewis, CE; Li, HX; Li, J; Li-Gao, R; Lin, HH; Lin, LA; Lin, X; Lind, L; Lindstrom, J; Linneberg, A; Liu, YH; Liu, YM; Lophatananon, A; Luan, J; Lubitz, SA; Lyytikainen, LP; Mackey, DA; Madden, PAF; Manning, AK; Mannisto, S; Marenne, G; Marten, J; Martin, NG; Mazul, AL; Meidtner, K; Metspalu, A; Mitchell, P; Mohlke, KL; Mook-Kanamori, DO; Morgan, A; Morris, AD; Morris, AP; Muller-Nurasyid, M; Munroe, PB; Nalls, MA; Nauck, M; Nelson, CP; Nelson, CP; Neville, M; Nielsen, SF; Nikus, K; Njolstad, PR; Nordestgaard, BG; Ntalla, I; O'Connel, JR; Oksa, H; Loohuis, LMO; Ophoff, RA; Owen, KR; Packard, CJ; Padmanabhan, S; Palmer, CNA; Pasterkamp, G; Patel, AP; Pattie, A; Pedersen, O; Peissig, PL; Peloso, GM; Pennell, CE; Perola, M; Perry, JA; Perry, JRB; Person, TN; Pirie, A; Polasek, O; Posthuma, D; Raitakari, OT; Rasheed, A; Rauramaa, R; Reilly, DF; Reiner, AP; Renstrom, F; Ridker, PM; Rioux, JD; Robertson, N; Robino, A; Rolandsson, O; Rudan, I; Ruth, KS; Saleheen, D; Salomaa, V; Samani, NJ; Sandow, K; Sapkota, Y; Sattar, N; Schmidt, MK; Schreiner, PJ; Schulze, MB; Scott, RA; Segura-Lepe, MP; Shah, S; Sim, XL; Sivapalaratnam, S; Small, KS; Smith, AV; Smith, JA; Southam, L; Spector, TD; Speliotes, EK; Starr, JM; Steinthorsdottir, V; Stringham, HM; Stumvoll, M; Surendran, P; 't Hart, LM; Tansey, KE; Tardif, JC; Taylor, KD; Teumer, A; Thompson, DJ; Thorsteinsdottir, U; Thuesen, BH; Tonjes, A; Tromp, G; Trompet, S; Tsafantakis, E; Tuomilehto, J; Tybjaerg-Hansen, A; Tyrer, JP; Uher, R; Uitterlinden, AG; Ulivi, S; van der Laan, SW; Van Der Leij, AR; van Duijn, CM; van Schoor, NM; van Setten, J; Varbo, A; Varga, TV; Varma, R; Edwards, DRV; Vermeulen, SH; Vestergaard, H; Vitart, V; Vogt, TF; Vozzi, D; Walker, M; Wang, FJ; Wang, CA; Wang, S; Wang, YQ; Wareham, NJ; Warren, HR; Wessel, J; Willems, SM; Wilson, JG; Witte, DR; Woods, MO; Wu, Y; Yaghootkar, H; Yao, J; Yao, P; Yerges-Armstrong, LM; Young, R; Zeggini, E; Zhan, XW; Zhang, WH; Zhao, JH; Zhao, W; Zhao, W; Zheng, H; Zhou, W; Rotter, JI; Boehnke, M; Kathiresan, S; McCarthy, MI; Willer, CJ; Stefansson, K; Borecki, IB; Liu, DJ; North, KE; Heard-Costa, NL; Pers, TH; Lindgren, CM; Oxvig, C; Kutalik, Z; Rivadeneira, F; Loos, RJF; Frayling, TM; Hirschhorn, JN; Deloukas, P; Lettre, G				Marouli, Eirini; Graff, Mariaelisa; Medina-Gomez, Carolina; Lo, Ken Sin; Wood, Andrew R.; Kjaer, Troels R.; Fine, Rebecca S.; Lu, Yingchang; Schurmann, Claudia; Highland, Heather M.; Rueger, Sina; Thorleifsson, Gudmar; Justice, Anne E.; Lamparter, David; Stirrups, Kathleen E.; Turcot, Valerie; Young, Kristin L.; Winkler, Thomas W.; Esko, Tonu; Karaderi, Tugce; Locke, Adam E.; Masca, Nicholas G. D.; Ng, Maggie C. Y.; Mudgal, Poorva; Rivas, Manuel A.; Vedantam, Sailaja; Mahajan, Anubha; Guo, Xiuqing; Abecasis, Goncalo; Aben, Katja K.; Adair, Linda S.; Alam, Dewan S.; Albrecht, Eva; Allin, Kristine H.; Allison, Matthew; Amouyel, Philippe; Appel, Emil V.; Arveiler, Dominique; Asselbergs, Folkert W.; Auer, Paul L.; Balkau, Beverley; Banas, Bernhard; Bang, Lia E.; Benn, Marianne; Bergmann, Sven; Bielak, Lawrence F.; Blueher, Matthias; Boeing, Heiner; Boerwinkle, Eric; Boeger, Carsten A.; Bonnycastle, Lori L.; Bork-Jensen, Jette; Bots, Michiel L.; Bottinger, Erwin P.; Bowden, Donald W.; Brandslund, Ivan; Breen, Gerome; Brilliant, Murray H.; Broer, Linda; Burt, Amber A.; Butterworth, Adam S.; Carey, David J.; Caulfield, Mark J.; Chambers, John C.; Chasman, Daniel I.; Chen, Yii-Der Ida; Chowdhury, Rajiv; Christensen, Cramer; Chu, Audrey Y.; Cocca, Massimiliano; Collins, Francis S.; Cook, James P.; Corley, Janie; Galbany, Jordi Corominas; Cox, Amanda J.; Cuellar-Partida, Gabriel; Danesh, John; Davies, Gail; de Bakker, Paul I. W.; de Borst, Gert J.; de Denus, Simon; de Groot, Mark C. H.; de Mutsert, Renee; Deary, Ian J.; Dedoussis, George; Demerath, Ellen W.; den Hollander, Anneke I.; Dennis, Joe G.; Di Angelantonio, Emanuele; Drenos, Fotios; Du, Mengmeng; Dunning, Alison M.; Easton, Douglas F.; Ebeling, Tapani; Edwards, Todd L.; Ellinor, Patrick T.; Elliott, Paul; Evangelou, Evangelos; Farmaki, Aliki-Eleni; Faul, Jessica D.; Feitosa, Mary F.; Feng, Shuang; Ferrannini, Ele; Ferrario, Marco M.; Ferrieres, Jean; Florez, Jose C.; Ford, Ian; Fornage, Myriam; Franks, Paul W.; Frikke-Schmidt, Ruth; Galesloot, Tessel E.; Gan, Wei; Gandin, Ilaria; Gasparini, Paolo; Giedraitis, Vilmantas; Giri, Ayush; Girotto, Giorgia; Gordon, Scott D.; Gordon-Larsen, Penny; Gorski, Mathias; Grarup, Niels; Grove, Megan L.; Gudnason, Vilmundur; Gustafsson, Stefan; Hansen, Torben; Harris, Kathleen Mullan; Harris, Tamara B.; Hattersley, Andrew T.; Hayward, Caroline; He, Liang; Heid, Iris M.; Heikkila, Kauko; Helgeland, Oyvind; Hernesniemi, Jussi; Hewitt, Alex W.; Hocking, Lynne J.; Hollensted, Mette; Holmen, Oddgeir L.; Hovingh, G. Kees; Howson, Joanna M. M.; Hoyng, Carel B.; Huang, Paul L.; Hveem, Kristian; Ikram, M. Arfan; Ingelsson, Erik; Jackson, Anne U.; Jansson, Jan-Hakan; Jarvik, Gail P.; Jensen, Gorm B.; Jhun, Min A.; Jia, Yucheng; Jiang, Xuejuan; Johansson, Stefan; Jorgensen, Marit E.; Jorgensen, Torben; Jousilahti, Pekka; Jukema, J. Wouter; Kahali, Bratati; Kahn, Rene S.; Kahonen, Mika; Kamstrup, Pia R.; Kanoni, Stavroula; Kaprio, Jaakko; Karaleftheri, Maria; Kardia, Sharon L. R.; Karpe, Fredrik; Kee, Frank; Keeman, Renske; Kiemeney, Lambertus A.; Kitajima, Hidetoshi; Kluivers, Kirsten B.; Kocher, Thomas; Komulainen, Pirjo; Kontto, Jukka; Kooner, Jaspal S.; Kooperberg, Charles; Kovacs, Peter; Kriebel, Jennifer; Kuivaniemi, Helena; Kury, Sebastien; Kuusisto, Johanna; La Bianca, Martina; Laakso, Markku; Lakka, Timo A.; Lange, Ethan M.; Lange, Leslie A.; Langefeld, Carl D.; Langenberg, Claudia; Larson, Eric B.; Lee, I-Te; Lehtimaki, Terho; Lewis, Cora E.; Li, Huaixing; Li, Jin; Li-Gao, Ruifang; Lin, Honghuang; Lin, Li-An; Lin, Xu; Lind, Lars; Lindstrom, Jaana; Linneberg, Allan; Liu, Yeheng; Liu, Yongmei; Lophatananon, Artitaya; Luan, Jian'an; Lubitz, Steven A.; Lyytikainen, Leo-Pekka; Mackey, David A.; Madden, Pamela A. F.; Manning, Alisa K.; Mannisto, Satu; Marenne, Gaelle; Marten, Jonathan; Martin, Nicholas G.; Mazul, Angela L.; Meidtner, Karina; Metspalu, Andres; Mitchell, Paul; Mohlke, Karen L.; Mook-Kanamori, Dennis O.; Morgan, Anna; Morris, Andrew D.; Morris, Andrew P.; Mueller-Nurasyid, Martina; Munroe, Patricia B.; Nalls, Mike A.; Nauck, Matthias; Nelson, Christopher P.; Nelson, Christopher P.; Neville, Matt; Nielsen, Sune F.; Nikus, Kjell; Njolstad, Pal R.; Nordestgaard, Borge G.; Ntalla, Ioanna; O'Connel, Jeffrey R.; Oksa, Heikki; Loohuis, Loes M. Olde; Ophoff, Roel A.; Owen, Katharine R.; Packard, Chris J.; Padmanabhan, Sandosh; Palmer, Colin N. A.; Pasterkamp, Gerard; Patel, Aniruddh P.; Pattie, Alison; Pedersen, Oluf; Peissig, Peggy L.; Peloso, Gina M.; Pennell, Craig E.; Perola, Markus; Perry, James A.; Perry, John R. B.; Person, Thomas N.; Pirie, Ailith; Polasek, Ozren; Posthuma, Danielle; Raitakari, Olli T.; Rasheed, Asif; Rauramaa, Rainer; Reilly, Dermot F.; Reiner, Alex P.; Renstrom, Frida; Ridker, Paul M.; Rioux, John D.; Robertson, Neil; Robino, Antonietta; Rolandsson, Olov; Rudan, Igor; Ruth, Katherine S.; Saleheen, Danish; Salomaa, Veikko; Samani, Nilesh J.; Sandow, Kevin; Sapkota, Yadav; Sattar, Naveed; Schmidt, Marjanka K.; Schreiner, Pamela J.; Schulze, Matthias B.; Scott, Robert A.; Segura-Lepe, Marcelo P.; Shah, Svati; Sim, Xueling; Sivapalaratnam, Suthesh; Small, Kerrin S.; Smith, Albert Vernon; Smith, Jennifer A.; Southam, Lorraine; Spector, Timothy D.; Speliotes, Elizabeth K.; Starr, John M.; Steinthorsdottir, Valgerdur; Stringham, Heather M.; Stumvoll, Michael; Surendran, Praveen; 't Hart, Leen M.; Tansey, Katherine E.; Tardif, Jean-Claude; Taylor, Kent D.; Teumer, Alexander; Thompson, Deborah J.; Thorsteinsdottir, Unnur; Thuesen, Betina H.; Toenjes, Anke; Tromp, Gerard; Trompet, Stella; Tsafantakis, Emmanouil; Tuomilehto, Jaakko; Tybjaerg-Hansen, Anne; Tyrer, Jonathan P.; Uher, Rudolf; Uitterlinden, Andre G.; Ulivi, Sheila; van der Laan, Sander W.; Van Der Leij, Andries R.; van Duijn, Cornelia M.; van Schoor, Natasja M.; van Setten, Jessica; Varbo, Anette; Varga, Tibor V.; Varma, Rohit; Edwards, Digna R. Velez; Vermeulen, Sita H.; Vestergaard, Henrik; Vitart, Veronique; Vogt, Thomas F.; Vozzi, Diego; Walker, Mark; Wang, Feijie; Wang, Carol A.; Wang, Shuai; Wang, Yiqin; Wareham, Nicholas J.; Warren, Helen R.; Wessel, Jennifer; Willems, Sara M.; Wilson, James G.; Witte, Daniel R.; Woods, Michael O.; Wu, Ying; Yaghootkar, Hanieh; Yao, Jie; Yao, Pang; Yerges-Armstrong, Laura M.; Young, Robin; Zeggini, Eleftheria; Zhan, Xiaowei; Zhang, Weihua; Zhao, Jing Hua; Zhao, Wei; Zhao, Wei; Zheng, He; Zhou, Wei; Rotter, Jerome I.; Boehnke, Michael; Kathiresan, Sekar; McCarthy, Mark I.; Willer, Cristen J.; Stefansson, Kari; Borecki, Ingrid B.; Liu, Dajiang J.; North, Kari E.; Heard-Costa, Nancy L.; Pers, Tune H.; Lindgren, Cecilia M.; Oxvig, Claus; Kutalik, Zoltan; Rivadeneira, Fernando; Loos, Ruth J. F.; Frayling, Timothy M.; Hirschhorn, Joel N.; Deloukas, Panos; Lettre, Guillaume		EPIC-InterAct Consortium; EPIC-CVD Consortium; CHD Exome Consortium; ExomeBP Consortium; T2D-Genes Consortium; GoT2D Genes Consortium; Global Lipids Genetics Consortium; ReproGen Consortium; MAGIC Investigators	Rare and low-frequency coding variants alter human adult height	NATURE			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; GENETIC ARCHITECTURE; INTERLEUKIN-11; MUTATIONS	Height is a highly heritable, classic polygenic trait with approximately 700 common associated variants identified through genome-wide association studies so far. Here, we report 83 height-associated coding variants with lower minor-allele frequencies (in the range of 0.1-4.8%) and effects of up to 2 centimetres per allele (such as those in IHH, STC2, AR and CRISPLD2), greater than ten times the average effect of common variants. In functional follow-up studies, rare height increasing alleles of STC2 (giving an increase of 1-2 centimetres per allele) compromised proteolytic inhibition of PAPP-A and increased cleavage of IGFBP-4 in vitro, resulting in higher bioavailability of insulin-like growth factors. These 83 height-associated variants overlap genes that are mutated in monogenic growth disorders and highlight new biological candidates (such as ADAMTS3, IL11RA and NOX4) and pathways (such as proteoglycan and glycosaminoglycan synthesis) involved in growth. Our results demonstrate that sufficiently large sample sizes can uncover rare and low-frequency variants of moderate-to-large effect associated with polygenic human phenotypes, and that these variants implicate relevant genes and pathways.	[Marouli, Eirini; Stirrups, Kathleen E.; Caulfield, Mark J.; Kanoni, Stavroula; Munroe, Patricia B.; Ntalla, Ioanna; Warren, Helen R.; Deloukas, Panos] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Graff, Mariaelisa; Highland, Heather M.; Justice, Anne E.; Young, Kristin L.; Mazul, Angela L.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Medina-Gomez, Carolina; Ikram, M. Arfan; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Rivadeneira, Fernando] Erasmus Sch Ctr, Dept Epidemiol, NL-3015 GE Rotterdam, Netherlands; [Medina-Gomez, Carolina; Broer, Linda; Uitterlinden, Andre G.; Rivadeneira, Fernando] Erasmus Sch Ctr, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Lo, Ken Sin; Turcot, Valerie; de Denus, Simon; Rioux, John D.; Tardif, Jean-Claude; Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Wood, Andrew R.; Ruth, Katherine S.; Yaghootkar, Hanieh; Frayling, Timothy M.] Univ Exeter, Sch Med, Genet Complex Traits, Exeter EX2 5DW, Devon, England; [Kjaer, Troels R.; Oxvig, Claus] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Fine, Rebecca S.; Esko, Tonu; Rivas, Manuel A.; Vedantam, Sailaja; Chasman, Daniel I.; Patel, Aniruddh P.; Kathiresan, Sekar; Hirschhorn, Joel N.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Fine, Rebecca S.; Vedantam, Sailaja] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Fine, Rebecca S.; Esko, Tonu; Vedantam, Sailaja; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Fine, Rebecca S.; Esko, Tonu; Vedantam, Sailaja; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Lu, Yingchang] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Epidemiol,Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37203 USA; [Lu, Yingchang; Schurmann, Claudia; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Lu, Yingchang; Schurmann, Claudia; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10069 USA; [Highland, Heather M.] Univ Texas Hlth Sci Ctr Houston, Univ Texas Grad Sch Biomed Sci Houston, Univ Texas Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Rueger, Sina; Kutalik, Zoltan] Univ Lausanne Hosp, Inst Social & Prevent Med, CH-1010 Lausanne, Switzerland; [Rueger, Sina; Lamparter, David; Bergmann, Sven; Kutalik, Zoltan] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Thorleifsson, Gudmar; Steinthorsdottir, Valgerdur; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet Amgen Inc, IS-101 Reykjavik, Iceland; [Lamparter, David; Bergmann, Sven] Univ Lausanne, Dept Comp Biol, CH-1011 Lausanne, Switzerland; [Stirrups, Kathleen E.] Univ Cambridge, Dept Hematol, Cambridge CB2 0PT, England; [Winkler, Thomas W.; Gorski, Mathias; Heid, Iris M.] Univ Regensburg, Dept Genet Epidemiol, D-93051 Regensburg, Germany; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Karaderi, Tugce; Mahajan, Anubha; Gan, Wei; Kitajima, Hidetoshi; Morris, Andrew P.; Robertson, Neil; Southam, Lorraine; McCarthy, Mark I.; Lindgren, Cecilia M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Locke, Adam E.; Abecasis, Goncalo; Jackson, Anne U.; Sim, Xueling; Stringham, Heather M.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Locke, Adam E.; Abecasis, Goncalo; Feng, Shuang; Jackson, Anne U.; Sim, Xueling; Stringham, Heather M.; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Locke, Adam E.] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63108 USA; [Masca, Nicholas G. D.; Nelson, Christopher P.; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Masca, Nicholas G. D.; Nelson, Christopher P.; Samani, Nilesh J.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Ng, Maggie C. Y.; Mudgal, Poorva; Bowden, Donald W.; Cox, Amanda J.] Wake Forest Sch Med, Ctr Diabet Res, Winston Salem, NC 27157 USA; [Ng, Maggie C. Y.; Bowden, Donald W.; Cox, Amanda J.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC 27157 USA; [Rivas, Manuel A.] Nuffield Dept Clin Med, Oxford OX3 7BN, England; [Guo, Xiuqing; Chen, Yii-Der Ida; Jia, Yucheng; Liu, Yeheng; Sandow, Kevin; Taylor, Kent D.; Yao, Jie; Rotter, Jerome I.] LABioMed Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Torrance, CA 90502 USA; [Aben, Katja K.] Netherland Comprehens Canc Org, NL-3501 DB Utrecht, Netherlands; [Aben, Katja K.; Galesloot, Tessel E.; Kiemeney, Lambertus A.; Kluivers, Kirsten B.; Vermeulen, Sita H.] Radboud Univ Nijmegen, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Adair, Linda S.; Linneberg, Allan] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Alam, Dewan S.] Ctr Control Chron Dis, Dhaka 1212, Bangladesh; [Albrecht, Eva; Heid, Iris M.; Mueller-Nurasyid, Martina] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Allin, Kristine H.; Appel, Emil V.; Bork-Jensen, Jette; Grarup, Niels; Hansen, Torben; Hollensted, Mette; Pedersen, Oluf; Vestergaard, Henrik; Pers, Tune H.] Univ Copenhagen, Fac Med & Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2100 Copenhagen, Denmark; [Allison, Matthew] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Amouyel, Philippe] INSERM, U1167, F-59019 Lille, France; [Amouyel, Philippe] Inst Pasteur, U1167, F-59019 Lille, France; [Amouyel, Philippe] Univ Lille, U1167, RID AGE Risk Factors & Mol Determinants Aging Rel, F-59019 Lille, France; [Arveiler, Dominique] Univ Strasbourg, Dept Epidemiol & Publ Hlth, F-67085 Strasbourg, France; [Arveiler, Dominique] Univ Hosp Strasbourg, Dept Publ Hlth, F-67081 Strasbourg, France; [Asselbergs, Folkert W.; van Setten, Jessica] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, Utrecht, Netherlands; [Asselbergs, Folkert W.] ICIN Netherland Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands; [Asselbergs, Folkert W.] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London, England; [Auer, Paul L.] Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA; [Balkau, Beverley] INSERM, Ctr Rech Epidemiol & Sante Populat CESP, U1018, Villejuif, France; [Banas, Bernhard; Boeger, Carsten A.; Gorski, Mathias] Univ Hosp Regensburg, Dept Nephrol, D-93042 Regensburg, Germany; [Bang, Lia E.] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Benn, Marianne; Kamstrup, Pia R.; Nielsen, Sune F.; Nordestgaard, Borge G.; Varbo, Anette] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Benn, Marianne; Frikke-Schmidt, Ruth; Jorgensen, Torben; Linneberg, Allan; Nielsen, Sune F.; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne; Varbo, Anette] Univ Copenhagen, Fac Med & Hlth Sci, DK-2200 Copenhagen, Denmark; [Bielak, Lawrence F.; Jhun, Min A.; Kardia, Sharon L. R.; Smith, Jennifer A.; Zhao, Wei] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Gorski, Mathias; Kovacs, Peter; Stumvoll, Michael] Univ Leipzig, IFB Adipos Dis, D-04103 Leipzig, Germany; [Blueher, Matthias; Stumvoll, Michael] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Boeing, Heiner] German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Epidemiol, D-14558 Nuthetal, Germany; [Boerwinkle, Eric; Grove, Megan L.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Bonnycastle, Lori L.; Collins, Francis S.] NHGRI, Med Genom & Metabol Genet Branch, NIH, Bethesda, MD 20892 USA; [Bots, Michiel L.; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bowden, Donald W.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Brandslund, Ivan] Lillebaelt Hosp, Dept Clin Biochem, DK-7100 Vejle, Denmark; [Brandslund, Ivan] Univ Southern Denmark, Inst Reg Hlth Res, DK-5000 Odense, Denmark; [Breen, Gerome] Kings Coll London, Inst Psychiat Psychol & Neurosci, MRC Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; [Breen, Gerome] NIHR Biomed Res Ctr Mental Hlth Maudsley, London SE5 8AF, England; [Brilliant, Murray H.; Peissig, Peggy L.; Person, Thomas N.] Marshfield Clin Res Fdn, Marshfield, WI 54449 USA; [Burt, Amber A.; Jarvik, Gail P.; Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Butterworth, Adam S.; Chowdhury, Rajiv; Danesh, John; Di Angelantonio, Emanuele; Howson, Joanna M. M.; Surendran, Praveen; Young, Robin] Univ Cambridge, Dept Publ Hlth & Primary Care, MRC BHF Cardiovasc Epidemiol Unit, Cambridge CB1 8RN, England; [Butterworth, Adam S.; Danesh, John; Di Angelantonio, Emanuele] Univ Cambridge, NIHR Blood & Transplant Res Unit Donor Hlth Genom, Cambridge CB1 8RN, England; [Carey, David J.; Kuivaniemi, Helena; Tromp, Gerard] Sigfried & Janet Weis Ctr Res, Danville, PA 17822 USA; [Caulfield, Mark J.; Munroe, Patricia B.; Warren, Helen R.] Queen Mary Univ, Barts & London Sch Med & Dent, NIHR Barts Cardiovasc Res Unit, London EC1M 6BQ, England; [Chambers, John C.; Kooner, Jaspal S.; Zhang, Weihua] London North West Healthcare NHS Trust, Ealing Hosp, Dept Cardiol, Middlesex UB1 3HW, England; [Chambers, John C.; Evangelou, Evangelos; Segura-Lepe, Marcelo P.; Zhang, Weihua] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Chambers, John C.; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Healthcare NHS Trust, London W12 0HS, England; [Chasman, Daniel I.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Chasman, Daniel I.; Patel, Aniruddh P.; Ridker, Paul M.; Kathiresan, Sekar] Harvard Med Sch, Boston, MA 02115 USA; [Chasman, Daniel I.; Chu, Audrey Y.; Ridker, Paul M.] Brigham & Womens & Harvard Med Sch, Div Prevent Med, Boston, MA 02115 USA; [Christensen, Cramer] Lillebaelt Hosp, Dept Med, DK-7100 Vejle, Denmark; [Chu, Audrey Y.; Heard-Costa, Nancy L.] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Cocca, Massimiliano] Univ Trieste, Dept Med Surg & Hlth Sci, I-34100 Trieste, Italy; [Cook, James P.; Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3GL, Merseyside, England; [Corley, Janie; Davies, Gail; Deary, Ian J.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Corley, Janie; Davies, Gail; Deary, Ian J.; Pattie, Alison] Univ Edinburgh, Dept Psychol, 7 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland; [Galbany, Jordi Corominas] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Cox, Amanda J.] Griffith Univ, Menzies Hlth Inst Queensland, Southport, Qld, Australia; [Cuellar-Partida, Gabriel] Univ Queensland, Diamantina Inst, Brisbane, Qld 4072, Australia; [Cuellar-Partida, Gabriel; Gordon, Scott D.; Martin, Nicholas G.; Sapkota, Yadav] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Danesh, John; Marenne, Gaelle; Southam, Lorraine; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Danesh, John] Univ Cambridge, Dept Med, Cambridge Escellence, British Heart Fdn, Cambridge CB2 0QQ, England; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Genet, NL-3584 CX Utrecht, Netherlands; [de Borst, Gert J.] Univ Med Ctr Utrecht, Dept Vasc Surg, Div Surg Specialties, NL-3584 CX Utrecht, Netherlands; [de Denus, Simon] Univ Montreal, Fac Pharm, Montreal, PQ H3T 1J4, Canada; [de Groot, Mark C. H.] Univ Med Ctr Utrecht, Div Lab & Pharm, Dept Clin Chem & Haematol, NL-3508 GA Utrecht, Netherlands; [de Groot, Mark C. H.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht Inst Pharmaceut Sci, NL-3508 TB Utrecht, Netherlands; [de Mutsert, Renee; Li-Gao, Ruifang; Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; [Dedoussis, George; Farmaki, Aliki-Eleni] Harokopio Univ, Sch Hlth Sci & Educ, Dept Nutr & Dietet, Athens 17671, Greece; [Demerath, Ellen W.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [den Hollander, Anneke I.; Hoyng, Carel B.] Radbound Univ Med Ctr, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands; [Dennis, Joe G.; Easton, Douglas F.; Thompson, Deborah J.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England; [Drenos, Fotios] UCL, Inst Cardiovasc Sci, London WC1E 6JF, England; [Drenos, Fotios] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Du, Mengmeng] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Du, Mengmeng] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10017 USA; [Dunning, Alison M.; Easton, Douglas F.; Pirie, Ailith; Tyrer, Jonathan P.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England; [Ebeling, Tapani] Oulu Univ Hosp, Dept Med, Oulu 90029, Finland; [Ebeling, Tapani] Univ Oulu, Res Unit Internal Med, FI-90014 Oulu, Finland; [Edwards, Todd L.; Giri, Ayush] Vanderbilt Univ, Vanderbilt Genet Inst, Inst Med & Publ Hlth, Dept Med,Div Epidemiol, Nashville, TN 37203 USA; [Ellinor, Patrick T.; Florez, Jose C.; Huang, Paul L.; Lubitz, Steven A.; Manning, Alisa K.; Patel, Aniruddh P.; Peloso, Gina M.; Sivapalaratnam, Suthesh; Kathiresan, Sekar] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ellinor, Patrick T.; Florez, Jose C.; Lubitz, Steven A.; Manning, Alisa K.; Peloso, Gina M.] Broad Inst, Med & Populat Genet Program, Cambridge, MA 02141 USA; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Evangelou, Evangelos] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Faul, Jessica D.] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI 48104 USA; [Feitosa, Mary F.; Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63108 USA; [Ferrannini, Ele] CNR Inst Clin Physiol, Pisa, Italy; [Ferrannini, Ele] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Ferrario, Marco M.] Univ Insubria, Dept Clin & Expt Med, Res Ctr Epidemiol & Prevent Med, I-21100 Varese, Italy; [Ferrieres, Jean] Toulouse Univ, Sch Med, F-31059 Toulouse, France; [Florez, Jose C.; Manning, Alisa K.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Ford, Ian; Packard, Chris J.; Padmanabhan, Sandosh; Sattar, Naveed; Young, Robin] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; [Fornage, Myriam; Lin, Li-An] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Franks, Paul W.; Renstrom, Frida; Varga, Tibor V.] Lund Univ, Dept Clin Sci, Genet & Mol Epidemiol Unit, SE-20502 Malmo, Sweden; [Franks, Paul W.] Harvard Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Franks, Paul W.] Umea Univ, Med Unit, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden; [Frikke-Schmidt, Ruth; Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Gandin, Ilaria; Gasparini, Paolo; Girotto, Giorgia; Morgan, Anna] Univ Trieste, Dept Med Sci, I-34137 Trieste, Italy; [Gasparini, Paolo; Girotto, Giorgia; Vozzi, Diego] Sidra Med & Res Ctr, Div Expt Genet, Doha 26999, Qatar; [Giedraitis, Vilmantas] Uppsala Univ, Dept Publ Hlth, Geriat, S-75185 Uppsala, Sweden; [Gordon-Larsen, Penny; Harris, Kathleen Mullan] Univ N Carolina, Caroline Populat Ctr, Chapel Hill, NC 27514 USA; [Gordon-Larsen, Penny] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA; [Gudnason, Vilmundur; Smith, Albert Vernon; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Gudnason, Vilmundur; Smith, Albert Vernon] Icelandic Heart Assoc, IS-201 Kopavogur, Iceland; [Gustafsson, Stefan; Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, S-75141 Uppsala, Sweden; [Harris, Kathleen Mullan] Univ N Carolina, Dept Sociol, Chapel Hill, NC 27514 USA; [Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Hattersley, Andrew T.] Univ Exeter, Univ Exeter Med Sch, Exeter EX2 5DW, Devon, England; [Hayward, Caroline; Marten, Jonathan; Vitart, Veronique] Univ Edinburgh, Inst Genet & Mol Med, MRCHGU, Edinburgh EH4 2XU, Midlothian, Scotland; [He, Liang] Duke Univ, Social Sci Res Inst, Biodemog Aging Res Unit, Durham, NC 27708 USA; [He, Liang; Heikkila, Kauko; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, FI-00014 Helsinki, Finland; [Dunning, Alison M.; Heikkila, Kauko; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland FIMM, FI-00014 Helsinki, Finland; [Helgeland, Oyvind; Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Helgeland, Oyvind; Johansson, Stefan; Njolstad, Pal R.] Univ Bergen, Dept Clin Sci, KG Jebson Ctr Diabet Res, N-5020 Bergen, Norway; [Hernesniemi, Jussi] Tampere Univ Hosp, Dept Cardiol, Ctr Heart, FI-33521 Tampere, Finland; [Hernesniemi, Jussi; Lehtimaki, Terho; Lyytikainen, Leo-Pekka] Fimlab Labs, Dept Clin Chem, Tampere 33520, Finland; [Hernesniemi, Jussi; Lehtimaki, Terho; Lyytikainen, Leo-Pekka] Univ Tampere, Sch Med, Dept Clin Chem, Tampere 33014, Finland; [Hewitt, Alex W.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; [Hewitt, Alex W.; Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Vis Sci, Perth, WA 6009, Australia; [Hewitt, Alex W.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Hocking, Lynne J.] Univ Edinburgh, Ctr Genom & Expt Med, Generat Scotland, Edinburgh EH4 2XU, Midlothian, Scotland; [Hocking, Lynne J.] Univ Aberdeen, Div Appl Med, Musculoskeletal Res Programme, Aberdeen AB25 2ZD, Scotland; [Holmen, Oddgeir L.] Norwegian Univ Sci & Technol, NTNU, Dept Publ Hlth, KG Jebsen Ctr Genet Epidemiol, N-7600 Trondheim, Norway; [Hovingh, G. Kees] AMC, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, N-7600 Levanger, Norway; [Ikram, M. Arfan] Erasmus Sch Ctr, Dept Neurol, NL-3015 GE Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus Sch Ctr, Dept Radiol, NL-3015 GE Rotterdam, Netherlands; [Ingelsson, Erik] Stanford Univ, Sch Med, Div Cardiovasc Med, Dept Med, Stanford, CA 94305 USA; [Jansson, Jan-Hakan; Rolandsson, Olov] Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden; [Jansson, Jan-Hakan] Res Unit Skelleftea, SE-93141 Skelleftea, Sweden; [Jarvik, Gail P.] Univ Washington, Dept Genom Sci, Seattle, WA 98195 USA; [Jensen, Gorm B.] Frederiksberg Univ Hosp, Copenhagen City Heart Study, DK-2000 Frederiksberg, Denmark; [Jiang, Xuejuan] Univ Calif Los Angeles, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Jiang, Xuejuan; Varma, Rohit] Univ Southern Calif, Keck Sch Med, Dept Ophthalmol, USC Roski Eye Inst, Los Angeles, CA 90089 USA; [Johansson, Stefan] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Jorgensen, Marit E.] Univ Southern Denmark, Natl Inst Publ Hlth, DK-1353 Copenhagen, Denmark; [Jorgensen, Marit E.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Jorgensen, Torben] Aalborg Hosp, DK-9000 Aalborg, Denmark; [Jorgensen, Torben; Linneberg, Allan; Thuesen, Betina H.] Capital Reg Denmark, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Jousilahti, Pekka; Kaprio, Jaakko; Kontto, Jukka; Lindstrom, Jaana; Mannisto, Satu; Perola, Markus; Salomaa, Veikko; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, FI-00271 Helsinki, Finland; [Jukema, J. Wouter; Trompet, Stella] Leiden Univ Med Ctr, Dept Cardiol, NL-2333 Leiden, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands, NL-2333 Utrecht, Netherlands; [Kahali, Bratati; Speliotes, Elizabeth K.; Zhou, Wei; Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Kahali, Bratati; Speliotes, Elizabeth K.; Zhou, Wei; Willer, Cristen J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kahali, Bratati; Speliotes, Elizabeth K.] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Kahn, Rene S.; Ophoff, Roel A.] Ctr Med Univ Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, NL-3584 CG Utrecht, Netherlands; [Kahonen, Mika] Univ Tampere, Sch Med, Dept Clin Physiol, Tampere 33014, Finland; [Karaleftheri, Maria] Echinos Med Ctr, Echinos, Greece; [Karpe, Fredrik; Neville, Matt; Owen, Katharine R.; Robertson, Neil; McCarthy, Mark I.] Univ Oxford, Radcliffe Dept Med, Oxford Ctr Diabetes Endocrinol & Metab, Oxford OX3 7LE, England; [Karpe, Fredrik; Neville, Matt; Owen, Katharine R.; McCarthy, Mark I.] Oxford Univ Hosp Trust, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LE, England; [Kee, Frank] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth Res, Belfast BT12 6BJ, Antrim, North Ireland; [Keeman, Renske; Schmidt, Marjanka K.] Netherlands Canc Inst, Antoni van Leewenhoek Hosp, NL-1066 CX Amsterdam, Netherlands; [Kocher, Thomas] Univ Med Greifswald, Dept Restorat Dent Periodontol & Endodontol, D-17475 Greifswald, Germany; [Komulainen, Pirjo; Lakka, Timo A.; Manning, Alisa K.; Rauramaa, Rainer] Kuopio Res Inst Exercise Med, Fdn Res Hlth Exercise & Nutr, Kuopio 70100, Finland; [Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Hammersmith Hosp Campus, London W12 0NN, England; [Kooperberg, Charles; Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Kriebel, Jennifer; Meidtner, Karina; Schulze, Matthias B.] German Ctr Diabet Res, D-85764 Munich, Germany; [Kriebel, Jennifer] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Kriebel, Jennifer] Helmholtz Zentrum Munchen German Res Ctr Environm, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Kuivaniemi, Helena] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Biomed Sci, Dept Psychiat, ZA-7505 Tygerberg, Western Cape, South Africa; [Kuivaniemi, Helena] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Biomed Sci, Div Mol Biol & Human Genet, ZA-7505 Tygerberg, Western Cape, South Africa; [Kury, Sebastien] CHU Nantes, Serv Genet Med, F-44093 Nantes, France; [Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio 70210, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [La Bianca, Martina; Robino, Antonietta; Ulivi, Sheila] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34137 Trieste, Italy; [Lakka, Timo A.] Univ Eastern Finland, Inst Biomed & Physiol, Kuopio 70210, Finland; [Lange, Ethan M.; Lange, Leslie A.; Mohlke, Karen L.; Wu, Ying] Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA; [Langefeld, Carl D.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Langefeld, Carl D.] Wake Forest Sch Med, Ctr Publ Hlth Genom, Winston Salem, NC 27157 USA; [Langenberg, Claudia; Luan, Jian'an; Perry, John R. B.; Scott, Robert A.; Wareham, Nicholas J.; Willems, Sara M.; Zhao, Jing Hua] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA 98101 USA; [Larson, Eric B.] Univ Washington, Dept Hlth Serv, Seattle, WA 98101 USA; [Lee, I-Te] Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung 407, Taiwan; [Lee, I-Te] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Lee, I-Te] Chung Shan Med Univ, Sch Med, Taichung 402, Taiwan; [Lewis, Cora E.] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL 35205 USA; [Li, Huaixing; Lin, Xu; Wang, Feijie; Wang, Yiqin; Yao, Pang; Zheng, He] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Lab Nutr & Metab, Shanghai 200031, Peoples R China; [Li, Jin] Stanford Univ, Sch Med, Div Cardiovasc Med, Dept Med, Palo Alto, CA 94305 USA; [Lin, Honghuang; Teumer, Alexander] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Lind, Lars] Uppsala Univ, S-75185 Uppsala, Sweden; [Linneberg, Allan] Rigshosp, Dept Expt Med, DK-2200 Copenhagen, Denmark; [Liu, Yongmei] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27157 USA; [Lophatananon, Artitaya] Warsaw Acad Med & Hosp, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Madden, Pamela A. F.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Meidtner, Karina; Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Mol Epidemiol, D-14558 Nuthetal, Germany; [Mitchell, Paul] Univ Sydney, Ctr Vis Res, Westmead Millennium Inst Med Res, Sydney, NSW 2022, Australia; [Mitchell, Paul] Univ Sydney, Dept Ophthalmol, Sydney, NSW 2022, Australia; [Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, NL-2300 RC Leiden, Netherlands; [Morris, Andrew D.; Polasek, Ozren; Rudan, Igor] Univ Edinburgh, Ctr Global Hlth Res, Ushar Inst Populat Hlth Sci & Informat, Edinburgh EH8 9AG, Midlothian, Scotland; [Mueller-Nurasyid, Martina] Univ Munich, Dept Med 1, D-81377 Munich, Germany; [Mueller-Nurasyid, Martina] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, D-80802 Munich, Germany; [Nalls, Mike A.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Nauck, Matthias] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, D-17475 Greifswald, Germany; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem, D-17475 Greifswald, Germany; [Nauck, Matthias] Univ Med Greifswald, Lab Med, D-17475 Greifswald, Germany; [Nikus, Kjell] Univ Tampere, Tampere Univ Hosp, Dept Cardiol, Ctr Heart, Tampere 33521, Finland; [Nikus, Kjell] Univ Tampere, Sch Med, Tampere 33521, Finland; [O'Connel, Jeffrey R.; Perry, James A.; Yerges-Armstrong, Laura M.] Univ Maryland, Sch Med, Dept Med, Program Personalized Med, Baltimore, MD 21201 USA; [Oksa, Heikki] Tampere Univ Hosp, Dept Med, Tampere 33521, Finland; [Loohuis, Loes M. Olde; Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Palmer, Colin N. A.] Ninewells Hosp & Med Sch, Med Res Inst, Pat Macpherson Ctr Pharmacogenet & Pharmacogenom, Dundee DD1 9SY, Scotland; [Pasterkamp, Gerard] Univ Med Ctr Utrecht, Div Labs & Pharm, Lab Clin Chem & Hematol, NL-3584 CX Utrecht, Netherlands; [van der Laan, Sander W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Lab Expt Cardiol, NL-3584 CX Utrecht, Netherlands; [Pennell, Craig E.; Wang, Carol A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Perola, Markus] Univ Helsinki, Inst Mol Med FIMM, FI-00014 Helsinki, Finland; [Perola, Markus] Univ Helsinki, Diabet & Obes Res Program, FI-00014 Helsinki, Finland; [Perola, Markus] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Polasek, Ozren] Univ Split, Sch Med, Split 21000, Croatia; [Posthuma, Danielle] Vrije Univ Amsterdam, Dept Complex Trait Genet, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands; [Posthuma, Danielle] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Neurosci Campus Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku 20521, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, FIN-20520 Turku, Finland; [Rasheed, Asif; Saleheen, Danish] Ctr Noncommunicable Dis, Karachi, Pakistan; [Rauramaa, Rainer] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, SF-70210 Kuopio, Finland; [Reilly, Dermot F.] MRL Merck & Co Inc, Genet & Pharmacogenom, Boston, MA 02115 USA; [Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Renstrom, Frida] Umea Univ, Dept Biobank Res, SE-90187 Umea, Sweden; [Ridker, Paul M.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Rioux, John D.; Tardif, Jean-Claude; Lettre, Guillaume] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3T 1J4, Canada; [Rolandsson, Olov] Umea Univ, Unit Family Med, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden; [Saleheen, Danish; Zhao, Wei] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Schreiner, Pamela J.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Shah, Svati] Duke Univ, Durham, NC 27703 USA; [Sim, Xueling] Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Sivapalaratnam, Suthesh] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England; [Sivapalaratnam, Suthesh] AMC, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Small, Kerrin S.; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; ['t Hart, Leen M.; van Schoor, Natasja M.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands; ['t Hart, Leen M.] Leiden Univ, Med Ctr, Dept Mol & Cell Biol, NL-2333 ZC Leiden, Netherlands; ['t Hart, Leen M.] Leiden Univ, Med Ctr, Dept Mol Epidemiol, NL-2333 ZC Leiden, Netherlands; [Tansey, Katherine E.] Cardiff Univ, Coll Biomed & Life Sci, Cardiff CF14 4EP, S Glam, Wales; [Tansey, Katherine E.] Univ Bristol, Dept Social & Community Med, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Teumer, Alexander] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Toenjes, Anke] Univ Leipzig, Dept Womens & Child Hlth, Ctr Pediat Res, D-04103 Leipzig, Germany; [Tromp, Gerard] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Biomed Sci, Div Human Genet & Mol Biol, ZA-7505 Tygerberg, Western Cape, South Africa; [Trompet, Stella] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, NL-2333 Leiden, Netherlands; [Tsafantakis, Emmanouil] Anogia Med Ctr, Anogia, Greece; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, A-3500 Krems, Austria; [Tuomilehto, Jaakko] Dasman Diabet Inst, Dasman 15462, Kuwait; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah 21589, Saudi Arabia; [Uher, Rudolf] Dalhousie Univ, Dept Psychiat, Halifax, NS B3H 4R2, Canada; [Van Der Leij, Andries R.] Univ Amsterdam, Dept Brain & Cognit, NL-1018 WS Amsterdam, Netherlands; [Edwards, Digna R. Velez] Vanderbilt Univ, Vanderbilt Genet Inst, Inst Med & Publ Hlth, Dept Obstet & Gynecol, Nashville, TN 37203 USA; [Vogt, Thomas F.] MRL Merck Co Inc, Cardiometab Dis, Kenilworth, NJ 07033 USA; [Walker, Mark] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Wang, Shuai] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Wessel, Jennifer] Indiana Univ, Fairbanks Sch Publ Hlth, Diabet Translat Res Ctr, Dept Epidemiol & Med, Indianapolis, IN 46202 USA; [Wessel, Jennifer] Indiana Univ, Sch Med, Indianapolis, IN 46202 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Witte, Daniel R.] Danish Diabet Acad, DK-5000 Odense, Denmark; [Witte, Daniel R.] Aarhus Univ, Dept Publ Hlth, DK-8000 Aarhus, Denmark; [Woods, Michael O.] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF A1B 3V6, Canada; [Yerges-Armstrong, Laura M.] GlaxoSmithKlein, King Of Prussia, PA 19406 USA; [Zhan, Xiaowei] Univ Texas Southwestern Med Ctr Dallas, Quantitat Biomed Res Ctr, Ctr Genet Host Def, Dept Clin Sci, Dallas, TX 75390 USA; [Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Liu, Dajiang J.] Penn State Univ, Coll Med, Inst Personalized Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA; [North, Kari E.] Dept Epidemiol, Chapel Hill, NC 27514 USA; [North, Kari E.] Carolina Ctr Genome Sci, Chapel Hill, NC 27514 USA; [Heard-Costa, Nancy L.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Pers, Tune H.] Statens Serum Inst, Dept Epidemiol Res, DK-2200 Copenhagen, Denmark; [Lindgren, Cecilia M.] Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford OX3 7BN, England; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10069 USA; [Hirschhorn, Joel N.] Harvard Med Sch, Dept Pediat & Genet, Boston, MA 02115 USA; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21589, Saudi Arabia	University of London; Queen Mary University London; University of North Carolina; University of North Carolina Chapel Hill; Erasmus University Rotterdam; Erasmus University Rotterdam; Universite de Montreal; University of Exeter; Aarhus University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Vanderbilt University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; University of Lausanne; University of Cambridge; University of Regensburg; University of Tartu; University of Oxford; Wellcome Centre for Human Genetics; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Washington University (WUSTL); University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Wake Forest University; Wake Forest University; University of Oxford; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Radboud University Nijmegen; University of North Carolina; University of North Carolina Chapel Hill; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Novo Nordisk Foundation; University of Copenhagen; University of California System; University of California San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Utrecht University; Utrecht University Medical Center; University of London; University College London; University of Wisconsin System; University of Wisconsin Milwaukee; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Regensburg; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Michigan System; University of Michigan; Leipzig University; Leipzig University; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Utrecht University; Utrecht University Medical Center; Wake Forest University; University of Southern Denmark; University of London; King's College London; University of Washington; University of Washington Seattle; University of Cambridge; University of Cambridge; University of London; Queen Mary University London; Imperial College London; Imperial College London; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Trieste; University of Liverpool; University of Edinburgh; University of Edinburgh; Radboud University Nijmegen; Griffith University; University of Queensland; QIMR Berghofer Medical Research Institute; Wellcome Trust Sanger Institute; University of Cambridge; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Universite de Montreal; Utrecht University; Utrecht University Medical Center; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harokopio University Athens; University of Minnesota System; University of Minnesota Twin Cities; Radboud University Nijmegen; University of Cambridge; University of London; University College London; University of Bristol; Fred Hutchinson Cancer Center; Memorial Sloan Kettering Cancer Center; University of Cambridge; University of Oulu; University of Oulu; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Imperial College London; University of Ioannina; University of Michigan System; University of Michigan; Washington University (WUSTL); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Pisa; University of Insubria; Universite de Franche-Comte; Universite Federale Toulouse Midi-Pyrenees (ComUE); Harvard University; Harvard Medical School; University of Glasgow; University of Texas System; University of Texas Health Science Center Houston; Lund University; Harvard University; Harvard T.H. Chan School of Public Health; Rigshospitalet; University of Copenhagen; University of Trieste; Sidra Medical & Research Center; Uppsala University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Iceland; Icelandic Heart Association; Uppsala University; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Exeter; University of Edinburgh; Duke University; University of Helsinki; University of Helsinki; University of Bergen; Haukeland University Hospital; University of Bergen; Tampere University; Tampere University Hospital; Tampere University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Lions Eye Institute; University of Western Australia; University of Tasmania; University of Edinburgh; University of Aberdeen; Norwegian University of Science & Technology (NTNU); University of Amsterdam; Academic Medical Center Amsterdam; Norwegian University of Science & Technology (NTNU); Erasmus University Rotterdam; Erasmus University Rotterdam; Stanford University; Umea University; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of Southern California; University of Bergen; Haukeland University Hospital; University of Southern Denmark; Steno Diabetes Center; Aalborg University; Aalborg University Hospital; Finland National Institute for Health & Welfare; Leiden University; Leiden University Medical Center (LUMC); Interuniversity Cardiology Institute of the Netherlands; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Utrecht University; Utrecht University Medical Center; Tampere University; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Queens University Belfast; Netherlands Cancer Institute; Greifswald Medical School; Imperial College London; Fred Hutchinson Cancer Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Stellenbosch University; Stellenbosch University; Nantes Universite; CHU de Nantes; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; IRCCS Burlo Garofolo; University of Eastern Finland; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest University; University of Washington; University of Washington Seattle; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University; University of Alabama System; University of Alabama Birmingham; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Stanford University; Boston University; Uppsala University; Rigshospitalet; University of Copenhagen; Wake Forest University; University of Warwick; Washington University (WUSTL); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Sydney; University of Sydney; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Edinburgh; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); German Centre for Cardiovascular Research; Greifswald Medical School; Greifswald Medical School; Tampere University; Tampere University Hospital; Tampere University; University System of Maryland; University of Maryland Baltimore; Tampere University; Tampere University Hospital; University of California System; University of California Los Angeles; University of Dundee; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Western Australia; University of Helsinki; University of Helsinki; University of Tartu; University of Split; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Turku; University of Turku; Kuopio University Hospital; University of Eastern Finland; University of Washington; University of Washington Seattle; Umea University; Harvard University; Brigham & Women's Hospital; Universite de Montreal; Umea University; University of Pennsylvania; Pennsylvania Medicine; University of Minnesota System; University of Minnesota Twin Cities; Duke University; National University of Singapore; University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam; University of London; King's College London; University of Edinburgh; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Cardiff University; University of Bristol; Greifswald Medical School; Leipzig University; Stellenbosch University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Danube University Krems; King Abdulaziz University; Dalhousie University; University of Amsterdam; Vanderbilt University; Newcastle University - UK; Boston University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Mississippi; University of Mississippi Medical Center; Aarhus University; Memorial University Newfoundland; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Boston University; Statens Serum Institut; University of Oxford; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; King Abdulaziz University	Deloukas, P (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England.; Lettre, G (corresponding author), Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada.; Hirschhorn, JN (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Hirschhorn, JN (corresponding author), Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA.; Hirschhorn, JN (corresponding author), Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA.; Lettre, G (corresponding author), Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3T 1J4, Canada.; Hirschhorn, JN (corresponding author), Harvard Med Sch, Dept Pediat & Genet, Boston, MA 02115 USA.; Deloukas, P (corresponding author), King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21589, Saudi Arabia.	joelh@broadinstitute.org; p.deloukas@qmul.ac.uk; guillaume.lettre@umontreal.ca	Raitakari, Olli/AAQ-7389-2021; Nordestgaard, Borge Gronne/ABF-1310-2020; Kaprio, Jaakko/A-1820-2008; Tromp, Gerard/B-2677-2017; Ruth, Katherine/K-2745-2019; Kiemeney, Lambertus A./D-3357-2009; Gudnason, Vilmundur/AAE-7126-2019; Kuivaniemi, Helena/Q-8178-2019; de Groot, Mark CH/A-9891-2012; Jørgensen, Torben/Z-1335-2018; Hollander, Anneke den/N-4911-2014; Franks, Paul/AAA-3300-2020; Teumer, Alexander/S-7438-2019; Kanoni, Stavroula/AAN-7161-2021; Stefansson, Kari/AAE-7187-2019; Benn, Marianne/O-4164-2019; Rudan, Igor/I-1467-2012; Pedersen, Oluf/Z-1731-2019; Rivas, Manuel/ABE-8173-2020; Polasek, Ozren/B-6002-2011; Chowdhury, Rajiv/AHB-1253-2022; Breen, Gerome/Y-2706-2019; Ferrario, Marco M./ABH-2115-2021; Palmer, Colin NA/C-7053-2008; Hernesniemi, Jussi/ABH-1842-2021; Locke, Adam/K-2000-2019; Wood, Andrew R/AAB-3807-2019; Rioux, John D/A-9599-2015; van der Laan, Sander W./N-1330-2019; Pennell, Craig/ABD-6902-2020; Allin, Kristine Højgaard/ABG-3463-2021; Karaderi, Tugce/W-8729-2019; Heikkilä, Kauko/E-5578-2019; Ikram, M. Arfan/AAM-5225-2021; Deary, Ian J/C-6297-2009; Evangelou, Evangelos/C-3033-2013; Tansey, Katherine E/B-1033-2013; Mitchell, Paul/P-1498-2014; Hveem, Kristian/AFV-4683-2022; KÜRY, Sébastien/G-5971-2015; Mackey, David A/H-5340-2014; Smith, Albert Vernon/AHC-3838-2022; Witte, Daniel/AAF-9535-2019; DiAngelantonio, Emanuele/ABE-6852-2020; Gandin, Ilaria/B-2634-2017; Pedersen, Oluf/AAG-8015-2020; Loos, Ruth J F/Q-2862-2016; Lin, Honghuang/A-3269-2019; Sim, Xueling/AAZ-6652-2020; Lin, LiAn/C-5819-2017; Li-Gao, Ruifang/B-7172-2018; Rotter, Jerome/AAY-6598-2021; Young, Kristin/Q-6908-2019; Müller-Nurasyid, Martina/I-8735-2018; zhang, weihua/GXV-1334-2022; Galesloot, Tessel/P-6667-2015; Cocca, Massimiliano/J-2951-2018; Vermeulen, Sita H./L-4716-2015; Aben, Katja KH/G-9686-2016; Kutalik, Zoltan/HHZ-5697-2022; Varga, Tibor/AAE-8035-2020; Rivadeneira, Fernando/O-5385-2015; Schmidt, Marjanka K/G-9058-2011; Medina-Gomez, Carolina/I-1725-2019; Nikus, Kjell/K-7813-2019; Lehtimäki, Terho/AAD-1094-2022; Ford, Ian/ABE-6145-2020; Dedoussis, George/AAN-7252-2021; Kriebel, Jennifer/N-4782-2017; Breen, Gerome D/A-5540-2010; Manning, Alisa Knodle/ABC-7711-2021; Uher, Rudolf/A-5477-2008; Kluivers, K.B./L-4439-2015; Mazul, Angela/J-8357-2019; Stumvoll, Michael/ABE-1121-2021; Lewis, Cora Elizabeth/ABE-6435-2020; Langenberg, Claudia/ABG-9067-2021; Schurmann, Claudia/L-1204-2016; Auer, Paul/AAC-5060-2019; Johansson, Stefan/C-4394-2011; Partida, Gabriel Cuellar/C-6686-2017; Asselbergs, Folkert W./ABD-6752-2021; 't Hart, Leen/ABG-3185-2021; Loos, Ruth/GON-5877-2022; Jukema, J. Wouter/ABD-6503-2021; Morgan, Anna/K-2238-2018; Grarup, Niels/K-2807-2015; Feitosa, Mary F/K-8044-2012; Study, GoDARTS/K-9448-2016; Marenne, Gaelle/AAU-8338-2020; Schulze, Matthias B/AAH-6906-2021; Dina, Christian R/D-3535-2015; Gasparini, Paolo/B-6173-2014; McCarthy, Mark/M-3763-2015; Girotto, Giorgia/I-9452-2018; Ferrieres, Jean/S-7993-2016; Robino, Antonietta/K-9398-2016; Sapkota, Yadav/O-2142-2015	Kaprio, Jaakko/0000-0002-3716-2455; Tromp, Gerard/0000-0002-7761-0806; Ruth, Katherine/0000-0003-4966-9170; Kiemeney, Lambertus A./0000-0002-2368-1326; Gudnason, Vilmundur/0000-0001-5696-0084; Kuivaniemi, Helena/0000-0001-5753-8766; de Groot, Mark CH/0000-0002-5764-5788; Teumer, Alexander/0000-0002-8309-094X; Kanoni, Stavroula/0000-0002-1691-9615; Benn, Marianne/0000-0002-1701-595X; Rudan, Igor/0000-0001-6993-6884; Pedersen, Oluf/0000-0002-3321-3972; Rivas, Manuel/0000-0003-1457-9925; Polasek, Ozren/0000-0002-5765-1862; Breen, Gerome/0000-0003-2053-1792; Palmer, Colin NA/0000-0002-6415-6560; Hernesniemi, Jussi/0000-0002-8111-6421; Locke, Adam/0000-0001-6227-198X; Wood, Andrew R/0000-0003-1726-948X; Rioux, John D/0000-0001-7560-8326; van der Laan, Sander W./0000-0001-6888-1404; Pennell, Craig/0000-0002-0937-6165; Karaderi, Tugce/0000-0001-9763-8139; Heikkilä, Kauko/0000-0002-9256-8028; Deary, Ian J/0000-0002-1733-263X; Evangelou, Evangelos/0000-0002-5488-2999; Tansey, Katherine E/0000-0002-9663-3376; KÜRY, Sébastien/0000-0001-5497-0465; Mackey, David A/0000-0001-7914-4709; Smith, Albert Vernon/0000-0003-1942-5845; Witte, Daniel/0000-0002-0769-2922; Gandin, Ilaria/0000-0003-3196-2491; Loos, Ruth J F/0000-0002-8532-5087; Lin, Honghuang/0000-0003-3043-3942; Sim, Xueling/0000-0002-1233-7642; Lin, LiAn/0000-0003-2731-1346; Li-Gao, Ruifang/0000-0003-0650-1351; Müller-Nurasyid, Martina/0000-0003-3793-5910; Galesloot, Tessel/0000-0002-2717-3679; Cocca, Massimiliano/0000-0002-1127-7596; Vermeulen, Sita H./0000-0003-4913-8601; Aben, Katja KH/0000-0002-0214-2147; Kutalik, Zoltan/0000-0001-8285-7523; Rivadeneira, Fernando/0000-0001-9435-9441; Schmidt, Marjanka K/0000-0002-2228-429X; Medina-Gomez, Carolina/0000-0001-7999-5538; Lehtimäki, Terho/0000-0002-2555-4427; Dedoussis, George/0000-0002-7798-6221; Kriebel, Jennifer/0000-0003-4270-018X; Breen, Gerome D/0000-0003-2053-1792; Uher, Rudolf/0000-0002-2998-0546; Kluivers, K.B./0000-0002-4681-4304; Mazul, Angela/0000-0002-1249-4613; Stumvoll, Michael/0000-0001-6225-8240; Lewis, Cora Elizabeth/0000-0002-2301-5796; Langenberg, Claudia/0000-0002-5017-7344; Schurmann, Claudia/0000-0003-4158-9192; Johansson, Stefan/0000-0002-2298-7008; Partida, Gabriel Cuellar/0000-0001-7648-4097; Asselbergs, Folkert W./0000-0002-1692-8669; 't Hart, Leen/0000-0003-4401-2938; Jukema, J. Wouter/0000-0002-3246-8359; Morgan, Anna/0000-0001-6290-445X; Grarup, Niels/0000-0001-5526-1070; Feitosa, Mary F/0000-0002-0933-2410; Marenne, Gaelle/0000-0002-4363-7170; Schulze, Matthias B/0000-0002-0830-5277; Dina, Christian R/0000-0002-7722-7348; Nordestgaard, Borge/0000-0002-1954-7220; He, Liang/0000-0001-6711-2021; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Lindstrom, Jaana/0000-0001-9255-020X; Brandslund, Ivan/0000-0002-4203-5442; Franks, Paul/0000-0002-0520-7604; Van Duijn, Cornelia/0000-0002-2374-9204; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Gordon, Scott/0000-0001-7623-328X; Allison, Matthew/0000-0003-0777-8272; Ferrario, Marco M/0000-0003-2741-7124; Allin, Kristine Hojgaard/0000-0002-6880-5759; Howson, Joanna/0000-0001-7618-0050; Thuesen, Betina/0000-0001-9772-4344; Elliott, Paul/0000-0002-7511-5684; Gasparini, Paolo/0000-0002-0859-0856; Frayling, Timothy/0000-0001-8362-2603; Huang, Paul/0000-0002-5436-8658; Ebeling, Tapani/0000-0003-0323-8893; Ellinor, Patrick/0000-0002-2067-0533; Mahajan, Anubha/0000-0001-5585-3420; Vestergaard, Henrik/0000-0003-3090-269X; Justice, Anne/0000-0002-8903-8712; Venkatasubramanian, Siddharth/0000-0002-5860-0768; McCarthy, Mark/0000-0002-4393-0510; Marouli, Eirini/0000-0001-6179-1609; Heard-Costa, Nancy/0000-0001-9730-0306; Linneberg, Allan/0000-0002-0994-0184; Hattersley, Andrew/0000-0001-5620-473X; Vitart, Veronique/0000-0002-4991-3797; Demerath, Ellen/0000-0002-4585-4064; Girotto, Giorgia/0000-0003-4507-6589; Wessel, Jennifer/0000-0002-7031-0085; Hansen, Torben/0000-0001-8748-3831; Faul, Jessica/0000-0002-6969-6478; Ewing, Ailith/0000-0002-2272-1277; Kahonen, Mika/0000-0002-4510-7341; Padmanabhan, Sandosh/0000-0003-3869-5808; Deloukas, Panos/0000-0001-9251-070X; Kontto, Jukka/0000-0003-3899-9852; Posthuma, Danielle/0000-0001-7582-2365; V. Varga, Tibor/0000-0002-2383-699X; Zhao, Wei/0000-0002-8301-9297; Smith, Jennifer Ann/0000-0002-3575-5468; Broer, Linda/0000-0003-0011-123X; Patel, Aniruddh/0000-0001-7871-9638; Ferrieres, Jean/0000-0001-6144-1297; Kahali, Bratati/0000-0003-2523-3778; Schreiner, Pamela/0000-0002-9920-6257; Pers, Tune/0000-0003-0207-4831; Robino, Antonietta/0000-0003-2152-2353; Fine, Rebecca/0000-0002-5972-4682; Marten, Jonathan/0000-0001-6916-2014; Bergmann, Sven/0000-0002-6785-9034; Butterworth, Adam/0000-0002-6915-9015; van Schoor, Natasja/0000-0002-0870-0795; Small, Kerrin/0000-0003-4566-0005; Wang, Carol/0000-0002-4301-3974; Caulfield, Mark/0000-0001-9295-3594; , Hanieh/0000-0001-9672-9477; Banas, Bernhard/0000-0003-2076-2195; Di Angelantonio, Emanuele/0000-0001-8776-6719; Kjaer, Troels Ronn/0000-0002-1668-1440; Hewitt, Alex/0000-0002-5123-5999; Hollensted, Mette/0000-0001-5572-3183; Liu, Dajiang/0000-0001-6553-858X; Kovacs, Peter/0000-0002-0290-5423; Amouyel, Philippe/0000-0001-9088-234X; Gan, Wei/0000-0002-1270-6495; Jorgensen, Marit Eika/0000-0001-8356-5565; Drenos, Fotios/0000-0003-2469-5516; Wang, Yiqin/0000-0003-4714-774X; Sapkota, Yadav/0000-0001-5943-9454; Lindgren, Cecilia/0000-0002-4903-9374; Oxvig, Claus/0000-0002-4715-9719; Jorgensen, Torben/0000-0001-9453-2830	BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [MC_PC_U127561128, G0601966, MR/L01341X/1, MR/L003120/1, G0600237, MR/M501633/2, MC_UU_12015/1, G0700931, MR/K002414/1, MC_UU_12015/2, MR/K007017/1, MR/L01632X/1, MC_UU_12013/3] Funding Source: UKRI; Lundbeck Foundation [R190-2014-3904] Funding Source: researchfish; Medical Research Council [1233641] Funding Source: researchfish; National Institute for Health Research [NF-SI-0616-10080, NF-SI-0611-10099, NF-SI-0611-10136, NF-SI-0512-10165, NF-SI-0611-10219, NF-SI-0512-10113] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF16OC0021496] Funding Source: researchfish; Wellcome Trust [098395/Z/12/Z] Funding Source: researchfish; Steno Diabetes Center Copenhagen (SDCC) [SDCC 3.A Complications] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: Medline; British Heart Foundation [SP/13/2/30111, RG/14/5/30893, RG/08/014/24067] Funding Source: Medline; Doris Duke Charitable Foundation [2014105] Funding Source: Medline; Medical Research Council [G0601966, MC_UU_12015/2, G0700931, MC_PC_U127561128, MC_UU_12015/1, MC_UU_12013/3, MR/K026992/1, MR/L01632X/1, MR/K007017/1, G9815508, G0700704, MR/K006584/1, MC_PC_15018, MR/L01341X/1, MR/L003120/1, MR/M501633/1, MR/K002414/1, MR/M501633/2, MC_PC_13040, G0600237] Funding Source: Medline; NCATS NIH HHS [UL1 TR000124, KL2 TR001109, UL1 TR001881] Funding Source: Medline; NCI NIH HHS [UM1 CA182913, P30 CA008748] Funding Source: Medline; NEI NIH HHS [R01 EY022310] Funding Source: Medline; NHGRI NIH HHS [U01 HG008657, U01 HG007417] Funding Source: Medline; NHLBI NIH HHS [K99 HL130580, R01 HL117078, K23 HL114724, R01 HL119443, T32 HL007055, R01 HL127564, HHSN268201100046C, N01 HC095159, R35 HL135824, HHSN268201300046C] Funding Source: Medline; NICHD NIH HHS [P2C HD050924, R01 HD057194] Funding Source: Medline; NIDDK NIH HHS [R01 DK107904, P30 DK063491, R01 DK075787, R01 DK106621, U01 DK062370, R01 DK089256, R01 DK072193, P30 DK020572, DP3 DK108220, R01 DK093757] Funding Source: Medline; NIGMS NIH HHS [T32 GM096911] Funding Source: Medline; NIH HHS [S10 OD018522] Funding Source: Medline; NIMH NIH HHS [R01 MH090553] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057194, P2CHD050924] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [UM1CA182913, T32CA009156, P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881, KL2TR001109, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022310] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL130580, R01HL127564, K23HL114724, R35HL135824, R01HL117078, R01HL119443, T32HL007055] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007417, U01HG008657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106621, P30DK063491, R01DK075787, P30DK020572, R01DK072193, R01DK093757, U01DK062370, R01DK107904, DP3DK108220, R01DK089256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM096911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006000] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Steno Diabetes Center Copenhagen (SDCC); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Danjou F, 2015, NAT GENET, V47, P1264, DOI 10.1038/ng.3307; Dauber A, 2016, EMBO MOL MED, V8, P363, DOI 10.15252/emmm.201506106; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Ito H, 2001, J BIOL CHEM, V276, P24023, DOI 10.1074/jbc.M100861200; Jepsen MR, 2015, J BIOL CHEM, V290, P3430, DOI 10.1074/jbc.M114.611665; Karaplis AC, 1998, ENDOCRINOLOGY, V139, P5255, DOI 10.1210/en.139.12.5255; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lamparter D, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004714; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Mastaitis J, 2015, ENDOCRINOLOGY, V156, P4502, DOI 10.1210/en.2015-1257; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Schwartz NB, 2002, GLYCOBIOLOGY, V12, p57R, DOI 10.1093/glycob/12.4.57R; Sidore C, 2015, NAT GENET, V47, P1272, DOI 10.1038/ng.3368; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Sims NA, 2005, J BONE MINER RES, V20, P1093, DOI 10.1359/JBMR.050209; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Takeuchi Y, 2002, J BIOL CHEM, V277, P49011, DOI 10.1074/jbc.M207804200; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Wakahara T, 2007, DEV BIOL, V303, P527, DOI 10.1016/j.ydbio.2006.11.041; Wei HS, 2013, INT J MOL SCI, V14, P21435, DOI 10.3390/ijms141121435; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	29	337	346	10	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					186	190		10.1038/nature21039	http://dx.doi.org/10.1038/nature21039			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28146470	Green Submitted, Green Accepted			2022-12-28	WOS:000393737500031
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Charging patients won't solve the NHS's problems	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Brook RH, 1984, EFFECT COINSURANCE H; Cooper C., 2013, INDEPENDENT; Corrie C, 2014, CASE GP CHARGES; Duffin C, 2013, PULSE, V356; Meikle J, 2015, GUARDIAN; O'Reilly Dermot, 2007, Eur J Gen Pract, V13, P231, DOI 10.1080/13814780701815082; Walker M, 2017, GUARDIAN	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2017	356								j611	10.1136/bmj.j611	http://dx.doi.org/10.1136/bmj.j611			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FU	28167636	Bronze, Green Published			2022-12-28	WOS:000394577900007
J	Gruneberg, U; Barr, F				Gruneberg, Ulrike; Barr, Francis			Organelle inheritance-what players have skin in the game?	SCIENCE			English	Editorial Material							AURORA-A; SPINDLE ORIENTATION; ENTRY		[Gruneberg, Ulrike] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Barr, Francis] Univ Oxford, Dept Biochem, Oxford, England	University of Oxford; University of Oxford	Gruneberg, U (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England.	ulrike.gruneberg@path.ox.ac.uk; francis.barr@bioch.ox.ac.uk	Gruneberg, Ulrike/AAY-2351-2020	Gruneberg, Ulrike/0000-0001-8344-0500	Medical Research Council [MR/K006703/1] Funding Source: Medline; MRC [MR/K006703/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asare A, 2017, SCIENCE, V355, DOI 10.1126/science.aah4701; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; di Pietro F, 2016, EMBO REP, V17, P1106, DOI 10.15252/embr.201642292; Gallini S, 2016, CURR BIOL, V26, P458, DOI 10.1016/j.cub.2015.12.051; Guizzunti G, 2016, P NATL ACAD SCI USA, V113, pE6590, DOI 10.1073/pnas.1610844113; Li XL, 2002, MOL CELL BIOL, V22, P4358, DOI 10.1128/MCB.22.12.4358-4365.2002; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Persico A, 2010, MOL BIOL CELL, V21, P3708, DOI 10.1091/mbc.E10-03-0243; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Wei JH, 2015, CELL, V162, P287, DOI 10.1016/j.cell.2015.06.014	10	2	2	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					459	460		10.1126/science.aam5981	http://dx.doi.org/10.1126/science.aam5981			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154036	Green Submitted			2022-12-28	WOS:000393183100020
J	Urry, CM				Urry, C. Megan			Vera Cooper Rubin (1928-2016)	SCIENCE			English	Biographical-Item									[Urry, C. Megan] Yale Univ, Yale Ctr Astron & Phys, New Haven, CT 06520 USA	Yale University	Urry, CM (corresponding author), Yale Univ, Yale Ctr Astron & Phys, New Haven, CT 06520 USA.	meg.urry@yale.edu	Urry, Meg/G-7381-2011	Urry, Meg/0000-0002-0745-9792				RUBIN VC, PUBLICATION LIST	1	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					462	462		10.1126/science.aam7920	http://dx.doi.org/10.1126/science.aam7920			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154038				2022-12-28	WOS:000393183100022
J	Horton, R				Horton, Richard			Offline: A new Berlin Declaration for STM publishing	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					350	350						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	28137683	Bronze			2022-12-28	WOS:000392804700014
J	Escobar, H				Escobar, Herton			SCIENTIFIC COMMUNITY Brazil's 'doomsday' scenario Grants in Rio go unpaid as science coffers are raided	SCIENCE			English	News Item																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					334	334		10.1126/science.355.6323.334	http://dx.doi.org/10.1126/science.355.6323.334			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126762				2022-12-28	WOS:000393172800011
J	Sinha, R; Hoon, M; Baudin, J; Okawa, H; Wong, ROL; Rieke, F				Sinha, Raunak; Hoon, Mrinalini; Baudin, Jacob; Okawa, Haruhisa; Wong, Rachel O. L.; Rieke, Fred			Cellular and Circuit Mechanisms Shaping the Perceptual Properties of the Primate Fovea	CELL			English	Article							RETINAL GANGLION-CELLS; MACAQUE MONKEY RETINA; MODULATION SENSITIVITY; IMMUNOCYTOCHEMICAL LOCALIZATION; FUNCTIONAL ARCHITECTURE; INHIBITION SHAPES; PERIPHERAL RETINA; RECEPTIVE-FIELD; AMACRINE CELLS; CONE VISION	The fovea is a specialized region of the retina that dominates the visual perception of primates by providing high chromatic and spatial acuity. While the foveal and peripheral retina share a similar core circuit architecture, they exhibit profound functional differences whose mechanisms are unknown. Using intracellular recordings and structure-function analyses, we examined the cellular and synaptic underpinnings of the primate fovea. Compared to peripheral vision, the fovea displays decreased sensitivity to rapid variations in light inputs; this difference is reflected in the responses of ganglion cells, the output cells of the retina. Surprisingly, and unlike in the periphery, synaptic inhibition minimally shaped the responses of foveal midget ganglion cells. This difference in inhibition cannot however, explain the differences in the temporal sensitivity of foveal and peripheral midget ganglion cells. Instead, foveal cone photoreceptors themselves exhibited slower light responses than peripheral cones, unexpectedly linking cone signals to perceptual sensitivity.	[Sinha, Raunak; Baudin, Jacob; Rieke, Fred] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Sinha, Raunak; Baudin, Jacob; Rieke, Fred] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Hoon, Mrinalini; Okawa, Haruhisa; Wong, Rachel O. L.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sinha, R; Rieke, F (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.; Sinha, R; Rieke, F (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.; Hoon, M (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	rsinha@uw.edu; mhoon@uw.edu; rieke@uw.edu		Baudin, Jacob/0000-0001-5233-7084	Human Frontier Science Foundation; Knights Templar Eye Foundation; Simons Foundation [324759]; ARCS foundation; HHMI; NIH [EY026070, EY11850, EY10699]; NATIONAL EYE INSTITUTE [R01EY010699, R01EY011850, K99EY026070, P30EY001730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266, R01GM056800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA032436] Funding Source: NIH RePORTER	Human Frontier Science Foundation(Human Frontier Science Program); Knights Templar Eye Foundation; Simons Foundation; ARCS foundation; HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank E.J. Chichilnisky, G. Horwitz, G.D. Field and J.M. Angueyra for helpful comments. We thank C. Puller for helpful discussions and suggestions. We thank R. Enz and H. Wassle for the GABAC antibody, T. Jacob for the GABA<INF>A</INF>alpha 1-fluorescent protein construct and T. Yoshimatsu for generating the GABA<INF>A</INF>alpha 1-YFP fusion construct. We thank M. Cafaro, S. Cunnington, and P. Newman for excellent technical assistance. This work is supported by the Human Frontier Science Foundation (long-term fellowship to R.S.), Knights Templar Eye Foundation (career starter grant to M.H.), Simons Foundation (324759 to F.R.), ARCS foundation (J.B.), HHMI (F.R.) and NIH grants (EY026070 to R.S., EY11850 to F.R. and EY10699 to R.O.W.).	Abbott CJ, 2012, VISUAL NEUROSCI, V29, P157, DOI 10.1017/S095252381200017X; Angueyra JM, 2013, NAT NEUROSCI, V16, P1692, DOI 10.1038/nn.3534; Baccus SA, 2008, J NEUROSCI, V28, P6807, DOI 10.1523/JNEUROSCI.4206-07.2008; Barrow AJ, 2009, J NEUROSCI, V29, P5841, DOI 10.1523/JNEUROSCI.5746-08.2009; BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; Ben-Ari Y, 2014, NEUROSCIENCE, V279, P187, DOI 10.1016/j.neuroscience.2014.08.001; Benardete EA, 1999, J PHYSIOL-LONDON, V519, P775, DOI 10.1111/j.1469-7793.1999.0775n.x; Benardete EA, 1999, VISUAL NEUROSCI, V16, P355, DOI 10.1017/S0952523899162151; Bischofberger J, 2006, PFLUG ARCH EUR J PHY, V453, P361, DOI 10.1007/s00424-006-0093-2; Buldyrev I, 2013, J PHYSIOL-LONDON, V591, P303, DOI 10.1113/jphysiol.2012.243113; Cafaro J, 2013, J NEUROSCI, V33, P6310, DOI 10.1523/JNEUROSCI.4964-12.2013; Cafaro J, 2010, NATURE, V468, P964, DOI 10.1038/nature09570; Calkins DJ, 2007, J NEUROSCI, V27, P2646, DOI 10.1523/JNEUROSCI.4739-06.2007; Calkins DJ, 1996, NATURE, V381, P613, DOI 10.1038/381613a0; CALKINS DJ, 1994, NATURE, V371, P70, DOI 10.1038/371070a0; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Connolly CN, 1996, P NATL ACAD SCI USA, V93, P9899, DOI 10.1073/pnas.93.18.9899; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P167, DOI 10.1113/jphysiol.1975.sp011086; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Endeman D, 2012, J PHYSIOL-LONDON, V590, P5581, DOI 10.1113/jphysiol.2012.240325; Enz R, 1996, J NEUROSCI, V16, P4479; Farrow K, 2013, NEURON, V78, P325, DOI 10.1016/j.neuron.2013.02.014; Fino E, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.002.2009; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; GRUNERT U, 1993, VISION RES, V33, P1, DOI 10.1016/0042-6989(93)90052-X; Hecht S, 1933, J GEN PHYSIOL, V17, P251, DOI 10.1085/jgp.17.2.251; Hendrickson AE, 1996, PERSPECT DEV NEUROBI, V3, P195; HENDRICKSON AE, 1994, INVEST OPHTH VIS SCI, V35, P3129; Hoon M, 2014, PROG RETIN EYE RES, V42, P44, DOI 10.1016/j.preteyeres.2014.06.003; Hornstein E. P., 2005, INVEST OPHTH VIS SCI, V46; Hornstein EP, 2005, J NEUROSCI, V25, P11201, DOI 10.1523/JNEUROSCI.3416-05.2005; Hsu A, 1998, VISION RES, V38, P2539, DOI 10.1016/S0042-6989(97)00370-2; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jadzinsky PD, 2013, ANNU REV NEUROSCI, V36, P403, DOI 10.1146/annurev-neuro-062012-170315; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; Kaplan E, 2001, PROG BRAIN RES, V134, P17; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; Kolb H, 2003, DOC OPHTHALMOL, V106, P67, DOI 10.1023/A:1022469002511; Kolb H, 2002, J COMP NEUROL, V453, P168, DOI 10.1002/cne.10405; Koulen P, 1998, J NEUROSCI, V18, P10136; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; Lee S, 2014, NEURON, V84, P708, DOI 10.1016/j.neuron.2014.10.021; Lye Ming H, 2007, J Vis Exp, P190, DOI 10.3791/190; Maier W, 2005, J NEUROSCI METH, V142, P1, DOI 10.1016/j.jneumeth.2004.07.006; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; Marshak DW, 2015, VISUAL NEUROSCI, V32, DOI 10.1017/S0952523815000036; McMahon MJ, 2004, J NEUROSCI, V24, P3736, DOI 10.1523/JNEUROSCI.5252-03.2004; MERIGAN WH, 1991, J NEUROSCI, V11, P994; Morgan JL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-8; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; Percival KA, 2014, J NEUROSCI, V34, P3821, DOI 10.1523/JNEUROSCI.4491-13.2014; Polyak S., 1957, VERTEBRATE VISUAL SY; Polyak S. L., 1941, RETINA-J RET VIT DIS; Protti DA, 2014, J PHYSIOL-LONDON, V592, P49, DOI 10.1113/jphysiol.2013.257352; PURPURA K, 1988, P NATL ACAD SCI USA, V85, P4534, DOI 10.1073/pnas.85.12.4534; ROVAMO J, 1988, VISION RES, V28, P785, DOI 10.1016/0042-6989(88)90025-9; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; SCHILLER PH, 1990, NATURE, V343, P68, DOI 10.1038/343068a0; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Seiple W, 1996, J OPT SOC AM A, V13, P658, DOI 10.1364/JOSAA.13.000658; Sivyer B, 2010, P NATL ACAD SCI USA, V107, P5628, DOI 10.1073/pnas.0909621107; Solomon SG, 2002, VISION RES, V42, P2893, DOI 10.1016/S0042-6989(02)00414-5; TYLER CW, 1985, J OPT SOC AM A, V2, P393, DOI 10.1364/JOSAA.2.000393; Venkataramani S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088560; Venkataramani S, 2010, J NEUROSCI, V30, P15664, DOI 10.1523/JNEUROSCI.2081-10.2010; Verweij J, 2003, J NEUROSCI, V23, P10249; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; WASSLE H, 1995, J COMP NEUROL, V361, P537, DOI 10.1002/cne.903610315; WAUGH SJ, 1994, J OPT SOC AM A, V11, P1199, DOI 10.1364/JOSAA.11.001199; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; WIKLER KC, 1990, J COMP NEUROL, V297, P499, DOI 10.1002/cne.902970404; Wu S M, 1992, Curr Opin Neurobiol, V2, P462, DOI 10.1016/0959-4388(92)90181-J; Yin L, 2014, J NEUROSCI, V34, P6596, DOI 10.1523/JNEUROSCI.4438-13.2014; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711	78	86	88	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					413	+		10.1016/j.cell.2017.01.005	http://dx.doi.org/10.1016/j.cell.2017.01.005			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28129540	Bronze, Green Accepted			2022-12-28	WOS:000396249600011
J	Wu, J; Platero-Luengo, A; Sakurai, M; Sugawara, A; Gil, MA; Yamauchi, T; Suzuki, K; Bogliotti, YS; Cuello, C; Valencia, MM; Okumura, D; Luo, JP; Vilarino, M; Parrilla, I; Soto, DA; Martinez, CA; Hishida, T; Sanchez-Bautista, S; Martinez-Martinez, ML; Wang, HL; Nohalez, A; Aizawa, E; Martinez-Redondo, P; Ocampo, A; Reddy, P; Roca, J; Maga, EA; Esteban, CR; Berggren, WT; Delicado, EN; Lajara, J; Guillen, I; Guillen, P; Campistol, JM; Martinez, EA; Ross, PJ; Belmonte, JCI				Wu, Jun; Platero-Luengo, Aida; Sakurai, Masahiro; Sugawara, Atsushi; Antonia Gil, Maria; Yamauchi, Takayoshi; Suzuki, Keiichiro; Bogliotti, Yanina Soledad; Cuello, Cristina; Valencia, Mariana Morales; Okumura, Daiji; Luo, Jingping; Vilarino, Marcela; Parrilla, Inmaculada; Soto, Delia Alba; Martinez, Cristina A.; Hishida, Tomoaki; Sanchez-Bautista, Sonia; Llanos Martinez-Martinez, M.; Wang, Huili; Nohalez, Alicia; Aizawa, Emi; Martinez-Redondo, Paloma; Ocampo, Alejandro; Reddy, Pradeep; Roca, Jordi; Maga, Elizabeth A.; Esteban, Concepcion Rodriguez; Berggren, W. Travis; Nunez Delicado, Estrella; Lajara, Jeronimo; Guillen, Isabel; Guillen, Pedro; Campistol, Josep M.; Martinez, Emilio A.; Juan Ross, Pablo; Belmonte, Juan Carlos Izpisua			Interspecies Chimerism with Mammalian Pluripotent Stem Cells	CELL			English	Article							HUMAN SOMATIC-CELLS; IN-VITRO; GENE-EXPRESSION; MULTIPLE GENES; GENERATION; NAIVE; DIFFERENTIATION; LINES; MOUSE; VIVO	Interspecies blastocyst complementation enables organ-specific enrichment of xenogenic pluripotent stem cell (PSC) derivatives. Here, we establish a versatile blastocyst complementation platform based on CRISPR-Cas9-mediated zygote genome editing and show enrichment of rat PSC-derivatives in several tissues of gene-edited organogenesis-disabled mice. Besides gaining insights into species evolution, embryogenesis, and human disease, interspecies blastocyst complementation might allow human organ generation in animals whose organ size, anatomy, and physiology are closer to humans. To date, however, whether human PSCs (hPSCs) can contribute to chimera formation in non-rodent species remains unknown. We systematically evaluate the chimeric competency of several types of hPSCs using a more diversified clade of mammals, the ungulates. We find that naive hPSCs robustly engraft in both pig and cattle pre-implantation blastocysts but show limited contribution to post-implantation pig embryos. Instead, an intermediate hPSC type exhibits higher degree of chimerism and is able to generate differentiated progenies in post-implantation pig embryos.	[Wu, Jun; Platero-Luengo, Aida; Sakurai, Masahiro; Sugawara, Atsushi; Yamauchi, Takayoshi; Suzuki, Keiichiro; Valencia, Mariana Morales; Okumura, Daiji; Luo, Jingping; Hishida, Tomoaki; Aizawa, Emi; Martinez-Redondo, Paloma; Ocampo, Alejandro; Reddy, Pradeep; Esteban, Concepcion Rodriguez; Berggren, W. Travis; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Antonia Gil, Maria; Cuello, Cristina; Parrilla, Inmaculada; Martinez, Cristina A.; Nohalez, Alicia; Roca, Jordi; Martinez, Emilio A.] Univ Murcia, Dept Anim Med & Surg, Campus Espinardo, E-30100 Murcia, Spain; [Bogliotti, Yanina Soledad; Vilarino, Marcela; Soto, Delia Alba; Wang, Huili; Maga, Elizabeth A.; Juan Ross, Pablo] Univ Calif Davis, Dept Anim Sci, One Shields Ave, Davis, CA 95616 USA; [Sanchez-Bautista, Sonia; Llanos Martinez-Martinez, M.; Nunez Delicado, Estrella; Lajara, Jeronimo; Guillen, Pedro] Univ Catolica San Antonio Murcia UCAM, Campus Jeronimos,135 Guadalupe, Murcia 30107, Spain; [Guillen, Isabel; Guillen, Pedro] Clin CEMTRO, Clin Ctr Fdn Pedro Guillen, Ave Ventisquero Condesa, Madrid 28035, Spain; [Campistol, Josep M.] Univ Barcelona, Hosp Clin Barcelona IDIBAPS, E-08007 Barcelona, Spain; [Okumura, Daiji] Kinki Univ, Dept Adv Biosci, Grad Sch Agr, 3327-204 Nakamachi, Nara 6318505, Japan	Salk Institute; University of Murcia; University of California System; University of California Davis; Universidad Catolica de Murcia; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Kindai University (Kinki University)	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Parrilla, Inmaculada/I-1045-2015; Martínez, Llanos/F-9711-2016; Wu, Jun/AAF-1830-2019; Núñez-Delicado, Estrella/AAR-9438-2021; Reddy, Pradeep/G-1770-2014; Martinez, Emilio A/I-1901-2015; Luengo, Aida Platero/ABE-3282-2020; Núñez-Delicado, Estrella/F-7053-2012; Bautista, Sonia S Sanchez/H-4881-2017; wang, hui/GRS-4730-2022; Platero Luengo, Aida/GNW-5468-2022; Platero-Luengo, Aida/A-6352-2017; Martinez, Cristina A/Q-9407-2019; wang, huimin/HDM-8421-2022; Roca, Jordi/H-9365-2015	Martínez, Llanos/0000-0003-3087-1977; Wu, Jun/0000-0001-9863-1668; Núñez-Delicado, Estrella/0000-0002-0554-2365; Reddy, Pradeep/0000-0002-9173-3845; Martinez, Emilio A/0000-0003-1260-9721; Luengo, Aida Platero/0000-0002-4693-7654; Núñez-Delicado, Estrella/0000-0002-0554-2365; Bautista, Sonia S Sanchez/0000-0001-7896-9215; Platero-Luengo, Aida/0000-0002-4693-7654; Martinez, Cristina A/0000-0001-6811-0191; Suzuki, Keiichiro/0000-0001-5603-9105; Roca, Jordi/0000-0002-4213-3093; Lajara Blesa, Jeronimo/0000-0003-1859-8998; Josep M, Campistol/0000-0001-6244-0253; Ocampo, Alejandro/0000-0002-3731-3647; Parrilla, Inmaculada/0000-0002-5121-758X; Sakurai, Masahiro/0000-0002-6376-0299; MARTINEZ REDONDO, PALOMA/0000-0002-5722-8335	Fundacion Seneca, Murcia, Spain [GERM 19892/GERM/15]; MINECO [BES-2013-064087, BES-2013-064069]; UC Davis Academic Senate New Research; UCAM; G. Harold and Leila Y. Mathers Charitable Foundation; Moxie Foundation; Fundacion Dr. Pedro Guillen; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Fundacion Seneca, Murcia, Spain(Fundacion Seneca); MINECO(Spanish Government); UC Davis Academic Senate New Research; UCAM; G. Harold and Leila Y. Mathers Charitable Foundation; Moxie Foundation; Fundacion Dr. Pedro Guillen; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.C.I.B. dedicates this paper to Dr. Rafael Matesanz, Director of the Spain's National Organ Transplant Organization. Rafael's work has helped save thousands of patients in need of an organ. He constitutes a relentless inspiration for those of us trying to understand and alleviate human disease. The authors are grateful to Xiomara Lucas, Maria Dolores Ortega, Moises Gonzalvez, Jose Antonio Godinez, and Jesus Gomis for their assistance throughout this work. We thank the staff of the Agropor S. A. and Porcisan S. A. piggeries (Murcia, Spain) for the help and excellent management of animals. We thank Joan Rowe, Bret McNabb, Aaron Prinz, and Kent Parker and their crews for excellent assistance with embryo transfers and pig care at UC Davis. We thank Mako Yamamoto for help with mouse embryo dissection. We would like to thank Uri Manor of the Salk Waitt Advanced Biophotonics Core for technical advice on imaging analysis. We would like to thank the Salk Stem Cell Core for providing cell culture reagents. We would like to thank May Schwarz and Peter Schwarz for administrative help. We thank David O'Keefe for critical reading and editing of the manuscript. This experimental study was supported by The Fundacion Seneca (GERM 19892/GERM/15), Murcia, Spain. The MINECO is acknowledged for their grant-based support (BES-2013-064087 and BES-2013-064069) (to C.A.M and A.N.). P.J.R was supported by a UC Davis Academic Senate New Research grant. Work in the laboratory of J.C.I.B. was supported by the UCAM, Fundacion Dr. Pedro Guillen, G. Harold and Leila Y. Mathers Charitable Foundation, and The Moxie Foundation.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Abeydeera LR, 2002, THERIOGENOLOGY, V57, P257, DOI 10.1016/S0093-691X(01)00670-7; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Funahashi H, 2000, BIOL REPROD, V63, P1437, DOI 10.1095/biolreprod63.5.1437; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Grupen CG, 2014, THERIOGENOLOGY, V81, P24, DOI 10.1016/j.theriogenology.2013.09.022; Hansen TR, 2014, ADV EXP MED BIOL, V759, P13, DOI [10.1007/978-1-4614-8887-3_1, 10.1007/978-1-4939-0817-2_2]; Hasler JF, 2014, THERIOGENOLOGY, V81, P152, DOI 10.1016/j.theriogenology.2013.09.010; Hishida T, 2011, CELL STEM CELL, V9, P37, DOI 10.1016/j.stem.2011.04.020; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Isotani A, 2011, GENES CELLS, V16, P397, DOI 10.1111/j.1365-2443.2011.01495.x; IZPISUABELMONTE JC, 1992, DEVELOPMENT, V115, P553; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Martinez EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104696; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Offield MF, 1996, DEVELOPMENT, V122, P983; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; PARRISH JJ, 1986, THERIOGENOLOGY, V25, P591, DOI 10.1016/0093-691X(86)90143-3; PETTERS RM, 1993, J REPROD FERTIL, P61; PURSEL VG, 1975, J ANIM SCI, V40, P99, DOI 10.2527/jas1975.40199x; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Ross PJ, 2008, REPRODUCTION, V136, P777, DOI 10.1530/REP-08-0045; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2016, CELL STEM CELL, V19, P502, DOI 10.1016/j.stem.2016.06.011; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsukiyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095329; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Weinberger L, 2016, NAT REV MOL CELL BIO, V17, P155, DOI 10.1038/nrm.2015.28; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu J, 2016, NATURE, V540, P51, DOI 10.1038/nature20573; Wu J, 2016, CELL, V165, P1572, DOI 10.1016/j.cell.2016.05.043; Wu J, 2015, CELL STEM CELL, V17, P509, DOI 10.1016/j.stem.2015.10.009; Wu J, 2015, NATURE, V521, P316, DOI 10.1038/nature14413; Xiang AP, 2008, HUM MOL GENET, V17, P27, DOI 10.1093/hmg/ddm282; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yoshioka K, 2012, ANIM REPROD SCI, V131, P23, DOI 10.1016/j.anireprosci.2012.01.018; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	57	287	302	3	191	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					473	+		10.1016/j.cell.2016.12.036	http://dx.doi.org/10.1016/j.cell.2016.12.036			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28129541	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000396249600015
J	Stafford, N				Stafford, Ned			John Balint OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												ns@europefn.net						BALINT J, PUBLICATION LIST	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2017	356								j369	10.1136/bmj.j369	http://dx.doi.org/10.1136/bmj.j369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HL	28119306				2022-12-28	WOS:000393177400011
J	Thornton, J				Thornton, Jacqui			Bulgaria attempts to combat discrimination against Roma	LANCET			English	Editorial Material								Innovative schemes in Bulgaria are enabling young Roma to study medicine while others are encouraging Roma people to become health mediators. Jacqui Thornton reports from Sofia.							Open Society Foundations	Open Society Foundations	JT received financial support from the non-governmental organisation Open Society Foundations to travel to Bulgaria for reporting for this feature.		0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					240	241		10.1016/S0140-6736(17)30136-8	http://dx.doi.org/10.1016/S0140-6736(17)30136-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9BC	28118905				2022-12-28	WOS:000392801200013
J	Clase, CM				Clase, Catherine M.			Review: Some drugs, added to hydration, prevent contrast-induced acute kidney injury	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Clase, Catherine M.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Clase, CM (corresponding author), McMaster Univ, Hamilton, ON, Canada.			Clase, Catherine/0000-0002-4538-5958				McDonald JS, 2015, MAYO CLIN PROC, V90, P1046, DOI 10.1016/j.mayocp.2015.05.016; SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104; Subramaniam RM, 2016, ANN INTERN MED, V164, P406, DOI 10.7326/M15-1456	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					JC9	JC9		10.7326/ACPJC-2017-166-2-009	http://dx.doi.org/10.7326/ACPJC-2017-166-2-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	28114465				2022-12-28	WOS:000391842600008
J	Hosamani, P; Verghese, A				Hosamani, Poonam; Verghese, Abraham			Inpatient Notes: Rituals in Chaos, the Sacred in the Profane	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MEDICINE		[Hosamani, Poonam; Verghese, Abraham] Stanford Univ, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA	Stanford University	Hosamani, P (corresponding author), Stanford Univ, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA.	poonamh@stanford.edu						Csoka AB, 2016, MED HEALTH CARE PHIL, V19, P163, DOI 10.1007/s11019-015-9678-x; Feldstein CBD, 2011, J PAIN SYMPTOM MANAG, V42, P155, DOI 10.1016/j.jpainsymman.2011.03.014; Verghese A, 2011, ANN INTERN MED, V155, P550, DOI 10.7326/0003-4819-155-8-201110180-00013; Welch JS, 2003, J RELIG HEALTH, V42, P21, DOI 10.1023/A:1022260610761	4	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					H02	H02		10.7326/M16-2737	http://dx.doi.org/10.7326/M16-2737			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	28114474				2022-12-28	WOS:000391842600011
J	Goodman-Bacon, AJ; Nikpay, SS				Goodman-Bacon, Andrew J.; Nikpay, Sayeh S.			Per Capita Caps in Medicaid - Lessons from the Past	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goodman-Bacon, Andrew J.] Vanderbilt Univ, Dept Econ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Nikpay, Sayeh S.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Goodman-Bacon, AJ (corresponding author), Vanderbilt Univ, Dept Econ, 221 Kirkland Hall, Nashville, TN 37235 USA.							Antos J, 2016, HLTH AFFAIRS BLOG; Committee on Ways and Means of the House of Representatives, 1961, MED RES AV MEET NEED; Goodman-Bacon A, 2016, NATL BUREAU EC RES W; Park E., 2016, COMMENTARY BLOCK GRA; Schottland CI, 1958, SOCIAL SECURITY B	5	14	14	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2017	376	11					1005	1007		10.1056/NEJMp1615696	http://dx.doi.org/10.1056/NEJMp1615696			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0QT	28146644				2022-12-28	WOS:000396403700002
J	Neoptolemos, JP; Palmer, DH; Ghaneh, P; Psarelli, EE; Valle, JW; Halloran, CM; Faluyi, O; O'Reilly, DA; Cunningham, D; Wadsley, J; Darby, S; Meyer, T; Gillmore, R; Anthoney, A; Lind, P; Glimelius, B; Falk, S; Izbicki, JR; Middleton, GW; Cummins, S; Ross, PJ; Wasan, H; McDonald, A; Crosby, T; Ma, YT; Patel, K; Sherriff, D; Soomal, R; Borg, D; Sothi, S; Hammel, P; Hackert, T; Jackson, R; Buchler, MW				Neoptolemos, John P.; Palmer, Daniel H.; Ghaneh, Paula; Psarelli, Eftychia E.; Valle, Juan W.; Halloran, Christopher M.; Faluyi, Olusola; O'Reilly, Derek A.; Cunningham, David; Wadsley, Jonathan; Darby, Suzanne; Meyer, Tim; Gillmore, Roopinder; Anthoney, Alan; Lind, Pehr; Glimelius, Bengt; Falk, Stephen; Izbicki, Jakob R.; Middleton, Gary William; Cummins, Sebastian; Ross, Paul J.; Wasan, Harpreet; McDonald, Alec; Crosby, Tom; Ma, Yuk Ting; Patel, Kinnari; Sherriff, David; Soomal, Rubin; Borg, David; Sothi, Sharmila; Hammel, Pascal; Hackert, Thilo; Jackson, Richard; Buechler, Markus W.		European Study Grp Pancreat Canc	Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial	LANCET			English	Article							FOLINIC ACID; CHEMOTHERAPY; THERAPY; CHEMORADIOTHERAPY; ADENOCARCINOMA; MODEL	Background The ESPAC-3 trial showed that adjuvant gemcitabine is the standard of care based on similar survival to and less toxicity than adjuvant 5-fluorouracil/folinic acid in patients with resected pancreatic cancer. Other clinical trials have shown better survival and tumour response with gemcitabine and capecitabine than with gemcitabine alone in advanced or metastatic pancreatic cancer. We aimed to determine the efficacy and safety of gemcitabine and capecitabine compared with gemcitabine monotherapy for resected pancreatic cancer. Methods We did a phase 3, two-group, open-label, multicentre, randomised clinical trial at 92 hospitals in England, Scotland, Wales, Germany, France, and Sweden. Eligible patients were aged 18 years or older and had undergone complete macroscopic resection for ductal adenocarcinoma of the pancreas (R0 or R1 resection). We randomly assigned patients (1: 1) within 12 weeks of surgery to receive six cycles of either 1000 mg/m(2) gemcitabine alone administered once a week for three of every 4 weeks (one cycle) or with 1660 mg/m(2) oral capecitabine administered for 21 days followed by 7 days' rest (one cycle). Randomisation was based on a minimisation routine, and country was used as a stratification factor. The primary endpoint was overall survival, measured as the time from randomisation until death from any cause, and assessed in the intention-to-treat population. Toxicity was analysed in all patients who received trial treatment. This trial was registered with the EudraCT, number 2007-004299-38, and ISRCTN, number ISRCTN96397434. Findings Of 732 patients enrolled, 730 were included in the final analysis. Of these, 366 were randomly assigned to receive gemcitabine and 364 to gemcitabine plus capecitabine. The Independent Data and Safety Monitoring Committee requested reporting of the results after there were 458 (95%) of a target of 480 deaths. The median overall survival for patients in the gemcitabine plus capecitabine group was 28.0 months (95% CI 23.5-31.5) compared with 25.5 months (22.7-27.9) in the gemcitabine group (hazard ratio 0.82 [95% CI 0.68-0.98], p=0.032). 608 grade 3-4 adverse events were reported by 226 of 359 patients in the gemcitabine plus capecitabine group compared with 481 grade 3-4 adverse events in 196 of 366 patients in the gemcitabine group. Interpretation The adjuvant combination of gemcitabine and capecitabine should be the new standard of care following resection for pancreatic ductal adenocarcinoma.	[Neoptolemos, John P.; Palmer, Daniel H.; Psarelli, Eftychia E.; Halloran, Christopher M.; Jackson, Richard] Univ Liverpool, Liverpool, Merseyside, England; [Neoptolemos, John P.; Ghaneh, Paula; Halloran, Christopher M.] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England; [Palmer, Daniel H.; Faluyi, Olusola] Clatterbridge Canc Ctr, Wirral, Merseyside, England; [Valle, Juan W.] Univ Manchester, Christie NHS Fdn Trust, Manchester, Lancs, England; [O'Reilly, Derek A.] Manchester Royal Infirm, Manchester, Lancs, England; [Cunningham, David] Royal Marsden Hosp, London, England; [Wadsley, Jonathan; Darby, Suzanne] Weston Pk Hosp, Sheffield, S Yorkshire, England; [Meyer, Tim; Gillmore, Roopinder] Royal Free Hosp, London, England; [Anthoney, Alan] St James Univ Hosp, Leeds, W Yorkshire, England; [Lind, Pehr] Karolinska Inst, Stockholm, Sweden; [Lind, Pehr] Clin Res Sormland, Eskilstuna, Sweden; [Glimelius, Bengt] Uppsala Univ, Uppsala, Sweden; [Falk, Stephen] Bristol Haematol & Oncol Ctr, Bristol, Avon, England; [Izbicki, Jakob R.] Univ Hamburg, Med Inst UKE, Hamburg, Germany; [Middleton, Gary William; Cummins, Sebastian] Royal Surrey Cty Hosp, Guildford, Surrey, England; [Ross, Paul J.] Guys Hosp, London, England; [Wasan, Harpreet] Hammersmith Hosp, London, England; [McDonald, Alec] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Crosby, Tom] Velindre Hosp, Cardiff, S Glam, Wales; [Ma, Yuk Ting] Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Patel, Kinnari] Churchill Hosp, Oxford, England; [Sherriff, David] Derriford Hosp, Plymouth, Devon, England; [Soomal, Rubin] Ipswich Hosp, Ipswich, Suffolk, England; [Borg, David] Skane Univ Hosp, Lund, Sweden; [Sothi, Sharmila] Univ Hosp Coventry, Coventry, W Midlands, England; [Hammel, Pascal] Hop Beaujon, Clichy, France; [Hackert, Thilo; Buechler, Markus W.] Heidelberg Univ, Heidelberg, Germany	University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Clatterbridge Cancer Centre; Christie NHS Foundation Trust; University of Manchester; University of Manchester; Royal Marsden NHS Foundation Trust; Weston Park Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Saint James's University Hospital; Karolinska Institutet; Uppsala University; Bristol Haematology & Oncology Centre; University of Hamburg; Royal Surrey County Hospital; Guy's & St Thomas' NHS Foundation Trust; Imperial College London; Beatson Oncology Centre; Velindre Hospital; University of Birmingham; University of Oxford; Derriford Hospital; Ipswich Hospital NHS Trust; Ipswich Hospital; Lund University; Skane University Hospital; University of Warwick; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Ruprecht Karls University Heidelberg	Neoptolemos, JP (corresponding author), Univ Liverpool, Liverpool, Merseyside, England.; Neoptolemos, JP (corresponding author), Univ Liverpool, Liverpool Clin & Canc Res UK Trials Unit, Owen & Ellen Evans Chair Surg, Liverpool L69 3GL, Merseyside, England.	j.p.neoptolemos@liverpool.ac.uk	Neoptolemos, John/HGU-7742-2022	wadsley, jonathan/0000-0002-1499-1277; Halloran, Christopher/0000-0002-5471-4178; Cunningham, David/0000-0001-5158-1069; Middleton, Gary/0000-0001-5695-3474; Ma, Yuk Ting/0000-0001-7830-6091; Hammel, Pascal/0000-0002-4630-4996; Wasan, Harpreet/0000-0002-6268-2030; Neoptolemos, John/0000-0002-6201-7399	Cancer Research UK; Cancer Research UK [8968, 16186, 16791, 11883, 17680, 15957] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10126, 08/29/02] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	Cancer Research UK.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Campbell F, 2009, HISTOPATHOLOGY, V55, P277, DOI 10.1111/j.1365-2559.2009.03376.x; Capello M, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv132; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; COX DR, 1972, J R STAT SOC B, V34, P187; Cunningham D, 2009, J CLIN ONCOL, V27, P5513, DOI 10.1200/JCO.2009.24.2446; Greenhalf W, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt347; Henderson R, 2000, Biostatistics, V1, P465, DOI 10.1093/biostatistics/1.4.465; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Liao WC, 2013, LANCET ONCOL, V14, P1095, DOI 10.1016/S1470-2045(13)70388-7; Neoptolemos JP, 2009, BRIT J CANCER, V100, P246, DOI 10.1038/sj.bjc.6604838; Neoptolemos JP, 2013, LANCET ONCOL, V14, P1034, DOI 10.1016/S1470-2045(13)70403-0; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Neoptolemos JP, 2001, LANCET, V358, P1576, DOI 10.1016/S0140-6736(01)06651-X; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Reni M, 2012, CANCER CHEMOTH PHARM, V69, P115, DOI 10.1007/s00280-011-1680-2; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Sinn M, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.4007; Sobin L, 2009, TNM CLASSIFICATION M; Sultana A, 2007, J CLIN ONCOL, V25, P2607, DOI 10.1200/JCO.2006.09.2551; Trotti A, 2007, LANCET ONCOL, V8, P613, DOI 10.1016/S1470-2045(07)70144-4; Uesaka K, 2016, LANCET, V388, P248, DOI 10.1016/S0140-6736(16)30583-9; Valle JW, 2014, J CLIN ONCOL, V32, P504, DOI 10.1200/JCO.2013.50.7657; Vivaldi C, 2016, INT J CANCER, V139, P938, DOI 10.1002/ijc.30125; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	30	1042	1083	5	84	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2017	389	10073					1011	1024		10.1016/S0140-6736(16)32409-6	http://dx.doi.org/10.1016/S0140-6736(16)32409-6			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN9UN	28129987	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000396345200023
J	Brawley, OW				Brawley, Otis W.			Accepting the Existence of Breast Cancer Overdiagnosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CHEMOTHERAPY		[Brawley, Otis W.] Amer Canc Soc, 250 Williams St NW, Atlanta, GA 30303 USA	American Cancer Society	Brawley, OW (corresponding author), Amer Canc Soc, 250 Williams St NW, Atlanta, GA 30303 USA.	otis.brawley@cancer.org						Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Brawley OW, 2014, CANCER-AM CANCER SOC, V120, P2800, DOI 10.1002/cncr.28788; DAVID H, 1988, PATHOL RES PRACT, V183, P356, DOI 10.1016/S0344-0338(88)80138-9; Griggs JJ, 2012, J CLIN ONCOL, V30, P3058, DOI 10.1200/JCO.2012.41.9564; Jorgensen KJ, 2017, ANN INTERN MED, V166, P313, DOI 10.7326/M16-0270; Kopans Daniel B, 2016, J Am Coll Radiol, V13, pR50, DOI 10.1016/j.jacr.2016.09.026; Nelson HD, 2016, ANN INTERN MED, V164, P256, DOI 10.7326/M15-0970; Rutter CE, 2016, CLIN BREAST CANCER, V16, P59, DOI 10.1016/j.clbc.2015.09.008; Welch HG, 2016, NEW ENGL J MED, V375, P1438, DOI 10.1056/NEJMoa1600249; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099	10	18	18	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					364	365		10.7326/M16-2850	http://dx.doi.org/10.7326/M16-2850			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28114628				2022-12-28	WOS:000396432800010
J	Voelker, R				Voelker, Rebecca			Ovarian Cancer Drug Approved	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					466	466		10.1001/jama.2017.0026	http://dx.doi.org/10.1001/jama.2017.0026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28170464				2022-12-28	WOS:000393564200007
J	Voelker, R				Voelker, Rebecca			First Drug for Rare Genetic Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					466	466		10.1001/jama.2017.0028	http://dx.doi.org/10.1001/jama.2017.0028			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28170465				2022-12-28	WOS:000393564200008
J	Voosen, P				Voosen, Paul			SPACE SCIENCE GPS satellites yield space weather data	SCIENCE			English	News Item																			0	1	1	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					443	443		10.1126/science.355.6324.443	http://dx.doi.org/10.1126/science.355.6324.443			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154029				2022-12-28	WOS:000393183100013
J	Kelliher, T; Starr, D; Richbourg, L; Chintamanani, S; Delzer, B; Nuccio, ML; Green, J; Chen, ZY; McCuiston, J; Wang, WL; Liebler, T; Bullock, P; Martin, B				Kelliher, Timothy; Starr, Dakota; Richbourg, Lee; Chintamanani, Satya; Delzer, Brent; Nuccio, Michael L.; Green, Julie; Chen, Zhongying; McCuiston, Jamie; Wang, Wenling; Liebler, Tara; Bullock, Paul; Martin, Barry			MATRILINEAL, a sperm-specific phospholipase, triggers maize haploid induction	NATURE			English	Article							POLLEN-TUBE GROWTH; IN-VIVO INDUCTION; ZEA-MAYS L.; MATERNAL HAPLOIDS; FERTILIZATION; ARABIDOPSIS; PLANTS; ELIMINATION; A(2)	Sexual reproduction in flowering plants involves double fertilization, the union of two sperm from pollen with two sex cells in the female embryo sac. Modern plant breeders increasingly seek to circumvent this process to produce doubled haploid individuals, which derive from the chromosome-doubled cells of the haploid gametophyte. Doubled haploid production fixes recombinant haploid genomes in inbred lines, shaving years off the breeding process(1). Costly, genotype-dependent tissue culture methods are used in many crops(2), while seed-based in vivo doubled haploid systems are rare in nature(3) and difficult to manage in breeding programmes(4). The multi-billion-dollar maize hybrid seed business, however, is supported by industrial doubled haploid pipelines using intraspecific crosses to in vivo haploid inducer males derived from Stock 6, first reported in 1959 (ref. 5), followed by colchicine treatment. Despite decades of use, the mode of action remains controversial(6-10). Here we establish, through fine mapping, genome sequencing, genetic complementation, and gene editing, that haploid induction in maize (Zea mays) is triggered by a frame-shift mutation in MATRILINEAL (MTL), a pollen-specific phospholipase, and that novel edits in MTL lead to a 6.7% haploid induction rate (the percentage of haploid progeny versus total progeny). Wildtype MTL protein localizes exclusively to sperm cytoplasm, and pollen RNA-sequence profiling identifies a suite of pollen-specific genes overexpressed during haploid induction, some of which may mediate the formation of haploid seed(11-15). These findings highlight the importance of male gamete cytoplasmic components to reproductive success and male genome transmittance. Given the conservation of MTL in the cereals, this discovery may enable development of in vivo haploid induction systems to accelerate breeding in crop plants.	[Kelliher, Timothy; Starr, Dakota; Richbourg, Lee; Nuccio, Michael L.; Green, Julie; Chen, Zhongying; McCuiston, Jamie; Wang, Wenling; Liebler, Tara; Martin, Barry] Syngenta Crop Protect, Seeds Res, 9 Davis Dr, Res Triangle Pk, NC 27709 USA; [Chintamanani, Satya; Bullock, Paul] Syngenta Seeds, 2369 330th St, Slater, IA 50244 USA; [Delzer, Brent] Syngenta Seeds, 4133 East Cty Rd O, Janesville, WI 53546 USA; [Martin, Barry] CiBO Technol, 155 2nd St, Cambridge, MA 02141 USA	Syngenta; Syngenta; Syngenta	Kelliher, T (corresponding author), Syngenta Crop Protect, Seeds Res, 9 Davis Dr, Res Triangle Pk, NC 27709 USA.	tim.kelliher@syngenta.com						BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Chang Ming-Tang, 2009, V63, P127; CHASE SS, 1969, BOT REV, V35, P117, DOI 10.1007/BF02858912; COE EH, 1959, AM NAT, V93, P381, DOI 10.1086/282098; Denninger P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5645; Dong X, 2013, THEOR APPL GENET, V126, P1713, DOI 10.1007/s00122-013-2086-9; Dresselhaus T, 2016, CURR BIOL, V26, pR125, DOI 10.1016/j.cub.2015.12.032; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; Hamamura Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5722; Hu HX, 2016, GENETICS, V202, P1267, DOI 10.1534/genetics.115.184234; Kasha K J, 1970, Nature, V225, P874, DOI 10.1038/225874a0; Kelliher T, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00414; Kelliher T, 2011, DEV BIOL, V350, P32, DOI 10.1016/j.ydbio.2010.11.005; Kim HJ, 2011, PLANT CELL, V23, P94, DOI 10.1105/tpc.110.074799; Kurihara D, 2015, DEVELOPMENT, V142, P4168, DOI 10.1242/dev.127613; La Camera S, 2005, PLANT J, V44, P810, DOI 10.1111/j.1365-313X.2005.02578.x; Leydon AR, 2015, PLANT PHYSIOL, V169, P485, DOI 10.1104/pp.15.00528; Liu CX, 2015, THEOR APPL GENET, V128, P2507, DOI 10.1007/s00122-015-2605-y; MASCARENHAS JP, 1966, AM J BOT, V53, P563, DOI 10.2307/2440006; Negrotto D, 2000, PLANT CELL REP, V19, P798, DOI 10.1007/s002999900187; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Prigge V, 2012, GENETICS, V190, P781, DOI 10.1534/genetics.111.133066; Qiu FZ, 2014, CURR PLANT BIOL, V1, P83, DOI 10.1016/j.cpb.2014.04.001; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; SARKAR KR, 1966, GENETICS, V54, P453; Schiott M, 2004, P NATL ACAD SCI USA, V101, P9502, DOI 10.1073/pnas.0401542101; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Segui-Simarro JM, 2007, J EXP BOT, V58, P1119, DOI 10.1093/jxb/erl271; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0044931, 10.1371/journal.pone.0039812]; Stelpflug SC, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.04.0025; Wu PH, 2014, EUPHYTICA, V196, P413, DOI 10.1007/s10681-013-1043-7; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xu XW, 2013, J EXP BOT, V64, P1083, DOI 10.1093/jxb/ers393; Zhai JX, 2015, P NATL ACAD SCI USA, V112, P3146, DOI 10.1073/pnas.1418918112; Zhao X, 2013, PLANT PHYSIOL, V163, P721, DOI 10.1104/pp.113.223982	37	177	200	17	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					105	+		10.1038/nature20827	http://dx.doi.org/10.1038/nature20827			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28114299				2022-12-28	WOS:000396119300040
J	Torjesen, I				Torjesen, Ingrid			Seeing same GP is linked to fewer hospital admissions	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							CONTINUITY; CARE											Barker I, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j84; Tammes P, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j373	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2017	356								j543	10.1136/bmj.j543	http://dx.doi.org/10.1136/bmj.j543			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BT	28153827				2022-12-28	WOS:000393450100009
J	McCall, B				McCall, Becky			UK failing to meet the needs of people with autism	LANCET			English	Editorial Material																			0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					351	351						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	28137684				2022-12-28	WOS:000392804700015
J	Kapos, V				Kapos, Valerie			CONSERVATION Seeing the forest through the trees Remote-sensing data identify functional trait variation in tropical forests	SCIENCE			English	Editorial Material									[Kapos, Valerie] UNEP World Conservat Monitoring Ctr, 219 Huntingdon Rd, Cambridge CB3 0DL, England		Kapos, V (corresponding author), UNEP World Conservat Monitoring Ctr, 219 Huntingdon Rd, Cambridge CB3 0DL, England.	val.kapos@unep-wcmc.org	Kapos, Valerie/G-3136-2010; Muchlinski, David/V-5031-2019	Kapos, Valerie/0000-0002-5739-8262; Muchlinski, David/0000-0002-2195-1943				Asner GP, 2017, SCIENCE, V355, P385, DOI 10.1126/science.aaj1987; Butchart SHM, 2015, CONSERV LETT, V8, P329, DOI 10.1111/conl.12158; Gardner TA, 2012, BIOL CONSERV, V154, P61, DOI 10.1016/j.biocon.2011.11.018; Guerrero AM, 2017, CONSERV BIOL, V31, P290, DOI 10.1111/cobi.12832; Harfoot MBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001841; IISD, 2016, UN BIOD C 2 17 DEC 2, V9; Keith DA, 2015, CONSERV LETT, V8, P214, DOI 10.1111/conl.12167; Law EA, 2015, ECOL APPL, V25, P70, DOI 10.1890/13-2014.1; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Scheiter S, 2013, NEW PHYTOL, V198, P957, DOI 10.1111/nph.12210; Shoo LP, 2017, CONSERV LETT, V10, P748, DOI 10.1111/conl.12327; Stork NE, 2017, CONSERV BIOL, V31, P924, DOI 10.1111/cobi.12883; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Uriarte M, 2016, BIOTROPICA, V48, P915, DOI 10.1111/btp.12411	14	3	4	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					347	349		10.1126/science.aal5120	http://dx.doi.org/10.1126/science.aal5120			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4FR	28126770				2022-12-28	WOS:000393172800019
J	Ma, WQ; Li, SH; Ma, SQ; Jia, LN; Zhang, FC; Zhang, Y; Zhang, JY; Wong, G; Zhang, SS; Lu, XC; Liu, M; Yan, JH; Li, W; Qin, C; Han, DS; Qin, CF; Wang, N; Li, XD; Gao, GF				Ma, Wenqiang; Li, Shihua; Ma, Shuoqian; Jia, Lina; Zhang, Fuchun; Zhang, Yong; Zhang, Jingyuan; Wong, Gary; Zhang, Shanshan; Lu, Xuancheng; Liu, Mei; Yan, Jinghua; Li, Wei; Qin, Chuan; Han, Daishu; Qin, Chengfeng; Wang, Na; Li, Xiangdong; Gao, George Fu			Zika Virus Causes Testis Damage and Leads to Male Infertility in Mice (vol 167, pg 1511, 2016)	CELL			English	Correction												xiangdongli@cau.edu.cn; gaof@im.ac.cn	Jia, li/GPW-8015-2022; li, jia/GVT-7587-2022; Gao, George Fu/ABD-5229-2021; Li, Shi-Hua/GQH-6298-2022; Qin, Cheng-Feng/I-6839-2019	Qin, Cheng-Feng/0000-0002-0632-2807				Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016	1	52	54	2	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					542	542		10.1016/j.cell.2017.01.009	http://dx.doi.org/10.1016/j.cell.2017.01.009			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28129543	Bronze			2022-12-28	WOS:000396249600020
J	Philips, CA; Sahney, A				Philips, Cyriac A.; Sahney, Amrish			Taenia solium	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Philips, Cyriac A.; Sahney, Amrish] Inst Liver & Biliary Sci, New Delhi, India	Institute of Liver & Biliary Sciences (ILBS)	Philips, CA (corresponding author), Inst Liver & Biliary Sci, New Delhi, India.	abbyphilips@gmail.com	Philips, Cyriac Abby/U-4517-2019	Philips, Cyriac Abby/0000-0002-9587-336X					0	1	1	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2017	376	4					E4	E4		10.1056/NEJMicm1606747	http://dx.doi.org/10.1056/NEJMicm1606747			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ3KR	28121503				2022-12-28	WOS:000393111600001
J	Abbasi, J				Abbasi, Jennifer			Large HIV Vaccine Trial Launches in South Africa	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					350	350		10.1001/jama.2016.20743	http://dx.doi.org/10.1001/jama.2016.20743			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118438				2022-12-28	WOS:000392509600005
J	Horton, R				Horton, Richard			Offline: Tackling the despair of England's NHS	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					238	238		10.1016/S0140-6736(17)30127-7	http://dx.doi.org/10.1016/S0140-6736(17)30127-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9BC	28118903				2022-12-28	WOS:000392801200011
J	Weiss, J; Freeman, M; Low, A; Fu, R; Kerfoot, A; Paynter, R; Motu'apuaka, M; Kondo, K; Kansagara, D				Weiss, Jessica; Freeman, Michele; Low, Allison; Fu, Rochelle; Kerfoot, Amy; Paynter, Robin; Motu'apuaka, Makalapua; Kondo, Karli; Kansagara, Devan			Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							ISOLATED SYSTOLIC HYPERTENSION; QUALITY-OF-LIFE; ELDERLY TRIAL; DOUBLE-BLIND; ANTIHYPERTENSIVE TREATMENT; CARDIOVASCULAR OUTCOMES; AFRICAN-AMERICAN; LACUNAR STROKE; RISK; PERINDOPRIL	Background: Recent guidelines recommend a systolic blood pressure (SBP) goal of less than 150 mm Hg for adults aged 60 years or older, but the balance of benefits and harms is unclear in light of newer evidence. Purpose: To systematically review the effects of more versus less intensive BP control in older adults. Data Sources: Multiple databases through January 2015 and MEDLINE to September 2016. Study Selection: 21 randomized, controlled trials comparing BP targets or treatment intensity, and 3 observational studies that assessed harms. Data Extraction: Two investigators extracted data, assessed study quality, and graded the evidence using published criteria. Data Synthesis: Nine trials provided high-strength evidence that BP control to less than 150/90 mm Hg reduces mortality (relative risk [RR], 0.90 [95% CI, 0.83 to 0.98]), cardiac events (RR, 0.77 [CI, 0.68 to 0.89]), and stroke (RR, 0.74 [CI, 0.65 to 0.84]). Six trials yielded low-to moderate-strength evidence that lower targets (= 140/85 mm Hg) are associated with marginally significant decreases in cardiac events (RR, 0.82 [CI, 0.64 to 1.00]) and deaths (RR, 0.86 [CI, 0.69 to 1.06]). Low-to moderate-strength evidence showed that lower BP targets do not increase falls or cognitive impairment. Limitation: Data relevant to frail elderly adults and the effect of multimorbidity are limited. Conclusion: Treatment to at least current guideline standards for BP (< 150/90 mm Hg) substantially improves health outcomes in older adults. There is less consistent evidence, largely from 1 trial targeting SBP less than 120 mm Hg, that lower BP targets are beneficial for high-risk patients. Lower BP targets did not increase falls or cognitive decline but are associated with hypotension, syncope, and greater medication burden.	[Freeman, Michele; Low, Allison; Kerfoot, Amy; Paynter, Robin; Motu'apuaka, Makalapua; Kondo, Karli; Kansagara, Devan] Vet Affairs Portland Hlth Care Syst, Mail Code RD71,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Weiss, Jessica; Fu, Rochelle] Oregon Hlth & Sci Univ, Mail Code SJH6,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University	Kansagara, D (corresponding author), Vet Affairs Portland Hlth Care Syst, Mail Code RD71,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	kansagar@ohsu.edu	Kondo, Karli/R-3994-2019	Kondo, Karli/0000-0002-4635-5056; Paynter, Robin/0000-0002-6969-4261	U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative	U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative(US Department of Veterans Affairs)	This research was funded by the U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative.	AMERY A, 1985, LANCET, V1, P1349; [Anonymous], 1991, JAMA, V265, P3255; APPLEGATE WB, 1994, ARCH INTERN MED, V154, P2154, DOI 10.1001/archinte.154.19.2154; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Berkman N. D., 2013, AHRQ PUBLICATION, V13; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Cook NR, 2016, ANN INTERN MED, V165, P786, DOI 10.7326/M16-1739; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Davis EM, 2011, HYPERTENSION, V57, P1061, DOI 10.1161/HYPERTENSIONAHA.111.169367; Degl'Innocenti A, 2004, J HUM HYPERTENS, V18, P239, DOI 10.1038/sj.jhh.1001657; Emdin CA, 2015, JAMA-J AM MED ASSOC, V313, P603, DOI 10.1001/jama.2014.18574; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Ferrucci L, 2001, CIRCULATION, V104, P1923, DOI 10.1161/hc4101.097520; Fletcher AE, 2002, J HYPERTENS, V20, P2069, DOI 10.1097/00004872-200210000-00028; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Gong LS, 1996, J HYPERTENS, V14, P1237, DOI 10.1097/00004872-199610000-00013; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103169; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jatos Study Grp, 2008, HYPERTENS RES, V31, P2115, DOI 10.1291/hypres.31.2115; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Liu H, 2013, J AM GERIATR SOC, V61, P875, DOI 10.1111/jgs.12259; Liu LS, 2005, J HYPERTENS, V23, P2157, DOI 10.1097/01.hjh.0000194120.42722.ac; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Margolis KL, 2014, J GEN INTERN MED, V29, P1599, DOI 10.1007/s11606-014-2961-3; Myers MG, 2010, HYPERTENSION, V55, P195, DOI 10.1161/HYPERTENSIONAHA.109.141879; Ogihara T, 2010, HYPERTENSION, V56, P196, DOI 10.1161/HYPERTENSIONAHA.109.146035; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Peng J, 2014, J AM MED DIR ASSOC, V15, P904, DOI 10.1016/j.jamda.2014.07.005; Peralta CA, 2016, CIRCULATION, V133, P584, DOI 10.1161/CIRCULATIONAHA.115.019657; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Peters R, 2010, AGE AGEING, V39, P609, DOI 10.1093/ageing/afq071; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Ruggenenti P, 2011, J HYPERTENS, V29, P207, DOI 10.1097/HJH.0b013e32834069bd; Sacktor N, 1999, J GERIATR PSYCH NEUR, V12, P1, DOI 10.1177/089198879901200102; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE; Tzourio C, 2003, ARCH INTERN MED, V163, P1069; van Dieren S, 2012, DIABETES RES CLIN PR, V98, P83, DOI 10.1016/j.diabres.2012.05.002; Verdecchia P, 2009, LANCET, V374, P525, DOI 10.1016/S0140-6736(09)61340-4; Wang JG, 2000, ARCH INTERN MED, V160, P211, DOI 10.1001/archinte.160.2.211; Warwick J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0328-1; Wei Y, 2013, J CLIN HYPERTENS, V15, P420, DOI 10.1111/jch.12094; Weiss J, 2015, 05225 VA ESP US DEP; Weiss J, 2015, PROSPERO; White CL, 2015, J AM GERIATR SOC, V63, P722, DOI 10.1111/jgs.13349; Wiklund Ingela, 1997, Blood Pressure, V6, P357, DOI 10.3109/08037059709062095; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050; Williamson JD, 2014, JAMA INTERN MED, V174, P324, DOI 10.1001/jamainternmed.2013.13656; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; Zanchetti A, 2003, J HYPERTENS, V21, P797, DOI 10.1097/00004872-200304000-00024	56	122	127	0	63	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					419	+		10.7326/M16-1754	http://dx.doi.org/10.7326/M16-1754			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28114673				2022-12-28	WOS:000397025800017
J	Lipska, KJ; Krumholz, HM				Lipska, Kasia J.; Krumholz, Harlan M.			Is Hemoglobin A(1c) the Right Outcome for Studies of Diabetes?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR OUTCOMES		[Lipska, Kasia J.] Yale Sch Med, Sect Endocrinol & Metab, Dept Internal Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, One Church St,Ste 200, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA	Yale University; Yale University	Krumholz, HM (corresponding author), Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, One Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020		National Institute on Aging; American Federation of Aging Research through the Paul Beeson Career Development Award [K23AG048359]; Yale Claude D. Pepper Older Americans Independence Center [P30AG021342]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG048359, P30AG021342] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation of Aging Research through the Paul Beeson Career Development Award; Yale Claude D. Pepper Older Americans Independence Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Lipska is supported by the National Institute on Aging and the American Federation of Aging Research through the Paul Beeson Career Development Award (grant K23AG048359) and by the Yale Claude D. Pepper Older Americans Independence Center (grant P30AG021342).	Abraira C, 2003, CLIN DIABETES, V21, P107, DOI [DOI 10.2337/DIACLIN.21.3.107, 10.2337/diaclin.21.3.107]; Center for Drug Evaluation and Research, 2008, GUID IND DIAB MELL E; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Rodriguez-Gutierrez R, 2016, CIRC-CARDIOVASC QUAL, V9, P504, DOI 10.1161/CIRCOUTCOMES.116.002901; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	8	64	64	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1017	1018		10.1001/jama.2017.0029	http://dx.doi.org/10.1001/jama.2017.0029			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28125758	Green Accepted			2022-12-28	WOS:000396713400010
J	Chai-Coetzer, CL; Antic, NA; Hamilton, GS; McArdle, N; Wong, K; Yee, BJ; Yeo, A; Ratnavadivel, R; Naughton, MT; Roebuck, T; Woodman, R; McEvoy, RD				Chai-Coetzer, Ching Li; Antic, Nick A.; Hamilton, Garun S.; McArdle, Nigel; Wong, Keith; Yee, Brendon J.; Yeo, Aeneas; Ratnavadivel, Rajeev; Naughton, Matthew T.; Roebuck, Teanau; Woodman, Richard; McEvoy, R. Doug			Physician Decision Making and Clinical Outcomes With Laboratory Polysomnography or Limited-Channel Sleep Studies for Obstructive Sleep Apnea	ANNALS OF INTERNAL MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; MOTOR-VEHICLE CRASH; PORTABLE SLEEP; DAYTIME SLEEPINESS; AMERICAN-COLLEGE; HOME DIAGNOSIS; AUTOTITRATION; MANAGEMENT	Background: The clinical utility of limited-channel sleep studies (which are increasingly conducted at home) versus laboratory polysomnography (PSG) for diagnosing obstructive sleep apnea (OSA) is unclear. Objective: To compare patient outcomes after PSG versus limited-channel studies. Design: Multicenter, randomized, noninferiority study. (Australian New Zealand Clinical Trials Registry: ACTRN126110009 26932) Setting: 7 academic sleep centers. Participants: Patients (n = 406) aged 25 to 80 years with suspected OSA. Intervention: Sleep study information disclosed to sleep physicians comprised level 1 (L1) PSG data (n = 135); level 3 (L3), which included airflow, thoracoabdominal bands, body position, electrocardiography, and oxygen saturation (n = 136); or level 4 (L4), which included oxygen saturation and heart rate (n = 135). Measurements: The primary outcome was change in Functional Outcomes of Sleep Questionnaire (FOSQ) score at 4 months. Secondary outcomes included the Epworth Sleepiness Scale (ESS), the Sleep Apnea Symptoms Questionnaire (SASQ), continuous positive airway pressure (CPAP) compliance, and physician decision making. ] Results: Change in FOSQ score was not inferior for L3 (mean difference [MD], 0.01 [95% CI, -0.47 to 0.49; P = 0.96]) or L4 (MD, -0.46 [CI, -0.94 to 0.02; P = 0.058]) versus L1 (noninferiority margin [NIM], -1.0). Compared with L1, change in ESS score was not inferior for L3 (MD, 0.08 [CI, -0.98 to 1.13; P = 0.89]) but was inconclusive for L4 (MD, 1.30 [CI, 0.26 to 2.35; P = 0.015]) (NIM, 2.0). For L4 versus L1, there was less improvement in SASQ score (-17.8 vs. -24.7; P = 0.018), less CPAP use (4.5 vs. 5.3 hours per night; P = 0.04), and lower physician diagnostic confidence (P = 0.003). Limitation: Limited-channel studies were simulated by extracting laboratory PSG data and were not done in the home. Conclusion: The results support manually scored L3 testing in routine practice. Poorer outcomes with L4 testing may relate, in part, to reduced physician confidence.	[Woodman, Richard] Flinders Univ S Australia, Flinders Ctr Epidemiol & Biostat, Sch Med, GPO Box 2100, Adelaide, SA 5001, Australia; Repatriat Gen Hosp, Adelaide, SA, Australia; [Yeo, Aeneas] Royal Adelaide Hosp, Dept Thorac Med, North Terrace, Adelaide, SA 5000, Australia; Monash Hlth, Melbourne, Vic, Australia; Monash Univ, Melbourne, Vic, Australia; [Naughton, Matthew T.; Roebuck, Teanau] Alfred Hosp, Dept Allergy Immunol & Resp Med, 55 Commercial Rd, Melbourne, Vic 3004, Australia; Sir Charles Gairdner Hosp, Perth, WA, Australia; Royal Prince Alfred Hosp, Sydney, NSW, Australia; Woolcock Inst Med Res, Sydney, NSW, Australia; [Ratnavadivel, Rajeev] Gosford Hosp, Resp & Sleep Med, Holden St, Gosford, NSW 2250, Australia; [Chai-Coetzer, Ching Li; Antic, Nick A.; McEvoy, R. Doug] Repatriat Gen Hosp, Adelaide Inst Sleep Hlth, Flinders Ctr Res Excellence, Daws Rd, Daw Pk, SA 5041, Australia; [Hamilton, Garun S.] Monash Med Ctr, Dept Lung & Sleep, 246 Clayton Rd, Clayton, Vic 3168, Australia; [McArdle, Nigel] Queen Elizabeth II Med Ctr, West Australian Sleep Disorders Res Inst, Internal Mailbox 201,Hosp Ave, Nedlands, WA 6009, Australia; [Wong, Keith; Yee, Brendon J.] Royal Prince Alfred Hosp, Resp & Sleep Med Unit, Missenden Rd, Camperdown, NSW 2050, Australia	Flinders University South Australia; Flinders University South Australia; Royal Adelaide Hospital; Monash University; Florey Institute of Neuroscience & Mental Health; University of Western Australia; University of Sydney; University of Sydney; Woolcock Institute of Medical Research; Flinders University South Australia; Monash University; University of Western Australia; University of Sydney	Chai-Coetzer, CL (corresponding author), Repatriat Gen Hosp, Sleep Hlth Serv, Daws Rd, Daw Pk, SA 5041, Australia.	chingli.chai-coezter@sa.gov.au	McEvoy, Doug/ABB-8052-2020; Yee, Brendon/AAD-7664-2020; Hamilton, Garun/I-6519-2013	McEvoy, Doug/0000-0002-5759-0094; Wong, Keith K H/0000-0001-5191-5233; Woodman, Richard/0000-0002-4094-1222; Yee, Brendon/0000-0002-2196-8649; Hamilton, Garun/0000-0002-1744-2839	National Health and Medical Research Council; Repat Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Repat Foundation	National Health and Medical Research Council and Repat Foundation.	Antic NA, 2009, AM J RESP CRIT CARE, V179, P501, DOI 10.1164/rccm.200810-1558OC; Atwood CW, 2012, SLEEP, V35, P735, DOI 10.5665/sleep.1848; Berry RB, 2008, SLEEP, V31, P1423; Billings ME, 2014, SLEEP, V37, P2017, DOI 10.5665/sleep.4262; Chai-Coetzer CL, 2013, JAMA-J AM MED ASSOC, V309, P997, DOI 10.1001/jama.2013.1823; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; Crawford MR, 2012, THORAX, V67, P920, DOI 10.1136/thoraxjnl-2012-201622; Flemons WW, 2003, CHEST, V124, P1543, DOI 10.1378/chest.124.4.1543; Goudge R, 2001, AM J RESP CRIT CARE, V163, pA933; Guerrero A, 2014, SLEEP, V37, P1363, DOI 10.5665/sleep.3932; Heinzer R, 2015, LANCET RESP MED, V3, P310, DOI 10.1016/S2213-2600(15)00043-0; Iber C., 2007, AASM MANUAL SCORING; Iftikhar IH, 2014, J HYPERTENS, V32, P2341, DOI 10.1097/HJH.0000000000000372; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kirsch DB, 2013, J CLIN SLEEP MED, V9, P5, DOI 10.5664/jcsm.2324; Kuna ST, 2011, AM J RESP CRIT CARE, V183, P1238, DOI 10.1164/rccm.201011-1770OC; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Masa JF, 2014, SLEEP, V37, P1953, DOI 10.5665/sleep.4248; Mulgrew AT, 2007, ANN INTERN MED, V146, P157, DOI 10.7326/0003-4819-146-3-200702060-00004; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Park JG, 2015, J CLIN SLEEP MED, V11, P411, DOI 10.5664/jcsm.4592; Parthasarathy S, 2013, J CLIN SLEEP MED, V9, P9, DOI 10.5664/jcsm.2326; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Phillips B, 2015, AM J RESP CRIT CARE, V192, P915, DOI 10.1164/rccm.201508-1544ED; Qaseem A, 2014, ANN INTERN MED, V161, P210, DOI 10.7326/M12-3187; Quan SF, 2013, J CLIN SLEEP MED, V9, P301, DOI 10.5664/jcsm.2570; Richardson J, 2014, PATIENT, V7, P85, DOI 10.1007/s40271-013-0036-x; Rosen CL, 2012, SLEEP, V35, P757, DOI 10.5665/sleep.1870; Siccoli MM, 2008, SLEEP, V31, P1551, DOI 10.1093/sleep/31.11.1551; Tregear S, 2010, SLEEP, V33, P1373, DOI 10.1093/sleep/33.10.1373; Tregear S, 2009, J CLIN SLEEP MED, V5, P573; Tufik S, 2010, SLEEP MED, V11, P441, DOI 10.1016/j.sleep.2009.10.005; Ward KL, 2015, J CLIN SLEEP MED, V11, P433, DOI 10.5664/jcsm.4600; Weaver T, 1998, AM J RESP CRIT CARE, V157, pA53; Weaver TE, 1997, SLEEP, V20, P835	38	37	37	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					332	+		10.7326/M16-1301	http://dx.doi.org/10.7326/M16-1301			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28114683				2022-12-28	WOS:000396432800006
J	Agus, MSD; Wypij, D; Hirshberg, EL; Srinivasan, V; Faustino, EV; Luckett, PM; Alexander, JL; Asaro, LA; Curley, MAQ; Steil, GM; Nadkarni, VM				Agus, M. S. D.; Wypij, D.; Hirshberg, E. L.; Srinivasan, V.; Faustino, E. V.; Luckett, P. M.; Alexander, J. L.; Asaro, L. A.; Curley, M. A. Q.; Steil, G. M.; Nadkarni, V. M.		HALF-PINT Study Investigators PALI	Tight Glycemic Control in Critically Ill Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE INSULIN THERAPY; RANDOMIZED CONTROLLED-TRIAL; PEDIATRIC CARDIAC-SURGERY; CARE-UNIT; NICE-SUGAR; MORTALITY; HYPERGLYCEMIA; SCORE; HYPOGLYCEMIA; VARIABILITY	BACKGROUND In multicenter studies, tight glycemic control targeting a normal blood glucose level has not been shown to improve outcomes in critically ill adults or children after cardiac surgery. Studies involving critically ill children who have not undergone cardiac surgery are lacking. METHODS In a 35-center trial, we randomly assigned critically ill children with confirmed hyperglycemia (excluding patients who had undergone cardiac surgery) to one of two ranges of glycemic control: 80 to 110 mg per deciliter (4.4 to 6.1 mmol per liter; lower-target group) or 150 to 180 mg per deciliter (8.3 to 10.0 mmol per liter; higher-target group). Clinicians were guided by continuous glucose monitoring and explicit methods for insulin adjustment. The primary outcome was the number of intensive care unit (ICU)-free days to day 28. RESULTS The trial was stopped early, on the recommendation of the data and safety monitoring board, owing to a low likelihood of benefit and evidence of the possibility of harm. Of 713 patients, 360 were randomly assigned to the lower-target group and 353 to the higher-target group. In the intention-to-treat analysis, the median number of ICU-free days did not differ significantly between the lower-target group and the higher-target group (19.4 days [interquartile range {IQR}, 0 to 24.2] and 19.4 days [IQR, 6.7 to 23.9], respectively; P = 0.58). In per-protocol analyses, the median time-weighted average glucose level was significantly lower in the lower-target group (109 mg per deciliter [IQR, 102 to 118]; 6.1 mmol per liter [IQR, 5.7 to 6.6]) than in the higher-target group (123 mg per deciliter [IQR, 108 to 142]; 6.8 mmol per liter [IQR, 6.0 to 7.9]; P< 0.001). Patients in the lower-target group also had higher rates of health care-associated infections than those in the highertarget group (12 of 349 patients [3.4%] vs. 4 of 349 [1.1%], P = 0.04), as well as higher rates of severe hypoglycemia, defined as a blood glucose level below 40 mg per deciliter (2.2 mmol per liter) (18 patients [5.2%] vs. 7 [2.0%], P = 0.03). No significant differences were observed in mortality, severity of organ dysfunction, or the number of ventilator-free days. CONCLUSIONS Critically ill children with hyperglycemia did not benefit from tight glycemic control targeted to a blood glucose level of 80 to 110 mg per deciliter, as compared with a level of 150 to 180 mg per deciliter.	[Agus, M. S. D.; Alexander, J. L.; Steil, G. M.] Boston Childrens Hosp, Div Med Crit Care, Boston, MA USA; [Wypij, D.; Asaro, L. A.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Hirshberg, E. L.] Harvard Med Sch, Boston, MA USA; [Hirshberg, E. L.] Univ Utah, Sch Med, Primary Childrens Hosp, Div Pediat Crit Care, Salt Lake City, UT USA; [Hirshberg, E. L.] Intermt Med Ctr, Murray, UT USA; [Srinivasan, V.; Nadkarni, V. M.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Srinivasan, V.; Curley, M. A. Q.; Nadkarni, V. M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Curley, M. A. Q.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Faustino, E. V.] Yale Sch Med, New Haven, CT USA; [Luckett, P. M.] Childrens Med Ctr Dallas, Dallas, TX USA; [Luckett, P. M.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Yale University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Agus, MSD (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	michael.agus@childrens.harvard.edu	Steil, Garry/R-7673-2019; Curley, Martha A/F-3579-2016; Jouvet, Philippe A/H-3293-2018	Curley, Martha A/0000-0001-5228-6694; Jouvet, Philippe A/0000-0001-5684-3398; Wypij, David/0000-0001-8367-8711; Biagas, Katherine/0000-0002-4669-703X; Medar, Shivanand/0000-0002-1379-6779; Asaro, Lisa/0000-0001-5736-0304; Srinivasan, Vijay/0000-0001-8259-3337; Faustino, Edward Vincent S./0000-0001-6155-2691; sapru, anil/0000-0003-1528-8249	National Heart, Lung, and Blood Institute, National Institutes of Health [U01HL107681-MA/VN, U01HL108028-DW]; Becton, Dickinson, and Company; Roche; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107681, U01HL108028] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Becton, Dickinson, and Company; Roche(Roche Holding); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (U01HL107681-MA/VN and U01HL108028-DW) from the National Heart, Lung, and Blood Institute, National Institutes of Health, by endowed chairs (to Drs. Agus and Nadkarni), and by a departmental investigatorship (to Dr. Steil).r Drs. Agus and Steil report holding a pending patent related to methods and systems for managing diabetes (U.S. provisional patent number, 62/326,496); and Dr. Steil, receiving fees for serving on an advisory board from Becton, Dickinson, and Company, consulting fees from Roche, and continuous glucose monitors and sensors for use in another study from Dexcom. No other potential conflict of interest relevant to this article was reported.	Agus MSD, 2012, NEW ENGL J MED, V367, P1208, DOI 10.1056/NEJMoa1206044; Agus MS, 2016, CONT CLIN TRIALS; [Anonymous], 2017, CDC NHSN SURVEILLANC; Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Ashley A, 2008, NATL REPORT PAEDIATR; Bellomo R, 2009, MAYO CLIN PROC, V84, P400, DOI 10.1016/S0025-6196(11)60557-0; BIER DM, 1977, DIABETES, V26, P1016, DOI 10.2337/diabetes.26.11.1016; De la Rosa GD, 2008, CRIT CARE, V12, DOI 10.1186/cc7017; Draper E, 2007, NATL REPORT PAEDIATR; Faustino EVS, 2010, PEDIATR CRIT CARE ME, V11, P690, DOI 10.1097/PCC.0b013e3181e8f502; Faustino EV, 2005, J PEDIATR-US, V146, P30, DOI 10.1016/j.jpeds.2004.08.076; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Fivez T, 2016, NEW ENGL J MED, V374, P1111, DOI 10.1056/NEJMoa1514762; Gaies MG, 2013, PEDIATR CRIT CARE ME, V14, P148, DOI 10.1097/PCC.0b013e31825b549a; Gaies MG, 2010, PEDIATR CRIT CARE ME, V11, P234, DOI 10.1097/PCC.0b013e3181b806fc; Gennari FJ, 1998, NEW ENGL J MED, V339, P451, DOI 10.1056/NEJM199808133390707; Hirshberg E, 2008, PEDIATR CRIT CARE ME, V9, P361, DOI 10.1097/PCC.0b013e318172d401; Hirshberg EL, 2013, PEDIATR CRIT CARE ME, V14, P123, DOI 10.1097/PCC.0b013e31826049b3; Jacobi J, 2012, CRIT CARE MED, V40, P3251, DOI 10.1097/CCM.0b013e3182653269; Jeschke MG, 2010, AM J RESP CRIT CARE, V182, P351, DOI 10.1164/rccm.201002-0190OC; Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6; Macrae D, 2014, NEW ENGL J MED, V370, P107, DOI 10.1056/NEJMoa1302564; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; Moghissi ES, 2009, DIABETES CARE, V32, P1119, DOI 10.2337/dc09-9029; Piper HG, 2006, PEDIATRICS, V118, P1176, DOI 10.1542/peds.2006-0347; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Qaseem A, 2014, AM J MED QUAL, V29, P95, DOI 10.1177/1062860613489339; Ruttimann UE, 1996, J PEDIATR-US, V128, P35, DOI 10.1016/S0022-3476(96)70425-0; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Srinivasan Vijay, 2004, Pediatr Crit Care Med, V5, P329, DOI 10.1097/01.PCC.0000128607.68261.7C; Steil GM, 2011, PEDIATR CRIT CARE ME, V12, P643, DOI 10.1097/PCC.0b013e31821926a5; Steil Garry M, 2009, J Diabetes Sci Technol, V3, P125; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 2009, J CLIN ENDOCR METAB, V94, P3163, DOI 10.1210/jc.2009-0663; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1	38	94	101	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2017	376	8					729	741		10.1056/NEJMoa1612348	http://dx.doi.org/10.1056/NEJMoa1612348			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JO	28118549	Green Accepted, Bronze			2022-12-28	WOS:000395627900006
J	Hampton, T				Hampton, Tracy			Scientists Discover Off Switch for Genome Editing Technique	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					465	465		10.1001/jama.2016.20535	http://dx.doi.org/10.1001/jama.2016.20535			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28170469				2022-12-28	WOS:000393564200003
J	Asare, A; Levorse, J; Fuchs, E				Asare, Amma; Levorse, John; Fuchs, Elaine			Coupling organelle inheritance with mitosis to balance growth and differentiation	SCIENCE			English	Article							PEROXISOMAL MEMBRANE-PROTEINS; OPTOGENETIC CONTROL; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; GENE-EXPRESSION; PEX11-BETA GENE; STEM-CELLS; DIVISION; PROLIFERATION; ACTIN	Balancing growth and differentiation is essential to tissue morphogenesis and homeostasis. How imbalances arise in disease states is poorly understood. To address this issue, we identified transcripts differentially expressed in mouse basal epidermal progenitors versus their differentiating progeny and those altered in cancers. We used an in vivo RNA interference screen to unveil candidates that altered the equilibrium between the basal proliferative layer and suprabasal differentiating layers forming the skin barrier. We found that epidermal progenitors deficient in the peroxisome-associated protein Pex11b failed to segregate peroxisomes properly and entered a mitotic delay that perturbed polarized divisions and skewed daughter fates. Together, our findings unveil a role for organelle inheritance in mitosis, spindle alignment, and the choice of daughter progenitors to differentiate or remain stem-like.	[Asare, Amma; Levorse, John; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Robin Chemers Neustein Lab Mammalian Cell Biol &, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Robin Chemers Neustein Lab Mammalian Cell Biol &, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Asare, Amma/0000-0002-4865-6864	Medical Scientist Training Program grant from the NIH [T32GM007739]; National Cancer Institute Ruth L. Kirschstein National Research Service Award for Individual Predoctoral Fellows [F31CA180724-03]; United Negro College Fund/Merck Science Initiative Graduate Fellowship; NIH [R37-AR27883]; NATIONAL CANCER INSTITUTE [F31CA180724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR027883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Medical Scientist Training Program grant from the NIH; National Cancer Institute Ruth L. Kirschstein National Research Service Award for Individual Predoctoral Fellows; United Negro College Fund/Merck Science Initiative Graduate Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Mazel and the Rockefeller University FACS facility for assistance in cell sorting, and C. Lai for assistance in high-throughput sequencing (Rockefeller University Genomics Resource Center). We thank E.F. lab members D. Oristian, M. Sribour, and L. Polak for assistance in mouse research; H.A. Pasolli for ultrastructure; M. Nikolova, J. Racelis, and E. Wong for technical assistance; S. Chai for generating and testing the K10RFP mice; and B. Keyes, I. Matos, S. Beronja, and E. Heller for discussions and suggestions. A. A. was supported by a Medical Scientist Training Program grant from the NIH under award number T32GM007739, National Cancer Institute Ruth L. Kirschstein National Research Service Award for Individual Predoctoral Fellows (F31CA180724-03), and a United Negro College Fund/Merck Science Initiative Graduate Fellowship. E.F. is a Howard Hughes Medical Institute Investigator. This work was supported by grants from the NIH (R37-AR27883 to E.F.). RNA-seq data are deposited in the Gene Expression Omnibus database under accession number GSE75931. The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to E.F. All reagents engineered in the course of this study are available from jdelacruz@rockefeller.edu under a material transfer agreement with the Rockefeller University. Plasmids are available from jdelacruz@rockefeller.edu under a material transfer agreement with Rockefeller University. Author contributions: A. A. and E.F. conceived the project, designed the experiments, and wrote the manuscript. A.A. performed the experiments. J.L. carried out key in utero lentiviral injections in the final 18 months of this project.	Abe I, 1998, FEBS LETT, V431, P468, DOI 10.1016/S0014-5793(98)00815-1; Ahlemeyer B, 2012, DIS MODEL MECH, V5, P125, DOI 10.1242/dmm.007708; Ballister ER, 2015, CURR BIOL, V25, pR407, DOI 10.1016/j.cub.2015.03.056; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Bharti P, 2011, J CELL SCI, V124, P1759, DOI 10.1242/jcs.079368; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Collings DA, 2003, PLANTA, V218, P204, DOI 10.1007/s00425-003-1096-2; Delille HK, 2010, J CELL SCI, V123, P2750, DOI 10.1242/jcs.062109; Duan LT, 2015, CHEM BIOL, V22, P671, DOI 10.1016/j.chembiol.2015.04.014; Ebberink MS, 2012, J MED GENET, V49, P307, DOI 10.1136/jmedgenet-2012-100778; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fagarasanu A, 2009, J CELL BIOL, V186, P541, DOI 10.1083/jcb.200904050; Fox MA, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-24; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; Gallini S, 2016, CURR BIOL, V26, P458, DOI 10.1016/j.cub.2015.12.051; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gotte K, 1998, MOL CELL BIOL, V18, P616; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Huyghe S, 2001, BIOCHEM J, V353, P673, DOI 10.1042/0264-6021:3530673; Janssen A, 2000, LAB INVEST, V80, P31, DOI 10.1038/labinvest.3780005; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384; Kobayashi S, 2007, EXP CELL RES, V313, P1675, DOI 10.1016/j.yexcr.2007.02.028; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Kotak S, 2014, EMBO J, V33, P1815, DOI 10.15252/embj.201488147; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; Krikken AM, 2009, FEBS J, V276, P1429, DOI 10.1111/j.1742-4658.2009.06883.x; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Li XL, 2002, MOL CELL BIOL, V22, P4358, DOI 10.1128/MCB.22.12.4358-4365.2002; Li XL, 2002, J CELL BIOL, V156, P643, DOI 10.1083/jcb.200112028; MARSHALL PA, 1995, J CELL BIOL, V129, P345, DOI 10.1083/jcb.129.2.345; Mathur J, 2002, PLANT PHYSIOL, V128, P1031, DOI 10.1104/pp.011018; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Nguyen T, 2006, J CELL SCI, V119, P636, DOI 10.1242/jcs.02776; Niessen MT, 2013, J CELL BIOL, V202, P887, DOI 10.1083/jcb.201307001; Orth T, 2007, PLANT CELL, V19, P333, DOI 10.1105/tpc.106.045831; Qian W, 2012, J CELL SCI, V125, P5745, DOI 10.1242/jcs.109769; Rohn JL, 2014, CURR BIOL, V24, P2598, DOI 10.1016/j.cub.2014.09.045; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; SAKAI Y, 1995, J BACTERIOL, V177, P6773, DOI 10.1128/jb.177.23.6773-6781.1995; Schollenberger L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013886; Schrader M, 2000, J CELL SCI, V113, P3663; Schrader M, 1996, EUR J CELL BIOL, V69, P24; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Seldin L, 2016, ELIFE, V5, DOI 10.7554/eLife.12504; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Bergeijk P, 2015, NATURE, V518, P111, DOI 10.1038/nature14128; Wiemer EAC, 1997, J CELL BIOL, V136, P71, DOI 10.1083/jcb.136.1.71; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Zheng Z, 2014, MOL BIOL CELL, V25, P606, DOI 10.1091/mbc.E13-08-0474	54	54	54	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324							eaah4701	10.1126/science.aah4701	http://dx.doi.org/10.1126/science.aah4701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154022	Green Accepted			2022-12-28	WOS:000393183100037
J	Dong, XC; Zhao, B; Iacob, RE; Zhu, JH; Koksal, AC; Lu, CF; Engen, JR; Springer, TA				Dong, Xianchi; Zhao, Bo; Iacob, Roxana E.; Zhu, Jianghai; Koksal, Adem C.; Lu, Chafen; Engen, John R.; Springer, Timothy A.			Force interacts with macromolecular structure in activation of TGF-beta	NATURE			English	Article							CRYSTAL-STRUCTURE; INTEGRIN; SCATTERING; FIBRONECTIN; LIGAND	Integrins are adhesion receptors that transmit force across the plasma membrane between extracellular ligands and the actin cytoskeleton. In activation of the transforming growth factor-beta 1 precursor (pro-TGF-beta 1), integrins bind to the prodomain, apply force, and release the TGF-beta growth factor. However, we know little about how integrins bind macromolecular ligands in the extracellular matrix or transmit force to them. Here we show how integrin alpha(V)beta(6) binds pro-TGF-beta 1 in an orientation biologically relevant for force-dependent release of TGF-beta from latency. The conformation of the prodomain integrin-binding motif differs in the presence and absence of integrin binding; differences extend well outside the interface and illustrate how integrins can remodel extracellular matrix. Remodelled residues outside the interface stabilize the integrin-bound conformation, adopt a conformation similar to earlier-evolving family members, and show how macromolecular components outside the binding motif contribute to integrin recognition. Regions in and outside the highly interdigitated interface stabilize a specific integrin/pro-TGF-beta orientation that defines the pathway through these macromolecules which actin-cytoskeleton-generated tensile force takes when applied through the integrin beta-subunit. Simulations of force-dependent activation of TGF-beta demonstrate evolutionary specializations for force application through the TGF-beta prodomain and through the beta- and not alpha-subunit of the integrin.	[Dong, Xianchi; Zhao, Bo; Zhu, Jianghai; Koksal, Adem C.; Lu, Chafen; Springer, Timothy A.] Harvard Med Sch, Childrens Hosp Boston, Boston, MA 02115 USA; [Dong, Xianchi; Zhao, Bo; Zhu, Jianghai; Koksal, Adem C.; Lu, Chafen; Springer, Timothy A.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Iacob, Roxana E.; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Northeastern University	Springer, TA (corresponding author), Harvard Med Sch, Childrens Hosp Boston, Boston, MA 02115 USA.; Springer, TA (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	timothy.springer@childrens.harvard.edu	Zhao, Bo/GVT-7665-2022	Zhao, Bo/0000-0002-2163-6484; Engen, John R./0000-0002-6918-9476; Koksal, Adem/0000-0002-3163-7421	National Institutes of Health [R01AR067288]; Charles A. King Trust; Bank of America, N.A.; Waters Corporation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King Trust; Bank of America, N.A.; Waters Corporation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grant R01AR067288, the Charles A. King Trust Postdoctoral Research Fellowship Program, Bank of America, N.A., Co-Trustee, and research collaboration with the Waters Corporation. For crystallography, SAXS, and simulations, we thank GM/CA-CAT beamline 23-ID at the Advanced Photon Source, beamline X9A at the National Synchotron Light Source, and the Pittsburgh Supercomputing Center, respectively.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Chen Y, 2015, CURR OPIN STRUC BIOL, V30, P89, DOI 10.1016/j.sbi.2015.02.001; Clarke J, 2005, PROTEIN FOLDING HANDBOOK, P1111, DOI 10.1002/9783527619498.ch31; Dong XC, 2014, NAT STRUCT MOL BIOL, V21, P1091, DOI 10.1038/nsmb.2905; Eng ET, 2011, J BIOL CHEM, V286, P35218, DOI 10.1074/jbc.M111.275107; Evans E, 1999, BIOPHYS J, V76, P2439, DOI 10.1016/S0006-3495(99)77399-6; Hinck A. P., 2016, COLD SPRING HARB PER, V8, DOI [10.1101/cshperspect.a022103, DOI 10.1101/CSHPERSPECT.A022103]; Iacob RE, 2013, J PHARM SCI-US, V102, P4315, DOI 10.1002/jps.23754; Janssens K, 2006, J MED GENET, V43, P1, DOI 10.1136/jmg.2005.033522; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Mi LZ, 2015, P NATL ACAD SCI USA, V112, P3710, DOI 10.1073/pnas.1501303112; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; Nordenfelt P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13119; Robertson IB, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021907; Robertson IB, 2013, CYTOKINE GROWTH F R, V24, P355, DOI 10.1016/j.cytogfr.2013.06.003; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Sen M, 2013, J CELL BIOL, V203, P629, DOI 10.1083/jcb.201308083; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Van Agthoven JF, 2014, NAT STRUCT MOL BIOL, V21, P383, DOI 10.1038/nsmb.2797; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wang S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01448; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhou MY, 2011, BLOOD, V117, P4623, DOI 10.1182/blood-2010-11-321596; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037	26	149	159	6	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					55	+		10.1038/nature21035	http://dx.doi.org/10.1038/nature21035			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28117447	Green Submitted, Green Accepted			2022-12-28	WOS:000396119300031
J	Tollefson, J				Tollefson, Jeff			ATMOSPHERIC SCIENCE Weather-data race heats up	NATURE			English	Editorial Material																			0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					18	18		10.1038/542018a	http://dx.doi.org/10.1038/542018a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6MY	28150790	Bronze			2022-12-28	WOS:000396119300010
J	Greer, SL; Rominski, SD				Greer, Scott L.; Rominski, Sarah D.			PERSONAL VIEW The global gag rule and what to do about it	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Greer, Scott L.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Rominski, Sarah D.] Univ Michigan, Sch Med, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Greer, SL (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA.		Finkelstein, Mikal/AAF-7278-2021	Greer, Scott Edward Lennarson/0000-0002-5288-0471				[Anonymous], 2017, PRESIDENTIAL MEMORAN; Bendavid E, 2011, B WORLD HEALTH ORGAN, V89, P873, DOI 10.2471/BLT.11.091660; Jones KM., 2011, EVALUATING MEXICO CI; Noack R., 2017, WASHINGTON POST	4	1	1	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2017	356								j511	10.1136/bmj.j511	http://dx.doi.org/10.1136/bmj.j511			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BQ	28148475				2022-12-28	WOS:000393449800005
J	Asner, GP; Martin, RE; Knapp, DE; Tupayachi, R; Anderson, CB; Sinca, F; Vaughn, NR; Llactayo, W				Asner, G. P.; Martin, R. E.; Knapp, D. E.; Tupayachi, R.; Anderson, C. B.; Sinca, F.; Vaughn, N. R.; Llactayo, W.			FOREST CONSERVATION Airborne laser-guided imaging spectroscopy to map forest trait diversity and guide conservation	SCIENCE			English	Article							BIODIVERSITY; CARBON	Functional biogeography may bridge a gap between field-based biodiversity information and satellite-based Earth system studies, thereby supporting conservation plans to protect more species and their contributions to ecosystem functioning. We used airborne laser-guided imaging spectroscopy with environmental modeling to derive large-scale, multivariate forest canopy functional trait maps of the Peruvian Andes-to-Amazon biodiversity hotspot. Seven mapped canopy traits revealed functional variation in a geospatial pattern explained by geology, topography, hydrology, and climate. Clustering of canopy traits yielded a map of forest beta functional diversity for land-use analysis. Up to 53% of each mapped, functionally distinct forest presents an opportunity for new conservation action. Mapping functional diversity advances our understanding of the biosphere to conserve more biodiversity in the face of land use and climate change.	[Asner, G. P.; Martin, R. E.; Knapp, D. E.; Tupayachi, R.; Anderson, C. B.; Sinca, F.; Vaughn, N. R.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Llactayo, W.] Minist Ambiente, Direcc Gen Ordenamiento Territorial, San Isidro, Lima, Peru	Carnegie Institution for Science	Asner, GP (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	gpa@carnegiescience.edu	Asner, Gregory/G-9268-2013; Tupayachi, Raul/F-3986-2011; Martin, Roberta/A-5073-2015	Asner, Gregory/0000-0001-7893-6421; Tupayachi, Raul/0000-0002-4661-2075; Sinca, Felipe/0000-0002-0505-9576; Vaughn, Nicholas/0000-0003-0428-2909; Martin, Roberta/0000-0003-3509-8530; Anderson, Christopher/0000-0001-7392-4368	John D. and Catherine T. MacArthur Foundation	John D. and Catherine T. MacArthur Foundation	Data maps are available at http://cao.carnegiescience.edu/maps. This study was funded by the John D. and Catherine T. MacArthur Foundation.	Asner GP, 2016, GLOBAL CHANGE BIOL, V22, P2216, DOI 10.1111/gcb.13164; Asner GP, 2015, REMOTE SENS ENVIRON, V158, P15, DOI 10.1016/j.rse.2014.11.011; Asner GP, 2014, P NATL ACAD SCI USA, V111, P5604, DOI 10.1073/pnas.1401181111; Asner GP, 2013, P NATL ACAD SCI USA, V110, P18454, DOI 10.1073/pnas.1318271110; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Chadwick KD, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020087; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Field C., 1986, EC PLANT FORM FUNCTI, P22; Fyllas NM, 2009, BIOGEOSCIENCES, V6, P2677, DOI 10.5194/bg-6-2677-2009; Girardin CAJ, 2010, GLOBAL CHANGE BIOL, V16, P3176, DOI 10.1111/j.1365-2486.2010.02235.x; Gornish ES, 2014, J VEG SCI, V25, P919, DOI 10.1111/jvs.12150; Gutierrez-Velez VH, 2013, REMOTE SENS ENVIRON, V129, P154, DOI 10.1016/j.rse.2012.10.033; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kokaly RF, 2009, REMOTE SENS ENVIRON, V113, pS78, DOI 10.1016/j.rse.2008.10.018; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myneni RB, 1997, IEEE T GEOSCI REMOTE, V35, P1380, DOI 10.1109/36.649788; Nemani RR, 1995, CLIMATIC CHANGE, V31, P395, DOI 10.1007/BF01095154; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Sakschewski B, 2016, NAT CLIM CHANGE, V6, P1032, DOI [10.1038/nclimate3109, 10.1038/NCLIMATE3109]; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Silman M. R., 2006, TROPICAL RAIN FOREST, P285; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; Townsend AR, 2008, TRENDS ECOL EVOL, V23, P424, DOI 10.1016/j.tree.2008.04.009; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; Ustin SL, 2004, BIOSCIENCE, V54, P523, DOI 10.1641/0006-3568(2004)054[0523:UISTSE]2.0.CO;2; Violle C, 2014, P NATL ACAD SCI USA, V111, P13690, DOI 10.1073/pnas.1415442111; von Humboldt Alexander, 1808, ASPECTS NATURE DIFFE	28	160	171	5	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					385	388		10.1126/science.aaj1987	http://dx.doi.org/10.1126/science.aaj1987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126815				2022-12-28	WOS:000393172800036
J	de Vrieze, J				de Vrieze, Jop			GLOBAL HEALTH Big studies clash over fetal growth rates New paper takes aim at global reference charts for unborn babies	SCIENCE			English	News Item																			0	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					336	336		10.1126/science.355.6323.336	http://dx.doi.org/10.1126/science.355.6323.336			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126764				2022-12-28	WOS:000393172800013
J	Spitzer, MH; Carmi, Y; Reticker-Flynn, NE; Kwek, SS; Madhireddy, D; Martins, MM; Gherardini, PF; Prestwood, TR; Chabon, J; Bendall, SC; Fong, L; Nolan, GP; Engleman, EG				Spitzer, Matthew H.; Carmi, Yaron; Reticker-Flynn, Nathan E.; Kwek, Serena S.; Madhireddy, Deepthi; Martins, Maria M.; Gherardini, Pier Federico; Prestwood, Tyler R.; Chabon, Jonathan; Bendall, Sean C.; Fong, Lawrence; Nolan, Garry P.; Engleman, Edgar G.			Systemic Immunity Is Required for Effective Cancer Immunotherapy	CELL			English	Article							REGULATORY T-CELLS; MASS CYTOMETRY; BREAST-CANCER; TUMOR; IDENTIFICATION; PATIENT	Immune responses involve coordination across cell types and tissues. However, studies in cancer immunotherapy have focused heavily on local immune responses in the tumor microenvironment. To investigate immune activity more broadly, we performed an organism-wide study in genetically engineered cancer models using mass cytometry. We analyzed immune responses in several tissues after immunotherapy by developing intuitive models for visualizing single-cell data with statistical inference. Immune activation was evident in the tumor and systemically shortly after effective therapy was administered. However, during tumor rejection, only peripheral immune cells sustained their proliferation. This systemic response was coordinated across tissues and required for tumor eradication in several immunotherapy models. An emergent population of peripheral CD4 T cells conferred protection against new tumors and was significantly expanded in patients responding to immunotherapy. These studies demonstrate the critical impact of systemic immune responses that drive tumor rejection.	[Spitzer, Matthew H.; Carmi, Yaron; Reticker-Flynn, Nathan E.; Martins, Maria M.; Prestwood, Tyler R.; Chabon, Jonathan; Bendall, Sean C.; Engleman, Edgar G.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Spitzer, Matthew H.; Madhireddy, Deepthi; Gherardini, Pier Federico; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Spitzer, Matthew H.; Nolan, Garry P.; Engleman, Edgar G.] Stanford Univ, Program Immunol, Stanford, CA 94305 USA; [Spitzer, Matthew H.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Kwek, Serena S.; Fong, Lawrence] Univ Calif San Francisco, Dept Med, Div Hematol & Oncol, San Francisco, CA 94143 USA; [Spitzer, Matthew H.; Fong, Lawrence] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Carmi, Yaron] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Ramat Aviv, Israel	Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Tel Aviv University; Sackler Faculty of Medicine	Spitzer, MH; Engleman, EG (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Spitzer, MH; Nolan, GP (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.; Spitzer, MH; Nolan, GP; Engleman, EG (corresponding author), Stanford Univ, Program Immunol, Stanford, CA 94305 USA.; Spitzer, MH (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Spitzer, MH (corresponding author), Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA.	matthew.spitzer@ucsf.edu; gnolan@stanford.edu; edengleman@stanford.edu	Bendall, Sean/AGG-0126-2022; Nolan, Garry/AAE-7903-2019; Reticker-Flynn, Nathan/R-7226-2019	Spitzer, Matthew/0000-0002-5291-3819; Nolan, Garry/0000-0002-8862-9043; Bendall, Sean/0000-0003-1341-2453; Reticker-Flynn, Nathan/0000-0002-9963-039X	NIH [F31CA189331, DP5OD023056, F32CA189408, U19AI057229, U19AI100627, R33CA183654, R01HL120724, R01CA196657, U54CA209971, R01AI118884]; DOD [OC110674, 11491122]; Gates Foundation [OPP1113682]; NIAID [HHSN272201200028C]; FDA [HHSF223201210194C BAA-12-00118]; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA196657, R33CA183654, F31CA189331, F32CA189408, U54CA209971] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, R01AI118884, U19AI100627] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD023056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Gates Foundation(Bill & Melinda Gates Foundation); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FDA(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G.K. Fragiadakis and L.E. Sanman for helpful conversations and feedback and A. Trejo and A. Jager for CyTOF maintenance. M.H.S., P.F.G., L.F., and G.P.N. are investigators of the Parker Institute for Cancer Immunotherapy. G.P.N. has a personal financial interest in, and S.C.B. has been a paid consultant for, Fluidigm, manufacturer of the mass cytometer utilized. E.G.E. is a founder and board member of Bolt Biotherapeutics, licensee of the therapy with alloIgG. This work was supported by NIH grants F31CA189331 and DP5OD023056 to M.H.S.; NIH grant F32CA189408 to N.R.F.; NIH grants U19AI057229, U19AI100627, R33CA183654, and R01HL120724, DOD grants OC110674 and 11491122, Gates Foundation grant OPP1113682, NIAID grant HHSN272201200028C, and FDA grant HHSF223201210194C BAA-12-00118 to G.P.N.; NIH grants R01CA196657 and U54CA209971 to G.P.N. and E.G.E.; and NIH grant R01AI118884 to E.G.E.	Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Bruggner RV, 2014, P NATL ACAD SCI USA, V111, pE2770, DOI 10.1073/pnas.1408792111; Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; Carmi Y, 2015, NATURE, V521, P99, DOI 10.1038/nature14424; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Cheng GY, 2012, J IMMUNOL, V189, P1780, DOI 10.4049/jimmunol.1103768; Cohen CJ, 2015, J CLIN INVEST, V125, P3981, DOI 10.1172/JCI82416; Cooley W.B., 1893, AM J MED SCI, V105, P487, DOI [10.1097/00000441-189305000-00001, DOI 10.1097/00000441-189305000-00001]; CORBETT TH, 1975, CANCER RES, V35, P2434; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; Hanninen A, 2011, EUR J IMMUNOL, V41, P634, DOI 10.1002/eji.201040760; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hotson AN, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaa9303; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Kwek SS, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1101204; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Pelletier N, 2010, NAT IMMUNOL, V11, P1110, DOI 10.1038/ni.1954; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rosenberg SA, 2014, NAT REV CLIN ONCOL, V11, P630, DOI 10.1038/nrclinonc.2014.174; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Spranger S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-3; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	41	484	498	11	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					487	+		10.1016/j.cell.2016.12.022	http://dx.doi.org/10.1016/j.cell.2016.12.022			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5CU	28111070	Bronze, Green Accepted			2022-12-28	WOS:000424595700001
J	Abbasi, J				Abbasi, Jennifer			CDC Says More Needle Exchange Programs Needed to Prevent HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					350	350		10.1001/jama.2016.19452	http://dx.doi.org/10.1001/jama.2016.19452			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118437				2022-12-28	WOS:000392509600004
J	Cooney, CR; Bright, JA; Capp, EJR; Chira, AM; Hughes, EC; Moody, CJA; Nouri, LO; Varley, ZK; Thomas, GH				Cooney, Christopher R.; Bright, Jen A.; Capp, Elliot J. R.; Chira, Angela M.; Hughes, Emma C.; Moody, Christopher J. A.; Nouri, Lara O.; Varley, Zoe K.; Thomas, Gavin H.			Mega-evolutionary dynamics of the adaptive radiation of birds	NATURE			English	Article							PRINCIPAL COMPONENTS; R PACKAGE; DIVERSIFICATION; DIVERSITY; SPECIATION; MODELS; REVEALS; TREE	The origin and expansion of biological diversity is regulated by both developmental trajectories(1,2) and limits on available ecological niches(3-7). As lineages diversify, an early and often rapid phase of species and trait proliferation gives way to evolutionary slow-downs as new species pack into ever more densely occupied regions of ecological niche space(6,8). Small clades such as Darwin's finches demonstrate that natural selection is the driving force of adaptive radiations, but how microevolutionary processes scale up to shape the expansion of phenotypic diversity over much longer evolutionary timescales is unclear(9). Here we address this problem on a global scale by analysing a crowdsourced dataset of three-dimensional scanned bill morphology from more than 2,000 species. We find that bill diversity expanded early in extant avian evolutionary history, before transitioning to a phase dominated by packing of morphological space. However, this early phenotypic diversification is decoupled from temporal variation in evolutionary rate: rates of bill evolution vary among lineages but are comparatively stable through time. We find that rare, but major, discontinuities in phenotype emerge from rapid increases in rate along single branches, sometimes leading to depauperate clades with unusual bill morphologies. Despite these jumps between groups, the major axes of within-group bill-shape evolution are remarkably consistent across birds. We reveal that macroevolutionary processes underlying global-scale adaptive radiations support Darwinian(9) and Simpsonian(4) ideas of microevolution within adaptive zones and accelerated evolution between distinct adaptive peaks.	[Cooney, Christopher R.; Bright, Jen A.; Capp, Elliot J. R.; Chira, Angela M.; Hughes, Emma C.; Moody, Christopher J. A.; Nouri, Lara O.; Varley, Zoe K.; Thomas, Gavin H.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Bright, Jen A.] Univ S Florida, Sch Geosci, Tampa, FL 33620 USA; [Bright, Jen A.] Univ S Florida, Ctr Virtualizat & Appl Spatial Technol, Tampa, FL 33620 USA; [Thomas, Gavin H.] Nat Hist Museum, Dept Life Sci, Bird Grp, Tring, Herts, England	University of Sheffield; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Natural History Museum London	Thomas, GH (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.; Thomas, GH (corresponding author), Nat Hist Museum, Dept Life Sci, Bird Grp, Tring, Herts, England.	gavin.thomas@sheffield.ac.uk	Thomas, Gavin/AAE-8959-2019; Bright, Jen/AAK-8750-2020; Hughes, Emma/AAT-1648-2020	Bright, Jen/0000-0002-9284-9591; Hughes, Emma/0000-0003-4682-6257; Thomas, Gavin/0000-0002-1982-6051; Cooney, Christopher/0000-0002-4872-9146	European Research Council [615709]; Royal Society University Research Fellowship [UF120016]	European Research Council(European Research Council (ERC)European Commission); Royal Society University Research Fellowship(Royal Society of London)	We thank M. Adams, H. van Grouw and R. Prys-Jones from the Bird Group at the NHM, Tring and H. McGhie at the Manchester Museum for providing access to and expertise in the collections: S. Meiri of Tel Aviv University for providing a sample of study skins; S. Stone of Mechlnovation Ltd for providing training and advice on 3D scanning; M. Groves, J. McLaughlin and M. Pidd of HRI Digital for the construction of http://www.markmybird.org; A. Beckerman for advice on analysing P matrices: E. Rayfield, A. Pigot, A. Mooers and A. White for providing valuable comments on pre-submission drafts of the manuscript. Finally, we are indebted to the volunteer citizen scientists at http://www.markmybird.org for helping to build the database of bird bill shape and contribute to our understanding of avian evolution. This work was funded by the European Research Council (grant number 615709 Project 'ToLERates') and bye Royal Society University Research Fellowship to G.H.T.(UF120016).	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Bright JA, 2016, P NATL ACAD SCI USA, V113, P5352, DOI 10.1073/pnas.1602683113; Brusatte SL, 2015, CURR BIOL, V25, pR888, DOI 10.1016/j.cub.2015.08.003; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Etienne RS, 2012, P ROY SOC B-BIOL SCI, V279, P1300, DOI 10.1098/rspb.2011.1439; Ezard THG, 2016, ECOL LETT, V19, P899, DOI 10.1111/ele.12626; Finarelli JA, 2013, EVOLUTION, V67, P3678, DOI 10.1111/evo.12222; Fruciano C, 2016, DEV GENES EVOL, V226, P139, DOI 10.1007/s00427-016-0537-4; Grant P.R., 1999, RECOGNITION STATES L, V2; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Hughes M, 2013, P NATL ACAD SCI USA, V110, P13875, DOI 10.1073/pnas.1302642110; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jonsson KA, 2012, P NATL ACAD SCI USA, V109, P6620, DOI 10.1073/pnas.1115835109; Klingenberg CP, 2013, HYSTRIX, V24, P15, DOI 10.4404/hystrix-24.1-7691; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Lamichhaney S, 2015, NATURE, V518, P371, DOI 10.1038/nature14181; Losos J.B., 2010, EVOLUTION DARWIN 1 1, P381; Lovette IJ, 2002, P ROY SOC B-BIOL SCI, V269, P37, DOI 10.1098/rspb.2001.1789; Mitchell JS, 2015, EVOLUTION, V69, P2414, DOI 10.1111/evo.12738; Mitchell JS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0608; Pennell MW, 2014, BIOINFORMATICS, V30, P2216, DOI 10.1093/bioinformatics/btu181; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Pigot AL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2013; Price T, 2008, SPECIATION BIRDS; Price TD, 2014, NATURE, V509, P222, DOI 10.1038/nature13272; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Rabosky DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089543; Rabosky DL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2958; Rabosky DL, 2010, P NATL ACAD SCI USA, V107, P22178, DOI 10.1073/pnas.1007606107; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Reznick DN, 2009, NATURE, V457, P837, DOI 10.1038/nature07894; Ricklefs Robert E., 2005, American Naturalist, V165, P651, DOI 10.1086/429676; Robinson MR, 2013, ECOL LETT, V16, P281, DOI 10.1111/ele.12047; Rohlf FJ, 2015, HYSTRIX, V26, P9, DOI 10.4404/hystrix-26.1-11264; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Slater GJ, 2015, P NATL ACAD SCI USA, V112, P4897, DOI 10.1073/pnas.1403666111; Thomas GH, 2012, METHODS ECOL EVOL, V3, P145, DOI 10.1111/j.2041-210X.2011.00132.x; Uyeda JC, 2015, SYST BIOL, V64, P677, DOI 10.1093/sysbio/syv019; Venditti C, 2011, NATURE, V479, P393, DOI 10.1038/nature10516; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	46	162	165	4	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					344	+		10.1038/nature21074	http://dx.doi.org/10.1038/nature21074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2LQ	28146475	Green Accepted, Green Submitted			2022-12-28	WOS:000394451600036
J	John, A				John, Alex			Equipoise in Research Integrating Ethics and Science in Human Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-RESEARCH		[John, Alex] Carnegie Mellon Univ, Dept Philosophy, Pittsburgh, PA 15213 USA	Carnegie Mellon University	John, A (corresponding author), Carnegie Mellon Univ, Dept Philosophy, Ctr Eth & Policy, 135 Baker Hall, Pittsburgh, PA 15213 USA.	ajlondon@andrew.cmu.edu		London, Alex/0000-0002-6450-0309				FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Guyatt G., 2015, CUREUS J MED SCIENCE, V3rd ed., DOI DOI 10.7759/CUR; Hellman D, 2002, J LAW MED ETHICS, V30, P375, DOI 10.1111/j.1748-720X.2002.tb00406.x; Lascarrou JB, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2016.20603, DOI 10.1001/JAMA.2016.20603]; Lilford RJ, 1995, J ROY SOC MED, V88, P552; London AJ, 2007, OXFORD HDB BIOETHICS, P571; London AJ, 2006, STAT MED, V25, P2869, DOI 10.1002/sim.2634; Miller PB, 2003, KENNEDY INST ETHIC J, V13, P93, DOI 10.1353/ken.2003.0014; Sackett DL, 2000, CAN MED ASSOC J, V163, P835; van der Graaf R, 2011, CLIN TRIALS, V8, P408, DOI 10.1177/1740774511409600	10	39	40	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					525	526		10.1001/jama.2017.0016	http://dx.doi.org/10.1001/jama.2017.0016			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ9RN	28170466				2022-12-28	WOS:000393564200021
J	Rubin, R				Rubin, Rita			Profile: Institute for Health Metrics and Evaluation, WA, USA	LANCET			English	Editorial Material													Rubin, Rita/AAD-1259-2020						0	9	12	2	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					493	493		10.1016/S0140-6736(17)30263-5	http://dx.doi.org/10.1016/S0140-6736(17)30263-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ5UH	28170325				2022-12-28	WOS:000393283400019
J	Rogers, JG; Pagani, FD; Tatooles, AJ; Bhat, G; Slaughter, MS; Birks, EJ; Boyce, SW; Najjar, SS; Jeevanandam, V; Anderson, AS; Gregoric, ID; Mallidi, H; Leadley, K; Aaronson, KD; Frazier, OH; Milano, CA				Rogers, Joseph G.; Pagani, Francis D.; Tatooles, Antone J.; Bhat, Geetha; Slaughter, Mark S.; Birks, Emma J.; Boyce, Steven W.; Najjar, Samer S.; Jeevanandam, Valluvan; Anderson, Allen S.; Gregoric, Igor D.; Mallidi, Hari; Leadley, Katrin; Aaronson, Keith D.; Frazier, O. H.; Milano, Carmelo A.			Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DRUG ADMINISTRATION-APPROVAL; CONTINUOUS-FLOW; INTERAGENCY REGISTRY; PUMP THROMBOSIS; CIRCULATORY SUPPORT; II DEVICE; BRIDGE; TRANSPLANT; EVENTS; UPDATE	BACKGROUND Mechanical circulatory support with a left ventricular assist device (LVAD) is an established treatment for patients with advanced heart failure. We compared a newer LVAD design (a small intrapericardial centrifugal-flow device) against existing technology (a commercially available axial-flow device) in patients with advanced heart failure who were ineligible for heart transplantation. METHODS We conducted a multicenter randomized trial involving 446 patients who were assigned, in a 2: 1 ratio, to the study (centrifugal-flow) device or the control (axial-flow) device. Adults who met contemporary criteria for LVAD implantation for permanent use were eligible to participate in the trial. The primary end point was survival at 2 years free from disabling stroke or device removal for malfunction or failure. The trial was powered to show noninferiority with a margin of 15 percentage points. RESULTS The intention-to treat-population included 297 participants assigned to the study device and 148 participants assigned to the control device. The primary end point was achieved in 164 patients in the study group and 85 patients in the control group. The analysis of the primary end point showed noninferiority of the study device relative to the control device (estimated success rates, 55.4% and 59.1%, respectively, calculated by the Weibull model; absolute difference, 3.7 percentage points; 95% upper confidence limit, 12.56 percentage points; P = 0.01 for noninferiority). More patients in the control group than in the study group had device malfunction or device failure requiring replacement (16.2% vs. 8.8%), and more patients in the study group had strokes (29.7% vs. 12.1%). Quality of life and functional capacity improved to a similar degree in the two groups. CONCLUSIONS In this trial involving patients with advanced heart failure who were ineligible for heart transplantation, a small, intrapericardial, centrifugal-flow LVAD was found to be noninferior to an axial-flow LVAD with respect to survival free from disabling stroke or device removal for malfunction or failure.	[Rogers, Joseph G.; Milano, Carmelo A.] Duke Univ, Sch Med, Durham, NC USA; [Pagani, Francis D.; Aaronson, Keith D.] Univ Michigan, Ann Arbor, MI 48109 USA; [Tatooles, Antone J.; Bhat, Geetha] Advocate Christ Med Ctr, Oak Lawn, IL USA; [Jeevanandam, Valluvan] Univ Chicago Med, Chicago, IL USA; [Anderson, Allen S.] Northwestern Mem Hosp, Chicago, IL USA; [Slaughter, Mark S.; Birks, Emma J.] Univ Louisville, Louisville, KY 40292 USA; [Boyce, Steven W.; Najjar, Samer S.] MedStar Heart Inst, Washington, DC USA; [Gregoric, Igor D.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Mallidi, Hari; Frazier, O. H.] Texas Heart Inst, Houston, TX USA; [Leadley, Katrin] HeartWare, Framingham, MA USA	Duke University; University of Michigan System; University of Michigan; Northwestern Memorial Hospital; University of Louisville; University of Texas System; University of Texas Health Science Center Houston; Texas Heart Institute	Rogers, JG (corresponding author), Duke Univ, Med Ctr, Div Cardiovasc Med, Duke Clin Res Inst, Box 3034 DUMC, Durham, NC 27710 USA.	joseph.rogers@duke.edu		Pagani, Francis/0000-0003-4430-9969; Anderson, Allen/0000-0001-7216-2613	HeartWare	HeartWare	Supported by HeartWare.	Aaronson KD, 2012, CIRCULATION, V125, P3191, DOI 10.1161/CIRCULATIONAHA.111.058412; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Interagency Registry for Mechanically Assisted Circulatory Support, 2016, APP O PROF ADV HEART; Interagency Registry for Mechanically Assisted Circulatory Support, 2013, APP A ADV EV DEF; Jeffries N, 2015, J HEART LUNG TRANSPL, V34, P1505, DOI 10.1016/j.healun.2015.10.036; Jorde UP, 2014, J AM COLL CARDIOL, V63, P1751, DOI 10.1016/j.jacc.2014.01.053; Kirklin JK, 2015, J HEART LUNG TRANSPL, V34, P1515, DOI 10.1016/j.healun.2015.10.024; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P12, DOI 10.1016/j.healun.2013.11.001; LaRose JA, 2010, ASAIO J, V56, P285, DOI 10.1097/MAT.0b013e3181dfbab5; Miller LW, 2007, NEW ENGL J MED, V357, P885, DOI 10.1056/NEJMoa067758; Najjar SS, 2014, J HEART LUNG TRANSPL, V33, P23, DOI 10.1016/j.healun.2013.12.001; Pagani FD, 2009, J AM COLL CARDIOL, V54, P312, DOI 10.1016/j.jacc.2009.03.055; Park SJ, 2012, CIRC-HEART FAIL, V5, P241, DOI 10.1161/CIRCHEARTFAILURE.111.963991; Slaughter MS, 2013, J HEART LUNG TRANSPL, V32, P675, DOI 10.1016/j.healun.2013.04.004; Slaughter MS, 2011, SEMIN THORAC CARDIOV, V23, P245, DOI 10.1053/j.semtcvs.2011.07.008; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Smedira NG, 2015, J HEART LUNG TRANSPL, V34, P1527, DOI 10.1016/j.healun.2015.10.027; Starling RC, 2014, NEW ENGL J MED, V370, P33, DOI 10.1056/NEJMoa1313385; Starling RC, 2011, J AM COLL CARDIOL, V57, P1890, DOI 10.1016/j.jacc.2010.10.062; Teuteberg JJ, 2015, JACC-HEART FAIL, V3, P818, DOI 10.1016/j.jchf.2015.05.011; Wieselthaler GM, 2010, J HEART LUNG TRANSPL, V29, P1218, DOI 10.1016/j.healun.2010.05.016	21	456	458	2	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 2	2017	376	5					451	460		10.1056/NEJMoa1602954	http://dx.doi.org/10.1056/NEJMoa1602954			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8WH	28146651	Bronze			2022-12-28	WOS:000393507200008
J	Stroebe, M; Stroebe, W; Schut, H; Boerner, K				Stroebe, Margaret; Stroebe, Wolfgang; Schut, Henk; Boerner, Kathrin			Grief is not a disease but bereavement merits medical awareness	LANCET			English	Editorial Material							COMPLICATED GRIEF		[Stroebe, Margaret; Schut, Henk] Univ Utrecht, Dept Clin Psychol, NL-3508 TC Utrecht, Netherlands; [Stroebe, Wolfgang] Univ Groningen, Dept Social & Org Psychol, Groningen, Netherlands; [Stroebe, Margaret] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands; [Boerner, Kathrin] Univ Massachusetts, Dept Gerontol, McCormack Grad Sch, Boston, MA 02125 USA	Utrecht University; University of Groningen; University of Groningen; University of Massachusetts System; University of Massachusetts Boston	Stroebe, M (corresponding author), Univ Utrecht, Dept Clin Psychol, NL-3508 TC Utrecht, Netherlands.; Stroebe, M (corresponding author), Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands.	m.s.stroebe@uu.nl	Schut, Henk/E-7487-2013; Boerner, Kathrin/M-1504-2019					[Anonymous], 2013, BEREAVEMENT STUDIES, DOI DOI 10.4324/9781315829753; Burke LA., 2013, COMPLICATED GRIEF SC, P145, DOI [10.4324/9780203105115, DOI 10.4324/9780203105115]; Doering BK, 2016, CURR OPIN PSYCHIATR, V29, P286, DOI 10.1097/YCO.0000000000000263; Doka K. J., 2011, KUBLER ROSS NEW PERS; Eisma MC, 2013, J ABNORM PSYCHOL, V122, P961, DOI 10.1037/a0034051; Galatzer-Levy IR, 2016, PERSPECT PSYCHOL SCI, V11, P195, DOI 10.1177/1745691615621277; Li J, 2016, PLOS MED, V11; O'Connor M.-F, 2013, COMPLICATED GRIEF SC, P204, DOI DOI 10.4324/9780203105115; Rolden HJA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115478; Shear MK, 2016, JAMA PSYCHIAT, V73, P685, DOI 10.1001/jamapsychiatry.2016.0892; Stroebe M, OMEGA J DEA IN PRESS; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Stroebe M, 2015, OMEGA-J DEATH DYING, V71, P272, DOI 10.1177/0030222815575504; Walter T, 2011, OMEGA-J DEATH DYING, V64, P275, DOI 10.2190/OM.64.4.a; Zisook S, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0482-8	15	27	27	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					347	349						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	28137681	Green Submitted			2022-12-28	WOS:000392804700012
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Social care crisis needs meaningful solutions, not tinkering and soundbites	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Bingham J., 2016, DAILY TELEGRAPH; Campbell D, 2016, GUARDIAN; Donovan T., 2016, COMMUNITY CARE; Health Committee, 2016, STAT SOC CAR FOLL LA; Healthwatch England, 2015, SAF HOM WHAT HAPP PE; Jayanetti C, 2016, GUARDIAN; King's Fund, 2016, SOC CAR OLD PEOPL HO; King's Fund Barker Commission, 2014, NEW SETTL SOC CAR FI; Local Government Association, 2014, PRESS COUNC AR PLANN; Mortimer J, 2015, BRIEFING HLTH CARE O; National Audit Office, 2014, IMP FUND CUTS LOC AU; National Audit Office, 2016, HC18 SESS 2016 17; RAVEN R J, 1988, American Museum Novitates, P1; Richmond Group of Charities, 2016, REAL LIV LIST VOIC P; Thane P., LECT KINGS COLL LOND; Younger R., 2016, ITV NEWS        1123	16	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2017	356								j436	10.1136/bmj.j436	http://dx.doi.org/10.1136/bmj.j436			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HW	28130267	Bronze, Green Published			2022-12-28	WOS:000393178500001
J	Iacobucci, G				Iacobucci, Gareth			NHS in 2017: Where next?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												giacobucci@bmj.com						Campbell D., HOSP TOLD CUT STAFF; Care Quality Commission, STAT CAR 2015 16; Carter P., 2016, OPERATIONAL PRODUCTI; Cole A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a725; Department for Business Energy and Industrial Strategy, 2016, COAL GEN GREAT BRIT; HAWKES N, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G2671; Owen C., 1989, Thatcheria, V24, P1; Honeyman M, 2016, DIGITAL NHS INTRO DI; Hunt J., 2016, COMMUNICATION; IACOBUCCI G, 2016, BMJ-BRIT MED J, V353, DOI DOI 10.1136/BMJ.I3423; Iacobucci G, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j204; Iacobucci G, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6738; Iacobucci G, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6691; Iacobucci G, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j41; Iacobucci G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6514; Iacobucci G, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i272; Iacobucci G, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6411; Iacobucci G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2274; Inman P., 2016, IFS WARNS BREXIT WOU; Lind S., 2015, PULSE; Meacock R, 2015, HEALTH ECON, V24, P907, DOI 10.1002/hec.3207; National Information Board, 2014, PERS HLTH CAR 2020; NHS England, 2016, GEN PRACT FORW VIEW; NHS England, 2014, 5 YEAR FORW VIEW; Nuffield Trust, 2014, COMP HLTH SYST UK NH; Nuffield Trust King's Fund Health Foundation, AUT STAT JOINT STAT; OECD, 2016, HLTH AT A GLANC; OECD. Health at a glance, 2016, HLTH GLANC 2016 DOES; RAVEN R J, 1988, American Museum Novitates, P1; Rimmer A., 2016, BMJ CAREERS; Royal College of Physicians, 2015, EV BREATH WE TAK LIF; WHITE C, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ.I309; Wise J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i109	33	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2017	356								j331	10.1136/bmj.j331	http://dx.doi.org/10.1136/bmj.j331			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HL	28119284				2022-12-28	WOS:000393177400005
J	Levine, M				Levine, Mitchell			In older adults with COPD, new opioid use was linked to increased risk for respiratory and all-cause mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Levine, Mitchell] McMaster Univ, Hamilton, ON, Canada	McMaster University	Levine, M (corresponding author), McMaster Univ, Hamilton, ON, Canada.								0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					JC11	JC11		10.7326/ACPJC-2017-166-2-011	http://dx.doi.org/10.7326/ACPJC-2017-166-2-011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	28114467				2022-12-28	WOS:000391842600010
J	Shahab, L; Goniewicz, ML; Blount, BC; Brown, J; McNeill, A; Alwis, KU; Feng, J; Wang, LQ; West, R				Shahab, Lion; Goniewicz, Maciej L.; Blount, Benjamin C.; Brown, Jamie; McNeill, Ann; Alwis, K. Udeni; Feng, June; Wang, Lanqing; West, Robert			Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users A Cross-sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							ELECTRONIC CIGARETTES; CARBON-MONOXIDE; RISK-ASSESSMENT; CANCER-RISK; TOBACCO; SMOKING; DELIVERY; SMOKERS; SAFETY; URINE	Background: Given the rapid increase in the popularity of e-cigarettes and the paucity of associated longitudinal healthrelated data, the need to assess the potential risks of long-term use is essential. Objective: To compare exposure to nicotine, tobacco-related carcinogens, and toxins among smokers of combustible cigarettes only, former smokers with long-term e-cigarette use only, former smokers with long-term nicotine replacement therapy (NRT) use only, long-term dual users of both combustible cigarettes and e-cigarettes, and long-term users of both combustible cigarettes and NRT. Design: Cross-sectional study. Setting: United Kingdom. Participants: The following 5 groups were purposively recruited: combustible cigarette-only users, former smokers with longterm (= 6 months) e-cigarette-only or NRT-only use, and longterm dual combustible cigarette-e-cigarette or combustible cigarette-NRT users (n = 36 to 37 per group; total n = 181). Measurements: Sociodemographic and smoking characteristics were assessed. Participants provided urine and saliva samples and were analyzed for biomarkers of nicotine, tobaccospecific N-nitrosamines (TSNAs), and volatile organic compounds (VOCs). Results: After confounders were controlled for, no clear between-group differences in salivary or urinary biomarkers of nicotine intake were found. The e-cigarette-only and NRT-only users had significantly lower metabolite levels for TSNAs (including the carcinogenic metabolite 4-(methylnitrosamino)-1-(3pyridyl)- 1-butanol [NNAL]) and VOCs (including metabolites of the toxins acrolein; acrylamide; acrylonitrile; 1,3-butadiene; and ethylene oxide) than combustible cigarette-only, dual combustible cigarette-e-cigarette, or dual combustible cigarette-NRT users. The e-cigarette-only users had significantly lower NNAL levels than all other groups. Combustible cigarette-only, dual combustible cigarette-NRT, and dual combustible cigarette-ecigarette users had largely similar levels of TSNA and VOC metabolites. Limitation: Cross-sectional design with self-selected sample. Conclusion: Former smokers with long-term e-cigarette-only or NRT-only use may obtain roughly similar levels of nicotine compared with smokers of combustible cigarettes only, but results varied. Long-term NRT-only and e-cigarette-only use, but not dual use of NRTs or e-cigarettes with combustible cigarettes, is associated with substantially reduced levels of measured carcinogens and toxins relative to smoking only combustible cigarettes.	[Shahab, Lion; West, Robert] UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington St, London WC1E 7HB, England; [McNeill, Ann] Kings Coll London, Inst Psychiat Psychol & Neurosci, Addict Dept, 4 Windsor Walk, London SE5 8AF, England; [Goniewicz, Maciej L.] Roswell Pk Canc Inst, Dept Hlth Behav, Elm & Carlton St, Buffalo, NY 14263 USA; [Blount, Benjamin C.; Alwis, K. Udeni; Feng, June; Wang, Lanqing] Ctr Dis Control & Prevent, Tobacco & Volatiles Branch, Div Sci Lab, Natl Ctr Environm Hlth, 4770 Buford Highway, Atlanta, GA 30341 USA; [Brown, Jamie] UCL, Dept Clin Educ & Hlth Psychol, 1-19 Torrington St, London WC1E 7HB, England	University of London; University College London; University of London; King's College London; Roswell Park Cancer Institute; Centers for Disease Control & Prevention - USA; University of London; University College London	Shahab, L (corresponding author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington St, London WC1E 7HB, England.	lion.shahab@ucl.ac.uk	Goniewicz, Maciej Lukasz/Z-1604-2019; Brown, Jamie/F-4413-2011; Goniewicz, Maciej L/D-8986-2012; Shahab, Lion/B-5835-2009; West, Robert/B-5414-2009	Goniewicz, Maciej Lukasz/0000-0001-6748-3068; Brown, Jamie/0000-0002-2797-5428; Shahab, Lion/0000-0003-4033-442X; West, Robert/0000-0001-6398-0921; McNeill, Ann/0000-0002-6223-4000	Cancer Research UK [C27061/A16929, C1417/A14135, C36048/A11654, C1417/A7972, C44576/A19501]; Society for the Study of Addiction; Medical Research Council; British Heart Foundation; Economic and Social Research Council; National Institute for Health Research under UK Clinical Research Collaboration [MR/K023195/1]; National Institute on Drug Abuse of the National Institutes of Health [R01DA037446, P30 CA016056]; National Cancer Institute of the National Institutes of Health [R01DA037446, P30 CA016056]; Roswell Park Alliance Foundation; Cancer Research UK [14135, 22962, 16929] Funding Source: researchfish; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1] Funding Source: researchfish; Versus Arthritis [19501] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Society for the Study of Addiction; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research under UK Clinical Research Collaboration(National Institute for Health Research (NIHR)); National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Roswell Park Alliance Foundation; Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	This work was supported by Cancer Research UK (grant C27061/A16929, with additional funding from grants C1417/A14135 and C36048/A11654). Dr. Brown's post is funded by a fellowship from the Society for the Study of Addiction, and Cancer Research UK also provides support (grants C1417/A7972 and C44576/A19501). Drs. McNeill and West are part of the UK Centre for Tobacco and Alcohol Studies, which is a UK Clinical Research Collaboration Public Health Research Centre of Excellence. Funding from the Medical Research Council, British Heart Foundation, Cancer Research UK, Economic and Social Research Council, and the National Institute for Health Research under the auspices of the UK Clinical Research Collaboration is gratefully acknowledged (grant MR/K023195/1). Dr. Goniewicz was supported by the National Institute on Drug Abuse and the National Cancer Institute of the National Institutes of Health (awards R01DA037446 and P30 CA016056, respectively) and by an award from Roswell Park Alliance Foundation.	Alwis KU, 2012, ANAL CHIM ACTA, V750, P152, DOI 10.1016/j.aca.2012.04.009; [Anonymous], 2004, TOB SMOK INV SMOK, V83; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brose LS, 2013, ADDICT BEHAV, V38, P2529, DOI 10.1016/j.addbeh.2013.04.006; Brown J, 2014, ADDICT BEHAV, V39, P1120, DOI 10.1016/j.addbeh.2014.03.009; Bullen C, 2010, TOB CONTROL, V19, P98, DOI 10.1136/tc.2009.031567; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Burns D M, 2008, Tob Control, V17, P132, DOI 10.1136/tc.2007.024158; Burstyn I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-18; Cohen JT, 2002, J TOXICOL ENV HEAL B, V5, P1, DOI 10.1080/10937400252972162; Dawkins L, 2014, PSYCHOPHARMACOLOGY, V231, P401, DOI 10.1007/s00213-013-3249-8; Dillon MC, 2010, BIOMARK INSIGHTS, V5, P57; Etter JF, 2011, TOB CONTROL, V20, P243, DOI 10.1136/tc.2010.042168; Fagerstrom K O, 1997, Tob Control, V6, P311; Farsalinos KE, 2015, ADDICTION, V110, P1352, DOI 10.1111/add.12942; Farsalinos KE, 2015, INT J ENV RES PUB HE, V12, P3439, DOI 10.3390/ijerph120403439; Farsalinos KE, 2014, THER ADV DRUG SAF, V5, P67, DOI 10.1177/2042098614524430; Farsalinos KE, 2014, SCI REP-UK, V4, DOI 10.1038/srep04133; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fowles J, 2003, TOB CONTROL, V12, P424, DOI 10.1136/tc.12.4.424; Goniewicz ML, 2017, NICOTINE TOB RES, V19, P160, DOI 10.1093/ntr/ntw160; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Hajek P, 2014, ADDICTION, V109, P1801, DOI 10.1111/add.12659; Haussmann HJ, 2012, CHEM RES TOXICOL, V25, P794, DOI 10.1021/tx200536w; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hecht SS, 2015, NICOTINE TOB RES, V17, P704, DOI 10.1093/ntr/ntu218; Hornung R.W., 1990, APPL OCCUP ENV HYG, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V89, P1; International Agency for Research on Cancer, 2012, IARC MON EV CARC RIS, V100E; International Agency for Research on Cancer, 1995, IARC MONOGRAPHS EVAL, V63; JACOB P, 1991, BIOL MASS SPECTROM, V20, P247, DOI 10.1002/bms.1200200503; Jacob P, 2002, CANCER EPIDEM BIOMAR, V11, P1668; JACOB P, 1981, J CHROMATOGR, V222, P61, DOI 10.1016/S0378-4347(00)81033-6; Jain RB, 2015, ENVIRON TOXICOL PHAR, V40, P471, DOI 10.1016/j.etap.2015.07.018; Jensen RP, 2015, NEW ENGL J MED, V372, P392, DOI 10.1056/NEJMc1413069; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Kim HJ, 2013, J CHROMATOGR A, V1291, P48, DOI 10.1016/j.chroma.2013.03.035; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; Le Houezec J, 2011, DRUG ALCOHOL REV, V30, P119, DOI 10.1111/j.1465-3362.2010.00264.x; Lee YH, 2015, ADDICT BEHAV, V48, P1, DOI 10.1016/j.addbeh.2015.04.003; Malaiyandi V, 2005, CLIN PHARMACOL THER, V77, P145, DOI 10.1016/j.clpt.2004.10.011; McGuffey JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101816; McMillen RC, 2015, NICOTINE TOB RES, V17, P1195, DOI 10.1093/ntr/ntu213; McNeill A., 2015, REPORT COMMISSIONED; McQueen A, 2011, NICOTINE TOB RES, V13, P860, DOI 10.1093/ntr/ntr088; McRobbie H, 2015, CANCER PREV RES, V8, P873, DOI 10.1158/1940-6207.CAPR-15-0058; MOORE D, 2009, BRIT MED J, V338, DOI DOI 10.1136/BMJ.B1024; Murray RP, 2009, NICOTINE TOB RES, V11, P1076, DOI 10.1093/ntr/ntp104; National Institute for Health and Care Excellence, 2013, SMOK HARM RED; Nelson VA, 2015, DRUG ALCOHOL DEPEN, V153, P300, DOI 10.1016/j.drugalcdep.2015.05.005; O'Brien KM, 2016, ENVIRON HEALTH PERSP, V124, P220, DOI 10.1289/ehp.1509693; Ouellet-Morin I, 2011, BRAIN BEHAV IMMUN, V25, P640, DOI 10.1016/j.bbi.2010.12.020; Rose JE, 2010, PSYCHOPHARMACOLOGY, V210, P1, DOI 10.1007/s00213-010-1810-2; Schraufnagel DE, 2014, AM J RESP CRIT CARE, V190, P611, DOI 10.1164/rccm.201407-1198PP; Shahab L, 2018, NICOTINE TOB RES, V20, P81, DOI 10.1093/ntr/ntw258; Shahab L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113045; Shahab L, 2012, DRUG ALCOHOL DEPEN, V121, P38, DOI 10.1016/j.drugalcdep.2011.08.011; Shields PG, 2011, CANCER PREV RES, V4, P1719, DOI 10.1158/1940-6207.CAPR-11-0453; Silla K, 2014, NICOTINE TOB RES, V16, P1050, DOI 10.1093/ntr/ntu019; Smith CJ, 1997, FOOD CHEM TOXICOL, V35, P1107, DOI 10.1016/S0278-6915(97)00063-X; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Stepanov I, 2014, INT J CANCER, V134, P2278, DOI 10.1002/ijc.28575; Stepanov I, 2009, CANCER RES, V69, P8236, DOI 10.1158/0008-5472.CAN-09-1084; Sussan TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116861; Vansickel AR, 2013, NICOTINE TOB RES, V15, P267, DOI 10.1093/ntr/ntr316; Vardavas CI, 2015, TOB CONTROL, V24, P442, DOI [10.1136/tobaccocontrol-2013-051394, 10.1136/tobaccocontrol-2012-050857]; Weaver VM, 2000, CANCER EPIDEM BIOMAR, V9, P749; Wei BNA, 2014, CLIN CHIM ACTA, V436, P290, DOI 10.1016/j.cca.2014.06.012; Xia BY, 2014, BIOMED CHROMATOGR, V28, P375, DOI 10.1002/bmc.3031	70	326	333	6	129	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					390	+		10.7326/M16-1107	http://dx.doi.org/10.7326/M16-1107			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9RM	28166548	Green Submitted, Green Accepted			2022-12-28	WOS:000397025800014
J	Shiels, MS; Chernyavskiy, P; Anderson, WF; Best, AF; Haozous, EA; Hartge, P; Rosenberg, PS; Thomas, D; Freedman, ND; de Gonzalez, AB				Shiels, Meredith S.; Chernyavskiy, Pavel; Anderson, William F.; Best, Ana F.; Haozous, Emily A.; Hartge, Patricia; Rosenberg, Philip S.; Thomas, David; Freedman, Neal D.; de Gonzalez, Amy Berrington			Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data	LANCET			English	Article							UNITED-STATES; AMERICAN-INDIANS; CIGARETTE-SMOKING; ALASKA NATIVES; RISK-FACTORS; HEALTH; RATES; INDIVIDUALS; PATTERNS; SERVICES	Background Reduction of premature mortality is a UN Sustainable Development Goal. Unlike other high-income countries, age-adjusted mortality in the USA plateaued in 2010 and increased slightly in 2015, possibly because of rising premature mortality. We aimed to analyse trends in mortality in the USA between 1999 and 2014 in people aged 25-64 years by age group, sex, and race and ethnicity, and to identify specific causes of death underlying the temporal trends. Methods For this analysis, we used cause-of-death and demographic data from death certificates from the US National Center for Health Statistics, and population estimates from the US Census Bureau. We estimated annual percentage changes in mortality using age-period-cohort models. Age-standardised excess deaths were estimated for 2000 to 2014 as observed deaths minus expected deaths (estimated from 1999 mortality rates). Findings Between 1999 and 2014, premature mortality increased in white individuals and in American Indians and Alaska Natives. Increases were highest in women and those aged 25-30 years. Among 30-year-olds, annual mortality increases were 2.3% (95% CI 2.1-2.4) for white women, 0.6% (0.5-0.7) for white men, and 4.3% (3.5-5.0) and 1.9% (1.3-2.5), respectively, for American Indian and Alaska Native women and men. These increases were mainly attributable to accidental deaths (primarily drug poisonings), chronic liver disease and cirrhosis, and suicide. Among individuals aged 25-49 years, an estimated 111 000 excess premature deaths occurred in white individuals and 6600 in American Indians and Alaska Natives during 2000-14. By contrast, premature mortality decreased substantially across all age groups in Hispanic individuals (up to 3.2% per year), black individuals (up to 3.9% per year), and Asians and Pacific Islanders (up to 2.6% per year), mainly because of declines in HIV, cancer, and heart disease deaths, resulting in an estimated 112 000 fewer deaths in Hispanic individuals, 311 000 fewer deaths in black individuals, and 34 000 fewer deaths in Asians and Pacific Islanders aged 25-64 years. During 2011-14, American Indians and Alaska Natives had the highest premature mortality, followed by black individuals. Interpretation Important public health successes, including HIV treatment and smoking cessation, have contributed to declining premature mortality in Hispanic individuals, black individuals, and Asians and Pacific Islanders. However, this progress has largely been negated in young and middle-aged (25-49 years) white individuals, and American Indians and Alaska Natives, primarily because of potentially avoidable causes such as drug poisonings, suicide, and chronic liver disease and cirrhosis. The magnitude of annual mortality increases in the USA is extremely unusual in high-income countries, and a rapid public health response is needed to avert further premature deaths.	[Shiels, Meredith S.; Chernyavskiy, Pavel; Anderson, William F.; Best, Ana F.; Hartge, Patricia; Rosenberg, Philip S.; Freedman, Neal D.; de Gonzalez, Amy Berrington] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Haozous, Emily A.] Univ New Mexico, Coll Nursing, Albuquerque, NM 87131 USA; [Thomas, David] NIDA, Div Epidemiol Serv & Prevent Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of New Mexico; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Shiels, MS (corresponding author), NCI, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr, Bethesda, MD 20892 USA.	shielsms@mail.nih.gov	Freedman, Neal David/B-9741-2015; Haozous, Emily/AAX-1119-2021; de gonzalez, amy berrington/L-7017-2017	Freedman, Neal David/0000-0003-0074-1098; Haozous, Emily/0000-0003-1363-1453; de gonzalez, amy berrington/0000-0002-7332-8387; Best, Ana/0000-0002-4467-1725; Rosenberg, Philip/0000-0001-6349-9126	US National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010150] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	US National Cancer Institute Intramural Research Program.	Ahmad F., 2016, Q PROVISIONAL ESTIMA; [Anonymous], 2015, DEATHS MORT RAT SEL; [Anonymous], 2015, ASS SECR PLANN EV IS; [Anonymous], 2014, OP PAINK PRESCR; Arias E, 2016, VALIDITY RACE HISPAN; Arias Elizabeth, 2008, Vital Health Stat 2, P1; Berterame S, 2016, LANCET, V387, P1644, DOI 10.1016/S0140-6736(16)00161-6; Buchanich JM, 2016, PREV MED, V89, P317, DOI 10.1016/j.ypmed.2016.04.007; Byers T, 2016, CA-CANCER J CLIN, V66, P359, DOI 10.3322/caac.21348; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Centers for Disease Control and Prevention National Center for Health Statistics, DEATH RAT 282 SEL CA; Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P354; Chen Li Hui, 2014, NCHS Data Brief, P1; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Cobb N, 2014, AM J PUBLIC HEALTH, V104, pS481, DOI 10.2105/AJPH.2014.301879; Department of Health and Human Services Indian Health Service, 2011, INP MENT HLTH ASS; Dominguez K, 2015, MMWR-MORBID MORTAL W, V64, P469; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; GBD, 2022, GBD COMPARE; Han B, 2015, JAMA-J AM MED ASSOC, V314, P1468, DOI 10.1001/jama.2015.11859; Hastings KG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124341; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Jacobs EJ, 2015, ANN EPIDEMIOL, V25, P179, DOI 10.1016/j.annepidem.2014.11.008; Jacobs-Wingo JL, 2016, AM J PUBLIC HEALTH, V106, P906, DOI 10.2105/AJPH.2015.303033; Jamal A, 2015, MMWR-MORBID MORTAL W, V64, P1233, DOI 10.15585/mmwr.mm6444a2; Jim MA, 2014, AM J PUBLIC HEALTH, V104, pS295, DOI 10.2105/AJPH.2014.301933; Jones CM, 2015, MMWR-MORBID MORTAL W, V64, P719; Kochanek Kenneth D, 2015, NCHS Data Brief, P1; Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1; Kunitz SJ, 2008, AM J PUBLIC HEALTH, V98, P404, DOI 10.2105/AJPH.2007.114538; Ma JM, 2015, JAMA-J AM MED ASSOC, V314, P1731, DOI 10.1001/jama.2015.12319; Men T, 2003, BRIT MED J, V327, P964, DOI 10.1136/bmj.327.7421.964; Murthy VH, 2017, JAMA-J AM MED ASSOC, V317, P133, DOI 10.1001/jama.2016.18215; Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9; Noymer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015812; Office for National Statistics, 2015, DEATH REG SUMM TABL; Office for National Statistics, 2016, DEATHS REL DRUG POIS; Parks SE, 2014, MMWR SURVEILL SUMM, V63, P1; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Rosenberg PS, 2014, CANCER EPIDEM BIOMAR, V23, P2296, DOI 10.1158/1055-9965.EPI-14-0300; Ross RE, 2015, J HEALTH CARE POOR U, V26, P1081, DOI 10.1353/hpu.2015.0129; Rudd RA, 2014, MORB MORTAL WKLY REP; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; United States Department of Health and Human Services, 2014, 2014 SURG GEN REP HL; Urban Indian Health Institute, 2012, ADDR DEPR AM IND AL	46	154	158	1	72	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2017	389	10073					1043	1054		10.1016/S0140-6736(17)30187-3	http://dx.doi.org/10.1016/S0140-6736(17)30187-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EN9UN	28131493	Green Accepted			2022-12-28	WOS:000396345200026
J	Cao, YL; Meng, SX; Chen, Y; Feng, JX; Gu, DD; Yu, B; Li, YJ; Yang, JY; Liao, S; Chan, DC; Gao, S				Cao, Yu-Lu; Meng, Shuxia; Chen, Yang; Feng, Jian-Xiong; Gu, Dong-Dong; Yu, Bing; Li, Yu-Jie; Yang, Jin-Yu; Liao, Shuang; Chan, David C.; Gao, Song			MFN1 structures reveal nucleotide-triggered dimerization critical for mitochondrial fusion	NATURE			English	Article							CRYSTAL-STRUCTURE; FISSION; OLIGOMERIZATION; MORPHOLOGY; MITOFUSINS; CURVATURE; MECHANISM; DYNAMICS; INSIGHTS; SYSTEM	Mitochondria are double-membraned organelles with variable shapes influenced by metabolic conditions, developmental stage, and environmental stimuli(1-4). Their dynamic morphology is a result of regulated and balanced fusion and fission processes(5,6). Fusion is crucial for the health and physiological functions of mitochondria, including complementation of damaged mitochondrial DNAs and the maintenance of membrane potential(6-8). Mitofusins are dynamin-related GTPases that are essential for mitochondrial fusion(9,10). They are embedded in the mitochondrial outer membrane and thought to fuse adjacent mitochondria via combined oligomerization and GTP hydrolysis(11-13). However, the molecular mechanisms of this process remain unknown. Here we present crystal structures of engineered human MFN1 containing the GTPase domain and a helical domain during different stages of GTP hydrolysis. The helical domain is composed of elements from widely dispersed sequence regions of MFN1 and resembles the 'neck' of the bacterial dynamin-like protein. The structures reveal unique features of its catalytic machinery and explain how GTP binding induces conformational changes to promote GTPase domain dimerization in the transition state. Disruption of GTPase domain dimerization abolishes the fusogenic activity of MFN1. Moreover, a conserved aspartate residue trigger was found to affect mitochondrial elongation in MFN1, probably through a GTP-loading-dependent domain rearrangement. Thus, we propose a mechanistic model for MFN1-mediated mitochondrial tethering, and our results shed light on the molecular basis of mitochondrial fusion and mitofusin-related human neuromuscular disorders(14).	[Cao, Yu-Lu; Chen, Yang; Feng, Jian-Xiong; Gu, Dong-Dong; Yu, Bing; Li, Yu-Jie; Yang, Jin-Yu; Liao, Shuang; Gao, Song] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China; [Meng, Shuxia; Chan, David C.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	State Key Lab Oncology South China; Sun Yat Sen University; California Institute of Technology	Gao, S (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China.	gaosong@sysucc.org.cn	Li, yu/HHZ-5236-2022; Chen, Yang/AFL-4729-2022; Li, YuJie/HGT-8657-2022; Chen, Yang/L-7304-2018	Chen, Yang/0000-0001-7661-5923; Gao, Song/0000-0001-7427-6681; Liao, Shuang/0000-0002-1016-6149	National Basic Research Program of China [2013CB910500]; National Natural Science Foundation of China [31200553]; Natural Science Foundation of Guangdong Province [2014TQ01R584, 20144030312015]; New Century Excellent Talents in University [NCET-12-0567]; Recruitment Program of Global Youth Experts; National Institutes of Health [GM110039, GM119388]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119388, R01GM083121, R01GM110039] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Recruitment Program of Global Youth Experts; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at beamline BL17U1 of SSRF for the help with the collection of diffraction data, W.-L. Huang and H.-Y. Wang for technical assistance, J. Hu and X. Guo for advice on liposome tethering assay, and O. Daumke for comments on the manuscript. This work was supported by grants of National Basic Research Program of China (2013CB910500), National Natural Science Foundation of China (31200553). Natural Science Foundation of Guangdong Province (2014TQ01R584 and 20144030312015), New Century Excellent Talents in University (NCET-12-0567) and the Recruitment Program of Global Youth Experts to S.G., and the National Institutes of Health (GM110039 and GM119388) to D.C.C.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Brandt T, 2016, ELIFE, V5, DOI 10.7554/eLife.14618; Byrnes LJ, 2013, EMBO J, V32, P369, DOI 10.1038/emboj.2012.353; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Franco A, 2016, NATURE, V540, P74, DOI 10.1038/nature20156; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Kozlov MM, 2014, CURR OPIN CELL BIOL, V29, P53, DOI 10.1016/j.ceb.2014.03.006; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu TY, 2015, P NATL ACAD SCI USA, V112, pE1851, DOI 10.1073/pnas.1504368112; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon HT, 2010, CELL, V140, P601, DOI 10.1016/j.cell.2010.02.017; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Ranieri M, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/293893; Rennie ML, 2014, STRUCTURE, V22, P1433, DOI 10.1016/j.str.2014.08.015; Richard JP, 2011, BIOCHEM J, V440, P185, DOI 10.1042/BJ20111243; Rojo M, 2002, J CELL SCI, V115, P1663; Santel A, 2001, J CELL SCI, V114, P867; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	51	159	167	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					372	+		10.1038/nature21077	http://dx.doi.org/10.1038/nature21077			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2LQ	28114303	Green Accepted			2022-12-28	WOS:000394451600042
J	Kaiser-Bunbury, CN; Mougal, J; Whittington, AE; Valentin, T; Gabriel, R; Olesen, JM; Bluthgen, N				Kaiser-Bunbury, Christopher N.; Mougal, James; Whittington, Andrew E.; Valentin, Terence; Gabriel, Ronny; Olesen, Jens M.; Bluethgen, Nico			Ecosystem restoration strengthens pollination network resilience and function	NATURE			English	Article							ALIEN PLANTS; BIODIVERSITY; SPECIALIZATION; METAANALYSIS; MUTUALISMS; TOLERANCE; DECLINES; IMPACTS	Land degradation results in declining biodiversity and the disruption of ecosystem functioning worldwide, particularly in the tropics(1). Vegetation restoration is a common tool used to mitigate these impacts and increasingly aims to restore ecosystem functions rather than species diversity(2). However, evidence from community experiments on the effect of restoration practices on ecosystem functions is scarce(3). Pollination is an important ecosystem function and the global decline in pollinators attenuates the resistance of natural areas and agro-environments to disturbances(4). Thus, the ability of pollination functions to resist or recover from disturbance (that is, the functional resilience)(5,6) may be critical for ensuring a successful restoration process'. Here we report the use of a community field experiment to investigate the effects of vegetation restoration, specifically the removal of exotic shrubs, on pollination. We analyse 64 plant-pollinator networks and the reproductive performance of the ten most abundant plant species across four restored and four unrestored, disturbed mountaintop communities. Ecosystem restoration resulted in a marked increase in pollinator species, visits to flowers and interaction diversity. Interactions in restored networks were more generalized than in unrestored networks, indicating a higher functional redundancy in restored communities. Shifts in interaction patterns had direct and positive effects on pollination, especially on the relative and total fruit production of native plants. Pollinator limitation was prevalent at unrestored sites only, where the proportion of flowers producing fruit increased with pollinator visitation, approaching the higher levels seen in restored plant communities. Our results show that vegetation restoration can improve pollination, suggesting that the degradation of ecosystem functions is at least partially reversible. The degree of recovery may depend on the state of degradation before restoration intervention and the proximity to pollinator source populations in the surrounding landscape(5,8). We demonstrate that network structure is a suitable indicator for pollination quality, highlighting the usefulness of interaction networks in environmental management(6,9).	[Kaiser-Bunbury, Christopher N.; Bluethgen, Nico] Tech Univ Darmstadt, Dept Biol, Ecol Networks, D-64287 Darmstadt, Germany; [Mougal, James; Valentin, Terence; Gabriel, Ronny] Seychelles Natl Pk Author, POB 1240, Mahe, Seychelles; [Whittington, Andrew E.] Bournemouth Univ, Dept Archaeol Anthropol & Forens Sci, Poole BH12 5BB, Dorset, England; [Olesen, Jens M.] Aarhus Univ, Dept Biosci, Ecol & Genet, DK-8000 Aarhus C, Denmark	Technical University of Darmstadt; Bournemouth University; Aarhus University	Kaiser-Bunbury, CN (corresponding author), Tech Univ Darmstadt, Dept Biol, Ecol Networks, D-64287 Darmstadt, Germany.	c.kaiserbunbury@gmail.com	Olesen, Jens M/A-3011-2009; Whittington, Andrew E/L-3179-2019; Kaiser-Bunbury, Christopher/C-5038-2012; Blüthgen, Nico/F-5983-2010	Olesen, Jens M/0000-0003-1998-1083; Whittington, Andrew E/0000-0002-0465-1172; Kaiser-Bunbury, Christopher/0000-0001-7254-3491; 	German Research Foundation [KA 3349/2-1]	German Research Foundation(German Research Foundation (DFG))	We thank the Seychelles National Parks Authority, the Ministry of Environment, Energy and Climate Change and the Seychelles Bureau of Standards for permission to conduct the work and administrative assistance. S. van de Velde and P. Acuna helped with data collection. J. Ghazoul, N. Bunbury, L. Turnbull, and D. Vazquez provided comments on earlier versions and C. Dormann, A. Hector, and M. Schleuning advised on statistics. C.N.K.-B. was funded by the German Research Foundation (KA 3349/2-1).	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Bengtsson J, 2003, AMBIO, V32, P389, DOI 10.1639/0044-7447(2003)032[0389:RRADL]2.0.CO;2; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Clewell A. F., 2013, ECOLOGICAL RESTORATI, DOI DOI 10.5822/978-1-59726-323-8; Devoto M, 2012, ECOL LETT, V15, P319, DOI 10.1111/j.1461-0248.2012.01740.x; Forup ML, 2008, J APPL ECOL, V45, P742, DOI 10.1111/j.1365-2664.2007.01390.x; Hagen M, 2012, ADV ECOL RES, V46, P89, DOI 10.1016/B978-0-12-396992-7.00002-2; Heleno R, 2010, ECOL APPL, V20, P1191, DOI 10.1890/09-1384.1; Kaiser-Bunbury CN, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv076; Kaiser-Bunbury CN, 2011, J ECOL, V99, P202, DOI 10.1111/j.1365-2745.2010.01732.x; Larsson M, 2005, OECOLOGIA, V146, P394, DOI 10.1007/s00442-005-0217-y; Morales CL, 2009, ECOL LETT, V12, P716, DOI 10.1111/j.1461-0248.2009.01319.x; McCann K, 2007, NATURE, V446, P29, DOI 10.1038/446029a; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Menz MHM, 2011, TRENDS PLANT SCI, V16, P4, DOI 10.1016/j.tplants.2010.09.006; Morris WF, 2010, ECOLOGY, V91, P1276, DOI 10.1890/08-2278.1; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; Oliver TH, 2015, TRENDS ECOL EVOL, V30, P673, DOI 10.1016/j.tree.2015.08.009; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Schleuning M, 2015, ECOGRAPHY, V38, P380, DOI 10.1111/ecog.00983; Thompson JN, 2001, BIOSCIENCE, V51, P15, DOI 10.1641/0006-3568(2001)051[0015:FOE]2.0.CO;2; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Tur C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078294; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; van Hengstum T, 2014, J ECOL, V102, P4, DOI 10.1111/1365-2745.12176; WALKER B, 1995, CONSERV BIOL, V9, P747, DOI 10.1046/j.1523-1739.1995.09040747.x	31	174	183	28	461	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					223	227		10.1038/nature21071	http://dx.doi.org/10.1038/nature21071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28135718	Green Accepted			2022-12-28	WOS:000393737500039
J	Owens, G				Owens, Geraint			E G Gerald Roberts OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		OWENS G, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2017	356								j501	10.1136/bmj.j501	http://dx.doi.org/10.1136/bmj.j501			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BO	28137725				2022-12-28	WOS:000393449600012
J	Abbasi, J				Abbasi, Jennifer			New Strategic Plan for Behavioral and Social Sciences Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					350	350		10.1001/jama.2016.20745	http://dx.doi.org/10.1001/jama.2016.20745			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118439				2022-12-28	WOS:000392509600006
J	Rumball-Smith, J; Shekelle, PG; Bates, DW				Rumball-Smith, Juliet; Shekelle, Paul G.; Bates, David W.			Using the Electronic Health Record to Understand and Minimize Overuse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LOW-VALUE CARE		[Rumball-Smith, Juliet; Shekelle, Paul G.] RAND Hlth, Santa Monica, CA USA; [Shekelle, Paul G.] Greater Angeles VA Healthcare Syst, Gen Internal Med, Los Angeles, CA USA; [Bates, David W.] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Bates, David W.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA	RAND Corporation; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Rumball-Smith, J (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90407 USA.	jrs@otagoalumni.ac.nz	Bates, David/AAE-7283-2019		ECRI Institute; SEA Medical Systems; Zynx; QPID; CDI (Negev) Ltd; Medicalis, Enelgy; ValeraHealth; Intensix; MCClone	ECRI Institute; SEA Medical Systems; Zynx; QPID; CDI (Negev) Ltd; Medicalis, Enelgy; ValeraHealth; Intensix; MCClone	Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Shekelle reported receiving personal fees from ECRI Institute and receiving royalties from UpToDate. Dr Bates reported receiving a grant from and serving on the advisory board of EarlySense; serving on the advisory boards of SEA Medical Systems, Zynx, QPID, and CDI (Negev) Ltd; and holding equity in Medicalis, Enelgy, ValeraHealth, Intensix, and MCClone. Dr Rumball-Smith reported no disclosures.	Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; Colla CH, 2017, MED CARE RES REV, V74, P507, DOI 10.1177/1077558716656970; Colla CH, 2014, NEW ENGL J MED, V371, P1280, DOI 10.1056/NEJMp1404503; Grady D, 2010, ARCH INTERN MED, V170, P749, DOI 10.1001/archinternmed.2010.90; Prasad V, 2012, JAMA-J AM MED ASSOC, V307, P37, DOI 10.1001/jama.2011.1960; Roman BR, 2014, ANN INTERN MED, V161, P149, DOI 10.7326/M14-0212; Rosenberg A, 2015, JAMA INTERN MED, V175, P1913, DOI 10.1001/jamainternmed.2015.5441; Willson A, 2015, BMJ QUAL SAF, V24, P611, DOI 10.1136/bmjqs-2015-004518	8	11	12	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					257	258		10.1001/jama.2016.18609	http://dx.doi.org/10.1001/jama.2016.18609			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114561				2022-12-28	WOS:000392089200008
J	Trecarichi, EM; Spagnolo, A; De-Giorgio, F; Pirronti, T; Inzani, F; Vetrugno, G				Trecarichi, Enrico Maria; Spagnolo, Angelico; De-Giorgio, Fabio; Pirronti, Tommaso; Inzani, Frediano; Vetrugno, Giuseppe			Excavated pulmonary lesions: differential diagnosis in a health-care worker	LANCET			English	Editorial Material									[Trecarichi, Enrico Maria] Fdn Policlin Univ Agostino Gemelli, Ist Clin Malattie Infett, Rome, Italy; [Pirronti, Tommaso] Fdn Policlin Univ Agostino Gemelli, Ist Radiol, Rome, Italy; [Inzani, Frediano] Fdn Policlin Univ Agostino Gemelli, Ist Anat Patol, Rome, Italy; [Vetrugno, Giuseppe] Fdn Policlin Univ Agostino Gemelli, Unita Risk Management, Rome, Italy; [Spagnolo, Angelico; De-Giorgio, Fabio] Univ Cattolica Sacro Cuore, Sez Med Legale, Ist Sanita Pubbl, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Trecarichi, EM (corresponding author), Fdn Policlin Univ Agostino Gemelli, Clin Malattie Infett, I-00168 Rome, Italy.	enricomaria.trecarichi@policlinicogemelli.it	vetrugno, giuseppe/M-3468-2017; De Giorgio, Fabio/AAB-7163-2022; Trecarichi, Enrico/AAQ-5600-2020; Inzani, Frediano/K-2091-2018	vetrugno, giuseppe/0000-0003-0181-2855; De Giorgio, Fabio/0000-0001-7433-0924					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 27	2017	389	10084					2138	2138		10.1016/S0140-6736(16)32403-5	http://dx.doi.org/10.1016/S0140-6736(16)32403-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EV7QE	28110983				2022-12-28	WOS:000401973300032
J	Reid, JA; Richards, TN; Loughran, TA; Mulvey, EP				Reid, Joan A.; Richards, Tara N.; Loughran, Thomas A.; Mulvey, Edward P.			The Relationships Among Exposure to Violence, Psychological Distress, and Gun Carrying Among Male Adolescents Found Guilty of Serious Legal Offenses A Longitudinal Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							MENTAL-ILLNESS; WEAPON; YOUTH; RISK; VICTIMIZATION; POSSESSION; BEHAVIORS; AMERICAN; TRAUMA; SCHOOL	Background: Gun violence and psychological problems are often conflated in public discourse on gun safety. However, few studies have empirically assessed the effect of exposure to violence when exploring the association between gun carrying and psychological distress. Objective: To examine the potential effect of exposure to violence on the associations between gun carrying and psychological distress among vulnerable adolescents. Design: Longitudinal cohort study. Setting: The Pathways to Desistance study, a study of youths found guilty of a serious criminal offense in Philadelphia County, Pennsylvania, or Maricopa County, Arizona. Participants: 1170 male youths aged 14 to 19 years who had been found guilty of a serious criminal offense. Measurements: Youths were assessed at baseline and at four 6-month intervals with regard to gun carrying ("Have you carried a gun?"), psychological distress (Global Severity Index), and exposure to violence (modified version of the Exposure to Violence Inventory). Results: At the bivariate level, gun carrying was consistently associated with higher levels of psychological distress. However, the association between psychological distress and gun carrying diminished or disappeared when exposure to violence was considered. Exposure to violence (as either a victim or a witness) was significantly related to gun carrying at all follow-up assessments, with increased odds of gun carrying ranging from 1.43 to 1.87 with each additional report of exposure to violence. Limitations: The study sample was limited to justice-involved male youths. Precarrying distress and exposure to violence could not be fully captured because many participants had initiated gun carrying before baseline. Conclusion: In male youths involved in the criminal justice system, the relationship between psychological distress and gun carrying seems to be influenced by exposure to violence (either experiencing or witnessing it). Further study is warranted to explore whether interventions after exposure to violence could reduce gun carrying in this population.	[Reid, Joan A.] Univ South Florida St Petersburg, 140 Harborwalk Ave South,DAV 266, St Petersburg, FL 33701 USA; [Richards, Tara N.] Univ Baltimore, Sch Criminal Justice, 1420 North Charles St,LAP519, Baltimore, MD 21201 USA; [Loughran, Thomas A.] Univ Maryland, Dept Criminol & Criminal Justice, 2220 Samuel J LeFrak Hall,7251 Preinkert Dr, College Pk, MD 20742 USA; [Mulvey, Edward P.] Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, 3811 OHara St, Pittsburgh, PA 15213 USA	State University System of Florida; University of South Florida; University System of Maryland; University of Baltimore; University System of Maryland; University of Maryland College Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Reid, JA (corresponding author), Univ South Florida St Petersburg, 140 Harborwalk Ave South,DAV 266, St Petersburg, FL 33701 USA.	jareid2@usf.edu	Reid, Joan A./AAL-9315-2021; Richards, Tara N./AAY-6760-2020	Reid, Joan A./0000-0002-8959-679X; Richards, Tara/0000-0001-9239-2192	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD086761] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 2006, J SCH VIOL, DOI [DOI 10.1300/J202V05N02_04, DOI 10.1300/J202V05N02_]; [Anonymous], BRIEF TREATMENT CRIS, DOI DOI 10.1093/BRIEF-TREATMENT/MHM010; Branas CC, 2009, AM J PUBLIC HEALTH, V99, P2034, DOI 10.2105/AJPH.2008.143099; David-Ferdon C, 2015, MMWR-MORBID MORTAL W, V64, P171; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Ericson N., 2001, ADDRESSING PROBLEM J; Esselmont C, 2014, DEVIANT BEHAV, V35, P215, DOI 10.1080/01639625.2013.834767; Fisher CE, 2013, ANN INTERN MED, V159, P423, DOI 10.7326/0003-4819-159-5-201309030-00679; Gambacorta D., 2016, PHILADELPHIA MA 0417; Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1; Hodges HJ, 2015, AM J ORTHOPSYCHIAT, V85, P211, DOI 10.1037/ort0000069; HUIZINGA D, 1991, J CRIM LAW CRIM, V82, P83, DOI 10.2307/1143790; Kilpatrick DG, 2003, J TRAUMA STRESS, V16, P119, DOI 10.1023/A:1022891005388; Loeber R, 2004, ARCH PEDIAT ADOL MED, V158, P138, DOI 10.1001/archpedi.158.2.138; Loughran TA, 2016, AM J PUBLIC HEALTH, V106, P350, DOI 10.2105/AJPH.2015.302971; Metzl JM, 2015, AM J PUBLIC HEALTH, V105, P240, DOI 10.2105/AJPH.2014.302242; Modzeleski W., 2004, FINAL REPORT FINDING; Mulvey Edward P, 2004, Youth Violence Juv Justice, V2, P213, DOI 10.1177/1541204004265864; Mulvey EP, 2000, RES PATHWAYS DESISTA, DOI [10.3886/ICPSR34488.v2, DOI 10.3886/ICPSR34488.V2]; Nansel TR, 2001, JAMA-J AM MED ASSOC, V285, P2094, DOI 10.1001/jama.285.16.2094; Putnam FW, 2006, JUVENILE FAM COURT J, V57, P1, DOI 10.1111/j.1755-6988.2006.tb00110.x; Richardson JB, 2013, AM J PUBLIC HEALTH, V103, pE5, DOI 10.2105/AJPH.2012.301160; Rubin R, 2016, JAMA-J AM MED ASSOC, V315, P119, DOI 10.1001/jama.2015.16421; Schubert Carol A, 2004, Youth Violence Juv Justice, V2, P237, DOI 10.1177/1541204004265875; Selner-O'Hagan MB, 1998, J CHILD PSYCHOL PSYC, V39, P215, DOI 10.1017/S002196309700187X; Shaffer J., 2002, JUVENILE JUSTICE B; Shetgiri R, 2016, J PEDIATR-US, V171, P277, DOI 10.1016/j.jpeds.2015.12.008; Skeem JL, 2006, J CONSULT CLIN PSYCH, V74, P967, DOI 10.1037/0022-006X.74.5.967; Spano R, 2013, CRIME DELINQUENCY, V59, P191, DOI 10.1177/0011128710372196; Swanson JW, 2015, BEHAV SCI LAW, V33, P199, DOI 10.1002/bsl.2172; Ursano RJ, 2012, ANN INTERN MED, V157, P905, DOI 10.7326/0003-4819-157-11-201212040-00542; van Geel M, 2014, JAMA PEDIATR, V168, P714, DOI 10.1001/jamapediatrics.2014.213; Vitaro F, 2007, CAMB HANDB PSYCHOL, P361; Webster DW, 2015, ANNU REV PUBL HEALTH, V36, P21, DOI 10.1146/annurev-publhealth-031914-122516; WEBSTER DW, 1993, AM J PUBLIC HEALTH, V83, P1604, DOI 10.2105/AJPH.83.11.1604; Wilcox P, 2006, JUSTICE Q, V23, P502, DOI 10.1080/07418820600985362	37	21	21	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					412	+		10.7326/M16-1648	http://dx.doi.org/10.7326/M16-1648			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9RM	28135726	Green Accepted			2022-12-28	WOS:000397025800016
J	Nuckols, TK				Nuckols, Teryl K.			With the Merit-Based Incentive Payment System, Pay for Performance Is Now National Policy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE		[Nuckols, Teryl K.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Nuckols, TK (corresponding author), Cedars Sinai Med Ctr, Div Gen Internal Med, Becker 113, Los Angeles, CA 90048 USA.	teryl.nuckols@cshs.org	Scott, Teryl Nuckols/AAH-9711-2021					Centers forMedicare & Medicaid Services, 2016, CMS QUAL MEAS DEV PL; Damberg CL, 2014, MEASURING SUCCESS HL; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Emanuel EJ, 2016, ANN INTERN MED, V164, P114, DOI 10.7326/M15-1330; Frankel BA, 2016, J GEN INTERN MED, V31, P840, DOI 10.1007/s11606-016-3693-3; Kondo K, 2015, UNDERSTANDING INTERV; Medicare Payment Advisory Commission, 2016, C MED PAYM POL MARCH; Mendelson A, 2017, ANN INTERN MED, V166, P341, DOI 10.7326/M16-1881	8	11	11	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					368	369		10.7326/M16-2947	http://dx.doi.org/10.7326/M16-2947			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28114662				2022-12-28	WOS:000396432800012
J	Perkel, JM				Perkel, Jeffrey M.			THE INTERNET OF THINGS COMES TO THE LAB	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008					0	54	55	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					125	126		10.1038/542125a	http://dx.doi.org/10.1038/542125a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6MY	28150787	Bronze			2022-12-28	WOS:000396119300047
J	Barker, I; Steventon, A; Deeny, SR				Barker, Isaac; Steventon, Adam; Deeny, Sarah R.			Association between continuity of care in general practice and hospital admissions for ambulatory care sensitive conditions: cross sectional study of routinely collected, person level data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE; INTERPERSONAL CONTINUITY; PATIENT SATISFACTION; QUALITY; IMPACT; VETERANS; OUTCOMES; LENGTH	OBJECTIVE To assess whether continuity of care with a general practitioner is associated with hospital admissions for ambulatory care sensitive conditions for older patients. DESIGN Cross sectional study. SETTING Linked primary and secondary care records from 200 general practices participating in the Clinical Practice Research Datalink in England. PARTICIPANTS 230 472 patients aged between 62 and 82 years and who experienced at least two contacts with a general practitioner between April 2011 and March 2013. MAIN OUTCOME MEASURE Number of hospital admissions for ambulatory care sensitive conditions (those considered manageable in primary care) per patient between April 2011 and March 2013. RESULTS We assessed continuity of care using the usual provider of care index, which we defined as the proportion of contacts occurring between April 2011 and March 2013 that were with the most frequently seen general practitioner. On average, the usual provider of care index score was 0.61. Continuity of care was lower among practices with more doctors (average score 0.59 in large practices versus 0.70 in small practices). Higher continuity of care was associated with fewer admissions for ambulatory care sensitive conditions. When modelled, controlling for demographic and clinical patient characteristics, an increase in the usual provider of care index of 0.2 for all patients would reduce these admissions by 6.22% (95% confidence interval 4.87% to 7.55%). There was greater evidence for an association among patients who were heavy users of primary care. Heavy users also experienced more admissions for ambulatory care sensitive conditions than other patients (0.36 admissions per patient for those with = 18 contacts with a general practitioner, compared with 0.04 admissions per patient for those with 2-4 contacts). CONCLUSIONS Strategies that improve the continuity of care in general practice may reduce secondary care costs, particularly for the heaviest users of healthcare. Promoting continuity might also improve the experience of patients and those working in general practice.	[Barker, Isaac; Steventon, Adam; Deeny, Sarah R.] Hlth Fdn, Data Analyt, London WC2E 9RA, England		Barker, I (corresponding author), Hlth Fdn, Data Analyt, London WC2E 9RA, England.	isaac.barker@health.org.uk						Adler R, 2010, FAM PRACT, V27, P171, DOI 10.1093/fampra/cmp099; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baird B, 2016, UNDERSTANDING PRESSU; BAKER R, 1995, BRIT J GEN PRACT, V45, P654; Bankart MJG, 2011, EMERG MED J, V28, P558, DOI 10.1136/emj.2010.108548; Bardsley M., 2016, UNDERSTANDING ANAL C; Bardsley M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002007; Barker I, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011422; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; BILLINGS J, 1993, HEALTH AFFAIR, V12, P162, DOI 10.1377/hlthaff.12.1.162; Blecker S, 2014, INT J QUAL HEALTH C, V26, P530, DOI 10.1093/intqhc/mzu065; Campbell JL, 2001, BRIT J GEN PRACT, V51, P644; Campbell SM, 2001, BMJ-BRIT MED J, V323, P784, DOI 10.1136/bmj.323.7316.784; Charlton J, 2013, J HEALTH SERV RES PO, V18, P215, DOI 10.1177/1355819613493772; Chen HM, 2017, CLIN NURS RES, V26, P266, DOI 10.1177/1054773815625467; Cheng SH, 2010, ARCH INTERN MED, V170, P1671, DOI 10.1001/archinternmed.2010.340; CLARK WAV, 1976, GEOGR ANAL, V8, P428; Cowling Thomas E, 2013, PLoS One, V8, pe66699, DOI 10.1371/journal.pone.0066699; Department of Health, 2014, TRANSF PRIM CAR; Edes T, 2014, J AM GERIATR SOC, V62, P1954, DOI 10.1111/jgs.13030; Freeman GK, 2003, FAM PRACT, V20, P623, DOI 10.1093/fampra/cmg601; Gunther S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-11; Guthrie Bruce, 2006, BMC Fam Pract, V7, P11, DOI 10.1186/1471-2296-7-11; HENDERSON C, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F1035; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Hibbard JH, 2007, HEALTH SERV RES, V42, P1443, DOI 10.1111/j.1475-6773.2006.00669.x; Hilbe JM., 2011, NEGATIVE BINOMIAL RE, DOI [10.1017/CBO9780511973420, DOI 10.1017/CBO9780511973420]; Huntley A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004746; Institute of Medicine, 2001, CROSSING THE QUALITY; Ionescu-Ittu R, 2007, CAN MED ASSOC J, V177, P1362, DOI 10.1503/cmaj.061615; Ipsos MORI, 2015, GP PAT SURV NAT SUMM; Jee SH, 2006, MED CARE RES REV, V63, P158, DOI 10.1177/1077558705285294; KASSLER WJ, 1991, ACAD MED, V66, P41, DOI 10.1097/00001888-199101000-00012; Katz DA, 2015, J AM GERIATR SOC, V63, P2510, DOI 10.1111/jgs.13841; Ladapo JA, 2014, HLTH AFFAIRS BLOG; Lin W, 2010, INT J QUAL HEALTH C, V22, P3, DOI 10.1093/intqhc/mzp059; Lloyd T, 2016, INT J INTEGR CARE, V16, DOI 10.5334/ijic.2450; Marshall M, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5698; National Survey of GPs, 2015, NAT SURV GPS FUT GEN; NHS England, 5 YEAR FORW VIEW; Office for National Statistics, 2010, ATL DEPR 2010; Osborn R, 2015, HEALTH AFFAIR, V34, P2104, DOI 10.1377/hlthaff.2015.1018; Poteliakhoff CRLLSE, 2012, CONTINUITY CARE OLDE, P1; Reddy A, 2015, JAMA INTERN MED, V175, P1157, DOI 10.1001/jamainternmed.2015.1853; Ridd MJ, 2015, BRIT J GEN PRACT, V65, pE305, DOI 10.3399/bjgp15X684829; Roland M, 2012, INT J INTEGR CARE, V12; Roland M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6017; Rosenblatt RA, 2000, AM J PUBLIC HEALTH, V90, P97, DOI 10.2105/AJPH.90.1.97; Royal College of General Practitioners, 2012, RCGP CONT CAR TOOLK; Royal College of General Practitioners, 2016, CONT CAR GEN PRACT; Salisbury C, 2009, BRIT J GEN PRACT, V59, P276, DOI 10.3399/bjgp09X420257; Saultz JW, 2005, ANN FAM MED, V3, P159, DOI 10.1370/afm.285; Saultz JW, 2004, ANN FAM MED, V2, P445, DOI 10.1370/afm.91; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Stroup W.W., 2012, GEN LINEAR MIXED MOD; Tian, 2012, DATA BRIEFING EMERGE; Tsai HY, 2015, INT J PUBLIC HEALTH, V60, P505, DOI 10.1007/s00038-015-0671-1; Whittington JW, 2015, MILBANK Q, V93, P263, DOI 10.1111/1468-0009.12122	58	190	194	0	42	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2017	356								j84	10.1136/bmj.j84	http://dx.doi.org/10.1136/bmj.j84			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8BQ	28148478	hybrid, Green Submitted			2022-12-28	WOS:000393449800014
J	Mervis, J				Mervis, Jeffrey			US POLICY The Trump era: 10 questions New president confronts a host of science-related issues	SCIENCE			English	News Item																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					333	334		10.1126/science.355.6323.333	http://dx.doi.org/10.1126/science.355.6323.333			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4FR	28126761				2022-12-28	WOS:000393172800010
J	Service, RF				Service, Robert F.			HIGH-PRESSURE PHYSICS Metallic hydrogen created in diamond vise Controversial claim may end 80-year quest for solid metal, but doubts remain	SCIENCE			English	News Item																			0	3	3	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					332	333		10.1126/science.355.6323.332	http://dx.doi.org/10.1126/science.355.6323.332			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126760				2022-12-28	WOS:000393172800009
J	Torjesen, I				Torjesen, Ingrid			NICE publishes guideline on diagnosing and managing cerebral palsy in young people	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Action Cerebral Palsy, 2016, VAR CAR AN CER PALS; National Institute for Health and Care Excellence, 2017, CER PALS 25S ASS MAN	2	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2017	356								j462	10.1136/bmj.j462	http://dx.doi.org/10.1136/bmj.j462			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HW	28130209				2022-12-28	WOS:000393178500004
J	Zarin, DA; Tse, T; Williams, RJ; Rajakannan, T				Zarin, Deborah A.; Tse, Tony; Williams, Rebecca J.; Rajakannan, Thiyagu			Update on Trial Registration 11 Years after the ICMJE Policy Was Established	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIALS; PUBLISHED PRIMARY OUTCOMES; PUBLICATION BIAS; CLINICAL-TRIALS; TRANSPARENCY; STATEMENT; TRUST		[Zarin, Deborah A.; Tse, Tony; Williams, Rebecca J.; Rajakannan, Thiyagu] NIH, Natl Lib Med, US Dept HHS, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Zarin, DA (corresponding author), NIH, Natl Lib Med, Bldg 38A,8600 Rockville Pike, Bethesda, MD 20894 USA.	dzarin@mail.nih.gov		Tse, Tony/0000-0002-9906-6864	Intramural Research Program of the National Library of Medicine, National Institutes of Health; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER	Intramural Research Program of the National Library of Medicine, National Institutes of Health; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Supported by the Intramural Research Program of the National Library of Medicine, National Institutes of Health.	ALTMAN DG, 1995, BRIT J CANCER, V72, P511, DOI 10.1038/bjc.1995.364; [Anonymous], 2016, FED REG; Boehringer Ingelheim, POL TRANSP PUBL CLIN; Centers for Medicare and Medicaid Services, 2014, GUID PUBL IND CMS ST; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; Department of Veterans Affairs Office of Research and Development, 2015, ORD SPONS CLIN TRIAL; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Doshi P, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5543; Drazen JM, 2007, NEW ENGL J MED, V356, P184, DOI 10.1056/NEJMe068291; Durivage H., 2012, CLIN TRIALS DISCLOSU; Dwan K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000031.pub2; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Fleming PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127495; Gulmezoglu AM, 2005, LANCET, V365, P1829, DOI 10.1016/S0140-6736(05)66589-0; Harriman SL, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1310-8; Hooft L, 2014, NETH J MED, V72, P349; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Hudson KL, 2016, JAMA-J AM MED ASSOC, V316, P1353, DOI 10.1001/jama.2016.14668; Huic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025258; Jones CW, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0520-3; Killeen S, 2014, ANN SURG, V259, P193, DOI 10.1097/SLA.0b013e318299d00b; Langendonk JG, 2015, NEW ENGL J MED, V373, P48, DOI 10.1056/NEJMoa1411481; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Niemann CU, 2015, NEW ENGL J MED, V373, P405, DOI 10.1056/NEJMoa1501969; O'Reilly EK, 2015, CTS-CLIN TRANSL SCI, V8, P48, DOI 10.1111/cts.12235; Pranic S, 2016, J CLIN EPIDEMIOL, V70, P26, DOI 10.1016/j.jclinepi.2015.07.007; Scott AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126230; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; The COMPare Trials Project, TRACK SWITCH OUTC CL; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; van Lent M, 2015, J CLIN EPIDEMIOL, V68, P1059, DOI 10.1016/j.jclinepi.2014.11.019; van Valkenhoef G, 2016, SYST REV, V5, DOI 10.1186/s13643-016-0283-8; Viergever RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084727; Wager E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5248; Weber WEJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3572; Wedzicha JA, 2016, NEW ENGL J MED, V374, P2222, DOI 10.1056/NEJMoa1516385; Weston J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010075; Zarin DA, 2016, NEW ENGL J MED, V375, P1998, DOI 10.1056/NEJMsr1611785; Zarin DA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001946; Zarin DA, 2013, ANN INTERN MED, V159, P65, DOI 10.7326/0003-4819-159-1-201307020-00011; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065; Zhang S, 2016, J NATL CANC I	43	130	131	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2017	376	4					383	391		10.1056/NEJMsr1601330	http://dx.doi.org/10.1056/NEJMsr1601330			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ3KR	28121511	Green Accepted			2022-12-28	WOS:000393111600014
J	Gellert, GA; Webster, SL; Gillean, JA; Melnick, ER; Kanzaria, HK				Gellert, George A.; Webster, S. Luke; Gillean, John A.; Melnick, Edward R.; Kanzaria, Hemal K.			Should US doctors embrace electronic health records?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ORDER ENTRY SYSTEMS; IMPACT; TIME		[Gellert, George A.; Webster, S. Luke; Gillean, John A.] CHRISTUS Hlth, San Antonio, TX USA; [Melnick, Edward R.] Yale Sch Med, Dept Emergency Med, New Haven, CT USA; [Kanzaria, Hemal K.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA	Yale University; University of California System; University of California San Francisco	Gellert, GA (corresponding author), CHRISTUS Hlth, San Antonio, TX USA.; Melnick, ER (corresponding author), Yale Sch Med, Dept Emergency Med, New Haven, CT USA.	ggellert33@gmail.com; edward.melnick@yale.edu			Agency for Healthcare Research and Quality [K08HS021271]; US Veterans Affairs / Robert Wood Johnson Clinical Scholars program	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); US Veterans Affairs / Robert Wood Johnson Clinical Scholars program	All authors have read and understood BMJ policy on declaration of interests and declare the following: ERM is supported in part by grant number K08HS021271 from the Agency for Healthcare Research and Quality. HKK has been supported by the US Veterans Affairs / Robert Wood Johnson Clinical Scholars program and has been a consultant for RAND Health and Castlight Health. The content does not necessarily represent the official views of any funding agency.	Amarasingham R, 2009, ARCH INTERN MED, V169, P108, DOI 10.1001/archinternmed.2008.520; American Medical Association, 2014, IMPR CAR PRIOR IMPR; Barnett ML, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3835; Charles Krista, 2014, Perspect Health Inf Manag, V11, p1b; Czernik Z, 2016, JAMA-J AM MED ASSOC, V315, P2399, DOI 10.1001/jama.2016.1722; Friedberg M.W., 2013, FACTORS AFFECTING PH; Gellert GA, 2015, JAMA-J AM MED ASSOC, V313, P1315, DOI 10.1001/jama.2014.17128; Georgiou A, 2013, ANN EMERG MED, V61, P644, DOI 10.1016/j.annemergmed.2013.01.028; Georgiou A, 2011, J AM MED INFORM ASSN, V18, P335, DOI 10.1136/amiajnl-2010-000043; Hafner K, 2014, NY TIMES; James JT, 2013, J PATIENT SAF, V9, P122, DOI 10.1097/PTS.0b013e3182948a69; Karsh BT, 2010, J AM MED INFORM ASSN, V17, P617, DOI 10.1136/jamia.2010.005637; Lidwell W., 2010, UNIVERSAL PRINCIPLES; Lyons AM, 2017, J AM MED INFORM ASSN, V24, P303, DOI 10.1093/jamia/ocw091; Makary MA, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2139; Melnick Edward R, 2015, EGEMS (Wash DC), V3, P1136, DOI 10.13063/2327-9214.1136; Mennemeyer ST, 2016, J AM MED INFORM ASSN, V23, P375, DOI 10.1093/jamia/ocv103; Nuckols TK, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-56; Ratanawongsa N, 2016, JAMA INTERN MED, V176, P125, DOI 10.1001/jamainternmed.2015.6186; Rosenbaum L, 2015, NEW ENGL J MED, V373, P1585, DOI 10.1056/NEJMp1509961; Schreiber R, 2014, APPL CLIN INFORM, V5, P685, DOI 10.4338/ACI-2014-04-RA-0029; Sinsky C, 2016, ANN INTERN MED, V165, P753, DOI 10.7326/M16-0961; Verdon DR, 2014, MED EC; Yu FB, 2009, AM J MED QUAL, V24, P278, DOI 10.1177/1062860609333626	24	12	12	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2017	356								j242	10.1136/bmj.j242	http://dx.doi.org/10.1136/bmj.j242			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ4HL	28119282				2022-12-28	WOS:000393177400002
J	Cao, XT; Wang, HH; Li, LM; Lo, S; Summerskill, W; Horton, R				Cao, Xuetao; Wang, Helena Hui; Li, Limin; Lo, Selina; Summerskill, William; Horton, Richard			The Lancet-CAMS Health Summit 2017: a call for abstracts from China	LANCET			English	Editorial Material									[Cao, Xuetao; Li, Limin] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Wang, Helena Hui; Lo, Selina] The Lancet, Beijing, Peoples R China; [Summerskill, William; Horton, Richard] The Lancet, London, England	Chinese Academy of Medical Sciences - Peking Union Medical College	Cao, XT (corresponding author), Chinese Acad Med Sci, Beijing 100730, Peoples R China.								0	0	0	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					237	237		10.1016/S0140-6736(17)30130-7	http://dx.doi.org/10.1016/S0140-6736(17)30130-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9BC	28118902	Bronze			2022-12-28	WOS:000392801200010
J	Cousins, S				Cousins, Sophie			Suicide in Indigenous Australians: a "catastrophic crisis"	LANCET			English	Editorial Material								Suicide prevention programmes for Indigenous Australians have been reported to be failing. An Indigenous-led national response to the crisis is needed, say experts. Sophie Cousins reports.											0	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					242	242		10.1016/S0140-6736(17)30137-X	http://dx.doi.org/10.1016/S0140-6736(17)30137-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9BC	28118906				2022-12-28	WOS:000392801200014
J	Donato, AA				Donato, Anthony A.			Semaglutide reduced a composite of CV events at 2 years in patients with type 2 diabetes and high CV risk	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MANAGEMENT		[Donato, Anthony A.] Reading Hlth Syst, Reading, PA 19612 USA		Donato, AA (corresponding author), Reading Hlth Syst, Reading, PA 19612 USA.							Chamberlain JJ, 2016, ANN INTERN MED, V164, P542, DOI 10.7326/M15-3016; Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892; Shyangdan DS, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-20; US Food and Drug Administration, 2008, GUID IND DIAB MELL E	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					JC8	JC8		10.7326/ACPJC-2017-166-2-008	http://dx.doi.org/10.7326/ACPJC-2017-166-2-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	28114464				2022-12-28	WOS:000391842600007
J	Yelland, M				Yelland, Michael			Review: Pregabalin reduces fibromyalgia pain but increases adverse events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DULOXETINE		[Yelland, Michael] Griffith Univ, Gold Coast, Qld, Australia	Griffith University	Yelland, M (corresponding author), Griffith Univ, Gold Coast, Qld, Australia.							Cording M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008244.pub3; Gilron I, 2016, PAIN, V157, P1532, DOI 10.1097/j.pain.0000000000000558; Lunn MPT, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007115.pub3; Moore RA, 2014, EUR J PAIN, V18, P67, DOI 10.1002/j.1532-2149.2013.00341.x; Nasser K, 2014, ARTHRIT CARE RES, V66, P293, DOI 10.1002/acr.22111	5	2	2	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					JC2	JC2		10.7326/ACPJC-2017-166-2-002	http://dx.doi.org/10.7326/ACPJC-2017-166-2-002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	28114458				2022-12-28	WOS:000391842600001
J	Harris, JA; Byhoff, E; Perumalswami, CR; Langa, KM; Wright, AA; Griggs, JJ				Harris, John A.; Byhoff, Elena; Perumalswami, Chithra R.; Langa, Kenneth M.; Wright, Alexi A.; Griggs, Jennifer J.			The Relationship of Obesity to Hospice Use and Expenditures A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							OF-LIFE CARE; PALLIATIVE CARE; MEDICARE BENEFICIARIES; FAMILY PERSPECTIVES; RISK-FACTORS; HEALTH; END; PATIENT; CANCER; COSTS	Background: Obesity complicates medical, nursing, and informal care in severe illness, but its effect on hospice use and Medicare expenditures is unknown. Objective: To describe the associations between body mass index (BMI) and hospice use and Medicare expenditures in the last 6 months of life. Design: Retrospective cohort. Setting: The HRS (Health and Retirement Study). Participants: 5677 community-dwelling Medicare fee-forservice beneficiaries who died between 1998 and 2012. Measurements: Hospice enrollment, days enrolled in hospice, in-home death, and total Medicare expenditures in the 6 months before death. Body mass index was modeled as a continuous variable with a quadratic functional form. Results: For decedents with BMI of 20 kg/m(2), the predicted probability of hospice enrollment was 38.3% (95% CI, 36.5% to 40.2%), hospice duration was 42.8 days (CI, 42.3 to 43.2 days), probability of in-home death was 61.3% (CI, 59.4% to 63.2%), and total Medicare expenditures were $ 42 803 (CI, $ 41 085 to $ 44 521). When BMI increased to 30 kg/m2, the predicted probability of hospice enrollment decreased by 6.7 percentage points (CI, -9.3 to -4.0 percentage points), hospice duration decreased by 3.8 days (CI, -4.4 to -3.1 days), probability of in-home death decreased by 3.2 percentage points (CI, -6.0 to -0.4 percentage points), and total Medicare expenditures increased by $ 3471 (CI, $ 955 to $ 5988). For morbidly obese decedents (BMI = 40 kg/m2), the predicted probability of hospice enrollment decreased by 15.2 percentage points (CI, -19.6 to -10.9 percentage points), hospice duration decreased by 4.3 days (CI, -5.7 to -2.9 days), and in-home death decreased by 6.3 percentage points (CI, -11.2 to -1.5 percentage points) versus decedents with BMI of 20 kg/m(2). Limitation: Baseline data were self-reported, and the interval between reported BMI and time of death varied. Conclusion: Among community-dwelling decedents in the HRS, increasing obesity was associated with reduced hospice use and in-home death and higher Medicare expenditures in the last 6 months of life.	[Byhoff, Elena; Perumalswami, Chithra R.] Univ Michigan, Dept Med, Inst Healthcare Policy & Innovat, 2800 Plymouth Rd,Bldg 10,Room G100, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Gerontol, Inst Healthcare Policy & Innovat, 2800 Plymouth Rd,Bldg 16,Room 444E, Ann Arbor, MI 48109 USA; [Griggs, Jennifer J.] Univ Michigan, Sch Publ Hlth, Dept Med & Hlth Management & Policy, Div Hematol & Oncol, 2800 Plymouth Rd,Bldg 16,Room 116W, Ann Arbor, MI 48109 USA; [Wright, Alexi A.] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Harris, JA (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, 300 Halket St,Suite 2328, Pittsburgh, PA 15213 USA.	harrisja@mail.magee.edu	Wright, Alexi/T-5793-2019	Perumalswami, Chithra/0000-0002-6679-1090; Harris, John/0000-0002-7907-8139; Langa, Kenneth/0000-0002-2798-1836; , Elena/0000-0003-3438-2695	National Institute on Aging [U01 AG009740, P30 AG024824]; Robert Wood Johnson Foundation; U.S. Department of Veterans Affairs; National Cancer Institute [K07 CA166210]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD063087] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K07CA166210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG009740] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Health and Retirement Study is funded by the National Institute on Aging (U01 AG009740) and performed at the Institute for Social Research, University of Michigan. Drs. Harris and Byhoff were supported by the Robert Wood Johnson Foundation at the time the manuscript was originally submitted. Dr. Byhoff was supported by the U.S. Department of Veterans Affairs. Dr. Perumalswami is supported by the Robert Wood Johnson Foundation and the U.S. Department of Veterans Affairs. Dr. Langa is supported by the U.S. Department of Veterans Affairs and the National Institute on Aging (P30 AG024824). Dr. Wright is supported by the National Cancer Institute (K07 CA166210).	Alley DE, 2010, AM J EPIDEMIOL, V172, P558, DOI 10.1093/aje/kwq168; Boyd K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4863; Broome CA, 2015, REHABIL NURS, V40, P92, DOI 10.1002/rnj.165; Budd GM, 2011, APPL NURS RES, V24, P127, DOI 10.1016/j.apnr.2009.05.001; Byhoff E, 2016, JAMA INTERN MED, V176, P1020, DOI 10.1001/jamainternmed.2016.2266; Carlson MDA, 2012, HEALTH AFFAIR, V31, P2690, DOI 10.1377/hlthaff.2012.0286; Casarett D, 2006, J AM GERIATR SOC, V54, P472, DOI 10.1111/j.1532-5415.2005.00628.x; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Chong HS, 2012, CRITICAL CARE MANAGE, P147; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P162, DOI 10.1093/geronb/gbr048; Dee Anne, 2014, BMC Res Notes, V7, P242, DOI 10.1186/1756-0500-7-242; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Durden ED, 2008, J OCCUP ENVIRON MED, V50, P991, DOI 10.1097/JOM.0b013e318182f730; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Gallagher S M, 1999, J Wound Ostomy Continence Nurs, V26, P292, DOI 10.1016/S1071-5754(99)90064-5; Gazelle G, 2007, NEW ENGL J MED, V357, P321, DOI 10.1056/NEJMp078067; Goodell T T, 1996, J Trauma Nurs, V3, P36; Griggs JJ, 2005, ARCH INTERN MED, V165, P1267, DOI 10.1001/archinte.165.11.1267; Gupta D, 2009, J PALLIAT MED, V12, P515, DOI 10.1089/jpm.2009.0043; Han B, 2006, MED CARE, V44, P731, DOI 10.1097/01.mlr.0000215858.37118.65; Harris John A, 2016, BMC Obes, V3, P24, DOI 10.1186/s40608-016-0105-5; Hauck K, 2010, MED CARE, V48, P335, DOI 10.1097/MLR.0b013e3181ca3d85; Huizinga MM, 2009, J GEN INTERN MED, V24, P1236, DOI 10.1007/s11606-009-1104-8; Institute of Medicine, 2014, DYING AM IMPR QUAL H; Kelley AS, 2014, J PALLIAT MED, V17, P506, DOI 10.1089/jpm.2013.0648; King DR, 2010, CRIT CARE MED, V38, pS478, DOI 10.1097/CCM.0b013e3181ec54f6; Maruthur NM, 2009, OBESITY, V17, P375, DOI 10.1038/oby.2008.480; Maruthur NM, 2009, J GEN INTERN MED, V24, P665, DOI 10.1007/s11606-009-0939-3; Miesfeldt S, 2012, J PALLIAT MED, V15, P548, DOI 10.1089/jpm.2011.0310; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Nwosu AC, 2012, J PALLIAT MED, V15, P7, DOI 10.1089/jpm.2011.0333; Obermeyer Z, 2015, HEALTH AFFAIR, V34, P993, DOI 10.1377/hlthaff.2014.1055; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Park NS, 2012, J PALLIAT MED, V15, P149, DOI 10.1089/jpm.2011.0220; Phillips J, 2013, J RADIOL NURS, V32, P21; Prescott HC, 2014, CRIT CARE MED, V42, P1766, DOI 10.1097/CCM.0000000000000336; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Quesenberry CP, 1998, ARCH INTERN MED, V158, P466, DOI 10.1001/archinte.158.5.466; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067; StataCorp, 2015, STAT 14 BAS REF MAN, P1359; Stevenson DG, 2012, NEW ENGL J MED, V367, P1683, DOI 10.1056/NEJMp1208465; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM, 2007, J PAIN SYMPTOM MANAG, V34, P120, DOI 10.1016/j.jpainsymman.2007.04.014; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Varney S., 2015, NY TIMES, pD1; Wong ES, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-175; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Wright AA, 2016, JAMA-J AM MED ASSOC, V315, P284, DOI 10.1001/jama.2015.18604; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863	53	12	12	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					381	+		10.7326/M16-0749	http://dx.doi.org/10.7326/M16-0749			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9RM	28166546	Green Accepted			2022-12-28	WOS:000397025800013
J	Thompson, JE; Stricker, PD				Thompson, James E.; Stricker, Phillip D.			Diagnostic accuracy of multi-parametric MRI and transrectal ultrasound-guided biopsy in prostate cancer	LANCET			English	Editorial Material							MORTALITY; MEN		[Thompson, James E.; Stricker, Phillip D.] St Vincents Prostate Canc Ctr, Garvan Inst Med Res, Darlinghurst, NSW, Australia; [Thompson, James E.; Stricker, Phillip D.] Kinghorn Canc Ctr, Darlinghurst, NSW, Australia; [Stricker, Phillip D.] Univ NSW, Kensington, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney	Thompson, JE (corresponding author), St Vincents Prostate Canc Ctr, Garvan Inst Med Res, Darlinghurst, NSW, Australia.; Thompson, JE (corresponding author), Kinghorn Canc Ctr, Darlinghurst, NSW, Australia.	drjethompson@gmail.com		Thompson, James/0000-0002-5115-9930; Stricker, Phillip/0000-0002-0934-0656				Ahmed HU, 2017, LANCET; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Cooperberg MR, 2015, EUR UROL, V67, P326, DOI 10.1016/j.eururo.2014.05.039; de Rooij M, 2014, AM J ROENTGENOL, V202, P343, DOI 10.2214/AJR.13.11046; Futterer JJ, 2015, EUR UROL, V68, P1045, DOI 10.1016/j.eururo.2015.01.013; Gronberg H, 2015, LANCET ONCOL, V16, P1667, DOI 10.1016/S1470-2045(15)00361-7; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; Klein EA, 2014, EUR UROL, V66, P550, DOI 10.1016/j.eururo.2014.05.004; Pokorny MR, 2014, EUR UROL, V66, P22, DOI 10.1016/j.eururo.2014.03.002; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Siddiqui MM, 2015, JAMA-J AM MED ASSOC, V313, P390, DOI 10.1001/jama.2014.17942; Thompson JE, 2016, J UROLOGY, V195, P1428, DOI 10.1016/j.juro.2015.10.140; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162	13	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					767	768		10.1016/S0140-6736(17)30121-6	http://dx.doi.org/10.1016/S0140-6736(17)30121-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9UU	28126331	hybrid			2022-12-28	WOS:000394966400005
J	Friedrich, MJ				Friedrich, M. J.			WHO Calls Off Global Zika Emergency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	3					246	246		10.1001/jama.2016.20447	http://dx.doi.org/10.1001/jama.2016.20447			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NL	28114564				2022-12-28	WOS:000426801400001
J	Cousins, S				Cousins, Sophie			Myanmar grapples with its high tuberculosis burden	LANCET			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					491	492		10.1016/S0140-6736(17)30262-3	http://dx.doi.org/10.1016/S0140-6736(17)30262-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ5UH	28170324				2022-12-28	WOS:000393283400018
J	Athey, S				Athey, Susan			Beyond prediction: Using big data for policy problems	SCIENCE			English	Editorial Material								Machine-learning prediction methods have been extremely productive in applications ranging from medicine to allocating fire and health inspectors in cities. However, there are a number of gaps between making a prediction and making a decision, and underlying assumptions need to be understood in order to optimize data-driven decision-making.	[Athey, Susan] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA	Stanford University	Athey, S (corresponding author), Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA.	athey@stanford.edu		Athey, Susan/0000-0001-6934-562X				[Anonymous], RETENTION FUTILITY T; [Anonymous], 2016, POVERTY HD WHAT DOES; Athey S., 2016, SOLVING HETEROGENEOU; Athey S, 2016, APPROXIMATE RESIDUAL; Athey S., 2002, CISC VIS NETW IND GL; Bakshy E., 2014, P 23 INT C WORLD WID; Bayati M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109264; Belloni A, 2014, REV ECON STUD, V81, P608, DOI 10.1093/restud/rdt044; Berk R., 2012, SPRINGER BRIEFS COMP; Blake T, 2015, ECONOMETRICA, V83, P155, DOI 10.3982/ECTA12423; Blumenstock J, 2015, SCIENCE, V350, P1073, DOI 10.1126/science.aac4420; Glaeser E.L., 2015, TECHNICAL REPORT; Glaeser EL, 2016, AM ECON REV, V106, P114, DOI 10.1257/aer.p20161027; Grimmer J, 2013, POLIT ANAL, V21, P267, DOI 10.1093/pan/mps028; Imbens GW, 2015, CAUSAL INFERENCE FOR STATISTICS, SOCIAL, AND BIOMEDICAL SCIENCES: AN INTRODUCTION, P1, DOI 10.1017/CBO9781139025751; Kamishima T., 2012, JOINT EUR C MACH LEA; Kang J.S., 2013, P 2013 C EMP METH NA, P1443; Naik N, 2016, AM ECON REV, V106, P128, DOI 10.1257/aer.p20161030; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Scott SL, 2015, APPL STOCH MODEL BUS, V31, P37, DOI 10.1002/asmb.2104	23	190	199	11	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					483	485		10.1126/science.aal4321	http://dx.doi.org/10.1126/science.aal4321			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154050				2022-12-28	WOS:000393183100034
J	Mayer, AL				Mayer, Audrey L.			A scientist on any schedule	SCIENCE			English	Editorial Material									[Mayer, Audrey L.] Michigan Technol Univ, Ecol & Environm Policy, Houghton, MI 49931 USA	Michigan Technological University	Mayer, AL (corresponding author), Michigan Technol Univ, Ecol & Environm Policy, Houghton, MI 49931 USA.	SciCareerEditor@aaas.org	Mayer, AL/AAO-3225-2020	Mayer, AL/0000-0003-3278-1182					0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					426	426		10.1126/science.355.6323.426	http://dx.doi.org/10.1126/science.355.6323.426			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4FR	28126823				2022-12-28	WOS:000393172800045
J	[Anonymous]				[Anonymous]			Veterans With Epilepsy Need More Than Seizure Control	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					352	352		10.1001/jama.2016.20110	http://dx.doi.org/10.1001/jama.2016.20110			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118465				2022-12-28	WOS:000392509600009
J	Moon, S; Leigh, J; Woskie, L; Checchi, F; Dzau, V; Fallah, M; Fitzgerald, G; Garrett, L; Gostin, L; Heymann, DL; Kickbusch, I; Morrison, JS; Piot, P; Sands, P; Sridhar, D; Jha, AK				Moon, Suerie; Leigh, Jennifer; Woskie, Liana; Checchi, Francesco; Dzau, Victor; Fallah, Mosoka; Fitzgerald, Gabrielle; Garrett, Laurie; Gostin, Lawrence; Heymann, David L.; Kickbusch, Ilona; Morrison, J. Stephen; Piot, Peter; Sands, Peter; Sridhar, Devi; Jha, Ashish K.			Post-Ebola reforms: ample analysis, inadequate action	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Moon, Suerie; Kickbusch, Ilona] Grad Inst Int & Dev Studies, Global Hlth Ctr, Geneva, Switzerland; [Leigh, Jennifer] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Woskie, Liana] Harvard Initiat Global Hlth Qual, Cambridge, MA USA; [Checchi, Francesco; Piot, Peter] London Sch Hyg & Trop Med, London, England; [Dzau, Victor] Natl Acad Med, Washington, DC USA; [Fallah, Mosoka] Natl Publ Hlth Inst Liberia, Monrovia, Liberia; [Fitzgerald, Gabrielle] Panorama, Seattle, WA USA; [Garrett, Laurie] Council Foreign Relat, New York, NY USA; [Gostin, Lawrence] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; Ctr Global Hlth Secur, Chatham House, London, England; [Heymann, David L.] Ctr Global Hlth Sci & Secur, Washington, DC USA; [Morrison, J. Stephen] Ctr Strateg & Int Studies, Global Hlth Policy Ctr, Washington, DC 20006 USA; [Sands, Peter] Mossavar Rahmani Ctr Business, Cambridge, MA USA; [Sridhar, Devi] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Jha, Ashish K.] Harvard Univ, Harvard Global Hlth Inst, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine; National Academies of Sciences, Engineering & Medicine; Georgetown University; Centre for Strategic & International Studies; University of Edinburgh; Harvard University	Moon, S (corresponding author), Grad Inst Int & Dev Studies, Global Hlth Ctr, Geneva, Switzerland.	suerie.moon@graduateinstitute.ch		Katz, Rebecca/0000-0002-7596-431X; Moon, Suerie/0000-0001-8504-1212; Checchi, Francesco/0000-0001-9030-5382; Woskie, Liana/0000-0002-7451-6849	WHO	WHO(World Health Organization)	We have read and understood BMJ policy on declaration of interests and declare the following: SM was study director of the Harvard-LSHTM (London School of Hygiene and Tropical Medicine) Independent Panel on the Global Response to Ebola, which is discussed in this paper. FC has been awarded a grant by WHO to support their new emergencies programme in areas related to public health and was lead author of WHO and emergency health: if not now, when, which is discussed in this paper. PP has grants from the Bill and Melinda Gates Foundation outside of the submitted work and was chairman of the Harvard-LSHTM panel. GF was the director of the Paul G. Allen Ebola Program in 2014-15 but maintains no current affiliation; she was also a member of the advisory group on reform of WHO's work in outbreaks and emergencies, whose reports are discussed in this paper. L Gostin is director of the WHO Collaborating Centre on Public Health Law and Human Rights, as well as serving on both the Harvard-LSHTM panel and the National Academy of Medicine (NAM) Commission on a Global Health Risk Framework for the Future, which is discussed in this paper. DH was a member of the Harvard-LSHTM panel and developed a concept paper with WHO for an emergency response workforce and background papers for both the UN and the NAM panels. IK served as a member of the independent WHO Ebola Interim Assessment Panel, which is discussed in this paper and is a member of the secretary general's Global Health Crises Task Force. PS is chairman of the NAM Commission and chairman of the World Bank's International Working Group on Financing Preparedness, which is also mentioned in the paper. He is lead non-executive director of the Department of Health in England, none of these positions is paid. VD is chairman of the International Oversight Group for the NAM Commission. AJ and DS are co-chairs of the Harvard-LSHTM panel. MF, L Garrett, and SJM are panellists and JL and LW are staff on the Harvard-LSHTM panel. RK has nothing to declare.	Abramowitz SA, 2015, PLOS NEGLECT TROP D, V9, DOI [DOI 10.1371/journal.pntd.0003706, DOI 10.1371/JOURNAL.PNTD.0003706]; [Anonymous], 2016, G7 LEADERS G7 ISE SH; Brende B, 2017, LANCET, V389, P233, DOI 10.1016/S0140-6736(17)30131-9; Checchi F, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i469; Check Hayden E, 2016, NATURE NEWS, DOI [10.1038/nature.2016.19186, DOI 10.1038/NATURE.2016.19186]; Commission on a Global Health Risk Framework for the Future, 2016, NEGL DIM GLOB SEC FR; Fan V., 2016, INCLUSIVE COST PANDE, DOI [10.3386/w22137, DOI 10.3386/W22137]; Gostin LO, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002042; Henao-Restrepo AM, 2016, LANCET; High-Level Panel on the Global Response to Health Crises, 2016, A70723 HIGH LEV PAN; Hyo-jin K, 2015, KOREA TIMES; International Committee of Medical Journal Editors, 2016, OV PUBL; Liberian Ministry of Health & West African Health Organization, 2016, FIN COMM MONR WORKSH; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; Pandemic Influenza Preparedness Framework Review Group, 2016, REV PAND INFL PREP F; Salama P, 2017, B WORLD HEALTH ORGAN, V95, P8, DOI 10.2471/BLT.17.030117; Sands P, 2016, LANCET, V388, P2443, DOI 10.1016/S0140-6736(16)30594-3; Sullivan PUS, 2016, C APPR CONT RES INCL; The National Academies of Sciences Engineering and Medicine, 2016, COMM CLIN TRIALS DUR; The White House, 2015, FACT SHEET US COMM G; UN General Assembly, 2016, STRENGTH GLOB HLTH A; UN Secretary General's Global Health Crises Task Force, 2016, SUMM 2 QUART M; United Nations, 2016, SECR GEN APP GLOB HL; United Nations General Assembly, 2016, LESS LEAM EX COORD A; World Bank, 2016, INT DEV ASS IDA 18 S; World Health Organization, 2016, IND OV ADV COMM WHO; World Health Organization, 2016, JOINT EXT EV TOOL IN; World Health Organization, 2016, ZIK RESP FUND; World Health Organization, 2016, 2 REP ADV GROUP REF; World Health Organization, 2015, DEV GLOB NORMS SHAR; World Health Organization, 2016, REP WHOS WORK HLTH E; World Health Organization, 2015, REP EB INT ASS PAN A; World Health Organization, 2015, ADV GROUP REF WHOS W; World Health Organization, 2016, EXT LIST EBOL REV; Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a	35	38	39	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2017	356								j280	10.1136/bmj.j280	http://dx.doi.org/10.1136/bmj.j280			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HK	28115316				2022-12-28	WOS:000393177300002
J	Barbey, C				Barbey, Christopher			A Mind-Body Duelist	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Barbey, Christopher] Harvard Univ, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University	Barbey, C (corresponding author), Harvard Univ, Dept Hlth Care Policy, Boston, MA 02115 USA.	barbey@hcp.med.harvard.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					261	261		10.1001/jama.2016.12484	http://dx.doi.org/10.1001/jama.2016.12484			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114558				2022-12-28	WOS:000392089200010
J	Bragg, F; Holmes, MV; Iona, A; Guo, Y; Du, HD; Chen, YP; Bian, Z; Yang, L; Herrington, W; Bennett, D; Turnbull, I; Liu, YM; Feng, SX; Chen, JS; Clarke, R; Collins, R; Peto, R; Li, LM; Chen, ZM				Bragg, Fiona; Holmes, Michael V.; Iona, Andri; Guo, Yu; Du, Huaidong; Chen, Yiping; Bian, Zheng; Yang, Ling; Herrington, William; Bennett, Derrick; Turnbull, Iain; Liu, Yongmei; Feng, Shixian; Chen, Junshi; Clarke, Robert; Collins, Rory; Peto, Richard; Li, Liming; Chen, Zhengming		China Kadoorie Biobank	Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; KADOORIE BIOBANK; FASTING GLUCOSE; BLOOD-GLUCOSE; GLOBAL BURDEN; RISK-FACTOR; 64 COHORTS; PREVALENCE; METAANALYSIS; HEALTH	IMPORTANCE In China, diabetes prevalence has increased substantially in recent decades, but there are no reliable estimates of the excess mortality currently associated with diabetes. OBJECTIVES To assess the proportional excess mortality associated with diabetes and estimate the diabetes-related absolute excess mortality in rural and urban areas of China. DESIGN, SETTING, AND PARTICIPANTS A 7-year nationwide prospective study of 512 869 adults aged 30 to 79 years from 10 (5 rural and 5 urban) regions in China, who were recruited between June 2004 and July 2008 and were followed up until January 2014. EXPOSURES Diabetes (previously diagnosed or detected by screening) recorded at baseline. MAIN OUTCOMES AND MEASURES All-cause and cause-specific mortality, collected through established death registries. Cox regression was used to estimate adjusted mortality rate ratio (RR) comparing individuals with diabetes vs those without diabetes at baseline. RESULTS Among the 512 869 participants, the mean (SD) age was 51.5 (10.7) years, 59% (n = 302 618) were women, and 5.9% (n = 30 280) had diabetes (4.1% in rural areas, 8.1% in urban areas, 5.8% of men, 6.1% of women, 3.1% had been previously diagnosed, and 2.8% were detected by screening). During 3.64 million person-years of follow-up, there were 24 909 deaths, including 3384 among individuals with diabetes. Compared with adults without diabetes, individuals with diabetes had a significantly increased risk of all-cause mortality (1373 vs 646 deaths per 100 000; adjusted RR, 2.00 [95% CI, 1.93-2.08]), which was higher in rural areas than in urban areas (rural RR, 2.17 [95% CI, 2.07-2.29]; urban RR, 1.83 [95% CI, 1.73-1.94]). Presence of diabetes was associated with increased mortality from ischemic heart disease (3287 deaths; RR, 2.40 [95% CI, 2.19-2.63]), stroke (4444 deaths; RR, 1.98 [95% CI, 1.81-2.17]), chronic liver disease (481 deaths; RR, 2.32 [95% CI, 1.76-3.06]), infections (425 deaths; RR, 2.29 [95% CI, 1.76-2.99]), and cancer of the liver (1325 deaths; RR, 1.54 [95% CI, 1.28-1.86]), pancreas (357 deaths; RR, 1.84 [95% CI, 1.35-2.51]), female breast (217 deaths; RR, 1.84 [95% CI, 1.24-2.74]), and female reproductive system (210 deaths; RR, 1.81 [95% CI, 1.20-2.74]). For chronic kidney disease (365 deaths), the RR was higher in rural areas (18.69 [95% CI, 14.22-24.57]) than in urban areas (6.83 [95% CI, 4.73-9.88]). Among those with diabetes, 10% of all deaths (16% rural; 4% urban) were due to definite or probable diabetic ketoacidosis or coma (408 deaths). CONCLUSIONS AND RELEVANCE Among adults in China, diabetes was associated with increased mortality from a range of cardiovascular and noncardiovascular diseases. Although diabetes was more common in urban areas, it was associated with greater excess mortality in rural areas.	[Bragg, Fiona; Holmes, Michael V.; Iona, Andri; Du, Huaidong; Chen, Yiping; Yang, Ling; Herrington, William; Bennett, Derrick; Turnbull, Iain; Clarke, Robert; Collins, Rory; Peto, Richard; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Bragg, Fiona; Holmes, Michael V.; Iona, Andri; Du, Huaidong; Chen, Yiping; Yang, Ling; Herrington, William; Bennett, Derrick; Turnbull, Iain; Clarke, Robert; Collins, Rory; Peto, Richard; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England; [Holmes, Michael V.; Iona, Andri; Du, Huaidong; Chen, Yiping; Yang, Ling] Univ Oxford, Med Res Council, Populat Hlth Res Unit, Oxford, England; [Guo, Yu; Bian, Zheng; Li, Liming] Chinese Acad Med Sci, Beijing, Peoples R China; [Liu, Yongmei] Qingdao Ctr Dis Control & Prevent, Qingdao, Peoples R China; [Feng, Shixian] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Chen, Junshi] Natl Ctr Food Safety Risk Assessment, Beijing, Peoples R China; [Li, Liming] Peking Univ, Sch Publ Hlth, Beijing, Peoples R China	University of Oxford; University of Oxford; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking University	Chen, ZM (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.; Li, LM (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China.	lmlee@vip.163.com; zhengming.chen@ctsu.ox.ac.uk	Collins, Rory/ABA-8487-2020; Bennett, Derrick/AFL-9254-2022; Holmes, Michael/AAA-2208-2021; Bennett, Derrick/AAH-1220-2022; , Bennett/O-7998-2019	Bennett, Derrick/0000-0002-9170-8447; Bennett, Derrick/0000-0002-9170-8447; Bragg, Fiona/0000-0002-9181-6886; Du, Huaidong/0000-0002-9814-0049	Kadoorie Charitable Foundation; UK Wellcome Trust [088158/Z/09/Z, 104085/Z/14/Z]; Chinese Ministry of Science and Technology; Chinese National Natural Science Foundation [81390541]; British Heart Foundation; UK Medical Research Council; Cancer Research UK; MRC [G0802432, MC_U137686851, MC_UU_12026/2, MC_PC_14135] Funding Source: UKRI; Medical Research Council [MC_PC_14135, MC_U137686851, MC_UU_12026/2, G0802432] Funding Source: researchfish	Kadoorie Charitable Foundation; UK Wellcome Trust(Wellcome Trust); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding/Support: Funding for the baseline survey was provided by the Kadoorie Charitable Foundation. Funding for the long-term continuation of the study was provided by grants 088158/Z/09/Z and 104085/Z/14/Z from the UK Wellcome Trust, grant 2011BAI09B01 from the Chinese Ministry of Science and Technology, and grant 81390541 from the Chinese National Natural Science Foundation. The British Heart Foundation, UK Medical Research Council, and Cancer Research UK provided core funding to the Oxford Clinical Trial Service Unit.	Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; An YL, 2015, DIABETES CARE, V38, P1365, DOI 10.2337/dc14-2498; Bragg F, 2014, DIABETIC MED, V31, P540, DOI 10.1111/dme.12392; Campbell PT, 2012, DIABETES CARE, V35, P1835, DOI 10.2337/dc12-0002; Chen ZM, 2015, LANCET, V386, P1447, DOI 10.1016/S0140-6736(15)00340-2; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Chen ZM, 2005, INT J EPIDEMIOL, V34, P1243, DOI 10.1093/ije/dyi174; Chinese Ministry of Health, 2011, CHIN STAT YB HLTH; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Liu J, 2007, AM HEART J, V153, P552, DOI 10.1016/j.ahj.2007.01.003; Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Peters SAE, 2014, DIABETOLOGIA, V57, P1542, DOI 10.1007/s00125-014-3260-6; Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sarwar N, 2010, LANCET, V376, P957, DOI 10.1016/S0140-6736(10)61450-X; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shen C, 2014, PREV MED, V64, P20, DOI 10.1016/j.ypmed.2014.03.021; Tancredi M, 2015, NEW ENGL J MED, V373, P1720, DOI 10.1056/NEJMoa1504347; United Nations Population Division, 2012, WORLD POP PROSP 2012; Woodward M, 2003, DIABETES CARE, V26, P360; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang G H, 1997, Biomed Environ Sci, V10, P1; Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6	31	240	309	5	139	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					280	289		10.1001/jama.2016.19720	http://dx.doi.org/10.1001/jama.2016.19720			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114552	Green Accepted			2022-12-28	WOS:000392089200015
J	Luo, S; Tong, L				Luo, Shukun; Tong, Liang			Molecular mechanism for the regulation of yeast separase by securin	NATURE			English	Article							SISTER-CHROMATID SEPARATION; COHESIN CLEAVAGE; STRUCTURAL BASIS; HUMAN-CELLS; ANAPHASE; RECOGNITION; BINDING; DOMAIN; LGN; PHOSPHORYLATION	Separase is a cysteine protease with a crucial role in the dissolution of cohesion among sister chromatids during chromosome segregation(1-7). In human tumours separase is overexpressed, making it a potential target for drug discover(8). The protease activity of separase is strictly regulated by the inhibitor securin, which forms a tight complex with separase and may also stabilize this enzyme(9-16). Separases are large, 140-250-kilodalton enzymes, with an amino-terminal alpha-helical region and a carboxy-terminal caspase-like catalytic domain. Although crystal structures of the C-terminal two domains of separase(17) and low-resolution electron microscopy reconstructions of the separase-securin complex(18,19) have been reported, the atomic structures of full-length separase and especially the complex with securin are unknown. Here we report crystal structures at up to 2.6 angstrom resolution of the yeast Saccharomyces cerevisiae separase-securin complex. The a-helical region of separase (also known as Esp1) contains four domains (I-IV), and a substrate-binding domain immediately precedes the catalytic domain and has tight associations with it. The separase-securin complex assumes a highly elongated structure. Residues 258-373 of securin (Pds1), named the separase interaction segment, are primarily in an extended conformation and traverse the entire length of separase, interacting with all of its domains. Most importantly, residues 258-269 of securin are located in the separase active site, illuminating the mechanism of inhibition. Biochemical studies confirm the structural observations and indicate that contacts outside the separase active site are crucial for stabilizing the complex, thereby defining an important function for the helical region of separase.	[Luo, Shukun; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu	Luo, Shukun/A-8371-2017; Luo, Shukun/AAT-8195-2021	Luo, Shukun/0000-0002-2766-3125; Luo, Shukun/0000-0002-2766-3125; Tong, Liang/0000-0002-0563-6468	NIH [R35GM118093, S1000012018, P41 GM103403]; NIH-ORIP HEI grant [S10 RR029205]; Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118093, P41GM103403] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012018] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-ORIP HEI grant; Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Zhang, S. Xiang and L. Cunha for carrying out initial studies on this project; S. Banerjee, K. Perry, R. Rajashankar, J. Schuermann, N. Sukumar for access to NE-CAT 24-C and 24-E beamlines at the Advanced Photon Source. This research is supported by grants R35GM118093 and S1000012018 from the NIH to L.T. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, funded by the NIH (P41 GM103403). The Pilatus 6M detector on 24-ID-C beam line is funded by an NIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated by Argonne National Laboratory under Contract no. DE-AC02-06CH11357.	Agarwal R, 2002, GENE DEV, V16, P1371, DOI 10.1101/gad.971402; Bachmann G, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160032; Carminati M, 2016, NAT STRUCT MOL BIOL, V23, P155, DOI 10.1038/nsmb.3152; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Csizmok V, 2008, J AM CHEM SOC, V130, P16873, DOI 10.1021/ja805510b; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hornig NCD, 2002, CURR BIOL, V12, P973, DOI 10.1016/S0960-9822(02)00847-3; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Lin ZH, 2016, NATURE, V532, P131, DOI 10.1038/nature17402; Nagao K, 2006, GENES CELLS, V11, P247, DOI 10.1111/j.1365-2443.2006.00941.x; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Pan Z, 2013, J MOL BIOL, V425, P1039, DOI 10.1016/j.jmb.2013.01.003; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sullivan M, 2004, J BIOL CHEM, V279, P1191, DOI 10.1074/jbc.M309761200; Sun YX, 2009, CELL, V137, P123, DOI 10.1016/j.cell.2009.01.040; Takayanagi H, 2015, ACTA CRYSTALLOGR F, V71, P175, DOI 10.1107/S2053230X14028143; Uhlmann F, 2003, BIOCHEM SOC SYMP, V70, P243, DOI 10.1042/bss0700243; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Viadiu H, 2005, NAT STRUCT MOL BIOL, V12, P552, DOI 10.1038/nsmb935; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Winter A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004548; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Yanagida M, 2000, GENES CELLS, V5, P1, DOI 10.1046/j.1365-2443.2000.00306.x; Zhang NG, 2014, J BIOMOL SCREEN, V19, P878, DOI 10.1177/1087057114520972; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	30	27	27	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					255	259		10.1038/nature21061	http://dx.doi.org/10.1038/nature21061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28146474	Green Accepted			2022-12-28	WOS:000393737500046
J	Carey, AL; Khan, MU; Engleberg, NC				Carey, Adrienne L.; Khan, Muhammed U.; Engleberg, N. Cary			A 24-Year-Old Man With a Left Frontal Brain Mass	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POLYMERASE-CHAIN-REACTION; ANTIRETROVIRAL THERAPY; LYMPHOMA; AIDS; DIAGNOSIS; BIOPSY; CSF		[Carey, Adrienne L.] Univ Michigan Hlth Syst, Dept Internal Med, Internal Med Pediat Residency Program, Ann Arbor, MI USA; [Khan, Muhammed U.] Cent Michigan Univ, Dept Med, Saginaw, MI USA; [Engleberg, N. Cary] Univ Michigan Hlth Syst, Div Infect Dis, Dept Internal Med, 3119P Taubman Ctr Box 5378,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Central Michigan University; University of Michigan System; University of Michigan	Engleberg, NC (corresponding author), Univ Michigan Hlth Syst, Div Infect Dis, Dept Internal Med, 3119P Taubman Ctr Box 5378,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	cengleb@med.umich.edu						[Anonymous], 2014, NEUROLOGY, V83, P235; Antinori A, 1997, NEUROLOGY, V48, P687, DOI 10.1212/WNL.48.3.687; Antinori A, 1999, J CLIN ONCOL, V17, P554, DOI 10.1200/JCO.1999.17.2.554; Corcoran C, 2008, J CLIN VIROL, V42, P433, DOI 10.1016/j.jcv.2008.03.017; Corr P, 2006, J PSYCHOSOM RES, V61, P295, DOI 10.1016/j.jpsychores.2006.05.011; Gopal S, 2013, JNCI-J NATL CANCER I, V105, P1221, DOI 10.1093/jnci/djt158; Koralnik IJ, APPROACH HIV INFECT; Lee AM, 2016, J NEUROL NEUROSUR PS, V87, P722, DOI 10.1136/jnnp-2015-312037; Rosenow JM, 2007, NEUROSURGERY, V61, P130, DOI 10.1227/01.neu.0000279733.28768.ff; Rubenstein JL, 2013, BLOOD, V122, P2318, DOI 10.1182/blood-2013-06-453084	10	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					527	528		10.1001/jama.2016.19156	http://dx.doi.org/10.1001/jama.2016.19156			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28170458				2022-12-28	WOS:000393564200022
J	Horton, R				Horton, Richard			Offline: A President, undone by prejudice	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					489	489		10.1016/S0140-6736(17)30268-4	http://dx.doi.org/10.1016/S0140-6736(17)30268-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ5UH	28170323	Bronze			2022-12-28	WOS:000393283400016
J	Webb, SA; Litton, E				Webb, Steven A.; Litton, Edward			Prevention is better than cure, but both require high quality evidence	LANCET			English	Editorial Material									[Webb, Steven A.] St John God Hosp Subiaco, Dept Intens Care, Subiaco, WA, Australia; [Litton, Edward] Fiona Stanley Hosp, Dept Intens Care, Perth, WA, Australia	St John of God Health Care	Webb, SA (corresponding author), St John God Hosp Subiaco, Subiaco, WA 6008, Australia.	steve.webb@uwa.edu.au	litton, edward/C-5384-2017	litton, edward/0000-0002-5125-6829				Angus DC, 2015, JAMA-J AM MED ASSOC, V314, P767, DOI 10.1001/jama.2015.7762; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Hurt AC, 2016, EMERG INFECT DIS, V22, P949, DOI 10.3201/eid2206.151037; Thongnoi P, 2017, LANCET, V389, P571, DOI 10.1016/S0140-6736(16)31334-4; Webb SAR, 2015, CRIT CARE MED, V43, P1767, DOI 10.1097/CCM.0000000000001058	5	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					572	572		10.1016/S0140-6736(16)32406-0	http://dx.doi.org/10.1016/S0140-6736(16)32406-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ5UH	28170336				2022-12-28	WOS:000393283400040
J	Tetlock, PE; Mellers, BA; Scoblic, JP				Tetlock, Philip E.; Mellers, Barbara A.; Scoblic, J. Peter			Bringing probability judgments into policy debates via forecasting tournaments	SCIENCE			English	Editorial Material							ACCOUNTABILITY; STRATEGIES; COMPLEXITY	Political debates often suffer from vague-verbiage predictions that make it difficult to assess accuracy and improve policy. A tournament sponsored by the U.S. intelligence community revealed ways in which forecasters can better use probability estimates to make predictions-even for seemingly "unique" events-and showed that tournaments are a useful tool for generating knowledge. Drawing on the literature about the effects of accountability, the authors suggest that tournaments may hold even greater potential as tools for depolarizing political debates and resolving policy disputes.	[Tetlock, Philip E.; Mellers, Barbara A.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Scoblic, J. Peter] Harvard Univ, Harvard Business Sch, Boston, MA 02163 USA	University of Pennsylvania; Harvard University	Tetlock, PE (corresponding author), Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA.	tetlock@wharton.upenn.edu			Carnegie Corporation; Open Philanthropy Network	Carnegie Corporation; Open Philanthropy Network	The authors thank the Carnegie Corporation and Open Philanthropy Network for funding.	Atanasov P, 2017, MANAGE SCI, V63, P691, DOI 10.1287/mnsc.2015.2374; Barnes A, 2016, INTELL NATL SECUR, V31, P327, DOI 10.1080/02684527.2014.994955; Kahneman D., 2011, THINKING FAST SLOW; Kent S., 1964, STUDIES INTELLIGENCE, V8, P49; Mellers B, 2001, PSYCHOL SCI, V12, P269, DOI 10.1111/1467-9280.00350; Mellers B, 2015, PERSPECT PSYCHOL SCI, V10, P267, DOI 10.1177/1745691615577794; Mellers B, 2015, J EXP PSYCHOL-APPL, V21, P1, DOI 10.1037/xap0000040; Mellers B, 2014, PSYCHOL SCI, V25, P1106, DOI 10.1177/0956797614524255; MOSTELLER F, 1990, STAT SCI, V0005; Taleb NN, 2011, FOREIGN AFF, V90, P33; TETLOCK PE, 1989, J PERS SOC PSYCHOL, V57, P632, DOI 10.1037/0022-3514.57.4.632; TETLOCK PE, 1983, J PERS SOC PSYCHOL, V45, P74, DOI 10.1037/0022-3514.45.1.74; Tetlock PE, 2014, CURR DIR PSYCHOL SCI, V23, P290, DOI 10.1177/0963721414534257; WALLSTEN TS, 1986, J EXP PSYCHOL GEN, V115, P348, DOI 10.1037/0096-3445.115.4.348	15	28	28	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					481	+		10.1126/science.aal3147	http://dx.doi.org/10.1126/science.aal3147			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154049				2022-12-28	WOS:000393183100033
J	Schulman, AR; Tavakkoli, A; Thompson, CC; Miller, AL; Loscalzo, J				Schulman, Allison R.; Tavakkoli, Ali; Thompson, Christopher C.; Miller, Amy L.; Loscalzo, Joseph			Making the Connection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GASTRIC BYPASS; MARGINAL ULCERATION; BARIATRIC SURGERY; RISK-FACTORS; MANAGEMENT; ULCERS		[Schulman, Allison R.; Thompson, Christopher C.; Miller, Amy L.; Loscalzo, Joseph] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Tavakkoli, Ali] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Miller, AL (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	almiller@partners.org	Loscalzo, Joseph/ABD-8980-2021					Arterburn DE, 2015, JAMA-J AM MED ASSOC, V313, P62, DOI 10.1001/jama.2014.16968; Azagury DE, 2011, ENDOSCOPY, V43, P950, DOI 10.1055/s-0030-1256951; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Buchwald H, 2013, OBES SURG, V23, P427, DOI 10.1007/s11695-012-0864-0; Carr WRJ, 2014, OBES SURG, V24, P1520, DOI 10.1007/s11695-014-1293-z; Coblijn UK, 2015, OBES SURG, V25, P805, DOI 10.1007/s11695-014-1482-9; Colquitt J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub2; Dallal Ramsey M, 2006, Surg Obes Relat Dis, V2, P455; Fronza Jeffrey S, 2012, Surg Obes Relat Dis, V8, pe60, DOI 10.1016/j.soard.2011.05.006; Jirapinyo P, 2012, GASTROINTEST ENDOSC, V76, P435, DOI 10.1016/j.gie.2012.03.681; Perry CD, 2008, ANN SURG, V247, P21, DOI 10.1097/SLA.0b013e318142cb4b; Rasmussen JJ, 2007, SURG ENDOSC, V21, P1090, DOI 10.1007/s00464-007-9285-x; Sakran N, 2012, OBESITY FACTS, V5, P538, DOI 10.1159/000342012; Steinemann DC, 2014, OBES SURG, V24, P741, DOI 10.1007/s11695-013-1152-3	14	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 2	2017	376	5					476	482		10.1056/NEJMcps1602495	http://dx.doi.org/10.1056/NEJMcps1602495			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8WH	28146669				2022-12-28	WOS:000393507200013
J	O'Dowd, A				O'Dowd, Adrian			Hunt wants "new relationship" with Europe on health after Brexit	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2017	356								j447	10.1136/bmj.j447	http://dx.doi.org/10.1136/bmj.j447			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HS	28126829				2022-12-28	WOS:000393178100011
J	Jonas, DE; Amick, HR; Feltner, C; Weber, RP; Arvanitis, M; Stine, A; Lux, L; Harris, RP				Jonas, Daniel E.; Amick, Halle R.; Feltner, Cynthia; Weber, Rachel Palmieri; Arvanitis, Marina; Stine, Alexander; Lux, Linda; Harris, Russell P.			Screening for Obstructive Sleep Apnea in Adults Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POSITIVE AIRWAY PRESSURE; RANDOMIZED CONTROLLED-TRIAL; CONTROLLED CROSSOVER TRIAL; PLACEBO-CONTROLLED TRIAL; ORAL APPLIANCE THERAPY; ALL-CAUSE MORTALITY; EXCESSIVE DAYTIME SLEEPINESS; HOME RESPIRATORY POLYGRAPHY; LIFE-STYLE INTERVENTION; HEART-FAILURE PATIENTS	IMPORTANCE Many adverse health outcomes are associated with obstructive sleep apnea (OSA). OBJECTIVE To review primary care-relevant evidence on screening adults for OSA, test accuracy, and treatment of OSA, to inform the US Preventive Services Task Force. DATA SOURCES MEDLINE, Cochrane Library, EMBASE, and trial registries through October 2015, references, and experts, with surveillance of the literature through October 5, 2016. STUDY SELECTION English-language randomized clinical trials (RCTs); studies evaluating accuracy of screening questionnaires or prediction tools, diagnostic accuracy of portable monitors, or association between apnea-hypopnea index (AHI) and health outcomes among community-based participants. DATA EXTRACTION AND SYNTHESIS Two investigators independently reviewed abstracts and full-text articles. When multiple similar studies were available, random-effects meta-analyses were conducted. MAIN OUTCOMES AND MEASURES Sensitivity, specificity, area under the curve (AUC), AHI, Epworth Sleepiness Scale (ESS) scores, blood pressure, mortality, cardiovascular events, motor vehicle crashes, quality of life, and harms. RESULTS A total of 110 studies were included (N = 46 188). No RCTs compared screening with no screening. In 2 studies (n = 702), the screening accuracy of the multivariable apnea prediction score followed by home portable monitor testing for detecting severe OSA syndrome (AHI > 30 and ESS score > 10) was AUC 0.80 (95% CI, 0.78 to 0.82) and 0.83 (95% CI, 0.77 to 0.90), respectively, but the studies oversampled high-risk participants and those with OSA and OSA syndrome. No studies prospectively evaluated screening tools to report calibration or clinical utility for improving health outcomes. Meta-analysis found that continuous positive airway pressure (CPAP) compared with sham was significantly associated with reduction of AHI (weighted mean difference [WMD], -33.8 [95% CI, -42.0 to -25.6]; 13 trials, 543 participants), excessive sleepiness assessed by ESS score (WMD, -2.0 [95% CI, -2.6 to -1.4]; 22 trials, 2721 participants), diurnal systolic blood pressure (WMD, -2.4 points [95% CI, -3.9 to -0.9]; 15 trials, 1190 participants), and diurnal diastolic blood pressure (WMD, -1.3 points [95% CI, -2.2 to -0.4]; 15 trials, 1190 participants). CPAP was associated with modest improvement in sleep-related quality of life (Cohen d, 0.28 [95% CI, 0.14 to 0.42]; 13 trials, 2325 participants). Mandibular advancement devices (MADs) and weight loss programs were also associated with reduced AHI and excessive sleepiness. Common adverse effects of CPAP and MADs included oral or nasal dryness, irritation, and pain, among others. In cohort studies, there was a consistent association between AHI and all-cause mortality. CONCLUSIONS AND RELEVANCE There is uncertainty about the accuracy or clinical utility of all potential screening tools. Multiple treatments for OSA reduce AHI, ESS scores, and blood pressure. Trials of CPAP and other treatments have not established whether treatment reduces mortality or improves most other health outcomes, except for modest improvement in sleep-related quality of life.	[Jonas, Daniel E.; Feltner, Cynthia; Arvanitis, Marina; Harris, Russell P.] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC USA; [Jonas, Daniel E.; Amick, Halle R.; Feltner, Cynthia; Weber, Rachel Palmieri; Stine, Alexander; Lux, Linda; Harris, Russell P.] Univ North Carolina Chapel Hill, RTI Int, Evidence Based Practice Ctr, Chapel Hill, NC USA; [Jonas, Daniel E.; Amick, Halle R.; Feltner, Cynthia; Weber, Rachel Palmieri; Arvanitis, Marina; Harris, Russell P.] Univ North Carolina Chapel Hill, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Arvanitis, Marina] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Stine, Alexander; Lux, Linda] RTI Int, Res Triangle Pk, NC USA; [Stine, Alexander] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Northwestern University; Research Triangle Institute; Duke University	Jonas, DE (corresponding author), 5034 Old Clin Bldg, Chapel Hill, NC 27599 USA.	daniel_jonas@med.unc.edu	Lux, Linda/GPX-3639-2022	Arvanitis, Marina/0000-0002-2186-5164	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA-290-2012-00015-I]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA-290-2012-00015-I, Task Order 4, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Aarab G, 2011, RESPIRATION, V81, P411, DOI 10.1159/000319595; Nigro CA, 2013, SLEEP BREATH, V17, P259, DOI 10.1007/s11325-012-0684-4; Alvarez D, 2009, PHYSIOL MEAS, V30, P967, DOI 10.1088/0967-3334/30/9/008; Alvarez D, 2012, MED ENG PHYS, V34, P1049, DOI 10.1016/j.medengphy.2011.11.009; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Andren A, 2013, SLEEP BREATH, V17, P705, DOI 10.1007/s11325-012-0746-7; [Anonymous], 1998, Ann Neurol, V43, P88; Arias MA, 2008, EUR RESPIR J, V32, P1009, DOI 10.1183/09031936.00007008; Arias MA, 2005, CIRCULATION, V112, P375, DOI 10.1161/CIRCULATIONAHA.104.501841; Back LJJ, 2009, LARYNGOSCOPE, V119, P1621, DOI 10.1002/lary.20562; Balk EM, 2011, AHRQ PUBLICATION, V11-EHC052-EF; Ballester E, 1999, AM J RESP CRIT CARE, V159, P495, DOI 10.1164/ajrccm.159.2.9804061; Barak-Shinar D, 2013, SLEEP BREATH, V17, P1109, DOI 10.1007/s11325-013-0812-9; Barbe F, 2001, ANN INTERN MED, V134, P1015, DOI 10.7326/0003-4819-134-11-200106050-00007; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Barbe F, 2010, AM J RESP CRIT CARE, V181, P718, DOI 10.1164/rccm.200901-0050OC; Bardwell Wayne A, 2007, Behav Sleep Med, V5, P21, DOI 10.1207/s15402010bsm0501_2; Barnes M, 2004, AM J RESP CRIT CARE, V170, P656, DOI 10.1164/rccm.200311-1571OC; Batool-Anwar S, 2016, J SLEEP RES, V25, P731, DOI 10.1111/jsr.12430; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bisognano JD, 2011, J AM COLL CARDIOL, V58, P765, DOI 10.1016/j.jacc.2011.06.008; Blackwell T, 2015, J AM GERIATR SOC, V63, P453, DOI 10.1111/jgs.13321; Bloch KE, 2000, AM J RESP CRIT CARE, V162, P246, DOI 10.1164/ajrccm.162.1.9908112; Bohning N, 2011, J TELEMED TELECARE, V17, P15, DOI 10.1258/jtt.2010.100205; Browaldh N, 2013, THORAX, V68, P846, DOI 10.1136/thoraxjnl-2012-202610; Bruyneel M, 2011, J SLEEP RES, V20, P201, DOI 10.1111/j.1365-2869.2010.00859.x; Campbell AJ, 2011, J SLEEP RES, V20, P207, DOI 10.1111/j.1365-2869.2010.00854.x; Campos-Rodriguez F, 2006, CHEST, V129, P1459, DOI 10.1378/chest.129.6.1459; Centers for Medicare and Medicaid Services, 2008, NAT COV DET NCD CONT; Chasens ER, 2014, WESTERN J NURS RES, V36, P294, DOI 10.1177/0193945913500567; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi JH, 2010, ACTA OTO-LARYNGOL, V130, P838, DOI 10.3109/00016480903431139; Chong MS, 2006, J AM GERIATR SOC, V54, P777, DOI 10.1111/j.1532-5415.2006.00694.x; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Continuous positive airway pressure (CPAP) in sleep apnea syndrome-primary research, 1993, HLTH TECHNOL ASSESS; Coughlin SR, 2007, EUR RESPIR J, V29, P720, DOI 10.1183/09031936.00043306; Craig SE, 2012, THORAX, V67, P1090, DOI 10.1136/thoraxjnl-2012-202178; Cross MD, 2008, THORAX, V63, P578, DOI 10.1136/thx.2007.081877; Desplan M, 2014, SLEEP MED, V15, P906, DOI 10.1016/j.sleep.2013.09.023; Dixon JB, 2012, JAMA-J AM MED ASSOC, V308, P1142, DOI 10.1001/2012.jama.11580; Duran-Cantolla J, 2015, MED ORAL PATOL ORAL, V20, pE605, DOI 10.4317/medoral.20649; Duran-Cantolla J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5991; Egea CJ, 2008, SLEEP MED, V9, P660, DOI 10.1016/j.sleep.2007.06.018; El Shayeb M, 2014, CAN MED ASSOC J, V186, pE25, DOI 10.1503/cmaj.130952; Engleman HM, 1997, THORAX, V52, P114, DOI 10.1136/thx.52.2.114; Engleman HM, 1999, AM J RESP CRIT CARE, V159, P461, DOI 10.1164/ajrccm.159.2.9803121; ENGLEMAN HM, 1994, LANCET, V343, P572, DOI 10.1016/S0140-6736(94)91522-9; Engleman HM, 1998, THORAX, V53, P341, DOI 10.1136/thx.53.5.341; Ensrud KE, 2012, SLEEP MED, V13, P1217, DOI 10.1016/j.sleep.2012.04.010; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Faccenda JF, 2001, AM J RESP CRIT CARE, V163, P344, DOI 10.1164/ajrccm.163.2.2005037; Ferguson KA, 2003, AM J RESP CRIT CARE, V167, P15, DOI 10.1164/rccm.2108050; Ferre A, 2012, J CLIN SLEEP MED, V8, P163, DOI 10.5664/jcsm.1770; Foster GD, 2009, ARCH INTERN MED, V169, P1619, DOI 10.1001/archinternmed.2009.266; Gami AS, 2004, CIRCULATION, V110, P364, DOI 10.1161/01.CIR.0000136587.68725.8E; Garg N, 2014, J CLIN SLEEP MED, V10, P879, DOI 10.5664/jcsm.3960; George CF, 1987, LANCET, V2, P447; Goehring C, 2004, STAT MED, V23, P125, DOI 10.1002/sim.1591; Gooneratne NS, 2011, SLEEP, V34, P435, DOI 10.1093/sleep/34.4.435; Gotsopoulos H, 2002, AM J RESP CRIT CARE, V166, P743, DOI 10.1164/rccm.200203-208OC; Gotsopoulos H, 2004, SLEEP, V27, P934, DOI 10.1093/sleep/27.5.934; Gottlieb DJ, 2014, NEW ENGL J MED, V370, P2276, DOI 10.1056/NEJMoa1306766; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Guerrero A, 2014, SLEEP, V37, P1363, DOI 10.5665/sleep.3932; Gurubhagavatula I, 2013, J CLIN HYPERTENS, V15, P279, DOI 10.1111/jch.12073; Hack M, 2000, THORAX, V55, P224, DOI 10.1136/thorax.55.3.224; Haensel A, 2007, SLEEP BREATH, V11, P239, DOI 10.1007/s11325-007-0115-0; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Hoyos CM, 2012, THORAX, V67, P1081, DOI 10.1136/thoraxjnl-2011-201420; Hrubos-Strom H, 2011, J SLEEP RES, V20, P162, DOI 10.1111/j.1365-2869.2010.00861.x; Hui DS, 2006, THORAX, V61, P1083, DOI 10.1136/thx.2006.064063; Iber C., 2007, AASM MANUAL SCORING; Ip MSM, 2004, AM J RESP CRIT CARE, V169, P348, DOI 10.1164/rccm.200306-767OC; Jelinek Michael, 2008, Evid Based Med, V13, P132, DOI 10.1136/ebm.13.5.132; Jenkinson C, 1999, LANCET, V353, P2100, DOI 10.1016/S0140-6736(98)10532-9; Johansson K, 2009, BMJ-BRIT MED J, V339, pb4609, DOI DOI 10.1136/BMJ.B4609; Johns M, 1997, SLEEP, V20, P844, DOI 10.1093/sleep/20.10.844; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Johnston CD, 2002, EUR J ORTHODONT, V24, P251, DOI 10.1093/ejo/24.3.251; Jonas DE, 2017, AHRQ PUBLICATION, V14-05216-EF-1; Jones A, 2013, SLEEP MED, V14, P1260, DOI 10.1016/j.sleep.2013.08.786; Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479; Kingshott RN, 2001, AM J RESP CRIT CARE, V163, P918, DOI 10.1164/ajrccm.163.4.2005036; Kline CE, 2013, INT J CARDIOL, V167, P1610, DOI 10.1016/j.ijcard.2012.04.108; Kline CE, 2012, J CLIN SLEEP MED, V8, P357, DOI 10.5664/jcsm.2022; Kohler M, 2008, EUR RESPIR J, V32, P1488, DOI 10.1183/09031936.00026608; Koutsourelakis I, 2008, EUR RESPIR J, V31, P110, DOI 10.1183/09031936.00087607; Kuna ST, 2013, SLEEP, V36, P641, DOI 10.5665/sleep.2618; Kushida CA, 2012, SLEEP, V35, P1593, DOI 10.5665/sleep.2226; LACHS MS, 1992, ANN INTERN MED, V117, P135, DOI 10.7326/0003-4819-117-2-135; Lam B, 2007, THORAX, V62, P354, DOI 10.1136/thx.2006.063644; Lam JCM, 2010, EUR RESPIR J, V35, P138, DOI 10.1183/09031936.00047709; Lee In-Soo, 2011, Drug Discov Today Dis Models, V8, P147; Lim W, 2007, J CLIN SLEEP MED, V3, P380; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Loredo JS, 2006, SLEEP, V29, P564, DOI 10.1093/sleep/29.4.564; Loredo JS, 1999, CHEST, V116, P1545, DOI 10.1378/chest.116.6.1545; Malow BA, 2008, NEUROLOGY, V71, P572, DOI 10.1212/01.wnl.0000323927.13250.54; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marshall NS, 2008, SLEEP, V31, P1079; Marshall NS, 2014, J CLIN SLEEP MED, V10, P355, DOI 10.5664/jcsm.3600; Marshall NS, 2005, THORAX, V60, P427, DOI 10.1136/thx.2004.032078; Martinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250; Masa JF, 2013, EUR RESPIR J, V41, P879, DOI 10.1183/09031936.00186811; Masa JF, 2011, THORAX, V66, P567, DOI 10.1136/thx.2010.152272; McArdle N, 2001, AM J RESP CRIT CARE, V164, P1459, DOI 10.1164/ajrccm.164.8.2008146; McMillan A, 2014, LANCET RESP MED, V2, P804, DOI 10.1016/S2213-2600(14)70172-9; Medical Advisory Secretariat, 2009, Ont Health Technol Assess Ser, V9, P1; Miletin MS, 2003, SLEEP MED, V4, P195, DOI 10.1016/S1389-9457(03)00031-5; Mills PJ, 2006, J APPL PHYSIOL, V100, P343, DOI 10.1152/japplphysiol.00494.2005; Montserrat JM, 2001, AM J RESP CRIT CARE, V164, P608, DOI 10.1164/ajrccm.164.4.2006034; Morales CR, 2012, SLEEP, V35, P1491, DOI 10.5665/sleep.2196; Moss J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/102164; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; Myers KA, 2013, JAMA-J AM MED ASSOC, V310, P731, DOI 10.1001/jama.2013.276185; Naismith SL, 2005, J CLIN SLEEP MED, V1, P374; Neikrug AB, 2014, SLEEP, V37, P177, DOI 10.5665/sleep.3332; Nguyen PK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-50; Nieto FJ, 2012, AM J RESP CRIT CARE, V186, P190, DOI 10.1164/rccm.201201-0130OC; Nigro CA, 2010, MEDICINA-BUENOS AIRE, V70, P53; Norman D, 2006, HYPERTENSION, V47, P840, DOI 10.1161/01.HYP.0000217128.41284.78; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Pamidi S, 2015, AM J RESP CRIT CARE, V192, P96, DOI 10.1164/rccm.201408-1564OC; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; Pereira EJ, 2013, J CLIN SLEEP MED, V9, P1259, DOI 10.5664/jcsm.3264; Petri N, 2008, J SLEEP RES, V17, P221, DOI 10.1111/j.1365-2869.2008.00645.x; Phillips CL, 2011, AM J RESP CRIT CARE, V184, P355, DOI 10.1164/rccm.201102-0316OC; Poupard L, 2012, SLEEP BREATH, V16, P419, DOI 10.1007/s11325-011-0518-9; Puhan MA, 2006, BMJ-BRIT MED J, V332, P266, DOI 10.1136/bmj.38705.470590.55; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Qaseem A, 2014, ANN INTERN MED, V161, P210, DOI 10.7326/M12-3187; Quan SF, 2006, SLEEP MED, V7, P498, DOI 10.1016/j.sleep.2006.02.005; Quinnell TG, 2014, THORAX, V69, P938, DOI 10.1136/thoraxjnl-2014-205464; Redline S, 1998, AM J RESP CRIT CARE, V157, P858, DOI 10.1164/ajrccm.157.3.9709042; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Robinson GV, 2006, EUR RESPIR J, V27, P1229, DOI 10.1183/09031936.06.00062805; Rofail LM, 2010, SLEEP, V33, P1106, DOI 10.1093/sleep/33.8.1106; Ruttanaumpawan P, 2008, J HYPERTENS, V26, P1163, DOI 10.1097/HJH.0b013e3282fb81ed; Morillo DS, 2013, MED BIOL ENG COMPUT, V51, P305, DOI 10.1007/s11517-012-0995-4; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Siccoli MM, 2008, SLEEP, V31, P1551, DOI 10.1093/sleep/31.11.1551; Smith LA, 2007, EUR HEART J, V28, P1221, DOI 10.1093/eurheartj/ehm131; Smith SS, 2008, SLEEP MED, V9, P739, DOI 10.1016/j.sleep.2007.08.004; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Tomfohr LM, 2011, SLEEP, V34, P121, DOI 10.1093/sleep/34.1.121; Toukh M, 2012, RESP PHYSIOL NEUROBI, V183, P218, DOI 10.1016/j.resp.2012.06.022; Tuomilehto H, 2013, JAMA INTERN MED, V173, P929, DOI 10.1001/jamainternmed.2013.389; Tuomilehto H, 2010, AM J CLIN NUTR, V92, P688, DOI 10.3945/ajcn.2010.29485; Tuomilehto HPI, 2009, AM J RESP CRIT CARE, V179, P320, DOI 10.1164/rccm.200805-669OC; U.S. Preventive Services Task Force, 2015, PROC MAN APP 6; US Preventive Services Task Force, 2016, METH PROC; Usui K, 2005, J AM COLL CARDIOL, V45, P2008, DOI 10.1016/j.jacc.2004.12.080; Vongpatanasin W, 2014, JAMA-J AM MED ASSOC, V311, P2216, DOI 10.1001/jama.2014.5180; Weaver TE, 2012, AM J RESP CRIT CARE, V186, P677, DOI 10.1164/rccm.201202-0200OC; Weinstock TG, 2012, SLEEP, V35, P617, DOI 10.5665/sleep.1816; West SL, 2010, 10EHC070EF AG HEALTH; West SD, 2007, THORAX, V62, P969, DOI 10.1136/thx.2006.074351; West SD, 2009, SLEEP MED, V10, P1056, DOI 10.1016/j.sleep.2008.11.007; Willis BH, 2008, FAM PRACT, V25, P390, DOI 10.1093/fampra/cmn051; Woodson BT, 2003, OTOLARYNG HEAD NECK, V128, P848, DOI 10.1016/S0194-5998(03)00461-3; Wozniak DR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007736.pub2; Yadollahi A, 2010, MED BIOL ENG COMPUT, V48, P1087, DOI 10.1007/s11517-010-0674-2; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Yeboah J, 2011, ATHEROSCLEROSIS, V219, P963, DOI 10.1016/j.atherosclerosis.2011.08.021; Young T, 1997, SLEEP, V20, P608, DOI 10.1093/sleep/20.8.608; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 2008, SLEEP, V31, P1071; Young Terry, 2009, WMJ, V108, P246	172	153	161	1	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					415	433		10.1001/jama.2016.19635	http://dx.doi.org/10.1001/jama.2016.19635			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118460				2022-12-28	WOS:000392509600023
J	Ravelli, A; Davi, S; Bracciolini, G; Pistorio, A; Consolaro, A; van Dijkhuizen, EHP; Lattanzi, B; Filocamo, G; Verazza, S; Gerloni, V; Gattinara, M; Pontikaki, I; Insalaco, A; De Benedetti, F; Civino, A; Presta, G; Breda, L; Marzetti, V; Pastore, S; Magni-Manzoni, S; Maggio, MC; Garofalo, F; Rigante, D; Gattorno, M; Malattia, C; Picco, P; Viola, S; Lanni, S; Ruperto, N; Martini, A				Ravelli, Angelo; Davi, Sergio; Bracciolini, Giulia; Pistorio, Angela; Consolaro, Alessandro; van Dijkhuizen, Evert Hendrik Pieter; Lattanzi, Bianca; Filocamo, Giovanni; Verazza, Sara; Gerloni, Valeria; Gattinara, Maurizio; Pontikaki, Irene; Insalaco, Antonella; De Benedetti, Fabrizio; Civino, Adele; Presta, Giuseppe; Breda, Luciana; Marzetti, Valentina; Pastore, Serena; Magni-Manzoni, Silvia; Maggio, Maria Cristina; Garofalo, Franco; Rigante, Donato; Gattorno, Marco; Malattia, Clara; Picco, Paolo; Viola, Stefania; Lanni, Stefano; Ruperto, Nicolino; Martini, Alberto		Italian Pediatric Rheumatology Stu	Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial	LANCET			English	Article							RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; PARENTERAL METHOTREXATE; SELECT CATEGORIES; DISEASE-ACTIVITY; CLINICAL-TRIAL; CHILDREN; EFFICACY; THERAPY; SAFETY	Background Little evidence-based information is available to guide the treatment of oligoarticular juvenile idiopathic arthritis. We aimed to investigate whether oral methotrexate increases the efficacy of intra-articular corticosteroid therapy. Methods We did this prospective, open-label, randomised trial at ten hospitals in Italy. Using a concealed computer-generated list, children younger than 18 years with oligoarticular-onset disease were randomly assigned (1: 1) to intraarticular corticosteroids alone or in combination with oral methotrexate (15 mg/m(2) maximum 20 mg). Corticosteroids used were triamcinolone hexacetonide (shoulder, elbow, wrist, knee, and tibiotalar joints) or methylprednisolone acetate (ie, subtalar and tarsal joints). We did not mask patients or investigators to treatment assignments. Our primary outcome was the proportion of patients in the intention-to-treat population who had remission of arthritis in all injected joints at 12 months. This trial is registered with European Union Clinical Trials Register, EudraCT number 2008-006741-70. Findings Between July 7, 2009, and March 31, 2013, we screened 226 participants and randomly assigned 102 to intra-articular corticosteroids alone and 105 to intra-articular corticosteroids plus methotrexate. 33 (32%) patients assigned to intra-articular corticosteroids alone and 39 (37%) assigned to intra-articular corticosteroids and methotrexate therapy had remission of arthritis in all injected joints (p=0.8). Adverse events were recorded for 20 (17%) patients who received methotrexate, which led to permanent treatment discontinuation in two patients (one due to increased liver transaminases and one due to gastrointestinal discomfort). No patient had a serious adverse event. Interpretation Concomitant administration of methotrexate did not augment the effectiveness of intra-articular corticosteroid therapy. Future studies are needed to define the optimal therapeutic strategies for oligoarticular juvenile idiopathic arthritis.	[Ravelli, Angelo; Davi, Sergio; Pistorio, Angela; Consolaro, Alessandro; van Dijkhuizen, Evert Hendrik Pieter; Gattorno, Marco; Malattia, Clara; Picco, Paolo; Viola, Stefania; Lanni, Stefano; Ruperto, Nicolino; Martini, Alberto] Ist Giannina Gaslini, Genoa, Italy; [Ravelli, Angelo; Bracciolini, Giulia; Consolaro, Alessandro; Verazza, Sara; Malattia, Clara; Martini, Alberto] Univ Genoa, Genoa, Italy; [Lattanzi, Bianca] Osped Riuniti Salesi Childrens Hosp, Azienda Osped Univ, Ancona, Italy; [Filocamo, Giovanni] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Gerloni, Valeria; Gattinara, Maurizio; Pontikaki, Irene] Ist Gaetano Pini, Milan, Italy; [Insalaco, Antonella; De Benedetti, Fabrizio; Magni-Manzoni, Silvia] Osped Pediat Bambino Gesu, Rome, Italy; [Civino, Adele; Presta, Giuseppe] Azienda Osped Cardinale G Panico, Tricase, Italy; [Breda, Luciana; Marzetti, Valentina] Osped Policlin, Chieti, Italy; [Pastore, Serena] IRCCS Burlo Garofolo, Trieste, Italy; [Maggio, Maria Cristina] Univ Palermo, Palermo, Italy; [Garofalo, Franco] Osped Inferm Biella, Biella, Italy; [Rigante, Donato] Univ Cattolica Sacro Cuore, Rome, Italy; [Rigante, Donato] Fdn Policlin Univ A Gemelli, Rome, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Ca Granda Ospedale Maggiore Policlinico; ASST Gaetano Pini CTO; IRCCS Bambino Gesu; IRCCS Burlo Garofolo; University of Palermo; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Ravelli, A (corresponding author), Ist Giannina Gaslini, Pediat Reumatol 2, I-16147 Genoa, Italy.	angeloravelli@gaslini.org	insalaco, antonella/AAW-5966-2021; Rigante, Donato/AAE-2660-2019; Pistorio, Angela/D-1375-2009; Gattorno, Marco/AAL-2974-2020; insalaco, antonella/AAA-5197-2020; Lattanzi, Bianca/J-7618-2018; van Dijkhuizen, Pieter/AAO-3828-2020; Civino, Adele/AAI-5499-2021; Filocamo, Giovanni/S-4446-2017; Davì, Sergio SD/J-5442-2018; Consolaro, Alessandro/J-8125-2016; de benedetti, fabrizio/J-9577-2018; Ruperto, Nicolino/K-3349-2018; Manzoni, Silvia Magni/Y-8809-2019; Magni-Manzoni, Silvia/AAJ-7737-2020; Rigante, Donato/Q-1044-2019; Malattia, Clara/ABI-2329-2020; Insalaco, Antonella/HGC-9288-2022	Pistorio, Angela/0000-0002-6895-8720; Gattorno, Marco/0000-0003-0704-1916; insalaco, antonella/0000-0003-1443-1840; Lattanzi, Bianca/0000-0002-2238-512X; Civino, Adele/0000-0002-0416-768X; Filocamo, Giovanni/0000-0002-9638-6512; Davì, Sergio SD/0000-0002-8707-8040; Consolaro, Alessandro/0000-0002-0065-7614; de benedetti, fabrizio/0000-0001-8749-8232; Ruperto, Nicolino/0000-0001-8407-7782; Manzoni, Silvia Magni/0000-0002-5714-1141; Magni-Manzoni, Silvia/0000-0002-5714-1141; Rigante, Donato/0000-0001-7032-7779; Malattia, Clara/0000-0002-0521-9488; Insalaco, Antonella/0000-0003-1443-1840; MARTINI, Alberto/0000-0001-7642-1459; Picco, Paolo/0000-0003-0686-0725	Italian Agency of Drug Evaluation	Italian Agency of Drug Evaluation	Italian Agency of Drug Evaluation.	Alsufyani K, 2004, J RHEUMATOL, V31, P179; Beukelman T, 2007, J RHEUMATOL, V34, P1918; Beukelman T, 2011, ARTHRIT CARE RES, V63, P465, DOI 10.1002/acr.20460; Bianchi G, 2016, ADV THER, V33, P369, DOI 10.1007/s12325-016-0295-8; Bloom BJ, 2011, RHEUMATOL INT, V31, P749, DOI 10.1007/s00296-010-1365-x; Consolaro A, 2016, J RHEUMATOL, V43, P683, DOI 10.3899/jrheum.160173; Consolaro A, 2014, ARTHRIT CARE RES, V66, P1703, DOI 10.1002/acr.22393; Felici E, 2005, J RHEUMATOL, V32, P1805; GIANNINI EH, 1992, NEW ENGL J MED, V326, P1043, DOI 10.1056/NEJM199204163261602; Guillaume S, 2000, ARTHRITIS RHEUM, V43, P1858, DOI 10.1002/1529-0131(200008)43:8<1858::AID-ANR23>3.0.CO;2-A; Klein A, 2012, ARTHRIT CARE RES, V64, P1349, DOI 10.1002/acr.21697; Lanni S, 2011, RHEUMATOLOGY, V50, P1627, DOI 10.1093/rheumatology/ker165; Lovell DJ, 2013, NAT REV RHEUMATOL, V9, P557, DOI 10.1038/nrrheum.2013.105; Marti P, 2008, EUR J PEDIATR, V167, P425, DOI 10.1007/s00431-007-0525-9; Oen K, 2002, J RHEUMATOL, V29, P1989; Papadopoulou C, 2013, J PEDIATR-US, V163, P879, DOI 10.1016/j.jpeds.2013.03.047; Papadopoulou C, 2013, ARTHRIT CARE RES, V65, P1112, DOI 10.1002/acr.21947; Petty RE, 2004, J RHEUMATOL, V31, P390; Ravelli A, 2007, LANCET, V369, P767, DOI 10.1016/S0140-6736(07)60363-8; Reiff A, 2006, J RHEUMATOL, V33, P985; Ruperto N, 2005, ARTHRITIS RHEUM-US, V52, P563, DOI 10.1002/art.20860; Ruperto N, 2004, ARTHRITIS RHEUM-US, V50, P2191, DOI 10.1002/art.20288; Scott C, 2010, CLIN EXP RHEUMATOL, V28, P774; Sherry DD, 1999, ARTHRITIS RHEUM, V42, P2330, DOI 10.1002/1529-0131(199911)42:11<2330::AID-ANR11>3.0.CO;2-B; Sobel RE, 2014, PEDIATR RHEUMATOL, V12, DOI 10.1186/1546-0096-12-29; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vidqvist KL, 2013, RHEUMATOLOGY, V52, P1999, DOI 10.1093/rheumatology/ket256; Wallace CA, 2005, ARTHRITIS RHEUM-US, V52, P3554, DOI 10.1002/art.21389; Wallace CA, 2011, ARTHRIT CARE RES, V63, P929, DOI 10.1002/acr.20497; Zulian F, 2004, RHEUMATOLOGY, V43, P1288, DOI 10.1093/rheumatology/keh313	30	36	35	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					909	916		10.1016/S0140-6736(17)30065-X	http://dx.doi.org/10.1016/S0140-6736(17)30065-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM4DL	28162781				2022-12-28	WOS:000395263400030
J	Solomon, B				Solomon, Benjamin			First-line treatment options for ALK-rearranged lung cancer	LANCET			English	Editorial Material							PROGRESSION-FREE; PHASE 1/2; CRIZOTINIB; SAFETY; ALECTINIB; SURVIVAL		[Solomon, Benjamin] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic 3000, Australia	Peter Maccallum Cancer Center	Solomon, B (corresponding author), Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic 3000, Australia.	ben.solomon@petermac.org		Solomon, Benjamin/0000-0003-3059-5730				Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Gainor JF, 2015, CLIN CANCER RES, V21, P2745, DOI 10.1158/1078-0432.CCR-14-3009; Gettinger SN, 2016, LANCET ONCOL, V17, P1683, DOI 10.1016/S1470-2045(16)30392-8; Hida T, LANCET IN PRESS; KIM DE, 2016, INT J PRECIS ENG MAN, V17, P1, DOI DOI 10.1016/S1470-2045(15)00614-2; Shaw AT, 2016, J THORAC ONCOL, V11, pS256, DOI 10.1016/j.jtho.2016.09.016; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Soria J. C., 2017, LANCET; Watanabe S, 2016, CLIN LUNG CANCER, V17, P528, DOI 10.1016/j.cllc.2016.05.001	11	8	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					884	886		10.1016/S0140-6736(17)30124-1	http://dx.doi.org/10.1016/S0140-6736(17)30124-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM4DL	28126330				2022-12-28	WOS:000395263400006
J	Wulffraat, N				Wulffraat, Nico			The value of old drugs for juvenile idiopathic arthritis	LANCET			English	Editorial Material							TRIAMCINOLONE ACETONIDE; METHOTREXATE; HEXACETONIDE; TRIAL		[Wulffraat, Nico] Univ Med Ctr Utrecht, Dept Paediat Rheumatol, NL-3508 AB Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Wulffraat, N (corresponding author), Univ Med Ctr Utrecht, Dept Paediat Rheumatol, NL-3508 AB Utrecht, Netherlands.	n.wulffraat@umcutrecht.nl	Wulffraat, Nico M/AAE-8929-2020	Wulffraat, Nico M/0000-0001-9548-5562	AbbVie; GlaxoSmithKline; Novartis; Pfizer; Roche; Sanofi; Sobi; ReumaFonds [LLP-10] Funding Source: researchfish	AbbVie(AbbVie); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Pfizer(Pfizer); Roche(Roche Holding); Sanofi; Sobi; ReumaFonds	I declare receipt of unrestricted grants from AbbVie, GlaxoSmithKline, Novartis, Pfizer, Roche, Sanofi, and Sobi.	Beukelman T, 2011, ARTHRIT CARE RES, V63, P465, DOI 10.1002/acr.20460; Foeldvari I, 2015, ARTHRIT CARE RES, V67, P1529, DOI 10.1002/acr.22613; Ravelli A, 1998, CLIN EXP RHEUMATOL, V16, P181; Ravelli A, 2016, LANCET; Ruperto N, 2004, ARTHRITIS RHEUM-US, V50, P2191, DOI 10.1002/art.20288; van Dijkhuizen EHP, 2016, CLIN EXP RHEUMATOL, V34, P148; Wulffraat NM, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-5; Zulian F, 2004, RHEUMATOLOGY, V43, P1288, DOI 10.1093/rheumatology/keh313; Zulian F, 2003, RHEUMATOLOGY, V42, P1254, DOI 10.1093/rheumatology/keg358	9	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					883	884		10.1016/S0140-6736(17)30180-0	http://dx.doi.org/10.1016/S0140-6736(17)30180-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM4DL	28162780				2022-12-28	WOS:000395263400005
J	McCracken, KW; Aihara, E; Martin, B; Crawford, CM; Broda, T; Treguier, J; Zhang, XH; Shannon, JM; Montrose, MH; Wells, JM				McCracken, Kyle W.; Aihara, Eitaro; Martin, Baptiste; Crawford, Calyn M.; Broda, Taylor; Treguier, Julie; Zhang, Xinghao; Shannon, John M.; Montrose, Marshall H.; Wells, James M.			Wnt/beta-catenin promotes gastric fundus specification in mice and humans (vol 541, pg 182, 2017)	NATURE			English	Correction															NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102551] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK102551] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		KYLE W, 2017, NATURE, V541, P182, DOI DOI 10.1038/NATURE21021	1	2	2	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					136	136		10.1038/nature21381	http://dx.doi.org/10.1038/nature21381			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28117442	Bronze			2022-12-28	WOS:000395671500048
J	Holl, KD				Holl, Karen D.			Restoring tropical forests from the bottom up	SCIENCE			English	Editorial Material							NATURAL REGENERATION; RESTORATION; SCALE; CHALLENGES; LANDSCAPES; LESSONS		[Holl, Karen D.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Holl, KD (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA.	kholl@ucsc.edu						Brancalion P. H. S., 2016, World Development Perspectives, V3, P15, DOI 10.1016/j.wdp.2016.11.003; Calle Z., 2013, Journal of Sustainable Forestry, V32, P677, DOI 10.1080/10549811.2013.817338; Chazdon RL, 2017, CONSERV LETT, V10, P125, DOI 10.1111/conl.12220; Chazdon RL, 2016, BIOTROPICA, V48, P716, DOI 10.1111/btp.12381; de Rezende CL, 2015, BIODIVERS CONSERV, V24, P2255, DOI 10.1007/s10531-015-0980-y; Feyera S, 2002, TREES-STRUCT FUNCT, V16, P245, DOI 10.1007/s00468-002-0161-y; Holl KD, 2011, FOREST ECOL MANAG, V261, P1558, DOI 10.1016/j.foreco.2010.07.004; Holl KD, 2017, J APPL ECOL, V54, P1091, DOI 10.1111/1365-2664.12814; IUCN (International Union for Conservation of Nature), 2014, ASS FOR LANDSC REST; Latawiec AE, 2015, FRONT ECOL ENVIRON, V13, P211, DOI 10.1890/140052; Lazos-Chavero E, 2016, BIOTROPICA, V48, P900, DOI 10.1111/btp.12391; Mansourian S, 2014, ENVIRON MANAGE, V53, P241, DOI 10.1007/s00267-013-0213-7; Melo FPL, 2013, ENVIRON SCI POLICY, V33, P395, DOI 10.1016/j.envsci.2013.07.013; Murcia C, 2016, CONSERV LETT, V9, P213, DOI 10.1111/conl.12199; Shoo LP, 2013, RESTOR ECOL, V21, P670, DOI 10.1111/rec.12048	15	117	119	7	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					455	456		10.1126/science.aam5432	http://dx.doi.org/10.1126/science.aam5432			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154033	Green Published			2022-12-28	WOS:000393183100017
J	Castelvecchi, D				Castelvecchi, Davide			Astronomers explore uses for AI-generated images	NATURE			English	News Item																			0	1	1	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					16	17		10.1038/542016a	http://dx.doi.org/10.1038/542016a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28150795	Bronze			2022-12-28	WOS:000396119300008
J	Appleby, J				Appleby, John			DATA BRIEFING Death clocks: How long have I got?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Nuffield Trust, London, England		Appleby, J (corresponding author), Nuffield Trust, London, England.	john.appleby@nuffieldtrust.org.uk						Abaris, HOW LONG WILL I LIV; Death Clock, MY DEATH TEST; Death Timer, WHEN WILL YOU DIE; Frijters P, 2005, 496 AUSTR NAT U CTR; Ganna A, 2015, UBBLE UK LONGEVITY E; Giltay EJ, 2004, ARCH GEN PSYCHIAT, V61, P1126, DOI 10.1001/archpsyc.61.11.1126; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; MedIndia, DEATH CLOCK LIF SPAN; Northwestern Mutual Life Insurance Company, LIF CALC; Office for National Statistics, 2016, NAT LIF TABL; Office for National Statistics, 2015, NAT LIF TABL; ONS Digital, 2015, LONG WILL MY PENS NE; Risk Prediction in Surgery, LIF EXP CALC; Rufus A., LIVE LONGER LIFE 15; Social Security Administration, CALC LIF EXP; Statistics New Zealand, 2016, HOW LONG WILL I LIV; Yau N., YEARS YOU HAVE LEFT	17	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2017	356								j346	10.1136/bmj.j346	http://dx.doi.org/10.1136/bmj.j346			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HS	28122708				2022-12-28	WOS:000393178100004
J	Wise, J				Wise, Jacqui			TOO MUCH MEDICINE Choosing Wisely: how the UK intends to reduce harmful medical overuse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jacquiyoung1@gmail.com						Campbell D., 2015, GUARDIAN; Choosing Wisely, CLIN REC; Malhotra A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2308; McCarthy M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5437; NICE, NICE GUID SAV PROD; PerryUndem Research/Communication, 2014, UNN TESTS PROC HLTH; Rosenberg A, 2015, JAMA INTERN MED, V175, P1913, DOI 10.1001/jamainternmed.2015.5441; Torjesen I, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5732	8	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2017	356								j370	10.1136/bmj.j370	http://dx.doi.org/10.1136/bmj.j370			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HS	28126848				2022-12-28	WOS:000393178100005
J	Bibbins-Domingo, K; Grossman, DC; Curry, SJ; Davidson, KW; Epling, JW; Garcia, FAR; Herzstein, J; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, CS; Mangione, CM; Phillips, WR; Phipps, MG; Pignone, MP; Silverstein, M; Tseng, CW				Bibbins-Domingo, Kirsten; Grossman, David C.; Curry, Susan J.; Davidson, Karina W.; Epling, John W., Jr.; Garcia, Francisco A. R.; Herzstein, Jessica; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Phillips, William R.; Phipps, Maureen G.; Pignone, Michael P.; Silverstein, Michael; Tseng, Chien-Wen		US Preventive Serv Task Force	Screening for Obstructive Sleep Apnea in Adults US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PREVALENCE; GUIDELINE; RISK; CARE	IMPORTANCE Based on data from the 1990s, estimated prevalence of obstructive sleep apnea (OSA) in the United States is 10% for mild OSA and 3.8% to 6.5% for moderate to severe OSA; current prevalence may be higher, given the increasing prevalence of obesity. Severe OSA is associated with increased all-cause mortality, cardiovascular disease and cerebrovascular events, diabetes, cognitive impairment, decreased quality of life, and motor vehicle crashes. OBJECTIVE To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for OSA in asymptomatic adults. EVIDENCE REVIEW The USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of screening for OSA in asymptomatic adults seen in primary care, including those with unrecognized symptoms. The USPSTF also evaluated the evidence on the benefits and harms of treatment of OSA on intermediate and final health outcomes. FINDINGS The USPSTF found insufficient evidence on screening for or treatment of OSA in asymptomatic adults or adults with unrecognized symptoms. Therefore, the USPSTF was unable to determine the magnitude of the benefits or harms of screening for OSA or whether there is a net benefit or harm to screening. CONCLUSIONS AND RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for OSA in asymptomatic adults. (I statement)	[Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grossman, David C.] Grp Hlth Res Inst, Seattle, WA USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Epling, John W., Jr.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Garcia, Francisco A. R.] Pima Cty Dept Hlth, Tucson, AZ USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Phipps, Maureen G.] Univ Washington, Seattle, WA 98195 USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Pignone, Michael P.] Univ Texas Austin, Austin, TX 78712 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Tseng, Chien-Wen] Univ Hawaii Manoa, Honolulu, HI 96822 USA	University of California System; University of California San Francisco; University of Iowa; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Duke University; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Brown University; University of Texas System; University of Texas Austin; Boston University; University of Hawaii System; University of Hawaii Manoa	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	chair@uspstf.net	Davidson, Karina/AAG-2388-2019; Epling, John W/J-1097-2019; Davidson, Karina/GWC-0996-2022; Phillips, William R./V-1065-2017	Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Phillips, William R./0000-0003-2802-4349; Kemper, Alex/0000-0001-5491-3997	USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	[Anonymous], 2008, NICE TECHN APPR GUID; Balk EM, 2011, 11EHC052 AG HEALTHC, V32; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Bixler EO, 2000, ARCH INTERN MED, V160, P2289, DOI 10.1001/archinte.160.15.2289; Caples SM, 2005, ANN INTERN MED, V142, P187, DOI 10.7326/0003-4819-142-3-200502010-00010; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Federal Motor Carrier Safety Administration, 2016, US DOT SEEKS INP SCR; Gurubhagavatula I, 2013, J CLIN HYPERTENS, V15, P279, DOI 10.1111/jch.12073; Hrubos-Strom H, 2011, J SLEEP RES, V20, P162, DOI 10.1111/j.1365-2869.2010.00861.x; Jonas DE, 2017, AHRQ PUBLICATION, V14-05216-EF-1; Jonas DE, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2016.19635, DOI 10.1001/JAMA.2016]; Mold JW, 2011, J AM BOARD FAM MED, V24, P138, DOI 10.3122/jabfm.2011.02.100095; Morales CR, 2012, SLEEP, V35, P1491, DOI 10.5665/sleep.2196; Myers KA, 2013, JAMA-J AM MED ASSOC, V310, P731, DOI 10.1001/jama.2013.276185; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Qaseem A, 2014, ANN INTERN MED, V161, P210, DOI 10.7326/M12-3187; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893; Young Terry, 2009, WMJ, V108, P246	22	112	116	2	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					407	414		10.1001/jama.2016.20325	http://dx.doi.org/10.1001/jama.2016.20325			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118461	Bronze			2022-12-28	WOS:000392509600022
J	Allen, KD; Oddone, EZ; Coffman, CJ; Jeffreys, AS; Bosworth, HB; Chatterjee, R; McDuffie, J; Strauss, JL; Yancy, WS; Datta, SK; Corsino, L; Dolor, RJ				Allen, Kelli D.; Oddone, Eugene Z.; Coffman, Cynthia J.; Jeffreys, Amy S.; Bosworth, Hayden B.; Chatterjee, Ranee; McDuffie, Jennifer; Strauss, Jennifer L.; Yancy, William S., Jr.; Datta, Santanu K.; Corsino, Leonor; Dolor, Rowena J.			Patient, Provider, and Combined Interventions for Managing Osteoarthritis in Primary Care A Cluster Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SYMPTOMATIC KNEE OSTEOARTHRITIS; SHARED DECISION-MAKING; DWELLING OLDER-ADULTS; CLINICAL-TRIALS; HIP OSTEOARTHRITIS; PAIN; MANAGEMENT; DISABILITY; COMMUNITY; QUALITY	Background: A single-site study showed that a combined patient and provider intervention improved outcomes for patients with knee osteoarthritis, but it did not assess separate effects of the interventions. Objective: To examine whether patient-based, provider-based, and patient-provider interventions improve osteoarthritis outcomes. Design: Cluster randomized trial with assignment to patient, provider, and patient-provider interventions or usual care. (ClinicalTrials. gov: NCT01435109) Setting: 10 Duke University Health System community-based primary care clinics. Participants: 537 outpatients with symptomatic hip or knee osteoarthritis. Intervention: The telephone-based patient intervention focused on weight management, physical activity, and cognitive behavioral pain management. The provider intervention involved electronic delivery of patient-specific osteoarthritis treatment recommendations to providers. Measurements: The primary outcome was the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) total score at 12 months. Secondary outcomes were objective physical function (Short Physical Performance Battery) and depressive symptoms (Patient Health Questionnaire). Linear mixed models assessed the difference in improvement among groups. Results: No difference was observed in WOMAC score changes from baseline to 12 months in the patient (-1.5 [95% CI, -5.1 to 2.0]; P = 0.40), provider (2.5 [CI, -0.9 to 5.9]; P = 0.152), or patient- provider (-0.7 [CI, -4.2 to 2.8]; P = 0.69) intervention groups compared with usual care. All groups had improvements in WOMAC scores at 12 months (range, -3.7 to -7.7). In addition, no differences were seen in objective physical function or depressive symptoms at 12 months in any of the intervention groups compared with usual care. Limitations: The study involved 1 health care network. Data on provider referrals were not collected. Conclusion: Contrary to a previous study of a combined patient and provider intervention for osteoarthritis in a Department of Veterans Affairs medical center, this study found no statistically significant improvements in the osteoarthritis intervention groups compared with usual care.	[Oddone, Eugene Z.; Coffman, Cynthia J.; Jeffreys, Amy S.; Bosworth, Hayden B.; McDuffie, Jennifer] Durham Vet Affairs Med Ctr, Hlth Serv Res & Dev 152, 508 Fulton St, Durham, NC 27705 USA; [Strauss, Jennifer L.] Durham Vet Affairs Med Ctr, Bldg 6,508 Fulton St, Durham, NC 27705 USA; Duke Univ, Durham, NC USA; Duke Univ, Med Ctr, Durham, NC USA; Univ N Carolina, Chapel Hill, NC USA; [Allen, Kelli D.] Univ North Carolina Chapel Hill, Thurston Arthrit Res Ctr, 3300 Thurston Bldg,CB 7280, Chapel Hill, NC 27599 USA; [Chatterjee, Ranee; Datta, Santanu K.; Dolor, Rowena J.] Duke Div Gen Internal Med, 411 West Chapel Hill St,Box 104427, Durham, NC 27710 USA; [Yancy, William S., Jr.] Duke Diet & Fitness Ctr, 501 Douglas St, Durham, NC 27705 USA; [Corsino, Leonor] Duke Dept Med, Box 3451, Durham, NC 27710 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Allen, KD (corresponding author), Univ North Carolina Chapel Hill, Thurston Arthrit Res Ctr, 3300 Thurston Bldg,CB 7280, Chapel Hill, NC 27599 USA.	kdallen@email.unc.edu		Dolor, Rowena/0000-0001-7317-9468	NIAMS of the NIH [1R01AR059673-01]; Department of Veterans Affairs Health Services Research and Development Service [CIN 13-410]	NIAMS of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Department of Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs)	By the NIAMS of the NIH under award 1R01AR059673-01 and contributions from the Department of Veterans Affairs Health Services Research and Development Service (CIN 13-410).	Allen KD, 2016, MUSCULOSKELET CARE, V14, P87, DOI 10.1002/msc.1116; Allen KD, 2016, ANN INTERN MED, V164, P73, DOI 10.7326/M15-0378; Allen KD, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-60; Allen KD, 2010, ANN INTERN MED, V153, P570, DOI 10.7326/0003-4819-153-9-201011020-00006; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; Angst F, 2002, J RHEUMATOL, V29, P131; [Anonymous], 1999, STAT MED, V18, P1905; Balding DJ, 2004, APPL LONGITUDINAL AN; Bellamy N, 2002, J RHEUMATOL, V29, P2473; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; BELLAMY N, 1986, CLIN RHEUMATOL, V5, P231, DOI 10.1007/BF02032362; Bennell KL, 2014, ARTHRITIS RHEUMATOL, V66, P950, DOI 10.1002/art.38317; Borm GF, 2007, J CLIN EPIDEMIOL, V60, P1234, DOI 10.1016/j.jclinepi.2007.02.006; Bozic KJ, 2013, J BONE JOINT SURG AM, V95A, P1633, DOI 10.2106/JBJS.M.00004; Brand CA, 2013, RHEUM DIS CLIN N AM, V39, P123, DOI 10.1016/j.rdc.2012.10.005; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Brooks MA, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-158; Centers for Disease Control and Prevention (CDC), 2002, MMWR MORB MORTAL WKL, V51, P948; Colbert CJ, 2013, ARTHRIT CARE RES, V65, P5, DOI 10.1002/acr.21811; Collins JE, 2014, OSTEOARTHR CARTILAGE, V22, P622, DOI 10.1016/j.joca.2014.03.009; Dhawan A, 2014, ARTHROSCOPY, V30, P65, DOI 10.1016/j.arthro.2013.09.002; DIEHR P, 1995, STAT MED, V14, P1491, DOI 10.1002/sim.4780141309; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dixon KE, 2007, HEALTH PSYCHOL, V26, P241, DOI 10.1037/0278-6133.26.3.241; Donner A, 2007, STAT MED, V26, P2036, DOI 10.1002/sim.2662; Dunlop DD, 2011, ARTHRITIS RHEUM-US, V63, P3372, DOI 10.1002/art.30562; Ehrich EW, 2000, J RHEUMATOL, V27, P2635; Elwyn G, 2016, PATIENT EDUC COUNS, V99, P571, DOI 10.1016/j.pec.2015.10.011; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Freedman M., 2007, Morbidity and Mortality Weekly Report, V56, P423; Ganz DA, 2006, ARTHRIT RHEUM-ARTHR, V55, P241, DOI 10.1002/art.21844; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Harada ND, 2001, MED SCI SPORT EXER, V33, P962, DOI 10.1097/00005768-200106000-00016; Hedeker D., 2006, LONGITUDINAL DATA AN; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hughes SL, 2006, GERONTOLOGIST, V46, P801, DOI 10.1093/geront/46.6.801; Hunter DJ, 2011, ARTHRIT CARE RES, V63, P31, DOI 10.1002/acr.20278; Hunter DJ, 2010, CLIN GERIATR MED, V26, P401, DOI 10.1016/j.cger.2010.03.003; Jinks C, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-59; Johnson VL, 2014, BEST PRACT RES CL RH, V28, P5, DOI 10.1016/j.berh.2014.01.004; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kotlarz H, 2009, ARTHRITIS RHEUM-US, V60, P3546, DOI 10.1002/art.24984; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Leffondre K, 2004, J CLIN EPIDEMIOL, V57, P1049, DOI 10.1016/j.jclinepi.2004.02.012; Li LC, 2011, J RHEUMATOL, V38, P2230, DOI 10.3899/jrheum.110264; Little R.J.A., 2002, STAT ANAL MISSING DA; Liu GHF, 2009, STAT MED, V28, P2509, DOI 10.1002/sim.3639; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; McDonough CM, 2010, CLIN GERIATR MED, V26, P387, DOI 10.1016/j.cger.2010.04.001; Messier SP, 2013, JAMA-J AM MED ASSOC, V310, P1263, DOI 10.1001/jama.2013.277669; Miller WR, 2002, COMMUNICATION; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; Paskins Z, 2015, ANN FAM MED, V13, P537, DOI 10.1370/afm.1866; Pasquale MK, 2014, PAIN PRACT, V14, P117, DOI 10.1111/papr.12066; Peters TJ, 2005, BRIT J GEN PRACT, V55, P205; Richmond J, 2010, J BONE JOINT SURG AM, V92A, P990, DOI 10.2106/JBJS.I.00982; Rini C, 2015, PAIN, V156, P837, DOI 10.1097/j.pain.0000000000000121; Rochon J, 1998, STAT MED, V17, P1643, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1643::AID-SIM869>3.0.CO;2-3; Somers TJ, 2012, PAIN, V153, P1199, DOI 10.1016/j.pain.2012.02.023; Stewart AL, 2001, MED SCI SPORT EXER, V33, P1126, DOI 10.1097/00005768-200107000-00010; Sun K, 2014, ARTHRIT CARE RES, V66, P1041, DOI 10.1002/acr.22262; Swanson AJ, 1999, J NERV MENT DIS, V187, P630, DOI 10.1097/00005053-199910000-00007; Turkiewicz A, 2014, OSTEOARTHR CARTILAGE, V22, P1826, DOI 10.1016/j.joca.2014.07.015; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Verkleij SPJ, 2012, ANN RHEUM DIS, V71, P1517, DOI 10.1136/annrheumdis-2011-200687; Weigl M, 2006, OSTEOARTHR CARTILAGE, V14, P641, DOI 10.1016/j.joca.2006.01.001; Wesseling J, 2015, J RHEUMATOL, V42, P1470, DOI 10.3899/jrheum.141036; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	70	16	16	1	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					401	+		10.7326/M16-1245	http://dx.doi.org/10.7326/M16-1245			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9RM	28114648	Green Accepted			2022-12-28	WOS:000397025800015
J	Mendelson, A; Kondo, K; Damberg, C; Low, A; Motuapuaka, M; Freeman, M; O'Neil, M; Relevo, R; Kansagara, D				Mendelson, Aaron; Kondo, Karli; Damberg, Cheryl; Low, Allison; Motuapuaka, Makalapua; Freeman, Michele; O'Neil, Maya; Relevo, Rose; Kansagara, Devan			The Effects of Pay-for-Performance Programs on Health, Health Care Use, and Processes of Care	ANNALS OF INTERNAL MEDICINE			English	Review							FINANCIAL INCENTIVES; OUTCOMES FRAMEWORK; DIABETES CARE; QUALITY INCENTIVES; HOSPITAL PAY; RISK-FACTORS; LONG-TERM; IMPACT; PHYSICIANS; ENGLAND	Background: The benefits of pay-for-performance (P4P) programs are uncertain. Purpose: To update and expand a prior review examining the effects of P4P programs targeted at the physician, group, managerial, or institutional level on process-of-care and patient outcomes in ambulatory and inpatient settings. Data Sources: PubMed from June 2007 to October 2016; MEDLINE, PsycINFO, CINAHL, Business Economics and Theory, Business Source Elite, Scopus, Faculty of 1000, and Gartner Research from June 2007 to February 2016. Study Selection: Trials and observational studies in ambulatory and inpatient settings reporting process-of-care, health, or utilization outcomes. Data Extraction: Two investigators extracted data, assessed study quality, and graded the strength of the evidence. Data Synthesis: Among 69 studies, 58 were in ambulatory settings, 52 reported process-of-care outcomes, and 38 reported patient outcomes. Low-strength evidence suggested that P4P programs in ambulatory settings may improve process-of-care outcomes over the short term (2 to 3 years), whereas data on longer-term effects were limited. Many of the positive studies were conducted in the United Kingdom, where incentives were larger than in the United States. The largest improvements were seen in areas where baseline performance was poor. There was no consistent effect of P4P on intermediate health outcomes (low-strength evidence) and insufficient evidence to characterize any effect on patient health outcomes. In the hospital setting, there was low-strength evidence that P4P had little or no effect on patient health outcomes and a positive effect on reducing hospital readmissions. Limitation: Few methodologically rigorous studies; heterogeneous population and program characteristics and incentive targets. Conclusion: Pay-for-performance programs may be associated with improved processes of care in ambulatory settings, but consistently positive associations with improved health outcomes have not been demonstrated in any setting.	[Kondo, Karli; Low, Allison; Motuapuaka, Makalapua; Freeman, Michele; O'Neil, Maya; Relevo, Rose; Kansagara, Devan] VA Portland Hlth Care Syst, Mail Code R&D 71,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Mendelson, Aaron] Oregon Hlth & Sci Univ, Mail Code MDYCHSE,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; RAND Corp, Santa Monica, CA USA; [Damberg, Cheryl] RAND Hlth, 1776 Main St, Santa Monica, CA 90407 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; RAND Corporation; RAND Corporation	Kansagara, D (corresponding author), VA Portland Hlth Care Syst, Mail Code R&D 71,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	kansagar@ohsu.edu	Callahan, Charles D/L-1641-2013; Kondo, Karli/R-3994-2019	Kondo, Karli/0000-0002-4635-5056	U.S. Department of Veterans Affairs; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS022981] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	U.S. Department of Veterans Affairs.	Alshamsan R, 2012, ANN FAM MED, V10, P228, DOI 10.1370/afm.1335; Andriole KP, 2010, J AM COLL RADIOL, V7, P198, DOI 10.1016/j.jacr.2009.11.011; Arrowsmith ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092205; Asch DA, 2015, JAMA-J AM MED ASSOC, V314, P1926, DOI 10.1001/jama.2015.14850; Benzer JK, 2014, J GEN INTERN MED, V29, P127, DOI 10.1007/s11606-013-2572-4; Berkman N, 2011, AHRQ PUBLICATION, V11-E006; Calvert M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1870; Casalino LP, 2016, HEALTH AFFAIR, V35, P401, DOI 10.1377/hlthaff.2015.1258; Chang RE, 2012, HEALTH AFFAIR, V31, P93, DOI 10.1377/hlthaff.2010.0402; Chen CC, 2016, HEALTH POLICY PLANN, V31, P83, DOI 10.1093/heapol/czv024; Chen HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161002; Chen YC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004197; Cheng SH, 2012, MED CARE, V50, P109, DOI 10.1097/MLR.0b013e31822d5d36; Colais P, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-393; Damberg CL, 2014, MEASURING SUCCESS HL; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Emanuel EJ, 2016, ANN INTERN MED, V164, P114, DOI 10.7326/M15-1330; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Esse T, 2013, J MANAGE CARE PHARM, V19, P317, DOI 10.18553/jmcp.2013.19.4.317; Evidence-based Synthesis Program Coordinating Center, 2014, ESP REP PROGR; Figueroa JF, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2214; Findlay S, 2016, HLTH AFFAIRS; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Gallagher N, 2015, DIABETIC MED, V32, P62, DOI 10.1111/dme.12575; Gillam S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f659; Gillam SJ, 2012, ANN FAM MED, V10, P461, DOI 10.1370/afm.1377; Greene J, 2013, HEALTH SERV RES, V48, P1415, DOI 10.1111/1475-6773.12033; Hamilton FL, 2016, NICOTINE TOB RES, V18, P341, DOI 10.1093/ntr/ntv107; Harrison MJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6423; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Houle SKD, 2012, ANN INTERN MED, V157, P889, DOI 10.7326/0003-4819-157-12-201212180-00009; Hsieh HM, 2016, PREV MED, V85, P53, DOI 10.1016/j.ypmed.2015.12.013; Hsieh HM, 2015, MED CARE, V53, P106, DOI 10.1097/MLR.0000000000000264; Institute of Medicine, 2001, REP BRIEF CROSS QUAL; Kalwij S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-802; Kansagara D, 2014, J GEN INTERN MED, V29, P607, DOI 10.1007/s11606-013-2764-y; Karunaratne K, 2013, NEPHROL DIAL TRANSPL, V28, P2107, DOI 10.1093/ndt/gft093; Kendrick T, 2015, J AFFECT DISORDERS, V186, P171, DOI 10.1016/j.jad.2015.06.052; Kiran T, 2014, ANN FAM MED, V12, P317, DOI 10.1370/afm.1664; Kirschner K, 2013, FAM PRACT, V30, P161, DOI 10.1093/fampra/cms055; Kizer KW, 2012, J GEN INTERN MED, V27, P395, DOI 10.1007/s11606-011-1981-5; Kondo K, 2015, UNDERSTANDING INTERV; Kondo KK, 2016, J GEN INTERN MED, V31, P61, DOI 10.1007/s11606-015-3567-0; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h904; Kontopantelis E, 2013, BMJ QUAL SAF, V22, P53, DOI 10.1136/bmjqs-2012-001033; Kristensen SR, 2014, NEW ENGL J MED, V371, P540, DOI 10.1056/NEJMoa1400962; Kruse GR, 2013, AM J MANAG CARE, V19, P554; Kuo RNC, 2011, J ONCOL PRACT, V7, pE8S, DOI 10.1200/JOP.2011.000314; Lee CY, 2015, AM J MANAG CARE, V21, pE35; Lee TT, 2010, AM J MANAG CARE, V16, P65; Lemak CH, 2015, HEALTH AFFAIR, V34, P645, DOI 10.1377/hlthaff.2014.0426; Li JH, 2014, HEALTH ECON, V23, P962, DOI 10.1002/hec.2971; Li YH, 2010, HEALTH POLICY PLANN, V25, P334, DOI 10.1093/heapol/czq006; Liao PJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003282; MacBride-Stewart SP, 2008, FAM PRACT, V25, P27, DOI 10.1093/fampra/cmm074; Martens JD, 2007, J EVAL CLIN PRACT, V13, P369, DOI 10.1111/j.1365-2753.2006.00707.x; Mason T, 2015, ADDICTION, V110, P1120, DOI 10.1111/add.12920; McLintock K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005178; Michel-Lepage A, 2016, EUR J HEALTH ECON, V17, P723, DOI 10.1007/s10198-015-0717-6; Millett C, 2009, J ROY SOC MED, V102, P369, DOI 10.1258/jrsm.2009.090171; Murray J, 2010, FAM PRACT, V27, P430, DOI 10.1093/fampra/cmq030; Norbury M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X583146; Parast L, 2015, J GEN INTERN MED, V30, P359, DOI 10.1007/s11606-014-3150-0; Pechlivanoglou P, 2015, HEALTH ECON, V24, P439, DOI 10.1002/hec.3030; Petersen LA, 2017, HEALTH SERV RES, V52, P1138, DOI 10.1111/1475-6773.12517; Petersen LA, 2013, JAMA-J AM MED ASSOC, V310, P1042, DOI 10.1001/jama.2013.276303; Powell AA, 2012, J GEN INTERN MED, V27, P405, DOI 10.1007/s11606-011-1906-3; Rat C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-301; Roland M, 2014, NEW ENGL J MED, V370, P1944, DOI 10.1056/NEJMhpr1316051; Rosenthal MB, 2016, HEALTH SERV RES, V51, P1444, DOI 10.1111/1475-6773.12426; Rosenthal MB, 2016, J GEN INTERN MED, V31, P289, DOI 10.1007/s11606-015-3521-1; Ryan A, 2014, HEALTH SERV RES, V49, P568, DOI 10.1111/1475-6773.12097; Ryan AM, 2015, HEALTH SERV RES, V50, P81, DOI 10.1111/1475-6773.12206; Scott A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008451.pub2; Share DA, 2012, HEALTH AFFAIR, V31, P1993, DOI 10.1377/hlthaff.2012.0328; Sicsic J, 2016, EUR J HLTH EC; Simpson CR, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X583407; Smith CJP, 2008, QJM-INT J MED, V101, P145, DOI 10.1093/qjmed/hcm155; Sutton M, 2010, HEALTH ECON, V19, P1, DOI 10.1002/hec.1440; Szatkowski L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-291; Taggar JS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-329; Tahrani AA, 2007, BRIT J GEN PRACT, V57, P483; Tan ECH, 2014, QUAL LIFE RES, V23, P689, DOI 10.1007/s11136-013-0502-x; Torchiana DF, 2013, HEALTH AFFAIR, V32, P1748, DOI 10.1377/hlthaff.2013.0377; Treadwell JR, 2011, FRAMEWORK BEST EVIDE; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Vaghela P, 2009, DIABETES CARE, V32, P427, DOI 10.2337/dc08-1999; Vamos EP, 2011, CAN MED ASSOC J, V183, pE809, DOI 10.1503/cmaj.101187; Vermeulen MJ, 2016, ANN EMERG MED, V67, P496, DOI 10.1016/j.annemergmed.2015.06.028; Wells G., 2014, NEWCASTLE OTTAWA SCA; Yang JH, 2016, INT J QUAL HEALTH C, V28, P580, DOI 10.1093/intqhc/mzw081; Young GJ, 2012, J ORGAN BEHAV, V33, P964, DOI 10.1002/job.1770; Zuckerman RB, 2016, NEW ENGL J MED, V374, P1543, DOI 10.1056/NEJMsa1513024	94	183	184	3	61	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					341	+		10.7326/M16-1881	http://dx.doi.org/10.7326/M16-1881			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO1BO	28114600				2022-12-28	WOS:000396432800007
J	Jackson, MG; Konter, JG; Becker, TW				Jackson, M. G.; Konter, J. G.; Becker, T. W.			Primordial helium entrained by the hottest mantle plumes	NATURE			English	Article							HIGH HE-3/HE-4 RATIOS; OCEAN ISLAND BASALTS; RARE-GAS SYSTEMATICS; MID-ATLANTIC RIDGE; ISOTOPE GEOCHEMISTRY; YELLOWSTONE PLUME; HIMU RESERVOIR; VOLCANIC-ROCKS; LOIHI SEAMOUNT; NOBLE-GASES	Helium isotopes provide an important tool for tracing early-Earth, primordial reservoirs that have survived in the planet's interior(1-3). Volcanic hotspot lavas, like those erupted at Hawaii and Iceland, can host rare, high He-3/He-4 isotopic ratios (up to 50 times(4) the present atmospheric ratio, Ra) compared to the lower He-3/He-4 ratios identified in mid-ocean-ridge basalts that form by melting the upper mantle (about 8Ra; ref. 5). A long-standing hypothesis maintains that the high-He-3/He-4 domain resides in the deep mantle(6-8), beneath the upper mantle sampled by mid-ocean-ridge basalts, and that buoyantly upwelling plumes from the deep mantle transport high-He-3/He-4 material to the shallow mantle beneath plume-fed hotspots. One problem with this hypothesis is that, while some hotspots have He-3/He-4 values ranging from low to high, other hotspots exhibit only low He-3/He-4 ratios. Here we show that, among hotspots suggested to overlie mantle plumes(9,10), those with the highest maximum He-3/He-4 ratios have high hotspot buoyancy fluxes and overlie regions with seismic low-velocity anomalies in the upper mantle(11), unlike plume-fed hotspots with only low maximum He-3/He-4 ratios. We interpret the relationships between He-3/He-4 values, hotspot buoyancy flux, and upper-mantle shear wave velocity to mean that hot plumes-which exhibit seismic low-velocity anomalies at depths of 200 kilometres-are more buoyant and entrain both high-He-3/He-4 and low-He-3/He-4 material. In contrast, cooler, less buoyant plumes do not entrain this high-He-3/He-4 material. This can be explained if the high-He-3/He-4 domain is denser than low-He-3/He-4 mantle components hosted in plumes, and if high-He-3/He-4 material is entrained from the deep mantle only by the hottest, most buoyant plumes(12). Such a dense, deep-mantle high-He-3/He-4 domain could remain isolated from the convecting mantle(13,14), which may help to explain the preservation of early Hadean (>4.5 billion years ago) geochemical anomalies in lavas sampling this reservoir(1-3).	[Jackson, M. G.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Konter, J. G.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Dept Geol & Geophys, 1680 East West Rd, Honolulu, HI 96822 USA; [Becker, T. W.] Univ Texas Austin, Jackson Sch Geosci, 1 Univ Stn,C1160, Austin, TX 78712 USA	University of California System; University of California Santa Barbara; University of Hawaii System; University of Hawaii Manoa; University of Texas System; University of Texas Austin	Jackson, MG (corresponding author), Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA.	jackson@geol.ucsb.edu	Konter, Jasper/G-5206-2012	Konter, Jasper/0000-0002-4853-5456; Becker, Thorsten/0000-0002-5656-4564	NSF [EAR-1347377, EAR-1624840];  [EAR-1460479];  [EAR-1338329];  [OCE-1538121]; Division Of Earth Sciences [1135452] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); ; ; ; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	R. G. Blotkamp inspired and guided fundamental development. We thank C. Dalton, M. Edwards, S. Grand, S. Halldorsson, C. Ji, M. Manga, A. McNamara, A. Reinhard, J. Ritsema, B. Romanowicz, R. Rudnick, F. Spera, I Tanimoto, P. van Keken, C. Williams and Q. Williams for discussion. The 2016 CIDER programme at University of California Santa Barbara is acknowledged for providing a venue for interdisciplinary collaboration. Constructive comments from D. Graham and S. King improved the manuscript. M.G.J. acknowledges grants from NSF that funded this research (EAR-1347377 and EAR-1624840). T.W.B. was supported in part by grants EAR-1460479 and EAR-1338329, and J.G.K. by OCE-1538121.	ALLEGRE CJ, 1983, NATURE, V303, P762, DOI 10.1038/303762a0; Ammon K, 2009, QUAT GEOCHRONOL, V4, P525, DOI 10.1016/j.quageo.2009.09.003; Auer L, 2014, J GEOPHYS RES-SOL EA, V119, P3006, DOI 10.1002/2013JB010773; Barfod DN, 1999, J GEOPHYS RES-SOL EA, V104, P29509, DOI 10.1029/1999JB900280; Becker TW, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000168; Boschi L, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001733; Breton T, 2013, EARTH PLANET SC LETT, V376, P126, DOI 10.1016/j.epsl.2013.06.020; Castillo PR, 2007, CHEM GEOL, V240, P205, DOI 10.1016/j.chemgeo.2007.02.012; Class C, 2005, NATURE, V436, P1107, DOI 10.1038/nature03930; Class C, 2005, EARTH PLANET SC LETT, V233, P391, DOI 10.1016/j.epsl.2005.02.029; Coltice N., 2005, EARTH PLANET SC LETT, V233, P391; Courtillot V, 2003, EARTH PLANET SC LETT, V205, P295, DOI 10.1016/S0012-821X(02)01048-8; Day JMD, 2011, EARTH PLANET SC LETT, V305, P226, DOI 10.1016/j.epsl.2011.03.006; Debaille V, 2009, GEOCHIM COSMOCHIM AC, V73, P3423, DOI 10.1016/j.gca.2009.03.002; Deschamps F, 2011, NAT GEOSCI, V4, P879, DOI [10.1038/NGEO1295, 10.1038/ngeo1295]; Doucelance R, 2003, GEOCHIM COSMOCHIM AC, V67, P3717, DOI 10.1016/S0016-7037(03)00161-3; DUNAI TJ, 1995, GEOCHIM COSMOCHIM AC, V59, P2767, DOI 10.1016/0016-7037(95)00172-V; Eiler JM, 1997, GEOCHIM COSMOCHIM AC, V61, P2281, DOI 10.1016/S0016-7037(97)00075-6; Erzinger, 2011, AGU FALL M; FARLEY KA, 1992, EARTH PLANET SC LETT, V111, P183, DOI 10.1016/0012-821X(92)90178-X; FARLEY KA, 1993, CONTRIB MINERAL PETR, V115, P75, DOI 10.1007/BF00712980; Franz G, 1999, CHEM GEOL, V157, P27, DOI 10.1016/S0009-2541(98)00195-8; French SW, 2015, NATURE, V525, P95, DOI 10.1038/nature14876; Garapic G, 2015, LITHOS, V228, P1, DOI 10.1016/j.lithos.2015.04.010; Garnero EJ, 2016, NAT GEOSCI, V9, P481, DOI [10.1038/ngeo2733, 10.1038/NGEO2733]; GRAHAM D, 1990, NATURE, V347, P545, DOI 10.1038/347545a0; Graham DW, 2009, J VOLCANOL GEOTH RES, V188, P128, DOI 10.1016/j.jvolgeores.2008.12.004; Graham D. W., 1996, SHALLOW LEVEL PROCES, P1; Graham DW, 2002, REV MINERAL GEOCHEM, V47, P247, DOI 10.2138/rmg.2002.47.8; GRAHAM DW, 1992, EARTH PLANET SC LETT, V110, P121, DOI 10.1016/0012-821X(92)90043-U; Graham DW, 1999, EARTH PLANET SC LETT, V167, P297, DOI 10.1016/S0012-821X(99)00030-8; GRAHAM DW, 1993, SCIENCE, V262, P2023, DOI 10.1126/science.262.5142.2023; Graham DW, 1998, EARTH PLANET SC LETT, V160, P241, DOI 10.1016/S0012-821X(98)00083-1; Halldorsson SA, 2014, GEOPHYS RES LETT, V41, P2304, DOI 10.1002/2014GL059424; Hanan BB, 1996, SCIENCE, V272, P991, DOI 10.1126/science.272.5264.991; Hansen SE, 2012, EARTH PLANET SC LETT, V319, P23, DOI 10.1016/j.epsl.2011.12.023; Hanyu T, 1997, NATURE, V390, P273, DOI 10.1038/36835; Hanyu T, 2014, GEOCHIM COSMOCHIM AC, V143, P232, DOI 10.1016/j.gca.2014.03.016; Hanyu T, 2014, GEOCHEM GEOPHY GEOSY, V15, P565, DOI 10.1002/2013GC005085; Hanyu T, 2011, EARTH PLANET SC LETT, V307, P377, DOI 10.1016/j.epsl.2011.05.012; HART SR, 1992, SCIENCE, V256, P517, DOI 10.1126/science.256.5056.517; Hilton DR, 2000, GEOCHIM COSMOCHIM AC, V64, P2119, DOI 10.1016/S0016-7037(00)00358-6; Hilton DR, 1999, EARTH PLANET SC LETT, V173, P53, DOI 10.1016/S0012-821X(99)00215-0; HILTON DR, 1995, NATURE, V373, P330, DOI 10.1038/373330a0; Hoernle K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8799; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; Honda M, 2005, EARTH PLANET SC LETT, V236, P597, DOI 10.1016/j.epsl.2005.05.038; Jackson M. G., CHEM GEOL IN PRESS; Jackson MG, 2007, EARTH PLANET SC LETT, V264, P360, DOI 10.1016/j.epsl.2007.09.023; Jackson MG, 2007, NATURE, V448, P684, DOI 10.1038/nature06048; Jackson MG, 2010, NATURE, V466, P853, DOI 10.1038/nature09287; Jackson MG, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001876; Jellinek AM, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000144; Kincaid C, 2013, NAT GEOSCI, V6, P395, DOI [10.1038/NGEO1774, 10.1038/ngeo1774]; King SD, 2014, PHYS EARTH PLANET IN, V235, P66, DOI 10.1016/j.pepi.2014.07.006; Konter JG, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003923; KURZ MD, 1982, NATURE, V297, P43, DOI 10.1038/297043a0; Kurz MD, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2002GC000439; Kurz MD, 1999, GEOCHIM COSMOCHIM AC, V63, P4139, DOI 10.1016/S0016-7037(99)00314-2; KURZ MD, 1983, EARTH PLANET SC LETT, V66, P388, DOI 10.1016/0012-821X(83)90154-1; KURZ MD, 1985, EARTH PLANET SC LETT, V74, P291, DOI 10.1016/S0012-821X(85)80001-7; Kurz MD, 1998, GEOCHIM COSMOCHIM AC, V62, P841, DOI 10.1016/S0016-7037(97)00383-9; KURZ MD, 1987, GEOCHIM COSMOCHIM AC, V51, P2905, DOI 10.1016/0016-7037(87)90366-8; Leonard T, 2016, GEOPHYS RES LETT, V43, P1132, DOI 10.1002/2015GL067131; Li MM, 2014, NAT GEOSCI, V7, P366, DOI [10.1038/ngeo2120, 10.1038/NGEO2120]; Lin SC, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001072; LUPTON JE, 1993, GEOPHYS RES LETT, V20, P1851, DOI 10.1029/93GL01271; Macpherson CG, 1998, GEOLOGY, V26, P1007, DOI 10.1130/0091-7613(1998)026<1007:HHHRIT>2.3.CO;2; Macpherson CG, 2005, EARTH PLANET SC LETT, V233, P411, DOI 10.1016/j.epsl.2005.02.037; Marty B, 1996, EARTH PLANET SC LETT, V144, P223, DOI 10.1016/0012-821X(96)00158-6; Montelli R, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001248; Moreira M, 2004, CR GEOSCI, V336, P983, DOI 10.1016/j.crte.2004.04.006; MOREIRA M, 1995, EARTH PLANET SC LETT, V133, P367, DOI 10.1016/0012-821X(95)00080-V; Moreira M, 2002, EARTH PLANET SC LETT, V198, P401, DOI 10.1016/S0012-821X(02)00519-8; Moreira M, 1999, EARTH PLANET SC LETT, V169, P189, DOI 10.1016/S0012-821X(99)00071-0; Moreira M, 2012, CHEM GEOL, V322, P91, DOI 10.1016/j.chemgeo.2012.06.014; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; Nicolaysen KP, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001540; O'Connor JM, 2015, GEOLOGY, V43, P715, DOI 10.1130/G36767.1; Parai R, 2009, EARTH PLANET SC LETT, V277, P253, DOI 10.1016/j.epsl.2008.10.014; Pik R, 2006, CHEM GEOL, V226, P100, DOI 10.1016/j.chemgeo.2005.09.016; POREDA RJ, 1993, EARTH PLANET SC LETT, V119, P319, DOI 10.1016/0012-821X(93)90141-U; Putirka K, 2008, GEOLOGY, V36, P283, DOI 10.1130/G24615A.1; Qin YL, 2009, GEOPHYS J INT, V177, P125, DOI 10.1111/j.1365-246X.2008.04032.x; Reid MR, 1996, EARTH PLANET SC LETT, V144, P213, DOI 10.1016/0012-821X(96)00166-5; Ritsema J, 2011, GEOPHYS J INT, V184, P1223, DOI 10.1111/j.1365-246X.2010.04884.x; Rizo H, 2016, SCIENCE, V352, P809, DOI 10.1126/science.aad8563; Samuel H, 2003, EARTH PLANET SC LETT, V207, P39, DOI 10.1016/S0012-821X(02)01125-1; Sarda P, 2000, J GEOPHYS RES-SOL EA, V105, P5973, DOI 10.1029/1999JB900282; Scarsi P, 1996, EARTH PLANET SC LETT, V144, P505, DOI 10.1016/S0012-821X(96)00185-9; Schilling JG, 1999, J GEOPHYS RES-SOL EA, V104, P10543, DOI 10.1029/1999JB900057; Simmons NA, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007631; Starkey NA, 2009, EARTH PLANET SC LETT, V277, P91, DOI 10.1016/j.epsl.2008.10.007; STAUDACHER T, 1989, EARTH PLANET SC LETT, V93, P210, DOI 10.1016/0012-821X(89)90069-1; Steinberger B, 2000, J GEOPHYS RES-SOL EA, V105, P11127, DOI 10.1029/1999JB900398; Steinberger B, 2006, GEOPHYS J INT, V167, P1461, DOI 10.1111/j.1365-246X.2006.03131.x; Stixrude L, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB002965; Stuart FM, 2003, NATURE, V424, P57, DOI 10.1038/nature01711; Valbracht PJ, 1997, EARTH PLANET SC LETT, V150, P399, DOI 10.1016/S0012-821X(97)00094-0; Waite GP, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003867; White WM, 2015, CHEM GEOL, V419, P10, DOI 10.1016/j.chemgeo.2015.09.026; Williams CD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9937; Workman RK, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000623; Yuan HY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022056; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.ea.14.050186.002425	106	55	58	3	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					340	+		10.1038/nature21023	http://dx.doi.org/10.1038/nature21023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2LQ	28166539				2022-12-28	WOS:000394451600035
J	Golden, RJ; Chen, B; Li, T; Braun, J; Manjunath, H; Chen, X; Wu, J; Schmid, V; Chang, TC; Kopp, F; Ramirez-Martinez, A; Tagliabracci, VS; Chen, ZJ; Xie, Y; Mendell, JT				Golden, Ryan J.; Chen, Beibei; Li, Tuo; Braun, Juliane; Manjunath, Hema; Chen, Xiang; Wu, Jiaxi; Schmid, Vanessa; Chang, Tsung-Cheng; Kopp, Florian; Ramirez-Martinez, Andres; Tagliabracci, Vincent S.; Chen, Zhijian J.; Xie, Yang; Mendell, Joshua T.			An Argonaute phosphorylation cycle promotes microRNA-mediated silencing	NATURE			English	Article							RNAI SCREEN; HUMAN-CELLS; C-MYC; TARGET; IDENTIFICATION; GENES; LET-7; MIRNA; EXPRESSION; PATHWAYS	MicroRNAs (miRNAs) perform critical functions in normal physiology and disease by associating with Argonaute proteins and downregulating partially complementary messenger RNAs (mRNAs). Here we use clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) genome-wide loss-of-function screening coupled with a fluorescent reporter of miRNA activity in human cells to identify new regulators of the miRNA pathway. By using iterative rounds of screening, we reveal a novel mechanism whereby target engagement by Argonaute 2 (AGO2) triggers its hierarchical, multi-site phosphorylation by CSNK1A1 on a set of highly conserved residues (S824-S834), followed by rapid dephosphorylation by the ANKRD52-PPP6C phosphatase complex. Although genetic and biochemical studies demonstrate that AGO2 phosphorylation on these residues inhibits target mRNA binding, inactivation of this phosphorylation cycle globally impairs miRNA-mediated silencing. Analysis of the transcriptome-wide binding profile of non-phosphorylatable AGO2 reveals a pronounced expansion of the target repertoire bound at steady-state, effectively reducing the active pool of AGO2 on a per-target basis. These findings support a model in which an AGO2 phosphorylation cycle stimulated by target engagement regulates miRNA:target interactions to maintain the global efficiency of miRNA-mediated silencing.	[Golden, Ryan J.; Li, Tuo; Braun, Juliane; Manjunath, Hema; Chen, Xiang; Chang, Tsung-Cheng; Kopp, Florian; Ramirez-Martinez, Andres; Tagliabracci, Vincent S.; Chen, Zhijian J.; Mendell, Joshua T.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Golden, Ryan J.] Univ Texas Southwestern Med Ctr Dallas, Med Scientist Training Program, Dallas, TX 75390 USA; [Chen, Beibei; Xie, Yang] Univ Texas Southwestern Med Ctr Dallas, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA; [Chen, Beibei; Xie, Yang] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Wu, Jiaxi] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Schmid, Vanessa] Univ Texas Southwestern Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Chen, Zhijian J.; Mendell, Joshua T.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Xie, Yang; Mendell, Joshua T.] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Mendell, Joshua T.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendell, JT (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.; Mendell, JT (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.; Mendell, JT (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA.; Mendell, JT (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.	Joshua.Mendell@UTSouthwestern.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251; Kopp, Florian/0000-0001-9952-635X; Golden, Ryan/0000-0003-3988-0730; Ramirez-Martinez, Andres/0000-0003-1300-1101	Cancer Prevention and Research Institute of Texas (CPRIT) [R1008, RP160249, RP101251, RP120718, RR150033]; National Institutes of Health [R01CA120185, R35CA197311, R01CA152301, R00DK099254]; Cancer Research Institute; Leopoldina Fellowship Program from the German National Academy of Sciences Leopoldina [LPDS 2014-12]; NATIONAL CANCER INSTITUTE [R01CA120185, P30CA142543, R01CA152301, R35CA197311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK099254] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Leopoldina Fellowship Program from the German National Academy of Sciences Leopoldina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Bartel, C. Cepko, D. Sabatini, P. Sharp, D. Trono, T. Tuschl, and F. Zhang for plasmids; A. Guzman and R. Bruce in the McDermott Center Next Generation Sequencing Core; A. Mobley and the University of Texas Southwestern Flow Cytometry Core; H. Ball and the University of Texas Southwestern Protein Chemistry Technology Core; S. Johnson for assistance with software implementation; J. Cabrera for assistance with figure preparation; and K. O'Donnell for advice on the manuscript. This work was supported by grants from the Cancer Prevention and Research Institute of Texas (CPRIT) (R1008 and RP160249 to J.T.M., RP101251 to Y.X., RP120718 to Z.J.C., and RR150033 to V.S.T.) and the National Institutes of Health (R01CA120185 and R35CA197311 to J.T.M., R01CA152301 to Y.X., and R00DK099254 to V.S.T.). T.L. is supported by a fellowship from Cancer Research Institute. F.K. is supported by the Leopoldina Fellowship Program (LPDS 2014-12) from the German National Academy of Sciences Leopoldina. J.T.M. and V.S.T. are CPRIT Scholars in Cancer Research. J.T.M. and Z.J.C. are Investigators of the Howard Hughes Medical Institute.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Flores-Jasso CF, 2013, RNA, V19, P271, DOI 10.1261/rna.036921.112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Ji M, 2011, AM J PATHOL, V179, P1645, DOI 10.1016/j.ajpath.2011.06.008; Jo MH, 2015, MOL CELL, V59, P117, DOI 10.1016/j.molcel.2015.04.027; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Parry DH, 2007, CURR BIOL, V17, P2013, DOI 10.1016/j.cub.2007.10.058; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Salomon WE, 2015, CELL, V162, P84, DOI 10.1016/j.cell.2015.06.029; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Wang CC, 1997, BLOOD, V89, P3019, DOI 10.1182/blood.V89.8.3019; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599; Zhou R, 2008, MOL CELL, V32, P592, DOI 10.1016/j.molcel.2008.10.018; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	38	152	155	2	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					197	202		10.1038/nature21025	http://dx.doi.org/10.1038/nature21025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28114302	Green Accepted			2022-12-28	WOS:000393737500033
J	Jacobson, KR				Jacobson, Karen R.			Tuberculosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							GAMMA RELEASE ASSAYS; HEALTH-CARE WORKERS; PULMONARY TUBERCULOSIS; DIAGNOSTIC YIELD; RISK-FACTORS; RIFAPENTINE; INFECTION; SMEAR; TRANSMISSION; PREVENTION						Gour, Abhishek/AAJ-7549-2021; Jacobson, Karen/AAX-9461-2021	Gour, Abhishek/0000-0003-4599-0389; Jacobson, Karen/0000-0003-4239-3685	American College of Physicians; FOGARTY INTERNATIONAL CENTER [K01TW009213] Funding Source: NIH RePORTER	American College of Physicians; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	American College of Physicians.	Alvarez GG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111986; Andrews JR, 2015, AM J RESP CRIT CARE, V191, P584, DOI 10.1164/rccm.201409-1704OC; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P7; [Anonymous], 1992, MMWR Recomm Rep, V41, P61; [Anonymous], FACT SHEET TRENDS TU; Belknap R, 2017, C RETR OPP INF SEATT; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Bunnet D, 2015, CHEST, V148, pE1, DOI 10.1378/chest.14-2463; Castro KG., 2012, MEDSCAPE; Centers for Disease Control and Prevention, 2014, LAT TUB INF GUID PRI; Centers for Disease Control and Prevention, 2010, MEN SUGG PROV STAT T; Centers for Disease Control and Prevention, 2016, DEC TREAT LAT TB INF; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P593; Chang KC, 2004, AM J RESP CRIT CARE, V170, P1124, DOI 10.1164/rccm.200407-905OC; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Critchley JA, 2013, LANCET INFECT DIS, V13, P223, DOI 10.1016/S1473-3099(12)70321-3; Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; European Centers for Disease Control and Prevention, 2012, MAN CONT MDR TB XDR; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Holtz TH, 2011, LANCET INFECT DIS, V11, P533, DOI 10.1016/S1473-3099(11)70057-3; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Iademarco MF, 2013, MMWR-MORBID MORTAL W, V62, P821; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Jo KW, 2014, RESP MED, V108, P654, DOI 10.1016/j.rmed.2014.01.010; Johnson DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096613; KAMAT SR, 1966, B WORLD HEALTH ORGAN, V34, P517; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Loeffler AM., 2010, PEDIAT TUBERCULOSIS; Luetkemeyer AF, 2016, CLIN INFECT DIS, V62, P1081, DOI 10.1093/cid/ciw035; Lv XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065037; Malekmohammad M, 2012, SCAND J INFECT DIS, V44, P369, DOI 10.3109/00365548.2011.643820; Mayosi BM, 2014, NEW ENGL J MED, V371, P2534, DOI 10.1056/NEJMc1413185; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mendelson M., 2007, BR MED B, V81-82, P149; Migliori GB, 2008, CLIN INFECT DIS, V46, P958, DOI 10.1086/528875; Nahid P, 2016, CLIN INFECT DIS, V63, pe147, DOI 10.1093/cid/ciw376; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; QIAGEN, 2013, FREQ ASK QUEST QUANT; Ribeiro-Rodrigues R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096564; RILEY RL, 1962, AM REV RESPIR DIS, V85, P511; Ringshausen FC, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-6; ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2; Sackoff JE, 2006, AM J OBSTET GYNECOL, V194, P451, DOI 10.1016/j.ajog.2005.07.054; Sandgren A, 2013, EUROSURVEILLANCE, P18, DOI DOI 10.2807/ESE.18.12.20431-EN; Saukkonen JJ, 2012, AM J RESP CRIT CARE, V185, P598, DOI 10.1164/rccm.201112-2174ED; Schutz C, 2010, EUR RESPIR J, V36, P1460, DOI 10.1183/09031936.00110210; Sharma SK, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007545.pub2; Slater ML, 2013, AM J RESP CRIT CARE, V188, P1005, DOI 10.1164/rccm.201305-0831OC; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites G, 2009, J INFECTION, V59, P167, DOI 10.1016/j.jinf.2009.06.011; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8; WHO, 2011, POL STAT AUT REAL TI; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2014, END TB STRAT GLOB ST; Zumla A, 1996, CLIN INFECT DIS, V23, P146, DOI 10.1093/clinids/23.1.146; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894; Zwerling A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054748; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	63	7	8	2	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2017	166	3					ITC17	+		10.7326/AITC201702070	http://dx.doi.org/10.7326/AITC201702070			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7DL	28166561				2022-12-28	WOS:000394781200002
J	Mytton, J; Evison, F; Chilton, PJ; Lilford, RJ				Mytton, Jemma; Evison, Felicity; Chilton, Peter J.; Lilford, Richard J.			Removal of all ovarian tissue versus conserving ovarian tissue at time of hysterectomy in premenopausal patients with benign disease: study using routine data and data linkage	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LUNG-CANCER; CARDIOVASCULAR MORTALITY; BILATERAL OOPHORECTOMY; REPRODUCTIVE FACTORS; COLORECTAL-CANCER; RISK; WOMEN; CONSERVATION	OBJECTIVE To conduct a nationwide study of associations between removal of all ovarian tissue versus conservation of at least one ovary at the time of hysterectomy and important health outcomes (ischaemic heart disease, cancer, and all cause mortality). STUDY DESIGN AND SETTING Retrospective analysis of the English Hospital Episode Statistics database linked to national registers of deprivation indices and of deaths. PARTICIPANTS 113 679 patients aged 35-45 who had had a hysterectomy for benign conditions between April 2004 and March 2014. EXPOSURES Bilateral ovarian removal versus no removal or unilateral ovarian removal (ovarian conservation). MAIN OUTCOME MEASURES Hospital admissions for ischaemic heart disease, cancer, or attempted suicide; deaths, overall and from heart disease, cancer, or suicide. Statistical adjustments were made using Cox regression and propensity score matching for potential confounders. RESULTS A third of patients had bilateral ovarian removal. Patients in the ovarian conservation group were less likely to be admitted for ischaemic heart disease after hysterectomy than were those in the bilateral removal group (adjusted hazard ratio 0.85, 95% confidence interval 0.77 to 0.93; P=0.001). They were also less likely to have a cancer related post-hysterectomy admission (adjusted hazard ratio 0.83, 0.78 to 0.89; P<0.001). A significant difference in all cause mortality was also seen: 0.60% (456/76 581) of patients with ovarian conservation compared with 1.01% (376/37 098) of patients with bilateral removal. Again, this difference in favour of ovarian conservation was significant (adjusted hazard ratio 0.64, 0.55 to 0.73; P<0.001). Fewer deaths related specifically to heart disease (adjusted hazard ratio 0.50, 0.28 to 0.90; P=0.02) and to cancer (0.54, 0.45 to 0.65; P<0.001) occurred in the ovarian conservation group than in the bilateral removal group. No significant difference between groups was found relating to suicide (attempted or completed). The results after propensity score matching were essentially unchanged. CONCLUSION Patients who had ovarian conservation had a significantly lower hazard of all cause mortality compared with those who had bilateral ovarian removal and also had lower death rates from ischaemic heart disease and cancer. Consistent with this observation, admissions to hospital for both ischaemic heart disease and cancer were also lower in the ovarian conservation group than in the bilateral removal group. Although removal of both ovaries protects against subsequent development of ovarian cancer, premenopausal women should be advised that this benefit comes at the cost of an increased risk of cardiovascular disease and of other (more prevalent) cancers and higher overall mortality.	[Mytton, Jemma; Evison, Felicity] Univ Hosp Birmingham NHS Fdn Trust, Birmingham B15 1JD, W Midlands, England; [Chilton, Peter J.] Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England; [Lilford, Richard J.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	University of Birmingham; University of Warwick; University of Warwick	Lilford, RJ (corresponding author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	r.j.lilford@warwick.ac.uk		Evison, Felicity/0000-0002-9378-7548; Chilton, Peter/0000-0001-8809-9735; Lilford, Richard/0000-0002-0634-984X	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) West Midlands	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) West Midlands(National Institute for Health Research (NIHR))	RJL and PJC were supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) West Midlands. This paper presents independent research, and the views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Baik CS, 2010, CANCER EPIDEM BIOMAR, V19, P2525, DOI 10.1158/1055-9965.EPI-10-0450; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Boggs DA, 2014, CANCER CAUSE CONTROL, V25, P507, DOI 10.1007/s10552-014-0353-y; Cancer Research UK, 2016, OV CANC INC STAT; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; de Kleijn MJJ, 2002, AM J EPIDEMIOL, V155, P339, DOI 10.1093/aje/155.4.339; Falconer H, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju410; Gallagher LG, 2013, CANCER CAUSE CONTROL, V24, P1305, DOI 10.1007/s10552-013-0208-y; Health and Social Care Information Centre, 2013, QUALITY NATIONALLY S; Jacobsen BK, 1999, J CLIN EPIDEMIOL, V52, P303, DOI 10.1016/S0895-4356(98)00170-X; Keiding N, 2016, J R STAT SOC A STAT, V179, P319, DOI 10.1111/rssa.12136; Koushik A, 2009, INT J CANCER, V125, P2428, DOI 10.1002/ijc.24560; Lilford RJ, 1997, BRIT MED J, V314, P160, DOI 10.1136/bmj.314.7075.160; McCarthy AM, 2012, CANCER PREV RES, V5, P847, DOI 10.1158/1940-6207.CAPR-11-0430; Ministry of Housing Communities & Local Government, 2015, ENGLISH INDICES DEPR; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Parker WH, 2013, OBSTET GYNECOL, V121, P709, DOI 10.1097/AOG.0b013e3182864350; Parker WH, 2009, OBSTET GYNECOL, V113, P1027, DOI 10.1097/AOG.0b013e3181a11c64; Pesatori AC, 2013, INT J CANCER, V132, P2630, DOI 10.1002/ijc.27926; Rivera CM, 2009, MENOPAUSE, V16, P15, DOI 10.1097/gme.0b013e31818888f7; Rivera CM, 2009, NEUROEPIDEMIOLOGY, V33, P32, DOI 10.1159/000211951; Rocca WA, 2006, LANCET ONCOL, V7, P821, DOI 10.1016/S1470-2045(06)70869-5; Segelman J, 2016, BRIT J SURG, V103, P908, DOI 10.1002/bjs.10143; Song F, 2013, OPEN ACCESS J CLIN T, V5, P71, DOI 10.2147/OAJCT.S34419; Tinetti ME, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4984	25	71	73	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2017	356								j372	10.1136/bmj.j372	http://dx.doi.org/10.1136/bmj.j372			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FU	28167486	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000394577900001
J	Clauset, A; Larremore, DB; Sinatra, R				Clauset, Aaron; Larremore, Daniel B.; Sinatra, Roberta			Data-driven predictions in the science of science	SCIENCE			English	Editorial Material							SLEEPING BEAUTIES; IMPACT	The desire to predict discoveries-to have some idea, in advance, of what will be discovered, by whom, when, and where-pervades nearly all aspects of modern science, from individual scientists to publishers, from funding agencies to hiring committees. In this Essay, we survey the emerging and interdisciplinary field of the "science of science" and what it teaches us about the predictability of scientific discovery. We then discuss future opportunities for improving predictions derived from the science of science and its potential impact, positive and negative, on the scientific community.	[Clauset, Aaron] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Clauset, Aaron] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Clauset, Aaron; Larremore, Daniel B.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Sinatra, Roberta] Cent European Univ, Ctr Network Sci, Budapest, Hungary; [Sinatra, Roberta] Cent European Univ, Dept Math, Budapest, Hungary; [Sinatra, Roberta] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Sinatra, Roberta] Northeastern Univ, Dept Phys, Boston, MA 02115 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; The Santa Fe Institute; Central European University; Central European University; Northeastern University; Northeastern University	Clauset, A (corresponding author), Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA.; Clauset, A (corresponding author), Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.; Clauset, A (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	aaron.clauset@colorado.edu	Sinatra, Roberta/G-9836-2012	Sinatra, Roberta/0000-0002-7558-1028; CLAUSET, AARON/0000-0002-3529-8746; Larremore, Daniel/0000-0001-5273-5234				[Anonymous], 1996, ERROR GROWTH EXPT KN, DOI DOI 10.7208/CHICAGO/9780226511993.001.0001; Barocas S, 2016, CALIF LAW REV, V104, P671, DOI 10.15779/Z38BG31; Petersen EB, 2007, STUD HIGH EDUC, V32, P475, DOI 10.1080/03075070701476167; Bornmann L, 2007, J INFORMETR, V1, P226, DOI 10.1016/j.joi.2007.03.001; Boudreau KJ, 2016, MANAGE SCI, V62, P2765, DOI 10.1287/mnsc.2015.2285; Clauset A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400005; Evans JA, 2011, SCIENCE, V331, P721, DOI 10.1126/science.1201765; Ginther DK, 2011, SCIENCE, V333, P1015, DOI 10.1126/science.1196783; Jones BF, 2011, P NATL ACAD SCI USA, V108, P18910, DOI 10.1073/pnas.1102895108; Ke Q, 2015, P NATL ACAD SCI USA, V112, P7426, DOI 10.1073/pnas.1424329112; Langford J., 2015, BLOG; Levin SG., 1992, STRIKING MOTHER LODE; Maher B, 2016, NATURE, V538, P444, DOI 10.1038/538444a; Merton RK, 1948, ANTIOCH REV, V8, P193, DOI DOI 10.2307/4609267; Moreira JAG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143108; Newman MEJ, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/68001; Ohsumi Y., 2016, NOBEL LECT AUTHOPHAG; PRICE DJD, 1965, SCIENCE, V149, P510; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; Shi F, 2015, SOC NETWORKS, V43, P73, DOI 10.1016/j.socnet.2015.02.006; Simonton DK, 1997, PSYCHOL REV, V104, P66, DOI 10.1037/0033-295X.104.1.66; Sinatra R, 2016, SCIENCE, V354, DOI 10.1126/science.aaf5239; Smaldino PE, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160384; van Raan AFJ, 2004, SCIENTOMETRICS, V59, P467, DOI 10.1023/B:SCIE.0000018543.82441.f1; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825; Way SF, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16), P1169	27	95	99	10	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					477	480		10.1126/science.aal4217	http://dx.doi.org/10.1126/science.aal4217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154048				2022-12-28	WOS:000393183100032
J	de Vivo, L; Bellesi, M; Marshall, W; Bushong, EA; Ellisman, MH; Tononi, G; Cirelli, C				de Vivo, Luisa; Bellesi, Michele; Marshall, William; Bushong, Eric A.; Ellisman, Mark H.; Tononi, Giulio; Cirelli, Chiara			Ultrastructural evidence for synaptic scaling across the wake/sleep cycle	SCIENCE			English	Article							LONG-TERM POTENTIATION; NEOCORTEX IN-VIVO; DENDRITIC SPINES; PLASTICITY; SYNAPSES; EXPERIENCE; MEMORY; SLEEP; BRAIN; TRAFFICKING	It is assumed that synaptic strengthening and weakening balance throughout learning to avoid runaway potentiation and memory interference. However, energetic and informational considerations suggest that potentiation should occur primarily during wake, when animals learn, and depression should occur during sleep. We measured 6920 synapses in mouse motor and sensory cortices using three-dimensional electron microscopy. The axon-spine interface (ASI) decreased similar to 18% after sleep compared with wake. This decrease was proportional to ASI size, which is indicative of scaling. Scaling was selective, sparing synapses that were large and lacked recycling endosomes. Similar scaling occurred for spine head volume, suggesting a distinction between weaker, more plastic synapses (similar to 80%) and stronger, more stable synapses. These results support the hypothesis that a core function of sleep is to renormalize overall synaptic strength increased by wake.	[de Vivo, Luisa; Bellesi, Michele; Marshall, William; Tononi, Giulio; Cirelli, Chiara] Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA; [Bellesi, Michele] Univ Politecn Marche, Sect Neurosci & Cell Biol, Dept Expt & Clin Med, Ancona, Italy; [Bushong, Eric A.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Ellisman, Mark H.] Univ Calif San Diego, Sch Med, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA	University of Wisconsin System; University of Wisconsin Madison; Marche Polytechnic University; University of California System; University of California San Diego; University of California System; University of California San Diego	Tononi, G; Cirelli, C (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	gtononi@wisc.edu; ccirelli@wisc.edu	de Vivo, Luisa/AAO-3944-2020; de Vivo, Luisa/AAL-3874-2021	de Vivo, Luisa/0000-0002-5676-9279; Bellesi, Michele/0000-0002-3922-0188	NIH of the National Center for Microscopy and Imaging research [DP 10D579, 1R01MH091326, 1R01MH099231, 1P01NS083514, P41GM103412]; Philips Respironics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099231, R01MH091326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS083514] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	NIH of the National Center for Microscopy and Imaging research; Philips Respironics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Christiensen, P. Horvath, S. Koebe, S. Loschky, R. Massopust, M. Nagai, and A. Schroeder for their contribution to the manual segmentation of SBEM images. This work was supported by NIH grants DP 10D579 (G.T.), 1R01MH091326 (G.T.), 1R01MH099231 (G.T. and C.C.), 1P01NS083514 (G.T. and C.C.), and P41GM103412 for support of the National Center for Microscopy and Imaging research (M.H.E.). The other authors declare no competing financial interests. G.T. is involved in a research study in humans supported by Philips Respironics; this study is not related to the work presented in the current manuscript. The other authors declare no competing financial interests. Data (ASI and HV measures) are available at http://centerforsleepandconsciousness.medwisc.edu.	Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Cane M, 2014, J NEUROSCI, V34, P2075, DOI 10.1523/JNEUROSCI.3353-13.2014; Cheetham CEJ, 2014, CEREB CORTEX, V24, P521, DOI 10.1093/cercor/bhs334; Chistiakova M, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00089; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DESMOND NL, 1988, BRAIN RES, V453, P308, DOI 10.1016/0006-8993(88)90171-0; Diering GH, 2014, NEURON, V84, P790, DOI 10.1016/j.neuron.2014.09.024; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Grosmark AD, 2016, SCIENCE, V351, P1440, DOI 10.1126/science.aad1935; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Holcomb PS, 2013, J NEUROSCI, V33, P12954, DOI 10.1523/JNEUROSCI.1087-13.2013; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Katz Y, 2009, NEURON, V63, P171, DOI 10.1016/j.neuron.2009.06.023; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Loewenstein Y, 2011, J NEUROSCI, V31, P9481, DOI 10.1523/JNEUROSCI.6130-10.2011; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Nishiyama J, 2015, NEURON, V87, P63, DOI 10.1016/j.neuron.2015.05.043; Ostroff LE, 2010, P NATL ACAD SCI USA, V107, P9418, DOI 10.1073/pnas.0913384107; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Tang Y, 2001, SYNAPSE, V41, P258, DOI 10.1002/syn.1083; Tao-Cheng JH, 2011, J NEUROSCI, V31, P4834, DOI 10.1523/JNEUROSCI.4745-10.2011; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; von der Malsburg C, 1973, Kybernetik, V14, P85; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035	35	283	288	1	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					507	510		10.1126/science.aah5982	http://dx.doi.org/10.1126/science.aah5982			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154076	Green Submitted, Green Accepted			2022-12-28	WOS:000393183100041
J	Sibanda, BL; Chirgadze, DY; Ascher, DB; Blundell, TL				Sibanda, Bancinyane L.; Chirgadze, Dimitri Y.; Ascher, David B.; Blundell, Tom L.			DNA-PKcs structure suggests an allosteric mechanism modulating DNA double-strand break repair	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; CATALYTIC SUBUNIT; 3-DIMENSIONAL STRUCTURE; CELL-CYCLE; DOMAIN; COMPLEX; KU; AUTOPHOSPHORYLATION; RECOMBINATION; DEFICIENCY	DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is a central component of nonhomologous end joining (NHEJ), repairing DNA double-strand breaks that would otherwise lead to apoptosis or cancer. We have solved its structure in complex with the C-terminal peptide of Ku80 at 4.3 angstrom resolution using x-ray crystallography. We show that the 4128-amino acid structure comprises three large structural units: the N-terminal unit, the Circular Cradle, and the Head. Conformational differences between the two molecules in the asymmetric unit are correlated with changes in accessibility of the kinase active site, which are consistent with an allosteric mechanism to bring about kinase activation. The location of KU80ct(194) in the vicinity of the breast cancer 1 (BRCA1) binding site suggests competition with BRCA1, leading to pathway selection between NHEJ and homologous recombination.	[Sibanda, Bancinyane L.; Chirgadze, Dimitri Y.; Ascher, David B.; Blundell, Tom L.] Univ Cambridge, Dept Biochem, Old Addenbrookes Site,80 Tennis Court Rd, Cambridge CB2 1GA, England; [Ascher, David B.] Univ Melbourne, Dept Biochem & Mol Biol, 30 Flemington Rd, Parkville, Vic 3052, Australia	University of Cambridge; University of Melbourne	Blundell, TL (corresponding author), Univ Cambridge, Dept Biochem, Old Addenbrookes Site,80 Tennis Court Rd, Cambridge CB2 1GA, England.	tlb20@cam.ac.uk		Chirgadze, Dimitri/0000-0001-9942-0993; Ascher, David/0000-0003-2948-2413	Wellcome Trust [093167/Z/10/Z]; BBSRC [BB/I024984/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I024984/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Model coordinates have been deposited in the Protein Data Bank under accession number 5LUQ. We thank J. Van den Heuvel at Helmholtz-Zentrum and particularly V. Jager, who prepared the HeLa cells. We are also grateful to the European Synchrotron Radiation Facility (beamlines ID29, ID14-1, and 1D14-2 in Grenoble, France) and Diamond (beamlines I04 and I03 in Oxford, UK) synchrotron sources, where the data were collected. This work was funded by the Wellcome Trust (grant 093167/Z/10/Z).	Araki R, 1997, P NATL ACAD SCI USA, V94, P2438, DOI 10.1073/pnas.94.6.2438; Boskovic J, 2003, EMBO J, V22, P5875, DOI 10.1093/emboj/cdg555; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chiu CY, 1998, J MOL BIOL, V284, P1075, DOI 10.1006/jmbi.1998.2212; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200; Davis AJ, 2014, NUCLEIC ACIDS RES, V42, P11487, DOI 10.1093/nar/gku824; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Harris R, 2004, J MOL BIOL, V335, P573, DOI 10.1016/j.jmb.2003.10.047; Jette N, 2015, PROG BIOPHYS MOL BIO, V117, P194, DOI 10.1016/j.pbiomolbio.2014.12.003; Leuther KK, 1999, EMBO J, V18, P1114, DOI 10.1093/emboj/18.5.1114; Meek K, 2012, NUCLEIC ACIDS RES, V40, P2964, DOI 10.1093/nar/gkr1211; Rivera-Calzada A, 2005, STRUCTURE, V13, P243, DOI 10.1016/j.str.2004.12.006; Schatz DG, 2004, IMMUNOL REV, V200, P5, DOI 10.1111/j.0105-2896.2004.00173.x; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; van der Burg M, 2009, CURR OPIN ALLERGY CL, V9, P503, DOI 10.1097/ACI.0b013e3283327e41; Villarreal SA, 2014, J STRUCT BIOL, V187, P76, DOI 10.1016/j.jsb.2013.12.002; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Weterings E, 2009, MOL CELL BIOL, V29, P1134, DOI 10.1128/MCB.00971-08; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Zhang ZM, 2004, STRUCTURE, V12, P495, DOI 10.1016/j.str.2004.02.007	30	121	125	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					520	+		10.1126/science.aak9654	http://dx.doi.org/10.1126/science.aak9654			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154079	Green Submitted			2022-12-28	WOS:000393183100044
J	Berry, M; Brink, E; Harris, J; Sleeman, KE				Berry, M.; Brink, E.; Harris, J.; Sleeman, K. E.			Supporting relatives and carers at the end of a patient's life	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Berry, M.] Imperial Sch Anaesthesia, Anaesthesia & Intens Care, London, England; [Brink, E.] Cambridge Cty Council, Adults Phys Disabil Team, Cambridge, England; [Harris, J.] Beyond Goodbye Project, Bereaved Mother & Daughter, Stroud, England; [Sleeman, K. E.] Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, Palliat Med, London, England	Imperial College London; University of London; King's College London	Sleeman, KE (corresponding author), Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, Palliat Med, London, England.	katherine.sleeman@kcl.ac.uk		Sleeman, Katherine/0000-0002-9777-4373	Academy of Medical Sciences (AMS) [AMS-SGCL10-Sleeman] Funding Source: researchfish; National Institute for Health Research [CL-2010-17-009, CS-2015-15-005] Funding Source: researchfish	Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))		Abernethy AP, 2008, SUPPORT CARE CANCER, V16, P585, DOI 10.1007/s00520-007-0342-8; [Anonymous], 2014, LEADERSHIP ALLIANCE; Azoulay E, 2002, AM J RESP CRIT CARE, V165, P438, DOI 10.1164/ajrccm.165.4.200108-006oc; COLLIS E, 2013, BMJ-BRIT MED J, V347, P23993, DOI DOI 10.1136/BMJ.F4085; General Medical Council, 2008, CONS PAT DOCT MAK DE; General Medical Council, 2009, CONF; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lebus C, 2014, J PALLIAT MED, V17, P712, DOI 10.1089/jpm.2013.0483; Mayor S, 2007, BRIT MED J, V334, P278, DOI 10.1136/bmj.39118.686100.DB; Neimeyer RA, 2012, COUNSELING CLIENTS N; Neimeyer RA, 2011, GRIEF BEREAVEMENT CO; SLEEMAN KE, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F2174; Sykes N, 2003, LANCET ONCOL, V4, P312, DOI 10.1016/S1470-2045(03)01079-9; The Greater Manchester Mental Health NHS Foundation Trust, THE HANDBOOK OF FAIT	14	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2017	356								j367	10.1136/bmj.j367	http://dx.doi.org/10.1136/bmj.j367			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BT	28154119	Green Published			2022-12-28	WOS:000393450100004
J	Loder, E				Loder, Elizabeth			Familiarity breeds better outcomes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												eloder@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2017	356								j558	10.1136/bmj.j558	http://dx.doi.org/10.1136/bmj.j558			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BT	28153976	Bronze, Green Published			2022-12-28	WOS:000393450100010
J	Yokose, J; Okubo-Suzuki, R; Nomoto, M; Ohkawa, N; Nishizono, H; Suzuki, A; Matsuo, M; Tsujimura, S; Takahashi, Y; Nagase, M; Watabe, AM; Sasahara, M; Kato, F; Inokuchi, K				Yokose, Jun; Okubo-Suzuki, Reiko; Nomoto, Masanori; Ohkawa, Noriaki; Nishizono, Hirofumi; Suzuki, Akinobu; Matsuo, Mina; Tsujimura, Shuhei; Takahashi, Yukari; Nagase, Masashi; Watabe, Ayako M.; Sasahara, Masakiyo; Kato, Fusao; Inokuchi, Kaoru			Overlapping memory trace indispensable for linking, but not recalling, individual memories	SCIENCE			English	Article							STIMULUS CONVERGENCE; BASOLATERAL AMYGDALA; NEURONS; FEAR; HIPPOCAMPAL; ACTIVATION	Memories are not stored in isolation from other memories but are integrated into associative networks. However, the mechanisms underlying memory association remain elusive. Using two amygdala-dependent behavioral paradigms-conditioned taste aversion (CTA) and auditory-cued fear conditioning (AFC)-in mice, we found that presenting the conditioned stimulus used for the CTA task triggered the conditioned response of the AFC task after natural coreactivation of the memories. This was accompanied through an increase in the overlapping neuronal ensemble in the basolateral amygdala. Silencing of the overlapping ensemble suppressed CTA retrieval-induced freezing. However, retrieval of the original CTA or AFC memory was not affected. A small population of coshared neurons thus mediates the link between memories. They are not necessary for recalling individual memories.	[Yokose, Jun; Okubo-Suzuki, Reiko; Nomoto, Masanori; Ohkawa, Noriaki; Suzuki, Akinobu; Tsujimura, Shuhei; Inokuchi, Kaoru] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Fac Med, Dept Biochem, 2630 Sugitani, Sugitani, Toyama 9300194, Japan; [Yokose, Jun; Okubo-Suzuki, Reiko; Nomoto, Masanori; Ohkawa, Noriaki; Nishizono, Hirofumi; Suzuki, Akinobu; Tsujimura, Shuhei; Inokuchi, Kaoru] Toyama Univ, Japan Sci & Technol Agcy JST, CREST, 2630 Sugitani, Sugitani, Toyama 9300194, Japan; [Nishizono, Hirofumi; Matsuo, Mina] Toyama Univ, Life Sci Res Ctr, Div Anim Expt Lab Life, 2630 Sugitani, Sugitani, Toyama 9300194, Japan; [Takahashi, Yukari; Nagase, Masashi; Watabe, Ayako M.; Kato, Fusao] Jikei Univ, Sch Med, Dept Neurosci, Tokyo 1058461, Japan; [Sasahara, Masakiyo] Toyama Univ, Fac Med, Dept Pathol, 2630 Sugitani, Sugitani, Toyama 9300194, Japan; [Ohkawa, Noriaki] Toyama Univ, JST, PRESTO, 2630 Sugitani, Sugitani, Toyama 9300194, Japan	University of Toyama; Japan Science & Technology Agency (JST); University of Toyama; University of Toyama; Jikei University; University of Toyama; Japan Science & Technology Agency (JST); University of Toyama	Inokuchi, K (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Fac Med, Dept Biochem, 2630 Sugitani, Sugitani, Toyama 9300194, Japan.; Inokuchi, K (corresponding author), Toyama Univ, CREST, Japan Sci & Technol Agcy JST, 2630 Sugitani, Sugitani, Toyama 9300194, Japan.	inokuchi@med.u-toyama.ac.jp	Inokuchi, Kaoru/AAI-9693-2020; Yokose, Jun/S-8123-2016	Inokuchi, Kaoru/0000-0002-5393-3133; Nomoto, Masanori/0000-0003-0301-6924; Nishizono, Hirofumi/0000-0002-9394-7089; Ohkawa, Noriaki/0000-0002-6754-9933; Yokose, Jun/0000-0002-1953-9378	CREST program of JST; Japan Society for the Promotion of Science KAKENHI grant [JP23220009, JP23650208, JP25293136, JP25430015, JP25860429, JP15K19194, 15K18344, JP25115002, JP26115523, JP15H01295, S1311009]; Mitsubishi Foundation; Uehara Memorial Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [25293093] Funding Source: KAKEN	CREST program of JST(Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mitsubishi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Deisseroth (Stanford University) for the ArchT 3.0-EYFP cDNA, H. Hioki and T. Kaneko (Kyoto University) for the STB vector, and H. Bito (Tokyo University) for the E-SARE cDNA. All members of the Inokuchi laboratory supported and discussed this study. This work was supported by the CREST program of JST; Japan Society for the Promotion of Science KAKENHI grant numbers JP23220009 (K. I.), JP23650208, JP25293136 (F. K.), JP25430015 (A. M. W.), JP25860429, JP15K19194 (Y. T.), and 15K18344 (M. Nomoto); a Grant-in-Aid for Scientific Research on Innovative Areas "Memory dynamism" [JP25115002 (K. I.) and JP26115523 (A. M. W.)] and " Microendophenotypes of psychiatric disorders" [JP15H01295 (A. M. W.)] from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT-Supported Program for the Strategic Research Foundation at Private Universities S1311009 (F. K.); the Mitsubishi Foundation; the Uehara Memorial Foundation; and the Takeda Science Foundation (support to K. I.). All data necessary to understand and assess the conclusions of this research are available in the supplementary materials.	Anderson J.R., 1973, HUMAN ASS MEMORY; Barot SK, 2008, P NATL ACAD SCI USA, V105, P20959, DOI 10.1073/pnas.0808996106; Brewin CR, 2003, CLIN PSYCHOL REV, V23, P339, DOI 10.1016/S0272-7358(03)00033-3; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Debiec J, 2006, P NATL ACAD SCI USA, V103, P3428, DOI 10.1073/pnas.0507168103; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Ferreira G, 2005, EUR J NEUROSCI, V22, P2596, DOI 10.1111/j.1460-9568.2005.04440.x; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Hashikawa K, 2013, J NEUROSCI, V33, P4958, DOI 10.1523/JNEUROSCI.5462-12.2013; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Holtmaat A, 2016, NAT NEUROSCI, V19, P1553, DOI 10.1038/nn.4418; Inui T, 2013, NEUROBIOL LEARN MEM, V106, P210, DOI 10.1016/j.nlm.2013.09.003; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; Kawashima T, 2013, NAT METHODS, V10, P889, DOI [10.1038/NMETH.2559, 10.1038/nmeth.2559]; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Nomoto M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12319; Ohkawa N, 2015, CELL REP, V11, P261, DOI 10.1016/j.celrep.2015.03.017; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Rashid AJ, 2016, SCIENCE, V353, P383, DOI 10.1126/science.aaf0594; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Rogerson T, 2014, NAT REV NEUROSCI, V15, P157, DOI 10.1038/nrn3667; Takeuchi T, 2016, NATURE, V537, P357, DOI 10.1038/nature19325; Tonegawa S, 2015, NEURON, V87, P918, DOI 10.1016/j.neuron.2015.08.002; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; Yuan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020486; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	29	56	59	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					398	402		10.1126/science.aal2690	http://dx.doi.org/10.1126/science.aal2690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126819				2022-12-28	WOS:000393172800040
J	Huang, YWA; Zhou, B; Wernig, M; Sudhof, TC				Huang, Yu-Wen Alvin; Zhou, Bo; Wernig, Marius; Sudhof, Thomas C.			ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and A beta Secretion	CELL			English	Article							APOLIPOPROTEIN-E; CONDITIONAL DELETION; KINASE; PROTEIN; BINDING; DISEASE; ACTIVATION; PROMOTER; AP-1; DUPLICATION	Human apolipoprotein E (ApoE) apolipoprotein is primarily expressed in three isoforms (ApoE2, ApoE3, and ApoE4) that differ only by two residues. ApoE4 constitutes the most important genetic risk factor for Alzheimer's disease (AD), ApoE3 is neutral, and ApoE2 is protective. How ApoE isoforms influence AD pathogenesis, however, remains unclear. Using ES-cell-derived human neurons, we show that ApoE secreted by glia stimulates neuronal A beta production with an ApoE4 > ApoE3 > ApoE2 potency rank order. We demonstrate that ApoE binding to ApoE receptors activates dual leucine-zipper kinase (DLK), a MAP-kinase kinase kinase that then activates MKK7 and ERK1/2 MAP kinases. Activated ERK1/2 induces cFos phosphorylation, stimulating the transcription factor AP-1, which in turn enhances transcription of amyloid-beta precursor protein (APP) and thereby increases amyloid-beta levels. This molecular mechanism also regulates APP transcription in mice in vivo. Our data describe a novel signal transduction pathway in neurons whereby ApoE activates a non-canonical MAP kinase cascade that enhances APP transcription and amyloid-beta synthesis.	[Huang, Yu-Wen Alvin; Zhou, Bo; Sudhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Huang, Yu-Wen Alvin; Zhou, Bo; Sudhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Zhou, Bo; Wernig, Marius] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Zhou, Bo; Wernig, Marius] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Sudhof, TC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Sudhof, TC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	tcs1@stanford.edu		Zhou, Bo/0000-0003-2082-7737	NIH [AG04813101]; NATIONAL INSTITUTE ON AGING [RF1AG048131] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. J. Herz for the RAP expression vector and ApoE antibodies. This study was supported by a grant from the NIH (AG04813101 to M.W. and T.C.S.).	Brouwers N, 2006, BRAIN, V129, P2984, DOI 10.1093/brain/awl212; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chen M, 2012, J NEUROSCI, V32, P13439, DOI 10.1523/JNEUROSCI.2039-12.2012; Christ A, 2012, DEV CELL, V22, P268, DOI 10.1016/j.devcel.2011.11.023; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fouquet M, 2014, NEUROPSYCHOL REV, V24, P290, DOI 10.1007/s11065-014-9263-8; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; Fukuyama K, 2000, J BIOL CHEM, V275, P21247, DOI 10.1074/jbc.M001488200; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; HERZ J, 1991, J BIOL CHEM, V266, P21232; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Lahiri DK, 2005, NEUROBIOL AGING, V26, P1329, DOI 10.1016/j.neurobiolaging.2004.11.005; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lu Y, 2014, CURR OPIN NEUROBIOL, V27, P135, DOI 10.1016/j.conb.2014.03.007; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Merritt SE, 1999, J BIOL CHEM, V274, P10195, DOI 10.1074/jbc.274.15.10195; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Morrison DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011254; Ohkubo N, 2001, J BIOL CHEM, V276, P3046, DOI 10.1074/jbc.M005070200; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Pak C, 2015, CELL STEM CELL, V17, P316, DOI 10.1016/j.stem.2015.07.017; Patzke C, 2016, J EXP MED, V213, P499, DOI 10.1084/jem.20150951; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Qiu ZH, 2004, J BIOL CHEM, V279, P34948, DOI 10.1074/jbc.M401055200; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Sebastiano V, 2014, SCI TRANSL MED, V6; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; Sleegers K, 2006, BRAIN, V129, P2977, DOI 10.1093/brain/awl203; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tedeschi A, 2013, EMBO REP, V14, P605, DOI 10.1038/embor.2013.64; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; WADE EJ, 1992, J VIROL, V66, P2407, DOI 10.1128/JVI.66.4.2407-2417.1992; Wang H, 2014, TRENDS ENDOCRIN MET, V25, P8, DOI 10.1016/j.tem.2013.10.003; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	47	267	274	6	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					427	+		10.1016/j.cell.2016.12.044	http://dx.doi.org/10.1016/j.cell.2016.12.044			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28111074	Green Accepted, Bronze			2022-12-28	WOS:000396249600012
J	Nowarski, R; Jackson, R; Flavell, RA				Nowarski, Roni; Jackson, Ruaidhri; Flavell, Richard A.			The Stromal Intervention: Regulation of Immunity and Inflammation at the Epithelial-Mesenchymal Barrier	CELL			English	Review							INNATE LYMPHOID-CELLS; CD103(+) DENDRITIC CELLS; HOMING T-CELLS; IKK-BETA; PULMONARY INFLAMMATION; INTESTINAL EPITHELIUM; TUFT CELLS; EXPRESSION; FIBROBLASTS; COLITIS	The immune system safeguards organ integrity by employing a balancing act of inflammatory and immunosuppressive mechanisms designed to neutralize foreign invaders and resolve injury. Maintaining or restoring a state of immune homeostasis is particularly challenging at barrier sites where constant exposure to immunogenic environmental agents may induce destructive inflammation. Recent studies underscore the role of epithelial and mesenchymal barrier cells in regulating immune cell function and local homeostatic and inflammatory responses. Here, we highlight immunoregulatory circuits engaging epithelial and mesenchymal cells in the intestine, airways, and skin and discuss how immune communications with hematopoietic cells and the microbiota orchestrate local immune homeostasis and inflammation.	[Nowarski, Roni; Jackson, Ruaidhri; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunol, 333 Cedar St, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunol, 333 Cedar St, New Haven, CT 06520 USA.; Flavell, RA (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA.	richard.flavell@yale.edu						Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Barros RD, 2016, CELL, V167, P203, DOI 10.1016/j.cell.2016.08.030; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Birchenough GMH, 2016, SCIENCE, V352, P1535, DOI 10.1126/science.aaf7419; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Branchfield K, 2016, SCIENCE, V351, P707, DOI 10.1126/science.aad7969; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Burkett PR, 2015, J CLIN INVEST, V125, P2211, DOI 10.1172/JCI78085; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Cao ZW, 2016, NAT MED, V22, P154, DOI 10.1038/nm.4035; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Chivukula RR, 2014, CELL, V157, P1104, DOI 10.1016/j.cell.2014.03.055; Denney L, 2015, IMMUNITY, V43, P945, DOI 10.1016/j.immuni.2015.10.012; Dickinson JD, 2016, AUTOPHAGY, V12, P397, DOI 10.1080/15548627.2015.1056967; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Driskell RR, 2015, TRENDS CELL BIOL, V25, P92, DOI 10.1016/j.tcb.2014.10.001; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Fujisawa T, 2011, AM J RESP CELL MOL, V45, P246, DOI 10.1165/rcmb.2009-0313OC; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Giacomin PR, 2015, J EXP MED, V212, P1513, DOI 10.1084/jem.20141831; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Harrison OJ, 2015, MUCOSAL IMMUNOL, V8, P1226, DOI 10.1038/mi.2015.13; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hooper LV, 2015, ADV IMMUNOL, V126, P129, DOI 10.1016/bs.ai.2014.11.003; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Hsia LT, 2016, P NATL ACAD SCI USA, V113, pE2162, DOI 10.1073/pnas.1603534113; Hu B, 2012, CELL, V149, P1207, DOI 10.1016/j.cell.2012.03.048; Hung C, 2013, AM J RESP CRIT CARE, V188, P820, DOI 10.1164/rccm.201212-2297OC; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Koliaraki V, 2015, J EXP MED, V212, P2235, DOI 10.1084/jem.20150542; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Koyama M, 2012, NAT MED, V18, P135, DOI 10.1038/nm.2597; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Kumar P, 2016, IMMUNITY, V44, P659, DOI 10.1016/j.immuni.2016.02.007; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Kurashima Y, 2014, IMMUNITY, V40, P530, DOI 10.1016/j.immuni.2014.01.014; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; McDonald KG, 2012, AM J PATHOL, V180, P984, DOI 10.1016/j.ajpath.2011.11.009; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mohapatra A, 2016, MUCOSAL IMMUNOL, V9, P275, DOI 10.1038/mi.2015.59; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Munoz M, 2015, IMMUNITY, V42, P321, DOI 10.1016/j.immuni.2015.01.011; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; Muzaki ARBM, 2016, MUCOSAL IMMUNOL, V9, P336, DOI 10.1038/mi.2015.64; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Nakahashi-Oda C, 2016, NAT IMMUNOL, V17, P441, DOI 10.1038/ni.3345; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Neufert C, 2013, J CLIN INVEST, V123, P1428, DOI 10.1172/JCI63748; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; Oh K, 2011, J EXP MED, V208, P1707, DOI 10.1084/jem.20101457; Owens BMJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00319; Pallangyo CK, 2015, J EXP MED, V212, P2253, DOI 10.1084/jem.20150576; Parker MW, 2014, J CLIN INVEST, V124, P1622, DOI 10.1172/JCI71386; Pascual-Reguant A., MUCOSAL IMM IN PRESS; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; PULLAN RD, 1994, GUT, V35, P353, DOI 10.1136/gut.35.3.353; Rajavelu P, 2015, J CLIN INVEST, V125, P2021, DOI 10.1172/JCI79422; Ramanan D, 2016, CELL HOST MICROBE, V19, P434, DOI 10.1016/j.chom.2016.03.003; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Reynolds JM, 2015, IMMUNITY, V42, P692, DOI 10.1016/j.immuni.2015.03.008; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Roulis M, 2014, P NATL ACAD SCI USA, V111, pE4658, DOI 10.1073/pnas.1415762111; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Scheibe K., 2016, GUT; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Shaker A, 2010, J CLIN INVEST, V120, P2081, DOI 10.1172/JCI40676; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Sujino T, 2016, SCIENCE, V352, P1581, DOI 10.1126/science.aaf3892; Sun QZ, 2015, J IMMUNOL, V195, P298, DOI 10.4049/jimmunol.1402465; Suwara MI, 2014, MUCOSAL IMMUNOL, V7, P684, DOI 10.1038/mi.2013.87; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Turner JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003698; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Vicente-Suarez I, 2015, MUCOSAL IMMUNOL, V8, P141, DOI 10.1038/mi.2014.51; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wang DR, 2014, CIRC RES, V114, P67, DOI 10.1161/CIRCRESAHA.114.301633; Weitnauer M, 2016, MUCOSAL IMMUNOL, V9, P287, DOI 10.1038/mi.2015.126; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Wu CF, 2013, AM J PATHOL, V182, P118, DOI 10.1016/j.ajpath.2012.09.009; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zhang LJ, 2015, SCIENCE, V347, P67, DOI 10.1126/science.1260972	126	104	108	3	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					362	375		10.1016/j.cell.2016.11.040	http://dx.doi.org/10.1016/j.cell.2016.11.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28129537	Bronze			2022-12-28	WOS:000396249600007
J	Tracy, DK; Wood, DM; Baumeister, D				Tracy, Derek K.; Wood, David M.; Baumeister, David			CLINICAL UPDATES Novel psychoactive substances: types, mechanisms of action, and effects	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RECREATIONAL USE; ACUTE TOXICITY; MANAGING ACUTE; MEPHEDRONE USE; KETAMINE; DRUGS; CANNABINOIDS; PREVALENCE; SERIES; SPICE		[Tracy, Derek K.] Oxleas NHS Fdn Trust, London, England; [Tracy, Derek K.] Kings Coll London, Cognit Schizophrenia & Imaging Lab, Dept Psychosis Studies, Inst Psychiat Psychol & Neurosci, London, England; [Wood, David M.] Guys & St Thomas NHS Fdn Trust, Clin Toxicol, London, England; [Wood, David M.] Kings Hlth Partners, London, England; [Wood, David M.] Kings Coll London, Sch Life Sci & Med, London, England; [Baumeister, David] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of London; King's College London	Tracy, DK (corresponding author), Oxleas NHS Fdn Trust, London, England.; Tracy, DK (corresponding author), Kings Coll London, Cognit Schizophrenia & Imaging Lab, Dept Psychosis Studies, Inst Psychiat Psychol & Neurosci, London, England.	derek.tracy@nhs.net	Tracy, Derek/AAE-1155-2021	Tracy, Derek/0000-0002-3609-9407				Backberg M, 2015, CLIN TOXICOL, V53, P609, DOI 10.3109/15563650.2015.1054505; Barker MJ, 2004, CNS DRUGS, V18, P37, DOI 10.2165/00023210-200418010-00004; Baumeister D, 2014, THER ADV PSYCHOPHARM, V4, P156, DOI 10.1177/2045125314527985; Baumeister D, 2015, THER ADV PSYCHOPHARM, V5, P97, DOI 10.1177/2045125314559539; Bhattacharyya S, 2010, NEUROPSYCHOPHARMACOL, V35, P764, DOI 10.1038/npp.2009.184; Bosak A, 2013, J MED TOXICOL, V9, P196, DOI 10.1007/s13181-013-0287-x; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Buser GL, 2014, CLIN TOXICOL, V52, P664, DOI 10.3109/15563650.2014.932365; Caddy C, 2014, THER ADV PSYCHOPHARM, V4, P75, DOI 10.1177/2045125313507739; Castaneto MS, 2014, DRUG ALCOHOL DEPEN, V144, P12, DOI 10.1016/j.drugalcdep.2014.08.005; Coppola M, 2015, DRUG ALCOHOL REV, V34, P109, DOI 10.1111/dar.12216; Corazza O, 2013, CNS NEUROSCI THER, V19, P454, DOI 10.1111/cns.12063; Corazza O, 2012, HUM PSYCHOPHARM CLIN, V27, P145, DOI 10.1002/hup.1242; Corkery JM, 2012, PROG NEURO-PSYCHOPH, V39, P259, DOI 10.1016/j.pnpbp.2012.05.022; Dargan PI, 2010, QJM-INT J MED, V103, P875, DOI 10.1093/qjmed/hcq134; Dargan PI, 2013, EUR J CLIN PHARMACOL, V69, P361, DOI 10.1007/s00228-012-1361-z; Dell'osso B, 2013, EUR PSYCHIAT, V28, P7, DOI 10.1016/j.eurpsy.2011.11.003; den Hollander B, 2013, PHARMACOL BIOCHEM BE, V103, P501, DOI 10.1016/j.pbb.2012.10.006; Dillon P, 2003, DRUG ALCOHOL DEPEN, V69, P23, DOI 10.1016/S0376-8716(02)00243-0; EMCDDA. Europol, 2016, EUR EU DRUG MARK REP; Fantegrossi WE, 2014, LIFE SCI, V97, P45, DOI 10.1016/j.lfs.2013.09.017; Fleckenstein AE, 2000, EUR J PHARMACOL, V406, P1, DOI 10.1016/S0014-2999(00)00639-7; Greene SL, 2008, EMERG MED AUSTRALAS, V20, P391, DOI 10.1111/j.1742-6723.2008.01114.x; Gunderson EW, 2012, AM J ADDICTION, V21, P320, DOI 10.1111/j.1521-0391.2012.00240.x; Gurney S M R, 2014, Forensic Sci Rev, V26, P53; Halberstadt AL, 2014, NEUROPHARMACOLOGY, V77, P200, DOI 10.1016/j.neuropharm.2013.08.025; Helander A, 2014, CLIN TOXICOL, V52, P901, DOI 10.3109/15563650.2014.943908; Hill SL, 2013, CLIN TOXICOL, V51, P487, DOI 10.3109/15563650.2013.802795; Hofer KE, 2012, ANN EMERG MED, V60, P97, DOI 10.1016/j.annemergmed.2011.11.018; Karila L, 2014, CURR PHARM DESIGN, V20, P4112, DOI 10.2174/13816128113199990620; Katselou M, 2015, FORENSIC TOXICOL, V33, P195, DOI 10.1007/s11419-015-0271-z; Lapoint J, 2011, CLIN TOXICOL, V49, P760, DOI 10.3109/15563650.2011.609822; Lawn W, 2014, J PSYCHOPHARMACOL, V28, P780, DOI 10.1177/0269881114523866; Liechti ME, 2001, PSYCHOPHARMACOLOGY, V154, P161, DOI 10.1007/s002130000648; Mangewala Vikas, 2013, Innov Clin Neurosci, V10, P10; McQuade D, 2013, EUR J CLIN PHARMACOL, V69, P373, DOI 10.1007/s00228-012-1379-2; Miotto K, 2013, DRUG ALCOHOL DEPEN, V132, P1, DOI 10.1016/j.drugalcdep.2013.06.016; Moosmann B, 2013, J MASS SPECTROM, V48, P1150, DOI 10.1002/jms.3279; Morgan CJA, 2009, ADDICTION, V104, P77, DOI 10.1111/j.1360-0443.2008.02394.x; Morris H, 2014, DRUG TEST ANAL, V6, P614, DOI 10.1002/dta.1620; Muetzelfeldt L, 2008, DRUG ALCOHOL DEPEN, V95, P219, DOI 10.1016/j.drugalcdep.2008.01.024; National Poisons Information Service Public Health England, 2015, NAT POIS INF SERV RE; NICHOLS DE, 1986, J PSYCHOACTIVE DRUGS, V18, P305, DOI 10.1080/02791072.1986.10472362; Nikolaou P, 2015, DRUG CHEM TOXICOL, V38, P113, DOI 10.3109/01480545.2014.911882; Papanti D, 2013, HUM PSYCHOPHARM CLIN, V28, P379, DOI 10.1002/hup.2312; Penders TM, 2013, J ECT, V29, pE59, DOI 10.1097/YCT.0b013e3182887bc2; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Prosser JM, 2012, J MED TOXICOL, V8, P33, DOI 10.1007/s13181-011-0193-z; Public Health England, 2015, AD SUBST MIS STAT NA; Schwope DM, 2012, J ANAL TOXICOL, V36, P405, DOI 10.1093/jat/bks044; Seely KA, 2013, FORENSIC SCI INT, V233, P416, DOI 10.1016/j.forsciint.2013.10.002; Shields JE, 2012, CLIN TOXICOL, V50, P438, DOI 10.3109/15563650.2012.683437; Siddiqi S, 2015, CLIN TOXICOL, V53, P54, DOI 10.3109/15563650.2014.983239; Simmler LD, 2013, BRIT J PHARMACOL, V168, P458, DOI 10.1111/j.1476-5381.2012.02145.x; Simmler LD, 2014, BIOCHEM PHARMACOL, V88, P237, DOI 10.1016/j.bcp.2014.01.024; Soussan C, 2014, NORD STUD ALCOHOL DR, V31, P207, DOI 10.2478/nsad-2014-0016; Spaderna M, 2013, PSYCHOPHARMACOLOGY, V228, P525, DOI 10.1007/s00213-013-3188-4; Studerus E, 2011, J PSYCHOPHARMACOL, V25, P1434, DOI 10.1177/0269881110382466; TNS Political & Social, 2014, YOUNG PEOPL DRUGS RE; Tracy DK, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6814; Uchiyama N, 2012, FORENSIC TOXICOL, V30, P114, DOI 10.1007/s11419-012-0136-7; Van Hout MC, 2017, INT J MENT HEALTH AD, V15, P565, DOI 10.1007/s11469-016-9650-x; Wikstrom M, 2013, J ANAL TOXICOL, V37, P43, DOI 10.1093/jat/bks086; Winstock A, 2011, ADDICTION, V106, P1991, DOI 10.1111/j.1360-0443.2011.03502.x; Winstock AR, 2012, BJU INT, V110, P1762, DOI 10.1111/j.1464-410X.2012.11028.x; Winstock AR, 2016, GLOBAL DRUG SURVEY 2; Wood DM, 2016, QJM-INT J MED, V109, P527, DOI 10.1093/qjmed/hcv208; Wood DM, 2015, CLIN TOXICOL, V53, P85, DOI 10.3109/15563650.2015.1004179; Xie ZH, 2009, BIOCHEM PHARMACOL, V78, P1095, DOI 10.1016/j.bcp.2009.05.031; Zanda MT, 2016, BEHAV PHARMACOL, V27, P489, DOI 10.1097/FBP.0000000000000241; Zimmermann US, 2009, DTSCH ARZTEBL INT, V106, P464, DOI 10.3238/arztebl.2009.0464	71	37	38	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2017	356								i6848	10.1136/bmj.i6848	http://dx.doi.org/10.1136/bmj.i6848			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HO	28122697	Green Published			2022-12-28	WOS:000393177700002
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Swapping systematic reviews for celebrity endorsements	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2017, HIGH RISK BIAS DOCTO; Carter C, 2013, DAILY TELEGRAPH; Cook J., 2012, DEBUNKING HDB; Dyer O, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j132; Nyhan B, 2010, WHEN CORRECTIONS FAI; Stiller B, 2016, CANC MOONSHOT; Stone K., 2015, HLTH NEWS REV   0813; Williamson P., 2016, NATURE	8	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2017	356								j228	10.1136/bmj.j228	http://dx.doi.org/10.1136/bmj.j228			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HK	28115310	Green Published, Bronze			2022-12-28	WOS:000393177300001
J	Harrison, N				Harrison, Natalie			Conrad Shawcross: art in search of discovery	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					245	245		10.1016/S0140-6736(17)30139-3	http://dx.doi.org/10.1016/S0140-6736(17)30139-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	EI9BC	28118907				2022-12-28	WOS:000392801200015
J	Thompson, WG				Thompson, Warren G.			Adding wearable technology to a behavioral program resulted in less weight loss than adding Web-based self-monitoring	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Thompson, Warren G.] Mayo Clin, Rochester, MN 55902 USA	Mayo Clinic	Thompson, WG (corresponding author), Mayo Clin, Rochester, MN 55902 USA.							Tsai AG, 2013, ANN INTERN MED, V159, pITC1, DOI 10.7326/0003-4819-159-5-201309030-01003; Wadden TA, 2012, CIRCULATION, V125, P1157, DOI 10.1161/CIRCULATIONAHA.111.039453	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					JC4	JC4		10.7326/ACPJC-2017-166-2-004	http://dx.doi.org/10.7326/ACPJC-2017-166-2-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	28114460				2022-12-28	WOS:000391842600003
J	Wenger, N; Mean, M; Castioni, J; Marques-Vidal, P; Waeber, G; Garnier, A				Wenger, Nathalie; Mean, Marie; Castioni, Julien; Marques-Vidal, Pedro; Waeber, Gerard; Garnier, Antoine			Allocation of Internal Medicine Resident Time in a Swiss Hospital: A Time and Motion Study of Day and Evening Shifts	ANNALS OF INTERNAL MEDICINE			English	Article							WORK; PATIENT; SERVICE; SPEND; DOCUMENTATION; PHYSICIANS; COMPLEXITY; BURNOUT; IMPACT	Background: Little current evidence documents how internal medicine residents spend their time at work, particularly with regard to the proportions of time spent in direct patient care versus using computers. Objective: To describe how residents allocate their time during day and evening hospital shifts. Design: Time and motion study. Setting: Internal medicine residency at a university hospital in Switzerland, May to July 2015. Participants: 36 internal medicine residents with an average of 29 months of postgraduate training. Measurements: Trained observers recorded the residents' activities using a tablet-based application. Twenty-two activities were categorized as directly related to patients, indirectly related to patients, communication, academic, nonmedical tasks, and transition. In addition, the presence of a patient or colleague and use of a computer or telephone during each activity was recorded. Results: Residents were observed for a total of 696.7 hours. Day shifts lasted 11.6 hours (1.6 hours more than scheduled). During these shifts, activities indirectly related to patients accounted for 52.4% of the time, and activities directly related to patients accounted for 28.0%. Residents spent an average of 1.7 hours with patients, 5.2 hours using computers, and 13 minutes doing both. Time spent using a computer was scattered throughout the day, with the heaviest use after 6:00 p.m. Limitation: The study involved a small sample from 1 institution. Conclusion: At this Swiss teaching hospital, internal medicine residents spent more time at work than scheduled. Activities indirectly related to patients predominated, and about half the workday was spent using a computer.	[Wenger, Nathalie; Mean, Marie; Castioni, Julien; Marques-Vidal, Pedro; Waeber, Gerard; Garnier, Antoine] Lausanne Univ Hosp, Dept Internal Med, Off BH10-642,Rue Bugnon 46, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Wenger, N (corresponding author), Lausanne Univ Hosp, Dept Internal Med, Off BH10-642,Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	nathalie.wenger@chuv.ch	Garnier, Antoine/J-6454-2018; Marques-Vidal, Pedro/C-9449-2009	Garnier, Antoine/0000-0001-8361-2210; Mean, Marie/0000-0003-0477-7899; Waeber, Gerard/0000-0003-4193-788X; Castioni, Julien/0000-0002-7260-9371; Marques-Vidal, Pedro/0000-0002-4548-8500	Information Technology Department; Department of Internal Medicine of Lausanne University Hospital	Information Technology Department; Department of Internal Medicine of Lausanne University Hospital	Information Technology Department and Department of Internal Medicine of Lausanne University Hospital.	Alkureishi MA, 2016, J GEN INTERN MED, V31, P548, DOI 10.1007/s11606-015-3582-1; Ammenwerth E, 2009, METHOD INFORM MED, V48, P84, DOI 10.3414/ME0569; Asaro PV, 2008, ACAD EMERG MED, V15, P908, DOI 10.1111/j.1553-2712.2008.00235.x; Block L, 2013, J GEN INTERN MED, V28, P1042, DOI 10.1007/s11606-013-2376-6; Dammacco Franco, 2012, Recenti Progressi in Medicina, V103, P248, DOI 10.1701/1104.12130; Day T Eugene, 2006, Curr Surg, V63, P136, DOI 10.1016/j.cursur.2005.12.001; Dugdale DC, 1999, J GEN INTERN MED, V14, pS34, DOI 10.1046/j.1525-1497.1999.00263.x; Fletcher KE, 2012, J GEN INTERN MED, V27, P1432, DOI 10.1007/s11606-012-2120-7; GILLANDERS W, 1971, J MED EDUC, V46, P142; Gopal R, 2005, ARCH INTERN MED, V165, P2595, DOI 10.1001/archinte.165.22.2595; GUARISCO S, 1994, J GEN INTERN MED, V9, P272, DOI 10.1007/BF02599655; Hom J, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0665-6; Kellett J, 2007, EUR J INTERN MED, V18, P509, DOI 10.1016/j.ejim.2007.10.001; Mamykina L, 2016, ACAD MED, V91, P827, DOI 10.1097/ACM.0000000000001148; Meyer B, 2016, B MED SUISSES, V97, P6; Nardi R, 2007, EUR J INTERN MED, V18, P359, DOI 10.1016/j.ejim.2007.05.002; Ouyang D, 2016, JAMA INTERN MED, V176, P252, DOI 10.1001/jamainternmed.2015.6831; PAYSON HE, 1961, NEW ENGL J MED, V264, P439, DOI 10.1056/NEJM196103022640906; Poissant L, 2005, J AM MED INFORM ASSN, V12, P505, DOI 10.1197/jamia.M1700; Ratanawongsa N, 2016, JAMA INTERN MED, V176, P125, DOI 10.1001/jamainternmed.2015.6186; Shanafelt TD, 2016, MAYO CLIN PROC, V91, P836, DOI 10.1016/j.mayocp.2016.05.007; Sinsky C, 2016, ANN INTERN MED, V165, P753, DOI 10.7326/M16-0961; Spychalla MT, 2014, OCHSNER J, V14, P545; Vanderschueren S, 2009, ACTA CLIN BELG, V64, P344, DOI 10.1179/acb.2009.054; Wachter RM, 2016, ANN INTERN MED, V165, pH02, DOI 10.7326/M16-1367; Westbrook JI, 2008, MED J AUSTRALIA, V188, P506, DOI 10.5694/j.1326-5377.2008.tb01762.x; WILSON A, 1992, BMJ-BRIT MED J, V304, P227, DOI 10.1136/bmj.304.6821.227; Zulman DM, 2016, JAMA-J AM MED ASSOC, V316, P923, DOI 10.1001/jama.2016.9538	28	47	47	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2017	166	8					579	+		10.7326/M16-2238	http://dx.doi.org/10.7326/M16-2238			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES1RF	28135724	Green Accepted			2022-12-28	WOS:000399304000018
J	Sugiura, A; Mattie, S; Prudent, J; McBride, HM				Sugiura, Ayumu; Mattie, Sevan; Prudent, Julien; McBride, Heidi M.			Newly born peroxisomes are a hybrid of mitochondrial and ER-derived pre-peroxisomes	NATURE			English	Article							MEMBRANE-PROTEINS; ENDOPLASMIC-RETICULUM; PEX3; BIOGENESIS; PATHWAY; IMPORT; MAINTENANCE; EVOLUTION; TRANSPORT; VESICLES	Peroxisomes function together with mitochondria in a number of essential biochemical pathways, from bile acid synthesis to fatty acid oxidation(1). Peroxisomes grow and divide from preexisting organelles(2), but can also emerge de novo in the cell(3). The physiological regulation of de novo peroxisome biogenesis remains unclear, and it is thought that peroxisomes emerge from the endoplasmic reticulum in both mammalian and yeast cells'. However, in contrast to the yeast system(5-8), a number of integral peroxisomal membrane proteins are imported into mitochondria in mammalian cells in the absence of peroxisomes, including Pex3, Pex12, Pex13, Pex14, Pex26, PMP34 and ALDP(9-15). Overall, the mitochondrial localization of peroxisomal membrane proteins in mammalian cells has largely been considered a mis-targeting artefact in which de novo biogenesis occurs exclusively from endoplasmic reticulum-targeted peroxins(16). Here, in following the generation of new peroxisomes within human patient fibroblasts lacking peroxisomes, we show that the essential import receptors Pex3 and Pex14 target mitochondria, where they are selectively released into vesicular pre-peroxisomal structures. Maturation of pre-peroxisomes containing Pex3 and Pex14 requires fusion with endoplasmic reticulum-derived vesicles carrying Pex16, thereby providing full import competence. These findings demonstrate the hybrid nature of newly born peroxisomes, expanding their functional links to mitochondria.	[Sugiura, Ayumu; Mattie, Sevan; Prudent, Julien; McBride, Heidi M.] McGill Univ, Montreal Neurol Inst, 3801 Univ Ave, Montreal, PQ H3A 2B4, Canada	McGill University	McBride, HM (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ Ave, Montreal, PQ H3A 2B4, Canada.	heidi.mcbride@mcgill.ca	McBride, Heidi M/C-1162-2008; Sugiura, Ayumu/G-3648-2018; McBride, Heidi M./ABD-5774-2021	McBride, Heidi M/0000-0003-4666-2280; Sugiura, Ayumu/0000-0002-4776-1478; McBride, Heidi M./0000-0003-4666-2280	CIHR grant MOP [133549]; Canada Research Chair; JSPS Postdoctoral Fellowship for Research Abroad; Quebec FRQS Studentship; CIHR [MFE-140925]	CIHR grant MOP(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); JSPS Postdoctoral Fellowship for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Quebec FRQS Studentship; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by CIHR grant MOP#133549 and a Canada Research Chair to H.M.M. A.S. was supported by a JSPS Postdoctoral Fellowship for Research Abroad, S.M. through a Quebec FRQS Studentship, and J.P. by a CIHR Postdoctoral Fellowship (MFE-140925). The authors thank P. Kim for critical reagents and advice, and M. Nguyen for help with import assays.	Agrawal G, 2016, BBA-MOL CELL RES, V1863, P892, DOI 10.1016/j.bbamcr.2015.09.014; Agrawal G, 2011, P NATL ACAD SCI USA, V108, P9113, DOI 10.1073/pnas.1018749108; Aranovich A, 2014, J CELL SCI, V127, P3675, DOI 10.1242/jcs.146282; Bolte K, 2015, BIOESSAYS, V37, P195, DOI 10.1002/bies.201400151; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Gould SB, 2016, TRENDS MICROBIOL, V24, P525, DOI 10.1016/j.tim.2016.03.005; Halbach A, 2006, J CELL SCI, V119, P2508, DOI 10.1242/jcs.02979; Kim PK, 2015, J MOL BIOL, V427, P1176, DOI 10.1016/j.jmb.2015.02.005; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Lam SK, 2010, P NATL ACAD SCI USA, V107, P21523, DOI 10.1073/pnas.1013397107; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Matsuzaki T, 2008, J CELL BIOL, V183, P1275, DOI 10.1083/jcb.200806062; Mayerhofer PU, 2016, TRAFFIC, V17, P117, DOI 10.1111/tra.12350; Mohanty A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00268; Muntau AC, 2000, AM J HUM GENET, V67, P967, DOI 10.1086/303071; Neufeld C, 2009, EMBO J, V28, P745, DOI 10.1038/emboj.2009.7; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Schmidt F, 2012, TRAFFIC, V13, P1244, DOI 10.1111/j.1600-0854.2012.01380.x; Schrader M, 2012, BBA-MOL BASIS DIS, V1822, P1343, DOI 10.1016/j.bbadis.2011.12.014; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; South ST, 2000, J CELL BIOL, V149, P1345, DOI 10.1083/jcb.149.7.1345; South ST, 1999, J CELL BIOL, V144, P255, DOI 10.1083/jcb.144.2.255; Titorenko VI, 2000, J CELL BIOL, V148, P29, DOI 10.1083/jcb.148.1.29; Toro AA, 2009, J CELL BIOCHEM, V107, P1083, DOI 10.1002/jcb.22210; van der Zand A, 2010, MOL BIOL CELL, V21, P2057, DOI 10.1091/mbc.E10-02-0082; Yamashita SI, 2014, AUTOPHAGY, V10, P1549, DOI 10.4161/auto.29329	29	217	220	3	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					251	254		10.1038/nature21375	http://dx.doi.org/10.1038/nature21375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28146471				2022-12-28	WOS:000393737500045
J	Molitch, ME				Molitch, Mark E.			Diagnosis and Treatment of Pituitary Adenomas A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CLINICAL-PRACTICE GUIDELINE; CUSHINGS-DISEASE; TRANSSPHENOIDAL SURGERY; DOPAMINE AGONISTS; RADIATION-THERAPY; NATURAL-HISTORY; GROWTH-HORMONE; UNITED-STATES; SINGLE-CENTER; FOLLOW-UP	IMPORTANCE Pituitary adenomas may hypersecrete hormones or cause mass effects. Therefore, early diagnosis and treatment are important. OBSERVATIONS Prevalence of pituitary adenomas ranges from 1 in 865 adults to 1 in 2688 adults. Approximately 50% are microadenomas (<10 mm); the remainder are macroadenomas (>= 10 mm). Mass effects cause headache, hypopituitarism, and visual field defects. Treatments include transsphenoidal surgery, medical therapies, and radiotherapy. Prolactinomas account for 32% to 66% of adenomas and present with amenorrhea, loss of libido, galactorrhea, and infertility in women and loss of libido, erectile dysfunction, and infertility in men; they are generally treated with the dopamine agonists cabergoline and bromocriptine. Growth hormone-secreting tumors account for 8% to 16% of tumors and usually present with enlargement of the lips, tongue, nose, hands, and feet and are diagnosed by elevated insulin-like growth factor 1 levels and growth hormone levels; initial treatment is surgical. Medical therapy with somatostatin analogues, cabergoline, and pegvisomant is often also needed. Adrenocorticotropic hormone (ACTH)-secreting tumors account for 2% to 6% of adenomas and are associated with obesity, hypertension, diabetes, and other morbidity. Measurement of a late-night salivary cortisol level is the best screening test but petrosal sinus sampling for ACTH may be necessary to distinguish a pituitary from an ectopic source. The primary treatment of Cushing disease (hypercortisolism due to ACTH-producing adenomas, which is the cause in approximately 65% of the cases of hypercortisolism) is adenoma resection and medical therapies including ketoconazole, mifepristone, and pasireotide. Hyperthyroidism due to thyroid-stimulating hormone-secreting tumors accounts for 1% of tumors and is treated with surgery and somatostatin analogues if not surgically cured. Clinically nonfunctioning adenomas account for 15% to 54% of adenomas and present with mass effects; surgery is generally required, although incidentally found tumors can be followed if they are asymptomatic. CONCLUSIONS AND RELEVANCE Patients with pituitary adenomas should be identified at an early stage so that effective treatment can be implemented. For prolactinomas, initial therapy is generally dopamine agonists. For all other pituitary adenomas, initial therapy is generally transsphenoidal surgery with medical therapy being reserved for those not cured by surgery.	[Molitch, Mark E.] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, 645 N Michigan Ave,Ste 530, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Molitch, ME (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, 645 N Michigan Ave,Ste 530, Chicago, IL 60611 USA.	molitch@northwestern.edu			Novartis; Ipsen; Corcept; Chiasma	Novartis(Novartis); Ipsen(Ipsen); Corcept; Chiasma	Dr Molitch has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. He reports having received research grant support from Novartis, Ipsen, Corcept, and Chiasma and has received honoraria for consultations from Novartis, Ipsen, Corcept, Chiasma, and Pfizer.	Abu Dabrh A, 2014, J CLIN ENDOCR METAB, V99, P4003, DOI 10.1210/jc.2014-2900; Agustsson TT, 2015, EUR J ENDOCRINOL, V173, P655, DOI 10.1530/EJE-15-0189; Amlashi FG, 2016, ENDOCRINE, V52, P427, DOI 10.1007/s12020-016-0863-3; Ammirati M, 2013, J NEUROL NEUROSUR PS, V84, P843, DOI 10.1136/jnnp-2012-303194; Anagnostis P, 2011, INT J CLIN PRACT, V65, P172, DOI 10.1111/j.1742-1241.2010.02537.x; Arita K, 2006, J NEUROSURG, V104, P884, DOI 10.3171/jns.2006.104.6.884; Barker FG, 2003, J CLIN ENDOCR METAB, V88, P4709, DOI 10.1210/jc.2003-030461; Baudry C, 2012, EUR J ENDOCRINOL, V167, P473, DOI 10.1530/EJE-12-0358; Beck-Peccoz P, 2013, EUR THYROID J, V2, P76, DOI 10.1159/000351007; Bernabeu I, 2013, PITUITARY, V16, P101, DOI 10.1007/s11102-012-0382-z; Bertagna X, 2013, J CLIN ENDOCR METAB, V98, P1307, DOI 10.1210/jc.2012-3200; Borson-Chazot F, 2012, ANN ENDOCRINOL-PARIS, V73, P497, DOI 10.1016/j.ando.2012.09.004; Buchfelder M, 2014, HAND CLINIC, V124, P151, DOI 10.1016/B978-0-444-59602-4.00011-3; Casanueva FF, 2006, CLIN ENDOCRINOL, V65, P265, DOI 10.1111/j.1365-2265.2006.02562.x; Castinetti F, 2014, J CLIN ENDOCR METAB, V99, P1623, DOI 10.1210/jc.2013-3628; Chanson P, 2015, ANN ENDOCRINOL-PARIS, V76, P239, DOI 10.1016/j.ando.2015.04.002; Cheer K, 2014, HAND CLINIC, V124, P141, DOI 10.1016/B978-0-444-59602-4.00010-1; Ciric I, 1997, NEUROSURGERY, V40, P225, DOI 10.1097/00006123-199702000-00001; Clayton RN, 2016, LANCET DIABETES ENDO, V4, P569, DOI 10.1016/S2213-8587(16)30005-5; Colao A, 2014, J CLIN ENDOCR METAB, V99, P791, DOI 10.1210/jc.2013-2480; Colao A, 2004, ENDOCR REV, V25, P102, DOI 10.1210/er.2002-0022; Colao A, 2012, NEW ENGL J MED, V366, P914, DOI 10.1056/NEJMoa1105743; Colao A, 2008, ENDOCR-RELAT CANCER, V15, P905, DOI 10.1677/ERC-08-0181; Cooper O, 2012, BEST PRACT RES CL EN, V26, P447, DOI 10.1016/j.beem.2012.01.002; Cote DJ, 2016, WORLD NEUROSURG, V88, P1, DOI 10.1016/j.wneu.2016.01.022; Daly AF, 2006, J CLIN ENDOCR METAB, V91, P4769, DOI 10.1210/jc.2006-1668; Daniel E, 2015, J CLIN ENDOCR METAB, V100, P4146, DOI 10.1210/jc.2015-2616; Day Patricia Fainstein, 2004, Pituitary, V7, P145, DOI 10.1007/s11102-005-1757-1; Dekkers OM, 2007, EUR J ENDOCRINOL, V156, P217, DOI 10.1530/eje.1.02334; Delgrange E, 2009, EUR J ENDOCRINOL, V160, P747, DOI 10.1530/EJE-09-0012; Ding D, 2014, J NEURO-ONCOL, V117, P445, DOI 10.1007/s11060-013-1262-8; DONOVAN LE, 1995, ARCH INTERN MED, V155, P181, DOI 10.1001/archinte.155.2.181; Dworakowska D, 2010, EUR J ENDOCRINOL, V163, P21, DOI 10.1530/EJE-09-1080; Famini P, 2011, J CLIN ENDOCR METAB, V96, P1633, DOI 10.1210/jc.2011-0168; Feldkamp J, 1999, CLIN ENDOCRINOL, V51, P109, DOI 10.1046/j.1365-2265.1999.00748.x; Fernandez A, 2010, CLIN ENDOCRINOL, V72, P377, DOI 10.1111/j.1365-2265.2009.03667.x; Fleseriu M, 2013, ENDOCR PRACT, V19, P313, DOI 10.4158/EP12149.RA; Fleseriu M, 2012, J CLIN ENDOCR METAB, V97, P2039, DOI 10.1210/jc.2011-3350; Fontana E, 2009, Rev Med Suisse, V5, P2172; Freda PU, 2011, J CLIN ENDOCR METAB, V96, P894, DOI 10.1210/jc.2010-1048; Gillam MP, 2006, ENDOCR REV, V27, P485, DOI 10.1210/er.2005-9998; Gruppetta M, 2013, PITUITARY, V16, P545, DOI 10.1007/s11102-012-0454-0; HALL WA, 1994, ANN INTERN MED, V120, P817, DOI 10.7326/0003-4819-120-10-199405150-00001; Holdaway IM, 2008, EUR J ENDOCRINOL, V159, P89, DOI 10.1530/EJE-08-0267; Honegger J, 2008, EUR J ENDOCRINOL, V158, P287, DOI 10.1530/EJE-07-0502; Igarashi T, 1999, NEUROL MED-CHIR, V39, P592, DOI 10.2176/nmc.39.592; Kanner AA, 2009, PITUITARY, V12, P15, DOI 10.1007/s11102-008-0089-3; Karavitaki N, 2007, CLIN ENDOCRINOL, V67, P938, DOI 10.1111/j.1365-2265.2007.02990.x; Karavitaki N, 2006, CLIN ENDOCRINOL, V65, P524, DOI 10.1111/j.1365-2265.2006.02627.x; Katznelson L, 2014, J CLIN ENDOCR METAB, V99, P3933, DOI 10.1210/jc.2014-2700; Lo Re V, 2016, AM J MED, V129, P283, DOI 10.1016/j.amjmed.2015.10.029; Loeffler JS, 2011, J CLIN ENDOCR METAB, V96, P1992, DOI 10.1210/jc.2011-0251; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Melmed S, 2011, J CLIN ENDOCR METAB, V96, P273, DOI 10.1210/jc.2010-1692; Melmed S, 2010, PITUITARY, V13, P18, DOI 10.1007/s11102-009-0191-1; Mercado M, 2007, CLIN ENDOCRINOL, V66, P859, DOI 10.1111/j.1365-2265.2007.02825.x; Mercado M, 2014, J CLIN ENDOCR METAB, V99, P4438, DOI 10.1210/jc.2014-2670; Molitch ME, 2015, MOL CELL ENDOCRINOL, V408, P185, DOI 10.1016/j.mce.2014.09.021; Molitch ME, 2015, EUR J ENDOCRINOL, V172, pR205, DOI 10.1530/EJE-14-0848; Molitch ME, 2014, HAND CLINIC, V124, P167, DOI 10.1016/B978-0-444-59602-4.00012-5; Molitch ME, 2014, J NEURO-ONCOL, V117, P421, DOI 10.1007/s11060-013-1270-8; Muller AF, 2004, J CLIN ENDOCR METAB, V89, P1503, DOI 10.1210/jc.2002-022049; Neggers SJCMM, 2011, PITUITARY, V14, P253, DOI 10.1007/s11102-010-0289-5; Neto LV, 2015, CLIN ENDOCRINOL, V82, P739, DOI 10.1111/cen.12684; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Nieman LK, 2015, J CLIN ENDOCR METAB, V100, P2807, DOI 10.1210/jc.2015-1818; Nishizawa S, 1998, NEUROSURGERY, V43, P1344, DOI 10.1097/00006123-199812000-00047; Noronha S, 2016, ENDOCRINE, V51, P205, DOI 10.1007/s12020-015-0727-2; Ono M, 2008, J CLIN ENDOCR METAB, V93, P4721, DOI 10.1210/jc.2007-2758; Patil CG, 2008, J CLIN ENDOCR METAB, V93, P358, DOI 10.1210/jc.2007-2013; Petersenn S, 2015, EUR J ENDOCRINOL, V172, pR227, DOI 10.1530/EJE-14-0883; Pivonello R, 2016, LANCET DIABETES ENDO, V4, P611, DOI 10.1016/S2213-8587(16)00086-3; Preda VA, 2012, EUR J ENDOCRINOL, V167, P137, DOI 10.1530/EJE-12-0274; Raappana A, 2010, J CLIN ENDOCR METAB, V95, P4268, DOI 10.1210/jc.2010-0537; Raff H, 2015, ENDOCRIN METAB CLIN, V44, P43, DOI 10.1016/j.ecl.2014.10.005; RAM Z, 1994, J NEUROSURG, V80, P37, DOI 10.3171/jns.1994.80.1.0037; Raverot G, 2014, EUR J ENDOCRINOL, V170, pR121, DOI 10.1530/EJE-13-1031; REINCKE M, 1990, JAMA-J AM MED ASSOC, V263, P2772, DOI 10.1001/jama.263.20.2772; Rokkas T, 2008, WORLD J GASTROENTERO, V14, P3484, DOI 10.3748/wjg.14.3484; Salvatori R, 2014, PITUITARY, V17, P13, DOI 10.1007/s11102-012-0460-2; Sandret L, 2011, J CLIN ENDOCR METAB, V96, P1327, DOI 10.1210/jc.2010-2443; Sanno N, 2003, EUR J ENDOCRINOL, V149, P123, DOI 10.1530/eje.0.1490123; Simonis G, 2007, MOVEMENT DISORD, V22, P1936, DOI 10.1002/mds.21639; Starke RM, 2010, CURR OPIN ENDOCRINOL, V17, P356, DOI 10.1097/MED.0b013e32833ab069; Swearingen B, 2012, J CLIN ENDOCR METAB, V97, P1073, DOI 10.1210/jc.2011-3237; Tjornstrand A, 2014, EUR J ENDOCRINOL, V171, P519, DOI 10.1530/EJE-14-0144; Valassi E, 2010, J CLIN ENDOCR METAB, V95, P1025, DOI 10.1210/jc.2009-2095; van der Lely AJ, 2012, J CLIN ENDOCR METAB, V97, P1589, DOI 10.1210/jc.2011-2508; Vilar L, 2010, PITUITARY, V13, P123, DOI 10.1007/s11102-009-0209-8; Wilson TJ, 2013, PITUITARY, V16, P459, DOI 10.1007/s11102-012-0457-x; Wolinski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088787	92	401	427	8	96	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					516	524		10.1001/jama.2016.19699	http://dx.doi.org/10.1001/jama.2016.19699			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28170483				2022-12-28	WOS:000393564200020
J	Bohannon, J				Bohannon, John			THE PULSE OF THE PEOPLE	SCIENCE			English	Editorial Material																			0	8	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					470	472		10.1126/science.355.6324.470	http://dx.doi.org/10.1126/science.355.6324.470			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154046				2022-12-28	WOS:000393183100030
J	Diering, GH; Nirujogi, RS; Roth, RH; Worley, PF; Pandey, A; Huganir, RL				Diering, Graham H.; Nirujogi, Raja S.; Roth, Richard H.; Worley, Paul F.; Pandey, Akhilesh; Huganir, Richard L.			Homer1a drives homeostatic scaling-down of excitatory synapses during sleep	SCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; ACTIVATION; MEMORY; WAKE; MODULATION; MICE; DEPRIVATION; PERSISTENCE; PROTEIN	Sleep is an essential process that supports learning and memory by acting on synapses through poorly understood molecular mechanisms. Using biochemistry, proteomics, and imaging in mice, we find that during sleep, synapses undergo widespread alterations in composition and signaling, including weakening of synapses through removal and dephosphorylation of synaptic AMPA-type glutamate receptors. These changes are driven by the immediate early gene Homer1a and signaling from group I metabotropic glutamate receptors mGluR1/5. Homer1a serves as a molecular integrator of arousal and sleep need via the wake- and sleep-promoting neuromodulators, noradrenaline and adenosine, respectively. Our data suggest that homeostatic scaling-down, a global form of synaptic plasticity, is active during sleep to remodel synapses and participates in the consolidation of contextual memory.	[Diering, Graham H.; Roth, Richard H.; Worley, Paul F.; Huganir, Richard L.] Johns Hopkins Univ, Kavli Neurosci Discovery Inst, Solomon Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Nirujogi, Raja S.; Pandey, Akhilesh] Johns Hopkins Univ, Inst Med Genet, Dept Biol Chem, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Kavli Neurosci Discovery Inst, Solomon Snyder Dept Neurosci, Baltimore, MD 21218 USA.	rhuganir@jhmi.edu	Pandey, Akhilesh/CAI-9458-2022	Pandey, Akhilesh/0000-0001-9943-6127; Nirujogi, Raja Sekhar/0000-0002-3177-8566	Canadian Institutes for Health Research; NIH [P50MH100024, R01NS036715, 51000021844]; Center for Proteornics Discovery at Johns Hopkins University; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH112151, P50MH100024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010309] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021844] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Proteornics Discovery at Johns Hopkins University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All proteomics data obtained in this study are available in the PRIDE repository with the data set identifier PXD004537. The authors thank members of the Huganir laboratory, especially I. Hong, S. Heo, and N. Hussain, for insightful comments and critical reading of the manuscript. Image analysis software was developed by R. Cudmore and D. Linden, Department of Neuroscience, Johns Hopkins University. G.H.D. is a recipient of a fellowship award from the Canadian Institutes for Health Research. Funding was or by an NIH grant (P50MH100024, R01NS036715, to R.L.H.), a NIH shared instrumentation grant (51000021844, to A.P), and the Center for Proteornics Discovery at Johns Hopkins University. Data are stored and curated on a secure server located in the Department of Neuroscience at Johns Hopkins University. Data will be made available upon request.	Ahnaou A, 2015, PSYCHOPHARMACOLOGY, V232, P1107, DOI 10.1007/s00213-014-3746-4; Ahnaou A, 2015, BEHAV BRAIN RES, V282, P218, DOI 10.1016/j.bbr.2015.01.009; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Bjorness TE, 2016, J NEUROSCI, V36, P3709, DOI 10.1523/JNEUROSCI.3906-15.2016; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Chen ZC, 2014, J NEUROSCI, V34, P9621, DOI 10.1523/JNEUROSCI.3991-13.2014; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diering GH, 2014, NEURON, V84, P790, DOI 10.1016/j.neuron.2014.09.024; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Hengen KB, 2016, CELL, V165, P180, DOI 10.1016/j.cell.2016.01.046; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Liu ZW, 2010, J NEUROSCI, V30, P8671, DOI 10.1523/JNEUROSCI.1409-10.2010; Mackiewicz M, 2008, PHYSIOL GENOMICS, V33, P91, DOI 10.1152/physiolgenomics.00189.2007; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Naidoo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035174; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Serchov T, 2015, NEURON, V87, P549, DOI 10.1016/j.neuron.2015.07.010; Thandi S, 2002, J NEUROCHEM, V83, P1139, DOI 10.1046/j.1471-4159.2002.01217.x; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vecsey CG, 2009, NATURE, V461, P1122, DOI 10.1038/nature08488; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Watson BO, 2016, NEURON, V90, P839, DOI 10.1016/j.neuron.2016.03.036; Zhang Y, 2015, NAT NEUROSCI, V18, P402, DOI 10.1038/nn.3936	30	253	261	1	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					511	+		10.1126/science.aai8355	http://dx.doi.org/10.1126/science.aai8355			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154077	Green Accepted			2022-12-28	WOS:000393183100042
J	Pennington, RT; Banda, K; Delgado-Salinas, A; Dexter, KG; Linares-Palomino, R; Olivera, A; Prado, D; Quintana, C; Riina, R				Pennington, R. Toby; Banda-R, Karina; Delgado-Salinas, Alfonso; Dexter, Kyle G.; Linares-Palomino, Reynaldo; Olivera-Filho, Ary; Prado, Darien; Quintana, Catalina; Riina, Ricarda		DRYFLOR	Forest conservation: Humans' handprints Response	SCIENCE			English	Letter									[DRYFLOR] Royal Bot Garden Edinburgh, Latin Amer & Caribbean Seasonally Dry Trop Forest, Edinburgh EH3 5LR, Midlothian, Scotland; [Pennington, R. Toby; Banda-R, Karina; Dexter, Kyle G.] Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland; [Banda-R, Karina] Fdn Ecosistemas Secos Colombia, Bogota, Colombia; [Delgado-Salinas, Alfonso] Univ Nacl Autonoma Mexico, Dept Bot, Mexico City, DF, Mexico; [Dexter, Kyle G.] Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland; [Linares-Palomino, Reynaldo] Univ Nacl Agr La Molina, Ave La Molina, Lima, Peru; [Linares-Palomino, Reynaldo] Smithsonian Conservat Biol Inst, Lima, Peru; [Olivera-Filho, Ary] Univ Fed Minas Gerais, ICB, Dept Bot, Belo Horizonte, MG, Brazil; [Prado, Darien] Univ Nacl Rosario, Fac Ciencias Agr, IICAR CONICET, S2125ZAA, Zavalla, Argentina; [Quintana, Catalina] Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas, Escuela Biol, Quito, Ecuador; [Riina, Ricarda] CSIC, RJB, E-28014 Madrid, Spain	Universidad Nacional Autonoma de Mexico; University of Edinburgh; University Nacional Agraria La Molina; Universidade Federal de Minas Gerais; National University of Rosario; Pontificia Universidad Catolica del Ecuador; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Pennington, RT (corresponding author), Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland.	t.pennington@rbge.ac.uk	Quintana, Catalina/AAX-7492-2020; Linares-Palomino, Reynaldo/AAI-1023-2020; Riina, Ricarda/J-1032-2014; Prado, Darien/K-6360-2019; Dexter, Kyle G/D-5589-2018	Linares-Palomino, Reynaldo/0000-0002-7631-5549; Riina, Ricarda/0000-0002-7423-899X; Prado, Darien/0000-0001-5112-7077; Dexter, Kyle G/0000-0001-9232-5221; Quintana, Catalina/0000-0003-4115-1705; Banda, Karina/0000-0001-5789-0110; Pennington, Toby/0000-0002-8196-288X	NERC [NE/I027797/1] Funding Source: UKRI; Natural Environment Research Council [NE/I027797/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		McMichael CNH, 2017, P NATL ACAD SCI USA, V114, P522, DOI 10.1073/pnas.1614577114; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x	2	0	0	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					467	467		10.1126/science.aal2602	http://dx.doi.org/10.1126/science.aal2602			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154044	Green Accepted			2022-12-28	WOS:000393183100028
J	Lucas, D				Lucas, Deirdre			Roshini M Alles OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		LUCAS D, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2017	356								j467	10.1136/bmj.j467	http://dx.doi.org/10.1136/bmj.j467			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BO	28137714				2022-12-28	WOS:000393449600004
J	Lee, S; Hippalgaonkar, K; Yang, F; Hong, JW; Ko, C; Suh, J; Liu, K; Wang, K; Urban, JJ; Zhang, X; Dames, C; Hartnoll, SA; Delaire, O; Wu, JQ				Sangwook, Lee; Hippalgaonkar, Kedar; Yang, Fan; Hong, Jiawang; Ko, Changhyun; Suh, Joonki; Liu, Kai; Wang, Kevin; Urban, Jeffrey J.; Zhang, Xiang; Dames, Chris; Hartnoll, Sean A.; Delaire, Olivier; Wu, Junqiao			Anomalously low electronic thermal conductivity in metallic vanadium dioxide	SCIENCE			English	Article							QUANTUM CRITICAL-POINT; WIEDEMANN-FRANZ LAW; MOTT TRANSITION; VO2; TRANSPORT; DRIVEN; SUPERCONDUCTIVITY; VIOLATION; NANOWIRES; LIQUID	In electrically conductive solids, the Wiedemann-Franz law requires the electronic contribution to thermal conductivity to be proportional to electrical conductivity. Violations of the Wiedemann-Franz law are typically an indication of unconventional quasiparticle dynamics, such as inelastic scattering, or hydrodynamic collective motion of charge carriers, typically pronounced only at cryogenic temperatures. We report an order-of-magnitude breakdown of the Wiedemann-Franz law at high temperatures ranging from 240 to 340 kelvin in metallic vanadium dioxide in the vicinity of its metal-insulator transition. Different from previously established mechanisms, the unusually low electronic thermal conductivity is a signature of the absence of quasiparticles in a strongly correlated electron fluid where heat and charge diffuse independently.	[Sangwook, Lee; Ko, Changhyun; Suh, Joonki; Liu, Kai; Wang, Kevin; Wu, Junqiao] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Hippalgaonkar, Kedar] Kyungpook Natl Univ, Sch Mat Sci & Engn, Daegu 41566, South Korea; [Hippalgaonkar, Kedar; Yang, Fan; Zhang, Xiang; Dames, Chris] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Hippalgaonkar, Kedar] ASTAR, Inst Mat Res & Engn, 2 Fusionopolis Way, Innovis, 08-03, Singapore 138634, Singapore; [Yang, Fan; Urban, Jeffrey J.] Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Hong, Jiawang] Beijing Inst Technol, Sch Aerosp Engn, Beijing 100081, Peoples R China; [Hong, Jiawang] Beijing Inst Technol, Inst Adv Struct Technol, Beijing 100081, Peoples R China; [Hong, Jiawang; Delaire, Olivier] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Liu, Kai; Zhang, Xiang; Dames, Chris; Wu, Junqiao] LBNL Berkeley, Div Mat Sci, Berkeley, CA 94720 USA; [Zhang, Xiang] King Abdulaziz Univ, Dept Phys, Jeddah 21589, Saudi Arabia; [Hartnoll, Sean A.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Delaire, Olivier] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA	University of California System; University of California Berkeley; Kyungpook National University; University of California System; University of California Berkeley; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Materials Research & Engineering (IMRE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Beijing Institute of Technology; Beijing Institute of Technology; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; King Abdulaziz University; Stanford University; Duke University	Wu, JQ (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.; Delaire, O (corresponding author), Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA.; Delaire, O (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA.	olivier.delaire@duke.edu; wuj@berkeley.edu	Zhang, Xiang/F-6905-2011; McCoy, Tina/P-3402-2019; Suh, Joonki/H-6755-2017; Hippalgaonkar, Kedar/K-2196-2015; Hong, Jiawang/B-2864-2009; Ko, Changhyun/E-1686-2011; Yang, Fan/K-1553-2015; Liu, Kai/A-4754-2012; Wu, Junqiao/G-7840-2011; Lee, Sangwook/O-9166-2015; Delaire, Olivier/AAZ-7838-2020; Hippalgaonkar, Kedar/HIK-3095-2022	Suh, Joonki/0000-0002-0221-8447; Hippalgaonkar, Kedar/0000-0002-1270-9047; Hong, Jiawang/0000-0002-9915-8072; Yang, Fan/0000-0002-8461-7790; Liu, Kai/0000-0002-0638-5189; Wu, Junqiao/0000-0002-1498-0148; Delaire, Olivier/0000-0003-1230-2834; Zhang, Xiang/0000-0002-3272-894X	Office of Science, Basic Energy Sciences, U.S. DOE [DE-AC02-05CH11231]; U.S. DOE, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division; Tsinghua-Berkeley Shenzhen Institute; U.S. DOE, Basic Energy Sciences Energy Frontier Research Center (DoE-LMI-EFRC) [DOE DE-AC02-05CH11231]; A*STAR of Singapore [M4070232.120]; Science and Engineering Research Council [152 72 00018]; National Science Foundation of China [11572040]; Thousand Young Talents Program of China; DOE Basic Energy Sciences award [DE-SC0016166]	Office of Science, Basic Energy Sciences, U.S. DOE(United States Department of Energy (DOE)); U.S. DOE, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Tsinghua-Berkeley Shenzhen Institute; U.S. DOE, Basic Energy Sciences Energy Frontier Research Center (DoE-LMI-EFRC)(United States Department of Energy (DOE)); A*STAR of Singapore(Agency for Science Technology & Research (A*STAR)); Science and Engineering Research Council(Agency for Science Technology & Research (A*STAR)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thousand Young Talents Program of China(Chinese Academy of Sciences); DOE Basic Energy Sciences award(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy (DOE) Early Career Award DE-FG02-11ER46796. Parts of this work were performed at the Molecular Foundry, a Lawrence Berkeley National Laboratory user facility supported by the Office of Science, Basic Energy Sciences, U.S. DOE, under contract DE-AC02-05CH11231, and used facilities of the Electronic Materials Program at LBNL supported by the Office of Science, Basic Energy Sciences, U.S. DOE, under contract DE-AC02-05CH11231. O.D. acknowledges funding from the U.S. DOE, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division. C.K. was partially supported by the Tsinghua-Berkeley Shenzhen Institute. K.H. and X.Z. were supported by U.S. DOE, Basic Energy Sciences Energy Frontier Research Center (DoE-LMI-EFRC) under award DOE DE-AC02-05CH11231. K.H. also acknowledges public sector funding from A*STAR of Singapore (M4070232.120) and Pharos Funding from the Science and Engineering Research Council (grant 152 72 00018). J.H. acknowledges support from the National Science Foundation of China (grant 11572040) and the Thousand Young Talents Program of China. Simulation work by J.H. at Oak Ridge National Laboratory was supported by DOE Basic Energy Sciences award DE-SC0016166. Theoretical calculations were performed using resources of the National Supercomputer Center in Guangzhou and the Oak Ridge Leadership Computing Facility. We thank R. Chen, D.F. Ogletree, E. Wong, J. Budai, and A. Said for technical assistance and helpful discussions. J.W. conceived the project; S.L. and J.S. synthesized the materials; S.L., K.H., K.L., and K.W. fabricated the devices; S.L. and K.H. performed the thermal and electrical measurements; C.K. performed Auger electron spectroscopy; F.Y., S.A.H., K.H., C.D., J.J.U., and X.Z. helped with data analysis and theoretical understanding; J.H. and O.D. performed the modeling of thermal conductivity from first-principles phonon dispersions; and all authors contributed to writing the manuscript.	ANDREEV VN, 1978, PHYS STATUS SOLIDI A, V48, pK153, DOI 10.1002/pssa.2210480257; BERGLUND CN, 1969, PHYS REV, V185, P1022, DOI 10.1103/PhysRev.185.1022; Bruin JAN, 2013, SCIENCE, V339, P804, DOI 10.1126/science.1227612; Budai JD, 2014, NATURE, V515, P535, DOI 10.1038/nature13865; Crossno J, 2016, SCIENCE, V351, P1058, DOI 10.1126/science.aad0343; Doiron-Leyraud N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.207001; Dong JK, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.176402; EMERY VJ, 1995, PHYS REV LETT, V74, P3253, DOI 10.1103/PhysRevLett.74.3253; Eyert V, 2002, ANN PHYS-BERLIN, V11, P650, DOI 10.1002/1521-3889(200210)11:9<650::AID-ANDP650>3.0.CO;2-K; Garg A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.096402; Gu Q, 2007, NANO LETT, V7, P363, DOI 10.1021/nl0624768; Guiton BS, 2005, J AM CHEM SOC, V127, P498, DOI 10.1021/ja045976g; Hartnoll SA, 2015, NAT PHYS, V11, P54, DOI [10.1038/NPHYS3174, 10.1038/nphys3174]; Kane CL, 1996, PHYS REV LETT, V76, P3192, DOI 10.1103/PhysRevLett.76.3192; Kim KS, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.156404; Kim P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.215502; Lee S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9573; Lee S, 2013, J AM CHEM SOC, V135, P4850, DOI 10.1021/ja400658u; Machida Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.236402; Mahajan R, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.125107; McCurdy AK, 1970, PHYS REV B-SOLID ST, V2, P4077, DOI 10.1103/PhysRevB.2.4077; Merino J, 2000, PHYS REV B, V61, P7996, DOI 10.1103/PhysRevB.61.7996; Oh DW, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3394016; Palsson G, 1998, PHYS REV LETT, V80, P4775, DOI 10.1103/PhysRevLett.80.4775; Pfau H, 2012, NATURE, V484, P493, DOI 10.1038/nature11072; Qazilbash MM, 2007, SCIENCE, V318, P1750, DOI 10.1126/science.1150124; Qazilbash MM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.205118; Tan XG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00466; Tanatar MA, 2007, SCIENCE, V316, P1320, DOI 10.1126/science.1140762; Wakeham N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1406; Zaanen J, 2004, NATURE, V430, P512, DOI 10.1038/430512a; Zhang Y, 2000, PHYS REV LETT, V84, P2219, DOI 10.1103/PhysRevLett.84.2219	33	226	231	38	490	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					371	+		10.1126/science.aag0410	http://dx.doi.org/10.1126/science.aag0410			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126811	Green Published			2022-12-28	WOS:000393172800032
J	Choueiri, TK; Motzer, RJ				Choueiri, Toni K.; Motzer, Robert J.			Systemic Therapy for Metastatic Renal-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BLIND PHASE-III; INTERFERON-ALPHA; OPEN-LABEL; CYTOREDUCTIVE NEPHRECTOMY; TARGETED THERAPY; BONE METASTASES; EVEROLIMUS; SUNITINIB; BEVACIZUMAB; CANCER	Until recently, there was a dearth of effective systemic therapies for kidney cancer. The incidence of the disease steadily increased from 1975 through 2008 and leveled off after 2008.(1-3) Currently, it is among the 10 most frequently diagnosed cancers in men and women in the United States, with more than an estimated 62,000 new cases in 2016.(4) The prognosis has historically been poor, with current 5-year survival rates of 74% overall, decreasing to 53% among patients with locoregional (stage III) disease and 8% among patients with metastatic disease. 1,3 Kidney cancer is a disease of the middle-aged and elderly: 91% of patients receive a diagnosis at 45 years of age or older, and 48% receive a diagnosis at 65 years of age or older. (1) Renal-cell carcinoma, the most common form of kidney cancer, occurs in 90% of cases and is nearly twice as common in men as in women. (3) The 5-year survival rate among patients with kidney cancer increased from 57% in 1987-1989 to 74% in 2006-2012(1); this increase was attributable in part to a higher proportion of indolent and low-stage tumors identified using improved early-detection techniques. (5) Still, one third of patients with kidney cancer present with regional or distant metastases, (1) and of patients with localized renal-cell carcinoma treated with nephrectomy with curative intent, approximately one quarter have relapses in distant sites. (6-8) Distant metastases occur most often in the lungs, lymph nodes, liver, bone, and brain. (9) Although more than 14,000 patients die from kidney cancer each year,(4) we have seen considerable progress in the systemic treatment of metastatic renal-cell carcinoma in the past 20 years.(10) Researchers have achieved a better understanding of the pathogenesis of the most common type of renal-cell carcinoma, clear-cell renal-cell carcinoma. This understanding has led to new agents, expanded treatment options, and increased rates of survival.	[Choueiri, Toni K.] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA; [Motzer, Robert J.] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, 1275 York Ave, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center	Choueiri, TK (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA.; Motzer, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	toni_choueiri@dfci.harvard.edu; motzerr@mskcc.org	Choueiri, Toni/K-5238-2019	Choueiri, Toni/0000-0002-9201-3217	Pfizer; Exelixis; Novartis; Merck; Bristol-Myers Squibb; Roche; AstraZeneca; Bayer; Eisai; Peloton Therapeutics; Prometheus Laboratories; Foundation Medicine; Calithera; Cerulean Pharma	Pfizer(Pfizer); Exelixis; Novartis(Novartis); Merck(Merck & Company); Bristol-Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); AstraZeneca(AstraZeneca); Bayer(Bayer AG); Eisai(Eisai Co Ltd); Peloton Therapeutics; Prometheus Laboratories; Foundation Medicine; Calithera; Cerulean Pharma(Dexcel Pharma)	Dr. Choueiri reports receiving fees for consulting and serving on advisory boards from Pfizer, Exelixis, Novartis, Merck, Bristol-Myers Squibb, Roche, AstraZeneca, Bayer, Eisai, Peloton Therapeutics, Prometheus Laboratories, Foundation Medicine, Calithera, and Cerulean Pharma and clinical-trial support to his hospital from Exelixis, TRACON Pharmaceuticals, GlaxoSmithKline, Peloton Therapeutics, Celldex Therapeutics, Pfizer, Novartis, Merck, Bristol-Myers Squibb, Roche, Agensys, and AstraZeneca; and Dr. Motzer, receiving consulting fees from Pfizer, Exelixis, Eisai, Novartis, Pharmacyclics, and Acceleron Pharma and clinical-trial support to his hospital from Pfizer, Eisai, Novartis, Bristol-Myers Squibb, Genentech/Roche, and GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.	Allard CB, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2015.06.014; Armstrong AJ, 2016, LANCET ONCOL, V17, P378, DOI 10.1016/S1470-2045(15)00515-X; Calderaro J, 2012, HISTOPATHOLOGY, V61, P428, DOI 10.1111/j.1365-2559.2012.04228.x; Cella D, 2016, LANCET ONCOL, V17, P994, DOI 10.1016/S1470-2045(16)30125-5; Choueiri TK, 2015, NEW ENGL J MED, V373, P1814, DOI 10.1056/NEJMoa1510016; Choueiri TK, 2014, ANN ONCOL, V25, P2178, DOI 10.1093/annonc/mdu445; Choueiri TK, 2016, CLIN CANC RES; Choueiri TK, 2016, J CLIN ONCOL; Choueiri TK, 2016, LANCET ONCOL, V17, P917, DOI 10.1016/S1470-2045(16)30107-3; Choueiri TK, 2015, CLIN CANCER RES, V21, P1071, DOI 10.1158/1078-0432.CCR-14-1993; Choueiri TK, 2013, J CLIN ONCOL, V31, P181, DOI 10.1200/JCO.2012.43.3383; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dabestani S, 2016, WORLD J UROL, V34, P1081, DOI 10.1007/s00345-016-1773-y; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; Di Napoli A, 2009, CANCER-AM CANCER SOC, V115, P2290, DOI 10.1002/cncr.24233; Diamond E, 2015, CRIT REV ONCOL HEMAT, V96, P518, DOI 10.1016/j.critrevonc.2015.08.007; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Escudier B, 2010, J CLIN ONCOL, V28, P2144, DOI 10.1200/JCO.2009.26.7849; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gill IS, 2010, NEW ENGL J MED, V362, P624, DOI 10.1056/NEJMcp0910041; Haas NB, 2012, MED ONCOL, V29, P761, DOI 10.1007/s12032-011-9829-8; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Hanna N, 2016, J CLIN ONCOL, V34, P3267, DOI 10.1200/JCO.2016.66.7931; Harshman LC, 2014, CANCER IMMUNOL RES, V2, P1132, DOI 10.1158/2326-6066.CIR-14-0193; Heng DYC, 2014, EUR UROL, V66, P704, DOI 10.1016/j.eururo.2014.05.034; Heng DYC, 2013, LANCET ONCOL, V14, P141, DOI 10.1016/S1470-2045(12)70559-4; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Heng DYC, 2009, J NATL COMPR CANC NE, V7, P659, DOI 10.6004/jnccn.2009.0046; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jonasch E, 2011, BJU INT, V107, P741, DOI 10.1111/j.1464-410X.2010.09626.x; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kavolius JP, 1998, J CLIN ONCOL, V16, P2261, DOI 10.1200/JCO.1998.16.6.2261; Klapper JA, 2008, CANCER-AM CANCER SOC, V113, P293, DOI 10.1002/cncr.23552; Kwiatkowski DJ, 2016, CLIN CANCER RES, V22, P2445, DOI 10.1158/1078-0432.CCR-15-2631; Kwiatkowski DJ, 2014, NEW ENGL J MED, V371, P778, DOI 10.1056/NEJMcibr1406613; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917; Lipton A, 2004, CLIN CANCER RES, V10, p6397S, DOI 10.1158/1078-0432.CCR-040030; Malouf GG, 2013, CLIN CANCER RES, V19, P4673, DOI 10.1158/1078-0432.CCR-12-3825; McDermott DF, 2015, CLIN CANCER RES, V21, P561, DOI 10.1158/1078-0432.CCR-14-1520; McKay RR, 2014, EUR UROL, V66, P502, DOI 10.1016/j.eururo.2014.02.040; Mckay RR, 2014, EUR UROL, V65, P577, DOI 10.1016/j.eururo.2013.08.012; Michaelson MD, 2015, CANCER-AM CANCER SOC, V121, P3435, DOI 10.1002/cncr.29503; Mickisch GHJ, 2001, LANCET, V358, P966, DOI 10.1016/S0140-6736(01)06103-7; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2016, LANCET ONCOL, V17, pE4, DOI 10.1016/S1470-2045(15)00543-4; Motzer RJ, 2015, LANCET ONCOL, V16, P1473, DOI 10.1016/S1470-2045(15)00290-9; Motzer RJ, 2015, J CLIN ONCOL, V33, P1430, DOI 10.1200/JCO.2014.59.0703; Motzer RJ, 2014, J CLIN ONCOL, V32, P2766, DOI 10.1200/JCO.2013.54.6911; Motzer RJ, 2014, NEW ENGL J MED, V370, P1769, DOI 10.1056/NEJMc1400731; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Nanus DM, 2004, CANCER-AM CANCER SOC, V101, P1545, DOI 10.1002/cncr.20541; National Cancer Institute, SURV EP END RES PROG; National Comprehensive Cancer Network, 2017, NCCN CLIN PRACT GUID; Negrier S, 2011, LANCET ONCOL, V12, P673, DOI 10.1016/S1470-2045(11)70124-3; Oudard S, 2007, J UROLOGY, V177, P1698, DOI 10.1016/j.juro.2007.01.063; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; RABINOVITCH RA, 1994, J CLIN ONCOL, V12, P206, DOI 10.1200/JCO.1994.12.1.206; Ravaud A, 2015, ANN ONCOL, V26, P1378, DOI 10.1093/annonc/mdv170; Rini BI, 2014, J CLIN ONCOL, V32, P752, DOI 10.1200/JCO.2013.50.5305; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Rini BI, 2010, J CLIN ONCOL, V28, P2137, DOI 10.1200/JCO.2009.26.5561; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Rosenblatt J, 2011, HEMATOL ONCOL CLIN N, V25, P793, DOI 10.1016/j.hoc.2011.04.010; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; SANDOCK DS, 1995, J UROLOGY, V154, P28, DOI 10.1016/S0022-5347(01)67215-X; Sankin A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00067; Shaikh T, 2015, UROLOGY, V86, P1165, DOI 10.1016/j.urology.2015.08.012; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sonpavde G, 2012, BRIT J CANCER, V107, P1009, DOI 10.1038/bjc.2012.399; Srigley JR, 2013, AM J SURG PATHOL, V37, P1469, DOI 10.1097/PAS.0b013e318299f2d1; Sternberg CN, 2013, EUR J CANCER, V49, P1287, DOI 10.1016/j.ejca.2012.12.010; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Straka C, 2013, J CLIN ONCOL, V31, pE401, DOI 10.1200/JCO.2012.47.7455; Surveillance Epidemiology and End Results Program, 2016, SURV EP RES PROGR SE; Tannir NM, 2016, EUR UROL, V69, P866, DOI 10.1016/j.eururo.2015.10.049; Thompson RH, 2007, CLIN CANCER RES, V13, P1757, DOI 10.1158/1078-0432.CCR-06-2599; Valenca LB, 2015, CLIN ADV HEMATOL ONC, V13, P383; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vera-Badillo FE, 2015, EUR UROL, V67, P740, DOI 10.1016/j.eururo.2014.05.010; Voss MH, 2014, CLIN CANCER RES, V20, P1955, DOI 10.1158/1078-0432.CCR-13-2345; Wang JM, 2016, ONCOTARGET, V7, P29901, DOI 10.18632/oncotarget.9093; Wyeth Pharmaceuticals, 2016, PRESCR INF TOR TEMS; Zhou L, 2016, ONCOGENE, V35, P2687, DOI 10.1038/onc.2015.343	95	680	695	6	107	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2017	376	4					354	366		10.1056/NEJMra1601333	http://dx.doi.org/10.1056/NEJMra1601333			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ3KR	28121507				2022-12-28	WOS:000393111600010
J	Chronis, C; Fiziev, P; Papp, B; Butz, S; Bonora, G; Sabri, S; Ernst, J; Plath, K				Chronis, Constantinos; Fiziev, Petko; Papp, Bernadett; Butz, Stefan; Bonora, Giancarlo; Sabri, Shan; Ernst, Jason; Plath, Kathrin			Cooperative Binding of Transcription Factors Orchestrates Reprogramming	CELL			English	Article							CHROMATIN; NETWORK; INTEGRATION; EFFICIENT; REVEAL; STATE; PLURIPOTENCY; ENHANCERS; ALIGNMENT; DYNAMICS	Oct4, Sox2, Klf4, and cMyc (OSKM) reprogram somatic cells to pluripotency. To gain a mechanistic understanding of their function, we mapped OSKM-binding, stage-specific transcription factors (TFs), and chromatin states in discrete reprogramming stages and performed loss-and gain-of-function experiments. We found that OSK predominantly bind active somatic enhancers early in reprogramming and immediately initiate their inactivation genome-wide by inducing the redistribution of somatic TFs away from somatic enhancers to sites elsewhere engaged by OSK, recruiting Hdac1, and repressing the somatic TF Fra1. Pluripotency enhancer selection is a stepwise process that also begins early in reprogramming through collaborative binding of OSK at sites with high OSK-motif density. Most pluripotency enhancers are selected later in the process and require OS and other pluripotency TFs. Somatic and pluripotency TFs modulate reprogramming efficiency when overexpressed by altering OSK targeting, somatic-enhancer inactivation, and pluripotency enhancer selection. Together, our data indicate that collaborative interactions among OSK and with stage-specific TFs direct both somatic-enhancer inactivation and pluripotency-enhancer selection to drive reprogramming.	[Chronis, Constantinos; Fiziev, Petko; Papp, Bernadett; Butz, Stefan; Bonora, Giancarlo; Sabri, Shan; Ernst, Jason; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Chronis, Constantinos; Fiziev, Petko; Papp, Bernadett; Butz, Stefan; Bonora, Giancarlo; Sabri, Shan; Ernst, Jason; Plath, Kathrin] Jonsson Comprehens Canc Ctr, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Bioinformat Program, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center	Ernst, J; Plath, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.; Ernst, J; Plath, K (corresponding author), Jonsson Comprehens Canc Ctr, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Bioinformat Program, Los Angeles, CA 90095 USA.	jason.ernst@ucla.edu; kplath@mednet.ucla.edu		Plath, Kathrin/0000-0001-7796-3372; Butz, Stefan/0000-0002-1545-8175; chronis, Constantinos/0000-0002-7783-8202	Leukemia and Lymphoma Research [10040]; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research (BSCRC) at UCLA; UCLA; NIH [R01ES024995, U01HG007912, P01-GM099134]; NSF [1254200]; Sloan Fellowship; BSCRC; David Geffen School of Medicine; Jonnson Comprehensive Cancer Center at UCLA, CIRM; CIRM [TG2-01169]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134] Funding Source: NIH RePORTER	Leukemia and Lymphoma Research; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research (BSCRC) at UCLA; UCLA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Sloan Fellowship(Alfred P. Sloan Foundation); BSCRC; David Geffen School of Medicine(University of California System); Jonnson Comprehensive Cancer Center at UCLA, CIRM; CIRM(California Institute for Regenerative Medicine); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to N.S.B. Thomas, K. Zaret, S. Smale, M. Pellegrini, S. Kurdistani, N. Davidson, W. Lowry, and K.P.'s lab for discussions and reading of the manuscript. C.C. was supported by CIRM (TG2-01169) and Leukemia and Lymphoma Research (#10040) fellowships; P.F. by CIRM (TG2-01169) and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research (BSCRC) at UCLA; G.B. by Whitcome, Dissertation Year and QCB fellowships from UCLA; J.E. by NIH (R01ES024995; U01HG007912), NSF (CAREER Award 1254200), and a Sloan Fellowship; and K.P. by the BSCRC, David Geffen School of Medicine, and Jonnson Comprehensive Cancer Center at UCLA, CIRM, and NIH (P01-GM099134).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buganim Y, 2014, CELL STEM CELL, V15, P295, DOI 10.1016/j.stem.2014.07.003; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Chen J, 2016, CELL REP, V14, P1540, DOI 10.1016/j.celrep.2016.01.013; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho R, 2013, CELL REP, V3, P2113, DOI 10.1016/j.celrep.2013.05.015; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu J, 2015, NAT CELL BIOL, V17, P856, DOI 10.1038/ncb3193; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pasque V, 2014, CELL, V159, P1681, DOI 10.1016/j.cell.2014.11.040; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Wagschal A, 2007, CSH PROTOC; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	47	264	272	5	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					442	+		10.1016/j.cell.2016.12.016	http://dx.doi.org/10.1016/j.cell.2016.12.016			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28111071	Green Accepted, Bronze			2022-12-28	WOS:000396249600013
J	Aaron, SD; Vandemheen, KL; FitzGerald, JM; Ainslie, M; Gupta, S; Lemiere, C; Field, SK; McIvor, RA; Hernandez, P; Mayers, I; Mulpuru, S; Alvarez, GG; Pakhale, S; Mallick, R; Boulet, LP				Aaron, Shawn D.; Vandemheen, Katherine L.; FitzGerald, J. Mark; Ainslie, Martha; Gupta, Samir; Lemiere, Catherine; Field, Stephen K.; McIvor, R. Andrew; Hernandez, Paul; Mayers, Irvin; Mulpuru, Sunita; Alvarez, Gonzalo G.; Pakhale, Smita; Mallick, Ranjeeta; Boulet, Louis-Philippe		Canadian Resp Res Network	Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY-CARE; OVERDIAGNOSIS; PREVALENCE; MANAGEMENT; CHILDREN; ILLNESS; COST	IMPORTANCE Although asthma is a chronic disease, the expected rate of spontaneous remissions of adult asthma and the stability of diagnosis are unknown. OBJECTIVE To determine whether a diagnosis of current asthma could be ruled out and asthma medications safely stopped in randomly selected adults with physician-diagnosed asthma. DESIGN, SETTING, AND PARTICIPANTS A prospective, multicenter cohort study was conducted in 10 Canadian cities from January 2012 to February 2016. Random digit dialing was used to recruit adult participants who reported a history of physician-diagnosed asthma established within the past 5 years. Participants using long-term oral steroids and participants unable to be tested using spirometry were excluded. Information from the diagnosing physician was obtained to determine how the diagnosis of asthma was originally made in the community. Of 1026 potential participants who fulfilled eligibility criteria during telephone screening, 701 (68.3%) agreed to enter into the study. All participants were assessed with home peak flow and symptom monitoring, spirometry, and serial bronchial challenge tests, and those participants using daily asthma medications had their medications gradually tapered off over 4 study visits. Participants in whom a diagnosis of current asthma was ultimately ruled out were followed up clinically with repeated bronchial challenge tests over 1 year. EXPOSURE Physician-diagnosed asthma established within the past 5 years. MAIN OUTCOMES AND MEASURES The primary outcomewas the proportion of participants in whom a diagnosis of current asthma was ruled out, defined as participants who exhibited no evidence of acute worsening of asthma symptoms, reversible airflow obstruction, or bronchial hyperresponsiveness after having all asthma medications tapered off and after a study pulmonologist established an alternative diagnosis. Secondary outcomes included the proportion with asthma ruled out after 12 months and the proportion who underwent an appropriate initial diagnostic workup for asthma in the community. RESULTS Of 701 participants (mean [SD] age, 51 [16] years; 467 women [67%]), 613 completed the study and could be conclusively evaluated for a diagnosis of current asthma. Current asthma was ruled out in 203 of 613 study participants (33.1%; 95% CI, 29.4%-36.8%). Twelve participants (2.0%) were found to have serious cardiorespiratory conditions that had been previously misdiagnosed as asthma in the community. After an additional 12 months of follow-up, 181 participants (29.5%; 95% CI, 25.9%-33.1%) continued to exhibit no clinical or laboratory evidence of asthma. Participants in whom current asthma was ruled out, compared with those in whom it was confirmed, were less likely to have undergone testing for airflow limitation in the community at the time of initial diagnosis (43.8% vs 55.6%, respectively; absolute difference, 11.8%; 95% CI, 2.1%-21.5%). CONCLUSIONS AND RELEVANCE Among adults with physician-diagnosed asthma, a current diagnosis of asthma could not be established in 33.1% who were not using daily asthma medications or had medications weaned. In patients such as these, reassessing the asthma diagnosis may be warranted.	[Aaron, Shawn D.; Vandemheen, Katherine L.; Mulpuru, Sunita; Alvarez, Gonzalo G.; Pakhale, Smita; Mallick, Ranjeeta] Univ Ottawa, Ottawa Hosp, Res Inst, 501 Smyth Rd,Gen Campus, Ottawa, ON K1H 8L6, Canada; [FitzGerald, J. Mark] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Ainslie, Martha] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Gupta, Samir] Univ Toronto, Dept Med, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Lemiere, Catherine] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Field, Stephen K.] Univ Calgary, Dept Med, Calgary, AB, Canada; [McIvor, R. Andrew] McMaster Univ, Firestone Inst Resp Hlth, Hamilton, ON, Canada; [Hernandez, Paul] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Mayers, Irvin] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Boulet, Louis-Philippe] Univ Laval, Hop Laval, Ctr Rech, Quebec City, PQ, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of British Columbia; University of Manitoba; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Universite de Montreal; University of Calgary; McMaster University; Dalhousie University; University of Alberta; Laval University	Aaron, SD (corresponding author), Univ Ottawa, Ottawa Hosp, Res Inst, 501 Smyth Rd,Gen Campus, Ottawa, ON K1H 8L6, Canada.	saaron@ohri.ca		Pakhale, Smita/0000-0002-4051-962X; Alvarez, Gonzalo G/0000-0003-1562-5305	Canadian Institutes of Health Research [MOP-115073]; Methapharm Inc; Trudell Medical International Inc	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Methapharm Inc; Trudell Medical International Inc	Funding/Support: This work was supported by grant MOP-115073 from the Canadian Institutes of Health Research. Methapharm Inc supplied provocholine; Trudell Medical International Inc supplied peak flow meters; and ASDE Survey Sampler Inc organized the random digit dialing.	Aaron SD, 2008, CAN MED ASSOC J, V179, P1121, DOI 10.1503/cmaj.081332; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Burney P, 1996, EUR RESPIR J, V9, P687; Bush A, 2016, ARCH DIS CHILD, V101, P688, DOI 10.1136/archdischild-2015-309053; California Department of Corrections and Rehabilitation, 2007, EXP PAN REP EXP PAN; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Drazen JM, 2009, NEW ENGL J MED, V360, P1671, DOI 10.1056/NEJMe0902057; Gershon AS, 2012, CHEST, V141, P1190, DOI 10.1378/chest.11-0831; Global Initiative for Asthma, 2016, GLOB STRAT ASTHM MAN; Heffler E, 2015, J ASTHMA, V52, P931, DOI 10.3109/02770903.2015.1026442; Horne R, 2002, PSYCHOL HEALTH, V17, P17, DOI 10.1080/08870440290001502; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; Looijmans-van den Akker I, 2016, BRIT J GEN PRACT, V66, pE152, DOI 10.3399/bjgp16X683965; Lougheed MD, 2012, CAN RESPIR J, V19, P127, DOI 10.1155/2012/635624; Lucas AEM, 2008, FAM PRACT, V25, P86, DOI 10.1093/fampra/cmn006; Luks VP, 2010, EUR RESPIR J, V36, P255, DOI 10.1183/09031936.00165109; Lynch BA, 2010, ALLERGY ASTHMA PROC, V31, pE48, DOI 10.2500/aap.2010.31.3358; McGlynn EA, 2015, JAMA-J AM MED ASSOC, V314, P2501, DOI 10.1001/jama.2015.13453; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Pakhale S, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-27; Reddel HK, 2015, EUR RESPIR J, V46, P622, DOI 10.1183/13993003.00853-2015; Schneider Antonius, 2009, BMC Pulm Med, V9, P31, DOI 10.1186/1471-2466-9-31; Weiss KB, 2000, J ALLERGY CLIN IMMUN, V106, P493, DOI 10.1067/mai.2000.109426; Yurdakul AS, 2005, J ASTHMA, V42, P843, DOI 10.1080/02770900500370981	24	247	253	1	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					269	279		10.1001/jama.2016.19627	http://dx.doi.org/10.1001/jama.2016.19627			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114551	Bronze			2022-12-28	WOS:000392089200014
J	Raith, EP; Udy, AA; Bailey, M; McGloughlin, S; MacIsaac, C; Bellomo, R; Pilcher, DV				Raith, Eamon P.; Udy, Andrew A.; Bailey, Michael; McGloughlin, Steven; MacIsaac, Christopher; Bellomo, Rinaldo; Pilcher, David V.		ANZICS; CORE	Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; SEPTIC SHOCK SEPSIS-3; ORGAN FAILURE; CLINICAL-CRITERIA; ANZROD MODEL; NEW-ZEALAND; PREDICTION; AUSTRALIA; RISK	IMPORTANCE The Sepsis-3 Criteria emphasized the value of a change of 2 or more points in the Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score, introduced quick SOFA (qSOFA), and removed the systemic inflammatory response syndrome (SIRS) criteria from the sepsis definition. OBJECTIVE Externally validate and assess the discriminatory capacities of an increase in SOFA score by 2 or more points, 2 or more SIRS criteria, or a qSOFA score of 2 or more points for outcomes among patients who are critically ill with suspected infection. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort analysis of 184 875 patients with an infection-related primary admission diagnosis in 182 Australian and New Zealand intensive care units (ICUs) from 2000 through 2015. EXPOSURES SOFA, qSOFA, and SIRS criteria applied to data collected within 24 hours of ICU admission. MAIN OUTCOMES AND MEASURES The primary outcomewas in-hospital mortality. In-hospital mortality or ICU length of stay (LOS) of 3 days or more was a composite secondary outcome. Discrimination was assessed using the area under the receiver operating characteristic curve (AUROC). Adjusted analyses were performed using a model of baseline risk determined using variables independent of the scoring systems. RESULTS Among 184 875 patients (mean age, 62.9 years [SD, 17.4]; women, 82 540 [44.6%]; most common diagnosis bacterial pneumonia, 32 634 [17.7%]), a total of 34 578 patients (18.7%) died in the hospital, and 102 976 patients (55.7%) died or experienced an ICU LOS of 3 days or more. SOFA score increased by 2 or more points in 90.1%; 86.7% manifested 2 or more SIRS criteria, and 54.4% had a qSOFA score of 2 or more points. SOFA demonstrated significantly greater discrimination for in-hospital mortality than SIRS criteria or qSOFA. SOFA also outperformed the other scores for the secondary end point. Findings were consistent for both outcomes in multiple sensitivity analyses. [GRAPHICS] CONCLUSIONS AND RELEVANCE Among adults with suspected infection admitted to an ICU, an increase in SOFA score of 2 or more had greater prognostic accuracy for in-hospital mortality than SIRS criteria or the qSOFA score. These findings suggest that SIRS criteria and qSOFA may have limited utility for predicting mortality in an ICU setting.	[Raith, Eamon P.; Udy, Andrew A.; McGloughlin, Steven; Pilcher, David V.] Alfred Hosp, Dept Intens Care & Hyperbar Med, Commercial Rd, Melbourne, Vic 3181, Australia; [Raith, Eamon P.] Univ Adelaide, Discipline Surg, Sch Med, Adelaide, SA, Australia; [Udy, Andrew A.; Bailey, Michael; Bellomo, Rinaldo; Pilcher, David V.] Monash Univ, Sch Publ Hlth & Prevent Med, Alfred Hosp, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia; [McGloughlin, Steven] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [MacIsaac, Christopher; Bellomo, Rinaldo] Royal Melbourne Hosp, Dept Intens Care, Melbourne, Vic, Australia; [MacIsaac, Christopher; Bellomo, Rinaldo] Univ Melbourne, Melbourne, Vic, Australia; [Bellomo, Rinaldo] Austin Hosp, Intens Care Unit, Melbourne, Vic, Australia; [Pilcher, David V.] Australian & New Zealand Intens Care Soc, Ctr Outcome & Resource Evaluat, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; University of Adelaide; Florey Institute of Neuroscience & Mental Health; Monash University; Florey Institute of Neuroscience & Mental Health; Royal Melbourne Hospital; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Pilcher, DV (corresponding author), Alfred Hosp, Dept Intens Care & Hyperbar Med, Commercial Rd, Melbourne, Vic 3181, Australia.	d.pilcher@alfred.org.au	Udy, Andrew/S-1314-2016; Bailey, Michael J/A-4499-2012	Udy, Andrew/0000-0002-6284-2022; Bailey, Michael J/0000-0002-5551-1401; Raith, Eamon/0000-0001-7060-2283; Pilcher, David/0000-0002-8939-7985; Bellomo, Rinaldo/0000-0002-1650-8939	Monash University; Alfred ICU Monash University; National Health and Medical Research Council of Australia; School of Public Health, Monash University; Monash University as an Alfred ICU Monash University; Monash University; Alfred ICU Monash University; National Health and Medical Research Council of Australia; School of Public Health, Monash University; Monash University as an Alfred ICU Monash University	Monash University(Monash University); Alfred ICU Monash University; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); School of Public Health, Monash University; Monash University as an Alfred ICU Monash University; Monash University(Monash University); Alfred ICU Monash University; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); School of Public Health, Monash University; Monash University as an Alfred ICU Monash University	Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Udy receives salary support from Monash University as an Alfred ICU Monash University practitioner fellow and receives support from the National Health and Medical Research Council of Australia (Early Career Fellowship). Dr Bailey receives salary support from the School of Public Health, Monash University. Dr Pilcher receives salary support from Monash University as an Alfred ICU Monash University practitioner fellow.	Albur M, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0139-z; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Castegren M, 2015, CRIT CARE RESUSC, V17, P174; Davis JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112224; Duke GJ, 2013, CRIT CARE RESUSC, V15, P191; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jung B, 2016, INTENS CARE MED, V42, P494, DOI 10.1007/s00134-016-4254-2; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Ou LX, 2016, CRIT CARE RESUSC, V18, P9; Paul E, 2016, CRIT CARE RESUSC, V18, P25; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Pilcher D, 2014, CRIT CARE RESUSC, V16, P3; Rivera-Fernandez R, 2007, J CRIT CARE, V22, P120, DOI 10.1016/j.jcrc.2006.09.005; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156	21	572	613	3	54	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					290	300		10.1001/jama.2016.20328	http://dx.doi.org/10.1001/jama.2016.20328			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114553				2022-12-28	WOS:000392089200016
J	De Backer, D; Dorman, T				De Backer, Daniel; Dorman, Todd			Surviving Sepsis Guidelines A Continuous Move Toward Better Care of Patients With Sepsis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTENSIVE-CARE		[De Backer, Daniel] Univ Libre Bruxelles, CHIREC Hosp, Dept Intens Care, Brussels, Belgium; [Dorman, Todd] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Universite Libre de Bruxelles; Johns Hopkins University	Dorman, T (corresponding author), Johns Hopkins Univ Hosp, Dept Anesthesiol, Crit Care Med, Turner 17,720 Rutland Ave, Baltimore, MD 21205 USA.	tdorman@jhmi.edu	De Backer, Daniel/AAF-4177-2020	De Backer, Daniel/0000-0001-9841-5762; dorman, todd/0000-0002-8616-8677				Angus DC, 2015, INTENS CARE MED, V41, P1549, DOI 10.1007/s00134-015-3822-1; Cecconi M, 2015, INTENS CARE MED, V41, P1529, DOI 10.1007/s00134-015-3850-x; Howell MD, 2017, JAMA-J AM MED ASSOC, V317, P847, DOI 10.1001/jama.2017.0131; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Levy MM, 2015, CRIT CARE MED, V43, P3, DOI [10.1097/CCM.0000000000000723, 10.1007/s00134-014-3496-0]; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rhodes A, 2015, INTENS CARE MED, V41, P1620, DOI 10.1007/s00134-015-3906-y; Roberts JA, 2014, CLIN INFECT DIS, V58, P1072, DOI 10.1093/cid/ciu027	9	54	55	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					807	808		10.1001/jama.2017.0059	http://dx.doi.org/10.1001/jama.2017.0059			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28114630				2022-12-28	WOS:000395505600015
J	Hofman, JM; Sharma, A; Watts, DJ				Hofman, Jake M.; Sharma, Amit; Watts, Duncan J.			Prediction and explanation in social systems	SCIENCE			English	Editorial Material							SCIENCE	Historically, social scientists have sought out explanations of human and social phenomena that provide interpretable causal mechanisms, while often ignoring their predictive accuracy. We argue that the increasingly computational nature of social science is beginning to reverse this traditional bias against prediction; however, it has also highlighted three important issues that require resolution. First, current practices for evaluating predictions must be better standardized. Second, theoretical limits to predictive accuracy in complex social systems must be better characterized, thereby setting expectations for what can be predicted or explained. Third, predictive accuracy and interpretability must be recognized as complements, not substitutes, when evaluating explanations. Resolving these three issues will lead to better, more replicable, and more useful social science.	[Hofman, Jake M.; Sharma, Amit; Watts, Duncan J.] Microsoft Res, 641 Ave Amer,7th Floor, New York, NY 10003 USA	Microsoft	Hofman, JM; Sharma, A; Watts, DJ (corresponding author), Microsoft Res, 641 Ave Amer,7th Floor, New York, NY 10003 USA.	jmh@microsoft.com; amshar@microsoft.com; duncan@microsoft.com						[Anonymous], 2015, SCIENCE, V349; Bakshy Eytan, 2011, P INT C WEB SEARCH D, P65, DOI [10.1145/1935826.1935845, DOI 10.1145/1935826.1935845]; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Cheng J, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P925, DOI 10.1145/2566486.2567997; Gelman A, 2014, AM SCI, V102, P460, DOI 10.1511/2014.111.460; Gigerenzer G., 2004, J SOCIO-ECON, V33, P587, DOI DOI 10.1016/J.SOCEC.2004.09.033; Jenders M, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P657; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Liberman M, 2010, COMPUT LINGUIST, V36, P595, DOI 10.1162/coli_a_00032; Martin T, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16), P683, DOI 10.1145/2872427.2883001; Ribeiro MT, 2016, P 22 ACM SIGKDD INT; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Schapire RE, 2003, LECT NOTES STAT, V171, P149, DOI 10.1007/978-0-387-21579-2_9; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Taleb N.N., 2010, BLACK SWAN IMPACT HI, DOI DOI 10.1176/PS.2009.60.11.1564; Watts D. J., 2011, EVERYTHING IS OBVIOU; Watts DJ, 2014, AM J SOCIOL, V120, P313, DOI 10.1086/678271	20	172	177	8	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					486	488		10.1126/science.aal3856	http://dx.doi.org/10.1126/science.aal3856			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154051				2022-12-28	WOS:000393183100035
J	Popkin, G				Popkin, Gabriel			FIRST TRIP TO THE STARS	NATURE			English	Editorial Material																		Anglada-Escude G, 2016, NATURE, V536, P437, DOI 10.1038/nature19106; LUBIN P., 2016, JBIS-J BRIT INTERPLA, V69, P40	2	13	13	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					20	22		10.1038/542020a	http://dx.doi.org/10.1038/542020a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6MY	28150784	Bronze			2022-12-28	WOS:000396119300011
J	Perry, A				Perry, Andrew			Charles Lyn Perry OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		PERRY A, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2017	356								j498	10.1136/bmj.j498	http://dx.doi.org/10.1136/bmj.j498			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BO	28137925				2022-12-28	WOS:000393449600010
J	Kaiser, J				Kaiser, Jocelyn			US POLICY Regulators drop controversial biospecimen consent proposal Researchers had pushed against Common Rule provision	SCIENCE			English	News Item																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					335	335		10.1126/science.355.6323.335	http://dx.doi.org/10.1126/science.355.6323.335			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126763				2022-12-28	WOS:000393172800012
J	McCook, A				McCook, Alison			OUT OF BOUNDS How a dispute at Harvard led to a grad student's forced mental exam and an extraordinary restraining order against a prominent scientist	SCIENCE			English	Editorial Material									[McCook, Alison] Retract Watch, Philadelphia, PA 19111 USA		McCook, A (corresponding author), Retract Watch, Philadelphia, PA 19111 USA.								0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					339	341		10.1126/science.355.6323.339	http://dx.doi.org/10.1126/science.355.6323.339			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4FR	28126767				2022-12-28	WOS:000393172800016
J	Fischer-Godde, M; Kleine, T				Fischer-Goedde, Mario; Kleine, Thorsten			Ruthenium isotopic evidence for an inner Solar System origin of the late veneer	NATURE			English	Article							PRIMITIVE UPPER-MANTLE; TERRESTRIAL PLANETS; OSMIUM ISOTOPE; CORE FORMATION; S-PROCESS; SIDEROPHILE ELEMENTS; PROTOPLANETARY DISK; EARTHS MANTLE; GIANT IMPACT; MOON	The excess of highly siderophile elements in the Earth's mantle is thought to reflect the addition of primitive meteoritic material after core formation ceased(1-4). This 'late veneer' either comprises material remaining in the terrestrial planet region after the main stages of the Earth's accretion(5,6), or derives from more distant asteroidal(7) or cometary(8) sources. Distinguishing between these disparate origins is important because a late veneer consisting of carbonaceous chondrite-like asteroids(7) or comets(8) could be the principal source of the Earth's volatiles and water. Until now, however, a 'genetic' link between the late veneer and such volatile-rich materials has not been established or ruled out. Such genetic links can be determined using ruthenium (Ru) isotopes, because the Ru in the Earth's mantle predominantly derives from the late veneer(9), and because meteorites exhibit Ru isotope variations arising from the heterogeneous distribution of stellar-derived dust(10,11). Although Ru isotopic data and the correlation of Ru and molybdenum (Mo) isotope anomalies in meteorites were previously used to argue that the late veneer derives from the same type of inner Solar System material as do Earth's main building blocks(6), the Ru isotopic composition of carbonaceous chondrites has not been determined sufficiently well to rule them out as a source of the late veneer. Here we show that all chondrites, including carbonaceous chondrites, have Ru isotopic compositions distinct from that of the Earth's mantle. The Ru isotope anomalies increase from enstatite to ordinary to carbonaceous chondrites, demonstrating that material formed at greater heliocentric distance contains larger Ru isotope anomalies. Therefore, these data refute an outer Solar System origin for the late veneer and imply that the late veneer was not the primary source of volatiles and water on the Earth.	[Fischer-Goedde, Mario; Kleine, Thorsten] Univ Munster, Inst Planetol, Wilhelm Klemm Str 10, D-48149 Munster, Germany	University of Munster	Fischer-Godde, M; Kleine, T (corresponding author), Univ Munster, Inst Planetol, Wilhelm Klemm Str 10, D-48149 Munster, Germany.	m.fischer-goedde@uni-muenster.de; thorsten.kleine@uni-muenster.de	Kleine, Thorsten/S-2792-2017	Kleine, Thorsten/0000-0003-4657-5961; Fischer-Godde, Mario/0000-0001-6839-9001	Deutsche Forschungsgemeinschaft [SFB-TRR 170]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the Meteorite Working Group at NASA, A. Bischoff and A. Greshake for providing the meteorite samples for this study, and K. Bermingham and B. O'Driscoll for providing the Shetland chromitite sample. We thank U. Heitmann, T. Kruijer and C. Proksche for their assistance, and A. Brandon, C. Brennecka and D. Papanastassiou for comments on the paper. This work was supported by the Deutsche Forschungsgemeinschaft (SFB-TRR 170, subproject B3-1). This is TRR 170 publication no. 11.	Albarede F, 2009, NATURE, V461, P1227, DOI 10.1038/nature08477; Alexander CMO, 2012, SCIENCE, V337, P721, DOI 10.1126/science.1223474; Ballhaus C, 2013, EARTH PLANET SC LETT, V362, P237, DOI 10.1016/j.epsl.2012.11.049; Becker H, 2006, GEOCHIM COSMOCHIM AC, V70, P4528, DOI 10.1016/j.gca.2006.06.004; Bisterzo S, 2011, MON NOT R ASTRON SOC, V418, P284, DOI 10.1111/j.1365-2966.2011.19484.x; Bottke WF, 2010, SCIENCE, V330, P1527, DOI 10.1126/science.1196874; Brandon AD, 2005, GEOCHIM COSMOCHIM AC, V69, P1619, DOI 10.1016/j.gca.2004.10.005; Brandon AD, 2005, SCIENCE, V309, P1233, DOI 10.1126/science.1115053; Brenan JM, 2009, NAT GEOSCI, V2, P798, DOI 10.1038/NGEO658; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Chen JH, 2010, GEOCHIM COSMOCHIM AC, V74, P3851, DOI 10.1016/j.gca.2010.04.013; Chou CL., 1978, P 9 LUN SCI C, V1, P219; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Dauphas N, 2004, EARTH PLANET SC LETT, V226, P465, DOI 10.1016/j.epsl.2004.07.026; Dauphas N, 2014, EARTH PLANET SC LETT, V407, P96, DOI 10.1016/j.epsl.2014.09.015; Fischer-Godde M, 2015, GEOCHIM COSMOCHIM AC, V168, P151, DOI 10.1016/j.gca.2015.07.032; Fischer-Godde M, 2012, GEOCHIM COSMOCHIM AC, V77, P135, DOI 10.1016/j.gca.2011.11.014; Hiroi T, 2001, SCIENCE, V293, P2234, DOI 10.1126/science.1063734; Konig S, 2014, EARTH PLANET SC LETT, V385, P110, DOI 10.1016/j.epsl.2013.10.036; Kruijer TS, 2013, EARTH PLANET SC LETT, V361, P162, DOI 10.1016/j.epsl.2012.10.014; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; Meisel T, 1996, NATURE, V383, P517, DOI 10.1038/383517a0; Rubie DC, 2015, ICARUS, V248, P89, DOI 10.1016/j.icarus.2014.10.015; Rubie DC, 2016, SCIENCE, V353, P1141, DOI 10.1126/science.aaf6919; Savina MR, 2004, SCIENCE, V303, P649, DOI 10.1126/science.3030649; Walker RJ, 2015, CHEM GEOL, V411, P125, DOI 10.1016/j.chemgeo.2015.06.028; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001; Wang ZC, 2013, NATURE, V499, P328, DOI 10.1038/nature12285; Wood BJ, 2010, NATURE, V465, P767, DOI 10.1038/nature09072; Yokoyama T, 2007, EARTH PLANET SC LETT, V259, P567, DOI 10.1016/j.epsl.2007.05.017	34	112	114	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2017	541	7638					525	527		10.1038/nature21045	http://dx.doi.org/10.1038/nature21045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6LX	28128236				2022-12-28	WOS:000396116600049
J	Halpern, SD; Goldberg, D				Halpern, Scott D.; Goldberg, David			Allocating Organs to Cognitively Impaired Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTELLECTUAL DISABILITY; TRANSPLANTATION; PREVALENCE; OUTCOMES; CHILDREN		[Halpern, Scott D.; Goldberg, David] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Halpern, Scott D.; Goldberg, David] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Halpern, Scott D.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Halpern, SD (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.; Halpern, SD (corresponding author), Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.; Halpern, SD (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA.							Daniels N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1850; Halpern SD, 2013, ANN INTERN MED, V159, P358, DOI 10.7326/0003-4819-159-5-201309030-00684; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; Wightman A, 2016, J PEDIATR GASTR NUTR, V62, P808, DOI 10.1097/MPG.0000000000001071; Wightman A, 2014, PEDIATR TRANSPLANT, V18, P714, DOI 10.1111/petr.12339	5	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2017	376	4					299	301		10.1056/NEJMp1613858	http://dx.doi.org/10.1056/NEJMp1613858			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ3KR	28121499				2022-12-28	WOS:000393111600004
J	Wilcox, MH; Gerding, DN; Poxton, IR; Kelly, C; Nathan, R; Birch, T; Cornely, OA; Rahav, G; Bouza, E; Lee, C; Jenkin, G; Jensen, W; Kim, YS; Yoshida, J; Gabryelski, L; Pedley, A; Eves, K; Tipping, R; Guris, D; Kartsonis, N; Dorr, MB				Wilcox, M. H.; Gerding, D. N.; Poxton, I. R.; Kelly, C.; Nathan, R.; Birch, T.; Cornely, O. A.; Rahav, G.; Bouza, E.; Lee, C.; Jenkin, G.; Jensen, W.; Kim, Y. -S.; Yoshida, J.; Gabryelski, L.; Pedley, A.; Eves, K.; Tipping, R.; Guris, D.; Kartsonis, N.; Dorr, M. -B.		MODIFY I Investigator; MODIFY II Investigator	Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOXIN-B; MONOCLONAL-ANTIBODIES; STRAIN TYPE; MORTALITY; RIBOTYPE; DISEASE; FIDAXOMICIN; PROTECTION; BACTERIAL; STOOL	BACKGROUND Clostridium difficile is the most common cause of infectious diarrhea in hospitalized patients. Recurrences are common after antibiotic therapy. Actoxumab and bezlotoxumab are human monoclonal antibodies against C. difficile toxins A and B, respectively. METHODS We conducted two double-blind, randomized, placebo-controlled, phase 3 trials, MODIFY I and MODIFY II, involving 2655 adults receiving oral standard-of-care antibiotics for primary or recurrent C. difficile infection. Participants received an infusion of bezlotoxumab (10 mg per kilogram of body weight), actoxumab plus bezlotoxumab (10 mg per kilogram each), or placebo; actoxumab alone (10 mg per kilogram) was given in MODIFY I but discontinued after a planned interim analysis. The primary end point was recurrent infection (new episode after initial clinical cure) within 12 weeks after infusion in the modified intention-to-treat population. RESULTS In both trials, the rate of recurrent C. difficile infection was significantly lower with bezlotoxumab alone than with placebo (MODIFY I: 17% [67 of 386] vs. 28% [109 of 395]; adjusted difference, -10.1 percentage points; 95% confidence interval [CI], -15.9 to -4.3; P<0.001; MODIFY II: 16% [62 of 395] vs. 26% [97 of 378]; adjusted difference, -9.9 percentage points; 95% CI, -15.5 to -4.3; P<0.001) and was significantly lower with actoxumab plus bezlotoxumab than with placebo (MODIFY I: 16% [61 of 383] vs. 28% [109 of 395]; adjusted difference, -11.6 percentage points; 95% CI, -17.4 to -5.9; P<0.001; MODIFY II: 15% [58 of 390] vs. 26% [97 of 378]; adjusted difference, -10.7 percentage points; 95% CI, -16.4 to -5.1; P<0.001). In prespecified subgroup analyses (combined data set), rates of recurrent infection were lower in both groups that received bezlotoxumab than in the placebo group in subpopulations at high risk for recurrent infection or for an adverse outcome. The rates of initial clinical cure were 80% with bezlotoxumab alone, 73% with actoxumab plus bezlotoxumab, and 80% with placebo; the rates of sustained cure (initial clinical cure without recurrent infection in 12 weeks) were 64%, 58%, and 54%, respectively. The rates of adverse events were similar among these groups; the most common events were diarrhea and nausea. CONCLUSIONS Among participants receiving antibiotic treatment for primary or recurrent C. difficile infection, bezlotoxumab was associated with a substantially lower rate of recurrent infection than placebo and had a safety profile similar to that of placebo. The addition of actoxumab did not improve efficacy. (Funded by Merck; MODIFY I and MODIFY II ClinicalTrials.gov numbers, NCT01241552 and NCT01513239.)	[Wilcox, M. H.] Leeds Teaching Hosp, Leeds, W Yorkshire, England; [Wilcox, M. H.] Univ Leeds, Leeds, W Yorkshire, England; [Poxton, I. R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Gerding, D. N.] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA; [Gerding, D. N.] Edward Hines Jr VA Hosp, Hines, IL USA; [Kelly, C.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Kelly, C.] Harvard Med Sch, Boston, MA USA; [Nathan, R.] Idaho Falls Infect Dis, Idaho Falls, ID USA; [Birch, T.] Holy Name Med Ctr, Teaneck, NJ USA; [Gabryelski, L.; Pedley, A.; Eves, K.; Tipping, R.; Guris, D.; Kartsonis, N.; Dorr, M. -B.] Merck, Kenilworth, NJ USA; [Cornely, O. A.] Univ Hosp Cologne, German Ctr Infect Res DZIF, Clin Trials Ctr Cologne ZKS Koln,Dept Intenal Med, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Rahav, G.] Sheba Med Ctr, Tel Hashomer, Israel; [Bouza, E.] Univ Complutense, Ctr Invest Biomed Red Enfermedades Resp CIBERES C, Inst Invest Sanitaria Gregorio Maranon, Hosp Gregorio Maranon, Madrid, Spain; [Lee, C.] St Josephs Healthcare, Hamilton, ON, Canada; [Jenkin, G.] Monash Hlth, Clayton, Vic, Australia; [Jensen, W.] Gustavo Fricke Hosp, Vina Del Mar, Chile; [Kim, Y. -S.] Inje Univ, Seoul Paik Hosp, Seoul, South Korea; [Yoshida, J.] Shimonoseki City Hosp, Shimonoseki, Yamaguchi, Japan	University of Leeds; University of Leeds; University of Edinburgh; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Merck & Company; German Center for Infection Research; University of Cologne; Chaim Sheba Medical Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Complutense University of Madrid; General University Gregorio Maranon Hospital; Inje University	Wilcox, MH (corresponding author), Leeds Gen Infirm, Old Med Sch, Div Microbiol, Leeds LS1 3EX, W Yorkshire, England.	mark.wilcox@nhs.net	Llewelyn, Martin/A-7194-2011; Glerup, Henning/R-2191-2019; Yoshida, Junichi/AAJ-4564-2020; Benes, Jiri/E-9885-2018; Llewelyn, Martin/Y-1472-2019; McGeer, Allison/AAB-6885-2020; Cornely, Oliver A./J-5095-2013; Bouza, Emilio/D-8661-2014; Blanco, Leire/O-5114-2017; Valiquette, Louis/J-5836-2019	Llewelyn, Martin/0000-0002-6811-1124; Glerup, Henning/0000-0002-8247-8766; Yoshida, Junichi/0000-0002-7183-8455; Benes, Jiri/0000-0002-2630-4737; McGeer, Allison/0000-0001-5647-6137; Cornely, Oliver A./0000-0001-9599-3137; Bouza, Emilio/0000-0001-6967-9267; Valiquette, Louis/0000-0002-8300-8416; Kallas, Esper/0000-0003-2026-6925; Gluud, Lise L/0000-0002-9462-4468; Janczewska, Ewa/0000-0002-5406-4603; Camou, Fabrice/0000-0003-4715-224X; Petersen, Andreas Munk/0000-0003-0531-0553; Lopez-Contreras, Joaquin/0000-0002-3166-4016; Chen, Yen-hsu/0000-0002-8667-4844; Steiner, Ted/0000-0002-3136-6668	Merck; Alere; Actelion Pharmaceuticals; Cubist Pharmaceuticals; Astellas; Optimer Pharmaceuticals; Sanofi Pasteur; Summit Pharmaceuticals; bio-Merieux; Da Volterra; Qiagen; Cerexa; Abbott; AstraZeneca; Pfizer; Durata Therapeutics; Seres Therapeutics; Valneva; Nabriva Therapeutics; Roche; Medicines Company; Basilea Pharmaceutica	Merck(Merck & Company); Alere; Actelion Pharmaceuticals; Cubist Pharmaceuticals; Astellas(Astellas Pharmaceuticals); Optimer Pharmaceuticals; Sanofi Pasteur; Summit Pharmaceuticals; bio-Merieux; Da Volterra; Qiagen; Cerexa; Abbott(Abbott Laboratories); AstraZeneca(AstraZeneca); Pfizer(Pfizer); Durata Therapeutics; Seres Therapeutics; Valneva; Nabriva Therapeutics; Roche(Roche Holding); Medicines Company; Basilea Pharmaceutica	Supported by Merck.; Dr. Wilcox reports receiving consulting fees from Alere, Actelion Pharmaceuticals, Cubist Pharmaceuticals, Astellas, Optimer Pharmaceuticals, Sanofi Pasteur, Summit Pharmaceuticals, bio-Merieux, Da Volterra, Qiagen, Cerexa, Abbott, AstraZeneca, Pfizer, Durata Therapeutics, Merck, Seres Therapeutics, Valneva, Nabriva Therapeutics, Roche, the Medicines Company, and Basilea Pharmaceutica, lecture fees from Actelion Pharmaceuticals, Cubist Pharmaceuticals, Astellas, Optimer Pharmaceuticals, Sanofi Pasteur, Summit Pharmaceuticals, bioMrieux, Da Volterra, Qiagen, AstraZeneca, and Pfizer, and grant support from Alere, Actelion Pharmaceuticals, Cubist Pharmaceuticals, Astellas, Optimer Pharmaceuticals, Sanofi Pasteur, Summit Pharmaceuticals, bioMrieux, Da Volterra, Qiagen, Cerexa, and Abbott; Dr. Gerding, receiving fees for serving on advisory boards from Actelion Pharmaceuticals, Rebiotix, and Summit Pharmaceuticals, consulting fees from Da Volterra, Pfizer, Cubist Pharmaceuticals, Sanofi Pasteur, Daiichi-Sankyo, and ViroPharma (now Shire), and a research grant from Seres Therapeutics, and holding patents related to the treatment and prevention of C. difficile infection (US No. 6,635,260, EU No. 0952773, CAN No. 2,232,001); Dr. Poxton, receiving fees for serving on an advisory board from Merck; Dr. Kelly, receiving travel support and fees for serving on advisory boards from Seres Therapeutics, Summit Pharmaceuticals, and Synthetic Biologics, lecture fees from Seres Therapeutics, and grant support from Institut Merieux, Entera Health, and Merck; Dr. Cornely, receiving consulting fees from Anacor Pharmaceuticals, Amplyx, Actelion Pharmaceuticals, Astellas, Basilea, Cidara Therapeutics, Da Volterra, F2G, Gilead, Janssen Pharmaceuticals, Matinas, Menarini Ricerche, Merck/Merck Sharp & Dohme, Paratek Pharmaceuticals, Scynexis, Seres, Summit, Vical, and Vifor Pharma, lecture fees from Astellas, Basilea, Gilead Sciences, and Merck Sharp & Dohme, and grant support from Actelion Pharmaceuticals, Aramis, Astellas, AstraZeneca, Basilea Pharmaceutica, Bayer, Cidara Therapeutics, F2G, Gilead, GlaxoSmithKline, MedPace, Melinta Therapeutics, Merck/Merck Sharp & Dohme, Miltenyi Biotec, Pfizer, Rempex, Roche, Sanofi Pasteur, Scynexis, Seres Therapeutics, and the Medicines Company; Dr. Rahav, receiving fees for lectures and serving on advisory boards from Pfizer and Merck Sharp & Dohme; Dr. Bouza, receiving fees for serving on advisory boards or payment for conferences from Merck Sharp & Dohme, Pfizer, Astellas, Sanofi Pasteur, Roche, and Basilea Pharmaceutica; Dr. Lee, receiving grant support from Rebiotix, Merck, and Actelion Pharmaceuticals and fees for serving on advisory boards from Rebiotix and Summit Pharmaceuticals; Dr. Yoshida, receiving clinical trial fees from Bayer, Astellas, Toyama Chemical Pharmaceuticals, and Sanofi; and Ms. Gabryelski, Dr. Pedley, Ms. Eves, Mr. Tipping, Dr. Guris, Dr. Kartsonis, and Dr. Dorr, being employees of and holding stock in Merck. No other potential conflict of interest relevant to this article was reported.	Abou Chakra CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030258; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Carter GP, 2015, MBIO, V6, DOI 10.1128/mBio.00551-15; Comely OA, 2012, CLIN INFECT DIS, V55, pS154, DOI 10.1093/cid/cis462; De Almeida MN, 2013, NEW ZEAL MED J, V126, P9; Fawley WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118150; Inns T, 2013, J HOSP INFECT, V84, P235, DOI 10.1016/j.jhin.2013.04.008; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kink JA, 1998, INFECT IMMUN, V66, P2018, DOI 10.1128/IAI.66.5.2018-2025.1998; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Leav BA, 2010, VACCINE, V28, P965, DOI 10.1016/j.vaccine.2009.10.144; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Lim SK, 2014, CLIN INFECT DIS, V58, P1723, DOI 10.1093/cid/ciu203; Louie TJ, 2012, CLIN INFECT DIS, V55, pS132, DOI 10.1093/cid/cis338; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; Morrison RH, 2011, CLIN INFECT DIS, V53, P1173, DOI 10.1093/cid/cir668; Rao K, 2015, CLIN INFECT DIS, V61, P233, DOI 10.1093/cid/civ254; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; See I, 2014, CLIN INFECT DIS, V58, P1394, DOI 10.1093/cid/ciu125; Shields K, 2015, ANAEROBE, V34, P59, DOI 10.1016/j.anaerobe.2015.04.012; Steele J, 2013, J INFECT DIS, V207, P323, DOI 10.1093/infdis/jis669; Thabit AK, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0140-6; TORRES JF, 1995, INFECT IMMUN, V63, P4619, DOI 10.1128/IAI.63.12.4619-4627.1995; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265	32	444	460	5	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2017	376	4					305	317		10.1056/NEJMoa1602615	http://dx.doi.org/10.1056/NEJMoa1602615			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ3KR	28121498	Bronze, Green Published			2022-12-28	WOS:000393111600006
J	Cohen, RN; Davis, AM				Cohen, Ronald N.; Davis, Andrew M.			Management of Adult Patients With Thyroid Nodules and Differentiated Thyroid Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYSTEM; GUIDELINES		[Cohen, Ronald N.] Univ Chicago, Sect Endocrinol Diabet & Metab, Chicago, IL 60637 USA; [Davis, Andrew M.] Univ Chicago, Gen Internal Med Sect, 4124 N LeClaire Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Davis, AM (corresponding author), Univ Chicago, Gen Internal Med Sect, 4124 N LeClaire Ave, Chicago, IL 60637 USA.	adavis@medicine.bsd.uchicago.edu						Grant EG, 2015, J AM COLL RADIOL, V12, P1272, DOI 10.1016/j.jacr.2015.07.011; Guth S, 2009, EUR J CLIN INVEST, V39, P699, DOI 10.1111/j.1365-2362.2009.02162.x; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Horvath E, 2009, J CLIN ENDOCR METAB, V94, P1748, DOI 10.1210/jc.2008-1724; Ito Y, 2007, THYROID, V17, P1269, DOI 10.1089/thy.2007.0014; Mandel SJ, 2004, JAMA-J AM MED ASSOC, V292, P2632, DOI 10.1001/jama.292.21.2632; Migdal AL, 2016, THYROID, V26, P825, DOI 10.1089/thy.2015.0674; Nikiforov YE, 2016, JAMA ONCOL, V2, P1023, DOI 10.1001/jamaoncol.2016.0386; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Tae HJ, 2007, THYROID, V17, P461, DOI 10.1089/thy.2006.0337	10	8	10	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					434	435		10.1001/jama.2016.18420	http://dx.doi.org/10.1001/jama.2016.18420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118436				2022-12-28	WOS:000392509600024
J	Bourgeois, FT; Hwang, TJ				Bourgeois, Florence T.; Hwang, Thomas J.			The Pediatric Research Equity Act Moves Into Adolescence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bourgeois, Florence T.; Hwang, Thomas J.] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA; [Bourgeois, Florence T.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Hwang, Thomas J.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Bourgeois, FT (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	florence.bourgeois@childrens.harvard.edu		Hwang, Thomas/0000-0003-0717-1497				Benjamin DK, 2009, ARCH PEDIAT ADOL MED, V163, P1080, DOI 10.1001/archpediatrics.2009.229; Czaja Angela S, 2015, J Pediatr Pharmacol Ther, V20, P186, DOI 10.5863/1551-6776-20.3.186; Institute of Medicine, 2012, SAF EFF MED CHILDR	3	35	35	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					259	260		10.1001/jama.2016.18131	http://dx.doi.org/10.1001/jama.2016.18131			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114560	Green Published			2022-12-28	WOS:000392089200009
J	Voelker, R				Voelker, Rebecca			Diabetes Drug Gains New Indication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					247	247		10.1001/jama.2016.19774	http://dx.doi.org/10.1001/jama.2016.19774			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NP	28114536				2022-12-28	WOS:000426802000004
J	Garthwaite, C; Graves, JA				Garthwaite, Craig; Graves, John A.			Success and Failure in the Insurance Exchanges	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Garthwaite, Craig] Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA; [Graves, John A.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Northwestern University; Vanderbilt University	Garthwaite, C (corresponding author), Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA.							Johnson C, 2016, WASHINGTON POST; Levitt L, 2016, WASHINGTON POST; Matthews A.W., 2016, WALL STREET J; Tracer Z, 2016, BLOOMBERG BUSINESSWE	4	17	17	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10					907	910		10.1056/NEJMp1614545	http://dx.doi.org/10.1056/NEJMp1614545			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JA	28146412				2022-12-28	WOS:000395626500002
J	Jorgensen, KJ; Gotzsche, PC; Kalager, M; Zahl, PH				Jorgensen, Karsten Juhl; Gotzsche, Peter C.; Kalager, Mette; Zahl, Per-Henrik			Breast Cancer Screening in Denmark A Cohort Study of Tumor Size and Overdiagnosis	ANNALS OF INTERNAL MEDICINE			English	Article							MAMMOGRAPHY; MORTALITY	Background: Effective breast cancer screening should detect early-stage cancer and prevent advanced disease. Objective: To assess the association between screening and the size of detected tumors and to estimate overdiagnosis (detection of tumors that would not become clinically relevant). Design: Cohort study. Setting: Denmark from 1980 to 2010. Participants: Women aged 35 to 84 years. Intervention: Screening programs offering biennial mammography for women aged 50 to 69 years beginning in different regions at different times. Measurements: Trends in the incidence of advanced (> 20 mm) and nonadvanced (<= 20 mm) breast cancer tumors in screened and nonscreened women were measured. Two approaches were used to estimate the amount of overdiagnosis: comparing the incidence of advanced and nonadvanced tumors among women aged 50 to 84 years in screening and nonscreening areas; and comparing the incidence for nonadvanced tumors among women aged 35 to 49, 50 to 69, and 70 to 84 years in screening and nonscreening areas. Results: Screening was not associated with lower incidence of advanced tumors. The incidence of nonadvanced tumors in-creased in the screening versus prescreening periods (incidence rate ratio, 1.49 [95% CI, 1.43 to 1.54]). The first estimation approach found that 271 invasive breast cancer tumors and 179 ductal carcinoma in situ (DCIS) lesions were overdiagnosed in 2010 (overdiagnosis rate of 24.4% [ including DCIS] and 14.7% [ excluding DCIS]). The second approach, which accounted for regional differences in women younger than the screening age, found that 711 invasive tumors and 180 cases of DCIS were overdiagnosed in 2010 (overdiagnosis rate of 48.3% [ including DCIS] and 38.6% [ excluding DCIS]). Limitation: Regional differences complicate interpretation. Conclusion: Breast cancer screening was not associated with a reduction in the incidence of advanced cancer. It is likely that 1 in every 3 invasive tumors and cases of DCIS diagnosed in women offered screening represent overdiagnosis (incidence increase of 48.3%).	[Jorgensen, Karsten Juhl; Gotzsche, Peter C.] Rigshosp, Nord Cochrane Ctr, Dept 7811, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Kalager, Mette] Univ Oslo, Inst Hlth & Soc, Dept Hlth Management & Hlth Econ, POB 1089, N-0318 Oslo, Norway; [Zahl, Per-Henrik] Norwegian Inst Publ Hlth, POB 4404, N-0403 Oslo, Norway	Rigshospitalet; University of Copenhagen; University of Oslo; Norwegian Institute of Public Health (NIPH)	Jorgensen, KJ (corresponding author), Rigshosp, Nord Cochrane Ctr, Dept 7811, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	kj@cochrane.dk		Jorgensen, Karsten/0000-0001-8554-0388				American Joint Committee on Cancer, 2002, CANC STAG HDB; [Anonymous], VAL DAN CANC REG SEL; Autier P, 2011, ANN ONCOL, V22, P1726, DOI 10.1093/annonc/mdq633; Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Carter JL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7773; Christiansen P, 2014, ACTA ONCOL, V53, P433, DOI 10.3109/0284186X.2013.874573; Francis A, 2015, CLIN ONCOL-UK, V27, P6, DOI 10.1016/j.clon.2014.09.015; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Gotzsche PC, 2012, CANCER CAUSE CONTROL, V23, P15, DOI 10.1007/s10552-011-9867-8; Harding C, 2015, JAMA INTERN MED, V175, P1483, DOI 10.1001/jamainternmed.2015.3043; Jensen A, 2005, INT J CANCER, V113, P464, DOI 10.1002/ijc.20604; Jorgensen Karsten J, 2009, BMC Womens Health, V9, P36, DOI 10.1186/1472-6874-9-36; Jorgensen KJ, 2015, ACTA ONCOL, V54, P133, DOI 10.3109/0284186X.2014.920958; Jorgensen KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1241; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Lousdal ML, 2014, EUR J PUBLIC HEALTH, V24, P1017, DOI 10.1093/eurpub/cku015; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Njor SH, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1064; Patnick J, 2011, NHS BREAST SCREENING; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Rostgaard K, 2010, ACTA ONCOL, V49, P313, DOI 10.3109/02841861003602074; Suhrke P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4692; Sundhedsstyrelsen. Statusrapport, 1997, TIDL OPSP BEH BRYSTK; Vainio H., 2002, IARC HDB CANC PREV, V7; von Euler-Chelpin M, 2006, EUR J EPIDEMIOL, V21, P203, DOI 10.1007/s10654-006-0002-1; Zahl PH, 2013, BRIT J CANCER, V109, P2014, DOI 10.1038/bjc.2013.427; Zahl Per-Henrik, 2012, Tidsskr Nor Laegeforen, V132, P414, DOI 10.4045/tidsskr.11.0195	29	86	87	1	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					313	+		10.7326/M16-0270	http://dx.doi.org/10.7326/M16-0270			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28114661				2022-12-28	WOS:000396432800004
J	Gilbert, H; Sutton, S; Morris, R; Petersen, I; Galton, S; Wu, Q; Parrott, S; Nazareth, I				Gilbert, Hazel; Sutton, Stephen; Morris, Richard; Petersen, Irene; Galton, Simon; Wu, Qi; Parrott, Steve; Nazareth, Irwin			Effectiveness of personalised risk information and taster sessions to increase the uptake of smoking cessation services (Start2quit): a randomised controlled trial	LANCET			English	Article							SMOKERS; PREDICTORS; HEALTH	Background National Health Service Stop Smoking Services (SSSs) off er help to smokers motivated to quit; however, attendance rates are low and recent figures show a downward trend. We aimed to assess the effectiveness of a two-component personalised intervention on attendance at SSSs. Methods We did this randomised controlled trial in 18 SSSs in England. Current smokers (aged >= 16 years) were identified from medical records in 99 general practices and invited to participate by their general practitioner. Individuals who gave consent, were motivated to quit, and had not attended the SSS within the past 12 months, were randomly assigned (3:2), via computer-generated randomisation with permuted blocks (block size of five), to receive either an individually tailored risk letter and invitation to attend a no-commitment introductory session run by the local SSS (intervention group) or a standard generic letter advertising the local SSS (control group). Randomisation was stratified by sex. Masking of participants to receipt of a personal letter and invitation to a taster session was not possible. The personal letter was generated by a research assistant, but the remainder of the research team were masked to group allocation. General practitioners, practice staff, and SSS advisers were unaware of their patients' allocation. The primary outcome was attendance at the first session of an SSS course within 6 months from randomisation. We did analysis by intention to treat. This trial is registered with Current Controlled Trials, number ISRCTN 76561916. Findings Recruitment, collection of baseline data, delivery of the intervention, and follow up of participants took place between Jan 31, 2011, and July 12, 2014. We randomly assigned 4384 smokers to the intervention group (n=2636) or the control group (n=1748); 4383 participants comprised the intention-to-treat population. Attendance at the first session of an SSS course was significantly higher in the intervention group than in the control group (458 [17.4%] vs 158 [9.0%] participants; unadjusted odds ratio 2.12 [ 95% CI 1.75-2.57]; p<0.0001). Interpretation Delivery of personalised risk information alongside an invitation to an introductory session more than doubled the odds of attending the SSS compared with a standard generic invitation to contact the service. This result suggests that a more proactive approach, combined with an opportunity to experience local services, can reduce patient barriers to receiving treatment and has high potential to increase uptake. Funding National Institutes of Health Research Health Technology Assessment. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.	[Gilbert, Hazel; Morris, Richard; Petersen, Irene; Nazareth, Irwin] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Sutton, Stephen] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Galton, Simon] NHS Camden, Smokefree Camden Publ Hlth, London, England; [Wu, Qi; Parrott, Steve] Univ York, Dept Hlth Sci, York, N Yorkshire, England	University of London; University College London; University of Cambridge; University of York - UK	Gilbert, H (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Res Dept Primary Care & Populat Hlth, London NW3 2PF, England.	hazel.gilbert@ucl.ac.uk	; Petersen, Irene/C-5702-2009	Parrott, Steven James/0000-0002-0165-1150; Nazareth, Irwin/0000-0003-2146-9628; Gilbert, Hazel/0000-0002-1254-6874; Morris, Richard/0000-0001-7240-4563; Petersen, Irene/0000-0002-0037-7524	National Institutes of Health Research Health Technology Assessment; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10041, 08/58/02] Funding Source: researchfish	National Institutes of Health Research Health Technology Assessment; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	National Institutes of Health Research Health Technology Assessment.	Abraham C., 1996, PREDICTING HLTH BEHA, P23; Allender S, 2009, TOB CONTROL, V18, P262, DOI 10.1136/tc.2008.026294; Balmford J, 2008, DRUG ALCOHOL REV, V27, P21, DOI 10.1080/09595230701710829; Bauld L, 2008, ADDICTION, V103, P1007, DOI 10.1111/j.1360-0443.2008.02255.x; Brose LS, 2011, THORAX, V66, P924, DOI 10.1136/thoraxjnl-2011-200251; Edwards AGK, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001865.pub2; Etter JF, 1998, AM J EPIDEMIOL, V147, P141; Ferguson J, 2005, ADDICTION, V100, P59, DOI 10.1111/j.1360-0443.2005.01028.x; Gilbert HM, 2012, PUBLIC HEALTH, V126, P308, DOI 10.1016/j.puhe.2011.11.010; Hammond D, 2004, ADDICTION, V99, P1042, DOI 10.1111/j.1360-0443.2004.00754.x; Hartmann-Boyce J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001118.pub3; Health and Social Care Information Centre, STAT NHS STOP SMOK S; Health and Social Care Information Centre, 2015, STAT SMOK ENGL 2015; Jackson D, 2014, ADDICTION, V109, P1986, DOI 10.1111/add.12721; Jarvis MJ, 2008, ADDICTION, V103, P1553, DOI 10.1111/j.1360-0443.2008.02297.x; Jha P, 2011, PUBLIC HEALTH REV, V33, P569, DOI 10.1007/BF03391651; Judge K, 2005, ADDICTION, V100, P46, DOI 10.1111/j.1360-0443.2005.01027.x; Kreuter MW, 1999, ANN BEHAV MED, V21, P276, DOI 10.1007/BF02895958; Lader D., 40 OFF NAT STAT OMN; LICHTENSTEIN E, 1992, J FAM PRACTICE, V34, P739; LICHTENSTEIN E, 1992, J CONSULT CLIN PSYCH, V60, P518, DOI 10.1037/0022-006X.60.4.518; McDermott MS, 2013, NICOTINE TOB RES, V15, P1239, DOI 10.1093/ntr/nts262; McNeill A, 2005, ADDICTION, V100, P1, DOI 10.1111/j.1360-0443.2005.01022.x; Murray RL, 2008, ADDICTION, V103, P998, DOI 10.1111/j.1360-0443.2008.02206.x; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; Noble M, 2007, ENGLISH INDICES DEPR; Office for National Statistics, 2013, STAT B AD SMOK HAB G; Paul CL, 2004, ADDICTION, V99, P907, DOI 10.1111/j.1360-0443.2004.00773.x; Roddy E, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-147; Sutton SR, 1982, SOCIAL PSYCHOL BEHAV, P303; Tannenbaum MB, 2015, PSYCHOL BULL, V141, P1178, DOI 10.1037/a0039729; Tzelepis F, 2013, ADDICTION, V108, P181, DOI 10.1111/j.1360-0443.2012.03998.x; Tzelepis F, 2009, NICOTINE TOB RES, V11, P1205, DOI 10.1093/ntr/ntp125; VELICER WF, 1992, PSYCHOL BULL, V111, P23, DOI 10.1037/0033-2909.111.1.23; Vidrine JI, 2013, JAMA INTERN MED, V173, P458, DOI 10.1001/jamainternmed.2013.3751; Wakefield M, 2003, TOB CONTROL, V12, P15, DOI 10.1136/tc.12.suppl_2.ii15; Weinstein ND, 2005, TOB CONTROL, V14, P55, DOI 10.1136/tc.2004.008375; West R., 2012, SMOKING SMOKING CESS; West R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4921; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	40	29	29	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					823	833		10.1016/S0140-6736(16)32379-0	http://dx.doi.org/10.1016/S0140-6736(16)32379-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9UU	28129989	Green Published, hybrid			2022-12-28	WOS:000394966400034
J	Halpern, KB; Shenhav, R; Matcovitch-Natan, O; Toth, B; Lemze, D; Golan, M; Massasa, EE; Baydatch, S; Landen, S; Moor, AE; Brandis, A; Giladi, A; Stokar-Avihail, A; David, E; Amit, I; Itzkovitz, S				Halpern, Keren Bahar; Shenhav, Rom; Matcovitch-Natan, Orit; Toth, Beata; Lemze, Doron; Golan, Matan; Massasa, Efi E.; Baydatch, Shaked; Landen, Shanie; Moor, Andreas E.; Brandis, Alexander; Giladi, Amir; Stokar-Avihail, Avigail; David, Eyal; Amit, Ido; Itzkovitz, Shalev			Single-cell spatial reconstruction reveals global division of labour in the mammalian liver	NATURE			English	Article							ZONAL GENE-EXPRESSION; MESSENGER-RNA; ZONATION; TISSUE; SEQ; METABOLISM; ENERGY	The mammalian liver consists of hexagon-shaped lobules that are radially polarized by blood flow and morphogens(1-4). Key liver genes have been shown to be differentially expressed along the lobule axis, a phenomenon termed zonation(5,6), but a detailed genome-wide reconstruction of this spatial division of labour has not been achieved. Here we measure the entire transcriptome of thousands of mouse liver cells and infer their lobule coordinates on the basis of a panel of zonated landmark genes, characterized with single-molecule fluorescence in situ hybridization(7). Using this approach, we obtain the zonation profiles of all liver genes with high spatial resolution. We find that around 50% of liver genes are significantly zonated and uncover abundant non-monotonic profiles that peak at the mid-lobule layers. These include a spatial order of bile acid biosynthesis enzymes that matches their position in the enzymatic cascade. Our approach can facilitate the reconstruction of similar spatial genomic blueprints for other mammalian organs.	[Halpern, Keren Bahar; Shenhav, Rom; Toth, Beata; Lemze, Doron; Golan, Matan; Massasa, Efi E.; Baydatch, Shaked; Landen, Shanie; Moor, Andreas E.; Stokar-Avihail, Avigail; Itzkovitz, Shalev] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Matcovitch-Natan, Orit; Giladi, Amir; David, Eyal; Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Brandis, Alexander] Weizmann Inst Sci, Biol Serv, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Itzkovitz, S (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.; Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.	ido.amit@weizmann.ac.il; shalev.itzkovitz@weizmann.ac.il		Moor, Andreas/0000-0001-8715-8449; Stokar-Avihail, Avigail/0000-0002-2869-5401	European Research Council [309788]; Israel Science Foundation; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Helen and Martin Kimmel award; Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics; Leir Charitable Foundations; Richard Jakubskind Laboratory of Systems Biology; Cymerman-Jakubskind Prize; Lord Sieff of Brimpton Memorial Fund; I-CORE program of the Planning and Budgeting Committee; Israel Science Foundation [1902/12, 1796/12, 1486/16]; EMBO Young Investigator Program; European Research Council under the European Union/ERC [335122]	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Helen and Martin Kimmel award; Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics; Leir Charitable Foundations; Richard Jakubskind Laboratory of Systems Biology; Cymerman-Jakubskind Prize; Lord Sieff of Brimpton Memorial Fund; I-CORE program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); European Research Council under the European Union/ERC(European Research Council (ERC))	We thank R. Milo and all members of our laboratory for valuable comments We thank M. Schwarz, A. Braeuning and S. Colnot for sharing their data and A. Sharp, E. Ariel, E. Hagai and Z. Gavish for help with experimental procedures. I.A. is supported by the European Research Council (309788), and the Israel Science Foundation, the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine and the Helen and Martin Kimmel award for innovative investigation. I.A. is the incumbent of the Alan and Laraine Fischer Career Development Chair S.I. is supported by the Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics, The Leir Charitable Foundations, Richard Jakubskind Laboratory of Systems Biology, Cymerman-Jakubskind Prize, The Lord Sieff of Brimpton Memorial Fund, the I-CORE program of the Planning and Budgeting Committee and the Israel Science Foundation (grants 1902/12 and 1796/12), the Israel Science Foundation grant No. 1486/16, the EMBO Young Investigator Program and the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement number 335122. S.I. is the incumbent of the Philip Harris and Gerald Ronson Career Development Chair.	Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Atger F, 2015, P NATL ACAD SCI USA, V112, pE6579, DOI 10.1073/pnas.1515308112; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Baze MM, 2010, PHYSIOL GENOMICS, V41, P275, DOI 10.1152/physiolgenomics.00075.2009; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Boylston W. H., 2016, IDENTIFICATION LONGE, V28, P125; Braeuning A, 2006, FEBS J, V273, P5051, DOI 10.1111/j.1742-4658.2006.05503.x; Colnot S, 2011, MOL PATHOL LIB, V5, P7, DOI 10.1007/978-1-4419-7107-4_2; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Gebhardt R, 2014, WORLD J GASTROENTERO, V20, P8491, DOI 10.3748/wjg.v20.i26.8491; Gille C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.62; Gougelet A, 2014, HEPATOLOGY, V59, P2344, DOI 10.1002/hep.26924; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Hailfinger S, 2006, HEPATOLOGY, V43, P407, DOI 10.1002/hep.21082; Halpern KB, 2015, CELL REP, V13, P2653, DOI 10.1016/j.celrep.2015.11.036; Halpern KB, 2015, MOL CELL, V58, P147, DOI 10.1016/j.molcel.2015.01.027; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Lyubimova A, 2013, NAT PROTOC, V8, P1743, DOI 10.1038/nprot.2013.109; Nagrath D, 2007, ANN BIOMED ENG, V35, P863, DOI 10.1007/s10439-007-9283-0; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Saito K, 2013, BIOCHEM BIOPH RES CO, V436, P730, DOI 10.1016/j.bbrc.2013.06.025; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; Tanami S., 2016, CELL TISSUE RES; Unterberger EB, 2014, INT J CANCER, V135, P1574, DOI 10.1002/ijc.28798; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2010, J PROTEOME RES, V9, P1894, DOI 10.1021/pr901057k	38	454	472	10	158	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					352	+		10.1038/nature21065	http://dx.doi.org/10.1038/nature21065			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2LQ	28166538	Green Accepted			2022-12-28	WOS:000394451600038
J	Pollack, CE; Armstrong, K; Grande, D				Pollack, Craig Evan; Armstrong, Katrina; Grande, David			A View from the Front Line - Physicians' Perspectives on ACA Repeal	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pollack, Craig Evan] Johns Hopkins Sch Med, Div Gen Internal Med, Baltimore, MD 21205 USA; [Armstrong, Katrina] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Grande, David] Univ Penn, Div Gen Internal Med, Perelman Sch Med, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine	Pollack, CE (corresponding author), Johns Hopkins Sch Med, Div Gen Internal Med, Baltimore, MD 21205 USA.		Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735				[Anonymous], 2015, EXP ATT PRIM CAR PRO; Blumberg LJ, 2016, IMPLICATIONS PARTIAL; Roe P, 2016, JAMA FORUM 3 CONGRES; Sanger-Katz Margot, 2016, NY TIMES	4	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2017	376	6							e8	10.1056/NEJMp1700144	http://dx.doi.org/10.1056/NEJMp1700144			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8XL	28122190				2022-12-28	WOS:000393510500005
J	Thompson, JD; Nicholson, TL; Liang, QY; Cantu, SH; Venkatramani, AV; Choi, S; Fedorov, IA; Viscor, D; Pohl, T; Lukin, MD; Vuletic, V				Thompson, Jeff D.; Nicholson, Travis L.; Liang, Qi-Yu; Cantu, Sergio H.; Venkatramani, Aditya V.; Choi, Soonwon; Fedorov, Ilya A.; Viscor, Daniel; Pohl, Thomas; Lukin, Mikhail D.; Vuletic, Vladan			Symmetry-protected collisions between strongly interacting photons	NATURE			English	Article							QUANTUM NONLINEAR OPTICS; MAJORANA FERMIONS; RYDBERG ATOMS	Realizing robust quantum phenomena in strongly interacting systems is one of the central challenges in modern physical science. Approaches ranging from topological protection to quantum error correction are currently being explored across many different experimental platforms, including electrons in condensed-matter systems', trapped atoms' and photons'. Although photon-photon interactions are typically negligible in conventional optical media, strong interactions between individual photons have recently been engineered in several systems(4-10). Here, using coherent coupling between light and Rydberg excitations in an ultracold atomic gas, we demonstrate a controlled and coherent exchange collision between two photons that is accompanied by a pi/2 phase shift. The effect is robust in that the value of the phase shift is determined by the interaction symmetry rather than the precise experimental parameters(7,10-13), and in that it occurs under conditions where photon absorption is minimal. The measured phase shift of 0.48(3)pi is in excellent agreement with a theoretical model. These observations open a route to realizing robust single-photon switches and all-optical quantum logic gates, and to exploring novel quantum many-body phenomena with strongly interacting photons.	[Thompson, Jeff D.; Venkatramani, Aditya V.; Choi, Soonwon; Lukin, Mikhail D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Thompson, Jeff D.] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; [Nicholson, Travis L.; Liang, Qi-Yu; Cantu, Sergio H.; Vuletic, Vladan] MIT, Dept Phys, Cambridge, MA 02139 USA; [Nicholson, Travis L.; Liang, Qi-Yu; Cantu, Sergio H.; Vuletic, Vladan] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Fedorov, Ilya A.] Russian Quantum Ctr, Moscow 143025, Russia; [Viscor, Daniel; Pohl, Thomas] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Pohl, Thomas] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus, Denmark	Harvard University; Princeton University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Russian Quantum Center; Max Planck Society; Aarhus University	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Vuletic, V (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.; Vuletic, V (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	lukin@physics.harvard.edu; vuletic@mit.edu	Nicholson, Travis L/O-1573-2018; Surov, Ilya A/J-3796-2015; Venkatramani, Aditya/GOK-0191-2022; Vuletic, Vladan/M-8736-2019	Nicholson, Travis L/0000-0002-0503-7991; Surov, Ilya A/0000-0001-5690-7507; Venkatramani, Aditya/0000-0002-0984-5654; Thompson, Jeff/0000-0001-8673-052X; Pohl, Thomas/0000-0002-4093-3644	NSF; Center for Ultracold Atoms; DARPA; ARO; ARO MURI; AFOSR MURI; ARL; U-FET [512862]; H-FETPROACT [640378]; DFG [SPP 1929]; Kwanjeong Educational Foundation; Direct For Mathematical & Physical Scien [1506284, 1505862] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Center for Ultracold Atoms; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); ARO; ARO MURI(MURI); AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); ARL(United States Department of DefenseUS Army Research Laboratory (ARL)); U-FET; H-FETPROACT; DFG(German Research Foundation (DFG)); Kwanjeong Educational Foundation; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge conversations with A. V. Gorshkov, M. J. Gullans, O. Firstenberg, S. Hofferberth and R. Johne. Funding was provided by the NSF, the Center for Ultracold Atoms, DARPA, ARO, ARO MURI, AFOSR MURI, the ARL, U-FET grant number 512862 (HAIRS), the H2020-FETPROACT-2014 grant number 640378 (RYSQ), the DFG (SPP 1929) and the Kwanjeong Educational Foundation.	Beck KM, 2016, P NATL ACAD SCI USA, V113, P9740, DOI 10.1073/pnas.1524117113; Beenakker CWJ, 2015, REV MOD PHYS, V87, P1037, DOI 10.1103/RevModPhys.87.1037; Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; Chang DE, 2014, NAT PHOTONICS, V8, P685, DOI [10.1038/NPHOTON.2014.192, 10.1038/nphoton.2014.192]; Dudin YO, 2012, SCIENCE, V336, P887, DOI 10.1126/science.1217901; Firstenberg O, 2013, NATURE, V502, P71, DOI 10.1038/nature12512; Friedler I, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.043803; Gorniaczyk H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12480; Gorniaczyk H, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.053601; Gorshkov AV, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.133602; Hacker B, 2016, NATURE, V536, P193, DOI 10.1038/nature18592; Kitaev AY., 2001, PHYS-USP+, V44, P131, DOI [10.1070/1063-7869/44/10S/S29, DOI 10.1070/1063-7869/44/10S/S29]; Lu L, 2014, NAT PHOTONICS, V8, P821, DOI [10.1038/nphoton.2014.248, 10.1038/NPHOTON.2014.248]; Lukin MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037901; Maghrebi MF, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.033838; Maxwell D, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.103001; Monroe C, 2013, SCIENCE, V339, P1164, DOI 10.1126/science.1231298; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Murray CR, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/9/092001; Petrosyan D, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.213601; Peyronel T, 2012, NATURE, V488, P57, DOI 10.1038/nature11361; Pritchard JD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.193603; Ravets S, 2014, NAT PHYS, V10, P914, DOI [10.1038/nphys3119, 10.1038/NPHYS3119]; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Schnyder AP, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195125; Schuster I, 2008, NAT PHYS, V4, P382, DOI 10.1038/nphys940; Sommer A., 2015, PREPRINT; Stern A, 2013, SCIENCE, V339, P1179, DOI 10.1126/science.1231473; Tiarks D, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600036; Tiarks D, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.053602	30	50	50	3	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					206	209		10.1038/nature20823	http://dx.doi.org/10.1038/nature20823			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28117443				2022-12-28	WOS:000393737500035
J	Wilfley, DE; Fitzsimmons-Craft, EE; Eichen, DM				Wilfley, Denise E.; Fitzsimmons-Craft, Ellen E.; Eichen, Dawn M.			Binge-Eating Disorder in Adults	ANNALS OF INTERNAL MEDICINE			English	Letter							COMORBIDITY		[Wilfley, Denise E.; Fitzsimmons-Craft, Ellen E.; Eichen, Dawn M.] Washington Univ, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Wilfley, DE (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.			Eichen, Dawn/0000-0001-5619-2177				Brownley KA, 2016, ANN INTERN MED, V165, P409, DOI 10.7326/M15-2455; Grilo CM, 2009, INT J EAT DISORDER, V42, P228, DOI 10.1002/eat.20599; Mitchell JE, 2016, INT J EAT DISORDER, V49, P319, DOI 10.1002/eat.22452; Wilfley DE, 2002, ARCH GEN PSYCHIAT, V59, P713, DOI 10.1001/archpsyc.59.8.713; Wilson GT, 2010, ARCH GEN PSYCHIAT, V67, P94, DOI 10.1001/archgenpsychiatry.2009.170	5	3	3	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2017	166	3					230	231		10.7326/L16-0622	http://dx.doi.org/10.7326/L16-0622			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7DL	28166553				2022-12-28	WOS:000394781200017
J	Zarocostas, J				Zarocostas, John			Three candidates compete for WHO Director-General post	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					490	490		10.1016/S0140-6736(17)30229-5	http://dx.doi.org/10.1016/S0140-6736(17)30229-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ5UH	28153382				2022-12-28	WOS:000393283400017
J	Curtis, KM; Peipert, JF				Curtis, Kathryn M.; Peipert, Jeffrey F.			Long-Acting Reversible Contraception	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDICAL ELIGIBILITY CRITERIA; PELVIC-INFLAMMATORY-DISEASE; BREAST-FEEDING WOMEN; INTRAUTERINE-DEVICE; UNINTENDED PREGNANCY; EXTENDED USE; LEVONORGESTREL; ETONOGESTREL; INSERTION; RECOMMENDATIONS	A 17-year-old high school student who has never been pregnant presents for advice regarding contraception. She has an unremarkable medical history and is planning to become sexually active with her boyfriend in the near future. Her primary concern is an unintended pregnancy, and she inquires about methods of contraception that are highly effective. How would you counsel her about options for contraception?	[Curtis, Kathryn M.] Ctr Dis Control & Prevent, MS F-17,4770 Buford Hwy NE, Atlanta, GA 30341 USA; [Peipert, Jeffrey F.] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA	Centers for Disease Control & Prevention - USA; Indiana University System; Indiana University Bloomington	Curtis, KM (corresponding author), Ctr Dis Control & Prevent, MS F-17,4770 Buford Hwy NE, Atlanta, GA 30341 USA.	kmc6@cdc.gov	Peipert, Jeffrey F./ABC-1981-2020		Teva Pharmaceuticals; Perrigo Pharmaceuticals; Bayer Healthcare; Merck	Teva Pharmaceuticals(Teva Pharmaceutical Industries); Perrigo Pharmaceuticals; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Merck(Merck & Company)	Dr. Peipert reports receiving fees for serving on advisory boards from Teva Pharmaceuticals and Perrigo Pharmaceuticals and grant support from Bayer Healthcare, Teva Pharmaceuticals, and Merck. No other potential conflict of interest relevant to this article was reported.	Ali M, 2016, HUM REPROD, V31, P2491, DOI 10.1093/humrep/dew222; Ames CM, 2012, CONTRACEPTION, V85, P51, DOI 10.1016/j.contraception.2011.05.002; Angelini Kim, 2016, Nurs Womens Health, V20, P197, DOI 10.1016/j.nwh.2016.01.004; [Anonymous], 2015, Obstet Gynecol, V126, pe44, DOI 10.1097/AOG.0000000000001106; Bahamondes L, 2015, HUM REPROD, V30, P2527, DOI 10.1093/humrep/dev221; Bednarek PH, 2011, NEW ENGL J MED, V364, P2208, DOI 10.1056/NEJMoa1011600; Beeson T, 2014, CONTRACEPTION, V89, P91, DOI 10.1016/j.contraception.2013.09.014; Berenson AB, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.028; Berry-Bibee EN, 2016, CONTRACEPTION, V94, P725, DOI 10.1016/j.contraception.2016.07.006; Biggs MA, 2013, CONTRACEPTION, V88, P629, DOI 10.1016/j.contraception.2013.05.012; Birgisson NE, 2015, J WOMENS HEALTH, V24, P349, DOI 10.1089/jwh.2015.5191; Birgisson NE, 2015, J WOMENS HEALTH, V24, P354, DOI 10.1089/jwh.2015.5190; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P878; Cleland K, 2012, HUM REPROD, V27, P1994, DOI 10.1093/humrep/des140; Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group The American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P983; Curtis KM, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6504a1; Daniels Kimberly, 2015, Natl Health Stat Report, P1; Diedrich JT, 2015, AM J OBSTET GYNECOL, V213, P822, DOI 10.1016/j.ajog.2015.08.077; FARLEY TMM, 1992, LANCET, V339, P785, DOI 10.1016/0140-6736(92)91904-M; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Gavin L, 2014, MMWR RECOMM REP, V63, P1; Grimes DA, 2009, CONTRACEPTION, V80, P497, DOI 10.1016/j.contraception.2009.06.005; Hall AM, 2016, J FAM PLAN REPROD H, V42, P36, DOI 10.1136/jfprhc-2014-101046; Harper CC, 2015, LANCET, V386, P562, DOI 10.1016/S0140-6736(14)62460-0; Harper CC, 2012, FAM MED, V44, P637; Heinemann K, 2015, CONTRACEPTION, V91, P280, DOI 10.1016/j.contraception.2015.01.011; Horton LG, 2016, CONTRACEPTION, V94, P582, DOI 10.1016/j.contraception.2016.07.017; Hubacher D, 2001, NEW ENGL J MED, V345, P561, DOI 10.1056/NEJMoa010438; Kavanaugh ML, 2015, OBSTET GYNECOL, V126, P917, DOI 10.1097/AOG.0000000000001094; Kroelinger CD, 2015, J WOMENS HEALTH, V24, P693, DOI 10.1089/jwh.2015.5401; Lopez LM, 2015, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD003036.PUB3; LUUKKAINEN T, 1990, ANN MED, V22, P85, DOI 10.3109/07853899009147248; Mansour D, 2008, EUR J CONTRACEP REPR, V13, P13, DOI 10.1080/13625180801959931; Mark A, 2013, CONTRACEPTION, V88, P619, DOI 10.1016/j.contraception.2013.05.009; McNicholas C, 2015, OBSTET GYNECOL, V125, P599, DOI 10.1097/AOG.0000000000000690; O'Neil-Callahan M, 2013, OBSTET GYNECOL, V122, P1083, DOI 10.1097/AOG.0b013e3182a91f45; Ortiz ME, 2007, CONTRACEPTION, V75, pS16, DOI 10.1016/j.contraception.2007.01.020; Ott MA, 2014, PEDIATRICS, V134, pE1244, DOI 10.1542/peds.2014-2299; Phillips SJ, 2016, CONTRACEPTION, V94, P226, DOI 10.1016/j.contraception.2015.09.010; Ricketts S, 2014, PERSPECT SEX REPRO H, V46, P125, DOI 10.1363/46e1714; Rosenstock JR, 2012, OBSTET GYNECOL, V120, P1298, DOI [10.1097/AOG.0b013e31827499bd, http://10.1097/AOG.0b013e31827499bd]; Rowe P, 2016, CONTRACEPTION, V93, P498, DOI 10.1016/j.contraception.2016.02.024; Secura GM, 2014, NEW ENGL J MED, V371, P1316, DOI 10.1056/NEJMoa1400506; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Sonalkar S, 2015, EUR J CONTRACEP REPR, V20, P4, DOI 10.3109/13625187.2014.971454; Sonfield A, 2016, ASSESSING GAP COST C; Stoddard AM, 2015, EUR J CONTRACEP REPR, V20, P223, DOI 10.3109/13625187.2015.1010639; TOIVONEN J, 1991, OBSTET GYNECOL, V77, P261, DOI 10.1097/00006250-199102000-00019; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Wu JP, 2014, CONTRACEPTION, V89, P495, DOI 10.1016/j.contraception.2014.02.011; Xu HN, 2012, OBSTET GYNECOL, V120, P21, DOI 10.1097/AOG.0b013e318259565a	53	43	43	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 2	2017	376	5					461	468		10.1056/NEJMcp1608736	http://dx.doi.org/10.1056/NEJMcp1608736			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8WH	28146650	Green Published			2022-12-28	WOS:000393507200009
J	Koh, MJ; Nguyen, TT; Lam, JK; Torker, S; Hyvl, J; Schrock, RR; Hoveyda, AH				Koh, Ming Joo; Nguyen, Thach T.; Lam, Jonathan K.; Torker, Sebastian; Hyvl, Jakub; Schrock, Richard R.; Hoveyda, Amir H.			Molybdenum chloride catalysts for Z-selective olefin metathesis reactions	NATURE			English	Article							CROSS-METATHESIS; TRIFLUOROMETHYLATION; INHIBITOR; COMPLEXES; METAL	The development of catalyst-controlled stereoselective olefin metathesis processes(1) has been a pivotal recent advance in chemistry. The incorporation of appropriate ligands within complexes based on molybdenum(2), tungsten(3) and ruthenium(4) has led to reactivity and selectivity levels that were previously inaccessible. Here we show that molybdenum monoaryloxide chloride complexes furnish higher-energy (Z) isomers of trifluoromethyl-substituted alkenes through cross-metathesis reactions with the commercially available, inexpensive and typically inert Z-1,1,1,4,4,4-hexafluoro-2-butene. Furthermore, otherwise inefficient and non-stereoselective transformations with Z-1,2-dichloroethene and 1,2-dibromoethene can be effected with substantially improved efficiency and Z selectivity. The use of such molybdenum monoaryloxide chloride complexes enables the synthesis of representative biologically active molecules and trifluoromethyl analogues of medicinally relevant compounds. The origins of the activity and selectivity levels observed, which contradict previously proposed principles(5), are elucidated with the aid of density functional theory calculations.	[Koh, Ming Joo; Nguyen, Thach T.; Torker, Sebastian; Hoveyda, Amir H.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA; [Lam, Jonathan K.; Hyvl, Jakub; Schrock, Richard R.] MIT, Dept Chem, Cambridge, MA 02139 USA	Boston College; Massachusetts Institute of Technology (MIT)	Hoveyda, AH (corresponding author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu	Koh, Ming Joo/M-6641-2018; Koh, Ming Joo/GOV-7124-2022; Hyvl, Jakub/Q-7055-2016; Koh, Ming Joo/O-8549-2019	Koh, Ming Joo/0000-0002-2534-4921; Koh, Ming Joo/0000-0002-2534-4921; Hyvl, Jakub/0000-0002-5509-5567; Koh, Ming Joo/0000-0002-2534-4921	United States National Institutes of Health, Institute of General Medical Sciences [GM-59426]; LaMattina Graduate Fellowship; Bristol-Myers Squibb; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059426] Funding Source: NIH RePORTER	United States National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); LaMattina Graduate Fellowship; Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the United States National Institutes of Health, Institute of General Medical Sciences (GM-59426). M.J.K. acknowledges support through LaMattina and Bristol-Myers Squibb Graduate Fellowships. We thank P. Muller for helping to obtain various X-ray structures and X. Shen for advice and experimental assistance. We are grateful to XiMo, AG for gifts of paraffin tablets.	Baasandorj M, 2011, J PHYS CHEM A, V115, P10539, DOI 10.1021/jp206195g; Choi S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5881; Choi WJ, 2015, CHEM SCI, V6, P1454, DOI 10.1039/c4sc02537g; ENGLISH AR, 1990, J MED CHEM, V33, P344, DOI 10.1021/jm00163a055; FUJITA M, 1986, TETRAHEDRON LETT, V27, P2139, DOI 10.1016/S0040-4039(00)84469-X; Gillis EP, 2015, J MED CHEM, V58, P8315, DOI 10.1021/acs.jmedchem.5b00258; Hafner A, 2013, EUR J ORG CHEM, V2013, P7996, DOI 10.1002/ejoc.201301070; Herbert MB, 2015, ANGEW CHEM INT EDIT, V54, P5018, DOI 10.1002/anie.201411588; Hoveyda A. H., 2014, HDB METATHESIS, P503; Hua XY, 1997, PAIN, V71, P313, DOI 10.1016/S0304-3959(97)00003-1; Ichikawa T, 2013, J FLUORINE CHEM, V152, P38, DOI 10.1016/j.jfluchem.2012.10.013; Imhof S, 2001, CHEM COMMUN, P1692, DOI 10.1039/b105031c; Innocenti P, 2012, J MED CHEM, V55, P3228, DOI 10.1021/jm201683b; Kelly M., 2006, Patent Appl., Patent No. [WO 2006/093832 A2, 2006093832, WO 2006093832]; Koh MJ, 2016, NATURE, V531, P459, DOI 10.1038/nature17396; Lin QY, 2014, J ORG CHEM, V79, P10434, DOI 10.1021/jo502040t; Liu XY, 2004, ANGEW CHEM INT EDIT, V43, P879, DOI 10.1002/anie.200353032; LUO XD, 1987, MED RES REV, V7, P29, DOI 10.1002/med.2610070103; Malcolmson SJ, 2008, NATURE, V456, P933, DOI 10.1038/nature07594; Marinescu SC, 2009, J AM CHEM SOC, V131, P58, DOI 10.1021/ja808308e; Mceachern E. J., 2014, Patent, Patent No. [WO 2014/032187 A1, 2014032187]; Meek SJ, 2011, NATURE, V471, P461, DOI 10.1038/nature09957; Nguyen TT, 2016, SCIENCE, V352, P569, DOI 10.1126/science.aaf4622; Poater A, 2007, J AM CHEM SOC, V129, P8207, DOI 10.1021/ja070625y; Ramachandran PV, 2015, ORG LETT, V17, P1252, DOI 10.1021/acs.orglett.5b00235; Ramirez MA, 2008, PHARMACOTHERAPY, V28, P646, DOI 10.1592/phco.28.5.646; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; Shimizu M, 2011, CHEM-ASIAN J, V6, P2536, DOI 10.1002/asia.201100176; Yu M, 2011, NATURE, V479, P88, DOI 10.1038/nature10563; Zlatopolskiy BD, 2004, EUR J ORG CHEM, V2004, P4492, DOI 10.1002/ejoc.200400480	30	97	99	6	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					80	+		10.1038/nature21043	http://dx.doi.org/10.1038/nature21043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28114300	Green Published, Green Accepted			2022-12-28	WOS:000396119300035
J	Lim, XZ				Lim, Xiaozhi			COOLING WITH HEAT	NATURE			English	News Item																			0	8	8	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					23	24		10.1038/542023a	http://dx.doi.org/10.1038/542023a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28150785				2022-12-28	WOS:000396119300012
J	Lerback, J; Hanson, B				Lerback, Jory; Hanson, Brooks			Journals invite too few women to referee	NATURE			English	Editorial Material							GENDER; ECOLOGY		[Lerback, Jory] Univ Utah, Salt Lake City, UT 84112 USA; [Lerback, Jory; Hanson, Brooks] Amer Geophys Union, Washington, DC 20009 USA	Utah System of Higher Education; University of Utah	Lerback, J (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.			Hanson, R. Brooks/0000-0001-6230-7145				Buckley HL, 2014, NEW ZEAL J ECOL, V38, P335; Dutt K, 2016, NAT GEOSCI, V9, P805, DOI [10.1038/NGEO2819, 10.1038/ngeo2819]; Filardo G, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i847; Fox CW, 2016, FUNCT ECOL, V30, P140, DOI 10.1111/1365-2435.12529; Freeman RB, 2015, J LABOR ECON, V33, pS289, DOI 10.1086/678973; Holmes MA, 2015, AM GEOPHYS UNION SP, V70, P1, DOI 10.1002/9781119067573; Kaatz A, 2014, TRENDS PHARMACOL SCI, V35, P371, DOI 10.1016/j.tips.2014.06.005; Primack RB, 2009, BIOL CONSERV, V142, P2415, DOI 10.1016/j.biocon.2009.06.021; US Bureau of Labor Statistics, 2015, 1059 US BUR LAB STAT; US National Science Foundation, 2015, WOM MIN PERS DIS SCI; Williams WM, 2015, P NATL ACAD SCI USA, V112, P5360, DOI 10.1073/pnas.1418878112	11	128	133	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2017	541	7638					455	457		10.1038/541455a	http://dx.doi.org/10.1038/541455a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6LX	28128272	Bronze			2022-12-28	WOS:000396116600022
J	Chhabra, KR; Sacks, GD; Dimick, JB				Chhabra, Karan R.; Sacks, Greg D.; Dimick, Justin B.			Surgical Decision Making Challenging Dogma and Incorporating Patient Preferences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL; APPENDICITIS; APPENDECTOMY		[Chhabra, Karan R.] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Sacks, Greg D.] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA; [Dimick, Justin B.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Dimick, Justin B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chhabra, KR (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.	kchhabra@partners.org	Chhabra, Karan/N-7265-2019		National Institutes of Health; Agency for Healthcare Research and Quality; BlueCross BlueShield of Michigan Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); BlueCross BlueShield of Michigan Foundation	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Dimick reported receiving grant funding from the National Institutes of Health, the Agency for Healthcare Research and Quality, and the BlueCross BlueShield of Michigan Foundation; that he is a cofounder of and holds equity interest in ArborMetrix, a company that makes software for profiling hospital quality and efficiency; and that he has received honoraria from Emory University, Stanford University, University of Pittsburgh, and Texas Heart Institute. No other authors reported disclosures.	Boss EF, 2016, OTOLARYNG HEAD NECK, V154, P405, DOI 10.1177/0194599815620558; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Haut ER, 2016, JAMA SURG, V151, P191, DOI 10.1001/jamasurg.2015.4218; Kruser JM, 2015, J AM GERIATR SOC, V63, P1805, DOI 10.1111/jgs.13615; Livingston E, 2015, JAMA-J AM MED ASSOC, V313, P2327, DOI 10.1001/jama.2015.6266; Salminen P, 2015, JAMA-J AM MED ASSOC, V313, P2340, DOI 10.1001/jama.2015.6154; Schultz JK, 2015, JAMA-J AM MED ASSOC, V314, P1364, DOI 10.1001/jama.2015.12076; Skou ST, 2015, NEW ENGL J MED, V373, P1597, DOI 10.1056/NEJMoa1505467	8	24	25	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					357	358		10.1001/jama.2016.18719	http://dx.doi.org/10.1001/jama.2016.18719			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118462				2022-12-28	WOS:000392509600013
J	Slomski, A				Slomski, Anita			Thiazide Diuretics Protect Bones as Well as Hearts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					351	351		10.1001/jama.2016.19038	http://dx.doi.org/10.1001/jama.2016.19038			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118450				2022-12-28	WOS:000392509600007
J	Cortegiani, A; Russotto, V; Giarratano, A				Cortegiani, Andrea; Russotto, Vincenzo; Giarratano, Antonino			Associations of Antifungal Treatments With Prevention of Fungal Infection in Critically Ill Patients Without Neutropenia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MANAGEMENT; GUIDELINE	CLINICAL QUESTION Are antifungal agents associated with lower rates of mortality and invasive fungal infections when administered before definitive diagnosis of an invasive fungal infection in critically ill patients without neutropenia? BOTTOM LINE Antifungal treatment administered prior to diagnosis of an invasive fungal infection is not associated with either higher or lower rates of all-cause mortality. Antifungal treatment in this setting is associated with lower rates of invasive fungal infections compared with placebo or no intervention in critically ill patients without neutropenia, but the quality of the evidence is low.	[Cortegiani, Andrea; Russotto, Vincenzo; Giarratano, Antonino] Univ Palermo, Sect Anesthesia Analgesia Intens Care & Emergency, Dept Biopathol & Med Biotechnol, Palermo, Italy	University of Palermo	Cortegiani, A (corresponding author), Univ Palermo, Via Vespro 129, I-90127 Palermo, Italy.	andrea.cortegiani@unipa.it	Russotto, Vincenzo/AAC-2388-2022; Cortegiani, Andrea/H-4902-2016; Russotto, Vincenzo/AAM-3265-2020	Cortegiani, Andrea/0000-0003-1416-9993; 	Pfizer; Merck Sharp Dohme; Gilead	Pfizer(Pfizer); Merck Sharp Dohme(Merck & Company); Gilead(Gilead Sciences)	Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Giarratano reported receiving institutional grants and personal fees from Pfizer, Merck Sharp & Dohme, and Gilead. No other disclosures were reported.	Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Cortegiani A, 2016, COCHRANE DB SYST REV, V1; Cortegiani A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1284-7; Kett DH, 2011, CRIT CARE MED, V39, P665, DOI 10.1097/CCM.0b013e318206c1ca; Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933; Playford EG, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004920.pub2	6	16	16	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					311	312		10.1001/jama.2016.16535	http://dx.doi.org/10.1001/jama.2016.16535			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114533				2022-12-28	WOS:000392089200019
J	Deng, YW; Zhai, KR; Xie, Z; Yang, DY; Zhu, XD; Liu, JZ; Wang, X; Qin, P; Yang, YZ; Zhang, GM; Li, Q; Zhang, JF; Wu, SQ; Milazzo, J; Mao, BZ; Wang, ET; Xie, H; Tharreau, D; He, ZH				Deng, Yiwen; Zhai, Keran; Xie, Zhen; Yang, Dongyong; Zhu, Xudong; Liu, Junzhong; Wang, Xin; Qin, Peng; Yang, Yuanzhu; Zhang, Guomin; Li, Qun; Zhang, Jianfu; Wu, Shuangqing; Milazzo, Jolle; Mao, Bizeng; Wang, Ertao; Xie, Huaan; Tharreau, Didier; He, Zuhua			Epigenetic regulation of antagonistic receptors confers rice blast resistance with yield balance	SCIENCE			English	Article							DISEASE RESISTANCE; TRANSPOSABLE ELEMENTS; DNA METHYLATION; GENE; PROTEIN; POLLEN; SYSTEM; PI9	Crop breeding aims to balance disease resistance with yield; however, single resistance (R) genes can lead to resistance breakdown, and R gene pyramiding may affect growth fitness. Here we report that the rice Pigm locus contains a cluster of genes encoding nucleotide-binding leucine-rich repeat (NLR) receptors that confer durable resistance to the fungus Magnaporthe oryzae without yield penalty. Among these NLR receptors, PigmR confers broad-spectrum resistance, whereas PigmS competitively attenuates PigmR homodimerization to suppress resistance. PigmS expression, and thus PigmR-mediated resistance, are subjected to tight epigenetic regulation. PigmS increases seed production to counteract the yield cost induced by PigmR. Therefore, our study reveals a mechanism balancing high disease resistance and yield through epigenetic regulation of paired antagonistic NLR receptors, providing a tool to develop elite crop varieties.	[Deng, Yiwen; Zhai, Keran; Yang, Dongyong; Liu, Junzhong; Wang, Xin; Li, Qun; Wang, Ertao; He, Zuhua] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Deng, Yiwen; Zhai, Keran; Yang, Dongyong; Liu, Junzhong; Wang, Xin; Li, Qun; Wang, Ertao; He, Zuhua] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Natl Ctr Plant Gene Res, Shanghai, Peoples R China; [Zhai, Keran; Yang, Dongyong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xie, Zhen; Mao, Bizeng; He, Zuhua] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Zhu, Xudong] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Qin, Peng; Yang, Yuanzhu] Sci Acad Hunan, State Key Lab Hybrid Rice & Yahua Seeds, Changsha, Hunan, Peoples R China; [Zhang, Guomin] Heilongjiang Acad Agr Sci, Harbin, Peoples R China; [Zhang, Jianfu; Xie, Huaan] Fujian Acad Agr Sci, Fuzhou, Peoples R China; [Wu, Shuangqing] Enshi Tujia & Miao Autonomous Prefecture Acad Agr, Enshi, Peoples R China; [Milazzo, Jolle; Tharreau, Didier] CIRAD Ctr Cooperat Int Rech Agronom Dev, UMR BGPI Biol & Genet Interact Plante Parasite, Montpellier, France; [He, Zuhua] Chinese Acad Sci, Collaborat Innovat Ctr Genet & Dev, Shanghai Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Heilongjiang Academy of Agricultural Sciences; Fujian Academy of Agricultural Sciences; CIRAD; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	He, ZH (corresponding author), Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.; He, ZH (corresponding author), Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Natl Ctr Plant Gene Res, Shanghai, Peoples R China.; He, ZH (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou, Zhejiang, Peoples R China.; He, ZH (corresponding author), Chinese Acad Sci, Collaborat Innovat Ctr Genet & Dev, Shanghai Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China.	zhhe@sibs.ac.cn	Tharreau, Didier/ABH-1048-2021; mao, bizeng/U-3958-2017; cxzhou, cxzhou/AEO-7639-2022; WANG, TAO ER/GYV-0174-2022; Wang, Ertao/GYU-4506-2022; Tharreau, Didier/AAI-8632-2020	mao, bizeng/0000-0001-9852-6171; Wang, Ertao/0000-0002-5178-3530; Tharreau, Didier/0000-0003-3961-6120; deng, yi wen/0000-0002-6074-5704; Liu, Junzhong/0000-0001-7751-6775; yang, dongyong/0000-0001-9368-2730	Chinese Academy of Sciences [XDA08010201-1]; Ministry of Agriculture of China [2014ZX08009-003-001]; National Natural Science Foundation of China [31330061]; Ministry of Science and Technology of China [2016YFD0100600]; Science and Technology Commission of Shanghai Municipality [201404040301037]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	We thank D. Weigel, X. Cao, and S. Y. He for critical comments; Q. Feng and B. Han for the BAC sequence; J. Liu, L. Zeng, J. Wang, X. Zhang, and S. Ye for rice growth; and X. Yin, M. Gao, and C. Tertois for inoculation. R. Tao, R. Chai, Z. Hao, Z. Wang, G. Lu, H. He, Y. Peng, and G. Pan helped with nursery testing. This work was supported by grants from the Chinese Academy of Sciences (XDA08010201-1), the Ministry of Agriculture of China (2014ZX08009-003-001), the National Natural Science Foundation of China (31330061), the Ministry of Science and Technology of China (2016YFD0100600), and the Science and Technology Commission of Shanghai Municipality (201404040301037). The supplementary materials contain additional data.	Amien S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000388; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Brown JKM, 2003, TRENDS GENET, V19, P667, DOI 10.1016/j.tig.2003.10.008; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Calarco JP, 2012, CELL, V151, P194, DOI 10.1016/j.cell.2012.09.001; Cui XK, 2014, CURR OPIN PLANT BIOL, V21, P83, DOI 10.1016/j.pbi.2014.07.001; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Denance N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00155; Deng YW, 2006, THEOR APPL GENET, V113, P705, DOI 10.1007/s00122-006-0338-7; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Gallet R, 2016, PHYTOPATHOLOGY, V106, P348, DOI 10.1094/PHYTO-07-15-0169-R; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Kikuchi K, 2003, NATURE, V421, P167, DOI 10.1038/nature01218; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Saleh D, 2014, NEW PHYTOL, V201, P1440, DOI 10.1111/nph.12627; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Takahashi A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-175; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Wei LQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-338; Wei LY, 2014, P NATL ACAD SCI USA, V111, P3877, DOI 10.1073/pnas.1318131111; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Zhang N, 2016, IMA FUNGUS, V7, P155, DOI 10.5598/imafungus.2016.07.01.09; Zhou B, 2006, MOL PLANT MICROBE IN, V19, P1216, DOI 10.1094/MPMI-19-1216	26	285	361	40	423	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328					962	965		10.1126/science.aai8898	http://dx.doi.org/10.1126/science.aai8898			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28154240				2022-12-28	WOS:000395181700042
J	Resnic, FS; Majithia, A; Marinac-Dabic, D; Robbins, S; Ssemaganda, H; Hewitt, K; Ponirakis, A; Loyo-Berrios, N; Moussa, I; Drozda, J; Normand, SL; Matheny, ME				Resnic, Frederic S.; Majithia, Arjun; Marinac-Dabic, Danica; Robbins, Susan; Ssemaganda, Henry; Hewitt, Kathleen; Ponirakis, Angelo; Loyo-Berrios, Nilsa; Moussa, Issam; Drozda, Joseph; Normand, Sharon-Lise; Matheny, Michael E.			Registry-Based Prospective, Active Surveillance of Medical-Device Safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; RISK; VALIDATION; SYSTEM; SCORE	BACKGROUND The process of assuring the safety of medical devices is constrained by reliance on voluntary reporting of adverse events. We evaluated a strategy of prospective, active surveillance of a national clinical registry to monitor the safety of an implantable vascular-closure device that had a suspected association with increased adverse events after percutaneous coronary intervention (PCI). METHODS We used an integrated clinical-data surveillance system to conduct a prospective, propensity-matched analysis of the safety of the Mynx vascular-closure device, as compared with alternative approved vascular-closure devices, with data from the CathPCI Registry of the National Cardiovascular Data Registry. The primary outcome was any vascular complication, which was a composite of access-site bleeding, access-site hematoma, retroperitoneal bleeding, or any vascular complication requiring intervention. Secondary safety end points were access-site bleeding requiring treatment and postprocedural blood transfusion. RESULTS We analyzed data from 73,124 patients who had received Mynx devices after PCI procedures with femoral access from January 1, 2011, to September 30, 2013. The Mynx device was associated with a significantly greater risk of any vascular complication than were alternative vascular-closure devices (absolute risk, 1.2% vs. 0.8%; relative risk, 1.59; 95% confidence interval [CI], 1.42 to 1.78; P<0.001); there was also a significantly greater risk of access-site bleeding (absolute risk, 0.4% vs. 0.3%; relative risk, 1.34; 95% CI, 1.10 to 1.62; P = 0.001) and transfusion (absolute risk, 1.8% vs. 1.5%; relative risk, 1.23; 95% CI, 1.13 to 1.34; P<0.001). The initial alerts occurred within the first 12 months of monitoring. Relative risks were greater in three prespecified high-risk subgroups: patients with diabetes, those 70 years of age or older, and women. All safety alerts were confirmed in an independent sample of 48,992 patients from April 1, 2014, to September 30, 2015. CONCLUSIONS A strategy of prospective, active surveillance of a clinical registry rapidly identified potential safety signals among recipients of an implantable vascular-closure device, with initial alerts occurring within the first 12 months of monitoring.	[Resnic, Frederic S.; Majithia, Arjun; Robbins, Susan; Ssemaganda, Henry] Lahey Hosp & Med Ctr, Comparat Effectiveness Res Inst, Burlington, MA USA; [Resnic, Frederic S.] Tufts Sch Med, Boston, MA USA; [Normand, Sharon-Lise] Harvard Med Sch, Boston, MA USA; [Normand, Sharon-Lise] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Marinac-Dabic, Danica; Loyo-Berrios, Nilsa] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA; [Hewitt, Kathleen; Ponirakis, Angelo] Amer Coll Cardiol, Natl Cardiovasc Data Registry, Washington, DC USA; [Moussa, Issam] First Coast Cardiovasc Inst, Jacksonville, FL USA; [Moussa, Issam] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA; [Drozda, Joseph] Mercy Hlth, St Louis, MO USA; [Matheny, Michael E.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Matheny, Michael E.] Vanderbilt Univ, Med Ctr, Ctr Populat Hlth Informat, Dept Biomed Informat, Nashville, TN USA; [Matheny, Michael E.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Matheny, Michael E.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	Lahey Hospital & Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; US Food & Drug Administration (FDA); American College of Cardiology; State University System of Florida; University of Central Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University	Resnic, FS (corresponding author), Lahey Hosp & Med Ctr, Dept Cardiovasc Med, 41 Mall Rd, Burlington, MA 01805 USA.	frederic.resnic@lahey.org	Matheny, Michael E/B-3541-2008	Matheny, Michael E/0000-0003-3217-4147; Normand, Sharon-Lise/0000-0001-7027-4769; Marinac-Dabic, Danica/0000-0002-1824-0104	Food and Drug Administration (FDA) [223200830058C, U01 FD004963]; William M. Wood Foundation; FDA [223201110172C, U01 FD004493]; Department of Veterans Affairs [VA HSRD CDA 08-020, VA HSRD IIR 11-292]; St. Jude Medical; FOOD AND DRUG ADMINISTRATION [U01FD004493, U01FD004963] Funding Source: NIH RePORTER	Food and Drug Administration (FDA)(United States Department of Health & Human Services); William M. Wood Foundation; FDA(United States Department of Health & Human Services); Department of Veterans Affairs(US Department of Veterans Affairs); St. Jude Medical(St. Jude Medical); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	Supported by grants (HHSF contract 223200830058C and U01 FD004963, to Dr. Resnic) from the Food and Drug Administration (FDA) and by the William M. Wood Foundation; a grant (HHSF contract 223201110172C through the MDEpiNet Methodology Center, to Drs. Resnic and Normand) from the FDA; a grant (U01 FD004493 through the MDEpiNet Medical Counter Measures Study, to Dr. Normand) from the FDA; and grants (VA HSR&D CDA 08-020 and VA HSR&D IIR 11-292, to Dr. Matheny) from the Department of Veterans Affairs.; Dr. Resnic reports receiving consulting fees from St. Jude Medical. No other potential conflict of interest relevant to this article was reported.	Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, MED DECIS MAKING, V29, P661, DOI 10.1177/0272989X09341755; Bernaards CA, 2007, STAT MED, V26, P1368, DOI 10.1002/sim.2619; Hauser RG, 2007, HEART RHYTHM, V4, P892, DOI 10.1016/j.hrthm.2007.03.041; Hauser RG, 2012, CIRC-CARDIOVASC QUAL, V5, P189, DOI 10.1161/CIRCOUTCOMES.111.962621; KESSLER DA, 1994, GEN HOSP PSYCHIAT, V16, P96, DOI 10.1016/0163-8343(94)90051-5; Krucoff MW, 2015, JAMA-J AM MED ASSOC, V314, P1691, DOI 10.1001/jama.2015.11036; Kumar A, 2015, CIRC-CARDIOVASC QUAL, V8, P38, DOI 10.1161/CIRCOUTCOMES.114.001123; Maisel WH, 2008, NEW ENGL J MED, V358, P985, DOI 10.1056/NEJMp0800495; Maisel WH, 2007, NEW ENGL J MED, V356, P981, DOI 10.1056/NEJMp068305; Matheny ME, 2006, J AM MED INFORM ASSN, V13, P180, DOI 10.1197/jamia.M1908; Matheny ME, 2007, AMIA ANN S P, V11, P518; Matheny ME, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-75; Matheny ME, 2009, MED DECIS MAKING, V29, P247, DOI 10.1177/0272989X08327110; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Mehran R, 2004, CIRCULATION, V109, P3073, DOI 10.1161/01.CIR.0000134694.78653.B6; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Normand SLT, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6848; O'Shea JC, 2004, AM HEART J, V147, P977, DOI 10.1016/j.ahj.2004.03.001; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Resnic FS, 2012, NEW ENGL J MED, V366, P875, DOI 10.1056/NEJMp1114865; Resnic FS, 2012, JACC-CARDIOVASC INTE, V5, P82, DOI 10.1016/j.jcin.2011.09.017; Resnic FS, 2010, JAMA-J AM MED ASSOC, V304, P2019, DOI 10.1001/jama.2010.1633; Rosen CJ, 2007, NEW ENGL J MED, V357, P844, DOI 10.1056/NEJMp078167; Shah JS, 2006, JAMA-J AM MED ASSOC, V296, P655, DOI 10.1001/jama.296.6.655; Steele GD, 2011, J ARTHROPLASTY, V26, P14, DOI 10.1016/j.arth.2011.03.027; Tavris DR, 2012, J INVASIVE CARDIOL, V24, P328; Vidi VD, 2011, CONTEMP CLIN TRIALS, V32, P307, DOI 10.1016/j.cct.2011.02.002	28	44	47	2	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2017	376	6					526	535		10.1056/NEJMoa1516333	http://dx.doi.org/10.1056/NEJMoa1516333			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8XL	28121489	Green Accepted			2022-12-28	WOS:000393510500007
J	Brownley, KA; Berkman, ND; Peat, CM; Lohr, KN; Bulik, CM				Brownley, Kimberly A.; Berkman, Nancy D.; Peat, Christine M.; Lohr, Kathleen N.; Bulik, Cynthia M.			Binge-Eating Disorder in Adults Response	ANNALS OF INTERNAL MEDICINE			English	Letter									[Brownley, Kimberly A.; Peat, Christine M.; Bulik, Cynthia M.] Univ N Carolina, Chapel Hill, NC 27514 USA; [Berkman, Nancy D.; Lohr, Kathleen N.] RTI Int, Res Triangle Pk, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute	Brownley, KA (corresponding author), Univ N Carolina, Chapel Hill, NC 27514 USA.			Brownley, Kim/0000-0002-5635-9229; Lohr, Kathleen/0000-0002-3825-0713; Berkman, Nancy/0000-0003-3617-1082				[Anonymous], 2014, AHRQ PUBLICATION, V10(12)-EHC063-EF; Berkman N.D., 2015, AHRQ PUBLICATION; Samson D, 2012, METHODS GUIDE MED TE, P1	3	3	5	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2017	166	3					231	232		10.7326/L16-0621	http://dx.doi.org/10.7326/L16-0621			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7DL	28166552				2022-12-28	WOS:000394781200018
J	Zuger, A				Zuger, Abigail			Bellevue Gets Its Biography	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Zuger, Abigail] Mt Sinai West & Mt Sinai St Lukes Hosp, Dept Med, New York, NY 10025 USA	Mount Sinai St. Luke's; Mount Sinai West	Zuger, A (corresponding author), Mt Sinai West & Mt Sinai St Lukes Hosp, Dept Med, New York, NY 10025 USA.	abigail.zuger@mountsinai.org							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					460	461		10.1001/jama.2016.20313	http://dx.doi.org/10.1001/jama.2016.20313			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28170457	Bronze			2022-12-28	WOS:000393564200001
J	Cederman, LE; Weidmann, NB				Cederman, Lars-Erik; Weidmann, Nils B.			Predicting armed conflict: Time to adjust our expectations?	SCIENCE			English	Editorial Material							POLICY	This Essay provides an introduction to the general challenges of predicting political violence, particularly compared with predicting other types of events (such as earthquakes). What is possible? What is less realistic? We aim to debunk myths about predicting violence, as well as to illustrate the substantial progress in this field.	[Cederman, Lars-Erik] Swiss Fed Inst Technol, Zurich, Switzerland; [Weidmann, Nils B.] Univ Konstanz, Constance, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Konstanz	Cederman, LE (corresponding author), Swiss Fed Inst Technol, Zurich, Switzerland.; Weidmann, NB (corresponding author), Univ Konstanz, Constance, Germany.	lcederman@ethz.ch; nils.weidmann@uni-konstanz.de	Weidmann, Nils B/P-8172-2016	Weidmann, Nils B/0000-0002-4791-4913	Alexander von Humboldt Foundation (Sofja Kovalevskaja Award)	Alexander von Humboldt Foundation (Sofja Kovalevskaja Award)(Alexander von Humboldt Foundation)	We thank H. Hegre, P. Hunziker, D. Lazer, and J. Wucherpfennig for comments on a draft of this paper and L. Kawerau for research assistance. N.B.W. acknowledges financial support from the Alexander von Humboldt Foundation (Sofja Kovalevskaja Award).	[Anonymous], 1997, EMERGENT ACTORS WORL; Beck N, 2000, AM POLIT SCI REV, V94, P21, DOI 10.2307/2586378; Brandt PT, 2011, CONFLICT MANAG PEACE, V28, P41, DOI 10.1177/0738894210388125; Hayek F.A., 2017, CRITICAL APPROACH SC, P332, DOI DOI 10.4324/9781351313087-22; Hegre H, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/5/054002; Helbing D, 2015, J STAT PHYS, V158, P735, DOI 10.1007/s10955-014-1024-9; Jerven M., 2013, POOR NUMBERS WE ARE; Lim M, 2007, SCIENCE, V317, P1540, DOI 10.1126/science.1142734; Milanovic B., 2016, GLOBAL INEQUALITY NE, P21; Muchlinski D, 2016, POLIT ANAL, V24, P87, DOI 10.1093/pan/mpv024; O'Brien SP, 2010, INT STUD REV, V12, P87, DOI 10.1111/j.1468-2486.2009.00914.x; Perry C, 2013, STABILITY, V2, DOI 10.5334/sta.cr; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Tetlock PE, 2017, SCIENCE, V355, P481, DOI 10.1126/science.aal3147; Ulfelder J., 2012, FOREIGN POLICY; Wang W, 2016, SCIENCE, V353, P1502, DOI 10.1126/science.aaf6758; Ward MD, 2010, J PEACE RES, V47, P363, DOI 10.1177/0022343309356491; Weidmann NB, 2016, AM J POLIT SCI, V60, P206, DOI 10.1111/ajps.12196; Weidmann NB, 2010, J CONFLICT RESOLUT, V54, P883, DOI 10.1177/0022002710371669; Weidmann NB, 2010, CONFLICT MANAG PEACE, V27, P159, DOI 10.1177/0738894209359119	21	60	60	7	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					474	476		10.1126/science.aal4483	http://dx.doi.org/10.1126/science.aal4483			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154047				2022-12-28	WOS:000393183100031
J	Wang, XD; Brandao, HB; Le, TBK; Laub, MT; Rudner, DZ				Wang, Xindan; Brandao, Hugo B.; Le, Tung B. K.; Laub, Michael T.; Rudner, David Z.			Bacillus subtilis SMC complexes juxtapose chromosome arms as they travel from origin to terminus	SCIENCE			English	Article							BACTERIAL CHROMOSOME; B. SUBTILIS; CONDENSIN; DNA; ORGANIZATION; REPLICATION; SEGREGATION; PROMOTES; GENOME; ARCHITECTURE	Structural maintenance of chromosomes (SMC) complexes play critical roles in chromosome dynamics in virtually all organisms, but how they function remains poorly understood. In the bacterium Bacillus subtilis, SMC-condensin complexes are topologically loaded at centromeric sites adjacent to the replication origin. Here we provide evidence that these ring-shaped assemblies tether the left and right chromosome arms together while traveling from the origin to the terminus (>2 megabases) at rates >50 kilobases per minute. Condensin movement scales linearly with time, providing evidence for an active transport mechanism. These data support a model in which SMC complexes function by processively enlarging DNA loops. Loop formation followed by processive enlargement provides a mechanism by which condensin complexes compact and resolve sister chromatids in mitosis and by which cohesin generates topologically associating domains during interphase.	[Wang, Xindan; Rudner, David Z.] Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA; [Brandao, Hugo B.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Le, Tung B. K.; Laub, Michael T.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Laub, Michael T.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Wang, Xindan] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Le, Tung B. K.] John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Indiana University System; Indiana University Bloomington; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Wang, XD; Rudner, DZ (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.; Wang, XD (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	xindan@indiana.edu; rudner@hms.harvard.edu	Wang, Xindan/Q-6600-2019	Wang, Xindan/0000-0001-6458-180X; Le, Tung BK/0000-0003-4764-8851; Laub, Michael/0000-0002-8288-7607; Brandao, Hugo/0000-0001-5496-0638	NIH [GM086466, GM073831, GM082899]; Natural Sciences and Engineering Research Council of Canada Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082899, R01GM086466, R01GM073831] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Hi-C and ChIP-seq data wee deposited in the Gene Expression Omnibus (accession no. GSE85612). We thank members of the Ruder and Bernhardt labs and J. Loparo for stimulating discussions; K. Marquis, C. Morlot, and A. Grossman to aritibodies; and S. Dove and K. Ramey for advice on ChIP-seq Support for this work comes from NIH grants GM086466 and GM073831 (D.Z.R..) and GM082899 (M.T.L.) H.B.B. was supported by a Natural Sciences and Engineering Research Council of Canada Fellowship. M.T.L. is an investigator of the Howard Hughes Medical Institute.	Alipour E, 2012, NUCLEIC ACIDS RES, V40, P11202, DOI 10.1093/nar/gks925; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Cabrera JE, 2003, MOL MICROBIOL, V50, P1493, DOI 10.1046/j.1365-2958.2003.03805.x; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Goloborodko A, 2016, ELIFE, V5, DOI 10.7554/eLife.14864; Gruber S, 2014, CURR BIOL, V24, P293, DOI 10.1016/j.cub.2013.12.049; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Kim H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10200; Le TBK, 2013, SCIENCE, V342, P731, DOI 10.1126/science.1242059; Marbouty M, 2015, MOL CELL, V59, P588, DOI 10.1016/j.molcel.2015.07.020; Marko JF, 2008, CHROMOSOME RES, V16, P469, DOI 10.1007/s10577-008-1233-7; Minnen A, 2016, CELL REP, V14, P2003, DOI 10.1016/j.celrep.2016.01.066; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Soh YM, 2015, MOL CELL, V57, P290, DOI 10.1016/j.molcel.2014.11.023; Stigler J, 2016, CELL REP, V15, P988, DOI 10.1016/j.celrep.2016.04.003; Strick TR, 2004, CURR BIOL, V14, P874, DOI 10.1016/j.cub.2004.04.038; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; Wang XD, 2015, GENE DEV, V29, P1661, DOI 10.1101/gad.265876.115; Wang XD, 2014, CURR BIOL, V24, P287, DOI 10.1016/j.cub.2013.11.050; Wilhelm L, 2015, ELIFE, V4, DOI 10.7554/eLife.06659	24	147	147	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					524	527		10.1126/science.aai8982	http://dx.doi.org/10.1126/science.aai8982			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154080	Green Submitted, Green Accepted			2022-12-28	WOS:000393183100045
J	Wu, QF; Shen, PX; He, J; Wang, XB; Zhang, F; Shao, Q; Zhu, RY; Mapelli, C; Qiao, JX; Poss, MA; Yu, JQ				Wu, Qing-Feng; Shen, Peng-Xiang; He, Jian; Wang, Xiao-Bing; Zhang, Forrest; Shao, Qian; Zhu, Ru-Yi; Mapelli, Claudio; Qiao, Jennifer X.; Poss, Michael A.; Yu, Jin-Quan			Formation of alpha-chiral centers by asymmetric beta-C(sp(3))-H arylation, alkenylation, and alkynylation	SCIENCE			English	Article							C-H ARYLATION; BETA-HYDROXYISOBUTYRIC ACID; BOND ACTIVATION; C(SP(3))-H BONDS; ISOBUTYRIC ACID; MILD CONDITIONS; LIGAND; FUNCTIONALIZATION; AUXILIARY; INDOLINES	The enzymatic beta-C-H hydroxylation of the feedstock chemical isobutyric acid has enabled the asymmetric synthesis of a wide variety of polyketides. The analogous transition metal-catalyzed enantioselective beta-C-H functionalization of isobutyric acid-derived substrates should provide a versatile method for constructing useful building blocks with enantioenriched a-chiral centers from this abundant C-4 skeleton. However, the desymmetrization of ubiquitous isopropyl moieties by organometallic catalysts has remained an unanswered challenge. Herein, we report the design of chiral mono-protected aminomethyl oxazoline ligands that enable desymmetrization of isopropyl groups via palladium insertion into the C(sp(3))-H bonds of one of the prochiral methyl groups. We detail the enantioselective beta-arylation, -alkenylation, and -alkynylation of isobutyric acid/2-aminoisobutyric acid derivatives, which may serve as a platform for the construction of a-chiral centers.	[Wu, Qing-Feng; Shen, Peng-Xiang; He, Jian; Wang, Xiao-Bing; Zhang, Forrest; Shao, Qian; Zhu, Ru-Yi; Yu, Jin-Quan] Scripps Res Inst, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Mapelli, Claudio; Qiao, Jennifer X.; Poss, Michael A.] Bristol Myers Squibb Co, Discovery Chem Res & Dev, POB 4000, Princeton, NJ 08543 USA	Scripps Research Institute; Bristol-Myers Squibb	Yu, JQ (corresponding author), Scripps Res Inst, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	yu200@scripps.edu	Zhu, Ruyi/AAO-4630-2021; He, Jian/R-9985-2016; Wang, Xiaobing/H-1541-2011; Wang, Xiaobing/H-5927-2019; Wu, Qingfeng/B-8045-2018	He, Jian/0000-0002-3388-3239; Wang, Xiaobing/0000-0001-5044-3721; Wang, Xiaobing/0000-0001-5044-3721; Wu, Qingfeng/0000-0003-2993-9882; Qiao, Jennifer/0000-0002-6685-2092	Scripps Research Institute; NIH (National Institute of General Medical Sciences) [2R01GM084019]; Bristol-Myers Squibb; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084019] Funding Source: NIH RePORTER	Scripps Research Institute; NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge The Scripps Research Institute, the NIH (National Institute of General Medical Sciences grant 2R01GM084019), and Bristol-Myers Squibb for financial support. We thank T. G. Saint-Denis, M. E. Farmers, and A. Tran for editorial assistance. J.-Q.Y conceived the concept. Q.-F.W. developed the chiral ligands, optimized the reaction conditions, and surveyed the substrate scope. P.-X.S. performed the sequential C-H functionalization reactions. J.H., X.-B.W., F.Z., and Q.S. optimized the chiral ligands. R.-Y.Z. performed the C-H bromination reaction. C.M., J.X.Q., and M.A.P. scaled up the C-H activation reaction for the preparation of beta-arylated 2-aminoisobutyric acids. J.-Q.Y. directed the project. Additional data supporting the conclusions are in the supplementary materials. Metrical parameters for the structures of L23 and 4c are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers 1518967 and 1518968, respectively.	Anas S, 2011, CHEM COMMUN, V47, P11483, DOI 10.1039/c1cc14292e; Bode JW, 2001, ANGEW CHEM INT EDIT, V40, P2082, DOI 10.1002/1521-3773(20010601)40:11<2082::AID-ANIE2082>3.0.CO;2-1; Chen G, 2016, SCIENCE, V353, P1023, DOI 10.1126/science.aaf4434; Chen G, 2015, J AM CHEM SOC, V137, P3338, DOI 10.1021/ja512690x; Corey E. J., 2010, ENANTIOSELECTIVE CHE; Engle KM, 2013, J ORG CHEM, V78, P8927, DOI 10.1021/jo400159y; Feng JJ, 2016, J AM CHEM SOC, V138, P5467, DOI 10.1021/jacs.6b02019; Giri R, 2005, ANGEW CHEM INT EDIT, V44, P7420, DOI 10.1002/anie.200502767; Giri R, 2005, ANGEW CHEM INT EDIT, V44, P2112, DOI 10.1002/anie.200462884; Giri R, 2012, J AM CHEM SOC, V134, P14118, DOI 10.1021/ja304643e; Giri R, 2009, CHEM SOC REV, V38, P3242, DOI 10.1039/b816707a; GOODHUE CT, 1971, BIOTECHNOL BIOENG, V13, P203, DOI 10.1002/bit.260130204; HASEGAWA J, 1981, J FERMENT TECHNOL, V59, P203; He C, 2015, ANGEW CHEM INT EDIT, V54, P15840, DOI 10.1002/anie.201508912; Holstein PM, 2016, ANGEW CHEM INT EDIT, V55, P2805, DOI 10.1002/anie.201511457; Holstein PM, 2015, ACS CATAL, V5, P4300, DOI 10.1021/acscatal.5b00898; Jain P., 2016, NAT CHEM, V134, P14118; Larionov E, 2013, CHEM SCI, V4, P1995, DOI 10.1039/c3sc00098b; Lawhorn BG, 2006, J AM CHEM SOC, V128, P16720, DOI 10.1021/ja066477d; Martin N, 2012, CHEM-EUR J, V18, P4480, DOI 10.1002/chem.201200018; Murai M, 2015, J ORG CHEM, V80, P5407, DOI 10.1021/acs.joc.5b00920; Musaev DG, 2012, J AM CHEM SOC, V134, P1690, DOI 10.1021/ja208661v; Nakanishi M, 2011, ANGEW CHEM INT EDIT, V50, P7438, DOI 10.1002/anie.201102639; Paterson I, 2004, ANGEW CHEM INT EDIT, V43, P4629, DOI 10.1002/anie.200460589; Renaudat A, 2010, ANGEW CHEM INT EDIT, V49, P7261, DOI 10.1002/anie.201003544; Sagan S, 2004, CURR MED CHEM, V11, P2799, DOI 10.2174/0929867043364108; Saget T, 2012, ANGEW CHEM INT EDIT, V51, P2238, DOI 10.1002/anie.201108511; Venkatraman J, 2001, CHEM REV, V101, P3131, DOI 10.1021/cr000053z; Wang H, 2016, ANGEW CHEM INT EDIT, V55, P15387, DOI 10.1002/anie.201609337; Xiao KJ, 2014, J AM CHEM SOC, V136, P8138, DOI 10.1021/ja504196j; Yan SB, 2015, ORG LETT, V17, P2458, DOI 10.1021/acs.orglett.5b00968; Yang L, 2017, CHEM SCI, V8, P1344, DOI 10.1039/c6sc04006c; Zhu RY, 2016, ANGEW CHEM INT EDIT, V55, P10578, DOI 10.1002/anie.201600791	33	130	129	6	215	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					499	+		10.1126/science.aal5175	http://dx.doi.org/10.1126/science.aal5175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154075	Green Accepted			2022-12-28	WOS:000393183100039
J	Kristensen, VN				Kristensen, Vessela N.			The Antigenicity of the Tumor Cell - Context Matters	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CANCER		[Kristensen, Vessela N.] Akershus Univ Hosp, Div Med, Dept Clin Mol Biol EpiGen, Lorenskog, Norway; [Kristensen, Vessela N.] Oslo Univ Hosp, Radiumhosp, Inst Canc Res, Dept Genet, Oslo, Norway	University of Oslo; University of Oslo	Kristensen, VN (corresponding author), Akershus Univ Hosp, Div Med, Dept Clin Mol Biol EpiGen, Lorenskog, Norway.; Kristensen, VN (corresponding author), Oslo Univ Hosp, Radiumhosp, Inst Canc Res, Dept Genet, Oslo, Norway.							Gros A, 2016, NAT MED, V22, P433, DOI 10.1038/nm.4051; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Stronen E, 2016, SCIENCE, V352, P1337, DOI 10.1126/science.aaf2288; Verdegaal EME, 2016, NATURE, V536, P91, DOI 10.1038/nature18945	4	14	16	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 2	2017	376	5					491	493		10.1056/NEJMcibr1613793	http://dx.doi.org/10.1056/NEJMcibr1613793			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8WH	28146670				2022-12-28	WOS:000393507200017
J	Morello, L; Reardon, S				Morello, Lauren; Reardon, Sara			Scientists struggle with Trump immigration ban	NATURE			English	News Item																			0	7	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					13	14		10.1038/nature.2017.21389	http://dx.doi.org/10.1038/nature.2017.21389			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28150786	Bronze			2022-12-28	WOS:000396119300006
J	Atran, S; Axelrod, R; Davis, R; Fischhoff, B				Atran, Scott; Axelrod, Robert; Davis, Richard; Fischhoff, Baruch			SCIENCE AND SECURITY Challenges in researching terrorism from the field Research must focus on how youth are engaged	SCIENCE			English	Editorial Material									[Atran, Scott; Axelrod, Robert; Davis, Richard; Fischhoff, Baruch] ARTIS Int Scottsdale, Scottsdale, AZ 85254 USA; [Atran, Scott] CNRS, F-75016 Paris, France; [Atran, Scott; Axelrod, Robert] Univ Michigan, Ann Arbor, MI 48109 USA; [Atran, Scott; Davis, Richard] Univ Oxford, Oxford OX1 3PA, England; [Fischhoff, Baruch] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA	Centre National de la Recherche Scientifique (CNRS); University of Michigan System; University of Michigan; University of Oxford; Carnegie Mellon University	Atran, S (corresponding author), ARTIS Int Scottsdale, Scottsdale, AZ 85254 USA.; Atran, S (corresponding author), CNRS, F-75016 Paris, France.; Atran, S (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.; Atran, S (corresponding author), Univ Oxford, Oxford OX1 3PA, England.	satran@umich.edu	Fischhoff, Baruch/I-9859-2014	Fischhoff, Baruch/0000-0002-3030-6874	Direct For Social, Behav & Economic Scie [1559387] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Atran S., 2015, YOUTH VIOLENT EXTREM; Atran S., 2009, THEORETICAL FRAMES P; Briggs B., 2015, GUARDIAN; Davulcu H., 2015, ILLUMINATING DARK NE, P84; Del Felice C., 2015, YOUTH IMPACT PEACE M; DoD, 2015, US DEP DEF FISC YEAR, P2; DoD, 2016, GUID FY2016 RES FUND, P9; Doosje B, 2016, CURR OPIN PSYCHOL, V11, P79, DOI 10.1016/j.copsyc.2016.06.008; Fair CC, 2012, PUBLIC OPIN QUART, V76, P688, DOI 10.1093/poq/nfs053; Green S. N., 2016, TURNING POINT NEW CO; Grimmer J, 2013, POLIT ANAL, V21, P267, DOI 10.1093/pan/mps028; Haverkamp R, 2014, CRIME LAW SOCIAL CH, V62, P257, DOI 10.1007/s10611-013-9466-6; Hoffman B, 2004, STUD CONFL TERROR, V27, P243, DOI 10.1080/10576100490466498; Horgan J, 2012, BEHAV SCI TERROR POL, V4, P195, DOI 10.1080/19434472.2011.594620; Johnson NF, 2016, SCIENCE, V352, P1459, DOI 10.1126/science.aaf0675; National Science Foundation, 2015, SCI ENG IND 2016; Norris J., 2015, J CRIM LAW CRIM, V105, P101; NSF, 2016, SURV FED FUNDS RES D; NSF, 2016, FY 2017 BUDG REQ C S; Perliger Arie, 2016, CRADLE GRAVE LIFECYC; Selim G., 2016, ISIS ONLINE COUNTERI	21	25	26	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					352	354		10.1126/science.aaj2037	http://dx.doi.org/10.1126/science.aaj2037			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4FR	28126773				2022-12-28	WOS:000393172800022
J	Chen, SJ; Wu, X; Wadas, B; Oh, JH; Varshavsky, A				Chen, Shun-Jia; Wu, Xia; Wadas, Brandon; Oh, Jang-Hyun; Varshavsky, Alexander			An N-end rule pathway that recognizes proline and destroys gluconeogenic enzymes	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; TERMINAL ACETYLATION; PROTEIN-FRAGMENTS; CATABOLITE DEGRADATION; MALATE-DEHYDROGENASE; CELLULAR-PROTEINS; SPLIT-UBIQUITIN; YEAST 2-HYBRID; GID COMPLEX; FRUCTOSE-1,6-BISPHOSPHATASE		[Chen, Shun-Jia; Wu, Xia; Oh, Jang-Hyun; Varshavsky, Alexander] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Wadas, Brandon] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	California Institute of Technology; Harvard University; Harvard Medical School	Varshavsky, A (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	avarsh@caltech.edu		Chen, Shun-Jia/0000-0002-5489-4930	NIH [DK039520, GM031530]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Bjorkman (Caltech) for her comments on the manuscript, and A. Melnykov and other members of the Varshavsky laboratory for discussions and helpful suggestions. Supported by NIH grants DK039520 and GM031530 (A.V.).	Aksnes H, 2016, TRENDS BIOCHEM SCI, V41, P746, DOI 10.1016/j.tibs.2016.07.005; Alibhoy AA, 2012, AUTOPHAGY, V8, P29, DOI 10.4161/auto.8.1.18104; Alibhoy Abbas A, 2011, World J Biol Chem, V2, P239, DOI 10.4331/wjbc.v2.i11.239; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Balsa-Martinez E, 2015, MOL CELL, V60, P509, DOI 10.1016/j.molcel.2015.11.005; Batalia MA, 1997, BIOPOLYMERS, V43, P281, DOI 10.1002/(SICI)1097-0282(1997)43:4<281::AID-BIP3>3.0.CO;2-R; Brower CS, 2013, MOL CELL, V50, P161, DOI 10.1016/j.molcel.2013.02.009; Brown CR, 2008, J BIOL CHEM, V283, P26116, DOI 10.1074/jbc.M709922200; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; Dorfel MJ, 2015, GENE, V567, P103, DOI 10.1016/j.gene.2015.04.085; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Dunkler A, 2012, METHODS MOL BIOL, V786, P115, DOI 10.1007/978-1-61779-292-2_7; Eldeeb M, 2016, PROTEIN PEPTIDE LETT, V23, P343, DOI 10.2174/0929866523666160108115809; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Fraenkel D. G., 2011, YEAST INTERMEDIARY M; Francis O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075217; Giardina Bennett J, 2013, Commun Integr Biol, V6, pe27216, DOI 10.4161/cib.27216; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Graciet E, 2010, TRENDS PLANT SCI, V15, P447, DOI 10.1016/j.tplants.2010.04.011; Hammerle M, 1998, J BIOL CHEM, V273, P25000, DOI 10.1074/jbc.273.39.25000; Hoffman M, 1996, GENETICS, V143, P1555; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kim MK, 2016, P NATL ACAD SCI USA, V113, P12438, DOI 10.1073/pnas.1612620113; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Kotter P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp578; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Menssen R, 2012, J BIOL CHEM, V287, P25602, DOI 10.1074/jbc.M112.363762; MINARD KI, 1992, J BIOL CHEM, V267, P17458; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Pfirrmann T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120342; Piatkov KI, 2014, P NATL ACAD SCI USA, V111, pE817, DOI 10.1073/pnas.1401639111; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Vidal M, 2014, NAT METHODS, V11, P1203, DOI 10.1038/nmeth.3182; Wadas B, 2016, J BIOL CHEM, V291, P20976, DOI 10.1074/jbc.M116.747956; Xiao Q, 2010, BIOCHEMISTRY-US, V49, P5588, DOI 10.1021/bi1005464; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yaneva R, 2010, MOL IMMUNOL, V47, P649, DOI 10.1016/j.molimm.2009.10.008	52	112	112	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323							eaal3655	10.1126/science.aal3655	http://dx.doi.org/10.1126/science.aal3655			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126757	Green Accepted, Green Submitted			2022-12-28	WOS:000393172800030
J	Bell, KJL; Hayen, A; Glasziou, P; Irwig, L; Bauer, DC				Bell, Katy J. L.; Hayen, Andrew; Glasziou, Paul; Irwig, Les; Bauer, Douglas C.			Change in Bone Mineral Density Is an Indicator of Treatment-Related Antifracture Effect	ANNALS OF INTERNAL MEDICINE			English	Letter							REGRESSION; THERAPY		[Bell, Katy J. L.; Irwig, Les] Univ Sydney, Sydney, NSW, Australia; [Hayen, Andrew] Univ Technol Sydney, Sydney, NSW, Australia; [Glasziou, Paul] Bond Univ, Bond, QLD, Australia; [Bauer, Douglas C.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of Sydney; University of Technology Sydney; Bond University; University of California System; University of California San Francisco	Bell, KJL (corresponding author), Univ Sydney, Sydney, NSW, Australia.		Glasziou, Paul/A-7832-2008; Bell, Katy/B-9650-2013	Glasziou, Paul/0000-0001-7564-073X; Bell, Katy/0000-0002-0137-3218; Hayen, Andrew/0000-0003-4046-8030				Bell KJL, 2016, J BONE MINER RES, V31, P1767, DOI 10.1002/jbmr.2847; Bell KJL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2266; Cummings SR, 2000, JAMA-J AM MED ASSOC, V283, P1318, DOI 10.1001/jama.283.10.1318; Cummings SR, 2001, J CLIN ENDOCR METAB, V86, P4001, DOI 10.1210/jcem.86.8.9997; Leslie WD, 2016, ANN INTERN MED, V165, P465, DOI 10.7326/M15-2937	5	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					152	152		10.7326/L16-0528	http://dx.doi.org/10.7326/L16-0528			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	28114470				2022-12-28	WOS:000391842600025
J	Lawrence, HC; Ness, DL				Lawrence, Hal C.; Ness, Debra L.			Planned Parenthood Provides Essential Services That Improve Women's Health	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lawrence, Hal C.] Amer Congress Obstetricians & Gynecologists, 409 12th St Southwest, Washington, DC 20024 USA; [Ness, Debra L.] Natl Partnership Women & Families, 1875 Connecticut Ave NW,Suite 650, Washington, DC 20009 USA		Lawrence, HC (corresponding author), Amer Congress Obstetricians & Gynecologists, 409 12th St Southwest, Washington, DC 20024 USA.	evp@acog.org						Frost JJ, 2010, CONTRACEPTIVE NEEDS; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Planned Parenthood Federation of America, 2017, THIS IS WHO WE AR, pwwwplannedparenthoodorg/files/6814/6833/9709/20160711_FS_General_d1pdf; Planned Parenthood Federation of America, 2017, URG NEED PLANN PAR H; Stevenson AJ, 2016, NEW ENGL J MED, V374, P853, DOI 10.1056/NEJMsa1511902; U.S. Department of Health and Human Services Office of Inspector General, 2017, ACC CAR PROV AV MED; Wood S., 2013, HLTH CTR FAMILY PLAN	7	2	2	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					443	+		10.7326/M17-0217	http://dx.doi.org/10.7326/M17-0217			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28166545				2022-12-28	WOS:000397025800021
J	Iacobucci, G				Iacobucci, Gareth			GP leaders in Northern Ireland to begin collecting resignation letters from practices	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j350	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2017	356								j503	10.1136/bmj.j503	http://dx.doi.org/10.1136/bmj.j503			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HW	28130244				2022-12-28	WOS:000393178500012
J	Murray, BJ				Murray, Benjamin J.			ATMOSPHERIC CHEMISTRY Cracking the problem of ice nucleation Electron microscope data explain why feldspars are key to nucleating ice particles in clouds	SCIENCE			English	Editorial Material							MIXED-PHASE CLOUDS; MINERALS		[Murray, Benjamin J.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Murray, BJ (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	b.j.murray@leeds.ac.uk	Murray, Benjamin/C-1219-2010	Murray, Benjamin/0000-0002-8198-8131				Atkinson JD, 2013, NATURE, V498, P355, DOI 10.1038/nature12278; Harrison AD, 2016, ATMOS CHEM PHYS, V16, P10927, DOI 10.5194/acp-16-10927-2016; Herbert RJ, 2015, GEOPHYS RES LETT, V42, P1599, DOI 10.1002/2014GL062729; Heymsfield AJ, 2011, SCIENCE, V333, P77, DOI 10.1126/science.1202851; Kiselev A, 2017, SCIENCE, V355, P367, DOI 10.1126/science.aai8034; Murray BJ, 2012, CHEM SOC REV, V41, P6519, DOI 10.1039/c2cs35200a; Murray BJ, 2010, NAT GEOSCI, V3, P233, DOI [10.1038/ngeo817, 10.1038/NGEO817]; Niedermeier D, 2015, J GEOPHYS RES-ATMOS, V120, P5036, DOI 10.1002/2014JD022814; Peckhaus A, 2016, ATMOS CHEM PHYS, V16, P11477, DOI 10.5194/acp-16-11477-2016; Tan I, 2016, SCIENCE, V352, P224, DOI 10.1126/science.aad5300; Vergara-Temprado J., 2016, ATMOS CHEM PHYS DISC, DOI [10.5194/acp-2016-822, DOI 10.5194/ACP-2016-822]; Yakobi-Hancock JD, 2013, ATMOS CHEM PHYS, V13, P11175, DOI 10.5194/acp-13-11175-2013	12	8	8	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					346	347		10.1126/science.aam5320	http://dx.doi.org/10.1126/science.aam5320			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4FR	28126769	Green Accepted			2022-12-28	WOS:000393172800018
J	Chen, QY; Tesmer, JJG				Chen, Qiuyan; Tesmer, John J. G.			A Receptor on Acid	CELL			English	Editorial Material							SEROTONIN 2A RECEPTOR; FUNCTIONAL SELECTIVITY; LSD	Wacker et al. report the crystal structure of LSD in complex with one of its major targets in the brain, the 5-HT2B receptor, the first such structure for any psychedelic drug. The results shed light on the molecular mechanisms underlying its ability to induce hallucinations with greater duration and potency than closely related compounds.	[Chen, Qiuyan; Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Chen, Qiuyan; Tesmer, John J. G.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Chen, Qiuyan; Tesmer, John J. G.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Tesmer, JJG (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.; Tesmer, JJG (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.; Tesmer, JJG (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	tesmerjj@umich.edu		Tesmer, John/0000-0003-1125-3727	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL071818] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Dolder PC, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv072; HOFMANN A, 1979, J PSYCHEDEL DRUG, V11, P53, DOI 10.1080/02791072.1979.10472092; Johnston LD, 2016, MONITORING FUTURE NA; Nichols DE, 2002, J MED CHEM, V45, P4344, DOI 10.1021/jm020153s; Schmid CL, 2008, P NATL ACAD SCI USA, V105, P1079, DOI 10.1073/pnas.0708862105; Schmid CL, 2010, J NEUROSCI, V30, P13513, DOI 10.1523/JNEUROSCI.1665-10.2010; TITELER M, 1988, PSYCHOPHARMACOLOGY, V94, P213; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wacker D, 2017, CELL, V168, P377, DOI 10.1016/j.cell.2016.12.033; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808	11	5	5	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					339	341		10.1016/j.cell.2017.01.012	http://dx.doi.org/10.1016/j.cell.2017.01.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28129534	Green Accepted, Bronze			2022-12-28	WOS:000396249600004
J	Moler, FW; Silverstein, FS; Holubkov, R; Slomine, BS; Christensen, JR; Nadkarni, VM; Meert, KL; Browning, B; Pemberton, VL; Page, K; Gildea, MR; Scholefield, BR; Shankaran, S; Hutchison, JS; Berger, JT; Ofori-Amanfo, G; Newth, CJL; Topjian, A; Bennett, KS; Koch, JD; Pham, N; Chanani, NK; Pineda, JA; Harrison, R; Dalton, HJ; Alten, J; Schleien, CL; Goodman, DM; Zimmerman, JJ; Bhalala, US; Schwarz, AJ; Porter, MB; Shah, S; Fink, EL; McQuillen, P; Wu, T; Skellett, S; Thomas, NJ; Nowak, JE; Baines, PB; Pappachan, J; Mathur, M; Lloyd, E; van der Jagt, EW; Dobyns, EL; Meyer, MT; Sanders, RC; Clark, AE; Dean, JM				Moler, F. W.; Silverstein, F. S.; Holubkov, R.; Slomine, B. S.; Christensen, J. R.; Nadkarni, V. M.; Meert, K. L.; Browning, B.; Pemberton, V. L.; Page, K.; Gildea, M. R.; Scholefield, B. R.; Shankaran, S.; Hutchison, J. S.; Berger, J. T.; Ofori-Amanfo, G.; Newth, C. J. L.; Topjian, A.; Bennett, K. S.; Koch, J. D.; Pham, N.; Chanani, N. K.; Pineda, J. A.; Harrison, R.; Dalton, H. J.; Alten, J.; Schleien, C. L.; Goodman, D. M.; Zimmerman, J. J.; Bhalala, U. S.; Schwarz, A. J.; Porter, M. B.; Shah, S.; Fink, E. L.; McQuillen, P.; Wu, T.; Skellett, S.; Thomas, N. J.; Nowak, J. E.; Baines, P. B.; Pappachan, J.; Mathur, M.; Lloyd, E.; van der Jagt, E. W.; Dobyns, E. L.; Meyer, M. T.; Sanders, R. C., Jr.; Clark, A. E.; Dean, J. M.		THAPCA Trial Investigators	Therapeutic Hypothermia after In-Hospital Cardiac Arrest in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; TRAUMATIC BRAIN-INJURY; WHOLE-BODY HYPOTHERMIA; CARDIOPULMONARY-RESUSCITATION; GUIDELINES UPDATE; CARE; EXPERIENCE; HYPERTHERMIA; SURVIVAL	BACKGROUND Targeted temperature management is recommended for comatose adults and children after out-of-hospital cardiac arrest; however, data on temperature management after in-hospital cardiac arrest are limited. METHODS In a trial conducted at 37 children's hospitals, we compared two temperature interventions in children who had had in-hospital cardiac arrest. Within 6 hours after the return of circulation, comatose children older than 48 hours and younger than 18 years of age were randomly assigned to therapeutic hypothermia (target temperature, 33.0 degrees C) or therapeutic normothermia (target temperature, 36.8 degrees C). The primary efficacy outcome, survival at 12 months after cardiac arrest with a score of 70 or higher on the Vineland Adaptive Behavior Scales, second edition (VABS-II, on which scores range from 20 to 160, with higher scores indicating better function), was evaluated among patients who had had a VABS-II score of at least 70 before the cardiac arrest. RESULTS The trial was terminated because of futility after 329 patients had undergone randomization. Among the 257 patients who had a VABS-II score of at least 70 before cardiac arrest and who could be evaluated, the rate of the primary efficacy outcome did not differ significantly between the hypothermia group and the normothermia group (36% [48 of 133 patients] and 39% [48 of 124 patients], respectively; relative risk, 0.92; 95% confidence interval [CI], 0.67 to 1.27; P=0.63). Among 317 patients who could be evaluated for change in neurobehavioral function, the change in VABS-II score from baseline to 12 months did not differ significantly between the groups (P = 0.70). Among 327 patients who could be evaluated for 1-year survival, the rate of 1-year survival did not differ significantly between the hypothermia group and the normothermia group (49% [81 of 166 patients] and 46% [74 of 161 patients], respectively; relative risk, 1.07; 95% CI, 0.85 to 1.34; P = 0.56). The incidences of blood-product use, infection, and serious adverse events, as well as 28-day mortality, did not differ significantly between groups. CONCLUSIONS Among comatose children who survived in-hospital cardiac arrest, therapeutic hypothermia, as compared with therapeutic normothermia, did not confer a significant benefit in survival with a favorable functional outcome at 1 year. (Funded by the National Heart, Lung, and Blood Institute; THAPCA-IH ClinicalTrials.gov number, NCT00880087.)	[Moler, F. W.; Silverstein, F. S.] Univ Michigan, Ann Arbor, MI 48109 USA; [Meert, K. L.; Shankaran, S.] Wayne State Univ, Detroit, MI USA; [Holubkov, R.; Browning, B.; Page, K.; Gildea, M. R.; Bennett, K. S.; Clark, A. E.; Dean, J. M.] Univ Utah, Salt Lake City, UT USA; [Slomine, B. S.; Christensen, J. R.] Kennedy Krieger Inst, Baltimore, MD USA; [Slomine, B. S.; Christensen, J. R.] Johns Hopkins Univ, Baltimore, MD USA; [Bhalala, U. S.] Johns Hopkins Childrens Ctr, Baltimore, MD USA; [Pemberton, V. L.] NHLBI, Bldg 10, Bethesda, MD 20892 USA; [Nadkarni, V. M.; Topjian, A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Fink, E. L.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Thomas, N. J.] Penn State Childrens Hosp, Hershey, PA USA; [Scholefield, B. R.] Birmingham Childrens Hosp, Birmingham, W Midlands, England; [Skellett, S.] Great Ormond St Hosp Sick Children, London, England; [Baines, P. B.] Alder Hey Childrens Hosp, Liverpool, Merseyside, England; [Pappachan, J.] Southampton Univ Hosp, Southampton, Hants, England; [Hutchison, J. S.] Hosp Sick Children, Toronto, ON, Canada; [Berger, J. T.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Ofori-Amanfo, G.] Duke Childrens Hosp, Durham, NC USA; [Newth, C. J. L.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Harrison, R.] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA USA; [Schwarz, A. J.] Childrens Hosp Orange Cty, Orange, CA 92668 USA; [McQuillen, P.] Univ Calif San Francisco, Benioff Childrens Hosp, San Francisco, CA 94143 USA; [Mathur, M.] Loma Linda Univ, Childrens Hosp, Loma Linda, CA 92350 USA; [Koch, J. D.] Univ Texas Southwestern Med Sch, Childrens Med Ctr Dallas, Dallas, TX USA; [Wu, T.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Pham, N.; Chanani, N. K.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Pineda, J. A.] Washington Univ, St Louis, MO USA; [Dalton, H. J.] Phoenix Childrens Hosp, Phoenix, AZ USA; [Alten, J.] Childrens Hosp Alabama, Birmingham, AL USA; [Schleien, C. L.] Columbia Univ, Childrens Hosp New York, Med Ctr, New York, NY USA; [van der Jagt, E. W.] Univ Rochester, Med Ctr, Golisano Childrens Hosp, Rochester, NY 14642 USA; [Goodman, D. M.] Robert Lurie Childrens Hosp Chicago, Chicago, IL USA; [Zimmerman, J. J.] Seattle Childrens Hosp, Seattle, WA USA; [Porter, M. B.] Univ Louisville, Kosair Childrens Hosp, Louisville, KY 40292 USA; [Shah, S.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Nowak, J. E.] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA; [Lloyd, E.] Nationwide Childrens Hosp, Columbus, OH USA; [Dobyns, E. L.] Childrens Hosp Colorado, Aurora, CO USA; [Meyer, M. T.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Sanders, R. C., Jr.] Arkansas Childrens Hosp, 800 Marshall St, Little Rock, AR 72202 USA	University of Michigan System; University of Michigan; Wayne State University; Utah System of Higher Education; University of Utah; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Birmingham; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Southampton; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Children's National Health System; Duke University; Children's Hospital Los Angeles; University of California System; University of California Los Angeles; Childrens Hospital of Orange County; University of California System; University of California San Francisco; Children's Hospital Los Angeles; Loma Linda University; University of Texas System; University of Texas Health San Antonio; Children's Healthcare of Atlanta (CHOA); Washington University (WUSTL); Phoenix Children's Hospital; Columbia University; University of Rochester; Ann & Robert H. Lurie Children's Hospital of Chicago; Seattle Children's Hospital; University of Louisville; University of Tennessee System; University of Tennessee Health Science Center; Children's Hospitals & Clinics of Minnesota; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Children's Hospital Colorado; Medical College of Wisconsin; Arkansas Children's Hospital	Moler, FW (corresponding author), Univ Michigan Hlth Syst, F-6900 UH S,SPF 5243,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	fmoler@umich.edu	McQuillen, Patrick/AAF-7119-2020; Skellett, Sophie/AAF-5538-2020; Pineda, Jose/W-2806-2019; Gazit, Avihu Z./J-4439-2019; Scholefield, Barney/ABG-7312-2021; Fink, Ericka/AAU-9792-2021; Curley, Martha A/F-3579-2016	Curley, Martha A/0000-0001-5228-6694; McQuillen, Patrick/0000-0002-8837-364X; Pappachan, John/0000-0002-3559-0595; Goodman, Denise/0000-0001-9766-9453; Shankaran, Seetha/0000-0001-5512-9571; Gazit, Avihu/0000-0002-6211-2636; Scholefield, Barney/0000-0002-6198-4985	National Heart, Lung, and Blood Institute [HL094345, HL094339]; THAPCA trials [HD044955, HD050531]; Pediatric Emergency Care Applied Research Network [U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008]; Collaborative Pediatric Critical Care Research Network [U10HD500009, U10HD050096, U10HD049981, U10HD049945, U10HD049983, U10HD050012, U01HD049934]; National Emergency Medical Services for Children Data Analysis Resource Center Demonstration grant [U07MC09174];  [UL1RR024986];  [UL1TR000433];  [U54HD087011];  [UL1TR000003];  [P30HD040677]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD050096, U10HD050096, U01HD049934, U10HD050012, U10HD049981, U54HD087011, U54HD079123, U10HD049983, P30HD040677] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD050009, R34HD050531, R21HD044955, U10HD049945] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433, UL1TR000003, UL1TR001422, UL1TR001878] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL094339, U10HL109741, U01HL094345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS075363] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); THAPCA trials; Pediatric Emergency Care Applied Research Network; Collaborative Pediatric Critical Care Research Network; National Emergency Medical Services for Children Data Analysis Resource Center Demonstration grant; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from the National Heart, Lung, and Blood Institute (HL094345, to Dr. Moler; and HL094339, to Dr. Dean), federal planning grants for the planning of the THAPCA trials (HD044955 and HD050531, both to Dr. Moler), cooperative agreements from the Pediatric Emergency Care Applied Research Network (U03MC00001, U03MC00003, U03MC00006, U03MC00007, and U03MC00008) and the Collaborative Pediatric Critical Care Research Network (U10HD500009, U10HD050096, U10HD049981, U10HD049945, U10HD049983, U10HD050012 and U01HD049934), and a National Emergency Medical Services for Children Data Analysis Resource Center Demonstration grant (U07MC09174). Several centers were supported by supplemental grants or cooperative agreements (UL1RR024986, UL1TR000433, U54HD087011, UL1TR000003, and P30HD040677).	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; *AM GUID SERV, 1995, MULL SCAL EARL LEARN; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Chan PS, 2016, JAMA-J AM MED ASSOC, V316, P1375, DOI 10.1001/jama.2016.14380; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; de Caen AR, 2015, CIRCULATION, V132, pS526, DOI 10.1161/CIR.0000000000000266; Doherty DR, 2009, CIRCULATION, V119, P1492, DOI 10.1161/CIRCULATIONAHA.108.791384; Field D, 2013, PEDIATRICS, V132, pE1247, DOI 10.1542/peds.2013-1754; Fink EL, 2010, PEDIATR CRIT CARE ME, V11, P66, DOI 10.1097/PCC.0b013e3181c58237; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Girotra S, 2013, CIRC-CARDIOVASC QUAL, V6, P42, DOI 10.1161/CIRCOUTCOMES.112.967968; Hickey RW, 2000, PEDIATRICS, V106, P118, DOI 10.1542/peds.106.1.118; Holubkov R, 2015, PEDIATR CRIT CARE ME, V16, P1, DOI 10.1097/PCC.0000000000000272; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hutchison J, 2006, DEV NEUROSCI-BASEL, V28, P291, DOI 10.1159/000094155; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Laptook AR, 2013, ANN NEUROL, V73, P520, DOI 10.1002/ana.23843; Marshall LF, 2001, J NEUROSURG, V95, P733, DOI 10.3171/jns.2001.95.5.0733; Meert KL, 2009, PEDIATR CRIT CARE ME, V10, P544, DOI 10.1097/PCC.0b013e3181a7045c; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Moler FW, 2013, PEDIATR CRIT CARE ME, V14, pE304, DOI 10.1097/PCC.0b013e31828a863a; Moler FW, 2011, CRIT CARE MED, V39, P141, DOI 10.1097/CCM.0b013e3181fa3c17; Moler FW, 2009, CRIT CARE MED, V37, P2259, DOI 10.1097/CCM.0b013e3181a00a6a; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Papile LA, 2014, PEDIATRICS, V133, P1146, DOI 10.1542/peds.2014-0899; Pemberton VL, 2013, PEDIATR CRIT CARE ME, V14, P19, DOI 10.1097/PCC.0b013e31825b860b; Psychological Corporation, 1999, WECHSLER ABBREVIATED; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2014, JAMA-J AM MED ASSOC, V312, P2629, DOI 10.1001/jama.2014.16058; Sparrow SS., 2005, VINELAND ADAPTIVE BE, V2nd ed, DOI [10.1037/t15164-000, DOI 10.1037/T15164-000]; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; Zeiner A, 2001, ARCH INTERN MED, V161, P2007, DOI 10.1001/archinte.161.16.2007	40	162	169	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2017	376	4					318	329		10.1056/NEJMoa1610493	http://dx.doi.org/10.1056/NEJMoa1610493			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ3KR	28118559	Green Accepted, Green Published			2022-12-28	WOS:000393111600007
J	Muckenthaler, MU; Rivella, S; Hentze, MW; Galy, B				Muckenthaler, Martina U.; Rivella, Stefano; Hentze, Matthias W.; Galy, Bruno			A Red Carpet for Iron Metabolism	CELL			English	Review							LACKING TRANSFERRIN RECEPTOR; BETA-THALASSEMIA; HEPCIDIN EXPRESSION; DOWN-REGULATION; MOUSE MODEL; REGULATORY PROTEINS; H-FERRITIN; RESPONSIVE ELEMENT; POLYCYTHEMIA-VERA; CHAPERONES PCBP1	200 billion red blood cells (RBCs) are produced every day, requiring more than 2 x 10(15) iron atoms every second to maintain adequate erythropoiesis. These numbers translate into 20 mL of blood being produced each day, containing 6 g of hemoglobin and 20 mg of iron. These impressive numbers illustrate why the making and breaking of RBCs is at the heart of iron physiology, providing an ideal context to discuss recent progress in understanding the systemic and cellular mechanisms that underlie the regulation of iron homeostasis and its disorders.	[Muckenthaler, Martina U.; Hentze, Matthias W.] European Mol Biol Lab, Mol Med Partnership Unit, Neuenheimer Feld 350, D-69120 Heidelberg, Germany; [Muckenthaler, Martina U.; Hentze, Matthias W.] Heidelberg Univ, Neuenheimer Feld 350, D-69120 Heidelberg, Germany; [Muckenthaler, Martina U.] Dept Pediat Oncol Hematol & Immunol, Neuenheimer Feld 153, D-69120 Heidelberg, Germany; [Rivella, Stefano] Childrens Hosp Philadelphia, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Hentze, Matthias W.] European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Galy, Bruno] German Canc Res Ctr, Div Virus Associated Carcinogenesis F170, Neuenheimer Feld 280, D-69120 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ)	Hentze, MW (corresponding author), European Mol Biol Lab, Mol Med Partnership Unit, Neuenheimer Feld 350, D-69120 Heidelberg, Germany.; Hentze, MW (corresponding author), Heidelberg Univ, Neuenheimer Feld 350, D-69120 Heidelberg, Germany.; Hentze, MW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	hentze@embl.de	Hentze, Matthias W/V-3980-2017	Hentze, Matthias W/0000-0002-4023-7876; Rivella, Stefano/0000-0002-0938-6558; Galy, Bruno/0000-0002-0501-6357; Muckenthaler, Martina/0000-0002-3778-510X	Deutsche Forschungsgemeinschaft [SFB1118, SFB1036, GA2075/3-1]; Dietmar Hopp Stiftung; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute of the National Institutes of Health [R01 DK095112, R01 DK090554, R01 HL102449]; Merganser Biotech; Ionis Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090554, R01DK095112] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dietmar Hopp Stiftung; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Merganser Biotech; Ionis Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	M.U.M. acknowledges funding from the Deutsche Forschungsgemeinschaft (SFB1118 and SFB1036) and the Dietmar Hopp Stiftung, S.R. from the National Institute of Diabetes and Digestive and Kidney Diseases and National Heart, Lung, and Blood Institute of the National Institutes of Health (R01 DK095112, R01 DK090554, and R01 HL102449), and B.G. from the Deutsche Forschungsgemeinschaft (GA2075/3-1). S.R. is supported for his work on minihepcidin by Merganser Biotech and for his work on Tmprss6-ASO by Ionis Pharmaceuticals. S.R. is consultant for Merganser Biotech and Ionis Pharmaceuticals.	Altamura S, 2014, CELL METAB, V20, P359, DOI 10.1016/j.cmet.2014.07.007; An XL, 2014, BLOOD, V123, P3466, DOI 10.1182/blood-2014-01-548305; Anderson ER, 2013, P NATL ACAD SCI USA, V110, pE4922, DOI 10.1073/pnas.1314197110; Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arezes J, 2015, CELL HOST MICROBE, V17, P47, DOI 10.1016/j.chom.2014.12.001; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babu KR, 2016, J MOL MED, V94, P347, DOI 10.1007/s00109-015-1362-3; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Barrientos T, 2015, EBIOMEDICINE, V2, P1705, DOI 10.1016/j.ebiom.2015.09.041; Bartnikas TB, 2010, AM J HEMATOL, V85, P958, DOI 10.1002/ajh.21872; Bellelli R, 2016, CELL REP, V14, P411, DOI 10.1016/j.celrep.2015.12.065; BERNSTEIN SE, 1987, J LAB CLIN MED, V110, P690; Besson-Fournier C, 2012, BLOOD, V120, P431, DOI 10.1182/blood-2012-02-411470; Bruno M, 2015, SEMIN HEMATOL, V52, P270, DOI 10.1053/j.seminhematol.2015.05.002; Busi MV, 2012, IUBMB LIFE, V64, P56, DOI 10.1002/iub.577; Canali S., 2016, BLOOD IN PRESS; Canali S, 2016, ENDOCRINOLOGY, V157, P1146, DOI 10.1210/en.2015-1747; Carmona U, 2014, CHEM COMMUN, V50, P15358, DOI 10.1039/c4cc07996e; Casanovas G, 2011, J MOL MED, V89, P811, DOI 10.1007/s00109-011-0751-5; Castoldi M, 2011, J CLIN INVEST, V121, P1386, DOI 10.1172/JCI44883; Casu C, 2016, BLOOD, V128, P265, DOI 10.1182/blood-2015-10-676742; Casu C, 2016, HAEMATOLOGICA, V101, pE8, DOI 10.3324/haematol.2015.133348; Chen CY, 2013, CELL METAB, V17, P343, DOI 10.1016/j.cmet.2013.01.013; Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chung J, 2014, J BIOL CHEM, V289, P7835, DOI 10.1074/jbc.M114.547778; Cianetti L, 2005, HAEMATOLOGICA, V90, P1595; Core AB, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00104; Cozzi A, 2013, J EXP MED, V210, P1779, DOI 10.1084/jem.20130315; Crielaard BJ, 2014, INT J BIOCHEM CELL B, V51, P89, DOI 10.1016/j.biocel.2014.03.029; Daher R, 2016, GASTROENTEROLOGY, V150, P672, DOI 10.1053/j.gastro.2015.10.049; Das N, 2015, J BIOL CHEM, V290, P23523, DOI 10.1074/jbc.C115.681643; Davuluri G, 2016, P NATL ACAD SCI USA, V113, pE1460, DOI 10.1073/pnas.1600077113; de Back DZ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00009; Deschemin JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061050; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Doty RT, 2015, J CLIN INVEST, V125, P4681, DOI 10.1172/JCI83054; Dowdle WE, 2014, NAT CELL BIOL, V16, P1069, DOI 10.1038/ncb3053; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Eldor A, 2002, BLOOD, V99, P36, DOI 10.1182/blood.V99.1.36; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Fernandes A, 2009, BLOOD, V114, P437, DOI 10.1182/blood-2008-03-146134; Ferreira C, 2001, BLOOD, V98, P525, DOI 10.1182/blood.V98.3.525; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Forejtnikova H, 2010, BLOOD, V116, P5357, DOI 10.1182/blood-2010-04-281360; Frey AG, 2014, P NATL ACAD SCI USA, V111, P8031, DOI 10.1073/pnas.1402732111; Fuqua BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098792; Galy B, 2008, CELL METAB, V7, P79, DOI 10.1016/j.cmet.2007.10.006; Galy B, 2013, CELL REP, V3, P844, DOI 10.1016/j.celrep.2013.02.026; Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863; Gardenghi S, 2007, BLOOD, V109, P5027, DOI 10.1182/blood-2006-09-048868; Gardenghi S, 2014, BLOOD, V123, P1137, DOI 10.1182/blood-2013-08-521625; Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717; Gassmann M, 2015, J APPL PHYSIOL, V119, P1432, DOI 10.1152/japplphysiol.00248.2015; Ghosh MC, 2013, CELL METAB, V17, P271, DOI 10.1016/j.cmet.2012.12.016; Goodnough JB, 2012, HEPATOLOGY, V56, P291, DOI 10.1002/hep.25615; Guida C, 2015, BLOOD, V125, P2265, DOI 10.1182/blood-2014-08-595256; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Guo SL, 2013, J CLIN INVEST, V123, P1531, DOI 10.1172/JCI66969; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Hamdi A, 2016, BBA-MOL CELL RES, V1863, P2859, DOI 10.1016/j.bbamcr.2016.09.008; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Harada N, 2011, ARCH BIOCHEM BIOPHYS, V508, P101, DOI 10.1016/j.abb.2011.02.001; Heeney MM, 2014, HEMATOL ONCOL CLIN N, V28, P637, DOI 10.1016/j.hoc.2014.04.009; Hider RC, 2011, BIOMETALS, V24, P1179, DOI 10.1007/s10534-011-9476-8; Jabara HH, 2016, NAT GENET, V48, P74, DOI 10.1038/ng.3465; Jenkitkasemwong S, 2015, CELL METAB, V22, P138, DOI 10.1016/j.cmet.2015.05.002; Kautz L, 2015, BLOOD, V126, P2031, DOI 10.1182/blood-2015-07-658419; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kerenyi MA, 2008, BLOOD, V112, P3878, DOI 10.1182/blood-2008-02-138339; Koch P.S., 2016, BLOOD IN PRESS; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kovtunovych G, 2014, BLOOD, V124, P1522, DOI 10.1182/blood-2014-02-554162; Lakhal-Littleton S, 2015, P NATL ACAD SCI USA, V112, P3164, DOI 10.1073/pnas.1422373112; Lane DJR, 2015, BBA-MOL CELL RES, V1853, P1130, DOI 10.1016/j.bbamcr.2015.01.021; Latour C, 2016, HEPATOLOGY, V63, P126, DOI 10.1002/hep.28254; Latour C, 2014, HEPATOLOGY, V59, P683, DOI 10.1002/hep.26648; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Lehmberg K, 2013, ANN HEMATOL, V92, P387, DOI 10.1007/s00277-012-1618-8; Leidgens S, 2013, J BIOL CHEM, V288, P17791, DOI 10.1074/jbc.M113.460253; Leimberg MJ, 2008, J CELL BIOCHEM, V103, P1211, DOI 10.1002/jcb.21499; Levi S, 2001, J BIOL CHEM, V276, P24437, DOI 10.1074/jbc.C100141200; Levi S, 2015, NEUROBIOL DIS, V81, P134, DOI 10.1016/j.nbd.2015.02.007; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Li HH, 2010, NAT MED, V16, P177, DOI 10.1038/nm.2073; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; Li L, 2010, P NATL ACAD SCI USA, V107, P3505, DOI 10.1073/pnas.0913192107; Li X, 2016, J CLIN INVEST, V126, P389, DOI 10.1172/JCI83831; Lim JE, 2005, NAT GENET, V37, P1270, DOI 10.1038/ng1659; Liu ZM, 2014, MOL CELL BIOL, V34, P2533, DOI 10.1128/MCB.00231-14; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Lymboussaki A, 2003, J HEPATOL, V39, P710, DOI 10.1016/S0168-8278(03)00408-2; Mancias JD, 2015, ELIFE, V4, DOI 10.7554/eLife.10308; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; Martelli A, 2015, CELL METAB, V21, P311, DOI 10.1016/j.cmet.2015.01.010; Mastrogiannaki M, 2012, BLOOD, V119, P587, DOI 10.1182/blood-2011-09-380337; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Mathieu JRR, 2014, HAEMATOLOGICA, V99, DOI 10.3324/haematol.2013.102319; Mayeur C, 2014, BLOOD, V124, P2116, DOI 10.1182/blood-2014-04-572644; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Mercurio S, 2015, HAEMATOLOGICA, V100, P720, DOI 10.3324/haematol.2014.114488; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Mleczko-Sanecka K, 2014, BLOOD, V123, P1574, DOI 10.1182/blood-2013-07-515957; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Nai A, 2016, BLOOD, V127, P2327, DOI 10.1182/blood-2015-11-681494; Nai A, 2015, BLOOD, V125, P1170, DOI 10.1182/blood-2014-08-596254; Nai A, 2012, BLOOD, V119, P5021, DOI 10.1182/blood-2012-01-401885; Nai A, 2011, BLOOD, V118, P4459, DOI 10.1182/blood-2011-06-364034; Nairz M, 2015, CELL HOST MICROBE, V18, P254, DOI 10.1016/j.chom.2015.06.017; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Ned RM, 2003, BLOOD, V102, P3711, DOI 10.1182/blood-2003-04-1086; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Pietrangelo A, 2016, LIVER INT, V36, P116, DOI 10.1111/liv.13020; POOTRAKUL P, 1988, BLOOD, V71, P1124; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Preza GC, 2011, J CLIN INVEST, V121, P4880, DOI 10.1172/JCI57693; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Ramos E, 2012, BLOOD, V120, P3829, DOI 10.1182/blood-2012-07-440743; Ramos P, 2013, NAT MED, V19, P437, DOI 10.1038/nm.3126; Ramos P, 2011, BLOOD, V117, P1379, DOI 10.1182/blood-2010-09-307462; Rausa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122696; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Rivella S, 2015, HAEMATOLOGICA, V100, P421, DOI 10.3324/haematol.2014.114827; Ross SL, 2012, CELL METAB, V15, P905, DOI 10.1016/j.cmet.2012.03.017; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Salvarani C, 1996, RHEUMATOL INT, V16, P45, DOI 10.1007/BF01816434; Sanchez M, 2011, BLOOD, V118, pE168, DOI 10.1182/blood-2011-04-343541; Sangokoya C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003408; Schmidt PJ, 2012, AM J HEMATOL, V87, P588, DOI 10.1002/ajh.23173; Schranzhofer M, 2006, BLOOD, V107, P4159, DOI 10.1182/blood-2005-05-1809; Senyilmaz D, 2015, NATURE, V525, P124, DOI 10.1038/nature14601; Sham RL, 2009, BLOOD, V114, P493, DOI 10.1182/blood-2009-04-216226; Shanmugam NKN, 2015, J BIOL CHEM, V290, P30637, DOI 10.1074/jbc.M115.689190; Shanmugam NKN, 2014, J IMMUNOL, V193, P1398, DOI 10.4049/jimmunol.1400278; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Shvartsman M, 2012, BIOMETALS, V25, P711, DOI 10.1007/s10534-012-9529-7; Siegert I, 2015, CELL REP, V13, P2048, DOI 10.1016/j.celrep.2015.11.005; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Soares MP, 2015, EMBO REP, V16, P1482, DOI 10.15252/embr.201540558; Sonnweber T, 2014, GUT, V63, P1951, DOI 10.1136/gutjnl-2013-305317; Stehling O, 2014, BIOCHIMIE, V100, P61, DOI 10.1016/j.biochi.2014.01.010; Stehling O, 2013, CELL METAB, V18, P187, DOI 10.1016/j.cmet.2013.06.015; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Taniguchi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9545; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; Theurl I, 2016, NAT MED, V22, P945, DOI 10.1038/nm.4146; Thompson JW, 2012, J BIOL CHEM, V287, P7357, DOI 10.1074/jbc.M111.308684; Troadec MB, 2011, BLOOD, V117, P5494, DOI 10.1182/blood-2010-11-319483; Vanoaica L, 2010, CELL METAB, V12, P273, DOI 10.1016/j.cmet.2010.08.003; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Viatte L, 2005, BLOOD, V105, P4861, DOI 10.1182/blood-2004-12-4608; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; WANG GL, 1993, BLOOD, V82, P3610; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Weizer-Stern O, 2006, BRIT J HAEMATOL, V135, P129, DOI 10.1111/j.1365-2141.2006.06258.x; Weizer-Stern O, 2006, AM J HEMATOL, V81, P479, DOI 10.1002/ajh.20549; White C, 2013, CELL METAB, V17, P261, DOI 10.1016/j.cmet.2013.01.005; Wilkinson N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00176; Wilkinson N, 2013, BLOOD, V122, P1658, DOI 10.1182/blood-2013-03-492454; Wilson K, 2015, NEW ENGL J MED, V373, P485, DOI 10.1056/NEJMc1507104; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Wu CK, 2001, NAT STRUCT BIOL, V8, P156, DOI 10.1038/84152; Wu XG, 2014, BLOOD, V124, P1335, DOI 10.1182/blood-2014-01-552281; Xu WJ, 2015, CELL REP, V13, P533, DOI 10.1016/j.celrep.2015.09.023; Yamamoto M, 2014, MOL CELL BIOL, V34, P1077, DOI 10.1128/MCB.00865-13; Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006; Zhang ZZ, 2011, BLOOD, V118, P1912, DOI 10.1182/blood-2011-01-330324; Zhao NN, 2016, J BIOL CHEM, V291, P12322, DOI 10.1074/jbc.M116.721191	186	564	590	17	165	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					344	361		10.1016/j.cell.2016.12.034	http://dx.doi.org/10.1016/j.cell.2016.12.034			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28129536	Bronze, Green Accepted			2022-12-28	WOS:000396249600006
J	Rao, S; Schieber, AMP; O'Connor, CP; Leblanc, M; Michel, D; Ayres, JS				Rao, Sheila; Schieber, Alexandria M. Palaferri; O'Connor, Carolyn P.; Leblanc, Mathias; Michel, Daniela; Ayres, Janelle S.			Pathogen-Mediated Inhibition of Anorexia Promotes Host Survival and Transmission	CELL			English	Article							VAGUS NERVE; CALORIE RESTRICTION; DIETARY RESTRICTION; DISEASE TOLERANCE; DEFENSE STRATEGY; IMMUNE-RESPONSE; MANDUCA-SEXTA; C57BL/6 MICE; INFECTION; VIRULENCE	Sickness-induced anorexia is a conserved behavior induced during infections. Here, we report that an intestinal pathogen, Salmonella Typhimurium, inhibits anorexia by manipulating the gut-brain axis. Inhibition of inflammasome activation by the S. Typhimurium effector, SlrP, prevented anorexia caused by IL-1b-mediated signaling to the hypothalamus via the vagus nerve. Rather than compromising host defenses, pathogen-mediated inhibition of anorexia increased host survival. SlrP-mediated inhibition of anorexia prevented invasion and systemic infection by wild-type S. Typhimurium, reducing virulence while increasing transmission to new hosts, suggesting that there are trade-offs between transmission and virulence. These results clarify the complex and contextual role of anorexia in host-pathogen interactions and suggest that microbes have evolved mechanisms to modulate sickness-induced behaviors to promote health of their host and their transmission at the expense of virulence.	[Rao, Sheila; Schieber, Alexandria M. Palaferri; Michel, Daniela; Ayres, Janelle S.] Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [O'Connor, Carolyn P.] Salk Inst Biol Studies, Flow Cytometry Core Facil, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Leblanc, Mathias] Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; Salk Institute	Ayres, JS (corresponding author), Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jayres@salk.edu		Palaferri Schieber, Alexandria/0000-0001-9468-8325; O'Connor, Carolyn/0000-0002-3301-7912	NIH [R01AI114929]; Nomis Foundation; Searle Scholar Foundation; Ray Thomas Edward Foundation; Nomis Foundation Postdoctoral Fellowship;  [CA014195]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114929] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nomis Foundation; Searle Scholar Foundation; Ray Thomas Edward Foundation; Nomis Foundation Postdoctoral Fellowship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Evans and B. Collins for use of the CLAMS equipment; M. Montminy for use of the EchoMRI; C. Fitzpatrick for help with FACS; G. Sulli for reagents; M. Abt for technical advice. This work was supported by NIH grant R01AI114929 (J.S.A.), The Nomis Foundation, the Searle Scholar Foundation (J.S.A.), the Ray Thomas Edward Foundation (J.S.A.), CA014195 and a Nomis Foundation Postdoctoral Fellowship (S.R.).	ALEXANDER M, 1981, ANNU REV MICROBIOL, V35, P113, DOI 10.1146/annurev.mi.35.100181.000553; Ayres JS, 2016, CELL, V165, P1323, DOI 10.1016/j.cell.2016.05.049; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; BEDOYAN JK, 1992, J INSECT PHYSIOL, V38, P525, DOI 10.1016/0022-1910(92)90078-R; Boyer L, 2004, NAT REV MICROBIOL, V2, P779, DOI 10.1038/nrmicro1005; Burger JMS, 2007, AGING CELL, V6, P63, DOI 10.1111/j.1474-9726.2006.00261.x; Dantzer R, 2009, IMMUNOL ALLERGY CLIN, V29, P247, DOI 10.1016/j.iac.2009.02.002; de Lartigue G, 2010, ENDOCRINOLOGY, V151, P3589, DOI 10.1210/en.2010-0106; DUNN PE, 1994, ANN NY ACAD SCI, V712, P117, DOI 10.1111/j.1749-6632.1994.tb33567.x; Ewald P, 1996, EVOLUTION INFECT DIS; Exton MS, 1997, APPETITE, V29, P369, DOI 10.1006/appe.1997.0116; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Galan JE, 1996, MOL MICROBIOL, V20, P263, DOI 10.1111/j.1365-2958.1996.tb02615.x; Goehler LE, 1999, J NEUROSCI, V19, P2799; Gordon JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004347; Hansen MK, 2001, AM J PHYSIOL-REG I, V280, pR929; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Johnstone LE, 2006, CELL METAB, V4, P313, DOI 10.1016/j.cmet.2006.08.003; Kristan DM, 2007, AGING CELL, V6, P817, DOI 10.1111/j.1474-9726.2007.00345.x; Kyriazakis I, 1998, ANIM BEHAV, V56, P265, DOI 10.1006/anbe.1998.0761; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Libert S, 2008, MOL IMMUNOL, V45, P810, DOI 10.1016/j.molimm.2007.06.353; Mackinnon MJ, 2008, VACCINE, V26, pC42, DOI 10.1016/j.vaccine.2008.04.012; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; McLaughlin LM, 2014, INTEGR BIOL-UK, V6, P438, DOI 10.1039/c3ib40177d; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; MURRAY MJ, 1979, AM J CLIN NUTR, V32, P593, DOI 10.1093/ajcn/32.3.593; Page AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068699; Paul REL, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-30; Pavlov VA, 2004, CELL MOL LIFE SCI, V61, P2322, DOI 10.1007/s00018-004-4102-3; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Ritz BW, 2008, J NUTR, V138, P2269, DOI 10.3945/jn.108.093633; Ruby T, 2012, FEMS MICROBIOL REV, V36, P600, DOI 10.1111/j.1574-6976.2012.00332.x; Schieber AMP, 2015, SCIENCE, V350, P558, DOI 10.1126/science.aac6468; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Sellin ME, 2014, CELL HOST MICROBE, V16, P237, DOI 10.1016/j.chom.2014.07.001; Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301; Sun DX, 2001, CLIN DIAGN LAB IMMUN, V8, P1003, DOI 10.1128/CDLI.8.5.1003-1011.2001; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Wickham ME, 2007, CURR BIOL, V17, P783, DOI 10.1016/j.cub.2007.03.067	49	85	88	3	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					503	+		10.1016/j.cell.2017.01.006	http://dx.doi.org/10.1016/j.cell.2017.01.006			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28129542	Green Accepted, Bronze			2022-12-28	WOS:000396249600016
J	Brophy, J				Brophy, James			Review: In type 2 diabetes, sodium-glucose cotransporter 2 inhibitors do not increase major CV events or mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Brophy, James] McGill Univ, Montreal, PQ, Canada	McGill University	Brophy, J (corresponding author), McGill Univ, Montreal, PQ, Canada.		brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875				Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; US Food and Drug Administration, 2008, GUID IND DIAB MELL E; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					JC7	JC7		10.7326/ACPJC-2017-166-2-007	http://dx.doi.org/10.7326/ACPJC-2017-166-2-007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	28114463				2022-12-28	WOS:000391842600006
J	Maselli, DJ; Peters, JI				Maselli, Diego J.; Peters, Jay I.			In refractory chronic cough, physiotherapy plus speech and language therapy improved quality of life at 4 weeks	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Maselli, Diego J.; Peters, Jay I.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Maselli, DJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.							Ryan Nicole M, 2010, Cough, V6, P5, DOI 10.1186/1745-9974-6-5; Vertigan AE, 2006, THORAX, V61, P1065, DOI 10.1136/thx.2006.064337	2	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					JC3	JC3		10.7326/ACPJC-2017-166-2-003	http://dx.doi.org/10.7326/ACPJC-2017-166-2-003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	28114459				2022-12-28	WOS:000391842600002
J	Minami, CA; Barnard, C; Bilimoria, KY				Minami, Christina A.; Barnard, Cynthia; Bilimoria, Karl Y.			Management of a Patient With a Latex Allergy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Minami, Christina A.; Bilimoria, Karl Y.] Northwestern Univ, Feinberg Sch Med, Dept Surg, SOQIC, 633 N St Clair,20th Floor, Chicago, IL 60611 USA; [Minami, Christina A.; Bilimoria, Karl Y.] Northwestern Univ, Feinberg Sch Med, Ctr Healthcare Studies, Chicago, IL 60611 USA; [Barnard, Cynthia] Northwestern Mem HealthCare, Div Qual, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Minami, CA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Surg, SOQIC, 633 N St Clair,20th Floor, Chicago, IL 60611 USA.; Minami, CA (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Healthcare Studies, Chicago, IL 60611 USA.	Christina-minami@northwestern.edu			Centers for Medicare & Medicaid Services-TCPI; Health Care Services Corporation-ISQIC program; American College of Surgeons; American Board of Surgeons; Accreditation Council for Graduate Medical Education	Centers for Medicare & Medicaid Services-TCPI; Health Care Services Corporation-ISQIC program; American College of Surgeons; American Board of Surgeons; Accreditation Council for Graduate Medical Education	Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Barnard reported receiving publication royalties from HCPRO and grants from Centers for Medicare & Medicaid Services-TCPI program and from Health Care Services Corporation-ISQIC program. Dr Bilimoria reported receiving grants from the American College of Surgeons, American Board of Surgeons, and the Accreditation Council for Graduate Medical Education; and personal fees from the American College of Surgeons. Dr Minami reported no disclosures.	Kachalia A, 2010, ANN INTERN MED, V153, P213, DOI 10.7326/0003-4819-153-4-201008170-00002; Poley GE, 2000, J ALLERGY CLIN IMMUN, V105, P1054, DOI 10.1067/mai.2000.106925	2	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					309	310		10.1001/jama.2016.20034	http://dx.doi.org/10.1001/jama.2016.20034			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114556				2022-12-28	WOS:000392089200018
J	Masri, A; Senussi, MH				Masri, Ahmad; Senussi, Mourad H.			Trump's Executive Order on Immigration - Detrimental Effects on Medical Training and Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Masri, Ahmad; Senussi, Mourad H.] Univ Pittsburgh, Inst Heart & Vasc, Med Ctr, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Masri, A (corresponding author), Univ Pittsburgh, Inst Heart & Vasc, Med Ctr, Pittsburgh, PA 15260 USA.		Senussi, Mourad H/L-1725-2019					[Anonymous], 2017, NY TIMES; Educational Commission for Foreign Medical Graduates, 2015, ANN REPORT; National Resident Matching Program, 2016, CHART OUTC MATCH INT; National Resident Matching Program and Educational Commission for Foreign Medical Graduates, 2014, CHART OUTC MATCH INT; United States Citizenship and Immigration Services', CONR 30 WAIV PROGR	5	17	17	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2017	376	19					E39	+		10.1056/NEJMp1701251	http://dx.doi.org/10.1056/NEJMp1701251			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU2WR	28146648				2022-12-28	WOS:000400891100005
J	Torres, H; Poorman, E; Tadepalli, U; Schoettler, C; Fung, CH; Mushero, N; Campbell, L; Basu, G; McCormick, D				Torres, Hugo; Poorman, Elisabeth; Tadepalli, Uma; Schoettler, Cynthia; Fung, Chin Ho; Mushero, Nicole; Campbell, Lauren; Basu, Gaurab; McCormick, Danny			Coverage and Access for Americans With Chronic Disease Under the Affordable Care Act A Quasi-Experimental Study	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE; INSURANCE-COVERAGE; UNITED-STATES; UNINSURANCE; ADULTS; DISPARITIES; ETHNICITY; OUTCOMES; MARGINS; COSTS	Background: Half of Americans have at least 1 chronic disease. Many in this group, particularly racial/ethnic minorities, lacked insurance coverage and access to care before the Patient Protection and Affordable Care Act (ACA) was enacted. Objective: To determine whether the ACA has had an effect on insurance coverage, access to care, and racial/ethnic disparities among adults with chronic disease. Design: Quasi-experimental policy intervention. Setting: Nationally representative, noninstitutionalized sample in the United States. Patients: 606 277 adults aged 18 to 64 years with a chronic disease. Intervention: Implementation of ACA provisions on 1 January 2014. Measurements: Self-reported insurance coverage, having a checkup, having a personal physician, and not having to forgo a needed physician visit because of cost. Results: After the ACA was implemented, insurance coverage increased by 4.9 percentage points (95% CI, 4.4 to 5.4), not having to forgo a physician visit increased by 2.4 percentage points (CI, 1.9 to 2.9), and having a checkup increased by 2.7 percentage points (CI, 2.2 to 3.4). Having a personal physician did not change (0.3 percentage points [CI, -0.2 to 0.8]). All outcomes varied considerably by state, and coverage increased more in states that expanded Medicaid. Although racial/ethnic minorities had greater improvements in some outcomes, approximately 1 in 5 black and 1 in 3 Hispanic persons with a chronic disease continued to lack coverage and access to care after ACA implementation. Limitation: The study examined data from only the first year of the ACA's major coverage expansion provisions. Conclusion: Although the ACA increased coverage and access for persons with chronic disease, substantial gaps remain, particularly for minorities and those in Medicaid nonexpansion states.	[Torres, Hugo; Poorman, Elisabeth; Tadepalli, Uma; Schoettler, Cynthia; Fung, Chin Ho; Mushero, Nicole; Campbell, Lauren; Basu, Gaurab; McCormick, Danny] Harvard Med Sch, Boston, MA USA; [Torres, Hugo; Poorman, Elisabeth; Schoettler, Cynthia; Fung, Chin Ho; Mushero, Nicole; Campbell, Lauren; Basu, Gaurab; McCormick, Danny] Cambridge Hlth Alliance, 1493 Cambridge St, Cambridge, MA 02139 USA; [Tadepalli, Uma] Univ Calif San Francisco, Sch Med, 4150 Clement St, San Francisco, CA 94121 USA	Harvard University; Harvard Medical School; Harvard University; Cambridge Health Alliance; University of California System; University of California San Francisco	Torres, H (corresponding author), Cambridge Hlth Alliance, 1493 Cambridge St, Cambridge, MA 02139 USA.	hatorres@challiance.org		Mushero, Nicole/0000-0003-0872-505X				[Anonymous], 2016, STRAT GOAL 1 STRENGT; Blumenthal D, 2015, NEW ENGL J MED, V372, P2451, DOI 10.1056/NEJMhpr1503614; Bodenheimer T, 2009, HEALTH AFFAIR, V28, P64, DOI 10.1377/hlthaff.28.1.64; Carman KG, 2015, HEALTH AFFAIR, V34, P1044, DOI 10.1377/hlthaff.2015.0266; Centers for Disease Control and Prevention, 2013, BRFSS COMB LANDL CEL; Centers for Disease Control and Prevention (CDC), 2014, BEH RISK FACT SURV S; Christopher AS, 2016, AM J PUBLIC HEALTH, V106, P63, DOI 10.2105/AJPH.2015.302925; Clemans-Cope L, 2012, HEALTH AFFAIR, V31, P920, DOI 10.1377/hlthaff.2011.1086; Congressional Budget Office, 2016, FED SUBS HLTH INS CO; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Hoffman C, 2008, ANN NY ACAD SCI, V1136, P149, DOI 10.1196/annals.1425.007; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; Lillie-Blanton M, 2005, HEALTH AFFAIR, V24, P398, DOI 10.1377/hlthaff.24.2.398; McCormick D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1480; McMorrow S, 2015, HEALTH AFFAIR, V34, P1774, DOI 10.1377/hlthaff.2015.0757; McWilliams JM, 2009, MILBANK Q, V87, P443, DOI 10.1111/j.1468-0009.2009.00564.x; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Nelson DE, 2003, AM J PUBLIC HEALTH, V93, P1335, DOI 10.2105/AJPH.93.8.1335; Parikh PB, 2014, J GEN INTERN MED, V29, P76, DOI 10.1007/s11606-013-2635-6; Shartzer A, 2016, HEALTH AFFAIR, V35, P161, DOI 10.1377/hlthaff.2015.0755; Solberg LI, 2004, AM J MANAG CARE, V10, P717; Sommers BD, 2015, JAMA-J AM MED ASSOC, V314, P366, DOI 10.1001/jama.2015.8421; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; The Henry J. Kaiser Family Foundation, 2016, HLTH REF IMPL TIM; The Henry J. Kaiser Family Foundation, 2012, STAT GETT JUMP START; Thorpe KE, 2015, HEALTH AFFAIR, V34, P1695, DOI 10.1377/hlthaff.2015.0323; Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; Wilper AP, 2008, ANN INTERN MED, V149, P170, DOI 10.7326/0003-4819-149-3-200808050-00006; Woolridge J.M.., 2002, ECONOMETRICS ANAL CR; Zhang XP, 2012, DIABETES CARE, V35, P1566, DOI 10.2337/dc12-0081	32	38	38	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2017	166	7					472	+		10.7326/M16-1256	http://dx.doi.org/10.7326/M16-1256			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ4PT	28114684				2022-12-28	WOS:000398061100009
J	Schiering, C; Wincent, E; Metidji, A; Iseppon, A; Li, Y; Potocnik, AJ; Omenetti, S; Henderson, CJ; Wolf, CR; Neberts, DW; Stockinger, B				Schiering, Chris; Wincent, Emma; Metidji, Amina; Iseppon, Andrea; Li, Ying; Potocnik, Alexandre J.; Omenetti, Sara; Henderson, Colin J.; Wolf, C. Roland; Neberts, Daniel W.; Stockinger, Brigitta			Feedback control of AHR signalling regulates intestinal immunity	NATURE			English	Article							ARYL-HYDROCARBON RECEPTOR; AGONISTS; GUT; INTERLEUKIN-22; ACTIVATION; DEFENSE; SYSTEM; MOUSE; CELLS	The aryl hydrocarbon receptor (AHR) recognizes xenobiotics as well as natural compounds such as tryptophan metabolites, dietary components and microbiota-derived factors(1-4), and it is important for maintenance of homeostasis at mucosal surfaces. AHR activation induces cytochrome P4501 (CYP1) enzymes, which oxygenate AHR ligands, leading to their metabolic clearance and detoxification(5). Thus, CYP1 enzymes have an important feedback role that curtails the duration of AHR signalling(6), but it remains unclear whether they also regulate AHR ligand availability in vivo. Here we show that dysregulated expression of Cyp1a1 in mice depletes the reservoir of natural AHR ligands, generating a quasi AHR-deficient state. Constitutive expression of Cyp1a1 throughout the body or restricted specifically to intestinal epithelial cells resulted in loss of AHR-dependent type 3 innate lymphoid cells and T helper 17 cells and increased susceptibility to enteric infection. The deleterious effects of excessive AHR ligand degradation on intestinal immune functions could be counter-balanced by increasing the intake of AHR ligands in the diet. Thus, our data indicate that intestinal epithelial cells serve as gatekeepers for the supply of AHR ligands to the host and emphasize the importance of feedback control in modulating AHR pathway activation.	[Schiering, Chris; Metidji, Amina; Iseppon, Andrea; Li, Ying; Omenetti, Sara; Stockinger, Brigitta] Francis Crick Inst, London, England; [Wincent, Emma] Swedish Toxicol Sci Res Ctr, Sedertalje, Sweden; [Potocnik, Alexandre J.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Henderson, Colin J.; Wolf, C. Roland] Univ Dundee, Sch Med, Div Canc Res, Dundee, Scotland; [Neberts, Daniel W.] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA	Francis Crick Institute; University of Edinburgh; University of Dundee; University System of Ohio; University of Cincinnati	Stockinger, B (corresponding author), Francis Crick Inst, London, England.	Brigitta.Stockinger@crick.ac.uk	Henderson, Colin/AAE-7141-2019	Henderson, Colin/0000-0002-4764-639X; Metidji, Amina/0000-0003-2785-7023; Omenetti, Sara/0000-0002-2443-3631; Wincent, Emma/0000-0003-1637-654X; Stockinger, Brigitta/0000-0001-8781-336X; Schiering, Chris/0000-0001-7902-6024; Potocnik, Alexandre/0000-0002-4730-8593	Francis Crick Institute from Cancer Research UK; UK Medical Research Council; Wellcome Trust; Wellcome Advanced Investigator Grant; Sir Henry Wellcome Fellowship; Fondation Acteria; Cancer Research UK Programme Grant [C4639/A10822]; Swedish Research Council FORMAS; National Institute of Environmental Health Sciences, NIH [R01 ES014403]; Cancer Research UK [10822, 22357, 19691] Funding Source: researchfish; The Francis Crick Institute [C30391/A19691, 10160, 10161] Funding Source: researchfish; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014403] Funding Source: NIH RePORTER	Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Advanced Investigator Grant; Sir Henry Wellcome Fellowship; Fondation Acteria; Cancer Research UK Programme Grant(Cancer Research UK); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); National Institute of Environmental Health Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Research UK(Cancer Research UK); The Francis Crick Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Francis Crick Institute which receives its core funding from Cancer Research UK, The UK Medical Research Council and the Wellcome Trust. We would like to acknowledge the Biological Research Facility at the Francis Crick Institute for expert breeding and maintenance of our mouse strains, the Histopathology Facility for help with sections and staining and the Flow Cytometry Facility. We thank G. Frankel (Imperial College) for the gift of antiserum to C. rodentium and Genentech, South San Francisco, California, for providing anti-IL-22 and IL-22-Fc. The study was supported by a Wellcome Advanced Investigator Grant (B.S.) and a Sir Henry Wellcome Fellowship and the Fondation Acteria (CS.). C.H. and C.R.W. are funded by Cancer Research UK Programme Grant C4639/A10822. E.W. is funded by the Swedish Research Council FORMAS and D.N. by National Institute of Environmental Health Sciences, NIH grant R01 ES014403.	Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152706299; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Chiaro CR, 2007, MOL PHARMACOL, V72, P1369, DOI 10.1124/mol.107.038968; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Dragin N, 2008, MOL PHARMACOL, V73, P1844, DOI 10.1124/mol.108.045658; Henderson CJ, 2015, BIOCHEM J, V465, P479, DOI 10.1042/BJ20140582; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ito SJ, 2007, J CLIN INVEST, V117, P1940, DOI 10.1172/JCI31647; Kerkvliet NI, 2002, INT IMMUNOPHARMACOL, V2, P277, DOI 10.1016/S1567-5769(01)00179-5; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Lahvis GP, 2005, MOL PHARMACOL, V67, P714, DOI 10.1124/mol.104.008888; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Mitchell KA, 2009, BIOCHEM PHARMACOL, V77, P947, DOI 10.1016/j.bcp.2008.10.028; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Soshilov AA, 2014, MOL CELL BIOL, V34, P1707, DOI 10.1128/MCB.01183-13; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Wincent E, 2012, P NATL ACAD SCI USA, V109, P4479, DOI 10.1073/pnas.1118467109; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	26	258	275	8	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					242	245		10.1038/nature21080	http://dx.doi.org/10.1038/nature21080			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28146477	Green Submitted, Green Accepted			2022-12-28	WOS:000393737500043
J	Fu, XW; Chen, B; Tang, J; Hassan, MT; Zewail, AH				Fu, Xuewen; Chen, Bin; Tang, Jau; Hassan, Mohammed Th; Zewail, Ahmed H.			Imaging rotational dynamics of nanoparticles in liquid by 4D electron microscopy	SCIENCE			English	Article							INSTANTANEOUS VELOCITY; PLASMONIC NANOBUBBLES; BROWNIAN-MOTION; GROWTH; NANOROD; CELLS; VISUALIZATION; DIFFUSION; PARTICLE; BEAM	In real time and space, four-dimensional electron microscopy (4D EM) has enabled observation of transient structures and morphologies of inorganic and organic materials. We have extended 4D EM to include liquid cells without the time resolution being limited by the response of the detector. Our approach permits the imaging of the motion and morphological dynamics of a single, same particle on nanometer and ultrashort time scales. As a first application, we studied the rotational dynamics of gold nanoparticles in aqueous solution. A full transition from the conventional diffusive rotation to superdiffusive rotation and further to a ballistic rotation was observed with increasing asymmetry of the nanoparticle morphology. We explored the underlying physics both experimentally and theoretically according to the morphological asymmetry of the nanoparticles.	[Fu, Xuewen; Chen, Bin; Tang, Jau; Hassan, Mohammed Th; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Tang, J (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	jautang@caltech.edu	, 付学文/R-5616-2016; Hassan, Mohammed TH/I-5793-2019; Chen, Bin/F-3870-2010	, 付学文/0000-0001-6116-4680; Hassan, Mohammed TH/0000-0002-9669-534X; Chen, Bin/0000-0002-6832-906X; Tang, Jau/0000-0003-2078-1513	Air Force Office of Scientific Research [FA9550-11-1-0055S]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the Air Force Office of Scientific Research, grant FA9550-11-1-0055S, for research conducted at The Gordon and Betty Moore Center for Physical Biology at the California Institute of Technology. We thank J. S. Baskin for very helpful discussion and for his help setting up the new femtosecond laser system. We appreciate J. K. Barton, R. A. Marcus, and J. F. Brady for helpful discussion and suggestions. We also thank J. Hu and H. Li for fruitful discussion.	Abrams IM., 1944, J APPL PHYS, V15, P607, DOI 10.1063/1.1707475; Barwick B, 2008, SCIENCE, V322, P1227, DOI 10.1126/science.1164000; Bodrova AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep30520; de Jonge N, 2009, P NATL ACAD SCI USA, V106, P2159, DOI 10.1073/pnas.0809567106; de Jonge N, 2011, NAT NANOTECHNOL, V6, P695, DOI [10.1038/NNANO.2011.161, 10.1038/nnano.2011.161]; Hassan MT, 2015, P NATL ACAD SCI USA, V112, P12944, DOI 10.1073/pnas.1517942112; Hong L, 2006, LANGMUIR, V22, P7128, DOI 10.1021/la061169e; Kheifets S, 2014, SCIENCE, V343, P1493, DOI 10.1126/science.1248091; Kwon OH, 2010, SCIENCE, V328, P1668, DOI 10.1126/science.1190470; Lachaine R, 2014, ACS PHOTONICS, V1, P331, DOI 10.1021/ph400018s; Langevin P, 1908, CR HEBD ACAD SCI, V146, P530; Li TC, 2010, SCIENCE, V328, P1673, DOI 10.1126/science.1189403; Liao HG, 2012, SCIENCE, V336, P1011, DOI 10.1126/science.1219185; Link S, 1999, CHEM PHYS LETT, V315, P12, DOI 10.1016/S0009-2614(99)01214-2; Lorenz UJ, 2014, SCIENCE, V344, P1496, DOI 10.1126/science.1253618; Lukianova-Hleb E, 2010, ACS NANO, V4, P2109, DOI 10.1021/nn1000222; Mukhija D, 2007, J COLLOID INTERF SCI, V314, P98, DOI 10.1016/j.jcis.2007.05.055; Peckys DB, 2011, NANO LETT, V11, P1733, DOI 10.1021/nl200285r; ROOSEN G, 1978, OPT COMMUN, V26, P432, DOI 10.1016/0030-4018(78)90240-7; Ross FM, 2015, SCIENCE, V350, DOI 10.1126/science.aaa9886; Sonnichsen C, 2005, NANO LETT, V5, P301, DOI 10.1021/nl048089k; Sutter E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5946; Thiberge S, 2004, P NATL ACAD SCI USA, V101, P3346, DOI 10.1073/pnas.0400088101; Williamson MJ, 2003, NAT MATER, V2, P532, DOI 10.1038/nmat944; Xu XH, 2016, J PHYS CHEM LETT, V7, P314, DOI 10.1021/acs.jpclett.5b02375; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654; Yurtsever A, 2009, SCIENCE, V326, P708, DOI 10.1126/science.1179314; Zeng ZY, 2014, NANO LETT, V14, P1745, DOI 10.1021/nl403922u; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135; Zheng HM, 2009, NANO LETT, V9, P2460, DOI 10.1021/nl9012369; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104	32	57	61	9	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					494	498		10.1126/science.aah3582	http://dx.doi.org/10.1126/science.aah3582			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154074				2022-12-28	WOS:000393183100038
J	Jonlin, EC				Jonlin, Erica C.			The Vaccine Race Science, Politics, and the Human Costs of Defeating Disease	SCIENCE			English	Book Review									[Jonlin, Erica C.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle	Jonlin, EC (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA.	ejonlin@u.washington.edu						Wadman Meredith, 2017, VACCINE RACE SCI POL	1	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					464	464		10.1126/science.aal3752	http://dx.doi.org/10.1126/science.aal3752			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154040				2022-12-28	WOS:000393183100024
J	Mayor, JR; Sanders, NJ; Classen, AT; Bardgett, RD; Clement, JC; Fajardo, A; Lavorel, S; Sundqvist, MK; Bahn, M; Chisholm, C; Cieraad, E; Gedalof, Z; Grigulis, K; Kudo, G; Oberski, DL; Wardle, DA				Mayor, Jordan R.; Sanders, Nathan J.; Classen, Aimee T.; Bardgett, Richard D.; Clement, Jean-Christophe; Fajardo, Alex; Lavorel, Sandra; Sundqvist, Maja K.; Bahn, Michael; Chisholm, Chelsea; Cieraad, Ellen; Gedalof, Ze'ev; Grigulis, Karl; Kudo, Gaku; Oberski, Daniel L.; Wardle, David A.			Elevation alters ecosystem properties across temperate treelines globally	NATURE			English	Article							TERRESTRIAL PLANTS; ALPINE ECOSYSTEMS; MICROBIAL BIOMASS; R PACKAGE; DIVERSITY; RESPONSES; NITROGEN; FOREST; VEGETATION; EVOLUTIONARY	Temperature is a primary driver of the distribution of biodiversity as well as of ecosystem boundaries(1,2). Declining temperature with increasing elevation in montane systems has long been recognized as a major factor shaping plant community biodiversity, metabolic processes, and ecosystem dynamics(3,4). Elevational gradients, as thermoclines, also enable prediction of long-term ecological responses to climate warming(5-7). One of the most striking manifestations of increasing elevation is the abrupt transitions from forest to treeless alpine tundra(8). However, whether there are globally consistent above-and belowground responses to these transitions remains an open question(4). To disentangle the direct and indirect effects of temperature on ecosystem properties, here we evaluate replicate treeline ecotones in seven temperate regions of the world. We find that declining temperatures with increasing elevation did not affect tree leaf nutrient concentrations, but did reduce ground-layer community-weighted plant nitrogen, leading to the strong stoichiometric convergence of ground-layer plant community nitrogen to phosphorus ratios across all regions. Further, elevation-driven changes in plant nutrients were associated with changes in soil organic matter content and quality (carbon to nitrogen ratios) and microbial properties. Combined, our identification of direct and indirect temperature controls over plant communities and soil properties in seven contrasting regions suggests that future warming may disrupt the functional properties of montane ecosystems, particularly where plant community reorganization outpaces treeline advance.	[Mayor, Jordan R.; Wardle, David A.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90187 Umea, Sweden; [Sanders, Nathan J.; Classen, Aimee T.; Chisholm, Chelsea] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum Denmark, DK-2100 Copenhagen O, Denmark; [Bardgett, Richard D.] Rocky Mt Biol Labs, POB 519, Crested Butte, CO 81224 USA; [Bardgett, Richard D.] Univ Manchester, Sch Earth & Environm Sci, Oxford Rd, Manchester M13 9PT, Lancs, England; [Clement, Jean-Christophe] Univ Grenoble Alpes, CNRS UMR 5553, Laboratoire dEcol Alpine, CS 40700, F-380589 Grenoble, France; [Clement, Jean-Christophe] Univ Savoie Mont Blanc, UMR 0042, CARRTEL, FR-73376 Le Bourget Du Lac, France; [Fajardo, Alex] Univ Austral Chile, Ctr Invest Ecosistemas Patagonia CIEP R10c1003, Coyhaique 5951601, Chile; [Sundqvist, Maja K.] Umea Univ, S-90187 Umea, Sweden; [Bahn, Michael] Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria; [Cieraad, Ellen] Landcare Res, POB 69040, Lincoln 7640, New Zealand; [Cieraad, Ellen] Leiden Univ, Inst Environm Sci, Einsteinweg 2, NL-2333 CC Leiden, Netherlands; [Gedalof, Ze'ev] Univ Guelph, Dept Geog, Guelph, ON N1G 2W1, Canada; [Kudo, Gaku] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan; [Oberski, Daniel L.] Univ Utrecht, Dept Methodol & Stat, NL-3584 CH Utrecht, Netherlands; [Sanders, Nathan J.; Classen, Aimee T.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA; [Wardle, David A.] Nanyang Technol Univ, Asian Sch Environm, 50 Nanyang Ave, Singapore 639798, Singapore	Swedish University of Agricultural Sciences; University of Copenhagen; University of Manchester; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Universidad Austral de Chile; Umea University; University of Innsbruck; Landcare Research - New Zealand; Leiden University; Leiden University - Excl LUMC; University of Guelph; Hokkaido University; Utrecht University; University of Vermont; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mayor, JR (corresponding author), Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90187 Umea, Sweden.	clavulina@gmail.com	, CLEMENT/C-8589-2011; Kudo, Gaku/A-2733-2015; Cieraad, Ellen/AAJ-6535-2021; Bahn, Michael/I-3536-2013; Classen, Aimee/AAM-5671-2021; Classen, Aimee/X-2984-2019; Classen, Aimee T/C-4035-2008; Wardle, David A./F-6031-2011; Sanders, Nathan/ABE-4335-2020; Oberski, Daniel/F-8421-2013; Sanders, Nathan/A-6945-2009	Kudo, Gaku/0000-0002-6488-818X; Cieraad, Ellen/0000-0002-9813-9590; Bahn, Michael/0000-0001-7482-9776; Classen, Aimee T/0000-0002-6741-3470; Wardle, David A./0000-0002-0476-7335; CLEMENT, Jean-Christophe/0000-0002-0841-7199; Oberski, Daniel/0000-0001-7467-2297; Sanders, Nathan/0000-0001-6220-6731	Wallenberg Scholars Award; Fondecyt [1120171]; National Science Foundation [NSF-1136703]; Carlsberg Fund; Danish National Research Foundation; US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-SC0010562]; UK Natural Environment Research Council; BiodivERsA project REGARDS [ANR-12-EBID-004-01]; REGARDS [FWF-I-1056]; Netherlands Organization for Scientific Research [VENI 451-14-017]; Natural Sciences and Engineering Research Council of Canada	Wallenberg Scholars Award; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); National Science Foundation(National Science Foundation (NSF)); Carlsberg Fund(Carlsberg Foundation); Danish National Research Foundation(Danmarks Grundforskningsfond); US Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BiodivERsA project REGARDS; REGARDS; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank Y. Amagai, B. Andersson, C. Arnoldi, P. Bellingham, A. Boily, B. Case, G. Crutsinger, M. Dawes, W. Gilliam, K. Gundale, N. Hendershot, H. Hall, M. Hotter, J. Lundholm, P. Manning, C. McClure, Q. Read, B. Roskilly, A. Shimokawabe, D. Stohr, and B. Turner for laboratory, logistical, or field assistance. This work was made possible by a Wallenberg Scholars Award to D.A.W.; regional support from Fondecyt 1120171 to A.F.; a National Science Foundation Dimensions of Biodiversity grant (NSF-1136703), a grant from the Carlsberg Fund, and support from the Danish National Research Foundation to the Center for Macroecology, Evolution, and Climate to N.J.S.; a US Department of Energy, Office of Science, Office of Biological and Environmental Research, Terrestrial Ecosystem Sciences Program Award (DE-SC0010562) to A.T.C.; support from the UK Natural Environment Research Council to R.D.B.; support from the BiodivERsA project REGARDS (ANR-12-EBID-004-01) to J.-C.C., S.L., K.G. and REGARDS (FWF-I-1056) to M.B.; support from the Netherlands Organization for Scientific Research (VENI 451-14-017) to D.L.O.; and, support from the Natural Sciences and Engineering Research Council of Canada to Z.G.	ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Asner GP, 2014, P NATL ACAD SCI USA, V111, P5604, DOI 10.1073/pnas.1401181111; Barton K, 2014, MUMIN MULTIMODEL INF; Beychok M., 2013, ATMOSPHERIC LAPSE RA; BOLLEN KA, 1987, SOCIOL METHOD RES, V15, P375, DOI 10.1177/0049124187015004002; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chadwick OA, 1999, NATURE, V397, P491, DOI 10.1038/17276; Chamberlain S, 2015, BRRANCHING FETCH PHY; Cieraad E, 2014, J BIOGEOGR, V41, P1456, DOI 10.1111/jbi.12308; DAVIS J, 1991, ARCTIC ALPINE RES, V23, P279, DOI 10.2307/1551605; Dunne JA, 2004, ECOLOGY, V85, P904, DOI 10.1890/03-8003; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Ernakovich JG, 2014, GLOBAL CHANGE BIOL, V20, P3256, DOI 10.1111/gcb.12568; Fajardo A, 2014, AM J BOT, V101, P788, DOI 10.3732/ajb.1400166; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gelman A., 2007, DATA ANAL USING REGR; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; Graham CH, 2014, ECOGRAPHY, V37, P711, DOI 10.1111/ecog.00578; Greenwood S, 2014, ARCT ANTARCT ALP RES, V46, P829, DOI 10.1657/1938-4246-46.4.829; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Harsch MA, 2011, GLOBAL ECOL BIOGEOGR, V20, P582, DOI 10.1111/j.1466-8238.2010.00622.x; Harsch MA, 2009, ECOL LETT, V12, P1040, DOI 10.1111/j.1461-0248.2009.01355.x; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Hoch G, 2012, GLOBAL ECOL BIOGEOGR, V21, P861, DOI 10.1111/j.1466-8238.2011.00731.x; Holtmeier FK, 2007, LANDSCAPE ONLINE, V1, P1, DOI [DOI 10.3097/L0.200701, DOI 10.3097/LO.200701]; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kichenin E, 2013, FUNCT ECOL, V27, P1254, DOI 10.1111/1365-2435.12116; Koller M., 2014, ROBUSTLMM ROBUST LIN; Korner C, 1998, OECOLOGIA, V115, P445, DOI 10.1007/s004420050540; Korner C, 2004, J BIOGEOGR, V31, P713, DOI 10.1111/j.1365-2699.2003.01043.x; Korner C., 2012, ALPINE TREELINES FUN; Kroppenstedt RM, 1985, CHEM METHODS BACTERI, P173; Kuznetsova A., 2014, IMERTEST TESTS RANDO; Leps J, 2003, MULTIVARIATE ANAL EC; Leps J, 2011, ECOGRAPHY, V34, P856, DOI 10.1111/j.1600-0587.2010.06904.x; Loomis PF, 2006, ECOSCIENCE, V13, P544, DOI 10.2980/1195-6860(2006)13[544:NCATLA]2.0.CO;2; Markesteijn L, 2007, AM J BOT, V94, P515, DOI 10.3732/ajb.94.4.515; Minder JR, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013493; Mueller-Dombois D., 1974, Aims and methods of vegetation ecology.; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Oberski D, 2014, J STAT SOFTW, V57, P1; Oksanen J., 2022, R PACKAGE VERSION; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Penuelas J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3934; Pepin N, 2015, NAT CLIM CHANGE, V5, P424, DOI [10.1038/nclimate2563, 10.1038/NCLIMATE2563]; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Quinn GP, 2005, EXPT DESIGN DATA ANA; R Development Core Team, 2009, R LANG ENV STAT COMP; RAO JNK, 1988, J AM STAT ASSOC, V83, P231, DOI 10.2307/2288945; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sistla SA, 2012, NEW PHYTOL, V196, P68, DOI 10.1111/j.1469-8137.2012.04234.x; Sundqvist MK, 2013, ANNU REV ECOL EVOL S, V44, P261, DOI 10.1146/annurev-ecolsys-110512-135750; Svenning JC, 2013, AM J BOT, V100, P1266, DOI 10.3732/ajb.1200469; Thebault A, 2014, OIKOS, V123, P729, DOI 10.1111/j.1600-0706.2013.00860.x; TUNLID A, 1989, APPL ENVIRON MICROB, V55, P1368, DOI 10.1128/AEM.55.6.1368-1374.1989; VITOUSEK PM, 1988, OECOLOGIA, V77, P565, DOI 10.1007/BF00377275; von Humboldt A., 1849, ASPECTS NATURE DIFFE, VII; WALKER T.W., 1958, SOIL SCI, V85, P307, DOI 10.1097/00010694-195806000-00004; WARDLE DA, 1993, FUNCT ECOL, V7, P346, DOI 10.2307/2390215; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577; Wickham H., 2015, R PACKAGE VERSION 04; Woods HA, 2003, FUNCT ECOL, V17, P237, DOI 10.1046/j.1365-2435.2003.00724.x; Wookey PA, 2009, GLOBAL CHANGE BIOL, V15, P1153, DOI 10.1111/j.1365-2486.2008.01801.x; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; Yu Q, 2015, ECOLOGY, V96, P2328, DOI 10.1890/14-1897.1; Yuan ZY, 2015, NAT CLIM CHANGE, V5, P465, DOI [10.1038/nclimate2549, 10.1038/NCLIMATE2549]; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872	76	134	138	29	452	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					91	+		10.1038/nature21027	http://dx.doi.org/10.1038/nature21027			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28117440	Green Published, Green Submitted			2022-12-28	WOS:000396119300037
J	Shabde, N; Craft, A				Shabde, Neela; Craft, Alan			Joan Elliott OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		ELLIOTT J, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2017	356								j470	10.1136/bmj.j470	http://dx.doi.org/10.1136/bmj.j470			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BO	28137822				2022-12-28	WOS:000393449600005
J	Butler, SM				Butler, Stuart M.			Repeal and Replace Obamacare: What Could It Mean?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Butler, Stuart M.] Brookings Inst, Econ Studies, Washington, DC 20036 USA; [Butler, Stuart M.] Georgetown Univ, Grad Sch, Washington, DC 20057 USA; [Butler, Stuart M.] Convergence Ctr Policy Resolut, Board Trustees, Washington, DC 20036 USA	Brookings Institution; Georgetown University	Butler, SM (corresponding author), Brookings Inst, Econ Studies, Washington, DC 20036 USA.; Butler, SM (corresponding author), Georgetown Univ, Grad Sch, Washington, DC 20057 USA.; Butler, SM (corresponding author), Convergence Ctr Policy Resolut, Board Trustees, Washington, DC 20036 USA.	smbutler@brookings.edu							0	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					244	245		10.1001/jama.2016.19918	http://dx.doi.org/10.1001/jama.2016.19918			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114538	Bronze			2022-12-28	WOS:000392089200003
J	Garcia, D				Garcia, David			Review: Compression stockings reduce symptomless DVT in airline passengers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRAVEL		[Garcia, David] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA	Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle	Garcia, D (corresponding author), Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA.							Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; Kuipers S, 2007, J INTERN MED, V262, P615, DOI 10.1111/j.1365-2796.2007.01867.x; Philbrick JT, 2007, J GEN INTERN MED, V22, P107, DOI 10.1007/s11606-006-0016-0	3	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					JC6	JC6		10.7326/ACPJC-2017-166-2-006	http://dx.doi.org/10.7326/ACPJC-2017-166-2-006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	28114462				2022-12-28	WOS:000391842600005
J	Voelker, MSJR				Voelker, Rebecca M. S. J.			Milk Products Seized After Salmonella Found at Plant	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					247	247		10.1001/jama.2016.19737	http://dx.doi.org/10.1001/jama.2016.19737			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114534				2022-12-28	WOS:000392089200005
J	Armstrong, K; Anderson, ME; Carethers, JM; Loscalzo, J; Parmacek, MS; Wachter, RM; Zeidel, ML				Armstrong, Katrina; Anderson, Mark E.; Carethers, John M.; Loscalzo, Joseph; Parmacek, Michael S.; Wachter, Robert M.; Zeidel, Mark L.			International Exchange and American Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Armstrong, Katrina] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Loscalzo, Joseph] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Zeidel, Mark L.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Anderson, Mark E.] Johns Hopkins Med, Baltimore, MD USA; [Carethers, John M.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Parmacek, Michael S.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wachter, Robert M.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Johns Hopkins University; Johns Hopkins Medicine; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco	Armstrong, K (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.		Loscalzo, Joseph/ABD-8980-2021					Japsen B., 2017, FORBES; The White House, 2017, PROT NAT FOR TERR EN	2	8	8	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2017	376	19					E40	+		10.1056/NEJMp1701339	http://dx.doi.org/10.1056/NEJMp1701339			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU2WR	28146413	Bronze			2022-12-28	WOS:000400891100006
J	Frieden, TR; Ethier, K; Schuchat, A				Frieden, Thomas R.; Ethier, Kathleen; Schuchat, Anne			Improving the Health of the United States With a "Winnable Battles" Initiative	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Frieden, Thomas R.; Ethier, Kathleen; Schuchat, Anne] US Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA		tfrieden@gmail.com		Frieden, Thomas/0000-0002-4759-2256				Adashi EY, COMMUNICATION; Freeman G, EARLY RELEASE SELECT; Frieden TR, 2015, NEW ENGL J MED, V373, P2281, DOI 10.1056/NEJMms1513641; Hamilton BE, 2015, CONTINUED DECLINES T; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361	5	12	11	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2017	317	9					903	904		10.1001/jama.2017.0436	http://dx.doi.org/10.1001/jama.2017.0436			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM8DM	28152127				2022-12-28	WOS:000395541500006
J	Fischer, MA; Avorn, J				Fischer, Michael A.; Avorn, Jerry			Step Therapy-Clinical Algorithms, Legislation, and Optimal Prescribing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAID PRIOR-AUTHORIZATION		[Fischer, Michael A.; Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA; [Fischer, Michael A.; Avorn, Jerry] Harvard Med Sch, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Fischer, MA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	mfischer@partners.org						Avorn J, 2017, JAMA-J AM MED ASSOC, V317, P361, DOI 10.1001/jama.2016.16036; Desai NR, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.033; Fischer MA, 2004, NEW ENGL J MED, V351, P2187, DOI 10.1056/NEJMsa042770; Fischer MA, 2007, HEALTH AFFAIR, V26, P800, DOI 10.1377/hlthaff.26.3.800; Kesselheim AS, 2013, JAMA INTERN MED, V173, P202, DOI 10.1001/2013.jamainternmed.997; Lee JL-Y, 2012, AM J MANAG CARE, V18, pe429; Singh JA, 2016, ARTHRIT CARE RES, V68, P1, DOI 10.1002/acr.22783; Thomas Katie, 2016, NY TIMES	8	11	11	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					801	802		10.1001/jama.2016.20619	http://dx.doi.org/10.1001/jama.2016.20619			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28166322				2022-12-28	WOS:000395505600012
J	Cummings, KM; Carpenter, MJ				Cummings, K. Michael; Carpenter, Matthew J.			Selling smoking cessation	LANCET			English	Editorial Material							QUIT ATTEMPTS; SERVICES		[Cummings, K. Michael; Carpenter, Matthew J.] Univ South Carolina, Hollings Canc Ctr Med, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; [Cummings, K. Michael; Carpenter, Matthew J.] Univ South Carolina, Hollings Canc Ctr Med, Canc Control & Prevent, Charleston, SC 29425 USA; [Cummings, K. Michael; Carpenter, Matthew J.] Med Univ South Carolina, Charleston, SC 29425 USA	Medical University of South Carolina	Cummings, KM (corresponding author), Univ South Carolina, Hollings Canc Ctr Med, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA.; Cummings, KM (corresponding author), Univ South Carolina, Hollings Canc Ctr Med, Canc Control & Prevent, Charleston, SC 29425 USA.; Cummings, KM (corresponding author), Med Univ South Carolina, Charleston, SC 29425 USA.	cummingk@musc.edu			Pfizer	Pfizer(Pfizer)	KMC has received grant funding from Pfizer to study the effect of a hospital-based tobacco cessation intervention, and has received funding as an expert witness in litigation filed against the tobacco industry. MJC declares no competing interests.	[Anonymous], 2013, DRUG ALCOHOL DEPEND, V128, P171; Carpenter MJ, 2011, ARCH INTERN MED, V171, P1901, DOI 10.1001/archinternmed.2011.492; Dobbie F, 2015, HEALTH TECHNOL ASSES, V19, DOI 10.3310/hta19950; Fulton EA, 2016, HEALTHCARE, V4, P31; Gibson JE, 2010, NICOTINE TOB RES, V12, pS64, DOI 10.1093/ntr/ntq119; Gilbert H, 2017, LANCET; Godfrey C, 2005, ADDICTION, V100, P70, DOI 10.1111/j.1360-0443.2005.01071.x; Green Party of Aotearoa, 2016, BUDG COMM ARTS FUND; Hopkinson NS, 2016, ADDICTION, V111, P2066, DOI 10.1111/add.13511; Kotz D, 2014, MAYO CLIN PROC, V89, P1360, DOI 10.1016/j.mayocp.2014.07.004; Lifestyle Statistics Team Health and Social Care Information Centre, 2015, STAT SMOK ENGL 2015; Tzelepis F, 2011, JNCI-J NATL CANCER I, V103, P922, DOI 10.1093/jnci/djr169; West R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4921	13	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					768	770		10.1016/S0140-6736(17)30125-3	http://dx.doi.org/10.1016/S0140-6736(17)30125-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9UU	28129988	hybrid			2022-12-28	WOS:000394966400006
J	Friedrich, MJ				Friedrich, M. J.			Highest Blood Pressure Levels Shift From Rich to Poor Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	3					246	246		10.1001/jama.2016.20449	http://dx.doi.org/10.1001/jama.2016.20449			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NL	28114565				2022-12-28	WOS:000426801400002
J	Carus-Cadavieco, M; Gorbati, M; Ye, L; Bender, F; van der Veldt, S; Kosse, C; Borgers, C; Lee, SY; Ramakrishnan, C; Hu, YB; Denisova, N; Ramm, F; Volitaki, E; Burdakov, D; Deisseroth, K; Ponomarenko, A; Korotkova, T				Carus-Cadavieco, Marta; Gorbati, Maria; Ye, Li; Bender, Franziska; van der Veldt, Suzanne; Kosse, Christin; Borgers, Christoph; Lee, Soo Yeun; Ramakrishnan, Charu; Hu, Yubin; Denisova, Natalia; Ramm, Franziska; Volitaki, Emmanouela; Burdakov, Denis; Deisseroth, Karl; Ponomarenko, Alexey; Korotkova, Tatiana			Gamma oscillations organize top-down signalling to hypothalamus and enable food seeking	NATURE			English	Article							WORKING-MEMORY; LATERAL SEPTUM; HIPPOCAMPUS; NEURONS; INFORMATION; ACTIVATION; FREQUENCY; RESPONSES; CIRCUITS; RHYTHMS	Both humans and animals seek primary rewards in the environment, even when such rewards do not correspond to current physiological needs. An example of this is a dissociation between food-seeking behaviour and metabolic needs, a notoriously difficult-to treat symptom of eating disorders. Feeding relies on distinct cell groups in the hypothalamus(1-4), the activity of which also changes in anticipation of feeding onset(5-7). The hypothalamus receives strong descending inputs from the lateral septum, which is connected, in turn, with cortical networks', but cognitive regulation of feeding-related behaviours is not yet understood. Cortical cognitive processing(9,10) involves gamma oscillations(11-15), which support memory(16,17), attention(18), cognitive flexibility(19) and sensory responses(20). These functions contribute crucially to feeding behaviour by unknown neural mechanisms. Here we show that coordinated gamma (30-90 Hz) oscillations in the lateral hypothalamus and upstream brain regions organize food seeking behaviour in mice. Gamma-rhythmic input to the lateral hypothalamus from somatostatin-positive lateral septum cells evokes food approach without affecting food intake. Inhibitory inputs from the lateral septum enable separate signalling by lateral hypothalamus neurons according to their feeding-related activity, making them fire at distinct phases of the gamma oscillation. Upstream, medial prefrontal cortical projections provide gamma rhythmic inputs to the lateral septum; these inputs are causally associated with improved performance in a food-rewarded learning task. Overall, our work identifies a top-down pathway that uses gamma synchronization to guide the activity of subcortical networks and to regulate feeding behaviour by dynamic reorganization of functional cell groups in the hypothalamus.	[Carus-Cadavieco, Marta; Gorbati, Maria; Bender, Franziska; van der Veldt, Suzanne; Hu, Yubin; Denisova, Natalia; Ramm, Franziska; Volitaki, Emmanouela; Ponomarenko, Alexey; Korotkova, Tatiana] Leibniz Inst Mol Pharmacol FMP, NeuroCure Cluster Excellence, Behav Neurodynam Grp, Berlin, Germany; [Ye, Li; Lee, Soo Yeun; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ye, Li; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Kosse, Christin; Burdakov, Denis] Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England; [Borgers, Christoph] Tufts Univ, Dept Math, Medford, MA 02155 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, W080 Clark Ctr,318 Campus Dr West, Stanford, CA 94305 USA	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Stanford University; Howard Hughes Medical Institute; Stanford University; Francis Crick Institute; Tufts University; Stanford University	Ponomarenko, A; Korotkova, T (corresponding author), Leibniz Inst Mol Pharmacol FMP, NeuroCure Cluster Excellence, Behav Neurodynam Grp, Berlin, Germany.	ponomarenko@fmp-berlin.de; korotkova@fmp-berlin.de	Core, Vector/CAF-4832-2022; Ponomarenko, Alexey/F-7783-2017	Ponomarenko, Alexey/0000-0002-5185-0107; Kosse, Christin/0000-0002-2836-0193; Carus Cadavieco, Marta/0000-0003-4050-9138; Denisova, Natalia/0000-0002-6076-5262; Hu, Yubin/0000-0002-7306-6591; Burdakov, Denis/0000-0002-9134-9165	Human Frontier Science Program (HFSP) [RGY0076/2012]; Deutsche Forschungsgemeinschaft (DFG) [Exc 257 NeuroCure, SPP1665]; NIH (the Collaborative Research in Computational Neuroscience, CRCNS) [1R01 NS067199]; German-Israeli Foundation for Scientific Research and Development [GIF: I-1326-421.13/2015]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067199] Funding Source: NIH RePORTER; Medical Research Council [1363890] Funding Source: researchfish	Human Frontier Science Program (HFSP)(Human Frontier Science Program); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH (the Collaborative Research in Computational Neuroscience, CRCNS); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank N. Kopell, A. Adamantidis, and C. Holman for their comments on earlier versions of the manuscript, C. Gutierrez-Herrera for providing ChETA-expressing Vgat-Cre mice for our first experiments, K. Weineck for help with experiments during the manuscript revision, I. Szabo for methodological advice, J. Rosner for help with confocal microscopy, and J. Poulet, M. Larkum, R. Sachdev and N. Takahashi for providing Sst-Cre mice. This work was supported by The Human Frontier Science Program (HFSP; RGY0076/2012, to T.K., D.B.), Deutsche Forschungsgemeinschaft (DFG; Exc 257 NeuroCure, to T.K. and A.P.; SPP1665, to AR), NIH (the Collaborative Research in Computational Neuroscience, CRCNS; 1R01 NS067199, to C.B.), The German-Israeli Foundation for Scientific Research and Development (GIF: I-1326-421.13/2015, to T.K.).	Bender F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9521; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; Cho KKA, 2015, NEURON, V85, P1332, DOI 10.1016/j.neuron.2015.02.019; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Herrera CG, 2016, NAT NEUROSCI, V19, P290, DOI 10.1038/nn.4209; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Kim H, 2016, CELL, V164, P208, DOI 10.1016/j.cell.2015.11.038; MENDELSON J, 1965, SCIENCE, V149, P559, DOI 10.1126/science.149.3683.559; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Risold PY, 1996, SCIENCE, V272, P1484, DOI 10.1126/science.272.5267.1484; ROLLS ET, 1976, BRAIN RES, V111, P53, DOI 10.1016/0006-8993(76)91048-9; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Sartor GC, 2012, J NEUROSCI, V32, P4623, DOI 10.1523/JNEUROSCI.4561-11.2012; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Steculorum SM, 2015, CELL, V162, P1404, DOI 10.1016/j.cell.2015.08.032; Takeuchi T, 2016, NATURE, V537, P357, DOI 10.1038/nature19325; Tgarashi K. M., 2014, NATURE, V510, P143; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; Waterson MJ, 2015, CELL METAB, V22, P962, DOI 10.1016/j.cmet.2015.09.026; Yamamoto J, 2014, CELL, V157, P845, DOI 10.1016/j.cell.2014.04.009; Ye L, 2016, CELL, V165, P1776, DOI 10.1016/j.cell.2016.05.010	30	72	72	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					232	236		10.1038/nature21066	http://dx.doi.org/10.1038/nature21066			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28146472				2022-12-28	WOS:000393737500041
J	Hampton, T				Hampton, Tracy			Drug Under Study for Diabetes a Potential Parkinson Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					465	465		10.1001/jama.2017.0111	http://dx.doi.org/10.1001/jama.2017.0111			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28170470				2022-12-28	WOS:000393564200004
J	Charles, R; Bonnett, T; Bonnett, P				Charles, Robert; Bonnett, Tess; Bonnett, Phil			Hypertensive disorder of pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREECLAMPSIA		[Charles, Robert; Bonnett, Phil] Sheffield Teaching Hosp Fdn Trust, Herries Rd, Sheffield, S Yorkshire, England; [Bonnett, Tess] Sheffield Teaching Hosp Fdn Trust, Obstet & Gynaecol, Herries Rd, Sheffield, S Yorkshire, England		Charles, R (corresponding author), Sheffield Teaching Hosp Fdn Trust, Herries Rd, Sheffield, S Yorkshire, England.	robcharles@doctors.org.uk						Bartsch E, 2016, BMJ-BRIT MED J, V356, pi1753, DOI 10.1136/bmj; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Gathiram P, 2016, CARDIOVASC J AFR, V27, P71, DOI 10.5830/CVJA-2016-009; Hart E, 2003, BJA CEPD REV, V356, P38; Knight M, 2015, KURINCZUK J BEHALF M; Krishnachetty B, 2011, ANAEST INTENS CARE M, V12, P116, DOI 10.1016/j.mpaic.2010.11.006; Leffert LR, 2015, INT J OBSTET ANESTH, V24, P264, DOI 10.1016/j.ijoa.2015.03.008; National Institute for Health and Care Excellence, 2011, HYP PREGN DIAGN MAN; Palei AC, 2013, ACTA PHYSIOL, V208, P224, DOI 10.1111/apha.12106; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]	11	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2017	356									10.1136/bmj.j285	http://dx.doi.org/10.1136/bmj.j285			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BT	28153855				2022-12-28	WOS:000393450100001
J	Sedhai, YR; Patel, D				Sedhai, Yub-Raj; Patel, Dhruvan			Calcific Pancreatitis Associated with Alcohol Use	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sedhai, Yub-Raj; Patel, Dhruvan] Mercy Catholic Med Ctr, Darby, PA 19153 USA		Sedhai, YR (corresponding author), Mercy Catholic Med Ctr, Darby, PA 19153 USA.	dr.sedhai@gmail.com	Sedhai, Yub Raj/AAS-8660-2021	Sedhai, Yub Raj/0000-0002-1755-5489; Patel, Dhruvan/0000-0001-5447-2415					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 2	2017	376	5					E6	E6		10.1056/NEJMicm1602248	http://dx.doi.org/10.1056/NEJMicm1602248			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8WH	28146660				2022-12-28	WOS:000393507200012
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: The NHS needs a new era of political leadership	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Straw E, 2014, STAND DELIVER DESIGN	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2017	356								j393	10.1136/bmj.j393	http://dx.doi.org/10.1136/bmj.j393			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BO	28137709	Green Published, Bronze			2022-12-28	WOS:000393449600002
J	Bian, L; Leslie, SJ; Cimpian, A				Bian, Lin; Leslie, Sarah-Jane; Cimpian, Andrei			PSYCHOLOGY Gender stereotypes about intellectual ability emerge early and influence children's interests	SCIENCE			English	Article							MATH PERFORMANCE; SEX-DIFFERENCES; THREAT; WOMEN; ACHIEVEMENT; GIRLS; METAANALYSIS; BRILLIANCE; IDENTITY; SCIENCE	Common stereotypes associate high-level intellectual ability (brilliance, genius, etc.) with men more than women. These stereotypes discourage women's pursuit of many prestigious careers; that is, women are underrepresented in fields whose members cherish brilliance (such as physics and philosophy). Here we show that these stereotypes are endorsed by, and influence the interests of, children as young as 6. Specifically, 6-year-old girls are less likely than boys to believe that members of their gender are "really, really smart." Also at age 6, girls begin to avoid activities said to be for children who are "really, really smart." These findings suggest that gendered notions of brilliance are acquired early and have an immediate effect on children's interests.	[Bian, Lin; Cimpian, Andrei] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; [Bian, Lin; Cimpian, Andrei] New York Univ, Dept Psychol, New York, NY 10003 USA; [Leslie, Sarah-Jane] Princeton Univ, Dept Philosophy, Princeton, NJ 08544 USA	University of Illinois System; University of Illinois Urbana-Champaign; New York University; Princeton University	Bian, L; Cimpian, A (corresponding author), Univ Illinois, Dept Psychol, Champaign, IL 61820 USA.; Bian, L; Cimpian, A (corresponding author), New York Univ, Dept Psychol, New York, NY 10003 USA.	linbian2@illinois.edu; andrei.cimpian@nyu.edu	Cimpian, Andrei/X-4605-2019	Cimpian, Andrei/0000-0002-3553-6097	Graduate College Dissertation Completion Fellowship from the University of Illinois; NSF [BCS-1530669]	Graduate College Dissertation Completion Fellowship from the University of Illinois; NSF(National Science Foundation (NSF))	We are grateful to the families who participated and to the members of the Cognitive Development Lab at the University of Illinois for research assistance and helpful discussion. We also thank J. R. Cimpian for insightful feedback on previous drafts. This research was supported by a Graduate College Dissertation Completion Fellowship from the University of Illinois (L.B.) and NSF grant BCS-1530669 (A.C. and S.-J.L.). The supplementary materials contain additional data. The data for these studies are also available on Open Science Framework: https://osf.io/yund6/?view_only=9a8505d4e87b456a89f255b43e21234e.	Ambady N, 2001, PSYCHOL SCI, V12, P385, DOI 10.1111/1467-9280.00371; Beilock SL, 2010, P NATL ACAD SCI USA, V107, P1860, DOI 10.1073/pnas.0910967107; Butler R., 2005, HDB COMPETENCE MOTIV, P202; Cimpian A, 2015, SCIENCE, V349, DOI 10.1126/science.aaa9892; Crowley K, 2001, PSYCHOL SCI, V12, P258, DOI 10.1111/1467-9280.00347; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Cvencek D, 2016, J EXP SOC PSYCHOL, V62, P50, DOI 10.1016/j.jesp.2015.09.015; Cvencek D, 2011, CHILD DEV, V82, P766, DOI 10.1111/j.1467-8624.2010.01529.x; Davies PG, 2002, PERS SOC PSYCHOL B, V28, P1615, DOI 10.1177/014616702237644; Dunham Y, 2016, DEVELOPMENTAL SCI, V19, P781, DOI 10.1111/desc.12321; Eccles J., 1984, DEV ACHIEVEMENT MOTI, P282; Emerson KTU, 2015, PERS SOC PSYCHOL B, V41, P295, DOI 10.1177/0146167214564969; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Furnham A, 2002, J GENET PSYCHOL, V163, P24, DOI 10.1080/00221320209597966; Galdi S, 2014, CHILD DEV, V85, P250, DOI 10.1111/cdev.12128; Ginther DK, 2015, SCIENCE, V349, DOI 10.1126/science.aaa9632; Huang F. L., 2015, AERA OPEN, V1, P1; Kirkcaldy B, 2007, EUR PSYCHOL, V12, P173, DOI 10.1027/1016-9040.12.3.173; Lecklider A., 2013, INVENTING EGGHEAD BA; Leslie SJ, 2015, SCIENCE, V347, P262, DOI 10.1126/science.1261375; Liben LS, 2001, J EXP CHILD PSYCHOL, V79, P346, DOI 10.1006/jecp.2000.2611; Mazei J, 2015, PSYCHOL BULL, V141, P85, DOI 10.1037/a0038184; Meyer M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00235; Murphy MC, 2007, PSYCHOL SCI, V18, P879, DOI 10.1111/j.1467-9280.2007.01995.x; Robinson-Cimpian JP, 2014, DEV PSYCHOL, V50, P1262, DOI 10.1037/a0035073; Rudman LA, 1998, J PERS SOC PSYCHOL, V74, P629, DOI 10.1037/0022-3514.74.3.629; Smith JL, 2014, PSYCHOL WOMEN QUART, V38, P447, DOI 10.1177/0361684313515840; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Storage D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150194; Tenenbaum HR, 2003, DEV PSYCHOL, V39, P34, DOI 10.1037//0012-1649.39.1.34; Upson S., 2012, SA MIND, V23, P63, DOI [10.1038/scientificamericanmind1112-63, DOI 10.1038/SCIENTIFICAMERICANMIND1112-63]; Voyer D, 2014, PSYCHOL BULL, V140, P1174, DOI 10.1037/a0036620; Wood W, 2012, ADV EXP SOC PSYCHOL, V46, P55, DOI 10.1016/B978-0-12-394281-4.00002-7	33	384	394	25	295	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					389	+		10.1126/science.aah6524	http://dx.doi.org/10.1126/science.aah6524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4FR	28126816				2022-12-28	WOS:000393172800037
J	Normile, D				Normile, Dennis			SCIENCE AND SECURITY Japanese military entices academics to break taboo Critics assail expansion of dual-use research program	SCIENCE			English	News Item																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					338	338		10.1126/science.355.6323.338	http://dx.doi.org/10.1126/science.355.6323.338			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126766				2022-12-28	WOS:000393172800015
J	Tieman, D; Zhu, GT; Resende, MFR; Lin, T; Taylor, M; Zhang, B; Ikeda, H; Liu, ZY; Fisher, J; Zemach, I; Monforte, AJ; Zamir, D; Granell, A; Kirst, M; Huang, S; Klee, H; Nguyen, C; Bies, D; Rambla, JL; Beltran, KSO				Tieman, Denise; Zhu, Guangtao; Resende, Marcio F. R., Jr.; Lin, Tao; Taylor, Mark; Zhang, Bo; Ikeda, Hiroki; Liu, Zhongyuan; Fisher, Josef; Zemach, Itay; Monforte, Antonio Jose; Zamir, Dani; Granell, Antonio; Kirst, Matias; Huang, Sanwen; Klee, Harry; Nguyen, Cuong; Bies, Dawn; Rambla, Jose Luis; Beltran, Kristty Stephanie Ortiz			PLANT SCIENCE A chemical genetic roadmap to improved tomato flavor	SCIENCE			English	Article								Modern commercial tomato varieties are substantially less flavorful than heirloom varieties. To understand and ultimately correct this deficiency, we quantified flavor-associated chemicals in 398 modern, heirloom, and wild accessions. A subset of these accessions was evaluated in consumer panels, identifying the chemicals that made the most important contributions to flavor and consumer liking. We found that modern commercial varieties contain significantly lower amounts of many of these important flavor chemicals than older varieties. Whole-genome sequencing and a genome-wide association study permitted identification of genetic loci that affect most of the target flavor chemicals, including sugars, acids, and volatiles. Together, these results provide an understanding of the flavor deficiencies in modern commercial varieties and the information necessary for the recovery of good flavor through molecular breeding.	[Tieman, Denise; Zhu, Guangtao; Lin, Tao; Huang, Sanwen; Klee, Harry] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, 7 Pengfei Rd,Dapeng Dist, Shenzhen, Peoples R China; [Tieman, Denise; Taylor, Mark; Zhang, Bo; Ikeda, Hiroki; Liu, Zhongyuan; Klee, Harry; Nguyen, Cuong; Bies, Dawn] Univ Florida, Plant Innovat Ctr, Hort Sci, POB 110690, Gainesville, FL 32611 USA; [Zhu, Guangtao; Lin, Tao; Huang, Sanwen] Chinese Acad Agr Sci, Minist Agr, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops,Sino, Beijing 100081, Peoples R China; [Resende, Marcio F. R., Jr.] RAPiD Genom, 747 SW 2nd Ave, Gainesville, FL 32601 USA; [Rambla, Jose Luis; Beltran, Kristty Stephanie Ortiz] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas Consejo Super Inv, Valencia, Spain; [Fisher, Josef; Zemach, Itay; Zamir, Dani] Hebrew Univ Jerusalem, Fac Agr, Rehovot, Israel; [Kirst, Matias] Univ Florida, Sch Forest Resources & Conservat, Genet Inst, Gainesville, FL 32611 USA	Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; State University System of Florida; University of Florida; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs; Universitat Politecnica de Valencia; Hebrew University of Jerusalem; State University System of Florida; University of Florida	Huang, S; Klee, H (corresponding author), Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, 7 Pengfei Rd,Dapeng Dist, Shenzhen, Peoples R China.; Klee, H (corresponding author), Univ Florida, Plant Innovat Ctr, Hort Sci, POB 110690, Gainesville, FL 32611 USA.; Huang, S (corresponding author), Chinese Acad Agr Sci, Minist Agr, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops,Sino, Beijing 100081, Peoples R China.	huangsanwen@caas.cn; hjklee@ufl.edu	Huang, Sanwen/ABE-9053-2020; Klee, Harry/A-7912-2008; Rambla, José L./B-5881-2011; MONFORTE, Antonio José/B-4784-2009	Huang, Sanwen/0000-0002-8547-5309; Rambla, José L./0000-0003-4704-2534; MONFORTE, Antonio José/0000-0003-3461-3094; Klee, Harry/0000-0003-3823-4518; Resende Jr., Marcio/0000-0002-2367-0766	NSF [IOS-0923312]; China National Key Research and Development Program for Crop Breeding [2016YFD0100307]; Leading Talents of Guangdong Province Program [00201515]; National Natural Science Foundation of China [31601756]; European Research Council [ERC-2011-AdG 294691]; European Commission Horizon program (TRADITOM grant) [634561]; Chinese Academy of Agricultural Science (ASTIP-CAAS); Shenzhen municipal and Dapeng district governments; Direct For Biological Sciences [1444543] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1564366] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); China National Key Research and Development Program for Crop Breeding; Leading Talents of Guangdong Province Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Research Council(European Research Council (ERC)European Commission); European Commission Horizon program (TRADITOM grant); Chinese Academy of Agricultural Science (ASTIP-CAAS); Shenzhen municipal and Dapeng district governments; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the NSF (grant IOS-0923312 to H.K.), the China National Key Research and Development Program for Crop Breeding (grant 2016YFD0100307 to S.H.), the Leading Talents of Guangdong Province Program (grant 00201515 to S.H.), the National Natural Science Foundation of China (grant 31601756 to G.Z.), the European Research Council (grant ERC-2011-AdG 294691 YIELD to D.Z.), and the European Commission Horizon 2020 program (TRADITOM grant 634561 to A.G. and D.Z.) This work was also supported by the Chinese Academy of Agricultural Science (ASTIP-CAAS) and the Shenzhen municipal and Dapeng district governments. We acknowledge the assistance of L. Kates in fieldwork and volatile, sugar, and acid quantification.	Baldwin EA, 2000, HORTSCIENCE, V35, P1013, DOI 10.21273/HORTSCI.35.6.1013; Buttery R. G., 1987, ACS SYM SER, V388, P213; DEIKMAN J, 1992, PLANT PHYSIOL, V100, P2013, DOI 10.1104/pp.100.4.2013; Fridman E, 2004, SCIENCE, V305, P1786, DOI 10.1126/science.1101666; Lewinsohn E, 2005, J AGR FOOD CHEM, V53, P3142, DOI 10.1021/jf047927t; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Oltman AE, 2014, J FOOD SCI, V79, pS2091, DOI 10.1111/1750-3841.12638; PENARRUBIA L, 1992, PLANT CELL, V4, P681, DOI 10.1105/tpc.4.6.681; Tieman D, 2012, CURR BIOL, V22, P1035, DOI 10.1016/j.cub.2012.04.016; Tieman D, 2010, PLANT J, V62, P113, DOI 10.1111/j.1365-313X.2010.04128.x; Vogel JT, 2010, J SCI FOOD AGR, V90, P2233, DOI 10.1002/jsfa.4076; Zanor MI, 2009, PLANT PHYSIOL, V150, P1204, DOI 10.1104/pp.109.136598; Zanor MI, 2009, J EXP BOT, V60, P2139, DOI 10.1093/jxb/erp086; Zhang B, 2016, P NATL ACAD SCI USA, V113, P12580, DOI 10.1073/pnas.1613910113; Zierler B, 2004, ANAL CHIM ACTA, V520, P3, DOI 10.1016/j.aca.2004.03.084	15	352	390	55	689	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					391	394		10.1126/science.aal1556	http://dx.doi.org/10.1126/science.aal1556			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126817				2022-12-28	WOS:000393172800038
J	Wang, TT; Sewatanon, J; Memoli, MJ; Wrammert, J; Bournazos, S; Bhaumik, SK; Pinsky, BA; Chokephaibulkit, K; Onlamoon, N; Pattanapanyasat, K; Taubenberger, JK; Ahmed, R; Ravetch, JV				Wang, Taia T.; Sewatanon, Jaturong; Memoli, Matthew J.; Wrammert, Jens; Bournazos, Stylianos; Bhaumik, Siddhartha Kumar; Pinsky, Benjamin A.; Chokephaibulkit, Kulkanya; Onlamoon, Nattawat; Pattanapanyasat, Kovit; Taubenberger, Jeffery K.; Ahmed, Rafi; Ravetch, Jeffrey V.			IgG antibodies to dengue enhanced for Fc gamma RIIIA binding determine disease severity	SCIENCE			English	Article							VIRUS-INFECTION; HEMORRHAGIC-FEVER; DEPENDENT ENHANCEMENT; IN-VITRO; CORRELATE; RECEPTOR; SEROTYPE; PATHOGENESIS; POLYMORPHISM; MACROPHAGES	Dengue virus (DENV) infection in the presence of reactive, non-neutralizing immunoglobulin G (IgG) (RNNIg) is the greatest risk factor for dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). Progression to DHF/DSS is attributed to antibody-dependent enhancement (ADE); however, because only a fraction of infections occurring in the presence of RNNIg advance to DHF/DSS, the presence of RNNIg alone cannot account for disease severity. We discovered that DHF/DSS patients respond to infection by producing IgGs with enhanced affinity for the activating Fc receptor Fc gamma RIIIA due to afucosylated Fc glycans and IgG1 subclass. RNNIg enriched for afucosylated IgG1 triggered platelet reduction in vivo and was a significant risk factor for thrombocytopenia. Thus, therapeutics and vaccines restricting production of afucosylated, IgG1 RNNIg during infection may prevent ADE of DENV disease.	[Wang, Taia T.; Bournazos, Stylianos; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10065 USA; [Wang, Taia T.; Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Sewatanon, Jaturong; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Sewatanon, Jaturong; Wrammert, Jens; Bhaumik, Siddhartha Kumar; Ahmed, Rafi] Emory Univ, Emory Vaccine Ctr, Sch Med, Atlanta, GA 30322 USA; [Sewatanon, Jaturong] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand; [Memoli, Matthew J.; Taubenberger, Jeffery K.] Natl Inst Hlth, Natl Inst Allergy & Infect Dis, Infect Dis Lab, Viral Pathogenesis & Evolut Sect, Bethesda, MD USA; [Wrammert, Jens; Bhaumik, Siddhartha Kumar] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA; [Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Chokephaibulkit, Kulkanya] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Paediat, Bangkok 10700, Thailand; [Onlamoon, Nattawat; Pattanapanyasat, Kovit] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Res & Dev, Bangkok 10700, Thailand	Rockefeller University; Stanford University; Emory University; Emory University; Mahidol University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Stanford University; Mahidol University; Mahidol University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10065 USA.	ravetch@rockefeller.edu	Taubenberger, Jeffery/AAQ-1407-2021; Ravetch, Jeffrey/Z-1596-2019; Onlamoon, Nattawat/AAR-8390-2020; Bournazos, Stylianos/ABH-1578-2021	Ravetch, Jeffrey/0000-0003-2024-9041; Pinsky, Benjamin/0000-0001-8751-4810	National Center for Advancing Translational Sciences, NIH [UL1TR001866]; Clinical and Translational Science Award program; NIH [IRO1AI099385]; American Foundation for AIDS Research Mathilde Krim Fellowship in Basic Biomedical Research [109519-60-RKVA]; National Institute of Allergy and Infectious Diseases of the NIH [U19AI111825, U19AI109946, U19AI057266, U01AI115651]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID); NIAID Extramural Clinical Research Acceleration Program; Rockefeller University; Stanford University School of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111825, ZIAAI001157, U19AI057266, U01AI115651, U19AI109946, R01AI099385, R01AI034662] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, NIH; Clinical and Translational Science Award program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for AIDS Research Mathilde Krim Fellowship in Basic Biomedical Research; National Institute of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID); NIAID Extramural Clinical Research Acceleration Program; Rockefeller University; Stanford University School of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Zhang and R. Sherwood at the Cornell Proteomics and Mass Spectrometry Facility for helpful discussions and excellent technical support. The authors also thank the staff of the Stanford Clinical Virology Laboratory for their assistance with dengue virus serologic testing. T.T.W. thanks B. Coller, S. J. Schlesinger, and the Rockefeller University KL2 Clinical Scholars Program for training and support. T.T.W. was supported, in part, by grant UL1TR001866 from the National Center for Advancing Translational Sciences, NIH, and the Clinical and Translational Science Award program. J.S. thanks S. Wang and S. Gunisetty for helping with preparation of sera from patient samples. K.P. was funded by NIH IRO1AI099385. S. B. was supported by an American Foundation for AIDS Research Mathilde Krim Fellowship in Basic Biomedical Research (109519-60-RKVA). Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the NIH under award numbers U19AI111825 (J.V.R.), U19AI109946 (J.V.R.), U19AI057266 (R. A. and J.W.), and U01AI115651 (R. A.). The influenza A virus challenge study was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), as well as the NIAID Extramural Clinical Research Acceleration Program. Support and infrastructure were also provided by The Rockefeller University and by Stanford University School of Medicine. Analysis of clinical samples in this work was approved by the Institutional Review Board of Rockefeller University (protocol # TWA-0804) (T.T.W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH. The data presented in this manuscript are in the main paper and in the supplementary materials.	Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2012, ANN NY ACAD SCI, V1253, P170, DOI 10.1111/j.1749-6632.2011.06305.x; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449; Blackley S, 2007, J VIROL, V81, P13325, DOI 10.1128/JVI.01568-07; Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280; FLEIT HB, 1982, P NATL ACAD SCI-BIOL, V79, P3275, DOI 10.1073/pnas.79.10.3275; Flipse J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29201; Flipse J, 2013, TRAFFIC, V14, P25, DOI 10.1111/tra.12012; Garcia G, 2010, AM J TROP MED HYG, V82, P1153, DOI 10.4269/ajtmh.2010.09-0353; Gonzalez D, 2005, INT J INFECT DIS, V9, P280, DOI 10.1016/j.ijid.2004.07.012; Graham RR, 1999, AM J TROP MED HYG, V61, P412, DOI 10.4269/ajtmh.1999.61.412; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P261; Herter S, 2013, MOL CANCER THER, V12, P2031, DOI 10.1158/1535-7163.MCT-12-1182; JONES DH, 1985, J IMMUNOL, V135, P3348; KLIKS S, 1990, AIDS RES HUM RETROV, V6, P993, DOI 10.1089/aid.1990.6.993; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; Kou ZH, 2011, VIROLOGY, V410, P240, DOI 10.1016/j.virol.2010.11.007; Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Loke H, 2002, AM J TROP MED HYG, V67, P102, DOI 10.4269/ajtmh.2002.67.102; Memoli MJ, 2015, CLIN INFECT DIS, V60, P693, DOI 10.1093/cid/ciu924; Modhiran N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000924; Mohsin SN, 2015, AM J TROP MED HYG, V93, P691, DOI 10.4269/ajtmh.15-0199; Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Ryan EJ, 2010, HUM IMMUNOL, V71, P829, DOI 10.1016/j.humimm.2010.05.007; Smith P, 2012, P NATL ACAD SCI USA, V109, P6181, DOI 10.1073/pnas.1203954109; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; Sun DS, 2007, J THROMB HAEMOST, V5, P2291, DOI 10.1111/j.1538-7836.2007.02754.x; Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026	38	181	190	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					395	+		10.1126/science.aai8128	http://dx.doi.org/10.1126/science.aai8128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126818	Green Accepted			2022-12-28	WOS:000393172800039
J	Beck, RW; Riddlesworth, T; Ruedy, K; Ahmann, A; Bergenstal, R; Haller, S; Kollman, C; Kruger, D; McGill, JB; Polonsky, W; Toschi, E; Wolpert, H; Price, D				Beck, Roy W.; Riddlesworth, Tonya; Ruedy, Katrina; Ahmann, Andrew; Bergenstal, Richard; Haller, Stacie; Kollman, Craig; Kruger, Davida; McGill, Janet B.; Polonsky, William; Toschi, Elena; Wolpert, Howard; Price, David		DIAMOND Study Grp	Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HYPOGLYCEMIC EVENTS; PUMP THERAPY; MANAGEMENT; IMPACT	IMPORTANCE Previous clinical trials showing the benefit of continuous glucose monitoring (CGM) in the management of type 1 diabetes predominantly have included adults using insulin pumps, even though the majority of adults with type 1 diabetes administer insulin by injection. OBJECTIVE To determine the effectiveness of CGM in adults with type 1 diabetes treated with insulin injections. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial conducted between October 2014 and May 2016 at 24 endocrinology practices in the United States that included 158 adults with type 1 diabetes who were using multiple daily insulin injections and had hemoglobin A(1c) (HbA(1c)) levels of 7.5% to 9.9%. INTERVENTIONS Random assignment 2: 1 to CGM (n = 105) or usual care (control group; n = 53). MAIN OUTCOMES AND MEASURES Primary outcome measure was the difference in change in central-laboratory-measured HbA(1c) level from baseline to 24 weeks. There were 18 secondary or exploratory end points, of which 15 are reported in this article, including duration of hypoglycemia at less than 70 mg/dL, measured with CGM for 7 days at 12 and 24 weeks. RESULTS Among the 158 randomized participants (mean age, 48 years [SD, 13]; 44% women; mean baseline HbA1c level, 8.6% [SD, 0.6%]; and median diabetes duration, 19 years [interquartile range, 10-31 years]), 155 (98%) completed the study. In the CGM group, 93% used CGM 6 d/wk or more in month 6. Mean HbA(1c) reduction from baseline was 1.1% at 12 weeks and 1.0% at 24 weeks in the CGM group and 0.5% and 0.4%, respectively, in the control group (repeated-measures model P < .001). At 24 weeks, the adjusted treatment-group difference in mean change in HbA1c level from baseline was -0.6% (95% CI, -0.8% to -0.3%; P < .001). Median duration of hypoglycemia at less than <70 mg/dL was 43 min/d (IQR, 27-69) in the CGM group vs 80 min/d (IQR, 36-111) in the control group (P = .002). Severe hypoglycemia events occurred in 2 participants in each group. CONCLUSIONS AND RELEVANCE Among adults with type 1 diabetes who used multiple daily insulin injections, the use of CGM compared with usual care resulted in a greater decrease in HbA(1c) level during 24 weeks. Further research is needed to assess longer-term effectiveness, as well as clinical outcomes and adverse effects.	[Beck, Roy W.; Riddlesworth, Tonya; Ruedy, Katrina; Kollman, Craig] Jaeb Ctr Hlth Res, 15310 Amberly Dr,Ste 350, Tampa, FL 33647 USA; [Ahmann, Andrew] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Bergenstal, Richard] Int Diabet Ctr, Pk Nicollet Inst, St Louis Pk, MN USA; [Haller, Stacie] Diabet & Glandular Dis Clin, San Antonio, TX USA; [Kruger, Davida] Henry Ford Med Ctr, Div Endocrinol, Detroit, MI USA; [McGill, Janet B.] Washington Univ, St Louis, MO USA; [Polonsky, William] Behav Diabet Inst, San Diego, CA USA; [Toschi, Elena; Wolpert, Howard] Joslin Diabet Ctr, Boston, MA 02215 USA; [Price, David] Dexcom Inc, San Diego, CA USA	JAEB Center For Health Research; Oregon Health & Science University; International Diabetes Center; Henry Ford Health System; Washington University (WUSTL); Harvard University; Joslin Diabetes Center, Inc.	Beck, RW (corresponding author), Jaeb Ctr Hlth Res, 15310 Amberly Dr,Ste 350, Tampa, FL 33647 USA.	rbeck@jaeb.org			Dexcom Inc	Dexcom Inc	Dexcom Inc provided funding for the trial to each investigator's institution.	Bailey Timothy S, 2015, J Diabetes Sci Technol, V9, P209, DOI 10.1177/1932296814559746; Battelino T, 2015, DIABETIC MED, V32, P1568, DOI 10.1111/dme.12825; Battelino T, 2012, DIABETOLOGIA, V55, P3155, DOI 10.1007/s00125-012-2708-9; Battelino T, 2011, DIABETES CARE, V34, P795, DOI 10.2337/dc10-1989; Beck RW, 2009, DIABETES CARE, V32, P1378, DOI 10.2337/dc09-0108; Bergenstal RM, 2010, NEW ENGL J MED, V363, P311, DOI 10.1056/NEJMoa1002853; Brod M, 2013, DIABETES OBES METAB, V15, P546, DOI 10.1111/dom.12070; Christiansen M, 2013, DIABETES TECHNOL THE, V15, P881, DOI 10.1089/dia.2013.0077; CLARKE WL, 1995, DIABETES CARE, V18, P517, DOI 10.2337/diacare.18.4.517; Davis RE, 2005, CURR MED RES OPIN, V21, P1477, DOI 10.1185/030079905X61929; Fiallo-Scharer R, 2011, DIABETES CARE, V34, P586, DOI 10.2337/dc10-1111; Foster NC, 2016, DIABETES CARE, V39, pE81, DOI 10.2337/dc16-0207; Fulcher Gregory, 2014, J Med Econ, V17, P751, DOI 10.3111/13696998.2014.946992; Grunberger G, 2014, ENDOCR PRACT, V20, P463, DOI 10.4158/EP14145.PS; Hirsch IB, 2010, DIABETES TECHNOL THE, V12, P679, DOI 10.1089/dia.2010.0015; Kovatchev BP, 2000, J CLIN ENDOCR METAB, V85, P4287, DOI 10.1210/jc.85.11.4287; Little R. J. A., 1987, STAT ANAL MISSING DA; Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078; Pickup J, 2011, INT J CLIN PRACT, V65, P16, DOI [10.1111/j.1742-1241.2010.02574.x, 10.1089/dia.2016.2503]; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Zisser Howard C, 2009, J Diabetes Sci Technol, V3, P1146	22	519	529	2	70	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					371	378		10.1001/jama.2016.19975	http://dx.doi.org/10.1001/jama.2016.19975			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118453				2022-12-28	WOS:000392509600019
J	Bonafide, CP; Jamison, DT; Foglia, EE				Bonafide, Christopher P.; Jamison, David T.; Foglia, Elizabeth E.			The Emerging Market of Smartphone-Integrated Infant Physiologic Monitors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bonafide, Christopher P.] Childrens Hosp Philadelphia, Div Gen Pediat, 34th St & Civic Ctr Blvd,Room 12NW80, Philadelphia, PA 19104 USA; [Bonafide, Christopher P.; Foglia, Elizabeth E.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Jamison, David T.] Hlth Devices Grp, Plymouth Meeting, PA USA; [Foglia, Elizabeth E.] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Bonafide, CP (corresponding author), Childrens Hosp Philadelphia, Div Gen Pediat, 34th St & Civic Ctr Blvd,Room 12NW80, Philadelphia, PA 19104 USA.	bonafide@email.chop.edu		Bonafide, Christopher/0000-0003-2823-5883	Mentored Patient-Oriented Research Career Development Awards from the National Heart, Lung, and Blood Institute of the National Institutes of Health [K23HL116427, 1K23HD084727-01A1]; National Institute for Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD084727] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL116427] Funding Source: NIH RePORTER	Mentored Patient-Oriented Research Career Development Awards from the National Heart, Lung, and Blood Institute of the National Institutes of Health; National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Mentored Patient-Oriented Research Career Development Awards (K23HL116427 and 1K23HD084727-01A1) from the National Heart, Lung, and Blood Institute of the National Institutes of Health (Dr Bonafide) and from the National Institute for Child Health and Human Development (Dr Foglia).	Brockmann PE, 2011, ARCH DIS CHILD-FETAL, V96, pF335, DOI 10.1136/adc.2010.196758; King D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6639; Moreno MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2592; Pettitt J, SMART SOCK COULD SAV; Plante TB, 2016, JAMA INTERN MED, V176, P700, DOI 10.1001/jamainternmed.2016.0157	5	22	22	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					353	354		10.1001/jama.2016.19137	http://dx.doi.org/10.1001/jama.2016.19137			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118463	Green Accepted			2022-12-28	WOS:000392509600011
J	[Anonymous]				[Anonymous]			Hypertension Control for 10 Million	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					352	352		10.1001/jama.2016.20203	http://dx.doi.org/10.1001/jama.2016.20203			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118466				2022-12-28	WOS:000392509600010
J	Heymann, DL				Heymann, David L.			Access to Medicine Index-what about sustainability?	LANCET			English	Editorial Material									[Heymann, David L.] Ctr Global Hlth Secur, Chatham House, London, England; [Heymann, David L.] London Sch Hyg & Trop Med, Infect Dis Epidemiol, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Heymann, DL (corresponding author), Ctr Global Hlth Secur, Chatham House, London, England.; Heymann, DL (corresponding author), London Sch Hyg & Trop Med, Infect Dis Epidemiol, London WC1E 7HT, England.	david.heymann@phe.gov.uk						Access to Medicine Foundation, 2016, ACC MED IND 2016; Hargreaves JR, 2011, LANCET, V378, P1885, DOI 10.1016/S0140-6736(11)60687-9; Husoy Onarheim K, 2016, LANC YOUTH COMM ESS; Johnson T, 2011, DEBATE GENERIC DRUG; Ward A, 2016, FINANCIAL TIMES; WHO, 2014, WEEKLY EPIDEMIOLOGIC, V89, P409; WHO, 2016, EL LEPR W PAC; WHO Regional Office for Africa, AN SUMM NEGL TROP DI; Wirtz VJ, 2016, LANCET	9	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					235	237		10.1016/S0140-6736(17)30128-9	http://dx.doi.org/10.1016/S0140-6736(17)30128-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9BC	28118901				2022-12-28	WOS:000392801200009
J	Elnahal, SM; Clancy, CM; Shulkin, DJ				Elnahal, Shereef M.; Clancy, Carolyn M.; Shulkin, David J.			A Framework for Disseminating Clinical Best Practices in the VA Health System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE-SYSTEM		[Elnahal, Shereef M.; Clancy, Carolyn M.; Shulkin, David J.] US Dept Vet Affairs, 810 Vermont Ave NW, Washington, DC 20420 USA	US Department of Veterans Affairs	Clancy, CM (corresponding author), US Dept Vet Affairs, 810 Vermont Ave NW, Washington, DC 20420 USA.	carolyn.clancy@va.gov						AcademyHealth, 2012, RES INS US EV BUILD; Friedman CP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001456; Institute of Medicine, 2001, CROSSING QUALITY CHA; Pronovost PJ, 2015, ACAD MED, V90, P165, DOI 10.1097/ACM.0000000000000610; Smith M, 2012, JAMA-J AM MED ASSOC, V308, P1637, DOI 10.1001/jama.2012.13664; US Department of Veterans Affairs (VA), 2016, PEND WAIT TIM US PRE; US Department of Veterans Affairs (VA), 2015, PEND WAIT TIM US PRE; US Department of Veterans Affairs (VA), 2016, VA QUAL OF CAR	8	20	20	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					255	256		10.1001/jama.2016.18764	http://dx.doi.org/10.1001/jama.2016.18764			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114562				2022-12-28	WOS:000392089200007
J	Rochwerg, B; Guyatt, G				Rochwerg, Bram; Guyatt, Gordon			In patients with severe sepsis, hydrocortisone did not prevent progression to septic shock	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INTERNATIONAL CONSENSUS DEFINITIONS		[Rochwerg, Bram; Guyatt, Gordon] McMaster Univ, Hamilton, ON, Canada	McMaster University	Rochwerg, B (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Rochwerg, Bram/AAE-7606-2020					Annane D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002243.pub3; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Siemieniuk RAC, 2015, ANN INTERN MED, V163, P519, DOI 10.7326/M15-0715; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					JC10	JC10		10.7326/ACPJC-2017-166-2-010	http://dx.doi.org/10.7326/ACPJC-2017-166-2-010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	28114466				2022-12-28	WOS:000391842600009
J	Sacks, HS				Sacks, Henry S.			In adults >= 70 years of age, an adjuvanted herpes zoster subunit vaccine reduced herpes zoster at a mean 3.7 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES		[Sacks, Henry S.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sacks, HS (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							[Anonymous], 1979, Br Med J, V1, P5; McLaughlin JM, 2015, J PRIM PREV, V36, P259, DOI 10.1007/s10935-015-0394-3; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Schmader K, 2001, CLIN INFECT DIS, V32, P1481, DOI 10.1086/320169; Williams WW, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6501a1	5	2	2	3	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					JC5	JC5		10.7326/ACPJC-2017-166-2-005	http://dx.doi.org/10.7326/ACPJC-2017-166-2-005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	28114461				2022-12-28	WOS:000391842600004
J	Armitage, JO; Gascoyne, RD; Lunning, MA; Cavalli, F				Armitage, James O.; Gascoyne, Randy D.; Lunning, Matthew A.; Cavalli, Franco			Non-Hodgkin lymphoma	LANCET			English	Review							B-CELL LYMPHOMA; PERIPHERAL T-CELL; CHOP PLUS RITUXIMAB; RECURRENT FOLLICULAR LYMPHOMA; CLINICAL-PRACTICE GUIDELINES; GENOME-WIDE ASSOCIATION; DOSE-ADJUSTED EPOCH; LEUKEMIA GROUP-B; PHASE-II; FOLLOW-UP	Lymphomas can affect any organ in the body, present with a wide range of symptoms, and be seen by primary care physicians and physicians from most specialties. They are traditionally divided into Hodgkin's lymphoma (which accounts for about 10% of all lymphomas) and non-Hodgkin lymphoma, which is the topic of this Seminar. Non-Hodgkin lymphoma represents a wide spectrum of illnesses that vary from the most indolent to the most aggressive malignancies. They arise from lymphocytes that are at various stages of development, and the characteristics of the specific lymphoma subtype reflect those of the cell from which they originated. Since this topic was last reviewed in The Lancet in 2012, advances in understanding the biology and genetics of non-Hodgkin lymphoma and the availability of new diagnostic methods and therapies have improved our ability to manage patients with this disorder.	[Armitage, James O.; Lunning, Matthew A.] Univ Nebraska, Med Ctr, Omaha, NE 68182 USA; [Gascoyne, Randy D.] British Columbia Canc Agcy, Vancouver, BC, Canada; [Gascoyne, Randy D.] British Columbia Canc Res Ctr, Vancouver, BC, Canada; [Cavalli, Franco] Oncol Inst Southern Switzerland, Bellinzona, Switzerland	University of Nebraska System; University of Nebraska Medical Center; British Columbia Cancer Agency; British Columbia Cancer Agency; Institute of Oncology Research (IOR)	Armitage, JO (corresponding author), Univ Nebraska, Med Ctr, Nebraska Med Ctr, Omaha, NE 68198 USA.	joarmita@unmc.edu	Gascoyne, Randy D/A-6009-2013	Gascoyne, Randy D/0000-0002-2610-5690				Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alzahrani M, 2016, ANN ONCOL, V27, P1095, DOI 10.1093/annonc/mdw137; [Anonymous], 2014, CLIN ADV HEMATOL ONC, V12, P18; Ardeshna KM, 2014, LANCET ONCOL, V15, P424, DOI 10.1016/S1470-2045(14)70027-0; Armitage JO, 2016, BLOOD, V127, P2804, DOI 10.1182/blood-2015-11-632745; Barrington SF, 2014, J CLIN ONCOL, V32, P3048, DOI 10.1200/JCO.2013.53.5229; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; BAYERDORFFER E, 1995, LANCET, V345, P1591, DOI 10.1016/S0140-6736(95)90113-2; Bernstein SH, 2009, J CLIN ONCOL, V27, P114, DOI 10.1200/JCO.2008.16.8021; Boffetta P, 2011, ANN ONCOL, V22, P27, DOI 10.1093/annonc/mdr167; Bosetti C, 2008, INT J CANCER, V123, P1917, DOI 10.1002/ijc.23722; Briski R, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.34; Byrd JC, 2014, J CLIN ONCOL, V32, P3039, DOI 10.1200/JCO.2014.55.8262; Cancer Research UK, NON HODGK LYMPH INC; Castellar ERP, 2014, BLOOD, V124, P1473, DOI 10.1182/blood-2014-04-571091; Castillo JJ, 2014, CL LYMPH MYELOM LEUK, V14, P122, DOI 10.1016/j.clml.2013.10.005; Casulo C, 2015, J CLIN ONCOL, V33, P2516, DOI 10.1200/JCO.2014.59.7534; Cerhan JR, 2015, BLOOD, V126, P2265, DOI 10.1182/blood-2015-04-537498; Cerhan JR, 2014, NAT GENET, V46, P1233, DOI 10.1038/ng.3105; Chang ET, 2011, BLOOD, V118, P1591, DOI 10.1182/blood-2011-02-336065; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Chihara D, 2016, BRIT J HAEMATOL, V172, P80, DOI 10.1111/bjh.13796; Chihara D, 2014, BRIT J HAEMATOL, V164, P536, DOI 10.1111/bjh.12659; Clarke CA, 2002, CANCER-AM CANCER SOC, V94, P2015, DOI 10.1002/cncr.10403; Cohen JB, 2016, CANCER-AM CANCER SOC, V122, P2356, DOI 10.1002/cncr.30068; Cohen JB, 2014, CANCER-AM CANCER SOC, V120, P1677, DOI 10.1002/cncr.28642; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Coiffier B, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-11; Colli C, 2004, J CUTAN PATHOL, V31, P232, DOI 10.1111/j.0303-6987.2003.00167.x; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; d'Amore F, 2015, ANN ONCOL, V26, pV108, DOI 10.1093/annonc/mdv201; de Leval L, 2011, HISTOPATHOLOGY, V58, P49, DOI 10.1111/j.1365-2559.2010.03704.x; Dunleavy K, 2013, NEW ENGL J MED, V369, P1915, DOI 10.1056/NEJMoa1308392; Dunleavy K, 2013, NEW ENGL J MED, V368, P1408, DOI 10.1056/NEJMoa1214561; El-Asmar J, 2016, BIOL BLOOD MARROW TR, V22, P802, DOI 10.1016/j.bbmt.2015.12.004; El-Galaly TC, 2015, J CLIN ONCOL, V33, P3993, DOI 10.1200/JCO.2015.62.0229; Ellin F, 2014, BLOOD, V124, P1570, DOI 10.1182/blood-2014-04-573089; Fenske TS, 2016, BRIT J HAEMATOL, V174, P235, DOI 10.1111/bjh.14046; Ferreri AJM, 2012, J CLIN ONCOL, V30, P2988, DOI 10.1200/JCO.2011.41.4466; Fisher RI, 2005, J CLIN ONCOL, V23, P8447, DOI 10.1200/JCO.2005.03.1674; Flinn IW, 2014, BLOOD, V123, P2944, DOI 10.1182/blood-2013-11-531327; Geisler CH, 2012, BRIT J HAEMATOL, V158, P355, DOI 10.1111/j.1365-2141.2012.09174.x; Ghielmini M, 2013, ANN ONCOL, V24, P561, DOI [10.1093/annonc/mds517, 10.1093/annonc/mdr388]; Giordano TP, 2010, JAMA-J AM MED ASSOC, V297, P2010; Lenz Georg, 2010, N Engl J Med, V362, P1417, DOI 10.1056/NEJMra0807082; Gisselbrecht C, 2010, J CLIN ONCOL, V28, P4184, DOI 10.1200/JCO.2010.28.1618; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Gregory G, 2013, NEURO-ONCOLOGY, V15, P1068, DOI 10.1093/neuonc/not032; Gutierrez-Garcia G, 2011, ANN ONCOL, V22, P397, DOI 10.1093/annonc/mdq359; Hamlin PA, 2005, BRIT J HAEMATOL, V130, P691, DOI 10.1111/j.1365-2141.2005.05661.x; Hermine O, 2016, LANCET, V388, P565, DOI 10.1016/S0140-6736(16)00739-X; Herrera AF, 2014, CANCER-AM CANCER SOC, V120, P1993, DOI 10.1002/cncr.28676; Hoelzer D, 2014, BLOOD, V124, P3870, DOI 10.1182/blood-2014-03-563627; Hoster E, 2008, BLOOD, V111, P558, DOI 10.1182/blood-2007-06-095331; Jacobson C, 2014, BLOOD, V124, P2913, DOI 10.1182/blood-2014-06-538504; Jares P, 2012, J CLIN INVEST, V122, P3416, DOI 10.1172/JCI61272; JOHNSON PWM, 1995, J CLIN ONCOL, V13, P140, DOI 10.1200/JCO.1995.13.1.140; Kalpadakis C, 2007, HEMATOL ONCOL, V25, P127, DOI 10.1002/hon.820; Khan AB, 2013, BLOOD, V122, P61, DOI 10.1182/blood-2012-12-473389; Khouri IF, 2008, BLOOD, V111, P5530, DOI 10.1182/blood-2008-01-136242; Kluin-Nelemans HC, 2012, NEW ENGL J MED, V367, P520, DOI 10.1056/NEJMoa1200920; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kothari J, 2014, BRIT J HAEMATOL, V165, P334, DOI 10.1111/bjh.12741; Kridel R, 2012, J CLIN INVEST, V122, P3424, DOI 10.1172/JCI63186; Kumar A, 2015, BRIT J HAEMATOL, V171, P776, DOI 10.1111/bjh.13766; Kwong YL, 2005, LEUKEMIA, V19, P2186, DOI 10.1038/sj.leu.2403955; Landsburg DJ, 2016, CANCER-AM CANCER SOC, V122, P559, DOI 10.1002/cncr.29781; Lenz G, 2005, J CLIN ONCOL, V23, P1984, DOI 10.1200/JCO.2005.08.133; Leonard JP, 2015, J CLIN ONCOL, V33, P3635, DOI 10.1200/JCO.2014.59.9258; Lepretre S, 2016, J CLIN ONCOL, V34, P572, DOI 10.1200/JCO.2015.61.5385; Lesokhin AM, 2016, J CLIN ONCOL, V34, P2698, DOI 10.1200/JCO.2015.65.9789; Liu Q, 2006, J CLIN ONCOL, V24, P1582, DOI 10.1200/JCO.2005.03.3696; MacManus MP, 1996, J CLIN ONCOL, V14, P1282, DOI 10.1200/JCO.1996.14.4.1282; Maddocks K, 2012, BLOOD, V125, P242; Magrath I, 1996, J CLIN ONCOL, V14, P925, DOI 10.1200/JCO.1996.14.3.925; Mamot C, 2015, J CLIN ONCOL, V33, P2523, DOI 10.1200/JCO.2014.58.9846; Martin A, 2009, HAEMATOL-HEMATOL J, V94, P744, DOI 10.3324/haematol.2009.006452; Meignan M, 2009, LEUKEMIA LYMPHOMA, V50, P1257, DOI 10.1080/10428190903040048; Melenotte C, 2016, BLOOD, V127, P113, DOI 10.1182/blood-2015-04-639617; Molina TJ, 2014, J CLIN ONCOL, V32, P3996, DOI 10.1200/JCO.2013.54.9493; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morton Lindsay M., 2014, Journal of the National Cancer Institute Monographs, P130, DOI 10.1093/jncimonographs/lgu013; Morton LM, 2005, CANCER EPIDEM BIOMAR, V14, P925, DOI 10.1158/1055-9965.EPI-04-0693; Morton LM, 2005, LANCET ONCOL, V6, P469, DOI 10.1016/S1470-2045(05)70214-X; Muller C, 2012, BLOOD, V119, P3276, DOI 10.1182/blood-2011-09-380949; Ng AK, 2016, J CLIN ONCOL, V34, P1443, DOI 10.1200/JCO.2015.64.9418; Nowakowski GS, 2015, J CLIN ONCOL, V33, P251, DOI 10.1200/JCO.2014.55.5714; O'Connor OA, 2015, J CLIN ONCOL, V33, P2492, DOI 10.1200/JCO.2014.59.2782; O'Connor OA, 2011, J CLIN ONCOL, V29, P1182, DOI 10.1200/JCO.2010.29.9024; Oh DH, 2016, BIOL BLOOD MARROW TR, V22, P941, DOI 10.1016/j.bbmt.2016.01.015; Pasqualucci L, 2014, CANCER CELL, V25, P132, DOI 10.1016/j.ccr.2013.12.012; Passerini CG, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt378; Perry AM, 2015, BLOOD, V126, P1484; Petrich AM, 2014, BLOOD, V124, P2354, DOI 10.1182/blood-2014-05-578963; Pfreundschuh M, 2014, HAEMATOLOGICA S1, V99, P540; PHILIP T, 1995, NEW ENGL J MED, V333, P1540, DOI 10.1056/NEJM199512073332305; Pro B, 2012, J CLIN ONCOL, V30, P2190, DOI 10.1200/JCO.2011.38.0402; Recher C, 2011, LANCET, V378, P1858, DOI 10.1016/S0140-6736(11)61040-4; Ribrag V, 2016, LANCET, V387, P2402, DOI 10.1016/S0140-6736(15)01317-3; Rizzieri DA, 2014, BRIT J HAEMATOL, V165, P102, DOI 10.1111/bjh.12736; Robak T, 2015, NEW ENGL J MED, V372, P944, DOI 10.1056/NEJMoa1412096; Rohatiner AZS, 2007, J CLIN ONCOL, V25, P2554, DOI 10.1200/JCO.2006.09.8327; Romaguera JE, 2010, BRIT J HAEMATOL, V150, P200, DOI 10.1111/j.1365-2141.2010.08228.x; ROSENBERG SA, 1985, J CLIN ONCOL, V3, P298, DOI 10.1200/JCO.1985.3.3.299; Ruan J, 2015, NEW ENGL J MED, V373, P1835, DOI 10.1056/NEJMoa1505237; Rummel M, 2016, LANCET ONCOL, V17, P57, DOI 10.1016/S1470-2045(15)00447-7; Rummel MJ, 2013, LANCET, V381, P1203, DOI 10.1016/S0140-6736(12)61763-2; Saha Abhik, 2011, Clin Cancer Res, V17, P3056, DOI 10.1158/1078-0432.CCR-10-2578; Salles G, 2011, LANCET, V377, P42, DOI 10.1016/S0140-6736(10)62175-7; Savage KJ, 2008, BLOOD, V111, P5496, DOI 10.1182/blood-2008-01-134270; Savage KJ, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.303.303; Sehn LH, 2005, J CLIN ONCOL, V23, P5027, DOI 10.1200/JCO.2005.09.137; Shankland KR, 2012, LANCET, V380, P848, DOI 10.1016/S0140-6736(12)60605-9; Shiels MS, 2013, CANCER EPIDEM BIOMAR, V22, P1069, DOI 10.1158/1055-9965.EPI-13-0040; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Sibon D, 2012, J CLIN ONCOL, V30, P3939, DOI 10.1200/JCO.2012.42.2345; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Stiff PJ, 2013, NEW ENGL J MED, V369, P1681, DOI 10.1056/NEJMoa1301077; Swenson WT, 2005, J CLIN ONCOL, V23, P5019, DOI 10.1200/JCO.2005.04.503; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Teckie S, 2015, INT J RADIAT ONCOL, V92, P130, DOI 10.1016/j.ijrobp.2015.01.040; Thomas DA, 1999, J CLIN ONCOL, V17, P2461, DOI 10.1200/JCO.1999.17.8.2461; Thompson CA, 2014, J CLIN ONCOL, V32, P3506, DOI 10.1200/JCO.2014.55.7561; Trneny M, 2016, LANCET ONCOL, V17, P319, DOI 10.1016/S1470-2045(15)00559-8; Trotman J, 2014, LANCET HAEMATOL, V1, pE17, DOI 10.1016/S2352-3026(14)70008-0; Tsai HJ, 2015, EUR J HAEMATOL, V94, P130, DOI 10.1111/ejh.12405; Vallisa D, 2005, J CLIN ONCOL, V23, P468, DOI 10.1200/JCO.2005.06.008; van de Schans SAM, 2012, ANN ONCOL, V23, P171, DOI 10.1093/annonc/mdr055; Vargo JA, 2015, J CLIN ONCOL, V33, P3710, DOI 10.1200/JCO.2015.61.7654; Villa D, 2010, ANN ONCOL, V21, P1046, DOI 10.1093/annonc/mdp432; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Wang ML, 2016, LANCET ONCOL, V17, P48, DOI 10.1016/S1470-2045(15)00438-6; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Wang SS, 2014, J NATL CANC I MONOGR, V48, P66; Wilson WH, 2008, J CLIN ONCOL, V26, P2717, DOI 10.1200/JCO.2007.13.1391; Wilson WH, 2015, NAT MED, V21, P922, DOI 10.1038/nm.3884; Wilson WH, 2012, HAEMATOL-HEMATOL J, V97, P758, DOI 10.3324/haematol.2011.056531; Windisch T, 2016, J CLIN ONCOL, V23, P8018; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; Xing KH, 2015, BRIT J HAEMATOL, V169, P520, DOI 10.1111/bjh.13320; Yamaguchi M, 2011, J CLIN ONCOL, V29, P4410, DOI 10.1200/JCO.2011.35.6287; Zelenetz AD, 2016, J NATL COMPR CANC NE, V14, P196, DOI 10.6004/jnccn.2016.0023; Zelenetz AD, 2014, J NATL COMPR CANC NE, V12, P1282, DOI 10.6004/jnccn.2014.0125; Zhang Y, 2008, AM J EPIDEMIOL, V167, P1321, DOI 10.1093/aje/kwn058; Zhou Z, 2014, BLOOD, V123, P837, DOI 10.1182/blood-2013-09-524108; Zintzaras E, 2005, ARCH INTERN MED, V165, P2337, DOI 10.1001/archinte.165.20.2337	148	253	272	22	104	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2017	390	10091					298	310		10.1016/S0140-6736(16)32407-2	http://dx.doi.org/10.1016/S0140-6736(16)32407-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA5IZ	28153383				2022-12-28	WOS:000405477900030
J	Clinton, C; Sridhar, D				Clinton, Chelsea; Sridhar, Devi			Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance	LANCET			English	Article								In this report we assess who pays for cooperation in global health through an analysis of the financial flows of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, TB and Malaria, and Gavi, the Vaccine Alliance. The past few decades have seen the consolidation of influence in the disproportionate roles the USA, UK, and the Bill & Melinda Gates Foundation have had in financing three of these four institutions. Current financing flows in all four case study institutions allow donors to finance and deliver assistance in ways that they can more closely control and monitor at every stage. We highlight three major trends in global health governance more broadly that relate to this development: towards more discretionary funding and away from core or longer-term funding; towards defined multi-stakeholder governance and away from traditional government-centred representation and decision-making; and towards narrower mandates or problem-focused vertical initiatives and away from broader systemic goals.	[Clinton, Chelsea] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Sridhar, Devi] Univ Edinburgh, Edinburgh Med Sch, Edinburgh EH8 9AG, Midlothian, Scotland	Columbia University; University of Edinburgh	Sridhar, D (corresponding author), Univ Edinburgh, Edinburgh Med Sch, Edinburgh EH8 9AG, Midlothian, Scotland.	devi.sridhar@ed.ac.uk			Country Coordinating Mechanisms for Global Fund	Country Coordinating Mechanisms for Global Fund	CC discloses that the Clinton Health Access Initiative (CHAI) has worked with the Global Fund as well as served on a few Country Coordinating Mechanisms for Global Fund grants and additionally has worked with the World Bank on health systems strengthening and rebuilding, among other areas, and also has had various interactions with WHO and Gavi. DS declares no competing interests.	Abbasi K, 1999, BMJ-BRIT MED J, V318, P1003, DOI 10.1136/bmj.318.7189.1003; Allen CE, 1950, INT ORGAN, V4, P27; Baeza C, 2012, WORLD BANK HLTH 2012; Baker BK, 2009, LANCET, V373, P1218, DOI 10.1016/S0140-6736(08)61487-7; Beigbeder Y, 1998, WORLD HLTH ORG BOSTO, P163; Blanchet N., 2013, GLOBAL COLLECTIVE AC; Bridgeman T., 2011, THESIS; Brown GW, 2010, REV INT STUD, V36, P511, DOI 10.1017/S0260210510000136; Clinton C, 2014, THESIS, P318; Commission on a Global Health Risk Framework for the Future, 2016, NEGL DIM GLOB SEC FR; Dieleman JL, 2016, LANCET, V387, P2536, DOI 10.1016/S0140-6736(16)30168-4; Fink S., 2014, NY TIMES; Garrett L, 2015, EBOLAS LESSONS MISHA; Gavi The Vaccine Alliance, 2014, ANN DON CONTR GAV 20; Gavi The Vaccine Alliance, 2014, GAVI ALL ANN FIN REP; Gavi The Vaccine Alliance, ADV MARK COMM PNEUM; GODLEE F, 1994, BRIT MED J, V309, P1424, DOI 10.1136/bmj.309.6966.1424; GODLEE F, 1994, BRIT MED J, V309, P1491, DOI 10.1136/bmj.309.6967.1491; HIV Vaccines and Microbicides Resource Tracking Working Group, 2012, INV END AIDS EP NEW; IHME, FIN GLOB HLTH 2015 D; Institute for Health Metrics and Evaluation, 2013, FIN GLOB HLTH 2013 T, P21; Institute for Health Metrics and Evaluation, 2014, FIN GLOB HLTH 2014 S, P122; Kim JY, 2013, POVERTY HLTH HUMAN F; Mahler H., 1987, 14 WORLD HLTH ASS MA, P144; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; Nelson D, DELEGATION INT ORG A; Sridhar D, 2016, GLOB POLICY, V4, P325; Steensen, 2014, MAKING EARMARKED FUN; Tenney S, 2014, HIST DICT WORLD BANK, P149; The Global Fund, GLOB FUND CONTR DAT; The Global Fund, REPL REP DOC; United Kingdom Department for International Development, 2011, MULT AID REV ENS MAX; WHO, ESS MED HLTH PROD; WHO, VOL CONTR; WHO, 2011, IND FORM EV WORLD HL; World Bank, 2011, EX DIR INT DEV ASS B; World Bank, 2015, POL ACC INF; World Bank. (2021b), OVERVIEW; World Health Organization, 2013, 66 WORLD HLTH ASS MA	39	26	26	1	35	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2017	390	10091					324	332		10.1016/S0140-6736(16)32402-3	http://dx.doi.org/10.1016/S0140-6736(16)32402-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA5IZ	28139255	Green Accepted			2022-12-28	WOS:000405477900032
J	Vinther, J; Parry, L; Briggs, DEG; Van Roy, P				Vinther, Jakob; Parry, Luke; Briggs, Derek E. G.; Van Roy, Peter			Ancestral morphology of crown-group molluscs revealed by a new Ordovician stem aculiferan	NATURE			English	Article							FOSSILS; APLACOPHORAN; ORIGIN; SPACE; AFFINITIES; PHYLOGENY; SCLERITES; EVOLUTION; CHITONS; RADULA	Exceptionally preserved fossils provide crucial insights into extinct body plans and organismal evolution(1). Molluscs, one of the most disparate animal phyla, radiated rapidly during the early Cambrian period (approximately 535-520 million years ago (Ma))(2). The problematic fossil taxa Halkieria(3) and Orthrozanclus(4) (grouped in Sachitida) have been assigned variously to stem-group annelids, brachiopods(4,5), stem-group molluscs(4) or stem-group aculiferans (Polyplacophora and Aplacophora)(6), but their affinities have remained controversial owing to a lack of preserved diagnostic characters. Here we describe a new early sachitid, Calvapilosa kroegeri gen. et sp. nov. from the Fezouata biota of Morocco(7,8) (Early Ordovician epoch, around 478 Ma). The new taxon is characterized by the presence of a single large anterior shell plate and polystichous radula bearing a median tooth and several lateral and uncinal teeth in more than 125 rows. Its flattened body is covered by hollow spinose sclerites, and a smooth, ventral girdle flanks an extensive mantle cavity. Phylogenetic analyses resolve C. kroegeri as a stem-group aculiferan together with other single-plated forms such as Maikhanella (Siphogonuchites) and Orthrozanclus; Halkieria is recovered closer to the aculiferan crown. These genera document the stepwise evolution of the aculiferan body plan from forms with a single, almost conchiferan-like shell through two-plated taxa such as Halkieria, to the eight-plated crown-group aculiferans. C. kroegeri therefore provides key evidence concerning the long debate about the crown molluscan affinities of sachitids. This new discovery strongly suggests that the possession of only a single calcareous shell plate and the presence of unmineralised sclerites are plesiomorphic (an ancestral trait) for the molluscan crown.	[Vinther, Jakob; Parry, Luke] Univ Bristol, Sch Biol Sci, Life Sci, Bldg 24 Tyndall Ave, Bristol BS8 1TQ, Avon, England; [Vinther, Jakob] Univ Bristol, Sch Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England; [Parry, Luke] Nat Hist Museum, Dept Earth Sci, Cromwell Rd, London SW7 5BD, England; [Briggs, Derek E. G.; Van Roy, Peter] Yale Univ, Dept Geol & Geophys, 210 Whitney Ave, New Haven, CT 06511 USA; [Briggs, Derek E. G.] Yale Peabody Museum Nat Hist, 170 Whitney Ave, New Haven, CT 06520 USA; [Van Roy, Peter] Univ Ghent, Dept Geol & Sci, Krijgslaan 281-S8, B-9000 Ghent, Belgium	University of Bristol; University of Bristol; Natural History Museum London; Yale University; Yale University; Ghent University	Vinther, J (corresponding author), Univ Bristol, Sch Biol Sci, Life Sci, Bldg 24 Tyndall Ave, Bristol BS8 1TQ, Avon, England.; Vinther, J (corresponding author), Univ Bristol, Sch Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	jakob.vinther@bristol.ac.uk	Vinther, Jakob/GZG-4679-2022	Parry, Luke/0000-0002-3910-0346; Vinther, Jakob/0000-0002-3584-9616; Van Roy, Peter/0000-0001-5330-8402	National Science Foundation [EAR-1053247]; Division of Invertebrate Paleontology, YPM; Natural Environment Research Council [1374103] Funding Source: researchfish; Division Of Earth Sciences [1053247] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division of Invertebrate Paleontology, YPM; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	M., B. and L. 'Ou Said' Ben Moula collected the specimens and provided support in the field. B. Kroger 'discovered' the holotype in 2014 among freshly collected and, at the time uninventoried, material at the YPM. L. Ben Moula and B. Tahiri provided practical assistance. S. Butts and J. Utrup curated specimens and facilitated access to the collections at the YPM. C. Graham provided support and access to digital imaging facilities at the Yale Digital Collections Center (YDC2). The drawings of C. kroegeri were made by Z. Dutta and the physical reconstruction was done by E. Horn (http://www.10tons.dk/). The research was supported by National Science Foundation Grant EAR-1053247 and by the Division of Invertebrate Paleontology, YPM.	BENGTSON S, 1992, LETHAIA, V25, P401, DOI 10.1111/j.1502-3931.1992.tb01644.x; Benton MJ, 2015, PALAEONTOL ELECTRON, V18; Boag TH, 2016, PALEOBIOLOGY, V42, P574, DOI 10.1017/pab.2016.20; BRIGGS DEG, 1991, AM SCI, V79, P130; Conway M. S., 1990, NATURE, V345, P802; Conway M. S., 1995, PHILOS T R SOC B, V347, P305, DOI DOI 10.1098/RSTB.1995.0029; EERNISSE DJ, 1994, MICROSCOPIC ANATOMY, V5, P55; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kroger B, 2005, PALAEONTOLOGY, V48, P781, DOI 10.1111/j.1475-4983.2005.00478.x; Morris SC, 2007, SCIENCE, V315, P1255, DOI 10.1126/science.1137187; Nielsen C, 2007, ACTA ZOOL-STOCKHOLM, V88, P231, DOI 10.1111/j.1463-6395.2007.00270.x; O'Reilly JE, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0975; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Salvini-Plawen Luitfried v., 1996, P29; SCHELTEMA AH, 1972, Z MORPHOL TIERE, V72, P361, DOI 10.1007/BF00283130; SCHELTEMA AH, 1993, BIOL BULL, V184, P57, DOI 10.2307/1542380; Scheltema AH, 2002, INVERTEBR BIOL, V121, P1; Schiemann S. M., 2016, PREPRINT; Schwabe E, 2010, SPIXIANA, V33, P171; Sigwart JD, 2007, P R SOC B, V274, P2413, DOI 10.1098/rspb.2007.0701; Smith MR, 2012, P ROY SOC B-BIOL SCI, V279, P4287, DOI 10.1098/rspb.2012.1577; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Sutton MD, 2012, NATURE, V490, P94, DOI 10.1038/nature11328; Sutton MD, 2001, NATURE, V410, P461, DOI 10.1038/35068549; Van Roy P, 2015, J GEOL SOC LONDON, V172, P541, DOI 10.1144/jgs2015-017; Van Roy P, 2010, NATURE, V465, P215, DOI 10.1038/nature09038; Vendrasco MJ, 2004, J PALEONTOL, V78, P675, DOI 10.1666/0022-3360(2004)078<0675:LCAEOS>2.0.CO;2; Vendrasco MJ, 2004, NATURE, V429, P288, DOI 10.1038/nature02548; Vinther J, 2015, PALAEONTOLOGY, V58, P19, DOI 10.1111/pala.12140; Vinther J, 2012, PALAEONTOLOGY, V55, P1007, DOI 10.1111/j.1475-4983.2012.01180.x; Vinther J, 2012, P ROY SOC B-BIOL SCI, V279, P1259, DOI 10.1098/rspb.2011.1773; Vinther J, 2009, PALAEONTOLOGY, V52, P689, DOI 10.1111/j.1475-4983.2009.00881.x; Waggoner B, 2003, INTEGR COMP BIOL, V43, P104, DOI 10.1093/icb/43.1.104; Williams A, 2002, PALAEONTOLOGY, V45, P845, DOI 10.1111/1475-4983.00264; Wingstrand K.G., 1985, Galathea Report, V16, P7	37	57	58	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					471	+		10.1038/nature21055	http://dx.doi.org/10.1038/nature21055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28166536	Green Submitted			2022-12-28	WOS:000395094100035
J	Stafford, N				Stafford, Ned			Elizaveta Glinka OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												ns@europefn.net						GLINKA E, PUBLICATION LIST	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2017	356								j676	10.1136/bmj.j676	http://dx.doi.org/10.1136/bmj.j676			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FV	28174151				2022-12-28	WOS:000394578000013
J	Thomas, JA; Gupta, R; Aithal, GP				Thomas, James A.; Gupta, Rohit; Aithal, Guruprasad P.			Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis	ANNALS OF INTERNAL MEDICINE			English	Letter							DISEASE		[Thomas, James A.; Gupta, Rohit] Prince Charles Hosp, Brisbane, Qld, Australia; [Thomas, James A.; Gupta, Rohit] Univ Queensland, Brisbane, Qld, Australia; [Aithal, Guruprasad P.] Univ Nottingham Hosp, Nottingham, England; [Aithal, Guruprasad P.] Univ Nottingham, Nottingham, England	Prince Charles Hospital; University of Queensland; University of Nottingham; University of Nottingham	Thomas, JA (corresponding author), Prince Charles Hosp, Brisbane, Qld, Australia.; Thomas, JA (corresponding author), Univ Queensland, Brisbane, Qld, Australia.		Thomas, James A/A-1272-2017	Thomas, James A/0000-0002-9122-950X; Gupta, Rohit/0000-0001-5195-4443; Aithal, Guruprasad/0000-0003-3924-4830	Medical Research Council [MR/N005953/1] Funding Source: Medline; MRC [MR/N005953/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agrawal S, 2016, SCAND J GASTROENTERO, P1; Aithal GP, 2008, GASTROENTEROLOGY, V135, P1176, DOI 10.1053/j.gastro.2008.06.047; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Cusi K, 2016, ANN INTERN MED, V165, P305, DOI 10.7326/M15-1774; Hippisley-Cox J, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3477	5	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2017	166	3					229	230		10.7326/L16-0628	http://dx.doi.org/10.7326/L16-0628			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7DL	28166555				2022-12-28	WOS:000394781200015
J	Kennedy, R; Wojcik, S; Lazer, D				Kennedy, Ryan; Wojcik, Stefan; Lazer, David			Improving election prediction internationally	SCIENCE			English	Article							FOREIGN-AID; BART	This study reports the results of a multiyear program to predict direct executive elections in a variety of countries from globally pooled data. We developed prediction models by means of an election data set covering 86 countries and more than 500 elections, and a separate data set with extensive polling data from 146 election rounds. We also participated in two live forecasting experiments. Our models correctly predicted 80 to 90% of elections in out-of-sample tests. The results suggest that global elections can be successfully modeled and that they are likely to become more predictable as more information becomes available in future elections. The results provide strong evidence for the impact of political institutions and incumbent advantage. They also provide evidence to support contentions about the importance of international linkage and aid. Direct evidence for economic indicators as predictors of election outcomes is relatively weak. The results suggest that, with some adjustments, global polling is a robust predictor of election outcomes, even in developing states. Implications of these findings after the latest U.S. presidential election are discussed.	[Kennedy, Ryan] Univ Houston, Ctr Int & Comparat Studies, Houston, TX 77004 USA; [Wojcik, Stefan; Lazer, David] Northeastern Univ, Lazer Lab, Boston, MA 02115 USA; [Wojcik, Stefan; Lazer, David] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA	University of Houston System; University of Houston; Northeastern University; Harvard University	Kennedy, R (corresponding author), Univ Houston, Ctr Int & Comparat Studies, Houston, TX 77004 USA.	rkennedy@uh.edu			Intelligence Advanced Research Projects Activity (IARPA) through Dol/NBC [D12PC000337]	Intelligence Advanced Research Projects Activity (IARPA) through Dol/NBC	Supported in part by the Intelligence Advanced Research Projects Activity (IARPA) through Dol/NBC contract no. D12PC000337. The views and conclusions contained herein are those of the a:hit:hors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied., of IARPA, Dol/NBC or the U.S. government. We acknowledge the invaluable work of the research assistants who helped with data collection, in all parts of this project.	Abramowitz A, 2012, PS-POLIT SCI POLIT, V45, P618, DOI 10.1017/S104909651200087X; [Anonymous], 2016, WASHINGTON POST; Ansolabehere Stephen, 2002, ELECTION LAW J, V1, P315, DOI DOI 10.1089/153312902760137578; Bellucci P, 2010, INT J FORECASTING, V26, P54, DOI 10.1016/j.ijforecast.2009.09.004; Berg J., 2008, HDB EXPT EC RESULTS, P742, DOI DOI 10.1016/S1574-0722(07)00080-7; Bleich J, 2014, ANN APPL STAT, V8, P1750, DOI 10.1214/14-AOAS755; Campbell JE, 2014, PS-POLIT SCI POLIT, V47, P769, DOI 10.1017/S104909651400122X; Campbell JE, 2012, PS-POLIT SCI POLIT, V45, P610, DOI 10.1017/S1049096512000856; Campbell JE, 2004, PS-POLIT SCI POLIT, V37, P733; CAMPBELL JE, 1987, PS, V20, P37, DOI 10.2307/419268; Cantu F, 2016, INT J PUBLIC OPIN R, V28, P96, DOI 10.1093/ijpor/edv004; Ceron A, 2014, NEW MEDIA SOC, V16, P340, DOI 10.1177/1461444813480466; Chipman HA, 2010, ANN APPL STAT, V4, P266, DOI 10.1214/09-AOAS285; Cook CE, 2014, PS-POLIT SCI POLIT, V47, P304, DOI 10.1017/S1049096514000079; Duch Raymond M., 2008, EC VOTE POLITICAL EC; Erikson RS, 2012, ELECT STUD, V31, P532, DOI 10.1016/j.electstud.2012.04.008; Fair R., 2011, PREDICTING PRESIDENT; Fisher SD, 2011, ELECT STUD, V30, P250, DOI 10.1016/j.electstud.2010.09.005; GELMAN A, 1990, AM J POLIT SCI, V34, P1142, DOI 10.2307/2111475; Gibson CC, 2015, WORLD DEV, V68, P323, DOI 10.1016/j.worlddev.2014.11.009; Gott JR, 2008, MATH COMPUT MODEL, V48, P1396, DOI 10.1016/j.mcm.2008.05.038; Graefe A, 2015, GER POLIT, V24, P195, DOI 10.1080/09644008.2015.1024240; Hyde SD, 2012, POLIT ANAL, V20, P191, DOI 10.1093/pan/mpr040; Jackman S, 2014, PS-POLIT SCI POLIT, V47, P317, DOI 10.1017/S1049096514000109; Jerome B, 2013, PS-POLIT SCI POLIT, V46, P479, DOI 10.1017/S1049096513000814; Knack S, 2004, INT STUD QUART, V48, P251, DOI 10.1111/j.0020-8833.2004.00299.x; Lewis-Beck MS, 2014, PS-POLIT SCI POLIT, V47, P284, DOI 10.1017/S104909651400002X; Lewis-Beck MS, 2008, FR POLITICS, V6, P106, DOI 10.1057/fp.2008.2; Licht AA, 2010, J CONFLICT RESOLUT, V54, P58, DOI 10.1177/0022002709351104; Linzer DA, 2013, J AM STAT ASSOC, V108, P124, DOI 10.1080/01621459.2012.737735; Lockerbie B, 2008, PS-POLIT SCI POLIT, V41, P713, DOI 10.1017/S1049096508081225; Magalhaes PC, 2012, INT J FORECASTING, V28, P769, DOI 10.1016/j.ijforecast.2012.04.007; Nadeau R, 2013, COMP POLIT STUD, V46, P551, DOI 10.1177/0010414012463877; Nadeau R, 2010, INT J FORECASTING, V26, P11, DOI 10.1016/j.ijforecast.2009.04.002; Norpoth H, 2014, PS-POLIT SCI POLIT, V47, P332, DOI 10.1017/S1049096514000146; Norris P, 2013, J DEMOCR, V24, P124, DOI 10.1353/jod.2013.0063; Phillips Cabell, 1948, NEW YORK TIMES  1107, pE4; Rothschild D, 2015, INT J FORECASTING, V31, P952, DOI 10.1016/j.ijforecast.2014.08.006; Rutenberg J., 2016, NY TIMES; Sang E. T. K., 2012, P WORKSHOP SEMANTIC, P53; Ufelder J., 2012, FOREIGN POLICY; Ulfelder J., 2012, FOREIGN POLICY; Vogel K. P., 2016, POLITICO        1109; Ward M., 2012, FOREIGN POLICY; Whiteley P.F., 2005, BRIT J POLIT INT REL, V7, P165, DOI DOI 10.1111/J.1467-856X.2005.00179.X	45	23	24	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					515	+		10.1126/science.aal2887	http://dx.doi.org/10.1126/science.aal2887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154078				2022-12-28	WOS:000393183100043
J	Sherratt, DJ				Sherratt, David J.			Chromosome stitch-up?	SCIENCE			English	Editorial Material							DNA; CONDENSIN		[Sherratt, David J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Sherratt, DJ (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	david.sherratt@bioch.ox.ac.uk		Sherratt, David/0000-0002-2104-5430	BBSRC [BB/I004785/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I004785/1] Funding Source: Medline; Wellcome Trust [200782/Z/16/Z] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Goloborodko A, 2016, ELIFE, V5, DOI 10.7554/eLife.14864; Graham JE, 2010, P NATL ACAD SCI USA, V107, P20263, DOI 10.1073/pnas.1007518107; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Marbouty M, 2015, MOL CELL, V59, P588, DOI 10.1016/j.molcel.2015.07.020; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Nolivos S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10466; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Wang XD, 2017, SCIENCE, V355, P524, DOI 10.1126/science.aai8982; Wang XD, 2015, GENE DEV, V29, P1661, DOI 10.1101/gad.265876.115; Wilhelm L, 2015, ELIFE, V4, DOI 10.7554/eLife.06659	12	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					460	461		10.1126/science.aam7183	http://dx.doi.org/10.1126/science.aam7183			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154037				2022-12-28	WOS:000393183100021
J	Thorlund, JB; Englund, M; Christensen, R; Nissen, N; Pihl, K; Jorgensen, U; Schjerning, J; Lohmander, LS				Thorlund, Jonas Bloch; Englund, Martin; Christensen, Robin; Nissen, Nis; Pihl, Kenneth; Jorgensen, Uffe; Schjerning, Jeppe; Lohmander, L. Stefan			Patient reported outcomes in patients undergoing arthroscopic partial meniscectomy for traumatic or degenerative meniscal tears: comparative prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTERIOR CRUCIATE LIGAMENT; MIDDLE-AGED PATIENTS; KNEE INJURY; SCORE KOOS; CONTROLLED-TRIAL; OSTEOARTHRITIS; SURGERY; METAANALYSIS; POPULATION; VALIDATION	Objectives To compare patient reported outcomes from before surgery to 52 weeks after surgery between individuals undergoing arthroscopic partial meniscectomy for traumatic meniscal tears and those for degenerative meniscal tears. Design Comparative prospective cohort study. Setting Four public orthopaedic departments in the Region of Southern Denmark. Participants were recruited between 1 February 2013 and 31 January 2014, and at one of the original four hospitals from 1 February 2014 to 31 January 2015. Participants Individuals selected from Knee Arthroscopy Cohort Southern Denmark, aged 18-55, and undergoing arthroscopic partial meniscectomy for a traumatic or degenerative meniscal tear (defined by a combination of age and symptom onset). Interventions Both participant groups underwent arthroscopic partial meniscectomy for a meniscal tear, with operating surgeons recording relevant information on knee pathology. Patient reported outcomes were recorded via online questionnaires. Main outcome measures Primary outcome was the average between-group difference in change on four of five subscales of the knee injury and osteoarthritis outcome score (KOOS). The four subscales covered pain, symptoms, sport and recreational function, and quality of life (KOOS4). A 95% confidence interval excluding differences greater than 10 KOOS points between groups was interpreted as absence of a clinically meaningful difference. Analyses adjusted for age, sex, and body mass index. Results 397 eligible adults (42% women) with a traumatic or degenerative meniscal tear (n= 141, mean age 38.7 years (standard deviation 10.9); n= 256, 46.6 years (6.4); respectively) were included in the main analysis. At 52 weeks after arthroscopic partial meniscectomy, 55 (14%) patients were lost to follow-up. Statistically, participants with degenerative meniscal tears had a significantly larger improvement in KOOS4 scores than those with traumatic tears (adjusted between-group difference -5.1 (95% confidence interval -8.9 to -1.3); P= 0.008). In the analysis including KOOS4 score at all time points, a significant time-by-group interaction was observed in both the unadjusted (P= 0.025) and adjusted analysis (P= 0.024), indicating better self-reported outcomes in participants with degenerative tears. However, the difference between groups was at no time point considered clinically meaningful. Conclusions These results question the current tenet that patients with traumatic meniscal tears experience greater improvements in patient reported outcomes after arthroscopic partial meniscectomy than patients with degenerative tears.	[Thorlund, Jonas Bloch; Pihl, Kenneth] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Odense, Denmark; [Englund, Martin; Lohmander, L. Stefan] Lund Univ, Fac Med, Dept Clin Sci Lund, Orthoped,Clin Epidemiol Unit, Lund, Sweden; [Englund, Martin] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; [Christensen, Robin] Bispebjerg & Frederiksberg Hosp, Parker Inst, Musculoskeletal Stat Unit, Copenhagen, Denmark; [Nissen, Nis] Lillebaelt Hosp, Dept Orthoped, Kolding, Denmark; [Jorgensen, Uffe] Odense Univ Hosp, Dept Orthoped & Traumatol, Odense, Denmark; [Schjerning, Jeppe] Lillebaelt Hosp, Dept Orthoped, Vejle, Denmark	University of Southern Denmark; Lund University; Boston University; University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; Odense University Hospital	Thorlund, JB (corresponding author), Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Odense, Denmark.	jthorlund@health.sdu.dk	Lohmander, Stefan/AAL-8314-2021; Thorlund, Jonas B/A-4278-2014; Englund, Martin/J-7245-2012; Thorlund, Jonas Bloch/N-1593-2019	Lohmander, Stefan/0000-0002-5424-9448; Thorlund, Jonas B/0000-0001-7789-8224; Englund, Martin/0000-0003-3320-2437; Thorlund, Jonas Bloch/0000-0001-7789-8224; Christensen, Robin/0000-0002-6600-0631; Pihl, Kenneth/0000-0001-6910-5255	Danish Council for Independent Research/Medical Sciences; Region of Southern Denmark	Danish Council for Independent Research/Medical Sciences(Det Frie Forskningsrad (DFF)); Region of Southern Denmark	This study was supported by an individual postdoctoral grant (JBT) from the Danish Council for Independent Research/Medical Sciences and funds from the Region of Southern Denmark. The funders had no role in any part of the study or in any decision about publication.	Anderson AF, 2011, AM J SPORT MED, V39, P926, DOI 10.1177/0363546511400533; Baker P, 2002, J RHEUMATOL, V29, P557; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P58, DOI 10.2106/00004623-200300002-00008; Brophy RH, 2014, J BONE JOINT SURG AM, V96A, P801, DOI 10.2106/JBJS.M.00105; Camanho Gilberto Luis, 2006, Clinics, V61, P133, DOI 10.1590/S1807-59322006000200008; Collins NJ, 2016, OSTEOARTHR CARTILAGE, V24, P1317, DOI 10.1016/j.joca.2016.03.010; Englund M, 2008, RHEUM DIS CLIN N AM, V34, P573, DOI 10.1016/j.rdc.2008.05.009; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Englund M, 2011, ANN RHEUM DIS, V70, P1733, DOI 10.1136/ard.2011.150052; Englund M, 2009, ARTHRITIS RHEUM-US, V60, P831, DOI 10.1002/art.24383; Frobell RB, 2010, NEW ENGL J MED, V363, P331, DOI 10.1056/NEJMoa0907797; Ghislain NA, 2016, J CLIN DIAGN RES, V10, pRC1, DOI 10.7860/JCDR/2016/16686.7569; GILLQUIST J, 1982, CLIN ORTHOP RELAT R, P29; HAMBERG P, 1984, ACTA ORTHOP SCAND, V55, P172, DOI 10.3109/17453678408992331; Haviv B, 2016, ARCH ORTHOP TRAUM SU, V136, P1297, DOI 10.1007/s00402-016-2504-y; Ingelsrud LH, 2015, AM J SPORT MED, V43, P1902, DOI 10.1177/0363546515584041; Khan M, 2014, CAN MED ASSOC J, V186, P1057, DOI 10.1503/cmaj.140433; Kim Jung-Ryul, 2013, Eur J Orthop Surg Traumatol, V23, P589, DOI 10.1007/s00590-012-1028-6; Kise NJ, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3740; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; LYSHOLM J, 1981, INT ORTHOP, V5, P265; Meredith DS, 2005, ARTHROSCOPY, V21, P211, DOI 10.1016/j.arthro.2004.10.003; Paradowski PT, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-38; Paulsen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035087; Paxton ES, 2011, ARTHROSCOPY, V27, P1275, DOI 10.1016/j.arthro.2011.03.088; POEHLING GG, 1990, CLIN SPORT MED, V9, P539; Roemer FW, 2017, EUR RADIOL, V27, P404, DOI 10.1007/s00330-016-4361-z; Roos EM, 1999, OSTEOARTHR CARTILAGE, V7, P216, DOI 10.1053/joca.1998.0153; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Roos EM, 2000, ARTHROSCOPY, V16, P619, DOI 10.1053/jars.2000.4818; Roos EM, 1998, SCAND J MED SCI SPOR, V8, P439, DOI 10.1111/j.1600-0838.1998.tb00465.x; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; Roos H, 1995, OSTEOARTHR CARTILAGE, V3, P261, DOI 10.1016/S1063-4584(05)80017-2; Rytter Soren, 2009, J Occup Med Toxicol, V4, P19, DOI 10.1186/1745-6673-4-19; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Sihvonen R, 2016, ANN INTERN MED, V164, P449, DOI 10.7326/M15-0899; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; Skou ST, 2015, NEW ENGL J MED, V373, P1597, DOI 10.1056/NEJMoa1505467; Smith GD, 2005, ARTHROSCOPY, V21, P1462, DOI 10.1016/j.arthro.2005.09.007; STOLLER DW, 1987, RADIOLOGY, V163, P731, DOI 10.1148/radiology.163.3.3575724; Sun YB, 2012, CURR OPIN RHEUMATOL, V24, P152, DOI 10.1097/BOR.0b013e32834e90c1; Thorlund JB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2747; Thorlund JB, 2014, ACTA ORTHOP, V85, P287, DOI 10.3109/17453674.2014.919558; Thorlund JB, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003399; Tubach F, 2005, ANN RHEUM DIS, V64, P34, DOI 10.1136/ard.2004.023028; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511	46	50	50	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2017	356								j356	10.1136/bmj.j356	http://dx.doi.org/10.1136/bmj.j356			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BT	28153861	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000393450100003
J	Hugo, W; Zaretsky, JM; Sun, L; Song, CY; Moreno, BH; Hu-Lieskovan, S; Berent-Maoz, B; Pang, J; Chmielowski, B; Cherry, G; Seja, E; Lomeli, S; Kong, XJ; Kelley, MC; Sosman, JA; Johnson, DB; Ribas, A; Lo, RS				Hugo, Willy; Zaretsky, Jesse M.; Sun, Lu; Song, Chunying; Moreno, Blanca Homet; Hu-Lieskovan, Siwen; Berent-Maoz, Beata; Pang, Jia; Chmielowski, Bartosz; Cherry, Grace; Seja, Elizabeth; Lomeli, Shirley; Kong, Xiangju; Kelley, Mark C.; Sosman, Jeffrey A.; Johnson, Douglas B.; Ribas, Antoni; Lo, Roger S.			Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma (vol 165, pg 35, 2016)	CELL			English	Correction												rlo@mednet.ucla.edu			NATIONAL CANCER INSTITUTE [P01CA168585, K23CA204726] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065	1	165	167	3	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					542	542		10.1016/j.cell.2017.01.010	http://dx.doi.org/10.1016/j.cell.2017.01.010			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28129544	Bronze			2022-12-28	WOS:000396249600019
J	Matheson, S				Matheson, Susan			Engineering a Biological Revolution	CELL			English	Editorial Material								The new field of synthetic biology promises to change health care, computer technology, the production of biofuels, and more. Students participating in the International Genetically Engineered Machine (iGEM) competition are on the front lines of this revolution.											0	3	4	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					329	332		10.1016/j.cell.2017.01.001	http://dx.doi.org/10.1016/j.cell.2017.01.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28129532	Bronze			2022-12-28	WOS:000396249600001
J	Prelec, D; Seung, HS; Mccoy, J				Prelec, Drazen; Seung, H. Sebastian; Mccoy, John			A solution to the single-question crowd wisdom problem	NATURE			English	Article							ANSWER KEY; CONFIDENCE; KNOWLEDGE; MODELS	Once considered provocative(1), the notion that the wisdom of the crowd is superior to any individual has become itself a piece of crowd wisdom, leading to speculation that online voting may soon put credentialed experts out of business(2,3). Recent applications include political and economic forecasting(4,5), evaluating nuclear safety(6), public policy(7), the quality of chemical probes(8), and possible responses to a restless volcano(9). Algorithms for extracting wisdom from the crowd are typically based on a democratic voting procedure. They are simple to apply and preserve the independence of personal judgment(10). However, democratic methods have serious limitations. They are biased for shallow, lowest common denominator information, at the expense of novel or specialized knowledge that is not widely shared(11,12). Adjustments based on measuring confidence do not solve this problem reliably(13). Here we propose the following alternative to a democratic vote: select the answer that is more popular than people predict. We show that this principle yields the best answer under reasonable assumptions about voter behaviour, while the standard 'most popular' or 'most confident' principles fail under exactly those same assumptions. Like traditional voting, the principle accepts unique problems, such as panel decisions about scientific or artistic merit, and legal or historical disputes. The potential application domain is thus broader than that covered by machine learning and psychometric methods, which require data across multiple questions(14-20).	[Prelec, Drazen] MIT, Sloan Sch Management, Cambridge, MA 02139 USA; [Prelec, Drazen] MIT, Dept Econ, Cambridge, MA 02139 USA; [Prelec, Drazen; Mccoy, John] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Seung, H. Sebastian] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Seung, H. Sebastian] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Princeton University; Princeton University	Prelec, D (corresponding author), MIT, Sloan Sch Management, Cambridge, MA 02139 USA.; Prelec, D (corresponding author), MIT, Dept Econ, Cambridge, MA 02139 USA.; Prelec, D (corresponding author), MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.	dprelec@mit.edu			NSF [SES-0519141]; Institute for Advanced Study (Prelec); Intelligence Advanced Research Projects Activity (IARPA) via the Department of Interior National Business Center [D11PC20058]	NSF(National Science Foundation (NSF)); Institute for Advanced Study (Prelec); Intelligence Advanced Research Projects Activity (IARPA) via the Department of Interior National Business Center	We thank M. Alam, A. Huang and D. Mijovic-Prelec for help with designing and conducting Study 3, and D. Suh with designing and conducting Study 4b. Supported by NSF SES-0519141, Institute for Advanced Study (Prelec), and Intelligence Advanced Research Projects Activity (IARPA) via the Department of Interior National Business Center contract number D11PC20058. The US Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright annotation thereon. The views and conclusions expressed herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of IARPA, DoI/NBC, or the US Government.	Anders R, 2012, J MATH PSYCHOL, V56, P452, DOI 10.1016/j.jmp.2013.01.004; Arrow KJ, 2008, SCIENCE, V320, P877, DOI 10.1126/science.1157679; Aspinall W, 2010, NATURE, V463, P294, DOI 10.1038/463294a; BATCHELDER WH, 1988, PSYCHOMETRIKA, V53, P71, DOI 10.1007/BF02294195; Budescu DV, 2015, MANAGE SCI, V61, P267, DOI 10.1287/mnsc.2014.1909; Chen KY, 2004, MANAGE SCI, V50, P983, DOI 10.1287/mnsc.1040.0247; Cooke R. M., 1991, EXPERTS UNCERTAINTY; Cooke RM, 2008, RELIAB ENG SYST SAFE, V93, P657, DOI 10.1016/j.ress.2007.03.005; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Goldstein DG, 2002, PSYCHOL REV, V109, P75, DOI 10.1037//0033-295X.109.1.75; Hertwig R, 2012, SCIENCE, V336, P303, DOI 10.1126/science.1221403; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Koriat A, 2012, SCIENCE, V336, P360, DOI 10.1126/science.1216549; Lebreton M, 2015, NAT NEUROSCI, V18, P1159, DOI 10.1038/nn.4064; Lee MD, 2014, JUDGM DECIS MAK, V9, P259; Lee MD, 2012, TOP COGN SCI, V4, P151, DOI 10.1111/j.1756-8765.2011.01175.x; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Mellers B, 2014, PSYCHOL SCI, V25, P1106, DOI 10.1177/0956797614524255; Morgan MG, 2014, P NATL ACAD SCI USA, V111, P7176, DOI 10.1073/pnas.1319946111; Oprea TI, 2009, NAT CHEM BIOL, V5, P441, DOI 10.1038/nchembio0709-441; Oravecz Z, 2015, PSYCHOMETRIKA, V80, P341, DOI 10.1007/s11336-013-9379-4; Prelec D, 2004, SCIENCE, V306, P462, DOI 10.1126/science.1102081; Simmons JP, 2011, J CONSUM RES, V38, P1, DOI 10.1086/658070; Sunstein Cass R., 2006, INFOTOPIA MANY MINDS; Surowiecki J., 2005, WISDOM CROWDS; Yi SKM, 2012, COGNITIVE SCI, V36, P452, DOI 10.1111/j.1551-6709.2011.01223.x	27	112	114	3	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2017	541	7638					532	535		10.1038/nature21054	http://dx.doi.org/10.1038/nature21054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6LX	28128245				2022-12-28	WOS:000396116600051
J	Rimmer, A				Rimmer, Abi			Making junior doctors' lives easier	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												arimmer@bmj.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2017	356								j402	10.1136/bmj.j402	http://dx.doi.org/10.1136/bmj.j402			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HO	28122809				2022-12-28	WOS:000393177700013
J	Qaseem, A; Wilt, TJ; Rich, R; Humphrey, LL; Frost, J; Forciea, MA				Qaseem, Amir; Wilt, Timothy J.; Rich, Robert; Humphrey, Linda L.; Frost, Jennifer; Forciea, Mary Ann		Amer Acad Family Physicians	Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							ISOLATED SYSTOLIC HYPERTENSION; CARDIOVASCULAR OUTCOMES; COGNITIVE FUNCTION; LACUNAR STROKE; ELDERLY TRIAL; DOUBLE-BLIND; PERINDOPRIL; INDAPAMIDE; PREVENTION; REDUCTION	Description: The American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP) jointly developed this guideline to present the evidence and provide clinical recommendations based on the benefits and harms of higher versus lower blood pressure targets for the treatment of hypertension in adults aged 60 years or older. Methods: This guideline is based on a systematic review of published randomized, controlled trials for primary outcomes and observational studies for harms only (identified through EMBASE, the Cochrane Database of Systematic Reviews, MEDLINE, and ClinicalTrials. gov), from database inception through January 2015. The MEDLINE search was updated through September 2016. Evaluated outcomes included all-cause mortality, morbidity and mortality related to stroke, major cardiac events (fatal and nonfatal myocardial infarction and sudden cardiac death), and harms. This guideline grades the evidence and recommendations using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) method. Target Audience and Patient Population: The target audience for this guideline includes all clinicians, and the target patient population includes all adults aged 60 years or older with hypertension. Recommendation 1: ACP and AAFP recommend that clinicians initiate treatment in adults aged 60 years or older with systolic blood pressure persistently at or above 150 mm Hg to achieve a target systolic blood pressure of less than 150 mm Hg to reduce the risk for mortality, stroke, and cardiac events. (Grade: strong recommendation, high-quality evidence). ACP and AAFP recommend that clinicians select the treatment goals for adults aged 60 years or older based on a periodic discussion of the benefits and harms of specific blood pressure targets with the patient. Recommendation 2: ACP and AAFP recommend that clinicians consider initiating or intensifying pharmacologic treatment in adults aged 60 years or older with a history of stroke or transient ischemic attack to achieve a target systolic blood pressure of less than 140 mm Hg to reduce the risk for recurrent stroke. (Grade: weak recommendation, moderate-quality evidence). ACP and AAFP recommend that clinicians select the treatment goals for adults aged 60 years or older based on a periodic discussion of the benefits and harms of specific blood pressure targets with the patient. Recommendation 3: ACP and AAFP recommend that clinicians consider initiating or intensifying pharmacologic treatment in some adults aged 60 years or older at high cardiovascular risk, based on individualized assessment, to achieve a target systolic blood pressure of less than 140 mm Hg to reduce the risk for stroke or cardiac events. (Grade: weak recommendation, lowquality evidence). ACP and AAFP recommend that clinicians select the treatment goals for adults aged 60 years or older based on a periodic discussion of the benefits and harms of specific blood pressure targets with the patient.	[Qaseem, Amir] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA USA; [Forciea, Mary Ann] Univ Pennsylvania Hlth Syst, 3615 Chestnut St, Philadelphia, PA 19104 USA; [Wilt, Timothy J.] Minneapolis Vet Affairs Med Ctr, One Vet Dr 111-0, Minneapolis, MN USA; Bladen Med Associates, Elizabethtown, NC 28337 USA; Community Care Lower Cape Fear, Wilmington, NC USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Frost, Jennifer] Amer Acad Family Phys, 11400 Tomahawk Creek Pkwy, Leawood, KS 66211 USA; [Rich, Robert] Bladen Med Associates, 300 A East McKay St,POB 517, Elizabethtown, NC 28337 USA; [Humphrey, Linda L.] Vet Affairs Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd, Portland, OR 97201 USA	American College of Physicians; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA USA.	aqaseem@acponline.org			ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	AMERY A, 1985, LANCET, V1, P1349; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; [Anonymous], 1980, LANCET, V1, P1261; APPLEGATE WB, 1994, ARCH INTERN MED, V154, P2154, DOI 10.1001/archinte.154.19.2154; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; BIRD AS, 1990, J HYPERTENS, V8, P147, DOI 10.1097/00004872-199002000-00008; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Choudhry NK, 2016, ANN INTERN MED, V164, P41, DOI 10.7326/M14-2427; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; EISEN SA, 1990, ARCH INTERN MED, V150, P1881, DOI 10.1001/archinte.150.9.1881; Fletcher AE, 2002, J HYPERTENS, V20, P2069, DOI 10.1097/00004872-200210000-00028; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Gong LS, 1996, J HYPERTENS, V14, P1237, DOI 10.1097/00004872-199610000-00013; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103169; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jatos Study Grp, 2008, HYPERTENS RES, V31, P2115, DOI 10.1291/hypres.31.2115; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Liu LS, 2005, J HYPERTENS, V23, P2157, DOI 10.1097/01.hjh.0000194120.42722.ac; Margolis KL, 2014, J GEN INTERN MED, V29, P1599, DOI 10.1007/s11606-014-2961-3; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nuesch R, 2001, BRIT MED J, V323, P142, DOI 10.1136/bmj.323.7305.142; Ogihara T, 2010, HYPERTENSION, V56, P196, DOI 10.1161/HYPERTENSIONAHA.109.146035; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Peralta CA, 2016, CIRCULATION, V133, P584, DOI 10.1161/CIRCULATIONAHA.115.019657; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Peters R, 2010, AGE AGEING, V39, P609, DOI 10.1093/ageing/afq071; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Ruggenenti P, 2011, J HYPERTENS, V29, P207, DOI 10.1097/HJH.0b013e32834069bd; Siu AL, 2015, ANN INTERN MED, V163, P778, DOI 10.7326/M15-2223; Skoog I, 2005, AM J HYPERTENS, V18, P1052, DOI 10.1016/j.amjhyper.2005.02.013; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Verdecchia P, 2009, LANCET, V374, P525, DOI 10.1016/S0140-6736(09)61340-4; Veterans Administration Cooperative Study Group, 1970, JAMA-J AM MED ASSOC, V213, P1143, DOI DOI 10.1001/JAMA.1970.03170330025003; Voyaki SM, 2001, J HYPERTENS, V19, P511, DOI 10.1097/00004872-200103000-00020; Wang JG, 2000, ARCH INTERN MED, V160, P211, DOI 10.1001/archinte.160.2.211; Weiss J, 2015, 05225 VA ESP US DEP; Weiss J, 2017, ANN INTERN MED, V166, P419, DOI 10.7326/M16-1754; White CL, 2015, J AM GERIATR SOC, V63, P722, DOI 10.1111/jgs.13349; Wiklund Ingela, 1997, Blood Pressure, V6, P357, DOI 10.3109/08037059709062095; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050; Williamson JD, 2014, JAMA INTERN MED, V174, P324, DOI 10.1001/jamainternmed.2013.13656; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8	47	243	254	0	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					430	+		10.7326/M16-1785	http://dx.doi.org/10.7326/M16-1785			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28135725				2022-12-28	WOS:000397025800018
J	Deplanque, G; Demartines, N				Deplanque, Gael; Demartines, Nicolas			Pancreatic cancer: are more chemotherapy and surgery needed?	LANCET			English	Editorial Material							METAANALYSIS		[Deplanque, Gael] Hop Riviera Chablais, Serv Oncol, CH-1800 Vevey, Switzerland; [Demartines, Nicolas] CHU Vaudois, Serv Chirurg Viscerale, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Deplanque, G (corresponding author), Hop Riviera Chablais, Serv Oncol, CH-1800 Vevey, Switzerland.	gael.deplanque@gmail.com		Demartines, Nicolas/0000-0002-1530-3114	Merck Sharp Dohme; Bayer; Bristol-Myers Squibb; Merck; AB Science; Amgen; Bavarian Nordic; Exelixis; Genentech; Janssen-Cilag; Lilly; PUMA; Roche; Sanofi; Sotio; Menarini	Merck Sharp Dohme(Merck & Company); Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck(Merck & Company); AB Science; Amgen(Amgen); Bavarian Nordic; Exelixis; Genentech(Roche HoldingGenentech); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly(Eli Lilly); PUMA; Roche(Roche Holding); Sanofi; Sotio; Menarini(Menarini Group)	GD reports grants and personal fees from Merck Sharp & Dohme, travel grants from Bayer, Bristol-Myers Squibb, and Merck, grants from AB Science, Amgen, Bavarian Nordic, Exelixis, Genentech, Janssen-Cilag, Lilly, Merck, PUMA, Roche, Sanofi, and Sotio, and personal fees from Menarini for advisory board membership, all outside the therapeutic area discussed here. ND declares no competing interests.	Boeck S, 2007, ONCOLOGY-BASEL, V72, P314, DOI 10.1159/000113054; Conroy T, 2016, EUR J CANCER, V57, P10, DOI 10.1016/j.ejca.2015.12.026; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Lassen K, 2013, CLIN NUTR, V32, P870, DOI 10.1016/j.clnu.2013.04.019; Liao WC, 2013, LANCET ONCOL, V14, P1095, DOI 10.1016/S1470-2045(13)70388-7; Neoptolemos JP, 2017, LANCET; Rombouts SJ, 2016, ANN SURG ONCOL, V23, P4352, DOI 10.1245/s10434-016-5373-2; Vasen H, 2016, J CLIN ONCOL, V34, P2010, DOI 10.1200/JCO.2015.64.0730	8	41	41	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2017	389	10073					985	986		10.1016/S0140-6736(17)30126-5	http://dx.doi.org/10.1016/S0140-6736(17)30126-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EN9UN	28129986	hybrid, Green Published			2022-12-28	WOS:000396345200001
J	Dias, RP; Silvera, IF				Dias, Ranga P.; Silvera, Isaac F.			Observation of the Wigner-Huntington transition to metallic hydrogen	SCIENCE			English	Article							PHASE-TRANSITION; MOLECULAR-HYDROGEN; SOLID HYDROGEN; DENSE HYDROGEN; PRESSURE; SUPERCONDUCTOR; DEUTERIUM; DIAMOND; FLUID; GPA	Producing metallic hydrogen has been a great challenge in condensed matter physics. Metallic hydrogen may be a room-temperature superconductor and metastable when the pressure is released and could have an important impact on energy and rocketry. We have studied solid molecular hydrogen under pressure at low temperatures. At a pressure of 495 gigapascals, hydrogen becomes metallic, with reflectivity as high as 0.91. We fit the reflectance using a Drude free-electron model to determine the plasma frequency of 32.5 +/- 2.1 electron volts at a temperature of 5.5 kelvin, with a corresponding electron carrier density of 7.7 +/- 1.1 x 10(23) particles per cubic centimeter, which is consistent with theoretical estimates of the atomic density. The properties are those of an atomic metal. We have produced the Wigner-Huntington dissociative transition to atomic metallic hydrogen in the laboratory.	[Dias, Ranga P.; Silvera, Isaac F.] Harvard Univ, Lyman Lab Phys, Cambridge, MA 02138 USA	Harvard University	Silvera, IF (corresponding author), Harvard Univ, Lyman Lab Phys, Cambridge, MA 02138 USA.	silvera@physics.harvard.edu		Silvera, Isaac/0000-0001-8586-8391; Dias, Ranga/0000-0002-0830-4928	NSF [DMR-1308641, ECS-0335765]; U.S. Department of Energy Stockpile Stewardship Academic Alliance Program [DE-NA0003346]	NSF(National Science Foundation (NSF)); U.S. Department of Energy Stockpile Stewardship Academic Alliance Program(United States Department of Energy (DOE))	We thank O. Noked, M. Zaghoo, R. Husband, and C. Meyers for assistance and discussions. O. Noked provided valuable assistance developing our general optical setup; R. Husband did the reactive ion etching, as well as the alumina coating M the diamonds; and M. Turner of the Walsworth group provided help for annealing our diamonds. The NSF, grant DMR-1308641 and the U.S. Department of Energy Stockpile Stewardship Academic Alliance Program grant DE-NA0003346, supported this research. Partial support was provided by a grant from A. Silvera and K. Silvera. Preparation of diamond surfaces was performed in part at the Center for Nanoscale Systems (CNS) a member of the National Nano technology Infrastructure Network (NNIN) which is supported by NSF under NSF award ECS-0335765. CNS is part of Harvard University. The data reported in this paper are tabulated and available from the authors. Both authors contributed equally to all aspects of this research.	Akahama Y, 2006, J APPL PHYS, V100, DOI 10.1063/1.2335683; ASHCROFT NW, 1968, PHYS REV LETT, V21, P1748, DOI 10.1103/PhysRevLett.21.1748; Attaccalite C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.114501; Azadi S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.165501; Babaev E, 2004, NATURE, V431, P666, DOI 10.1038/nature02910; Bonev SA, 2004, NATURE, V431, P669, DOI 10.1038/nature02968; Borinaga M, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.174308; BROVMAN EG, 1972, SOV PHYS JETP-USSR, V34, P1300; Chen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3064; Cole JW, 2008, AIP CONF PROC, V969, P977, DOI 10.1063/1.2845066; Dalladay-Simpson P, 2016, NATURE, V529, P63, DOI 10.1038/nature16164; Deemyad S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.155701; Dias R., 2016, ARXIV160302162V1; Eremets MI, 2011, NAT MATER, V10, P927, DOI [10.1038/NMAT3175, 10.1038/nmat3175]; Eremets M. I, 2016, LOW TEMPERATURE PHAS; Eremets MI, 2003, J RAMAN SPECTROSC, V34, P515, DOI 10.1002/jrs.1044; Fortov VE, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.185001; Ginzburg VL, 2004, REV MOD PHYS, V76, P981, DOI 10.1103/RevModPhys.76.981; HEMLEY RJ, 1988, PHYS REV LETT, V61, P857, DOI 10.1103/PhysRevLett.61.857; Howie RT, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.125501; Kittel C., 2018, INTRO SOLID STATE PH; Knudson MD, 2015, SCIENCE, V348, P1455, DOI 10.1126/science.aaa7471; LORENZANA HE, 1989, PHYS REV LETT, V63, P2080, DOI 10.1103/PhysRevLett.63.2080; Loubeyre P, 2002, NATURE, V416, P613, DOI 10.1038/416613a; McMahon JM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.144515; McMahon JM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.165302; McMinis J, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.105305; Norman GE, 2015, CONTRIB PLASM PHYS, V55, P215, DOI 10.1002/ctpp.201400088; Palik E. D., 1997, HDB OPTICAL CONSTANT, VIII; Pierleoni C, 2016, P NATL ACAD SCI USA, V113, P4953, DOI 10.1073/pnas.1603853113; RUOFF AL, 1991, J APPL PHYS, V69, P6413, DOI 10.1063/1.348845; SILVERA IF, 1981, PHYS REV LETT, V47, P39, DOI 10.1103/PhysRevLett.47.39; SILVERA IF, 1980, REV MOD PHYS, V52, P393, DOI 10.1103/RevModPhys.52.393; SURH MP, 1992, PHYS REV B, V45, P8239, DOI 10.1103/PhysRevB.45.8239; Vohra Y.K, 1991, P 13 AIRAPT INT C HI; Weir ST, 1996, PHYS REV LETT, V76, P1860, DOI 10.1103/PhysRevLett.76.1860; Wigner E, 1935, J CHEM PHYS, V3, P764, DOI 10.1063/1.1749590; Wooten F., 2013, OPTICAL PROPERTIES S; Zaghoo M, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.155128; Zha C. S., 2016, APS MARCH M 2016 BAL; Zha CS, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.146402	42	320	335	12	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					715	718		10.1126/science.aal1579	http://dx.doi.org/10.1126/science.aal1579			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28126728	Green Submitted			2022-12-28	WOS:000395117700034
J	Pewen, WF				Pewen, William F.			The Politics of Fear Medecins Sans Frontieres and the West African Ebola Epidemic	SCIENCE			English	Book Review												pewen@vaccinology.org						Hofman M., 2017, POLITICS FEAR MED SA; MSF, 2015, PUSH LIM YEAR LARG E	2	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					463	463		10.1126/science.aal4493	http://dx.doi.org/10.1126/science.aal4493			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154039				2022-12-28	WOS:000393183100023
J	Stone, R; Wadman, M				Stone, Richard; Wadman, Meredith			POLICY Immigration order threatens overseas talent	SCIENCE			English	News Item																			0	1	3	6	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					439	440		10.1126/science.355.6324.439	http://dx.doi.org/10.1126/science.355.6324.439			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154025				2022-12-28	WOS:000393183100009
J	Ma, DL; Vano-Galvan, S				Ma, Dong-Lai; Vano-Galvan, Sergio			Actinic Granuloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ma, Dong-Lai] Beijing Union Med Coll Hosp, Beijing, Peoples R China; [Vano-Galvan, Sergio] Hosp Ramon & Cajal, Madrid, Spain	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Hospital Universitario Ramon y Cajal	Ma, DL (corresponding author), Beijing Union Med Coll Hosp, Beijing, Peoples R China.	mdonglai@sohu.com		Vano-Galvan, Sergio/0000-0003-2773-7494					0	2	2	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 2	2017	376	5					475	475		10.1056/NEJMicm1600384	http://dx.doi.org/10.1056/NEJMicm1600384			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8WH	28146657				2022-12-28	WOS:000393507200011
J	Underwood, E				Underwood, Emily			THE POLLUTED BRAIN The microscopic particles sifting from freeways and power plants don't just harm your heart and lungs. They may also attack your brain	SCIENCE			English	Editorial Material																			0	60	61	3	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					342	345		10.1126/science.355.6323.342	http://dx.doi.org/10.1126/science.355.6323.342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126768				2022-12-28	WOS:000393172800017
J	Plichta, JK; Hughes, K				Plichta, Jennifer K.; Hughes, Kevin			Radiation-Induced Angiosarcoma after Breast-Cancer Treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Plichta, Jennifer K.] Duke Univ, Durham, NC 27708 USA; [Hughes, Kevin] Massachusetts Gen Hosp, Boston, MA 02114 USA	Duke University; Harvard University; Massachusetts General Hospital	Plichta, JK (corresponding author), Duke Univ, Durham, NC 27708 USA.	jennifer.plichta@duke.edu	Plichta, Jennifer K/L-5450-2016	Plichta, Jennifer K/0000-0002-7411-0558					0	12	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2017	376	4					367	367		10.1056/NEJMicm1516482	http://dx.doi.org/10.1056/NEJMicm1516482			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ3KR	28121510				2022-12-28	WOS:000393111600011
J	Reiling, J				Reiling, Jennifer			Dust And Its Dangers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Baskerville C., 1912, NEW YORK MED J  1123; Hoffman F. L, 1916, DIS OCCUPATION VOCAT, P777; Rees RR, 1916, SCIENCE, V44, P618, DOI 10.1126/science.44.1139.618	3	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					324	324		10.1001/jama.2016.18797	http://dx.doi.org/10.1001/jama.2016.18797			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114539				2022-12-28	WOS:000392089200031
J	Tobias, M				Tobias, Martin			Social rank: a risk factor whose time has come?	LANCET			English	Editorial Material							INEQUALITIES; HEALTH		[Tobias, Martin] Tobias Cheung Consulting, Wanaka, New Zealand		Tobias, M (corresponding author), Tobias Cheung Consulting, Wanaka, New Zealand.	martintobias.nz@gmail.com						Adler NE, 2016, JAMA-J AM MED ASSOC, V316, P1641, DOI 10.1001/jama.2016.14058; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Ki-moon B, 2015, TRANSF OUR WORLD 203; Ki-Moon B, 2015, MILL DEV GOALS REP 2; Manor O, 2003, SOC SCI MED, V57, P2217, DOI 10.1016/S0277-9536(03)00097-2; Marmot M, 2015, HLTH GAP CHALLENGE U; Stringhini S, 2017, LANCET; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; World Health Organization, 2008, COMM SOC DET HLTH CL; World Health Organization, 2013, GLOB ACT PLAN PREV C	10	11	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2017	389	10075					1172	1174		10.1016/S0140-6736(17)30191-5	http://dx.doi.org/10.1016/S0140-6736(17)30191-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP1KL	28159389	hybrid			2022-12-28	WOS:000397143700010
J	Zajacova, A; Montez, JK				Zajacova, Anna; Montez, Jennifer Karas			Macro-level perspective to reverse recent mortality increases	LANCET			English	Editorial Material							TRENDS		[Zajacova, Anna] Univ Western Ontario, Dept Sociol, Social Sci Ctr, London, ON N6A 5C2, Canada; [Montez, Jennifer Karas] Syracuse Univ, Dept Sociol, Syracuse, NY USA	Western University (University of Western Ontario); Syracuse University	Zajacova, A (corresponding author), Univ Western Ontario, Dept Sociol, Social Sci Ctr, London, ON N6A 5C2, Canada.	anna.zajacova@uwo.ca						Borrell C, 2014, EPIDEMIOL REV, V36, P31, DOI 10.1093/epirev/mxt002; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; McKinlay J.B., 1986, SOCIOLOGY HLTH ILLNE, V2nd edn., P484; Minton J., 2016, INT J EPIDEMIOL; Montez JK, 2016, SSM-POPUL HLTH, V2, P561, DOI 10.1016/j.ssmph.2016.07.004; Montez JK, 2013, J HEALTH SOC BEHAV, V54, P165, DOI [10.1177/0022146513491066, 10.1177/0022146513481230]; Montez JK, 2013, AM J PUBLIC HEALTH, V103, P473, DOI 10.2105/AJPH.2012.301128; Sasson I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163412; Sasson I, 2016, DEMOGRAPHY, V53, P269, DOI 10.1007/s13524-015-0453-7; Shiels MS, 2017, LANCET	10	13	13	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2017	389	10073					991	992		10.1016/S0140-6736(17)30186-1	http://dx.doi.org/10.1016/S0140-6736(17)30186-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EN9UN	28131492				2022-12-28	WOS:000396345200004
J	Pardi, N; Hogan, MJ; Pelc, RS; Muramatsu, H; Andersen, H; DeMaso, CR; Dowd, KA; Sutherland, LL; Scearce, RM; Parks, R; Wagner, W; Granados, A; Greenhouse, J; Walker, M; Willis, E; Yu, JS; Mcgee, CE; Sempowski, GD; Mui, BL; Tam, YK; Huang, YJ; Vanlandingham, D; Holmes, VM; Balachandran, H; Sahu, S; Lifton, M; Higgs, S; Hensley, SE; Madden, TD; Hope, MJ; Kariko, K; Santra, S; Graham, BS; Lewis, MG; Pierson, TC; Haynes, BF; Weissman, D				Pardi, Norbert; Hogan, Michael J.; Pelc, Rebecca S.; Muramatsu, Hiromi; Andersen, Hanne; DeMaso, Christina R.; Dowd, Kimberly A.; Sutherland, Laura L.; Scearce, Richard M.; Parks, Robert; Wagner, Wendeline; Granados, Alex; Greenhouse, Jack; Walker, Michelle; Willis, Elinor; Yu, Jae-Sung; McGee, Charles E.; Sempowski, Gregory D.; Mui, Barbara L.; Tam, Ying K.; Huang, Yan-Jang; Vanlandingham, Dana; Holmes, Veronica M.; Balachandran, Harikrishnan; Sahu, Sujata; Lifton, Michelle; Higgs, Stephen; Hensley, Scott E.; Madden, Thomas D.; Hope, Michael J.; Kariko, Katalin; Santra, Sampa; Graham, Barney S.; Lewis, Mark G.; Pierson, Theodore C.; Haynes, Barton F.; Weissman, Drew			Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination	NATURE			English	Article							LIPID NANOPARTICLES; INFECTION; VACCINES; PSEUDOURIDINE; THERAPEUTICS; SPECIFICITY; EXPRESSION; IMMUNITY; VECTORS; THERAPY	Zika virus (ZIKV) has recently emerged as a pandemic associated with severe neuropathology in newborns and adults(1). There are no ZIKV-specific treatments or preventatives. Therefore, the development of a safe and effective vaccine is a high priority. Messenger RNA (mRNA) has emerged as a versatile and highly effective platform to deliver vaccine antigens and therapeutic proteins(2,3). Here we demonstrate that a single low-dose intradermal immunization with lipid-nanoparticle-encapsulated nucleoside-modified mRNA (mRNA-LNP) encoding the pre-membrane and envelope glycoproteins of a strain from the ZIKV outbreak in 2013 elicited potent and durable neutralizing antibody responses in mice and non-human primates. Immunization with 30 mu g of nucleoside-modified ZIKV mRNA-LNP protected mice against ZIKV challenges at 2 weeks or 5 months after vaccination, and a single dose of 50 mu g was sufficient to protect non-human primates against a challenge at 5 weeks after vaccination. These data demonstrate that nucleoside-modified mRNA-LNP elicits rapid and durable protective immunity and therefore represents a new and promising vaccine candidate for the global fight against ZIKV.	[Pardi, Norbert; Hogan, Michael J.; Muramatsu, Hiromi; Holmes, Veronica M.; Weissman, Drew] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Pelc, Rebecca S.; DeMaso, Christina R.; Dowd, Kimberly A.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Andersen, Hanne; Wagner, Wendeline; Granados, Alex; Greenhouse, Jack; Walker, Michelle; Lewis, Mark G.] Bioqual Inc, Rockville, MD 20850 USA; [Sutherland, Laura L.; Scearce, Richard M.; Parks, Robert; Yu, Jae-Sung; McGee, Charles E.; Sempowski, Gregory D.; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Hensley, Scott E.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mui, Barbara L.; Tam, Ying K.; Madden, Thomas D.; Hope, Michael J.] Acuitas Therapeut, Vancouver, BC V6T 1Z3, Canada; [Huang, Yan-Jang; Vanlandingham, Dana; Higgs, Stephen] Kansas State Univ, Coll Vet Med, Diagnost Med & Pathobiol, Manhattan, KS 66506 USA; [Huang, Yan-Jang; Vanlandingham, Dana; Higgs, Stephen] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA; [Balachandran, Harikrishnan; Sahu, Sujata; Lifton, Michelle; Santra, Sampa] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Kariko, Katalin] BioNTech RNA Pharmaceut, Goldgrube 12, D-55131 Mainz, Germany; [Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); BIOQUAL Inc.; Duke University; University of Pennsylvania; Pennsylvania Medicine; Kansas State University; Kansas State University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; BioNTech SE; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Weissman, D (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	dreww@upenn.edu	Graham, Barney S./AAC-5898-2019	Graham, Barney S./0000-0001-8112-0853; Hogan, Michael/0000-0002-6244-2993; Pelc, Rebecca/0000-0001-5080-4945; Elyard, Hanne/0000-0003-1103-9608; Balachandran, Harikrishnan/0000-0001-9336-0555; Dowd, Kimberly/0000-0003-3641-6852; Sempowski, Gregory/0000-0003-0391-6594	NIH [UC6-AI058607, AI100645, U19-AI057229, T32 AI007632-14, R01-AI050484, R01-AI124429, R01-AI084860]; Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University; NIAID Division of Intramural Research; Vaccine Research Center; Takeda Pharmaceuticals, New Frontier Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007632, UC6AI058607, R01AI124429, R01AI041860, ZIAAI001209, UM1AI100645, R01AI090788, T32AI055428, T32AI070077, U19AI057229, R01AI050484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University; NIAID Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Takeda Pharmaceuticals, New Frontier Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Tesh at the UTMB World Reference Center for Emerging Viruses and Arboviruses for providing ZIKV stocks. We gratefully acknowledge the technical or administrative support of M. Bertrand, L. Arwood, C. Sample, M. J. Barr, C. Vivian, T. Gurley and M. A. Moody, E. E. Ooi, S. Lok, H.-X. Liao, S. Awasthi, L. Hook, F. Shaheen, and the UPenn CFAR. The Virology Unit of the Duke Regional Biocontainment Laboratory (Duke Human Vaccine Institute) received support from the NIH, UC6-AI058607. The Duke Center for HIV/AIDS Vaccine Immunology received support from NIH AI100645. D.V. received funding from the Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University. R.S.P., C.R.D., K.A.D., T.C.P. and B.S.G. were funded by the NIAID Division of Intramural Research and the Vaccine Research Center. S.E.H. received funding through NIH U19-AI057229. M. J. Hog. received funding from NIH T32 AI007632-14. D.W. received funding from NIH R01-AI050484, R01-AI124429 and R01-AI084860, and Takeda Pharmaceuticals, New Frontier Science.	Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Abbink P, 2015, J VIROL, V89, P1512, DOI 10.1128/JVI.02950-14; Andries O, 2015, J CONTROL RELEASE, V217, P337, DOI 10.1016/j.jconrel.2015.08.051; Baronti C, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00500-14; Beck AS, 2015, EXPERT REV VACCINES, V14, P1479, DOI 10.1586/14760584.2015.1083430; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2; Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14; Jayaraman M, 2012, ANGEW CHEM INT EDIT, V51, P8529, DOI 10.1002/anie.201203263; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Ledgerwood JE, 2010, VACCINE, V29, P304, DOI 10.1016/j.vaccine.2010.10.037; Maier MA, 2013, MOL THER, V21, P1570, DOI 10.1038/mt.2013.124; Minor PD, 2015, VIROLOGY, V479, P379, DOI 10.1016/j.virol.2015.03.032; Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21; Pardi N, 2015, J CONTROL RELEASE, V217, P345, DOI 10.1016/j.jconrel.2015.08.007; Pardi Norbert, 2013, Methods Mol Biol, V969, P29, DOI 10.1007/978-1-62703-260-5_2; Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030; Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; Sumida SM, 2004, J VIROL, V78, P2666, DOI 10.1128/JVI.78.6.2666-2673.2004; Thess A, 2015, MOL THER, V23, P1456, DOI 10.1038/mt.2015.103; Wang PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008325; Weissman D, 2000, J IMMUNOL, V165, P4710, DOI 10.4049/jimmunol.165.8.4710; Weissman D, 2015, EXPERT REV VACCINES, V14, P265, DOI 10.1586/14760584.2015.973859; Weissman Drew, 2013, Methods Mol Biol, V969, P43, DOI 10.1007/978-1-62703-260-5_3	31	485	510	16	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					248	+		10.1038/nature21428	http://dx.doi.org/10.1038/nature21428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28151488	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000395688700040
J	Doshi, P				Doshi, Peter			Medical response to Trump requires truth seeking and respect for patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												pdoshi@bmj.com						Cha AE., 2015, WASHINGTON POST; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3037; Johnson J., 2017, WASHINGTON POST; National Academies of Sciences Engineering and Medicine, 2011, ADVERSE EFFECTS VACC; Shear Michael D, 2017, NY TIMES; Spayd L., 2016, NY TIMES; Trump D., 2016, ADDITION WINNING ELE; Zito S., 2016, NEW YORK POST	8	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2017	356								j661	10.1136/bmj.j661	http://dx.doi.org/10.1136/bmj.j661			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FV	28174155				2022-12-28	WOS:000394578000008
J	Blease, CR; Bishop, FL; Kaptchuk, TJ				Blease, C. R.; Bishop, F. L.; Kaptchuk, T. J.			Informed consent and clinical trials: where is the placebo effect?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXPERIENCES		[Blease, C. R.] Univ Coll Dublin, Sch Philosophy, Dublin, Ireland; [Blease, C. R.; Kaptchuk, T. J.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA 02115 USA; [Bishop, F. L.] Univ Southampton, Dept Psychol, Southampton, Hants, England	University College Dublin; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Southampton	Blease, CR (corresponding author), Univ Coll Dublin, Sch Philosophy, Dublin, Ireland.; Blease, CR (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA 02115 USA.	charlotteblease@gmail.com			NCCIH/NIH [2K24 AT004095, R01 AT008573, R61 AT009306, R01 AT005280, P01 AT006663]; NIMH/NIH [R01 MH102279]; Foundation for the Science of the Therapeutic Encounter; National Center for Complementary & Integrative Health [R01AT008573] Funding Source: NIH RePORTER	NCCIH/NIH; NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Foundation for the Science of the Therapeutic Encounter; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	TJK is supported by NCCIH/NIH grants #2K24 AT004095. R01 AT008573, R61 AT009306, R01 AT005280 and P01 AT006663, NIMH/NIH grant # R01 MH102279, and a grant from Foundation for the Science of the Therapeutic Encounter.	Appelbaum Paul S, 2004, IRB, V26, P1, DOI 10.2307/3564231; BERGMANN JF, 1994, CLIN TRIAL META-ANAL, V29, P41; Bishop FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039661; Bishop FL, 2012, QUAL HEALTH RES, V22, P1138, DOI 10.1177/1049732312448544; Bishop FL, 2016, EUR J PERS CENT HEAL, V356, P609; Chvetzoff G, 2003, J NATL CANCER I, V95, P19, DOI 10.1093/jnci/95.1.19; Di Blasi Z, 2002, BMJ-BRIT MED J, V325, P1329, DOI 10.1136/bmj.325.7376.1329; Falagas ME, 2009, AM J SURG, V198, P420, DOI 10.1016/j.amjsurg.2009.02.010; FISHER S, 1965, PSYCHOPHARMACOLOGIA, V7, P57, DOI 10.1007/BF00404165; Freeman EW, 2015, PSYCHOSOM MED, V77, P167, DOI 10.1097/PSY.0000000000000143; Golomb BA, 2010, ANN INTERN MED, V153, P532, DOI 10.7326/0003-4819-153-8-201010190-00010; Greville-Harris M, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5627; Jansen LA, 2016, CANCER-AM CANCER SOC, V122, P1238, DOI 10.1002/cncr.29908; Kam-Hansen S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006175; Kaptchuk TJ, 2015, NEW ENGL J MED, V373, P8, DOI 10.1056/NEJMp1504023; Kaptchuk TJ, 2009, CULT MED PSYCHIAT, V33, P382, DOI 10.1007/s11013-009-9141-7; Keranen T, 2015, BMC MED ETHICS, V16, DOI 10.1186/1472-6939-16-2; Lidz CW, 2015, CAMB Q HEALTHC ETHIC, V24, P231, DOI 10.1017/S096318011400053X; Mendel J, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4626; Reijula E, 2015, EPILEPSY BEHAV, V48, P29, DOI 10.1016/j.yebeh.2015.05.013; Sorokin I, 2015, CURR UROL REP, V16, DOI 10.1007/s11934-015-0544-4; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Tramer MR, 1998, EUR J CANCER, V34, P1836, DOI 10.1016/S0959-8049(98)00161-0; Wells RE, 2012, AM J BIOETHICS, V12, P22, DOI 10.1080/15265161.2011.652798; White P, 2012, PAIN, V153, P455, DOI 10.1016/j.pain.2011.11.007; World Medical Association, 2013, 64 WORLD MED ASS; Zou K, 2016, ANN RHEUM DIS, V75, P1964, DOI 10.1136/annrheumdis-2015-208387	27	41	41	2	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2017	356								j463	10.1136/bmj.j463	http://dx.doi.org/10.1136/bmj.j463			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8BX	28159769	Green Published, Green Accepted			2022-12-28	WOS:000393450500002
J	Clery, D				Clery, Daniel			ASTRONOMY U.S. observers seek a more perfect union	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					442	443		10.1126/science.355.6324.442	http://dx.doi.org/10.1126/science.355.6324.442			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154028				2022-12-28	WOS:000393183100012
J	Gittoes, OMJ; Gittoes, NJL				Gittoes, Oliver M. J.; Gittoes, Neil J. L.			SPOT DIAGNOSIS Breathlessness and neck swelling after a rugby gameBreathlessness and neck swelling after a rugby game	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gittoes, Oliver M. J.] Bromsgrove Sch, Bromsgrove, Worcs, England; [Gittoes, Neil J. L.] Queen Elizabeth Hosp, Ctr Endocrinol Diabet & Metab, Heritage Bldg, Birmingham, W Midlands, England	University of Birmingham	Gittoes, NJL (corresponding author), Queen Elizabeth Hosp, Ctr Endocrinol Diabet & Metab, Heritage Bldg, Birmingham, W Midlands, England.	Neil.Gittoes@UHB.NHS.UK						Fitzwater JW, 2015, J PEDIATR SURG, V50, P983, DOI 10.1016/j.jpedsurg.2015.03.024; Gasser CRB, 2017, PEDIATR EMERG CARE, V33, P370, DOI 10.1097/PEC.0000000000000625; Richer EJ, 2016, J PEDIATR SURG, V51, P1778, DOI 10.1016/j.jpedsurg.2016.05.024; Sahni Sonu, 2013, N Am J Med Sci, V5, P460, DOI 10.4103/1947-2714.117296	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2017	356								j311	10.1136/bmj.j311	http://dx.doi.org/10.1136/bmj.j311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BT	28154129	Green Published			2022-12-28	WOS:000393450100002
J	Miranda, SP				Miranda, Stephen P.			Learning to Drive - Early Exposure to End-of-Life Conversations in Medical Training	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Miranda, Stephen P.] Univ Rochester, Sch Med & Dent, Rochester, NY 14611 USA	University of Rochester	Miranda, SP (corresponding author), Univ Rochester, Sch Med & Dent, Rochester, NY 14611 USA.							BLOOM BENJAMIN S., 1956, HDB 1 COGNITIVE DOMA	1	2	2	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 2	2017	376	5					413	415		10.1056/NEJMp1609234	http://dx.doi.org/10.1056/NEJMp1609234			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8WH	28146668				2022-12-28	WOS:000393507200004
J	Moscicki, RA; Tandon, PK				Moscicki, Richard A.; Tandon, P. K.			Drug-Development Challenges for Small Biopharmaceutical Companies	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ONSET POMPE-DISEASE; ACID ALPHA-GLUCOSIDASE; CYSTIC-FIBROSIS; REPLACEMENT THERAPY; PARKINSONS-DISEASE; TRANSPLANTATION; MUTATION		[Moscicki, Richard A.] US FDA, Ctr Drug Evaluat & Res, 10001 New Hampshire Ave, Silver Spring, MD 20993 USA; [Tandon, P. K.] Sanofi Genzyme, Cambridge, MA USA	US Food & Drug Administration (FDA); Sanofi-Aventis; Genzyme Corporation	Moscicki, RA (corresponding author), US FDA, Ctr Drug Evaluat & Res, 10001 New Hampshire Ave, Silver Spring, MD 20993 USA.; Tandon, PK (corresponding author), Ultragenyx Pharmaceut, 60 Leveroni Ct, Novato, CA 94949 USA.	richard.moscicki@fda.hhs.gov; ptandon@ultragenyx.com						Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Barrett PM, 2012, HUM MOL GENET, V21, pR66, DOI 10.1093/hmg/dds345; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Goetz CG, 2008, MOVEMENT DISORD, V23, P690, DOI 10.1002/mds.21894; Hauser RA, 2001, MOVEMENT DISORD, V16, P983; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033; Kishnani PS, 2006, J PEDIATR-US, V149, P89, DOI 10.1016/j.jpeds.2006.02.035; Olanow CW, 1996, TRENDS NEUROSCI, V19, P102, DOI 10.1016/S0166-2236(96)80038-5; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Schumacher JM, 2000, NEUROLOGY, V54, P1042, DOI 10.1212/WNL.54.5.1042; Thomas D, 2015, EMERGING THERAPEUTIC; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x	14	6	6	2	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 2	2017	376	5					469	474		10.1056/NEJMra1510070	http://dx.doi.org/10.1056/NEJMra1510070			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8WH	28146666	Bronze			2022-12-28	WOS:000393507200010
J	Obermeyer, Z; Cohn, B; Wilson, M; Jena, AB; Cutler, DM				Obermeyer, Ziad; Cohn, Brent; Wilson, Michael; Jena, Anupam B.; Cutler, David M.			Early death after discharge from emergency departments: analysis of national US insurance claims data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADMISSION RATES; OUTCOMES; MISDIAGNOSIS; DIAGNOSIS; PATTERNS; RESPECT; HOME	OBJECTIVE To measure incidence of early death after discharge from emergency departments, and explore potential sources of variation in risk by measurable aspects of hospitals and patients. DESIGN Retrospective cohort study. SETTING Claims data from the US Medicare program, covering visits to an emergency department, 2007-12. PARTICIPANTS Nationally representative 20% sample of Medicare fee for service beneficiaries. As the focus was on generally healthy people living in the community, patients in nursing facilities, aged >= 90, receiving palliative or hospice care, or with a diagnosis of a life limiting illnesses, either during emergency department visits (for example, myocardial infarction) or in the year before (for example, malignancy) were excluded. MAIN OUTCOME MEASURE Death within seven days after discharge from the emergency department, excluding patients transferred or admitted as inpatients. RESULTS Among discharged patients, 0.12% (12 375/10 093 678, in the 20% sample over 2007-12) died within seven days, or 10 093 per year nationally. Mean age at death was 69. Leading causes of death on death certificates were atherosclerotic heart disease (13.6%), myocardial infarction (10.3%), and chronic obstructive pulmonary disease (9.6%). Some 2.3% died of narcotic overdose, largely after visits for musculoskeletal problems. Hospitals in the lowest fifth of rates of inpatient admission from the emergency department had the highest rates of early death (0.27%)-3.4 times higher than hospitals in the highest fifth (0.08%)-despite the fact that hospitals with low admission rates served healthier populations, as measured by overall seven day mortality among all comers to the emergency department. Small increases in admission rate were linked to large decreases in risk. In multivariate analysis, emergency departments that saw higher volumes of patients (odds ratio 0.84, 95% confidence interval 0.81 to 0.86) and those with higher charges for visits (0.75, 0.74 to 0.77) had significantly fewer deaths. Certain diagnoses were more common among early deaths compared with other emergency department visits: altered mental status (risk ratio 4.4, 95% confidence interval 3.8 to 5.1), dyspnea (3.1, 2.9 to 3.4), and malaise/fatigue (3.0, 2.9 to 3.7). CONCLUSIONS Every year, a substantial number of Medicare beneficiaries die soon after discharge from emergency departments, despite no diagnosis of a life limiting illnesses recorded in their claims. Further research is needed to explore whether these deaths were preventable.	[Obermeyer, Ziad; Wilson, Michael] Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA; [Obermeyer, Ziad; Jena, Anupam B.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Obermeyer, Ziad; Cohn, Brent; Wilson, Michael] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Cutler, David M.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University	Obermeyer, Z (corresponding author), Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA.; Obermeyer, Z (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA.; Obermeyer, Z (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.	zobermeyer@bwh.harvard.edu		Cutler, David/0000-0002-4949-8917	Office of the Director of the National Institutes of Health [DP5 OD012161]; Laura and John Arnold Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012161, DP5OD017897] Funding Source: NIH RePORTER	Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laura and John Arnold Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a grant from the Office of the Director of the National Institutes of Health (DP5 OD012161) to ZO and a grant from the Laura and John Arnold Foundation. This research was independent from funders. The funder had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The views presented here are those of the authors and not necessarily those of the Laura and John Arnold Foundation, its directors, officers, or staff.	Baker C, 2015, ACCIDENT EMERGENCY S; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Bynum JPW, 2004, J AM GERIATR SOC, V52, P187, DOI 10.1111/j.1532-5415.2004.52054.x; Capp R, 2014, AM J EMERG MED, V32, P837, DOI 10.1016/j.ajem.2014.03.033; Collinson PO, 2000, BRIT MED J, V320, P1702, DOI 10.1136/bmj.320.7251.1702; Cooper GS, 1999, MED CARE, V37, P706, DOI 10.1097/00005650-199907000-00010; Doyle JJ, 2015, J POLIT ECON, V123, P170, DOI 10.1086/677756; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Gabayan GZ, 2016, ANN EMERG MED, V68, P43, DOI 10.1016/j.annemergmed.2016.01.007; Gabayan GZ, 2013, ACAD EMERG MED, V20, P778, DOI 10.1111/acem.12181; Gabayan GZ, 2011, ANN EMERG MED, V58, P551, DOI 10.1016/j.annemergmed.2011.07.001; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Garcia Tamyra Carroll, 2010, NCHS Data Brief, P1; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality, CLIN CLASSIFICATIONS; Institute of Medicine, 2015, IMPR DIAGN HLTH CAR; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P2572, DOI 10.1001/jama.2013.7103; KEFER MP, 1994, ANN EMERG MED, V24, P1102, DOI 10.1016/S0196-0644(94)70239-X; Kowalski RG, 2004, JAMA-J AM MED ASSOC, V291, P866, DOI 10.1001/jama.291.7.866; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; LEE TH, 1987, AM J CARDIOL, V60, P219, DOI 10.1016/0002-9149(87)90217-7; Levy CR, 2005, J AM GERIATR SOC, V53, P2060, DOI 10.1111/j.1532-5415.2005.00523.x; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Mayer PL, 1996, STROKE, V27, P1558, DOI 10.1161/01.STR.27.9.1558; McGrath PD, 2000, JAMA-J AM MED ASSOC, V284, P3139, DOI 10.1001/jama.284.24.3139; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P447; Newman-Toker DE, 2009, JAMA-J AM MED ASSOC, V301, P1060, DOI 10.1001/jama.2009.249; Pines JM, 2013, MED CARE RES REV, V70, P218, DOI 10.1177/1077558712470565; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Research Data Assistance Center (ResDAC) U of M, ID HOSP CALIMS EM RO; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; SCHOR S, 1976, JAMA-J AM MED ASSOC, V236, P941; Schuur JD, 2012, NEW ENGL J MED, V367, P391, DOI 10.1056/NEJMp1204431; Singh H, 2013, BMJ QUAL SAF, V22, P789, DOI 10.1136/bmjqs-2013-002387; Sklar DP, 2007, ANN EMERG MED, V49, P735, DOI 10.1016/j.annemergmed.2006.11.018; Venkatesh AK, 2015, MED CARE, V53, P237, DOI 10.1097/MLR.0000000000000261; Venkatesh AK, 2013, AM J EMERG MED, V31, P1520, DOI 10.1016/j.ajem.2013.07.019; Vermeulen MJ, 2007, STROKE, V38, P1216, DOI 10.1161/01.STR.0000259661.05525.9a; Wachter RM, 2010, HEALTH AFFAIR, V29, P1605, DOI 10.1377/hlthaff.2009.0513; WENNBERG JE, 1987, JAMA-J AM MED ASSOC, V257, P933, DOI 10.1001/jama.257.7.933; Wennberg JE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f549	43	47	47	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2017	356								j239	10.1136/bmj.j239	http://dx.doi.org/10.1136/bmj.j239			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8BQ	28148486	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000393449800001
J	Camunas-Soler, J; Alemany, A; Ritort, F				Camunas-Soler, Joan; Alemany, Anna; Ritort, Felix			Experimental measurement of binding energy, selectivity, and allostery using fluctuation theorems	SCIENCE			English	Article							PROTEIN-DNA INTERACTIONS; MECHANICAL STABILITY; ECHINOMYCIN BINDING; MOLECULE; COOPERATIVITY; ENDONUCLEASE; EQUILIBRIUM; RECOGNITION; SPECIFICITY; ENERGETICS	Thermodynamic bulk measurements of binding reactions rely on the validity of the law of mass action and the assumption of a dilute solution. Yet, important biological systems such as allosteric ligand-receptor binding, macromolecular crowding, or misfolded molecules may not follow these assumptions and may require a particular reaction model. Here we introduce a fluctuation theorem for ligand binding and an experimental approach using single-molecule force spectroscopy to determine binding energies, selectivity, and allostery of nucleic acids and peptides in a model-independent fashion. A similar approach could be used for proteins. This work extends the use of fluctuation theorems beyond unimolecular folding reactions, bridging the thermodynamics of small systems and the basic laws of chemical equilibrium.	[Camunas-Soler, Joan; Alemany, Anna; Ritort, Felix] Univ Barcelona, Fac Fis, Dept Fis Mat Condensada, Small Biosyst Lab, Barcelona, Spain; [Camunas-Soler, Joan; Alemany, Anna; Ritort, Felix] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Bioingn Biomat & Nano, Madrid, Spain; [Camunas-Soler, Joan] Stanford Univ, Dept Bioengn, Stanford, CA 94304 USA; [Camunas-Soler, Joan] Stanford Univ, Dept Appl Phys, Stanford, CA 94304 USA; [Alemany, Anna] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Alemany, Anna] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Instituto de Salud Carlos III; Stanford University; Stanford University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Ritort, F (corresponding author), Univ Barcelona, Fac Fis, Dept Fis Mat Condensada, Small Biosyst Lab, Barcelona, Spain.; Ritort, F (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Bioingn Biomat & Nano, Madrid, Spain.	fritort@gmail.com	Alemany, Anna/AAO-9622-2021	Camunas-Soler, Joan/0000-0001-6148-8132	European Research Council (ERC) MagReps [267 862]; Framework Programme 7 Infernos [308850]; Catalan Institution for Research and Advanced Studies (ICREA); Ministerio de Economia y Competitividad [FIS2013-47796-P]	European Research Council (ERC) MagReps(European Research Council (ERC)); Framework Programme 7 Infernos; Catalan Institution for Research and Advanced Studies (ICREA)(ICREA); Ministerio de Economia y Competitividad(Spanish Government)	We acknowledge funding from the European Research Council (ERC) MagReps (grant 267 862), Framework Programme 7 Infernos (grant 308850), the Catalan Institution for Research and Advanced Studies (ICREA) Academia 2013, and Ministerio de Economia y Competitividad (grant FIS2013-47796-P). All data used in this study are included in the main text and in the supplementary materials.	Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034; Alemany A, 2012, NAT PHYS, V8, P688, DOI [10.1038/NPHYS2375, 10.1038/nphys2375]; Bailly C, 1996, BIOCHEMISTRY-US, V35, P1150, DOI 10.1021/bi951696p; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Cao Y, 2007, P NATL ACAD SCI USA, V104, P15677, DOI 10.1073/pnas.0705367104; Collin D, 2005, NATURE, V437, P231, DOI 10.1038/nature04061; Crooks GE, 2000, PHYS REV E, V61, P2361, DOI 10.1103/PhysRevE.61.2361; Fierz B, 2012, J AM CHEM SOC, V134, P19548, DOI 10.1021/ja308908p; Hann E, 2007, BIOPHYS J, V92, pL79, DOI 10.1529/biophysj.106.102475; Heidarsson PO, 2014, P NATL ACAD SCI USA, V111, P13069, DOI 10.1073/pnas.1401065111; Huguet JM, 2010, P NATL ACAD SCI USA, V107, P15431, DOI 10.1073/pnas.1001454107; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; JenJacobson L, 1997, BIOPOLYMERS, V44, P153; Junier I, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.070602; Junker JP, 2005, BIOPHYS J, V89, pL46, DOI 10.1529/biophysj.105.072066; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; Koch SJ, 2002, BIOPHYS J, V83, P1098, DOI 10.1016/S0006-3495(02)75233-8; Koirala D, 2011, NAT CHEM, V3, P782, DOI [10.1038/NCHEM.1126, 10.1038/nchem.1126]; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Leng FF, 2003, NUCLEIC ACIDS RES, V31, P6191, DOI 10.1093/nar/gkg826; LESSER DR, 1990, SCIENCE, V250, P776, DOI 10.1126/science.2237428; Liphardt J, 2002, SCIENCE, V296, P1832, DOI 10.1126/science.1071152; Maragakis P, 2008, J PHYS CHEM B, V112, P6168, DOI 10.1021/jp077037r; McDonnell JM, 2001, CURR OPIN CHEM BIOL, V5, P572, DOI 10.1016/S1367-5931(00)00251-9; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Schnell S, 2004, PROG BIOPHYS MOL BIO, V85, P235, DOI 10.1016/j.pbiomolbio.2004.01.012; Shank EA, 2010, NATURE, V465, P637, DOI 10.1038/nature09021; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; TERRY BJ, 1983, J BIOL CHEM, V258, P9820; Thastrom A, 2004, BIOCHEMISTRY-US, V43, P736, DOI 10.1021/bi0302043; VANDYKE MM, 1984, SCIENCE, V225, P1122, DOI 10.1126/science.6089341; Yu H, 2012, P NATL ACAD SCI USA, V109, P5283, DOI 10.1073/pnas.1107736109	34	41	41	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					412	+		10.1126/science.aah4077	http://dx.doi.org/10.1126/science.aah4077			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126820	Green Submitted			2022-12-28	WOS:000393172800043
J	Liu, SF; Xu, ZY; Leng, H; Zheng, P; Yang, JY; Chen, KF; Feng, JX; Li, Q				Liu, Shaofeng; Xu, Zhiyun; Leng, He; Zheng, Pu; Yang, Jiayi; Chen, Kaifu; Feng, Jianxun; Li, Qing			RPA binds histone H3-H4 and functions in DNA replication-coupled nucleosome assembly	SCIENCE			English	Article							SINGLE-STRANDED-DNA; DAMAGE RESPONSE; CHROMATIN; YEAST; ACETYLATION; INHERITANCE; INVITRO; PROTEIN	DNA replication-coupled nucleosome assembly is essential to maintain genome integrity and retain epigenetic information. Multiple involved histone chaperones have been identified, but how nucleosome assembly is coupled to DNA replication remains elusive. Here we show that replication protein A (RPA), an essential replisome component that binds single-stranded DNA, has a role in replication-coupled nucleosome assembly. RPA directly binds free H3-H4. Assays using a synthetic sequence that mimics freshly unwound single-stranded DNA at replication fork showed that RPA promotes DNA-(H3-H4) complex formation immediately adjacent to double-stranded DNA. Further, an RPA mutant defective in H3-H4 binding exhibited attenuated nucleosome assembly on nascent chromatin. Thus, we propose that RPA functions as a platform for targeting histone deposition to replication fork, through which RPA couples nucleosome assembly with ongoing DNA replication.	[Liu, Shaofeng; Xu, Zhiyun; Leng, He; Zheng, Pu; Yang, Jiayi; Feng, Jianxun; Li, Qing] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Liu, Shaofeng; Xu, Zhiyun; Leng, He; Zheng, Pu; Yang, Jiayi; Feng, Jianxun; Li, Qing] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Liu, Shaofeng] Tsinghua Univ, Sch Life Sci, Peking Univ Tsinghua Univ Natl Inst Biol Sci Join, Beijing 100084, Peoples R China; [Leng, He] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Chen, Kaifu] Houston Methodist, DeBakey Heart & Vasc Ctr, Ctr Cardiovasc Regenerat, Houston, TX 77030 USA	Peking University; Peking University; Tsinghua University; Peking University; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center	Li, Q (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.; Li, Q (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.	li.qing@pku.edu.cn		Zheng, Pu/0000-0002-8047-1472	National Natural Science Foundation of China (NSFC) [31322017, 31370767]; NIH [HL100397]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Z. Zhang, R. Burgess, K.-M. Chan, and H. Wu for critical reading of the manuscript. We thank M. Wold, O. Aparcio, R. Xu, G. Li, S. Brill, M. Grunstein, G. Camilloni, and J. Tyler for reagents and suggestions for experimental procedures. We thank the Biodynamic Optical Imaging Center (BIOPIC) sequencing facility at Peking University for assistance with sequencing. This work was supported by National Natural Science Foundation of China (NSFC) grants (31322017 and 31370767). K.C. is supported, in part, by an NIH grant (HL100397). The high-throughput sequencing data sets have been deposited at the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database (accession identifier GSE83648).	ALMOUZNI G, 1990, NUCLEIC ACIDS RES, V18, P5767, DOI 10.1093/nar/18.19.5767; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; Donham DC, 2011, NUCLEIC ACIDS RES, V39, P5449, DOI 10.1093/nar/gkr097; Foltman M, 2013, CELL REP, V3, P892, DOI 10.1016/j.celrep.2013.02.028; Gilmore JM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011544; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Gurard-Levin ZA, 2014, ANNU REV BIOCHEM, V83, P487, DOI 10.1146/annurev-biochem-060713-035536; HEYER WD, 1990, EMBO J, V9, P2321, DOI 10.1002/j.1460-2075.1990.tb07404.x; Huang HD, 2015, NAT STRUCT MOL BIOL, V22, P618, DOI 10.1038/nsmb.3055; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; MCKNIGHT SL, 1977, CELL, V12, P795, DOI 10.1016/0092-8674(77)90278-1; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; RUIZCARRILLO A, 1975, SCIENCE, V190, P117, DOI 10.1126/science.1166303; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yang JY, 2016, CELL REP, V14, P1128, DOI 10.1016/j.celrep.2015.12.096; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601	24	40	41	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					415	419		10.1126/science.aah4712	http://dx.doi.org/10.1126/science.aah4712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126821				2022-12-28	WOS:000393172800044
J	Makri, A				Makri, Anita			Climate Change and the Health of Nations Famines, Fevers, and the Fate of Populations	SCIENCE			English	Book Review												anita_makri@yahoo.com						McMichael A, 2017, CLIMATE CHANGE HLTH	1	0	0	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					355	355		10.1126/science.aak9693	http://dx.doi.org/10.1126/science.aak9693			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4FR	28126774				2022-12-28	WOS:000393172800023
J	Ding, JJ; Shao, F				Ding, Jingjin; Shao, Feng			SnapShot: The Noncanonical Inflammasome	CELL			English	Editorial Material									[Ding, Jingjin] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Ding, Jingjin; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; National Institute of Biological Sciences, Beijing	Ding, JJ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Ding, JJ (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.			Ding, Jingjin/0000-0001-9941-7997				Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Shi JJ, 2015, J NANO RES-SW, V32, P32, DOI 10.4028/www.scientific.net/JNanoR.32.32; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036	3	52	57	3	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					544	+		10.1016/j.cell.2017.01.008	http://dx.doi.org/10.1016/j.cell.2017.01.008			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28129545	Bronze			2022-12-28	WOS:000396249600021
J	Barth, J; de Boer, WEL; Busse, JW; Hoving, JL; Kedzia, S; Couban, R; Fischer, K; von Allmen, DY; Spanjer, J; Kunz, R				Barth, Jurgen; de Boer, Wout E. L.; Busse, Jason W.; Hoving, Jan L.; Kedzia, Sarah; Couban, Rachel; Fischer, Katrin; von Allmen, David Y.; Spanjer, Jerry; Kunz, Regina			Inter-rater agreement in evaluation of disability: systematic review of reproducibility studies	BMJ-BRITISH MEDICAL JOURNAL			English	Review							WORK ABILITY; MEDICAL EVALUATION; SAMPLE-SIZE; RELIABILITY; VALIDITY; DEPRESSION; GUIDELINES; DISORDERS; INTERVIEW; SCALE	OBJECTIVES To explore agreement among healthcare professionals assessing eligibility for work disability benefits. DESIGN Systematic review and narrative synthesis of reproducibility studies. DATA SOURCES Medline, Embase, and PsycINFO searched up to 16 March 2016, without language restrictions, and review of bibliographies of included studies. ELIGIBILITY CRITERIA Observational studies investigating reproducibility among healthcare professionals performing disability evaluations using a global rating of working capacity and reporting inter-rater reliability by a statistical measure or descriptively. Studies could be conducted in insurance settings, where decisions on ability to work include normative judgments based on legal considerations, or in research settings, where decisions on ability to work disregard normative considerations. Teams of paired reviewers identified eligible studies, appraised their methodological quality and generalisability, and abstracted results with pretested forms. As heterogeneity of research designs and findings impeded a quantitative analysis, a descriptive synthesis stratified by setting (insurance or research) was performed. RESULTS From 4562 references, 101 full text articles were reviewed. Of these, 16 studies conducted in an insurance setting and seven in a research setting, performed in 12 countries, met the inclusion criteria. Studies in the insurance setting were conducted with medical experts assessing claimants who were actual disability claimants or played by actors, hypothetical cases, or short written scenarios. Conditions were mental (n= 6, 38%), musculoskeletal (n= 4, 25%), or mixed (n= 6, 38%). Applicability of findings from studies conducted in an insurance setting to real life evaluations ranged from generalisable (n= 7, 44%) and probably generalisable (n= 3, 19%) to probably not generalisable (n= 6, 37%). Median inter-rater reliability among experts was 0.45 (range intraclass correlation coefficient 0.86 to kappa-0.10). Interrater reliability was poor in six studies (37%) and excellent in only two (13%). This contrasts with studies conducted in the research setting, where the median inter-rater reliability was 0.76 (range 0.91-0.53), and 71% (5/7) studies achieved excellent inter-rater reliability. Reliability between assessing professionals was higher when the evaluation was guided by a standardised instrument (23 studies, P= 0.006). No such association was detected for subjective or chronic health conditions or the studies' generalisability to real world evaluation of disability (P= 0.46, 0.45, and 0.65, respectively). CONCLUSIONS Despite their common use and far reaching consequences for workers claiming disabling injury or illness, research on the reliability of medical evaluations of disability for work is limited and indicates high variation in judgments among assessing professionals. Standardising the evaluation process could improve reliability. Development and testing of instruments and structured approaches to improve reliability in evaluation of disability are urgently needed.	[Barth, Jurgen; de Boer, Wout E. L.; Kedzia, Sarah; von Allmen, David Y.; Kunz, Regina] Univ Basel, Univ Basel Hosp, EbIM, Res & Educ,Dept Clin Res, Spitalstr 8 12, CH-4031 Basel, Switzerland; [Barth, Jurgen] Univ Zurich Hosp, Inst Complementary & Integrat Med, Zurich, Switzerland; [Barth, Jurgen] Univ Zurich, Zurich, Switzerland; [Busse, Jason W.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4K1, Canada; [Busse, Jason W.; Couban, Rachel] McMaster Univ, Dept Anaesthesia, Hamilton, ON L8S 4K1, Canada; [Busse, Jason W.] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON L8S 4K1, Canada; [Hoving, Jan L.] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, Amsterdam, Netherlands; [Hoving, Jan L.] AMC UMCG UWV VUmc, Res Ctr Insurance Med, Amsterdam, Netherlands; [Fischer, Katrin] Inst Humans Complex Syst, Sch Appl Psychol, Olten, Switzerland; [Spanjer, Jerry] Dutch Natl Inst Employee Benefits Schemes, Groningen, Netherlands; [Spanjer, Jerry] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands	University of Basel; University of Zurich; University Zurich Hospital; University of Zurich; McMaster University; McMaster University; McMaster University; University of Amsterdam; Academic Medical Center Amsterdam; FHNW University of Applied Sciences & Arts Northwestern Switzerland; University of Groningen	Kunz, R (corresponding author), Univ Basel, Univ Basel Hosp, EbIM, Res & Educ,Dept Clin Res, Spitalstr 8 12, CH-4031 Basel, Switzerland.	regina.kunz@usb.ch	Hoving, Jan L/O-2235-2013; Busse, Jason/CAH-3696-2022; Couban, Rachel/AAV-1568-2021; Barth, Jürgen/F-9987-2011	Hoving, Jan L/0000-0002-0461-4013; Busse, Jason/0000-0002-0178-8712; Couban, Rachel/0000-0001-8672-2845; Barth, Jürgen/0000-0001-7096-7178; von Allmen, David/0000-0003-3722-3462; Kunz, Regina/0000-0003-0931-8990				Alexiou G., 2014, THE INDEPENDENT 0422; Anner J, 2014, DISABIL REHABIL, V36, P848, DOI 10.3109/09638288.2013.821180; Anner Jessica, 2012, BMC Public Health, V12, P470, DOI 10.1186/1471-2458-12-470; Bachmann M, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0967-6; Berns S, 2007, BIPOLAR DISORD, V9, P3, DOI 10.1111/j.1399-5618.2007.00305.x; Busse JW, 2014, CAN MED ASSOC J, V186, pE627, DOI 10.1503/cmaj.130863; Chopra P, 2002, AUST NZ J PSYCHIAT, V36, P127, DOI 10.1046/j.1440-1614.2002.00976.x; Cicchetti D, 2006, J NERV MENT DIS, V194, P557, DOI 10.1097/01.nmd.0000230392.83607.c5; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; CLARK WL, 1988, SPINE, V13, P332, DOI 10.1097/00007632-198803000-00019; DARADKEH TK, 1994, BRIT J PSYCHIAT, V165, P683, DOI 10.1192/bjp.165.5.683; DEKORT WLAM, 1992, SCAND J WORK ENV HEA, V18, P246, DOI 10.5271/sjweh.1582; Dell-Kuster S, 2014, SCAND J WORK ENV HEA, V40, P493, DOI 10.5271/sjweh.3440; Dickmann JRM, 2007, FORTSCHR NEUROL PSYC, V75, P397, DOI 10.1055/s-2006-944303; EDWARDS W, 1954, PSYCHOL BULL, V51, P380, DOI 10.1037/h0053870; Elder A. G., 1994, Occupational Medicine (Oxford), V44, P231, DOI 10.1093/occmed/44.5.231; Fleiss JL., 2003, STAT METHODS RATES P, V3rd ed; Fleiss JL., 2003, STAT METHODS RATES P; Hannula JA, 2006, NORD J PSYCHIAT, V60, P372, DOI 10.1080/08039480600937140; Hesse B, 2011, REHABILITATION, V50, P17, DOI 10.1055/s-0030-1270432; HILL J, 1989, BRIT J PSYCHIAT, V155, P24, DOI 10.1192/bjp.155.1.24; Ikezawa Y, 2010, J OCCUP REHABIL, V20, P367, DOI 10.1007/s10926-010-9230-z; Ingravallo F, 2008, J SLEEP RES, V17, P111, DOI 10.1111/j.1365-2869.2008.00630.x; International Social Security Association, COUNTR PROF; Karanicolas PJ, 2009, J BONE JOINT SURG AM, V91A, P99, DOI 10.2106/JBJS.H.01624; Kleinfield NR, 2009, NY TIMES; Kobak KA, 2009, J CLIN PSYCHOPHARM, V29, P82, DOI 10.1097/JCP.0b013e318192e4d7; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Lax MB, 2004, INT J OCCUP ENV HEAL, V10, P1; Lederer P, 1998, Gesundheitswesen, V60, P415; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lucas NP, 2010, J CLIN EPIDEMIOL, V63, P854, DOI 10.1016/j.jclinepi.2009.10.002; Manchikanti L, 2000, Pain Physician, V3, P201; Meershoek A, 2007, SOCIOL HEALTH ILL, V29, P497, DOI 10.1111/j.1467-9566.2007.01009.x; Mundo E, 2010, RIV PSICHIATR, V45, P214; Nozu M, 1995, Seishin Shinkeigaku Zasshi, V97, P217; OKPAKU SO, 1994, AM J PUBLIC HEALTH, V84, P1791, DOI 10.2105/AJPH.84.11.1791; Organisation for economic Co-operation and development, 2010, SICKN DIS WORK BREAK; Peterson KW, 1997, J OCCUP ENVIRON MED, V39, P509, DOI 10.1097/00043764-199706000-00004; Pizala H., 2010, THESIS; Rudbeck M, 2011, SCAND J PUBLIC HEALT, V39, P766, DOI 10.1177/1403494811418282; Schellart Antonius J M, 2013, BMC Res Notes, V6, P225, DOI 10.1186/1756-0500-6-225; Schreuder JAH, 2012, DISABIL REHABIL, V34, P1814, DOI 10.3109/09638288.2012.665125; Slebus FG, 2010, OCCUP MED-OXFORD, V60, P307, DOI 10.1093/occmed/kqq079; Spanjer J, 2010, WORK, V37, P405, DOI 10.3233/WOR-2010-1094; Spanjer J, 2008, DISABIL REHABIL, V30, P1885, DOI 10.1080/09638280701688185; Spanjer J, 2010, J OCCUP REHABIL, V20, P33, DOI 10.1007/s10926-009-9203-2; Spanjer J, 2009, J REHABIL MED, V41, P267, DOI 10.2340/16501977-0323; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5	49	37	37	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2017	356								j14	10.1136/bmj.j14	http://dx.doi.org/10.1136/bmj.j14			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ4HO	28122727	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000393177700005
J	Hurley, R				Hurley, Richard			THE BMJ CHRISTMAS APPEAL 2016-17 How volunteering for a global charity helps eye care back home	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rhurley@bmj.com							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2017	356								j390	10.1136/bmj.j390	http://dx.doi.org/10.1136/bmj.j390			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HO	28122699				2022-12-28	WOS:000393177700012
J	Mokdad, AH; Dwyer-Lindgren, L; Fitzmaurice, C; Stubbs, RW; Bertozzi-Villa, A; Morozoff, C; Charara, R; Allen, C; Naghavi, M; Murray, CJL				Mokdad, Ali H.; Dwyer-Lindgren, Laura; Fitzmaurice, Christina; Stubbs, Rebecca W.; Bertozzi-Villa, Amelia; Morozoff, Chloe; Charara, Raghid; Allen, Christine; Naghavi, Mohsen; Murray, Christopher J. L.			Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; BREAST-CANCER; RISK-FACTORS; PREVALENCE; OBESITY; DISEASE; FUTURE; BURDEN; LEVEL; RATES	INTRODUCTION Cancer is a leading cause of morbidity and mortality in the United States and results in a high economic burden. OBJECTIVE To estimate age-standardized mortality rates by US county from 29 cancers. DESIGN AND SETTING Deidentified death records from the National Center for Health Statistics (NCHS) and population counts from the Census Bureau, the NCHS, and the Human Mortality Database from 1980 to 2014 were used. Validated small area estimation models were used to estimate county-level mortality rates from 29 cancers: lip and oral cavity; nasopharynx; other pharynx; esophageal; stomach; colon and rectum; liver; gallbladder and biliary; pancreatic; larynx; tracheal, bronchus, and lung; malignant skin melanoma; nonmelanoma skin cancer; breast; cervical; uterine; ovarian; prostate; testicular; kidney; bladder; brain and nervous system; thyroid; mesothelioma; Hodgkin lymphoma; non-Hodgkin lymphoma; multiplemyeloma; leukemia; and all other cancers combined. EXPOSURE County of residence. MAIN OUTCOMES AND MEASURES Age-standardized cancer mortality rates by county, year, sex, and cancer type. RESULTS A total of 19 511 910 cancer deaths were recorded in the United States between 1980 and 2014, including 5 656 423 due to tracheal, bronchus, and lung cancer; 2 484 476 due to colon and rectum cancer; 1 573 593 due to breast cancer; 1 077 030 due to prostate cancer; 1 157 878 due to pancreatic cancer; 209 314 due to uterine cancer; 421 628 due to kidney cancer; 487 518 due to liver cancer; 13 927 due to testicular cancer; and 829 396 due to non-Hodgkin lymphoma. Cancer mortality decreased by 20.1%(95% uncertainty interval [UI], 18.2%-21.4%) between 1980 and 2014, from 240.2 (95% UI, 235.8-244.1) to 192.0 (95% UI, 188.6-197.7) deaths per 100 000 population. There were large differences in the mortality rate among counties throughout the period: in 1980, cancer mortality ranged from 130.6 (95% UI, 114.7-146.0) per 100 000 population in Summit County, Colorado, to 386.9 (95% UI, 330.5-450.7) in North Slope Borough, Alaska, and in 2014 from 70.7 (95% UI, 63.2-79.0) in Summit County, Colorado, to 503.1 (95% UI, 464.9-545.4) in Union County, Florida. For many cancers, there were distinct clusters of counties with especially high mortality. The location of these clusters varied by type of cancer and were spread in different regions of the United States. Clusters of breast cancer were present in the southern belt and along the Mississippi River, while liver cancer was high along the Texas-Mexico border, and clusters of kidney cancer were observed in North and South Dakota and counties in West Virginia, Ohio, Indiana, Louisiana, Oklahoma, Texas, Alaska, and Illinois. CONCLUSIONS AND RELEVANCE Cancer mortality declined overall in the United States between 1980 and 2014. Over this same period, there were important changes in trends, patterns, and differences in cancer mortality among US counties. These patterns may inform further research into improving prevention and treatment.	[Mokdad, Ali H.; Dwyer-Lindgren, Laura; Fitzmaurice, Christina; Stubbs, Rebecca W.; Bertozzi-Villa, Amelia; Morozoff, Chloe; Charara, Raghid; Allen, Christine; Naghavi, Mohsen; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Murray, CJL (corresponding author), Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Mokdad, Ali H./AAD-1232-2022	Mokdad, Ali H./0000-0002-4994-3339; Dwyer-Lindgren, Laura/0000-0002-3872-6451	Robert Wood Johnson Foundation [72305]; National Institute on Aging [5P30AG047845-02]; John W. Stanton and Theresa E. Gillespie; NATIONAL INSTITUTE ON AGING [P30AG047845] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); John W. Stanton and Theresa E. Gillespie; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the Robert Wood Johnson Foundation (grant 72305), the National Institute on Aging (grant 5P30AG047845-02), and John W. Stanton and Theresa E. Gillespie.	Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; [Anonymous], 2021, LANG ENV STAT COMP; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Dwyer-Lindgren L, 2016, JAMA-J AM MED ASSOC, V316, P2385, DOI 10.1001/jama.2016.13645; Dwyer-Lindgren L, 2015, AM J PUBLIC HEALTH, V105, P1120, DOI 10.2105/AJPH.2014.302313; Dwyer-Lindgren L, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-5; Dwyer-Lindgren L, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-7; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Ghazarian AA, 2015, CANCER-AM CANCER SOC, V121, P4181, DOI 10.1002/cncr.29643; Henley S. Jane, 2011, Morbidity and Mortality Weekly Report, V60, P1243; Hert KA, 2014, NUTR RES, V34, P58, DOI 10.1016/j.nutres.2013.10.005; Johnston R, 2014, J NUTR HEALTH AGING, V18, P234, DOI 10.1007/s12603-013-0387-y; Kristensen K, 2016, J STAT SOFTW, V70, P1; Lansdorp-Vogelaar I, 2015, CANCER-AM CANCER SOC, V121, P3676, DOI 10.1002/cncr.29561; Lauterstein Dana, 2014, Curr Drug Abuse Rev, V7, P29; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2009, ANNU REV PUBL HEALTH, V30, P43, DOI 10.1146/annurev.publhealth.031308.100226; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Murray CJL, 1999, EPIDEMIOLOGY, V10, P594, DOI 10.1097/00001648-199909000-00029; National Center for Health Statistics, 2012, BRIDG RAC INT EST RE; National Center for Health Statistics, 2015, VINT 2014 POSTC EST; National Center for Health Statistics, 2004, BRIDG RAC INT EST RE; National Center for Health Statistics, 2014, NAT VIT STAT SYST MU; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Radley DC, 2012, NEW ENGL J MED, V367, P3, DOI 10.1056/NEJMp1204516; Rehm CD, 2016, JAMA-J AM MED ASSOC, V315, P2542, DOI 10.1001/jama.2016.7491; Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936; Surveillance Epidemiology and End Results Program, 2016, SEER STAT DAT INC SE; Toriola AT, 2013, BREAST CANCER RES TR, V138, P665, DOI 10.1007/s10549-013-2500-7; U. S. Cancer Statistics Working Group, 2015, US CANC STAT 1999 20; Urban LE, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140335; US Preventive Services Task Force, 2016, FIN RES PLAN PROST C; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Yabroff KR, 2011, CANCER EPIDEM BIOMAR, V20, P2006, DOI 10.1158/1055-9965.EPI-11-0650	34	240	242	5	85	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					388	406		10.1001/jama.2016.20324	http://dx.doi.org/10.1001/jama.2016.20324			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI5BW	28118455	Green Accepted			2022-12-28	WOS:000392509600021
J	Buchbinder, M				Buchbinder, Mara			Extremis A Documentary Look at End-of-Life Decisions in the ICU	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Buchbinder, Mara] Univ N Carolina, Ctr Bioeth, Dept Social Med, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Buchbinder, M (corresponding author), Univ N Carolina, Ctr Bioeth, Dept Social Med, Chapel Hill, NC 27514 USA.	mara_buchbinder@med.unc.edu		Buchbinder, Mara/0000-0002-2319-662X				Chapple H.S., 2010, NO PLACE DYING HOSP; Kaufman Sharon, 2006, TIME DIE AM HOSP SHA	2	0	0	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					240	241		10.1001/jama.2016.20009	http://dx.doi.org/10.1001/jama.2016.20009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114529				2022-12-28	WOS:000392089200001
J	Mcrae, JF; Clayton, S; Fitzgerald, TW; Kaplanis, J; Prigmore, E; Rajan, D; Sifrim, A; Aitken, S; Akawi, N; Alvi, M; Ambridge, K; Barrett, DM; Bayzetinova, T; Jones, P; Jones, WD; King, D; Krishnappa, N; Mason, LE; Singh, T; Tivey, AR; Ahmed, M; Anjum, U; Archer, H; Armstrong, R; Awada, J; Balasubramanian, M; Banka, S; Baralle, D; Barnicoat, A; Batstone, P; Baty, D; Bennett, C; Berg, J; Bernhard, B; Bevan, AP; Bitner-Glindzicz, M; Blair, E; Blyth, M; Bohanna, D; Bourdon, L; Bourn, D; Bradley, L; Brady, A; Brent, S; Brewer, C; Brunstrom, K; Bunyan, DJ; Burn, J; Canham, N; Castle, B; Chandler, K; Chatzimichali, E; Cilliers, D; Clarke, A; Clasper, S; Clayton-Smith, J; Clowes, V; Coates, A; Cole, T; Colgiu, I; Collins, A; Collinson, MN; Connell, F; Cooper, N; Cox, H; Cresswell, L; Cross, G; Crow, Y; D'Alessandro, M; Dabir, T; Davidson, R; Davies, S; de Vries, D; Dean, J; Deshpande, C; Devlin, G; Dixit, A; Dobbie, A; Donaldson, A; Donnai, D; Donnelly, D; Donnelly, C; Douglas, A; Douzgou, S; Duncan, A; Eason, J; Ellard, S; Ellis, I; Elmslie, F; Evans, K; Everest, S; Fendick, T; Fisher, R; Flinter, F; Foulds, N; Fry, A; Fryer, A; Gardiner, C; Gaunt, L; Ghali, N; Gibbons, R; Gill, H; Goodship, J; Goudie, D; Gray, E; Green, A; Greene, P; Greenhalgh, L; Gribble, S; Harrison, R; Harrison, L; Harrison, V; Hawkins, R; He, L; Hellens, S; Henderson, A; Hewitt, S; Hildyard, L; Hobson, E; Holden, S; Holder, M; Holder, S; Hollingsworth, G; Homfray, T; Humphreys, M; Hurst, J; Hutton, B; Ingram, S; Irving, M; Islam, L; Jackson, A; Jarvis, J; Jenkins, L; Johnson, D; Jones, E; Josifova, D; Joss, S; Kaemba, B; Kazembe, S; Kelsell, R; Kerr, B; Kingston, H; Kini, U; Kinning, E; Kirby, G; Kirk, C; Kivuva, E; Kraus, A; Kumar, D; Kumar, VKA; Lachlan, K; Lam, W; Lampe, A; Langman, C; Lees, M; Lim, D; Longman, C; Lowther, G; Lynch, SA; Magee, A; Maher, E; Male, A; Mansour, S; Marks, K; Martin, K; Maye, U; McCann, E; McConnell, V; McEntagart, M; McGowan, R; McKay, K; McKee, S; McMullan, DJ; McNerlan, S; McWilliam, C; Mehta, S; Metcalfe, K; Middleton, A; Miedzybrodzka, Z; Miles, E; Mohammed, S; Montgomery, T; Moore, D; Morgan, S; Morton, J; Mugalaasi, H; Murday, V; Murphy, H; Naik, S; Nemeth, A; Nevitt, L; Newbury-Ecob, R; Norman, A; O'Shea, R; Ogilvie, C; Ong, KR; Park, SM; Parker, MJ; Patel, C; Paterson, J; Payne, S; Perrett, D; Phipps, J; Pilz, DT; Pollard, M; Pottinger, C; Poulton, J; Pratt, N; Prescott, K; Price, S; Pridham, A; Procter, A; Purnell, H; Quarrell, O; Ragge, N; Rahbari, R; Randall, J; Rankin, J; Raymond, L; Rice, D; Robert, L; Roberts, E; Roberts, J; Roberts, P; Roberts, G; Ross, A; Rosser, E; Saggar, A; Samant, S; Sampson, J; Sandford, R; Sarkar, A; Schweiger, S; Scott, R; Scurr, I; Selby, A; Seller, A; Sequeira, C; Shannon, N; Sharif, S; Shaw-Smith, C; Shearing, E; Shears, D; Sheridan, E; Simonic, I; Singzon, R; Skitt, Z; Smith, A; Smith, K; Smithson, S; Sneddon, L; Splitt, M; Squires, M; Stewart, F; Stewart, H; Straub, V; Suri, M; Sutton, V; Swaminathan, GJ; Sweeney, E; Tatton-Brown, K; Taylor, C; Taylor, R; Tein, M; Temple, K; Thomson, J; Tischkowitz, M; Tomkins, S; Torokwa, A; Treacy, B; Turner, C; Turnpenny, P; Tysoe, C; Vandersteen, A; Varghese, V; Vasudevan, P; Vijayarangakannan, P; Vogt, J; Wakeling, E; Wallwark, S; Waters, J; Weber, A; Wellesley, D; Whiteford, M; Widaa, S; Wilcox, S; Wilkinson, E; Williams, D; Williams, N; Wilson, L; Woods, G; Wragg, C; Wright, M; Yates, L; Yau, M; Nellaker, C; Parker, M; Firth, HV; Wright, CF; FitzPatrick, DR; Barrett, JC; Hurles, ME				McRae, Jeremy F.; Clayton, Stephen; Fitzgerald, Tomas W.; Kaplanis, Joanna; Prigmore, Elena; Rajan, Diana; Sifrim, Alejandro; Aitken, Stuart; Akawi, Nadia; Alvi, Mohsan; Ambridge, Kirsty; Barrett, Daniel M.; Bayzetinova, Tanya; Jones, Philip; Jones, Wendy D.; King, Daniel; Krishnappa, Netravathi; Mason, Laura E.; Singh, Tarjinder; Tivey, Adrian R.; Ahmed, Munaza; Anjum, Uruj; Archer, Hayley; Armstrong, Ruth; Awada, Jana; Balasubramanian, Meena; Banka, Siddharth; Baralle, Diana; Barnicoat, Angela; Batstone, Paul; Baty, David; Bennett, Chris; Berg, Jonathan; Bernhard, Birgitta; Bevan, A. Paul; Bitner-Glindzicz, Maria; Blair, Edward; Blyth, Moira; Bohanna, David; Bourdon, Louise; Bourn, David; Bradley, Lisa; Brady, Angela; Brent, Simon; Brewer, Carole; Brunstrom, Kate; Bunyan, David J.; Burn, John; Canham, Natalie; Castle, Bruce; Chandler, Kate; Chatzimichali, Elena; Cilliers, Deirdre; Clarke, Angus; Clasper, Susan; Clayton-Smith, Jill; Clowes, Virginia; Coates, Andrea; Cole, Trevor; Colgiu, Irina; Collins, Amanda; Collinson, Morag N.; Connell, Fiona; Cooper, Nicola; Cox, Helen; Cresswell, Lara; Cross, Gareth; Crow, Yanick; D'Alessandro, Mariella; Dabir, Tabib; Davidson, Rosemarie; Davies, Sally; de Vries, Dylan; Dean, John; Deshpande, Charu; Devlin, Gemma; Dixit, Abhijit; Dobbie, Angus; Donaldson, Alan; Donnai, Dian; Donnelly, Deirdre; Donnelly, Carina; Douglas, Angela; Douzgou, Sofia; Duncan, Alexis; Eason, Jacqueline; Ellard, Sian; Ellis, Ian; Elmslie, Frances; Evans, Karenza; Everest, Sarah; Fendick, Tina; Fisher, Richard; Flinter, Frances; Foulds, Nicola; Fry, Andrew; Fryer, Alan; Gardiner, Carol; Gaunt, Lorraine; Ghali, Neeti; Gibbons, Richard; Gill, Harinder; Goodship, Judith; Goudie, David; Gray, Emma; Green, Andrew; Greene, Philip; Greenhalgh, Lynn; Gribble, Susan; Harrison, Rachel; Harrison, Lucy; Harrison, Victoria; Hawkins, Rose; He, Liu; Hellens, Stephen; Henderson, Alex; Hewitt, Sarah; Hildyard, Lucy; Hobson, Emma; Holden, Simon; Holder, Muriel; Holder, Susan; Hollingsworth, Georgina; Homfray, Tessa; Humphreys, Mervyn; Hurst, Jane; Hutton, Ben; Ingram, Stuart; Irving, Melita; Islam, Lily; Jackson, Andrew; Jarvis, Joanna; Jenkins, Lucy; Johnson, Diana; Jones, Elizabeth; Josifova, Dragana; Joss, Shelagh; Kaemba, Beckie; Kazembe, Sandra; Kelsell, Rosemary; Kerr, Bronwyn; Kingston, Helen; Kini, Usha; Kinning, Esther; Kirby, Gail; Kirk, Claire; Kivuva, Emma; Kraus, Alison; Kumar, Dhavendra; Kumar, V. K. Ajith; Lachlan, Katherine; Lam, Wayne; Lampe, Anne; Langman, Caroline; Lees, Melissa; Lim, Derek; Longman, Cheryl; Lowther, Gordon; Lynch, Sally A.; Magee, Alex; Maher, Eddy; Male, Alison; Mansour, Sahar; Marks, Karen; Martin, Katherine; Maye, Una; McCann, Emma; McConnell, Vivienne; McEntagart, Meriel; McGowan, Ruth; McKay, Kirsten; McKee, Shane; McMullan, Dominic J.; McNerlan, Susan; McWilliam, Catherine; Mehta, Sarju; Metcalfe, Kay; Middleton, Anna; Miedzybrodzka, Zosia; Miles, Emma; Mohammed, Shehla; Montgomery, Tara; Moore, David; Morgan, Sian; Morton, Jenny; Mugalaasi, Hood; Murday, Victoria; Murphy, Helen; Naik, Swati; Nemeth, Andrea; Nevitt, Louise; Newbury-Ecob, Ruth; Norman, Andrew; O'Shea, Rosie; Ogilvie, Caroline; Ong, Kai-Ren; Park, Soo-Mi; Parker, Michael J.; Patel, Chirag; Paterson, Joan; Payne, Stewart; Perrett, Daniel; Phipps, Julie; Pilz, Daniela T.; Pollard, Martin; Pottinger, Caroline; Poulton, Joanna; Pratt, Norman; Prescott, Katrina; Price, Sue; Pridham, Abigail; Procter, Annie; Purnell, Hellen; Quarrell, Oliver; Ragge, Nicola; Rahbari, Raheleh; Randall, Josh; Rankin, Julia; Raymond, Lucy; Rice, Debbie; Robert, Leema; Roberts, Eileen; Roberts, Jonathan; Roberts, Paul; Roberts, Gillian; Ross, Alison; Rosser, Elisabeth; Saggar, Anand; Samant, Shalaka; Sampson, Julian; Sandford, Richard; Sarkar, Ajoy; Schweiger, Susann; Scott, Richard; Scurr, Ingrid; Selby, Ann; Seller, Anneke; Sequeira, Cheryl; Shannon, Nora; Sharif, Saba; Shaw-Smith, Charles; Shearing, Emma; Shears, Debbie; Sheridan, Eamonn; Simonic, Ingrid; Singzon, Roldan; Skitt, Zara; Smith, Audrey; Smith, Kath; Smithson, Sarah; Sneddon, Linda; Splitt, Miranda; Squires, Miranda; Stewart, Fiona; Stewart, Helen; Straub, Volker; Suri, Mohnish; Sutton, Vivienne; Swaminathan, Ganesh Jawahar; Sweeney, Elizabeth; Tatton-Brown, Kate; Taylor, Cat; Taylor, Rohan; Tein, Mark; Temple, Karen; Thomson, Jenny; Tischkowitz, Marc; Tomkins, Susan; Torokwa, Audrey; Treacy, Becky; Turner, Claire; Turnpenny, Peter; Tysoe, Carolyn; Vandersteen, Anthony; Varghese, Vinod; Vasudevan, Pradeep; Vijayarangakannan, Parthiban; Vogt, Julie; Wakeling, Emma; Wallwark, Sarah; Waters, Jonathon; Weber, Astrid; Wellesley, Diana; Whiteford, Margo; Widaa, Sara; Wilcox, Sarah; Wilkinson, Emily; Williams, Denise; Williams, Nicola; Wilson, Louise; Woods, Geoff; Wragg, Christopher; Wright, Michael; Yates, Laura; Yau, Michael; Nellaker, Chris; Parker, Michael; Firth, Helen V.; Wright, Caroline F.; FitzPatrick, David R.; Barrett, Jeffrey C.; Hurles, Matthew E.			Prevalence and architecture of de novo mutations in developmental disorders	NATURE			English	Article							INTELLECTUAL DISABILITY; HEART-DEFECTS; DISCOVERY; GENETICS; GENOME; GENES; METAANALYSIS; FRAMEWORK; VARIANTS; SEQUENCE	The genomes of individuals with severe, undiagnosed developmental disorders are enriched in damaging de novo mutations (DNMs) in developmentally important genes. Here we have sequenced the exomes of 4,293 families containing individuals with developmental disorders, and meta-analysed these data with data from another 3,287 individuals with similar disorders. We show that the most important factors influencing the diagnostic yield of DNMs are the sex of the affected individual, the relatedness of their parents, whether close relatives are affected and the parental ages. We identified 94 genes enriched in damaging DNMs, including 14 that previously lacked compelling evidence of involvement in developmental disorders. We have also characterized the phenotypic diversity among these disorders. We estimate that 42% of our cohort carry pathogenic DNMs in coding sequences; approximately half of these DNMs disrupt gene function and the remainder result in altered protein function. We estimate that developmental disorders caused by DNMs have an average prevalence of 1 in 213 to 1 in 448 births, depending on parental age. Given current global demographics, this equates to almost 400,000 children born per year.	[McRae, Jeremy F.; Clayton, Stephen; Fitzgerald, Tomas W.; Kaplanis, Joanna; Prigmore, Elena; Rajan, Diana; Sifrim, Alejandro; Akawi, Nadia; Ambridge, Kirsty; Barrett, Daniel M.; Bayzetinova, Tanya; Jones, Philip; Jones, Wendy D.; King, Daniel; Krishnappa, Netravathi; Mason, Laura E.; Singh, Tarjinder; Tivey, Adrian R.; Awada, Jana; Bevan, A. Paul; Brent, Simon; Chatzimichali, Elena; Colgiu, Irina; de Vries, Dylan; Gray, Emma; Gribble, Susan; He, Liu; Hildyard, Lucy; Hutton, Ben; Kelsell, Rosemary; Middleton, Anna; Perrett, Daniel; Pollard, Martin; Rahbari, Raheleh; Randall, Josh; Saggar, Anand; Swaminathan, Ganesh Jawahar; Vijayarangakannan, Parthiban; Widaa, Sara; Wilkinson, Emily; Firth, Helen V.; Wright, Caroline F.; FitzPatrick, David R.; Barrett, Jeffrey C.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Aitken, Stuart; Greene, Philip; Jackson, Andrew; Lampe, Anne; Maher, Eddy; Moore, David; FitzPatrick, David R.] Univ Edinburgh, Western Gen Hosp, MRC Human Genet Unit, MRC IGMM, Edinburgh EH4 2XU, Midlothian, Scotland; [Alvi, Mohsan] Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England; [Ahmed, Munaza; Baralle, Diana; Bunyan, David J.; Collins, Amanda; Collinson, Morag N.; Harrison, Lucy; Harrison, Victoria; Lachlan, Katherine; Temple, Karen; Torokwa, Audrey; Wellesley, Diana] Southampton Univ Hosp, Princess Anne Hosp, Wessex Clin Genet Serv, Coxford Rd, Southampton SO16 5YA, Hants, England; [Ahmed, Munaza; Baralle, Diana; Bunyan, David J.; Collins, Amanda; Collinson, Morag N.; Foulds, Nicola; Harrison, Lucy; Harrison, Victoria; Lachlan, Katherine; Temple, Karen; Torokwa, Audrey; Wellesley, Diana] Salisbury Dist Hosp, Salisbury NHS Fdn Trust, Wessex Reg Genet Lab, Odstock Rd, Salisbury SP2 8BJ, Wilts, England; [Ahmed, Munaza; Bunyan, David J.; Collins, Amanda; Harrison, Lucy; Harrison, Victoria; Lachlan, Katherine; Temple, Karen; Torokwa, Audrey; Wellesley, Diana] Univ Southampton, Fac Med, Bldg 85,Life Sci Bldg,Highfield Campus, Southampton SO17, Hants, England; [Anjum, Uruj; Elmslie, Frances; Homfray, Tessa; Mansour, Sahar; Marks, Karen; Tatton-Brown, Kate; Taylor, Rohan] Univ London, South West Thames Reg Genet Ctr, St Georges Healthcare NHS Trust, Cranmer Terrace, London SW17 0RE, England; [Archer, Hayley; Clarke, Angus; Davies, Sally; Evans, Karenza; Fry, Andrew; Morgan, Sian; Mugalaasi, Hood; Procter, Annie; Sampson, Julian; Varghese, Vinod] Univ Wales Hosp, Inst Med Genet, Heath Pk, Cardiff CF14 4XW, Wales; [Archer, Hayley; Clarke, Angus; Davies, Sally; Evans, Karenza; Fry, Andrew; Morgan, Sian; Mugalaasi, Hood; Procter, Annie; Sampson, Julian; Varghese, Vinod] Glan Clwyd Gen Hosp, Dept Clin Genet, Block 12, Rhyl, Denbigh, Wales; [Armstrong, Ruth; Holden, Simon; Mehta, Sarju; Park, Soo-Mi; Raymond, Lucy; Sandford, Richard; Simonic, Ingrid; Tischkowitz, Marc; Treacy, Becky; Wallwark, Sarah; Wilcox, Sarah; Woods, Geoff; Firth, Helen V.] East Anglian Med Genet Serv, Cambridge Univ Hosp, NHS Fdn Trust, Box 134,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Balasubramanian, Meena; Ingram, Stuart; Johnson, Diana; Nevitt, Louise; Parker, Michael J.; Smith, Kath; Taylor, Cat] Sheffield Reg Genet Serv, Sheffield Childrens NHS Trust, Western Bank, Sheffield S10 2TH, S Yorkshire, England; [Banka, Siddharth; Chandler, Kate; Clayton-Smith, Jill; Donnelly, Carina; Douzgou, Sofia; Gaunt, Lorraine; Jones, Elizabeth; Kingston, Helen; Metcalfe, Kay; Miles, Emma; Murphy, Helen] Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester Ctr Genom Med, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester M13 9WL, Lancs, England; [Barnicoat, Angela; Bitner-Glindzicz, Maria; Brunstrom, Kate; Hollingsworth, Georgina; Hurst, Jane; Jenkins, Lucy; Kumar, V. K. Ajith; Male, Alison; Rosser, Elisabeth; Scott, Richard] Hosp Children NHS Fdn Trust, Great Ormond St Hosp, North East Thames Reg Genet Serv, Great Ormond St, London WC1N 3JH, England; [Batstone, Paul; D'Alessandro, Mariella; Dean, John; McGowan, Ruth; McWilliam, Catherine; Miedzybrodzka, Zosia; Ross, Alison; Samant, Shalaka] Dept Med Genet Med Sch, North Scotland Reg Genet Serv, NHS Grampian, Foresterhill, Aberdeen AB25 2ZD, Scotland; [Baty, David; Berg, Jonathan; Pratt, Norman; Rice, Debbie; Schweiger, Susann] Ninewells Hosp, East Scotland Reg Genet Serv, Dept Pathol, Human Genet Unit NHS Tayside, Dundee DD1 9SY, Scotland; [Bennett, Chris; Blyth, Moira; Coates, Andrea; Dobbie, Angus; Hobson, Emma; Kraus, Alison; Roberts, Paul; Sheridan, Eamonn; Smith, Audrey; Squires, Miranda; Thomson, Jenny] Leeds Teaching Hosp NHS Trust, Chapel Allerton Hosp, Dept Clin Genet, Yorkshire Reg Genet Serv, Chapeltown Rd, Leeds LS7 4SA, W Yorkshire, England; [Bernhard, Birgitta; Bourdon, Louise; Brady, Angela; Canham, Natalie; Clowes, Virginia; Holder, Muriel; Sequeira, Cheryl; Singzon, Roldan; Vandersteen, Anthony; Wakeling, Emma] North West London Hosp NHS Trust, North West Thames Reg Genet Ctr, Kennedy Galton Ctr, Northwick Pk & St Marks NHS Trust Watford Rd, Harrow HA1 3UJ, Middx, England; [Blair, Edward; Cilliers, Deirdre; Clasper, Susan; Gibbons, Richard; Kini, Usha; Phipps, Julie; Poulton, Joanna; Price, Sue; Pridham, Abigail; Purnell, Hellen; Seller, Anneke; Shears, Debbie; Stewart, Helen] Oxford Radcliffe Hosp NHS Trust, Oxford Reg Genet Serv, Churchill Old Rd, Oxford OX3 7LJ, England; [Bohanna, David; Cooper, Nicola; Cox, Helen; Islam, Lily; Jarvis, Joanna; Kirby, Gail; Lim, Derek; McMullan, Dominic J.; Morton, Jenny; Naik, Swati; Norman, Andrew; Ong, Kai-Ren; Patel, Chirag; Ragge, Nicola; Sharif, Saba; Tein, Mark; Vogt, Julie; Williams, Denise] Birmingham Womens Hosp, Birmingham Womens NHS Fdn Trust, West Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Bourn, David; Burn, John; Fisher, Richard; Goodship, Judith; Hellens, Stephen; Henderson, Alex; Montgomery, Tara; Splitt, Miranda; Straub, Volker; Wright, Michael; Yates, Laura] Newcastle Tyne Hosp NHS Fdn Trust, Inst Human Genet, Int Ctr Life, Northern Genet Serv, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Bradley, Lisa; Dabir, Tabib; Donnelly, Deirdre; Humphreys, Mervyn; Kirk, Claire; McConnell, Vivienne; McKee, Shane; McNerlan, Susan; Stewart, Fiona] Belfast City Hosp, Northern Ireland Reg Genet Ctr, Belfast Hlth & Social Care Trust, Lisburn Rd, Belfast, Antrim, North Ireland; [Brewer, Carole; Castle, Bruce; Devlin, Gemma; Ellard, Sian; Everest, Sarah; Kivuva, Emma; Rankin, Julia; Shaw-Smith, Charles; Turner, Claire; Turnpenny, Peter; Tysoe, Carolyn] Royal Devon & Exeter Hosp Heavitree, Royal Devon & Exeter NHS Fdn Trust, Peninsula Clin Genet Serv, Dept Clin Genet, Gladstone Rd, Exeter EX1 2ED, Devon, England; [Flinter, Frances; Irving, Melita; Josifova, Dragana; Langman, Caroline; Ogilvie, Caroline; Robert, Leema; Yau, Michael] Guys Hosp, Guys & St Thomas NHS Fdn Trust, South East Thames Reg Genet Ctr, Great Maze Pond, London SE1 9RT, England; [Cresswell, Lara; Kaemba, Beckie; Kazembe, Sandra; Vasudevan, Pradeep] Univ Hosp Leicester NHS Trust, Leicester Genet Ctr, Leicester Royal Infirm NHS Trust, Leicester LE1 5WW, Leics, England; [Cross, Gareth; Dixit, Abhijit; Eason, Jacqueline; Harrison, Rachel; Martin, Katherine; Sarkar, Ajoy; Shannon, Nora; Suri, Mohnish] Nottingham Univ Hosp NHS Trust, City Hosp Campus, Nottingham Reg Genet Serv, Hucknall Rd, Nottingham NG5, England; [Duncan, Alexis; Gardiner, Carol; Joss, Shelagh; Kinning, Esther; Murday, Victoria; Pilz, Daniela T.; Whiteford, Margo; Williams, Nicola] West Scotland Reg Genet Serv, Inst Med Genet, Yorkhill Hosp, NHS Greater Glasgow & Clyde, Glasgow G3 8SJ, Lanark, Scotland; [Donaldson, Alan; Hawkins, Rose; Newbury-Ecob, Ruth; Wragg, Christopher] St Michaels Hosp, Univ Hosp Bristol NHS Fdn Trust, Bristol Genet Serv Avon, St Michaels Hill, Somerset, NJ USA; [Douglas, Angela; Fryer, Alan; Greenhalgh, Lynn; Maye, Una; Roberts, Gillian; Sutton, Vivienne; Sweeney, Elizabeth] Royal Liverpool Childrens Hosp Alder Hey, Dept Clin Genet, Liverpool Womens NHS Fdn Trust, Merseyside & Cheshire Genet Serv, Eaton Rd, Liverpool L12 2AP, Merseyside, England; [Gill, Harinder; Green, Andrew; Lynch, Sally A.; O'Shea, Rosie] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin 12, Ireland; Glan Clwyd Gen Hosp, Dept Clin Genet, Block 12, Rhyl LL18 5UJ, Denbigh, Wales; [Nellaker, Chris] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet Gynaecol, Womens Ctr, Oxford OX3 9DU, England; [Nellaker, Chris] Univ Oxford, Dept Engn Sci, Inst Biomed Engn, Old Rd Campus Res Bldg, Oxford OX3 7DQ, England; [Nellaker, Chris] Univ Oxford, Big Data Inst, Roosevelt Dr, Oxford OX3 7LF, England; [Parker, Michael] Univ Oxford, Nuffield Dept Populat Hlth, Ethox Ctr, Old Rd Campus, Oxford OX3 7LF, England	Wellcome Trust Sanger Institute; University of Edinburgh; University of Oxford; University of Southampton; Salisbury District Hospital; University of Southampton; St Georges University London; University of London; Oxford University Hospitals NHS Foundation Trust; University of Cambridge; Sheffield Children's NHS Foundation Trust; University of Manchester; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Dundee; Chapel Allerton Hospital; University of Leeds; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Birmingham Women's Hospital; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Belfast City Hospital; University of Exeter; Guy's & St Thomas' NHS Foundation Trust; University Hospitals of Leicester NHS Trust; University of Leicester; Nottingham University Hospital NHS Trust; University of Glasgow; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; University of Oxford; University of Oxford; University of Oxford; University of Oxford		meh@sanger.ac.uk	Poulton, Joanna/AAB-4828-2021; Sifrim, Alejandro/AAY-2019-2021; Houge, Sofia Douzgou/I-2049-2019; Fry, Andrew/AAN-2730-2020; Suri, Mohnish/HIK-0223-2022; King, Daniel/AAM-8024-2021; Ghali, Neeti/L-5665-2019; Ogilve, Caroline/AAW-3793-2021; Tobias, Edward/D-4246-2009; Pollard, Martin O./G-7205-2012; Tischkowitz, Marc/O-4452-2018; Crow, Yanick J/N-6120-2014; Balasubramanian, Meena/AGB-4083-2022; LACHLAN, KATHERINE/ABH-6991-2020; KRISHNAPPA, NETRAVATHI/AAD-9576-2021; Akawi, Nadia/AAX-2650-2020; Fry, Andrew/AFK-7448-2022; Jackson, Andrew/D-3442-2009	Sifrim, Alejandro/0000-0001-8247-4020; Houge, Sofia Douzgou/0000-0001-8890-7544; Fry, Andrew/0000-0001-9778-6924; Suri, Mohnish/0000-0001-9037-701X; King, Daniel/0000-0001-6451-712X; Ghali, Neeti/0000-0003-2847-1376; Tobias, Edward/0000-0003-2649-7695; Pollard, Martin O./0000-0001-8738-0920; Tischkowitz, Marc/0000-0002-7880-0628; Crow, Yanick J/0000-0001-7211-7564; Balasubramanian, Meena/0000-0003-1488-3695; LACHLAN, KATHERINE/0000-0002-3816-7346; Akawi, Nadia/0000-0001-6311-7028; Fry, Andrew/0000-0001-9778-6924; Blyth, Moira/0000-0002-4312-413X; Ellard, Sian/0000-0002-7620-5526; Wright, Caroline/0000-0003-2958-5076; Poulton, Joanna/0000-0002-2460-5587; Middleton, Anna/0000-0003-3103-8098; Straub, Volker/0000-0001-9046-3540; Barrett, Jeffrey/0000-0002-1152-370X; Nellaker, Christoffer/0000-0002-2887-2068; McKee, Shane/0000-0002-1772-0106; Kaplanis, Joanna/0000-0003-1142-6683; Clayton, Stephen/0000-0001-5223-9695; Murphy, Helen/0000-0002-5489-0614; Green, Andrew/0000-0002-1077-7417; Irving, Melita/0000-0002-2997-4461; Singh, Tarjinder/0000-0003-0601-6815; FitzPatrick, David R./0000-0003-4861-969X; Ellis, Ian/0000-0001-5292-8474; Yates, Laura Michelle/0000-0002-7963-625X; Burn, John/0000-0002-9823-2322; Rahbari, Raheleh/0000-0002-1839-7785; Bevan, Paul/0000-0002-0656-9164; de Vries, Dylan/0000-0002-0953-0257; Jackson, Andrew/0000-0002-8739-2646; Temple, Isabel Karen/0000-0002-6045-1781; Lim, Derek/0000-0002-6915-1363; Lynch, Sally Ann/0000-0003-3540-1333; Sneddon, Linda/0000-0002-3519-0057; Banka, Siddharth/0000-0002-8527-2210	Health Innovation Challenge Fund [HICF-1009-003]; Wellcome Trust; UK Department of Health; Wellcome Trust Sanger Institute [WT098051]; National Institutes for Health Research, through the Comprehensive Clinical Research Network; MRC Human Genetics Unit; Engineering and Physical Sciences Research Council [1380788] Funding Source: researchfish; Medical Research Council [MC_PC_U127561093, MR/M014568/1, G0800674] Funding Source: researchfish; MRC [G0800674, MC_PC_U127561093, MR/M014568/1] Funding Source: UKRI	Health Innovation Challenge Fund; Wellcome Trust(Wellcome TrustEuropean Commission); UK Department of Health; Wellcome Trust Sanger Institute(Wellcome Trust); National Institutes for Health Research, through the Comprehensive Clinical Research Network; MRC Human Genetics Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the families for their participation and patience. We are grateful to the Exome Aggregation Consortium for making their data available. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the UK Department of Health, and the Wellcome Trust Sanger Institute (grant WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the UK Department of Health. The study has UK Research Ethics Committee approval (10/H0305/83, granted by the Cambridge South Research Ethics Committee and GEN/284/12, granted by the Republic of Ireland Research Ethics Committee). The research team acknowledges the support of the National Institutes for Health Research, through the Comprehensive Clinical Research Network. We thank the Sanger Human Genome Informatics team, the Sample Management team, the Illumina High-Throughput team, the New Pipeline Group team, the DNA pipelines team and the Core Sequencing team for their support in generating and processing the data. D.R.F. is funded through an MRC Human Genetics Unit program grant to the University of Edinburgh. Finally we acknowledge the contribution of two esteemed DDD clinical collaborators, J. Tolmie and L. Brueton, who died during the course of the study.	Akawi N, 2015, NAT GENET, V47, P1363, DOI 10.1038/ng.3410; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Bragin E, 2014, NUCLEIC ACIDS RES, V42, pD993, DOI 10.1093/nar/gkt937; Central Intelligence Agency, 2016, WORLD FACTBOOK, V2016; Cohen J. S., 2016, CLIN GENET; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Copen CE, 2015, V64; de Ligt J, 2013, CURR OPIN GENET DEV, V23, P257, DOI 10.1016/j.gde.2013.01.007; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; El Chehadeh S, 2017, EUR J HUM GENET, V25, P43, DOI 10.1038/ejhg.2016.133; Felzenszwalb PF, 2010, IEEE T PATTERN ANAL, V32, P1627, DOI 10.1109/TPAMI.2009.167; Ferry Q, 2014, ELIFE, V3, DOI 10.7554/eLife.02020; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Hirata H, 2013, AM J HUM GENET, V92, P681, DOI 10.1016/j.ajhg.2013.03.021; Homan CC, 2014, AM J HUM GENET, V94, P470, DOI 10.1016/j.ajhg.2014.02.004; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu JL, 2009, HUM MUTAT, V30, P1535, DOI 10.1002/humu.21095; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Meynert AM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-247; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Okur V, 2016, HUM GENET, V135, P699, DOI 10.1007/s00439-016-1661-y; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Ramu A, 2013, NAT METHODS, V10, P985, DOI 10.1038/nmeth.2611; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sheridan E, 2013, LANCET, V382, P1350, DOI 10.1016/S0140-6736(13)61132-0; Sifrim A, 2016, NAT GENET, V48, P1060, DOI 10.1038/ng.3627; Springett A., 2013, CONGENITAL ANOMALY S; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Wong WSW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10486; World Bank Group, 2020, WORLD DEV IND; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Xiong XH, 2013, PROC CVPR IEEE, P532, DOI 10.1109/CVPR.2013.75; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	52	690	692	4	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					433	+		10.1038/nature21062	http://dx.doi.org/10.1038/nature21062			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28135719	Green Submitted, Green Accepted			2022-12-28	WOS:000395094100027
J	Halabi, SF; Omer, SB				Halabi, Sam F.; Omer, Saad B.			A Global Vaccine Injury Compensation System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROGRAMS		[Halabi, Sam F.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Halabi, Sam F.] Univ Missouri, Sch Law, Columbia, MO 65211 USA; [Omer, Saad B.] Emory Univ, Sch Med, Atlanta, GA USA	Georgetown University; University of Missouri System; University of Missouri Columbia; Emory University	Halabi, SF (corresponding author), ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	sfh9@georgetown.edu		Halabi, Sam/0000-0002-4603-8480				Berkley S., 2016, GLOBAL MANAGEMENT IN; Halabi SF, 2015, PUBLIC HLTH RESPONSE; Halabi SF, 2015, TULANE J INT COMP LA, V24, P131; Looker C, 2011, B WORLD HEALTH ORGAN, V89, P371, DOI 10.2471/BLT.10.081901; Mello MM, 2008, BIOETHICS, V22, P32, DOI 10.1111/j.1467-8519.2007.00590.x; Omer SB, 2016, JAMA-J AM MED ASSOC, V315, P1227, DOI 10.1001/jama.2016.2237; Wilson K, 2007, CAN MED ASSOC J, V176, P1681, DOI 10.1503/cmaj.070610	7	13	13	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					471	472		10.1001/jama.2016.19492	http://dx.doi.org/10.1001/jama.2016.19492			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28114657	Green Published			2022-12-28	WOS:000393564200011
J	Borden, JH				Borden, John H.			A retirement 'hobby'	SCIENCE			English	Editorial Material								After flunking out of undergraduate premed in 1957, spending 4 years growing up in the Marine Corps, returning to academic life, and falling in love with insects, I spent 37 happy years as a faculty member at a research-intensive university. When I turned 65 in 2003, I was shocked to face the looming doom of mandatory retirement. I still had my health and energy, and I wasn't ready for lawn bowling. I wanted to work. Hanging around the university was not an option; the department chair had already claimed my office. So, with some trepidation, I moved to industry. I'm now in my 14th year on the "dark side"-and it has been a great adventure.	[Borden, John H.] Simon Fraser Univ, Burnaby, BC, Canada; [Borden, John H.] Scotts Miracle Gro, Delta, BC, Canada	Simon Fraser University	Borden, JH (corresponding author), Simon Fraser Univ, Burnaby, BC, Canada.; Borden, JH (corresponding author), Scotts Miracle Gro, Delta, BC, Canada.	SciCareerEditor@aaas.org							0	0	0	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					542	542		10.1126/science.355.6324.542	http://dx.doi.org/10.1126/science.355.6324.542			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154083				2022-12-28	WOS:000393183100047
J	McCarthy, M				McCarthy, Michael			Travel ban threatens medical research and access to care in the US, medical groups warn	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Trump D, 2017, EXECUTIVE ORDER PROT	1	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2017	356								j545	10.1136/bmj.j545	http://dx.doi.org/10.1136/bmj.j545			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BP	28143900				2022-12-28	WOS:000393449700007
J	Fletcher, RJ; Lopes, R; Man, J; Navon, N; Smith, RP; Zwierlein, MW; Hadzibabic, Z				Fletcher, Richard J.; Lopes, Raphael; Man, Jay; Navon, Nir; Smith, Robert P.; Zwierlein, Martin W.; Hadzibabic, Zoran			QUANTUM GASES Two- and three-body contacts in the unitary Bose gas	SCIENCE			English	Article							SYSTEM	In many-body systems governed by pairwise contact interactions, a wide range of observables is linked by a single parameter, the two-body contact, which quantifies two-particle correlations. This profound insight has transformed our understanding of strongly interacting Fermi gases. Using Ramsey interferometry, we studied coherent evolution of the resonantly interacting Bose gas, and we show here that it cannot be explained by only pairwise correlations. Our experiments reveal the crucial role of three-body correlations arising from Efimov physics and provide a direct measurement of the associated three- body contact.	[Fletcher, Richard J.; Lopes, Raphael; Man, Jay; Navon, Nir; Smith, Robert P.; Hadzibabic, Zoran] Univ Cambridge, Cavendish Lab, J J Thomson Ave, Cambridge CB3 0HE, England; [Zwierlein, Martin W.] MIT, MIT Harvard Ctr Ultracold Atoms, Dept Phys, Cambridge, MA 02139 USA; [Zwierlein, Martin W.] MIT, Elect Res Lab, Cambridge, MA 02139 USA	University of Cambridge; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Fletcher, RJ (corresponding author), Univ Cambridge, Cavendish Lab, J J Thomson Ave, Cambridge CB3 0HE, England.	rfletch@mit.edu	Hadzibabic, Zoran/B-8102-2011; Lopes, Raphael/W-8139-2019; Smith, Robert P/A-1286-2014	Hadzibabic, Zoran/0000-0002-0118-9285; Lopes, Raphael/0000-0003-3877-8478; Smith, Robert P/0000-0002-6881-5690; Navon, Nir/0000-0002-8917-3463	U.K. Engineering and Physical Sciences Research Council [EP/N011759/1]; European Research Council (QBox); U.S. Army Research Office (ARO); U.S. Air Force Office of Scientific Research (AFOSR); Trinity College, Cambridge; Royal Society; European Union Marie Curie program [MSCA-IF-2015 704832]; AFOSR Multidisciplinary University Research Initiative on exotic quantum phases; U.S. NSF; ARO; EPSRC [EP/N011759/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/N011759/1, 1102563, 1492093] Funding Source: researchfish	U.K. Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council (QBox)(European Research Council (ERC)); U.S. Army Research Office (ARO); U.S. Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Trinity College, Cambridge; Royal Society(Royal Society of London); European Union Marie Curie program(European Commission); AFOSR Multidisciplinary University Research Initiative on exotic quantum phases; U.S. NSF(National Science Foundation (NSF)); ARO; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are indebted to E. Braaten for his crucial input toward the derivation of the numerical prefactors in Eq. 1 and a critical reading of the manuscript. We thank M. Robert de Saint Vincent for contributions in the early stages of the project, M. Sohmen for experimental assistance, and S. Kokkelmans, E. Cornell, D. Papoular, F. Werner, I. Bouchoule, I. Chuang, and J. Dalibard for helpful discussions. This work was supported by the U.K. Engineering and Physical Sciences Research Council (grant no. EP/N011759/1), the European Research Council (QBox), the U.S. Army Research Office (ARO), and the U.S. Air Force Office of Scientific Research (AFOSR). N.N. acknowledges support from Trinity College, Cambridge; R.P.S. from the Royal Society; R.L. from the European Union Marie Curie program (grant no. MSCA-IF-2015 704832); and M.W.Z. from the AFOSR Multidisciplinary University Research Initiative on exotic quantum phases, U.S. NSF, and ARO. Data supporting this publication are available for download at https://doi.org/10.17863/CAM.7184.	Barth M, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.062716; Baym G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.190407; Braaten E, 2013, J PHYS B-AT MOL OPT, V46, DOI 10.1088/0953-4075/46/21/215203; Braaten E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.153005; Braaten E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.223004; Campbell RLD, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.063611; Castin Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.223201; Cetina M, 2016, SCIENCE, V354, P96, DOI 10.1126/science.aaf5134; Chevy F, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/19/192001; Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; EFIMOV V, 1970, PHYS LETT B, VB 33, P563, DOI 10.1016/0370-2693(70)90349-7; Eismann U, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.021025; Ferlaino F, 2011, FEW-BODY SYST, V51, P113, DOI 10.1007/s00601-011-0260-7; Fletcher RJ, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.125303; Gaunt AL, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.200406; Hu MG, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.055301; Inguscio M., 2007, ULTRACOLD FERMI GASE; Jag M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.075302; Jorgensen NB, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.055302; Kokkelmans SJJMF, 1997, PHYS REV A, V56, pR4389, DOI 10.1103/PhysRevA.56.R4389; Kraemer T, 2006, NATURE, V440, P315, DOI 10.1038/nature04626; Li W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228702; Lysebo M, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.032702; Machtey O, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.210406; Makotyn P, 2014, NAT PHYS, V10, P116, DOI [10.1038/NPHYS2850, 10.1038/nphys2850]; Piatecki S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4503; Punk M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.170404; Rem BS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.163202; Roy S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.053202; Schneider W, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.021601; Smith DH, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.110402; Stoof HTC, 2014, J LOW TEMP PHYS, V174, P159, DOI 10.1007/s10909-013-0958-7; Tan S, 2008, ANN PHYS-NEW YORK, V323, P2952, DOI 10.1016/j.aop.2008.03.004; Werner F, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.053633; Wild RJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.145305; Zaccanti M, 2009, NAT PHYS, V5, P586, DOI 10.1038/NPHYS1334; Zwerger W., 2011, LECT NOTES PHYS, V836; Zwierlein M. W., 2014, NOVEL SUPERFLUIDS, V2	38	68	68	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					377	+		10.1126/science.aai8195	http://dx.doi.org/10.1126/science.aai8195			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126813	Green Submitted			2022-12-28	WOS:000393172800034
J	Terrer, C; Vicca, S; Hungate, BA; Phillips, RP; Reich, PB; Franklin, O; Stocker, BD; Fisher, JB; Prentice, IC				Terrer, Cesar; Vicca, Sara; Hungate, Bruce A.; Phillips, Richard P.; Reich, Peter B.; Franklin, Oskar; Stocker, Benjamin D.; Fisher, Joshua B.; Prentice, I. Colin			Response to Comment on "Mycorrhizal association as a primary control of the CO2 fertilization effect"	SCIENCE			English	Editorial Material							ELEVATED CO2; CARBON; TEMPERATURE; IMPACT; FUNGI	Norby et al. center their critique on the design of the data set and the response variable used. We address these criticisms and reinforce the conclusion that plants that associate with ectomycorrhizal fungi exhibit larger biomass and growth responses to elevated CO2 compared with plants that associate with arbuscular mycorrhizae.	[Terrer, Cesar; Stocker, Benjamin D.; Prentice, I. Colin] Imperial Coll London, Dept Life Sci, AXA Chair Programme Biosphere & Climate Impacts, Silwood Pk Campus,Buckhurst Rd, Ascot SL5 7PY, Berks, England; [Vicca, Sara] Univ Antwerp, Dept Biol, Ctr Excellence PLECO Plant & Vegetat Ecol, B-2610 Antwerp, Belgium; [Hungate, Bruce A.] No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA; [Hungate, Bruce A.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Phillips, Richard P.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2751, Australia; [Franklin, Oskar] Int Inst Appl Syst Anal, Ecosyst Serv & Management Program, Laxenburg, Austria; [Franklin, Oskar] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden; [Fisher, Joshua B.] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA; [Fisher, Joshua B.] Univ Calif Los Angeles, Joint Inst Reg Earth Syst Sci & Engn, Los Angeles, CA 90095 USA	Imperial College London; University of Antwerp; Northern Arizona University; Northern Arizona University; Indiana University System; Indiana University Bloomington; University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University; International Institute for Applied Systems Analysis (IIASA); Swedish University of Agricultural Sciences; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles	Terrer, C (corresponding author), Imperial Coll London, Dept Life Sci, AXA Chair Programme Biosphere & Climate Impacts, Silwood Pk Campus,Buckhurst Rd, Ascot SL5 7PY, Berks, England.	c.terrer@imperial.ac.uk	Terrer, Cesar/R-1103-2018; Phillips, Richard P/C-6429-2009; Vicca, Sara/I-3637-2012; Stocker, Benjamin David/K-3194-2015	Terrer, Cesar/0000-0002-5479-3486; Phillips, Richard P/0000-0002-1345-4138; Vicca, Sara/0000-0001-9812-5837; Stocker, Benjamin David/0000-0003-2697-9096; Reich, Peter/0000-0003-4424-662X; Prentice, Iain Colin/0000-0002-1296-6764; Franklin, Oskar/0000-0002-0376-4140	Imperial College Ph.D. studentship; International Institute for Applied System Analysis (IIASA); Climate Change Manipulation Experiments in Terrestrial Ecosystems (ClimMani) European Cooperation in Science and Technology (COST) Action [ES1308]; NSF (Ecosystem Studies Program) [1153401]; DOE (Environmental System Science Program); Royal Netherlands Academy of Arts and Sciences; DOE; INTERFACE; New Phytologist trust; European Research Council [ERC-SyG-610028 IMBALANCE-P]; Swiss National Science Foundation; Direct For Biological Sciences [1242531] Funding Source: National Science Foundation	Imperial College Ph.D. studentship; International Institute for Applied System Analysis (IIASA); Climate Change Manipulation Experiments in Terrestrial Ecosystems (ClimMani) European Cooperation in Science and Technology (COST) Action; NSF (Ecosystem Studies Program)(National Science Foundation (NSF)); DOE (Environmental System Science Program)(United States Department of Energy (DOE)); Royal Netherlands Academy of Arts and Sciences; DOE(United States Department of Energy (DOE)); INTERFACE; New Phytologist trust; European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank D. Blumenthal, M. Hovenden, A. Talhelm, A. Finzi, P. Newton, N. Chiariello, C. Kammann, C. Muller, C. Field, and M. Schneider, who provided data and advice. This research is a contribution to the Imperial College initiative Grand Challenges in Ecosystems and the Environment and the AXA Chair Programme in Biosphere and Climate Impacts. C.T. was supported by an Imperial College Ph.D. studentship within this program and the International Institute for Applied System Analysis (IIASA). S.V. is a postdoctoral fellow of the Research Foundation-Flanders (FWO). C.T. and S.V. acknowledge support from Climate Change Manipulation Experiments in Terrestrial Ecosystems (ClimMani) European Cooperation in Science and Technology (COST) Action (ES1308). R.P.P. acknowledges support from NSF (Ecosystem Studies Program 1153401) and DOE (Environmental System Science Program). R.P.P. and C.T. thank the Royal Netherlands Academy of Arts and Sciences, DOE, INTERFACE, and the New Phytologist trust for funding the workshop "Climate models revisited: The biogeochemical consequences of mycorrhizal dynamics." S.V. and O.F. acknowledge support from the European Research Council grant ERC-SyG-610028 IMBALANCE-P. Part of J.B.F.'s contribution was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration. B.D.S. is funded by the Swiss National Science Foundation. All authors contributed to the development of the conceptual framework and to the writing of this Response.	Fisher JB, 2016, GLOBAL CHANGE BIOL, V22, P2596, DOI 10.1111/gcb.13264; Fisher JB, 2014, ANNU REV ENV RESOUR, V39, P91, DOI 10.1146/annurev-environ-012913-093456; Hobbie EA, 2006, ECOLOGY, V87, P563, DOI 10.1890/05-0755; Hyvonen R, 2007, NEW PHYTOL, V173, P463, DOI 10.1111/j.1469-8137.2007.01967.x; Lin GG, 2017, NEW PHYTOL, V213, P1440, DOI 10.1111/nph.14206; Norby RJ, 2017, SCIENCE, V355, DOI 10.1126/science.aai7976; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Shi M, 2016, GLOBAL CHANGE BIOL, V22, P1299, DOI 10.1111/gcb.13131; Sigurdsson BD, 2013, TREE PHYSIOL, V33, P1192, DOI 10.1093/treephys/tpt043; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sulman BN, 2014, NAT CLIM CHANGE, V4, P1099, DOI [10.1038/nclimate2436, 10.1038/NCLIMATE2436]; Talbot JM, 2015, SOIL BIOL BIOCHEM, V88, P441, DOI 10.1016/j.soilbio.2015.05.006; Terrer C, 2016, SCIENCE, V353, P72, DOI 10.1126/science.aaf4610; Vicca S, 2012, ECOL LETT, V15, P520, DOI 10.1111/j.1461-0248.2012.01775.x; Warren JM, 2015, NEW PHYTOL, V205, P59, DOI 10.1111/nph.13034	17	3	6	6	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323								10.1126/science.aai8242	http://dx.doi.org/10.1126/science.aai8242			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4FR	28126782	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000393172800029
J	Lowe, E; Patil, S				Lowe, Emily; Patil, Sachin			SPOT DIAGNOSIS Management of subacute airway emergency after blunt neck trauma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lowe, Emily; Patil, Sachin] Southampton Gen Hosp, Southampton, Hants, England	University of Southampton	Lowe, E (corresponding author), Southampton Gen Hosp, Southampton, Hants, England.	emily.lowe@doctors.org.uk						Chiti-Batelli S, 2005, ACTA OTO-LARYNGOL, V125, P443, DOI 10.1080/00016480410017233; Findlay JM, 2013, INTERACT CARDIOV TH, V17, P179, DOI 10.1093/icvts/ivt118; Singh Arvind, 2008, J Med Case Rep, V2, P8, DOI 10.1186/1752-1947-2-8; Srivastava Seema, 2008, Cases J, V1, P294, DOI 10.1186/1757-1626-1-294	4	0	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2017	356								j141	10.1136/bmj.j141	http://dx.doi.org/10.1136/bmj.j141			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HS	28126713				2022-12-28	WOS:000393178100003
J	Nalla, P; Dacruz, TA; Obuobie, K				Nalla, Preethi; Dacruz, Thomas Alexander; Obuobie, Kofi			CASE REVIEW Tiredness in a patient treated with itraconazole	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nalla, Preethi] Univ Wales Hosp, Diabet & Endocrinol, Cardiff, S Glam, Wales; [Dacruz, Thomas Alexander] Univ Wales Hosp, Diabet Endocrinol, Cardiff, S Glam, Wales; [Obuobie, Kofi] Royal Gwent Hosp, Diabet & Endocrinol, Newport, Gwent, Wales	Cardiff University; Cardiff University; Royal Gwent Hospital	Nalla, P (corresponding author), Univ Wales Hosp, Diabet & Endocrinol, Cardiff, S Glam, Wales.	preethin_nalla@yahoo.com						Albert Benjamin B, 2015, J Cyst Fibros, V14, pe9, DOI 10.1016/j.jcf.2014.09.007; Bondugulapati LNR, 2016, CLIN ENDOCRINOL, V85, P165, DOI 10.1111/cen.13073; Charmandari E, 2014, LANCET, V383, P2152, DOI 10.1016/S0140-6736(13)61684-0; Clinical Knowledge Summaries, ADD S DIS; Gilchrist FJ, 2013, J CYST FIBROS, V12, P399, DOI 10.1016/j.jcf.2012.10.007; Howlett Wass J., SURG GUIDELINES ADDI; Howlett Wass J., CARING PATIENT ADDIS; Husebye ES, 2014, J INTERN MED, V275, P104, DOI 10.1111/joim.12162; Lapi F, 2013, EUR RESPIR J, V42, P79, DOI 10.1183/09031936.00080912; Molimard M, 2008, DRUG SAFETY, V31, P769, DOI 10.2165/00002018-200831090-00005; Mortimer KJ, 2006, THORAX, V61, P405, DOI 10.1136/thx.2005.052456; Vaidya B, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2385; Venkatakrishnan K, 2000, CLIN PHARMACOKINET, V38, P111, DOI 10.2165/00003088-200038020-00002; Woods DR, 2006, BMJ-BRIT MED J, V332, P469, DOI 10.1136/bmj.332.7539.469	14	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2017	356								i6819	10.1136/bmj.i6819	http://dx.doi.org/10.1136/bmj.i6819			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HS	28126837				2022-12-28	WOS:000393178100002
J	Picco, A; Irastorza-Azcarate, I; Specht, T; Boke, D; Pazos, I; Rivier-Cordey, AS; Devos, DP; Kaksonen, M; Gallego, O				Picco, Andrea; Irastorza-Azcarate, Ibai; Specht, Tanja; Boeke, Dominik; Pazos, Irene; Rivier-Cordey, Anne-Sophie; Devos, Damien P.; Kaksonen, Marko; Gallego, Oriol			The In Vivo Architecture of the Exocyst Provides Structural Basis for Exocytosis	CELL			English	Article							PROTEIN HOMOLOGY DETECTION; MOLECULAR ARCHITECTURE; SECRETORY VESICLES; PLASMA-MEMBRANE; SEC6/8 COMPLEX; YEAST; RESOLUTION; IDENTIFICATION; LOCALIZATION; ENDOCYTOSIS	The structural characterization of protein complexes in their native environment is challenging but crucial for understanding the mechanisms that mediate cellular processes. We developed an integrative approach to reconstruct the 3D architecture of protein complexes in vivo. We applied this approach to the exocyst, a hetero-octameric complex of unknown structure that is thought to tether secretory vesicles during exocytosis with a poorly understood mechanism. We engineered yeast cells to anchor the exocyst on defined landmarks and determined the position of its subunit termini at nanometer precision using fluorescence microscopy. We then integrated these positions with the structural properties of the subunits to reconstruct the exocyst together with a vesicle bound to it. The exocyst has an open hand conformation made of rod-shaped subunits that are interlaced in the core. The exocyst architecture explains how the complex can tether secretory vesicles, placing them in direct contact with the plasma membrane.	[Picco, Andrea; Specht, Tanja; Boeke, Dominik; Kaksonen, Marko] EMBL, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Irastorza-Azcarate, Ibai; Devos, Damien P.] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany; [Irastorza-Azcarate, Ibai; Devos, Damien P.] Univ Pablo de Olavide, CSIC, CABD, Carretera Utrera Km1, Seville 41013, Spain; [Pazos, Irene; Gallego, Oriol] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, C Baldiri Reixac 10, Barcelona 08028, Spain; [Picco, Andrea; Rivier-Cordey, Anne-Sophie; Kaksonen, Marko] Univ Geneva, Dept Biochem, Quai Ernest Ansermet 30, CH-1211 Geneva, Switzerland; [Picco, Andrea; Rivier-Cordey, Anne-Sophie; Kaksonen, Marko] Univ Geneva, NCCR Chem Biol, Quai Ernest Ansermet 30, CH-1211 Geneva, Switzerland	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Geneva; University of Geneva	Kaksonen, M (corresponding author), EMBL, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.; Devos, DP (corresponding author), Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany.; Devos, DP (corresponding author), Univ Pablo de Olavide, CSIC, CABD, Carretera Utrera Km1, Seville 41013, Spain.; Gallego, O (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, C Baldiri Reixac 10, Barcelona 08028, Spain.; Kaksonen, M (corresponding author), Univ Geneva, Dept Biochem, Quai Ernest Ansermet 30, CH-1211 Geneva, Switzerland.; Kaksonen, M (corresponding author), Univ Geneva, NCCR Chem Biol, Quai Ernest Ansermet 30, CH-1211 Geneva, Switzerland.	damienpdevos@gmail.com; marko.kaksonen@unige.ch; oriol.gallego@irbbarcelona.org	Gallego, Oriol/R-9559-2018; devos, damien/ABH-5348-2020; Gallego, Oriol/S-2933-2019; Picco, Andrea/AAG-5023-2019; Irastorza, Ibai/ABI-7349-2020	Gallego, Oriol/0000-0001-7479-2563; Gallego, Oriol/0000-0001-7479-2563; Irastorza, Ibai/0000-0001-5245-2322; Kaksonen, Marko/0000-0003-3645-7689; Picco, Andrea/0000-0003-2548-9183; Devos, Damien/0000-0002-9453-4753	Ramon y Cajal program [RYC-2011-07967]; MINECO [BFU2012-36385]; Severo Ochoa Award of Excellence from MINECO (Government of Spain); EIPOD fellowship; Swiss National Science Foundation grant [31003A_163267]; Junta de Andalucia, Captacion del Conocimiento para Andalucia (C2A) program	Ramon y Cajal program(Spanish Government); MINECO(Spanish Government); Severo Ochoa Award of Excellence from MINECO (Government of Spain)(Spanish Government); EIPOD fellowship; Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF)); Junta de Andalucia, Captacion del Conocimiento para Andalucia (C2A) program(Junta de Andalucia)	We thank Carlos Fernandez-Tornero, Christoph W. Muller, Maya Topf, Raul Mendez, Ignasi Fita, Ori Avinoam, Camilla Godlee, Wanda Kukulski, Bernd Klaus and Wolfgang Huber for critical discussions. Anne-Claude Gavin, Arun Kumar, Marc Abella, Nereida Jimenez, Amy J. Curwin, and Michael Knop for expert help and the sharing of reagents. O.G. was funded by the Ramon y Cajal program (RYC-2011-07967) and a grant from MINECO (BFU2012-36385). IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain). A.P. acknowledges an EIPOD fellowship and M.K. the Swiss National Science Foundation grant (31003A_163267) and NCCR Chemical Biology. D.P.D. and I.I.-A. are financed by the Junta de Andalucia, Captacion del Conocimiento para Andalucia (C2A) program.	Aravamudhan P, 2014, CURR BIOL, V24, P1437, DOI 10.1016/j.cub.2014.05.014; Boeke D, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145422; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Churchman LS, 2006, BIOPHYS J, V90, P668, DOI 10.1529/biophysj.105.065599; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Clark AG, 2013, BIOPHYS J, V105, P570, DOI 10.1016/j.bpj.2013.05.057; Croteau NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004443; Dacks JB, 2008, P NATL ACAD SCI USA, V105, P588, DOI 10.1073/pnas.0707318105; Dong G, 2005, NAT STRUCT MOL BIOL, V12, P1094, DOI 10.1038/nsmb1017; Donovan KW, 2015, J CELL BIOL, V210, P181, DOI 10.1083/jcb.201501118; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dubuke M.L., 2015, J BIOL CHEM; Erzberger JP, 2014, CELL, V158, P1123, DOI 10.1016/j.cell.2014.07.044; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Fogelgren B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001361; Fotso P, 2005, J BIOL CHEM, V280, P27613, DOI 10.1074/jbc.M504597200; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gallego O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062195; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Ha JY, 2016, NAT STRUCT MOL BIOL, V23, P758, DOI 10.1038/nsmb.3263; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; Hartley D.A., 1993, CELLULAR INTERACTION; He B, 2007, J CELL BIOL, V176, P771, DOI 10.1083/jcb.200606134; Heider MR, 2016, NAT STRUCT MOL BIOL, V23, P59, DOI 10.1038/nsmb.3146; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Joglekar AP, 2009, CURR BIOL, V19, P694, DOI 10.1016/j.cub.2009.02.056; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Khmelinskii A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023794; Kukulski W, 2012, CELL, V150, P508, DOI 10.1016/j.cell.2012.05.046; Luo GZ, 2013, J CELL BIOL, V202, P97, DOI 10.1083/jcb.201211093; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Matern HT, 2001, P NATL ACAD SCI USA, V98, P9648, DOI 10.1073/pnas.171317898; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Picco A, 2015, ELIFE, V4, DOI 10.7554/eLife.04535; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Roth D, 1998, MOL BIOL CELL, V9, P1725, DOI 10.1091/mbc.9.7.1725; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saffarian S, 2008, BIOPHYS J, V94, P2333, DOI 10.1529/biophysj.107.117234; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schneidman-Duhovny D, 2014, CURR OPIN STRUC BIOL, V28, P96, DOI 10.1016/j.sbi.2014.08.001; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Shen MY, 2005, CHEM PHYS LETT, V405, P224, DOI 10.1016/j.cplett.2005.02.029; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Skruzny M, 2012, P NATL ACAD SCI USA, V109, pE2533, DOI 10.1073/pnas.1207011109; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Teodoro RO, 2013, EMBO J, V32, P2039, DOI 10.1038/emboj.2013.147; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; WALWORTH NC, 1987, J CELL BIOL, V105, P163, DOI 10.1083/jcb.105.1.163; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wiederkehr A, 2004, J CELL BIOL, V167, P875, DOI 10.1083/jcb.200408001; Yamamoto A, 2013, J CANCER RES CLIN, V139, P533, DOI 10.1007/s00432-012-1356-2; Yamashita M, 2010, NAT STRUCT MOL BIOL, V17, P180, DOI 10.1038/nsmb.1722; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	68	47	47	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					400	+		10.1016/j.cell.2017.01.004	http://dx.doi.org/10.1016/j.cell.2017.01.004			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28129539	Bronze, Green Published			2022-12-28	WOS:000396249600010
J	Rubinstein, JL				Rubinstein, John L.			Cryo-EM Captures the Dynamics of Ion Channel Opening	CELL			English	Editorial Material								In this issue of Cell, Hite and MacKinnon (2017) report the open conformation structure of Slo2.2, a neuronal Na+-activated K+ channel. More importantly, 3D classification of electron cryomicroscopy (cryo-EM) images allows visualization of the structural transition that occurs as the open probability of individual channels increases with added sodium.	[Rubinstein, John L.] Hosp Sick Children, Mol Struct & Funct Program, Toronto, ON M5G 0A4, Canada; [Rubinstein, John L.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Rubinstein, John L.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Rubinstein, JL (corresponding author), Hosp Sick Children, Mol Struct & Funct Program, Toronto, ON M5G 0A4, Canada.; Rubinstein, JL (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.; Rubinstein, JL (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada.	john.rubinstein@utoronto.ca		Rubinstein, John/0000-0003-0566-2209				Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Fernandez IS, 2013, SCIENCE, V342, P824, DOI 10.1126/science.1240585; Hite RK, 2017, CELL, V168, P390, DOI 10.1016/j.cell.2016.12.030; Hite RK, 2015, NATURE, V527, P198, DOI 10.1038/nature14958; Huang R, 2016, P NATL ACAD SCI USA, V113, pE4190, DOI 10.1073/pnas.1603980113; Khoshouei M., 2016, BIORXIV; Razinkov I, 2016, J STRUCT BIOL, V195, P190, DOI 10.1016/j.jsb.2016.06.001; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365	8	7	8	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					341	343		10.1016/j.cell.2017.01.011	http://dx.doi.org/10.1016/j.cell.2017.01.011			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28129535	Bronze			2022-12-28	WOS:000396249600005
J	Szewczak, L; Green, R; Macrae, I; Mayr, C				Szewczak, Lara; Green, Rachel; Macrae, Ian; Mayr, Christine			The Long Tail of mRNA Regulation	CELL			English	Editorial Material								Long stretches of RNA trail after the coding region in most eukaryotic mRNAs. These 3' untranslated regions (3' UTRs) hold the key for many aspects of regulated gene expression, influencing mRNA stability, protein synthesis, and ultimately protein function. Lara Szewczak asked Rachel Green, Ian Macrae, and Christine Mayr about how dynamic regulation by proteins and microRNAs works within 3' UTRs. An annotated excerpt of the conversation appears below, and the full conversation is available with the article online.											0	2	2	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					335	338						4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28129533	Bronze			2022-12-28	WOS:000396249600003
J	Maraka, S; Mwangi, R; McCoy, RG; Yao, XX; Sangaralingham, LR; Ospina, NMS; O'Keeffe, DT; De Ycaza, AEE; Rodriguez-Gutierrez, R; Coddington, CC; Stan, MN; Brito, JP; Montori, VM				Maraka, Spyridoula; Mwangi, Raphael; McCoy, Rozalina G.; Yao, Xiaoxi; Sangaralingham, Lindsey R.; Ospina, Naykky M. Singh; O'Keeffe, Derek T.; De Ycaza, Ana E. Espinosa; Rodriguez-Gutierrez, Rene; Coddington, Charles C.; Stan, Marius N.; Brito, Juan P.; Montori, Victor M.			Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MANAGEMENT; GUIDELINES; ASSOCIATION; DYSFUNCTION; MISCARRIAGE; ADHERENCE; DIAGNOSIS; OUTCOMES; THERAPY; DISEASE	OBJECTIVE To estimate the effectiveness and safety of thyroid hormone treatment among pregnant women with subclinical hypothyroidism. DESIGN Retrospective cohort study. SETTING Large US administrative database between 1 January 2010 and 31 December 2014. PARTICIPANTS 5405 pregnant women with subclinical hypothyroidism, defined as untreated thyroid stimulating hormone (TSH) concentration 2.5-10 mIU/L. EXPOSURE Thyroid hormone therapy. MAIN OUTCOME MEASURE Pregnancy loss and other pre-specified maternal and fetal pregnancy related adverse outcomes. RESULTS Among 5405 pregnant women with subclinical hypothyroidism, 843 with a mean pre-treatment TSH concentration of 4.8 (SD 1.7) mIU/L were treated with thyroid hormone and 4562 with a mean baseline TSH concentration of 3.3 (SD 0.9) mIU/L were not treated (P< 0.01). Compared with the untreated group, treated women had lower adjusted odds of pregnancy loss (odds ratio 0.62, 95% confidence interval 0.48 to 0.82) but higher odds of preterm delivery (1.60, 1.14 to 2.24), gestational diabetes (1.37, 1.05 to 1.79), and pre-eclampsia (1.61, 1.10 to 2.37); other pregnancy related adverse outcomes were similar between the two groups. The adjusted odds of pregnancy loss were lower in treated women than in untreated women if their pre-treatment TSH concentration was 4.1-10 mIU/L (odds ratio 0.45, 0.30 to 0.65) but not if it was 2.5-4.0 mIU/L (0.91, 0.65 to 1.23) (P< 0.01). CONCLUSION Thyroid hormone treatment was associated with decreased risk of pregnancy loss among women with subclinical hypothyroidism, especially those with pre-treatment TSH concentrations of 4.1-10 mIU/L. However, the increased risk of other pregnancy related adverse outcomes calls for additional studies evaluating the safety of thyroid hormone treatment in this patient population.	[Maraka, Spyridoula] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Div Endocrinol & Metab, Little Rock, AR 72205 USA; [Maraka, Spyridoula] Cent Arkansas Vet Hlth Care Syst, Little Rock, AR 72205 USA; [Maraka, Spyridoula; Ospina, Naykky M. Singh; Rodriguez-Gutierrez, Rene; Brito, Juan P.; Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit Endocrinol KER Endo, Rochester, MN 55905 USA; [Mwangi, Raphael; McCoy, Rozalina G.; Yao, Xiaoxi; Sangaralingham, Lindsey R.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA; [McCoy, Rozalina G.] Mayo Clin, Dept Med, Div Primary Care Internal Med, Rochester, MN 55905 USA; [Yao, Xiaoxi] Mayo Clin, Div Hlth Care Policy & Res, Dept Hlth Serv Res, Rochester, MN 55905 USA; [Sangaralingham, Lindsey R.] Optum Labs, Cambridge, MA 02142 USA; [Ospina, Naykky M. Singh] Univ Florida, Dept Med, Div Endocrinol, Gainesville, FL 32610 USA; [O'Keeffe, Derek T.] Natl Univ Ireland, Div Endocrinol, Dept Med, Galway, Ireland; [O'Keeffe, Derek T.; De Ycaza, Ana E. Espinosa; Stan, Marius N.; Brito, Juan P.; Montori, Victor M.] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA; [Rodriguez-Gutierrez, Rene] Autonomous Univ Nuevo Leon, Univ Hosp Dr Jose E Gonzalez, Dept Internal Med, Div Endocrinol, Monterrey 64460, Mexico; [Coddington, Charles C.] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN 55905 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Optum; State University System of Florida; University of Florida; Ollscoil na Gaillimhe-University of Galway; Mayo Clinic; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Mayo Clinic	McCoy, RG (corresponding author), Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA.; McCoy, RG (corresponding author), Mayo Clin, Dept Med, Div Primary Care Internal Med, Rochester, MN 55905 USA.	mccoy.rozalina@mayo.edu		Maraka, Spyridoula/0000-0001-7259-132X; Montori, Victor/0000-0003-0595-2898; O'Keeffe, Derek/0000-0001-8501-2382; Stan, Marius/0000-0002-1408-8125; Yao, Xiaoxi/0000-0001-9906-7106	Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery	Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery	This study was funded by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. The funders had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Aguayo A, 2013, J TRACE ELEM MED BIO, V27, P302, DOI 10.1016/j.jtemb.2013.07.002; Blatt AJ, 2012, J CLIN ENDOCR METAB, V97, P777, DOI 10.1210/jc.2011-2038; Briesacher BA, 2008, PHARMACOTHERAPY, V28, P437, DOI 10.1592/phco.28.4.437; Center for Disease Control and Prevention, 2015, BIRTH DAT; Chan S, 2015, CLIN ENDOCRINOL, V82, P313, DOI 10.1111/cen.12605; Dashe JS, 2005, OBSTET GYNECOL, V106, P753, DOI 10.1097/01.AOG.0000175836.41390.73; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Haymart MR, 2010, THYROID, V20, P301, DOI 10.1089/thy.2009.0321; Hershman DL, 2015, J CLIN ONCOL, V33, P1053, DOI 10.1200/JCO.2014.58.3062; Lazarus J, 2014, EUR THYROID J, V3, P76, DOI 10.1159/000362597; Liu HX, 2014, THYROID, V24, P1642, DOI 10.1089/thy.2014.0029; Maraka S, 2016, THYROID, V26, P980, DOI 10.1089/thy.2016.0014; Maraka S, 2016, THYROID, V26, P580, DOI 10.1089/thy.2015.0418; Maraka S, 2015, JAMA INTERN MED, V175, P1088, DOI 10.1001/jamainternmed.2015.1348; MARUO T, 1991, ACTA ENDOCRINOL-COP, V125, P58, DOI 10.1530/acta.0.1250058; NEGRO R, 2014, BMJ-BRIT MED J, V349, pG4929, DOI DOI 10.1136/BMJ.G4929; Negro R, 2010, J CLIN ENDOCR METAB, V95, P1699, DOI 10.1210/jc.2009-2009; Ospina NS, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0435-z; Rodriguez-Gutierrez R, 2016, LANCET DIABETES ENDO, V4, P706, DOI 10.1016/S2213-8587(15)00468-4; Sheehan PM, 2015, J CLIN ENDOCR METAB, V100, P4325, DOI 10.1210/jc.2015-3074; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; STIRRAT GM, 1990, LANCET, V336, P673, DOI 10.1016/0140-6736(90)92159-F; Vaidya B, 2012, EUR J ENDOCRINOL, V166, P49, DOI 10.1530/EJE-11-0729; Wallace PJ, 2014, HEALTH AFFAIR, V33, P1187, DOI 10.1377/hlthaff.2014.0038; Wang S, 2012, J ENDOCRINOL INVEST, V35, P322, DOI 10.3275/7772	26	73	84	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2017	356								i6865	10.1136/bmj.i6865	http://dx.doi.org/10.1136/bmj.i6865			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HO	28122781	Green Published, hybrid			2022-12-28	WOS:000393177700003
J	Avorn, J				Avorn, Jerry			Academic Detailing "Marketing" the Best Evidence to Clinicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONTROLLED-TRIAL		[Avorn, Jerry] Harvard Med Sch, Boston, MA USA; [Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Harvard Med Sch, Boston, MA USA.; Avorn, J (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.	avorn@post.harvard.edu						AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; AVORN J, 1992, NEW ENGL J MED, V327, P168, DOI 10.1056/NEJM199207163270306; Avorn J, 2015, NEW ENGL J MED, V373, P967, DOI 10.1056/NEJMhle1506365; Dreischulte T, 2016, NEW ENGL J MED, V374, P1053, DOI 10.1056/NEJMsa1508955; Fischer MA, 2012, HEALTH AFFAIR, V31, P2206, DOI 10.1377/hlthaff.2012.0817; Kesselheim AS, JAMA-J AM MED ASSOC, DOI [10.1001/jama/2016.20640, DOI 10.1001/JAMA/2016.20640]; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; SCHAFFNER W, 1983, JAMA-J AM MED ASSOC, V250, P1728, DOI 10.1001/jama.250.13.1728; Solomon DH, 2001, ARCH INTERN MED, V161, P1897, DOI 10.1001/archinte.161.15.1897; SOUMERAI SB, 1986, MED CARE, V24, P313, DOI 10.1097/00005650-198604000-00003	10	56	58	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					361	362		10.1001/jama.2016.16036	http://dx.doi.org/10.1001/jama.2016.16036			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118458				2022-12-28	WOS:000392509600015
J	Podolsky, SH				Podolsky, Scott H.			Historical Perspective on the Rise and Fall and Rise of Antibiotics and Human Weight Gain	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SEVERE ACUTE MALNUTRITION; GUT MICROBIOTA; OBESITY; PROBIOTICS; GROWTH; LIFE; AMOXICILLIN; INCREASES; CHILDREN	In recent medical and popular literature, audiences have been asked to consider whether antibiotics have contributed to the rising obesity epidemic. Prominent magazines have stated that weight may be adversely affected by antibiotics that destroy existing microbiomes and replace them with less helpful ones. However, there is a long history of efforts to investigate the relationship between antibiotics and human weight gain. In the early 1950s, amid initial findings that low doses of antibiotics served as growth promoters in animal livestock, investigators explored the role of antibiotics as magic bullets for human malnutrition. Nevertheless, early enthusiasm was tempered by controlled studies showing that antibiotics did not serve as useful, nonspecific growth promoters for humans. In subsequent decades, against the backdrop of rising concern over antibiotic resistance, investigators studying the role of antibiotics in acute malnutrition have had to navigate a more complicated public health calculus. In a related historical stream, scientists since the 1910s have explored the role of the intestinal microflora in human health. By the 2000s, as increasing resources and more sophisticated tools were devoted to understanding the microbiome (a term coined in 2001), attention would turn to the role of antibiotics and the intestinal microflora in the rising obesity epidemic. Despite scientific and commercial enthusiasm, easy answers (whether about antibiotics or probiotics) have again given way to an appreciation for the complexity of human growth. History encourages caution about our hopes for simplistic answers for presumed "fat drugs" and slimming probiotics alike.	[Podolsky, Scott H.] Harvard Med Sch, 641 Huntington Ave, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Podolsky, SH (corresponding author), Harvard Med Sch, 641 Huntington Ave, Boston, MA 02115 USA.	scott_podolsky@hms.harvard.edu						Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Angelakis E, 2013, LANCET INFECT DIS, V13, P889, DOI 10.1016/S1473-3099(13)70179-8; [Anonymous], 1954, J AGR FOOD CHEM, V2, P1148; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Blanton LV, 2016, SCIENCE, V352, DOI 10.1126/science.aad9359; Blaser MJ, 2014, MISSING MICROBES OVE; Bud Robert, 2007, PENICILLIN TRIUMPH T; Cox LM, 2015, NAT REV ENDOCRINOL, V11, P182, DOI 10.1038/nrendo.2014.210; Davies J, 2001, SCIENCE, V291, P2316; Dubos R, 1985, MAN ADAPTING; FAO, 2001, EV HLTH NUTR PROP PR; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Gerber JS, 2016, JAMA-J AM MED ASSOC, V315, P1258, DOI 10.1001/jama.2016.2395; Gough EK, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2267; GUZMAN MA, 1958, AM J CLIN NUTR, V6, P430, DOI 10.1093/ajcn/6.4.430; HAIGHT TH, 1955, J NUTR, V56, P151; Hamblin J, 2015, ATLANTIC; Harley ITW, 2012, MOL METAB, V1, P21, DOI 10.1016/j.molmet.2012.07.002; Heid M, 2013, CAN PROBIOTICS HELP; Isanaka S, 2016, NEW ENGL J MED, V374, P444, DOI 10.1056/NEJMoa1507024; Jukes TH, 1955, ANTIBIOTICS NUTR; Kaempffert W, 1951, NY TIMES, pB9; Kendall AI, 1916, BACTERIOLOGY GEN PAT; Kennedy P., 2014, NY TIMES; Kirchhelle C, 2015, THESIS; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; Lederberg J, 2001, SCIENTIST, V15, P8; Lederberg J, 2001, BROOKLYN LAW REV, V67, P7; Lederberg J, 1967, COMMUNICATION; Lederberg J., 1992, I MED US COMMITTEE; Levenson M., 1951, NY TIMES, P27; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; LILLY DM, 1965, SCIENCE, V147, P747, DOI 10.1126/science.147.3659.747; LOUGHLIN E H, 1957, Antibiot Annu, V5, P99; LUCKEY TD, 1977, AM J CLIN NUTR, V30, P1753; Luckey TD, 1959, ANTIBIOTICS THEIR CH, P174; MACDOUGALL L G, 1957, J Trop Pediatr (Lond), V3, P74; MACKAY IFS, 1956, J NUTR, V59, P155, DOI 10.1093/jn/59.1.155; Metchnikoff E., 1908, PROLONGATION LIFE OP; Million M, 2013, CLIN MICROBIOL INFEC, V19, P305, DOI 10.1111/1469-0691.12172; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Osterberg KL, 2015, OBESITY, V23, P2364, DOI 10.1002/oby.21230; Park A., 2015, TIME; PERRINI F, 1951, Boll Soc Ital Biol Sper, V27, P1151; Podolsky S, 1998, B HIST MED, V72, P1, DOI 10.1353/bhm.1998.0056; Podolsky SH, 2012, LANCET, V380, P1810, DOI 10.1016/S0140-6736(12)62018-2; Podolsky SH, 2015, ANTIBIOTIC ERA: REFORM, RESISTANCE, AND THE PURSUIT OF A RATIONAL THERAPEUTICS, P1; Raoult D, 2008, EUR J CLIN MICROBIOL, V27, P631, DOI 10.1007/s10096-008-0490-x; Rawson TM, 2016, NEW ENGL J MED, V375, P190, DOI 10.1056/NEJMc1605388; Rettger LF, 1921, TREATISE TRANSFORMAT; ROBINSON P, 1952, LANCET, V262, P52; ROSENBERG IH, 1974, AM J CLIN NUTR, V27, P304, DOI 10.1093/ajcn/27.3.304; Sangodeyi F.I., 2014, THESIS HARVARD U; Schwartz BS, 2016, INT J OBESITY, V40, P615, DOI 10.1038/ijo.2015.218; Scott FI, 2016, GASTROENTEROLOGY, V151, P120, DOI 10.1053/j.gastro.2016.03.006; Scrimshaw N.S., 1953, NUTRITION S SERIES, V7, P101; Scrimshaw NS, 2010, J NUTR, V140, P394, DOI 10.3945/jn.109.114694; Scrimshaw NS, 1968, INTERACTIONS NUTR IN; Sifferlin A, 2015, TIME; SNELLING CE, 1952, CAN MED ASSOC J, V66, P6; Squibb RL, 1956, P 1 INT C US ANT AGR, P268; Stanton C, 2001, AM J CLIN NUTR, V73, p476S, DOI 10.1093/ajcn/73.2.476s; STOKSTAD ELR, 1949, J BIOL CHEM, V180, P647; STOKSTAD ELR, 1950, P SOC EXP BIOL MED, V73, P523, DOI 10.3181/00379727-73-17731; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tappan J., 2013, GLOBAL HLTH AFRICA H, P92; Ternak G, 2005, MED HYPOTHESES, V64, P14, DOI 10.1016/j.mehy.2004.08.003; Trehan I, 2013, NEW ENGL J MED, V368, P425, DOI 10.1056/NEJMoa1202851; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414	72	14	14	1	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					133	+		10.7326/M16-1855	http://dx.doi.org/10.7326/M16-1855			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	28114473				2022-12-28	WOS:000391842600018
J	Ware, RE; de Montalembert, M; Tshilolo, L; Abboud, MR				Ware, Russell E.; de Montalembert, Mariane; Tshilolo, Leon; Abboud, Miguel R.			Sickle cell disease	LANCET			English	Review							TRANSFUSION-TRANSMITTED INFECTIONS; SUB-SAHARAN AFRICA; TRANSCRANIAL DOPPLER; PULMONARY-HYPERTENSION; FETAL-HEMOGLOBIN; YOUNG-CHILDREN; PHASE-II; MARROW-TRANSPLANTATION; ERYTHROCYTE SURVIVAL; IRON CONCENTRATION	Sickle cell disease is a common and life-threatening haematological disorder that affects millions of people worldwide. Abnormal sickle-shaped erythrocytes disrupt blood flow in small vessels, and this vaso-occlusion leads to distal tissue ischaemia and inflammation, with symptoms defining the acute painful sickle-cell crisis. Repeated sickling and ongoing haemolytic anaemia, even when subclinical, lead to parenchymal injury and chronic organ damage, causing substantial morbidity and early mortality. Currently available treatments are limited to transfusions and hydroxycarbamide, although stem cell transplantation might be a potentially curative therapy. Several new therapeutic options are in development, including gene therapy and gene editing. Recent advances include systematic universal screening for stroke risk, improved management of iron overload using oral chelators and non-invasive MRI measurements, and point-of-care diagnostic devices. Controversies include the role of haemolysis in sickle cell disease pathophysiology, optimal management of pregnancy, and strategies to prevent cerebrovascular disease.	[Ware, Russell E.] Cincinnati Childrens Hosp Med Ctr, Div Hematol, Dept Pediat, Cincinnati, OH 45229 USA; [de Montalembert, Mariane] Hop Necker Enfants Malad, Dept Pediat, LABEX GR Ex, Paris, France; [Tshilolo, Leon] Ctr Hosp Monkole, Kinshasa, DEM REP CONGO; [Abboud, Miguel R.] Amer Univ Beirut, Dept Pediat, Beirut, Lebanon	Cincinnati Children's Hospital Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; American University of Beirut	Ware, RE (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Hematol, Dept Pediat, Cincinnati, OH 45229 USA.	russell.ware@cchmc.org			Bristol-Meyers Squibb; Biomedomics; Global Blood Therapeutics; NovaLaboratories; Bayer Pharmaceuticals; Addmedica; Novartis; AFD, a French Cooperative Agency for international projects on sickle cell disease in four African countries; France Expertise/Initiative; Pfizer; Bristol-Meyers Squibb; Biomedomics; Global Blood Therapeutics; NovaLaboratories; Bayer Pharmaceuticals; Addmedica; Novartis; AFD, a French Cooperative Agency for international projects on sickle cell disease in four African countries; France Expertise/Initiative; Pfizer	Bristol-Meyers Squibb(Bristol-Myers Squibb); Biomedomics; Global Blood Therapeutics; NovaLaboratories; Bayer Pharmaceuticals(Bayer AG); Addmedica; Novartis(Novartis); AFD, a French Cooperative Agency for international projects on sickle cell disease in four African countries; France Expertise/Initiative; Pfizer(Pfizer); Bristol-Meyers Squibb(Bristol-Myers Squibb); Biomedomics; Global Blood Therapeutics; NovaLaboratories; Bayer Pharmaceuticals(Bayer AG); Addmedica; Novartis(Novartis); AFD, a French Cooperative Agency for international projects on sickle cell disease in four African countries; France Expertise/Initiative; Pfizer(Pfizer)	REW reports grants and non-financial support from Bristol-Meyers Squibb, non-financial support and material donation from Addmedica, Grants from Biomedomics, and personal fees from Global Blood Therapeutics, NovaLaboratories, and Bayer Pharmaceuticals, outside the submitted work. MdM reports grants from Addmedica during the study, grants and personal fees from Novartis and grants from Pfizer outside the submitted work. LT is a member of the advisory board of SEBIA and Pierre Fabre Foundations. He has financial support from AFD, a French Cooperative Agency for international projects on sickle cell disease in four African countries. Other financial support was received from France Expertise/Initiative that concerns a study on malaria resistance. MRA reports grants from Eli Lilly, Pfizer, MAST therapeutics, Hemaquest, Shire, Astra Zeneca, outside the submitted work. He also reports personal fees from Pfizer and Novartis, and has participated on steering committees and advisory boards for Eli Lilly, Pfizer, and Novartis.	Adam SS, 2013, PEDIATR BLOOD CANCER, V60, P550, DOI 10.1002/pbc.24443; ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; Adams RJ, 2005, NEW ENGL J MED, V353, P2769; ADAMS RJ, 1998, NEW ENGL J MED, V339, P5, DOI [DOI 10.1056/NEJM199807023390102, 10.1056/NEJM199807023390102]; Martinez PA, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-97; Angelucci E, 2014, HAEMATOLOGICA, V99, P811, DOI 10.3324/haematol.2013.099747; Anyanwu JN, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5599; Ataga KI, 2017, NEW ENGL J MED, V376, P429, DOI 10.1056/NEJMoa1611770; Ataga KI, 2011, BRIT J HAEMATOL, V153, P92, DOI 10.1111/j.1365-2141.2010.08520.x; BALKARAN B, 1992, J PEDIATR-US, V120, P360, DOI 10.1016/S0022-3476(05)80897-2; Bartolucci P, 2016, J AM SOC NEPHROL, V27, P1847, DOI 10.1681/ASN.2014111126; Bernaudin F, 2007, BLOOD, V110, P2749, DOI 10.1182/blood-2007-03-079665; Bernaudin F, 2015, BLOOD, V125, P1653, DOI 10.1182/blood-2014-09-599852; Bolanos-Meade J, 2012, BLOOD, V120, P4285, DOI 10.1182/blood-2012-07-438408; Breda L, 2016, BLOOD, V128, P1139, DOI 10.1182/blood-2016-01-691089; Brousse V, 2015, BRIT J HAEMATOL, V170, P615, DOI 10.1111/bjh.13477; Brousse V, 2012, BRIT J HAEMATOL, V156, P643, DOI 10.1111/j.1365-2141.2011.08999.x; Bunn HF, 2010, BLOOD, V116, P687, DOI 10.1182/blood-2010-02-268193; Canver MC, 2016, BLOOD, V127, P2536, DOI 10.1182/blood-2016-01-678128; Casas J, 2015, TRANSFUSION, V55, P1388, DOI 10.1111/trf.12987; Cataldo G, 2015, PAIN, V156, P722, DOI 10.1097/j.pain.0000000000000104; Caughey MC, 2015, BRIT J HAEMATOL, V170, P416, DOI 10.1111/bjh.13447; Cavazzana M, 2015, AM SOC HEM 57 ANN M; CHARACHE S, 1992, BLOOD, V79, P2555; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Chou ST, 2016, HEMATOL ONCOL CLIN N, V30, P591, DOI 10.1016/j.hoc.2016.01.011; Chou ST, 2013, HEMATOL-AM SOC HEMAT, P439, DOI 10.1182/asheducation-2013.1.439; Chou ST, 2013, BLOOD, V122, P1062, DOI 10.1182/blood-2013-03-490623; Cokic VP, 2008, BLOOD, V111, P1117, DOI 10.1182/blood-2007-05-088732; Colah R, 2014, CURR OPIN HEMATOL, V21, P215, DOI 10.1097/MOH.0000000000000029; Couque N, 2016, BRIT J HAEMATOL, V173, P927, DOI 10.1111/bjh.14015; Dallas MH, 2013, BIOL BLOOD MARROW TR, V19, P820, DOI 10.1016/j.bbmt.2013.02.010; Darbari DS, 2006, AM J HEMATOL, V81, P858, DOI 10.1002/ajh.20685; de Montalembert M, 2011, HAEMATOL-HEMATOL J, V96, P801, DOI 10.3324/haematol.2010.038307; de Montalembert M, 2010, HAEMATOL-HEMATOL J, V95, P4, DOI 10.3324/haematol.2009.020172; de Montalembert M, 2006, HAEMATOLOGICA, V91, P125; Deane CR, 2010, HAEMATOL-HEMATOL J, V95, P1287, DOI 10.3324/haematol.2010.022624; DeBaun MR, 2014, NEW ENGL J MED, V371, P699, DOI 10.1056/NEJMoa1401731; Drawz P, 2016, CLIN J AM SOC NEPHRO, V11, P207, DOI 10.2215/CJN.03940415; Dulmovits BM, 2016, BLOOD, V127, P1481, DOI 10.1182/blood-2015-09-667923; Dwyre DM, 2011, VOX SANG, V100, P92, DOI 10.1111/j.1423-0410.2010.01426.x; Elmariah H, 2014, AM J HEMATOL, V89, P530, DOI 10.1002/ajh.23683; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; FALK RJ, 1992, NEW ENGL J MED, V326, P910, DOI 10.1056/NEJM199204023261402; Ferster A, 1996, BLOOD, V88, P1960, DOI 10.1182/blood.V88.6.1960.bloodjournal8861960; Field JJ, 2013, BLOOD, V121, P3329, DOI 10.1182/blood-2012-11-465963; Fitzhugh CD, 2005, PEDIATR BLOOD CANCER, V45, P982, DOI 10.1002/pbc.20296; Fitzhugh CD, 2010, AM J HEMATOL, V85, P36, DOI 10.1002/ajh.21569; Galadanci NA, 2015, PEDIATR BLOOD CANCER, V62, P395, DOI 10.1002/pbc.25289; GAO WY, 1995, P NATL ACAD SCI USA, V92, P8333, DOI 10.1073/pnas.92.18.8333; Geyer HL, 2014, BLOOD, V124, P3529, DOI 10.1182/blood-2014-05-577635; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin MT, 2016, LANCET, V387, P2565, DOI 10.1016/S0140-6736(16)00647-4; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gluckman E, 2017, BLOOD, V129, P1548, DOI 10.1182/blood-2016-10-745711; Gordeuk VR, 2016, BLOOD, V127, P820, DOI 10.1182/blood-2015-08-618561; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Gulbis B, 2005, BLOOD, V105, P2685, DOI 10.1182/blood-2004-07-2704; Hamideh D, 2013, PEDIATR BLOOD CANCER, V60, P1482, DOI 10.1002/pbc.24557; Hankins JS, 2015, AM J HEMATOL, V90, P1099, DOI 10.1002/ajh.24198; Hankins JS, 2009, BLOOD, V113, P4853, DOI 10.1182/blood-2008-12-191643; Hebbel RP, 2011, AM J HEMATOL, V86, P123, DOI 10.1002/ajh.21952; Heeney MM, 2016, NEW ENGL J MED, V374, P625, DOI 10.1056/NEJMoa1512021; Heeney MM, 2015, NATHAN OSKIS HEMATOL, P675; Hoban MD, 2016, BLOOD, V127, P839, DOI 10.1182/blood-2015-09-618587; Hoffbrand AV, 2012, BLOOD, V120, P3657, DOI 10.1182/blood-2012-05-370098; Howard J, 2013, LANCET, V381, P930, DOI 10.1016/S0140-6736(12)61726-7; Hsieh MM, 2014, JAMA-J AM MED ASSOC, V312, P48, DOI 10.1001/jama.2014.7192; IHME Human Development Network World Bank, 2013, THE GLOBAL BURDEN OF; Jayaraman S, 2010, TRANSFUSION, V50, P433, DOI 10.1111/j.1537-2995.2009.002402.x; Kamani NR, 2012, BIOL BLOOD MARROW TR, V18, P1265, DOI 10.1016/j.bbmt.2012.01.019; Karafin MS, 2015, BLOOD CELL MOL DIS, V55, P304, DOI 10.1016/j.bcmd.2015.07.010; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; King LGC, 2015, J PEDIATR-US, V167, P702, DOI 10.1016/j.jpeds.2015.06.028; Kinney TR, 1999, BLOOD, V94, P1550; Kumar AA, 2014, P NATL ACAD SCI USA, V111, P14864, DOI 10.1073/pnas.1414739111; Kutlar A, 2012, AM J HEMATOL, V87, P536, DOI 10.1002/ajh.23147; Lanzkron S, 2013, PUBLIC HEALTH REP, V128, P110, DOI 10.1177/003335491312800206; Laurin LP, 2014, NEPHROL DIAL TRANSPL, V29, P1211, DOI 10.1093/ndt/gft295; Le PQ, 2015, PEDIATR BLOOD CANCER, V62, P1956, DOI 10.1002/pbc.25608; Lesage N, 2015, EUR J OBSTET GYN R B, V194, P183, DOI 10.1016/j.ejogrb.2015.09.016; Lettre G, 2016, LANCET, V387, P2554, DOI 10.1016/S0140-6736(15)01341-0; Mabaera R, 2008, EXP HEMATOL, V36, P1057, DOI 10.1016/j.exphem.2008.06.014; Malinowski AK, 2015, BLOOD, V126, P2424, DOI 10.1182/blood-2015-06-649319; McCavit TL, 2011, J PEDIATR-US, V158, P505, DOI 10.1016/j.jpeds.2010.11.025; McGann PT, 2016, AM J HEMATOL, V91, P205, DOI 10.1002/ajh.24232; McGann PT, 2016, PEDIATR BLOOD CANCER, V63, P98, DOI 10.1002/pbc.25705; McGann PT, 2015, J PEDIATR-US, V167, P1314, DOI 10.1016/j.jpeds.2015.08.068; McLaughlin JF, 2016, TRANSFUSION, V56, P1014, DOI 10.1111/trf.13418; Nath KA, 2015, NAT REV NEPHROL, V11, P161, DOI 10.1038/nrneph.2015.8; Ndeezi G, 2016, LANCET GLOB HEALTH, V4, pE195, DOI 10.1016/S2214-109X(15)00288-0; Nickel RS, 2014, BLOOD, V124, P861, DOI 10.1182/blood-2014-05-575209; Niss O, 2016, JACC-CARDIOVASC IMAG, V9, P243, DOI 10.1016/j.jcmg.2015.05.013; Novelli EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114309; Ohene-Frempong K, 1998, BLOOD, V91, P288; Okam MM, 2015, BLOOD, V125, P3668, DOI 10.1182/blood-2015-03-635391; Oksenberg D, 2016, BRIT J HAEMATOL, V175, P141, DOI 10.1111/bjh.14214; Oteng-Ntim E, 2015, BLOOD, V125, P3316, DOI 10.1182/blood-2014-11-607317; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; PLATT OS, 1984, J CLIN INVEST, V74, P652, DOI 10.1172/JCI111464; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POWARS D, 1978, AM J MED, V65, P461, DOI 10.1016/0002-9343(78)90772-6; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; Quinn CT, 2016, AM J HEMATOL, V91, P1195, DOI 10.1002/ajh.24562; Ranque B, 2014, LANCET HAEMATOL, V1, pE64, DOI 10.1016/S2352-3026(14)00007-6; Reardon DA, 2009, BRIT J CANCER, V101, P1995, DOI 10.1038/sj.bjc.6605411; Reeves SL, 2016, JAMA PEDIATR, V170, P550, DOI 10.1001/jamapediatrics.2015.4859; Reid ME, 2014, AM J HEMATOL, V89, P709, DOI 10.1002/ajh.23725; Sachdev V, 2007, J AM COLL CARDIOL, V49, P472, DOI 10.1016/j.jacc.2006.09.038; Saraf SL, 2014, BRIT J HAEMATOL, V164, P729, DOI 10.1111/bjh.12690; Savage WJ, 2015, AM J HEMATOL, V90, P273, DOI 10.1002/ajh.23945; Seck M, 2016, TRANSFUS CLIN BIOL, V23, P98, DOI 10.1016/j.tracli.2015.11.001; Serjeant GR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011783; Sharpe CC, 2014, BLOOD, V123, P3720, DOI 10.1182/blood-2014-02-557439; Shenoy S, 2016, BLOOD, V128, P2561, DOI 10.1182/blood-2016-05-715870; Silva GS, 2006, CEREBROVASC DIS, V21, P38, DOI 10.1159/000089592; Telen MJ, 2016, BLOOD, V127, P810, DOI 10.1182/blood-2015-09-618553; Telen MJ, 2015, BLOOD, V125, P2656, DOI 10.1182/blood-2014-06-583351; Thornburg CD, 2009, PEDIATR BLOOD CANCER, V52, P609, DOI 10.1002/pbc.21738; Tshilolo L, 2008, PUBLIC HEALTH, V122, P933, DOI 10.1016/j.puhe.2007.12.005; Tshilolo L, 2012, ANEMIA, V2012, DOI 10.1155/2012/105349; Valadi N, 2006, NEUROLOGY, V67, P572, DOI 10.1212/01.wnl.0000230150.39429.8e; Van Zuuren EJ, 2013, COCHRANE DB SYST REV, V6; Verlhac S, 2014, PEDIATR RADIOL, V44, P587, DOI 10.1007/s00247-014-2880-9; Vichinsky E, 2013, AM J HEMATOL, V88, P1068, DOI 10.1002/ajh.23569; VICHINSKY EP, 1995, NEW ENGL J MED, V333, P206, DOI 10.1056/NEJM199507273330402; Vincent L, 2013, BLOOD, V122, P1853, DOI 10.1182/blood-2013-04-498105; Walters MC, 2016, BIOL BLOOD MARROW TR, V22, P207, DOI 10.1016/j.bbmt.2015.10.017; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wang WC, 2001, J PEDIATR-US, V139, P790, DOI 10.1067/mpd.2001.119590; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Ware RE, 2004, J PEDIATR-US, V145, P346, DOI 10.1016/j.jpeds.2004.04.058; Ware RE, 2016, LANCET, V387, P661, DOI 10.1016/S0140-6736(15)01041-7; Ware RE, 2012, BLOOD, V119, P3925, DOI 10.1182/blood-2011-11-392340; Wood JC, 2005, BLOOD, V106, P1460, DOI 10.1182/blood-2004-10-3982; Wood JC, 2016, BRIT J HAEMATOL, V172, P122, DOI 10.1111/bjh.13791; Wood JC, 2015, AM J HEMATOL, V90, P806, DOI 10.1002/ajh.24089; World Health Organization Regional Office for Africa, 2010, SICKL CELL DIS STRAT; Yang XX, 2013, LAB CHIP, V13, P1464, DOI 10.1039/c3lc41302k; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517; Yee MM, 2011, CLIN J AM SOC NEPHRO, V6, P2628, DOI 10.2215/CJN.01600211; Zhu JQ, 2014, BLOOD, V124, P1146, DOI 10.1182/blood-2013-10-534842; Zimmerman SA, 2004, BLOOD, V103, P2039, DOI 10.1182/blood-2003-07-2475	145	402	411	4	212	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2017	390	10091					311	323		10.1016/S0140-6736(17)30193-9	http://dx.doi.org/10.1016/S0140-6736(17)30193-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA5IZ	28159390				2022-12-28	WOS:000405477900031
J	Donato, F; Jacobsen, RI; Moser, MB; Moser, EI				Donato, Flavio; Jacobsen, R. Irene; Moser, May-Britt; Moser, Edvard I.			Stellate cells drive maturation of the entorhinal-hippocampal circuit	SCIENCE			English	Article							RECEPTIVE-FIELDS; CEREBRAL-CORTEX; GRID CELLS; SPATIAL REPRESENTATION; PATH-INTEGRATION; GANGLION-CELLS; VISUAL-CORTEX; COGNITIVE MAP; RAT; NEURONS	The neural representation of space relies on a network of entorhinal-hippocampal cell types with firing patterns tuned to different abstract features of the environment. To determine how this network is set up during early postnatal development, we monitored markers of structural maturation in developing mice, both in naive animals and after temporally restricted pharmacogenetic silencing of specific cell populations. We found that entorhinal stellate cells provide an activity-dependent instructive signal that drives maturation sequentially and unidirectionally through the intrinsic circuits of the entorhinal-hippocampal network. The findings raise the possibility that a small number of autonomously developing neuronal populations operate as intrinsic drivers of maturation across widespread regions of the cortex.	[Donato, Flavio; Moser, Edvard I.] Norwegian Univ Sci & Technol, Norwegian Brain Ctr, Kavli Inst Syst Neurosci, Olav Kyrres Gate 9, N-7491 Trondheim, Norway; Norwegian Univ Sci & Technol, Norwegian Brain Ctr, Ctr Neural Computat, Olav Kyrres Gate 9, N-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Donato, F; Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Norwegian Brain Ctr, Kavli Inst Syst Neurosci, Olav Kyrres Gate 9, N-7491 Trondheim, Norway.	flavio.donato@ntnu.no; edvard.moser@ntnu.no	Jacobsen, Ragnhild Irene/ABE-4300-2020	Jacobsen, Ragnhild Irene/0000-0001-9521-5044; Donato, Flavio/0000-0002-0732-1654	European Research Council [338865, 268598]; Kavli Foundation; Egil and Pauline Braathen and Fred Kavli Centre for Cortical Microcircuits; Louis-Jeantet Prize for Medicine; Centre of Excellence Scheme; National Infrastructure Scheme of the Research Council of Norway (Centre for Neural Computation) [223262, 197467]; European Molecular Biology Organization long-term fellowship [ALTF 246-2013]	European Research Council(European Research Council (ERC)European Commission); Kavli Foundation; Egil and Pauline Braathen and Fred Kavli Centre for Cortical Microcircuits; Louis-Jeantet Prize for Medicine; Centre of Excellence Scheme; National Infrastructure Scheme of the Research Council of Norway (Centre for Neural Computation); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO))	We thank A. M. Amundsgard, A. Buroy, V. Frolov, K. Haugen, E. Krakvik, B. B. Lofaldli, and H. Waade for technical assistance; P. Caroni, S. Arber, and P. Capelli for training on in utero injections; C. Kentros and R. Raveendran for viral reagents; and M. Witter for discussion. This work was supported by two Advanced Investigator Grants from the European Research Council ("GRIDCODE" grant agreement no. 338865 and "ENSEMBLE" grant agreement no. 268598), the Kavli Foundation, the Egil and Pauline Braathen and Fred Kavli Centre for Cortical Microcircuits, the Louis-Jeantet Prize for Medicine, the Centre of Excellence Scheme and the National Infrastructure Scheme of the Research Council of Norway (Centre for Neural Computation grant agreement no. 223262, "NORBRAIN1" grant agreement no. 197467), and the European Molecular Biology Organization long-term fellowship (ALTF 246-2013). F.D., M.-B.M., and E. I. M. designed the experiments and analyses. F.D. and R.I.J. performed the experiments. F.D. performed the analyses. F.D. and E. I. M. wrote the paper with input from all authors.	ANDERSEN P, 1971, EXP BRAIN RES, V13, P222; ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bjerknes TL, 2015, CURR BIOL, V25, P103, DOI 10.1016/j.cub.2014.11.009; Bjerknes TL, 2014, NEURON, V82, P71, DOI 10.1016/j.neuron.2014.02.014; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burr HS, 1916, J EXP ZOOL, V20, P27, DOI 10.1002/jez.1400200202; Cajal S., 1893, ANAL SOC ESP HIST NA, V22, P53; Cappaert N. L. M., 2015, THE RAT NERVOUS SYST, P511; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Doischer D, 2008, J NEUROSCI, V28, P12956, DOI 10.1523/JNEUROSCI.2890-08.2008; Druckmann S, 2014, NEURON, V81, P629, DOI 10.1016/j.neuron.2013.11.026; DRYER L, 1994, PERSPECT DEV NEUROBI, V2, P163; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Gao P, 2014, CELL, V159, P775, DOI 10.1016/j.cell.2014.10.027; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HJORTHSIMONSEN A, 1971, J COMP NEUROL, V142, P417, DOI 10.1002/cne.901420403; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; LEVIMONTALCINI R, 1949, J COMP NEUROL, V91, P209, DOI 10.1002/cne.900910204; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Miao CL, 2015, NEURON, V88, P590, DOI 10.1016/j.neuron.2015.09.051; Moser EI, 2014, NAT REV NEUROSCI, V15, P466, DOI 10.1038/nrn3766; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Muessig L, 2015, NEURON, V86, P1167, DOI 10.1016/j.neuron.2015.05.011; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Paxinos G., 2012, PAXINOS AND FRANKLIN; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Ray S, 2016, ELIFE, V5, DOI 10.7554/eLife.13343; Rowland DC, 2016, ANNU REV NEUROSCI, V39, P19, DOI 10.1146/annurev-neuro-070815-013824; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; Telley L, 2016, SCIENCE, V351, P1443, DOI 10.1126/science.aad8361; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003; YECKEL MF, 1990, P NATL ACAD SCI USA, V87, P5832, DOI 10.1073/pnas.87.15.5832	53	65	66	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI				eaai8178	10.1126/science.aai8178	http://dx.doi.org/10.1126/science.aai8178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28154241	Green Accepted			2022-12-28	WOS:000396351200035
J	Howell, MD; Davis, AM				Howell, Michael D.; Davis, Andrew M.			Management of Sepsis and Septic Shock	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GOAL-DIRECTED RESUSCITATION		[Howell, Michael D.] Univ Chicago, Ctr Healthcare Delivery Sci & Innovat, Chicago, IL 60637 USA; [Howell, Michael D.] Univ Chicago, Pulm & Crit Care, Chicago, IL 60637 USA; [Davis, Andrew M.] Univ Chicago, Gen Internal Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Howell, MD (corresponding author), Univ Chicago, 850 E 58th St, Chicago, IL 60615 USA.	mdh@uchicago.edu						Damiani E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125827; Levy MM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0705-8; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Rhee C, 2014, NEW ENGL J MED, V370, P1673, DOI 10.1056/NEJMp1400276; Rhodes A, CRIT CARE MED, DOI [10.1097/CCM.00000000000022555, DOI 10.1097/CCM.00000000000022555]; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Wall MJ, 2015, ANN AM THORAC SOC, V12, P1597, DOI 10.1513/AnnalsATS.201509-625ED; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	10	110	115	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					847	+		10.1001/jama.2017.0131	http://dx.doi.org/10.1001/jama.2017.0131			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28114603				2022-12-28	WOS:000395505600022
J	Zhao, D; Lu, X; Wang, GC; Lan, ZD; Liao, WT; Li, J; Liang, X; Chen, JR; Shah, S; Shang, XY; Tang, M; Deng, PN; Dey, P; Chakravarti, D; Chen, PW; Spring, DJ; Navone, NM; Troncoso, P; Zhang, JH; Wang, YA; DePinho, RA				Zhao, Di; Lu, Xin; Wang, Guocan; Lan, Zhengdao; Liao, Wenting; Li, Jun; Liang, Xin; Chen, Jasper Robin; Shah, Sagar; Shang, Xiaoying; Tang, Ming; Deng, Pingna; Dey, Prasenjit; Chakravarti, Deepavali; Chen, Peiwen; Spring, Denise J.; Navone, Nora M.; Troncoso, Patricia; Zhang, Jianhua; Wang, Y. Alan; DePinho, Ronald A.			Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer	NATURE			English	Article							PROSTATE-CANCER; BETA-TRCP; MUTANT-CELLS; VULNERABILITIES; PHOSPHORYLATION; DELETION	Synthetic lethality and collateral lethality are two well-validated conceptual strategies for identifying therapeutic targets in cancers with tumour-suppressor gene deletions(1-3). Here, we explore an approach to identify potential synthetic-lethal interactions by screening mutually exclusive deletion patterns in cancer genomes. We sought to identify 'synthetic-essential' genes: those that are occasionally deleted in some cancers but are almost always retained in the context of a specific tumour-suppressor deficiency. We also posited that such synthetic-essential genes would be therapeutic targets in cancers that harbour specific tumour-suppressor deficiencies. In addition to known synthetic-lethal interactions, this approach uncovered the chromatin helicase DNA-binding factor CHD1 as a putative synthetic-essential gene in PTEN-deficient cancers. In PTEN-deficient prostate and breast cancers, CHD1 depletion profoundly and specifically suppressed cell proliferation, cell survival and tumorigenic potential. Mechanistically, functional PTEN stimulates the GSK3 beta-mediated phosphorylation of CHD1 degron domains, which promotes CHD1 degradation via the beta-TrCP-mediated ubiquitination-proteasome pathway. Conversely, PTEN deficiency results in stabilization of CHD1, which in turn engages the trimethyl lysine-4 histone H3 modification to activate transcription of the pro-tumorigenic TNF-NF-kappa B gene network. This study identifies a novel PTEN pathway in cancer and provides a framework for the discovery of 'trackable' targets in cancers that harbour specific tumour-suppressor deficiencies.	[Zhao, Di; Lu, Xin; Wang, Guocan; Lan, Zhengdao; Liao, Wenting; Liang, Xin; Chen, Jasper Robin; Shah, Sagar; Shang, Xiaoying; Deng, Pingna; Dey, Prasenjit; Chakravarti, Deepavali; Chen, Peiwen; Spring, Denise J.; Wang, Y. Alan; DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Li, Jun; Tang, Ming; Zhang, Jianhua] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77054 USA; [Navone, Nora M.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Troncoso, Patricia] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wang, YA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	yalanwang@mdanderson.org; rdepinho@mdanderson.org		Zhao, Di/0000-0001-6253-7127; Chen, Jasper/0000-0001-6070-5940; Spring, Denise J./0000-0002-4593-0901; Chen, Peiwen/0000-0002-8129-9328; DePinho, Ronald/0000-0002-5625-577X	University of Texas [MDACC 600649-80-116647-21]; DOD [W81XWH-14-1-0576]; NIH-NCI [1K99CA194289]; DOD PCRP [W81XWH-14-1-0429]; CPRIT [RP140106-DC]; NIH [P01 CA117969, R01 CA084628]; NATIONAL CANCER INSTITUTE [R01CA084628, P01CA117969, K99CA194289, R00CA194289, P30CA016672] Funding Source: NIH RePORTER	University of Texas; DOD(United States Department of Defense); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD PCRP; CPRIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. W. Hayward for the BPH1 cell line; P. Shepherd for the PDX models, Y. Chen for Flag-tagged beta-TrCP plasmid; T. Gutschner for CRISPR X330-Cherry vector; Y. L. Deribe for the HA-tagged PTEN plasmid; S. Jiang and K. Zhao for assistance in maintenance of mouse colonies; Q. E. Chang for assistance in IHC slides scanning; and the MD Anderson Sequencing and Microarray Facility (SMF) and Flow Cytometry and Cellular Imaging Core Facility. This work was supported in part by the Odyssey Program and Theodore N. Law Endowment For Scientific Achievement at The University of Texas MDACC 600649-80-116647-21 (D.Z.); DOD Prostate Cancer Research Program (PCRP) Idea Development Award-New Investigator Option W81XWH-14-1-0576 (X. Lu); NIH Pathway to Independence (PI) Award (K99/R00)-NCI: 1K99CA194289 (G.W.); DOD PCRP W81XWH-14-1-0429 (P. Dey.); CPRIT research training award RP140106-DC (D.C.); NIH grants P01 CA117969 (R.A.D.) and R01 CA084628 (R.A.D.).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Burkhardt L, 2013, CANCER RES, V73, P2795, DOI 10.1158/0008-5472.CAN-12-1342; Cairns P, 1997, CANCER RES, V57, P4997; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; de la Cruz FF, 2015, ANNU REV PHARMACOL, V55, P513, DOI 10.1146/annurev-pharmtox-010814-124511; Dillon LM, 2014, CURR DRUG TARGETS, V15, P65, DOI 10.2174/1389450114666140106100909; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Huang S, 2012, ONCOGENE, V31, P4164, DOI 10.1038/onc.2011.590; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Jin R, 2015, ONCOGENE, V34, P3700, DOI 10.1038/onc.2014.302; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Mason JM, 2014, CANCER CELL, V26, P163, DOI 10.1016/j.ccr.2014.05.006; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Rodrigues LU, 2015, CANCER RES, V75, P1021, DOI 10.1158/0008-5472.CAN-14-1596; Strack P, 2000, ONCOGENE, V19, P3529, DOI 10.1038/sj.onc.1203647; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Wan XH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009332; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	30	114	116	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					484	+		10.1038/nature21357	http://dx.doi.org/10.1038/nature21357			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28166537	Green Accepted			2022-12-28	WOS:000395094100038
J	Gostin, LO; Friedman, EA				Gostin, Lawrence O.; Friedman, Eric A.			Reimagining WHO: leadership and action for a new Director-General	LANCET			English	Article							CANDIDATES; HEALTH	Three candidates to be the next WHO Director-General remain: Tedros Adhanom Ghebreyesus, David Nabarro, and Sania Nishtar. The World Health Assembly's ultimate choice will lead an organisation facing daunting internal and external challenges, from its own funding shortfalls to antimicrobial resistance and immense health inequities. The new Director-General must transform WHO into a 21st century institution guided by the right to health. Topping the incoming Director-General's agenda will be a host of growing threats-risks to global health security, antimicrobial resistance, non-communicable diseases, and climate change-but also the transformative potential of the Sustainable Development Goals, including their universal health coverage target. Throughout, the next Director-General should emphasise equality, including through national health equity strategies and, more boldly still, advancing the Framework Convention on Global Health. Success in these areas will require a reinvigorated WHO, with sustainable financing, greater multisector engagement, enhanced accountability and transparency, and strengthened normative leadership. WHO must also evolve its governance to become far more welcoming of civil society and communities. To create the foundation for these transformative changes, the Director-General will need to focus first on gaining political support. This entails improving accountability and transparency to gain member state trust, and enabling meaningful civil society participation in WHO's governance and standing up for the right to health to gain civil society support. Ultimately, in the face of a global environment marked by heightened nationalism and xenophobia, member states must empower the next Director-General to enable WHO to be a bulwark for health and human rights, serving as an inspiring contra-example to today's destructive politics, demonstrating that the community of nations are indeed stronger together.	[Gostin, Lawrence O.; Friedman, Eric A.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], 2008, CLOS GAP GEN HLTH EQ; Buse K, 2017, LANCET, V389, P33, DOI 10.1016/S0140-6736(16)32611-3; Campbell-Lendrum D., 2016, 2 GLOB C HLTH CLIM P; Douste-Blazy P., 2016, COMMUNICATION   1101; Friedman EA, 2015, HLTH HUMAN RIGH 1005; Ghebreyesus TA, 2016, TEDROS TOGETHER HLTH; Gordon C, 2016, IMAXI BLOG      1212; Gostin LO, 2017, PUBLIC HEALTH, V144, P4, DOI 10.1016/j.puhe.2016.11.001; Gostin LO, 2017, HEALTH AFFAIR, V36, P159, DOI 10.1377/hlthaff.2016.1492; Gostin LO, 2016, LANCET GLOB HEALTH, V4, pE890, DOI 10.1016/S2214-109X(16)30219-4; Hammer M, 2012, POWER EQUITY ACCOUNT; Henrion E., 2015, EVALUATION WHOS PRES; High-Level Panel on Access to Medicines, 2016, HIGH LEVEL PANEL ACC; Horton R, 2016, LANCET, V388, P2072, DOI 10.1016/S0140-6736(16)31847-5; Luber G., 2016, BALB J HLTH IMP CLIM; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; Review on Anti-Microbial Resistance, 2016, REV ANTIMICROBIAL RE; Silberschmidt G, 2008, LANCET, V371, P1483, DOI 10.1016/S0140-6736(08)60634-0; UK Department for International Development, 2016, RIS STAND MULT DEV R; United Nations, 2015, REP C PART UN FRAM C; United Nations High-Level Commission on Health Employment and Economic Growth, 2016, WORK HLTH GROWTH INV; WHO, 2013, 1325ADD2 WHO EB; WHO, 2016, HOUS IND AIR POLL HL; WHO, 2016, A6924 WHO; WHO, 2016, PROP PROGR IN PRESS; WHO, 2014, HLTH ENV CLIM HLTH O; WHO, 2014, FRAM STRENGTH EV ORG; WHO, 2016, WHO FIN DIAL 2016 M; WHO, 2020, GLOB STRAT HUM RES H; WHO, CAND WHO DIR GEN; WHO. IHR, 2005, IHR 2005 MON EV FRAM; WHO. World Health Organization organigram, 2016, WHO ORG; World Health Assembly, 2016, WHA6924; World Health Assembly, 2015, 681 WHA; World Health Assembly, 2016, WHA6910; World Health Organisation, 2016, REV PAND INFL PREP F; World Health Organisation Secretariat, 2016, FRAM INT PEOPL CTR H; World Health Organization, 2016, AMB OUTD AIR QUAL HL; World Health Organization (WHO), 2011, PAND INFL PREP FRAM	39	2	2	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2017	389	10070					755	759		10.1016/S0140-6736(17)30203-9	http://dx.doi.org/10.1016/S0140-6736(17)30203-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9KK	28139256	Green Submitted			2022-12-28	WOS:000394938900036
J	Andersen, LW; Granfeldt, A; Callaway, CW; Bradley, SM; Soar, J; Nolan, JP; Kurth, T; Donnino, MW				Andersen, Lars W.; Granfeldt, Asger; Callaway, Clifton W.; Bradley, Steven M.; Soar, Jasmeet; Nolan, Jerry P.; Kurth, Tobias; Donnino, Michael W.		American Heart Association's	Association Between Tracheal Intubation During Adult In-Hospital Cardiac Arrest and Survival	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY CARDIOVASCULAR CARE; ADVANCED AIRWAY MANAGEMENT; ADVANCED LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; MEDICAL-SERVICES; TIME; REGISTRY; DOCUMENTATION; EPINEPHRINE; MECHANISMS	IMPORTANCE Tracheal intubation is common during adult in-hospital cardiac arrest, but little is known about the association between tracheal intubation and survival in this setting. OBJECTIVE To determine whether tracheal intubation during adult in-hospital cardiac arrest is associated with survival to hospital discharge. DESIGN, SETTING, AND PARTICIPANTS Observational cohort study of adult patients who had an in-hospital cardiac arrest from January 2000 through December 2014 included in the Get With The Guidelines-Resuscitation registry, a US-based multicenter registry of in-hospital cardiac arrest. Patients who had an invasive airway in place at the time of cardiac arrest were excluded. Patients intubated at any given minute (from 0-15 minutes) were matched with patients at risk of being intubated within the same minute (ie, still receiving resuscitation) based on a time-dependent propensity score calculated from multiple patient, event, and hospital characteristics. EXPOSURE Tracheal intubation during cardiac arrest. MAIN OUTCOMES AND MEASURES The primary outcome was survival to hospital discharge. Secondary outcomes included return of spontaneous circulation (ROSC) and a good functional outcome. A cerebral performance category score of 1 (mild or no neurological deficit) or 2 (moderate cerebral disability) was considered a good functional outcome. RESULTS The propensity-matched cohort was selected from 108 079 adult patients at 668 hospitals. The median age was 69 years (interquartile range, 58-79 years), 45 073 patients (42%) were female, and 24 256 patients (22.4%) survived to hospital discharge. Of 71 615 patients (66.3%) who were intubated within the first 15 minutes, 43 314 (60.5%) were matched to a patient not intubated in the same minute. Survival was lower among patients who were intubated compared with those not intubated: 7052 of 43 314 (16.3%) vs 8407 of 43 314 (19.4%), respectively (risk ratio [RR] = 0.84; 95% CI, 0.81-0.87; P<.001). The proportion of patients with ROSC was lower among intubated patients than those not intubated: 25 022 of 43 311 (57.8%) vs 25 685 of 43 310 (59.3%), respectively (RR = 0.97; 95% CI, 0.96-0.99; P<.001). Good functional outcome was also lower among intubated patients than those not intubated: 4439 of 41 868 (10.6%) vs 5672 of 41 733 (13.6%), respectively (RR = 0.78; 95% CI, 0.75-0.81; P<.001). Although differences existed in prespecified subgroup analyses, intubation was not associated with improved outcomes in any subgroup. CONCLUSIONS AND RELEVANCE Among adult patients with in-hospital cardiac arrest, initiation of tracheal intubation within any given minute during the first 15 minutes of resuscitation, compared with no intubation during that minute, was associated with decreased survival to hospital discharge. Although the study design does not eliminate the potential for confounding by indication, these findings do not support early tracheal intubation for adult in-hospital cardiac arrest.	[Andersen, Lars W.] Aarhus Univ Hosp, Res Ctr Emergency Med, Norrebrogade 44,Bygning 30,1 Sal, DK-8000 Aarhus C, Denmark; [Andersen, Lars W.; Granfeldt, Asger] Aarhus Univ Hosp, Dept Anesthesiol, Aarhus, Denmark; [Andersen, Lars W.; Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Callaway, Clifton W.] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA USA; [Bradley, Steven M.] VA Eastern Colorado Hlth Care Syst, Div Cardiol, Dept Med, Denver, CO USA; [Bradley, Steven M.] Minneapolis Heart Inst, Minneapolis, MN USA; [Soar, Jasmeet] Southmead Hosp, Anaesthesia & Intens Care Med, Bristol, England; [Nolan, Jerry P.] Univ Bristol, Bristol, England; [Nolan, Jerry P.] Royal United Hosp, Dept Anaesthesia & Intens Care Med, Bath, Avon, England; [Kurth, Tobias] Charite, Inst Publ Hlth, Berlin, Germany; [Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Div Pulm & Crit Care, Boston, MA 02215 USA	Aarhus University; Aarhus University; Harvard University; Beth Israel Deaconess Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Minneapolis Heart Institute Foundation; Southmead Hospital; University of Bristol; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Beth Israel Deaconess Medical Center	Andersen, LW (corresponding author), Aarhus Univ Hosp, Res Ctr Emergency Med, Norrebrogade 44,Bygning 30,1 Sal, DK-8000 Aarhus C, Denmark.	lwandersen@clin.au.dk	Nolan, Jerry P./ABF-2561-2020; Soar, Jasmeet/HGA-2279-2022; Bradley, Steven/AID-7839-2022; Kurth, Tobias/A-9243-2012	Soar, Jasmeet/0000-0001-5970-6073; Kurth, Tobias/0000-0001-7169-2620; Nolan, Jerry/0000-0003-3141-3812; Girotra, Saket/0000-0002-4784-4513; Churpek, Matthew/0000-0002-4030-5250; Andersen, Lars Wiuff/0000-0001-5752-8082; Granfeldt, Asger/0000-0002-7241-6131	National Heart, Lung, and Blood Institute [1K24HL127101-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL127101] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Donnino is supported by grant 1K24HL127101-01 from the National Heart, Lung, and Blood Institute.	Andersen LW, 2016, JAMA-J AM MED ASSOC, V316, P1786, DOI 10.1001/jama.2016.14486; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Benger J, 2016, BRIT J ANAESTH, V116, P262, DOI 10.1093/bja/aev477; Benoit JL, 2015, RESUSCITATION, V93, P124, DOI 10.1016/j.resuscitation.2015.06.005; Callaway CW, 2015, CIRCULATION, V132, pS84, DOI 10.1161/CIR.0000000000000273; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Chan PS, 2009, JAMA-J AM MED ASSOC, V302, P1195, DOI 10.1001/jama.2009.1340; Donnino MW, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3028; Dumot JA, 2001, ARCH INTERN MED, V161, P1751, DOI 10.1001/archinte.161.14.1751; Fouche PF, 2014, PREHOSP EMERG CARE, V18, P244, DOI 10.3109/10903127.2013.831509; Fredriksson M, 2010, AM HEART J, V159, P749, DOI 10.1016/j.ahj.2010.01.015; Frisch A, 2014, RESUSCITATION, V85, P1111, DOI 10.1016/j.resuscitation.2014.05.002; GOLDENBERG IF, 1986, CHEST, V90, P90, DOI 10.1378/chest.90.1.90; Hasegawa K, 2013, JAMA-J AM MED ASSOC, V309, P257, DOI 10.1001/jama.2012.187612; Kang K, 2016, AM J EMERG MED, V34, P128, DOI 10.1016/j.ajem.2015.09.036; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Kim J, 2014, RESUSCITATION, V85, P623, DOI 10.1016/j.resuscitation.2014.01.017; Kramer-Johansen J, 2006, RESUSCITATION, V68, P61, DOI 10.1016/j.resuscitation.2005.05.020; Kyriacou DN, 2016, JAMA-J AM MED ASSOC, V316, P1818, DOI 10.1001/jama.2016.16435; Li YFP, 2001, J AM STAT ASSOC, V96, P870, DOI 10.1198/016214501753208573; Link MS, 2015, CIRCULATION, V132, pS444, DOI 10.1161/CIR.0000000000000261; Lu B, 2005, BIOMETRICS, V61, P721, DOI 10.1111/j.1541-0420.2005.00356.x; Maignan M, 2015, RESUSCITATION, V93, P113, DOI 10.1016/j.resuscitation.2015.06.002; Miglioretti DL, 2007, AM J EPIDEMIOL, V165, P453, DOI 10.1093/aje/kwk020; Nakahara S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6829; Nichol G, 2015, NEW ENGL J MED, V373, P2203, DOI 10.1056/NEJMoa1509139; Peace JM, 2014, RESUSCITATION, V85, P266, DOI 10.1016/j.resuscitation.2013.10.013; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; Perkins GD, 2015, RESUSCITATION, V96, P328, DOI 10.1016/j.resuscitation.2014.11.002; Rabitsch W, 2003, RESUSCITATION, V57, P27, DOI 10.1016/S0300-9572(02)00435-5; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; The American Hospital Association, 2014, AHA ANN SURV DAT FIS; TORTOLANI AJ, 1990, RESUSCITATION, V20, P115, DOI 10.1016/0300-9572(90)90047-I; Wnent J, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0124-0; Yeung J, 2014, RESUSCITATION, V85, P898, DOI 10.1016/j.resuscitation.2014.02.018; Zou GY, 2013, STAT METHODS MED RES, V22, P661, DOI 10.1177/0962280211427759; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	40	104	111	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					494	506		10.1001/jama.2016.20165	http://dx.doi.org/10.1001/jama.2016.20165			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28118660	Green Accepted			2022-12-28	WOS:000393564200018
J	Subrahmanian, VS; Kumar, S				Subrahmanian, V. S.; Kumar, Srijan			Predicting human behavior: The next frontiers	SCIENCE			English	Editorial Material								Machine learning has provided researchers with new tools for understanding human behavior. In this article, we briefly describe some successes in predicting behaviors and describe the challenges over the next few years.	[Subrahmanian, V. S.; Kumar, Srijan] Univ Maryland, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Subrahmanian, VS (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	vs@cs.umd.edu; srijan@cs.umd.edu	Subrahmanian, Venkatramanan/ABA-7399-2021	Kumar, Srijan/0000-0002-5796-3532				Almomani A, 2013, IEEE COMMUN SURV TUT, V15, P2070, DOI 10.1109/SURV.2013.030713.00020; Sipos R, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P1867, DOI 10.1145/2623330.2623340; Stewart Charles J., 2012, PERSUASION SOCIAL MO, V6th; Subrahmanian V., 2012, COMPUTATIONAL ANAL T; Subrahmanian VS, 2016, COMPUTER, V49, P38, DOI 10.1109/MC.2016.183	5	41	41	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					489	489		10.1126/science.aam7032	http://dx.doi.org/10.1126/science.aam7032			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154052				2022-12-28	WOS:000393183100036
J	Callaway, E				Callaway, Ewen			Gene drives meet the resistance	NATURE			English	News Item																		Drury D., 2016, PREPRINT AT BIORXIV; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Miles A., 2016, PREPRINT AR BIORXIV; Unckless RL, 2016, GENETICS	4	17	17	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					15	15		10.1038/542015a	http://dx.doi.org/10.1038/542015a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28150791	Bronze			2022-12-28	WOS:000396119300007
J	Rao, DA; Gurish, MF; Marshall, JL; Slowikowski, K; Fonseka, CY; Liu, YY; Donlin, LT; Henderson, LA; Wei, K; Mizoguchi, F; Teslovich, NC; Weinblatt, ME; Massarotti, EM; Coblyn, JS; Helfgott, SM; Lee, YC; Todd, DJ; Ykerk, VPB; Goodman, SM; Pernis, AB; Ivashkiv, LB; Karlson, EW; Nigrovic, PA; Filer, A; Buckley, CD; Lederer, JA; Raychaudhuri, S; Renner, MBB				Rao, Deepak A.; Gurish, Michael F.; Marshall, Jennifer L.; Slowikowski, Kamil; Fonseka, Chamith Y.; Liu, Yanyan; Donlin, Laura T.; Henderson, Lauren A.; Wei, Kevin; Mizoguchi, Fumitaka; Teslovich, Nikola C.; Weinblatt, Michael E.; Massarotti, Elena M.; Coblyn, Jonathan S.; Helfgott, Simon M.; Lee, Yvonne C.; Todd, Derrick J.; Ykerk, Vivian P. B.; Goodman, Susan M.; Pernis, Alessandra B.; Ivashkiv, Lionel B.; Karlson, Elizabeth W.; Nigrovic, Peter A.; Filer, Andrew; Buckley, Christopher D.; Lederer, James A.; Raychaudhuri, Soumya; Renner, Michael B. B.			Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis	NATURE			English	Article							FOLLICULAR HELPER; EXTRAVASATION; CXCL13; BCL6	CD4(+) T cells are central mediators of autoimmune pathology; however, defining their key effector functions in specific autoimmune diseases remains challenging. Pathogenic CD4(+) T cells within affected tissues may be identified by expression of markers of recent activation(1). Here we use mass cytometry to analyse activated T cells in joint tissue from patients with rheumatoid arthritis, a chronic immune-mediated arthritis that affects up to 1% of the population(2). This approach revealed a markedly expanded population of PD-1(hi)CXCR5(-)CD4(+) T cells in synovium of patients with rheumatoid arthritis. However, these cells are not exhausted, despite high PD-1 expression. Rather, using multidimensional cytometry, transcriptomics, and functional assays, we define a population of PD-1(hi)CXCR5(-) 'peripheral helper' T (T-PH) cells that express factors enabling B-cell help, including IL-21, CXCL13, ICOS, and MAF. Like PD-1(hi)CXCR5(+) T follicular helper cells, T-PH cells induce plasma cell differentiation in vitro through IL-21 secretion and SLAMF5 interaction (refs 3, 4). However, global transcriptomics highlight differences between T-PH cells and T follicular helper cells, including altered expression of BCL6 and BLIMP1 and unique expression of chemokine receptors that direct migration to inflamed sites, such as CCR2, CX3CR1, and CCR5, in T-PH cells. T-PH cells appear to be uniquely poised to promote B-cell responses and antibody production within pathologically inflamed non-lymphoid tissues.	[Rao, Deepak A.; Gurish, Michael F.; Slowikowski, Kamil; Fonseka, Chamith Y.; Liu, Yanyan; Henderson, Lauren A.; Wei, Kevin; Mizoguchi, Fumitaka; Teslovich, Nikola C.; Weinblatt, Michael E.; Karlson, Elizabeth W.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Wei, Kevin; Todd, Derrick J.; Goodman, Susan M.] Harvard Med Sch, Boston, MA 02115 USA; [Marshall, Jennifer L.; Henderson, Lauren A.; Helfgott, Simon M.; Todd, Derrick J.] Univ Birmingham, Queen Elizabeth Hosp, Inst Inflammat & Ageing, Rheumatol Res Grp, Birmingham B15 2WB, W Midlands, England; [Gurish, Michael F.; Liu, Yanyan; Lee, Yvonne C.; Goodman, Susan M.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Marshall, Jennifer L.; Donlin, Laura T.; Teslovich, Nikola C.; Helfgott, Simon M.; Lee, Yvonne C.] Harvard Med Sch, Boston, MA 02115 USA; [Slowikowski, Kamil; Todd, Derrick J.; Karlson, Elizabeth W.] MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02138 USA; [Rao, Deepak A.; Helfgott, Simon M.; Ykerk, Vivian P. B.; Karlson, Elizabeth W.] Harvard Univ, Cambridge, MA 02138 USA; [Fonseka, Chamith Y.] Partners Ctr Personalized Genet Med, Boston, MA 02115 USA; [Donlin, Laura T.; Henderson, Lauren A.] Harvard Univ, Bioinformat & Integrat Genom, Cambridge, MA 02138 USA; [Helfgott, Simon M.] Harvard Univ, Biol & Biomed Sci, Cambridge, MA 02138 USA; [Todd, Derrick J.; Karlson, Elizabeth W.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY USA; [Helfgott, Simon M.; Ivashkiv, Lionel B.; Buckley, Christopher D.; Raychaudhuri, Soumya] Hosp Special Surg, David Z Rosensweig Genom Res Ctr, New York, NY 10021 USA; [Marshall, Jennifer L.; Wei, Kevin; Coblyn, Jonathan S.; Lee, Yvonne C.; Ivashkiv, Lionel B.] Boston Childrens Hosp, Divis Immunol, Boston, MA 02115 USA; [Coblyn, Jonathan S.; Pernis, Alessandra B.; Nigrovic, Peter A.] Hosp Special Surg, Div Rheumatol, 535 E 70th St, New York, NY 10021 USA; [Slowikowski, Kamil; Mizoguchi, Fumitaka; Massarotti, Elena M.; Goodman, Susan M.] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA; [Massarotti, Elena M.; Lee, Yvonne C.; Ykerk, Vivian P. B.; Pernis, Alessandra B.] Hosp Special Surg, Autoimmun & Inflammat Program, New York, NY 10021 USA; [Donlin, Laura T.; Goodman, Susan M.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Henderson, Lauren A.; Weinblatt, Michael E.; Goodman, Susan M.] Karolinska Inst, Reumatol Unit, S-17176 Stockholm, Sweden; [Mizoguchi, Fumitaka; Massarotti, Elena M.; Lee, Yvonne C.; Todd, Derrick J.] Karolinska Univ Hosp Solna, S-17176 Stockholm, Sweden; [Massarotti, Elena M.; Todd, Derrick J.; Ivashkiv, Lionel B.] Univ Manchester, Inst Inflammat & Repair, Manchester M13 9PT, Lancs, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Birmingham; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Cornell University; Harvard University; Brigham & Women's Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Manchester	Rao, DA (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.	darao@partners.org; mbrenner@research.bwh.harvard.edu	liu, yan/HGV-1365-2022; Mizoguchi, Fumitaka/Y-3271-2018; Buckley, Christopher/AAN-6378-2021; Slowikowski, Kamil/K-3728-2016; Lee, Yvonne Claire/AAL-4826-2021; Filer, Andrew/AAP-9179-2021; Donlin, Laura T/P-2483-2019	Mizoguchi, Fumitaka/0000-0002-3956-7122; Buckley, Christopher/0000-0001-6924-6402; Slowikowski, Kamil/0000-0002-2843-6370; Lee, Yvonne Claire/0000-0002-2105-3393; Filer, Andrew/0000-0001-8164-6249; Donlin, Laura T/0000-0002-1428-090X; Rao, Deepak/0000-0001-9672-7746; Raychaudhuri, Soumya/0000-0002-1901-8265; Marshall, Jennifer/0000-0002-1727-8290	William Docken Inflammatory Autoimmune Disease Fund; Mallinckrodt Research Fellowship; NIH [5U01GM092691-05, 1U19 AI111224-01]; Doris Duke Charitable Foundation [2013097]; Rheumatology Research Foundation Scientist Development Award; Arthritis Research UK [19791, 18547]; Fundacion Bechara;  [T32 AR007530-31];  [R01 AR064850-03];  [K01 AR066063];  [FP7-HEALTH-F2-2012-305549 EuroTEAM];  [P30 AR070253]; Versus Arthritis [20088, 19791] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG009379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046713, R01AR064850, K01AR066063, R01AR048114, R01AR063759, P30AR070253, UH2AR067691, R01AR065538, T32AR007530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER	William Docken Inflammatory Autoimmune Disease Fund; Mallinckrodt Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Rheumatology Research Foundation Scientist Development Award; Arthritis Research UK(Versus Arthritis); Fundacion Bechara; ; ; ; ; ; Versus Arthritis(Versus Arthritis); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by T32 AR007530-31 and the William Docken Inflammatory Autoimmune Disease Fund (to M.B.B.), Mallinckrodt Research Fellowship (to D.A.R.), R01 AR064850-03 (to Y.C.L.), NIH 5U01GM092691-05, 1U19 AI111224-01 and Doris Duke Charitable Foundation Grant #2013097 (to S.R.), Rheumatology Research Foundation Scientist Development Award (to L.A.H.), K01 AR066063 (to L.T.D.), Arthritis Research UK programme grant # 19791 (to C.D.B.), and Arthritis Research UK Clinician Scientist Fellowship # 18547 (to A.F.). J.L.M was supported by the FP7-HEALTH-F2-2012-305549 EuroTEAM. P.A.N. was supported by P30 AR070253 and the Fundacion Bechara. We thank A. Chicoine and the BWH Human Immunology Center Flow Cytometry Core for assistance with cell sorting.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Van V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10875; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kamphorst AO, 2013, CURR OPIN IMMUNOL, V25, P381, DOI 10.1016/j.coi.2013.03.003; Kenefeck R, 2015, J CLIN INVEST, V125, P292, DOI 10.1172/JCI76238; Kobayashi S, 2013, ARTHRITIS RHEUM-US, V65, P3063, DOI 10.1002/art.38173; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Manzo A, 2008, ARTHRITIS RHEUM, V58, P3377, DOI 10.1002/art.23966; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Shen P, 2015, NAT REV IMMUNOL, V15, P441, DOI 10.1038/nri3857; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; Weinstein JS, 2014, BLOOD, V124, P3719, DOI 10.1182/blood-2014-06-582700; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862	24	497	517	6	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					110	+		10.1038/nature20810	http://dx.doi.org/10.1038/nature20810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28150777	Green Accepted, Green Submitted			2022-12-28	WOS:000396119300041
J	Shipley, WU; Seiferheld, W; Lukka, HR; Major, PP; Heney, NM; Grignon, DJ; Sartor, O; Patel, MP; Bahary, JP; Zietman, AL; Pisansky, TM; Zeitzer, KL; Lawton, CAF; Feng, FY; Lovett, RD; Balogh, AG; Souhami, L; Rosenthal, SA; Kerlin, KJ; Dignam, JJ; Pugh, SL; Sandler, HM				Shipley, W. U.; Seiferheld, W.; Lukka, H. R.; Major, P. P.; Heney, N. M.; Grignon, D. J.; Sartor, O.; Patel, M. P.; Bahary, J. -P.; Zietman, A. L.; Pisansky, T. M.; Zeitzer, K. L.; Lawton, C. A. F.; Feng, F. Y.; Lovett, R. D.; Balogh, A. G.; Souhami, L.; Rosenthal, S. A.; Kerlin, K. J.; Dignam, J. J.; Pugh, S. L.; Sandler, H. M.		NRG Oncology RTOG	Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BICALUTAMIDE 150 MG; MEDIAN FOLLOW-UP; PHASE-III TRIAL; ANDROGEN DEPRIVATION; CARDIOVASCULAR MORTALITY; RADIOTHERAPY; RTOG; MONOTHERAPY; CASTRATION; CARCINOMA	BACKGROUND Salvage radiation therapy is often necessary in men who have undergone radical prostatectomy and have evidence of prostate-cancer recurrence signaled by a persistently or recurrently elevated prostate-specific antigen (PSA) level. Whether antiandrogen therapy with radiation therapy will further improve cancer control and prolong overall survival is unknown. METHODS In a double-blind, placebo-controlled trial conducted from 1998 through 2003, we assigned 760 eligible patients who had undergone prostatectomy with a lymphadenectomy and had disease, as assessed on pathological testing, with a tumor stage of T2 (confined to the prostate but with a positive surgical margin) or T3 (with histologic extension beyond the prostatic capsule), no nodal involvement, and a detectable PSA level of 0.2 to 4.0 ng per milliliter to undergo radiation therapy and receive either antiandrogen therapy (24 months of bicalutamide at a dose of 150 mg daily) or daily placebo tablets during and after radiation therapy. The primary end point was the rate of overall survival. RESULTS The median follow-up among the surviving patients was 13 years. The actuarial rate of overall survival at 12 years was 76.3% in the bicalutamide group, as compared with 71.3% in the placebo group (hazard ratio for death, 0.77; 95% confidence interval, 0.59 to 0.99; P = 0.04). The 12-year incidence of death from prostate cancer, as assessed by means of central review, was 5.8% in the bicalutamide group, as compared with 13.4% in the placebo group (P<0.001). The cumulative incidence of metastatic prostate cancer at 12 years was 14.5% in the bicalutamide group, as compared with 23.0% in the placebo group (P = 0.005). The incidence of late adverse events associated with radiation therapy was similar in the two groups. Gynecomastia was recorded in 69.7% of the patients in the bicalutamide group, as compared with 10.9% of those in the placebo group (P<0.001). CONCLUSIONS The addition of 24 months of antiandrogen therapy with daily bicalutamide to salvage radiation therapy resulted in significantly higher rates of long-term overall survival and lower incidences of metastatic prostate cancer and death from prostate cancer than radiation therapy plus placebo.	[Shipley, W. U.; Heney, N. M.; Zietman, A. L.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Shipley, W. U.; Heney, N. M.; Zietman, A. L.] Harvard Med Sch, Boston, MA USA; [Seiferheld, W.; Dignam, J. J.; Pugh, S. L.] NRG Oncol Stat & Data Management Ctr, Philadelphia, PA USA; [Zeitzer, K. L.] Einstein Med Ctr, Philadelphia, PA USA; [Lukka, H. R.; Major, P. P.; Patel, M. P.] Hamilton Hlth Sci, Juravinski Canc Ctr, Hamilton, ON, Canada; [Bahary, J. -P.] Ctr Hosp Univ Montreal, Notre Dame Hosp, Montreal, PQ, Canada; [Souhami, L.] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Balogh, A. G.] Tom Baker Canc Clin, Calgary, AB, Canada; [Grignon, D. J.] Indiana Univ, Indianapolis, IN 46204 USA; [Sartor, O.] Tulane Univ, New Orleans, LA 70118 USA; [Pisansky, T. M.] Mayo Clin, Rochester, MN USA; [Lawton, C. A. F.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Feng, F. Y.] Univ Michigan, Ann Arbor, MI 48109 USA; [Lovett, R. D.] Univ Vermont, Med Ctr, Burlington, VT USA; [Rosenthal, S. A.] Radiat Oncol Ctr, Sacramento, CA USA; [Sandler, H. M.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Kerlin, K. J.] Wayne Radiat Oncol, Goldsboro, NC USA; [Dignam, J. J.] Univ Chicago, Chicago, IL 60637 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; McMaster University; Universite de Montreal; McGill University; Tom Baker Cancer Clinic; University of Calgary; Indiana University System; Indiana University-Purdue University Indianapolis; Tulane University; Mayo Clinic; Medical College of Wisconsin; University of Michigan System; University of Michigan; University of Vermont; University of Vermont Medical Center; Cedars Sinai Medical Center; University of Chicago	Shipley, WU (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, 55 Fruit St,Cox 3, Boston, MA 02114 USA.	wshipley@partners.org			National Cancer Institute [U10CA21661, U10CA180868, U10CA180822, UG1CA189867]; AstraZeneca; AbbVie; Actavis Specialty Pharmaceuticals; Sanofi; Janssen Pharmaceuticals; Astellas Pharma; Amgen; Bayer; Ferring Pharmaceuticals; Medivation Astellas; GenomeDx; Celgene; Varian Medical Systems; Medivation; Clovis Oncology; Blue Earth Diagnostics; NATIONAL CANCER INSTITUTE [U10CA180801, U10CA021661, U10CA180868, U10CA180822, UG1CA189867] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AstraZeneca(AstraZeneca); AbbVie(AbbVie); Actavis Specialty Pharmaceuticals; Sanofi; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Astellas Pharma(Astellas Pharmaceuticals); Amgen(Amgen); Bayer(Bayer AG); Ferring Pharmaceuticals(Ferring Pharmaceuticals); Medivation Astellas(Astellas Pharmaceuticals); GenomeDx; Celgene(Bristol-Myers SquibbCelgene Corporation); Varian Medical Systems; Medivation; Clovis Oncology; Blue Earth Diagnostics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants (U10CA21661, U10CA180868, U10CA180822, and UG1CA189867) from the National Cancer Institute and AstraZeneca.; Dr. Shipley reports having held stock in PFS Genomics (he no longer holds the stock); Dr. Lukka, receiving honoraria from AstraZeneca, Janssen Pharmaceuticals, Astellas Pharma, Amgen, AbbVie, Bayer, Actavis Specialty Pharmaceuticals, Sanofi, and Ferring Pharmaceuticals, receiving grant support to his institution from AstraZeneca, AbbVie, Actavis Specialty Pharmaceuticals, and Sanofi, and serving as a meeting coordinator for the GU Radiation Oncologists of Canada, which is sponsored by AstraZeneca, Janssen Pharmaceuticals, Astellas Pharma, Amgen, AbbVie, Bayer, Actavis Specialty Pharmaceuticals, Sanofi, and Ferring Pharmaceuticals; Dr. Feng, receiving fees for serving on advisory boards from Medivation Astellas, GenomeDx, and Celgene, receiving grant support from Varian Medical Systems and Celgene, and being the founder and president (unpaid) of PFS Genomics; Dr. Souhami, receiving lecture fees from Varian Medical Systems; and Dr. Sandler, receiving consulting fees from Sanofi, Medivation, Clovis Oncology, Janssen Pharmaceuticals, Ferring Pharmaceuticals, and Blue Earth Diagnostics and lecture fees from Varian Medical Systems. No other potential conflict of interest relevant to this article was reported.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; American Joint Committee on Cancer AJCC, 1997, AJCC CANC STAGING MA; Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502; Carrie C, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.5006; Cooperberg MR, 2015, JAMA-J AM MED ASSOC, V314, P80, DOI 10.1001/jama.2015.6036; COX DR, 1972, J R STAT SOC B, V34, P187; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Efstathiou JA, 2008, EUR UROL, V54, P816, DOI 10.1016/j.eururo.2008.01.021; Efstathiou JA, 2009, J CLIN ONCOL, V27, P92, DOI 10.1200/JCO.2007.12.3752; GAYNOR JJ, 1993, J AM STAT ASSOC, V88, P400, DOI 10.2307/2290318; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hanks GE, 2003, J CLIN ONCOL, V21, P3972, DOI 10.1200/JCO.2003.11.023; Iversen P, 1998, UROLOGY, V51, P389, DOI 10.1016/S0090-4295(98)00004-1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mullins JK, 2012, J UROLOGY, V188, P2219, DOI 10.1016/j.juro.2012.08.028; Parker C, 2007, CLIN ONCOL-UK, V19, P167, DOI 10.1016/j.clon.2007.01.001; Pilepich MV, 1997, J CLIN ONCOL, V15, P1013, DOI 10.1200/JCO.1997.15.3.1013; Pisansky TM, 2000, J UROLOGY, V163, P845, DOI 10.1016/S0022-5347(05)67817-2; Shipley WU, 2011, J CLIN ONCOL S, V29; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Trock BJ, 2008, JAMA-J AM MED ASSOC, V299, P2760, DOI 10.1001/jama.299.23.2760; Tyrrell CJ, 1998, EUR UROL, V33, P447, DOI 10.1159/000019634; Valicenti RK, 2013, INT J RADIAT ONCOL, V86, P822, DOI 10.1016/j.ijrobp.2013.05.029; Voog JC, 2016, EUR UROL, V69, P204, DOI 10.1016/j.eururo.2015.08.027; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Wirth MP, 2004, J UROLOGY, V172, P1865, DOI 10.1097/01.ju.0000140159.94703.80; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	30	376	377	2	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 2	2017	376	5					417	428		10.1056/NEJMoa1607529	http://dx.doi.org/10.1056/NEJMoa1607529			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8WH	28146658	Green Accepted			2022-12-28	WOS:000393507200005
J	Black, ME				Black, Mary E.			PERSONAL VIEW A smoke-free NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Black, Mary E.] Publ Hlth England, London, England	Public Health England	Black, ME (corresponding author), Publ Hlth England, London, England.	maryethnablack@me.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2017	356								j500	10.1136/bmj.j500	http://dx.doi.org/10.1136/bmj.j500			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BQ	28148483				2022-12-28	WOS:000393449800004
J	Muse, ED; Barrett, PM; Steinhubl, SR; Topol, EJ				Muse, Evan D.; Barrett, Paddy M.; Steinhubl, Steven R.; Topol, Eric J.			Digital medicine Towards a smart medical home	LANCET			English	Editorial Material									[Muse, Evan D.; Barrett, Paddy M.; Steinhubl, Steven R.; Topol, Eric J.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Muse, ED (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.	emuse@scripps.edu			NCATS NIH HHS [KL2 TR001112, UL1 TR001114] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001112, UL1TR001114] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))			0	29	30	2	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					358	358						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	28137686	Green Accepted			2022-12-28	WOS:000392804700019
J	Cho, A				Cho, Adrian			ASTROPHYSICS Can dark matter vanquish controversial rival theory? Challenge from modified Newtonian dynamics rebutted	SCIENCE			English	News Item																			0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					337	337		10.1126/science.355.6323.337	http://dx.doi.org/10.1126/science.355.6323.337			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126765				2022-12-28	WOS:000393172800014
J	Christe, KO				Christe, Karl O.			INORGANIC CHEMISTRY Polynitrogen chemistry enters the ring A cyclo-N-5(-) anion has been synthesized as a stable salt and characterized	SCIENCE			English	Editorial Material							STABILITY; N-5(+); N5+N5		[Christe, Karl O.] Univ Southern Calif, Hydrocarbon Res Inst, LHI 106, Los Angeles, CA 90089 USA; [Christe, Karl O.] Univ Southern Calif, Dept Chem, LHI 106, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Christe, KO (corresponding author), Univ Southern Calif, Hydrocarbon Res Inst, LHI 106, Los Angeles, CA 90089 USA.; Christe, KO (corresponding author), Univ Southern Calif, Dept Chem, LHI 106, Los Angeles, CA 90089 USA.	kchriste@usc.edu						Bazanov B, 2016, ANGEW CHEM INT EDIT, V55, P13233, DOI 10.1002/anie.201605400; Butler RN, 2008, J ORG CHEM, V73, P1354, DOI 10.1021/jo702423z; Christe KO, 2007, PROPELL EXPLOS PYROT, V32, P194, DOI 10.1002/prep.200700020; Christe KO, 1999, ANGEW CHEM INT EDIT, V38, P2004, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<2004::AID-ANIE2004>3.0.CO;2-7; Curtius T., 1890, N3H BER DTSCH CHE, V23, P3023; Dixon DA, 2004, J AM CHEM SOC, V126, P834, DOI 10.1021/ja0303182; Eremets MI, 2004, NAT MATER, V3, P558, DOI 10.1038/nmat1146; Nguyen MT, 2003, COORDIN CHEM REV, V244, P93, DOI 10.1016/S0010-8545(03)00101-2; Vij A, 2002, ANGEW CHEM INT EDIT, V41, P3051, DOI 10.1002/1521-3773(20020816)41:16<3051::AID-ANIE3051>3.0.CO;2-T; Zhang C, 2017, SCIENCE, V355, P374, DOI 10.1126/science.aah3840	10	61	65	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					351	351		10.1126/science.aal5057	http://dx.doi.org/10.1126/science.aal5057			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4FR	28126772				2022-12-28	WOS:000393172800021
J	Dauphas, N				Dauphas, Nicolas			The isotopic nature of the Earth's accreting material through time	NATURE			English	Article							CORE FORMATION; TERRESTRIAL PLANETS; MOON; ORIGIN; DIFFERENTIATION	The Earth formed by accretion of Moon-to Mars-size embryos coming from various heliocentric distances. The isotopic nature of these bodies is unknown. However, taking meteorites as a guide, most models assume that the Earth must have formed from a heterogeneous assortment of embryos with distinct isotopic compositions(1-3). High-precision measurements, however, show that the Earth, the Moon and enstatite meteorites have almost indistinguishable isotopic compositions(4-10). Models have been proposed that reconcile the Earth-Moon similarity with the inferred heterogeneous nature of Earth-forming material, but these models either require specific geometries for the Moon-forming impact(11,12) or can explain only one aspect of the Earth-Moon similarity (that is, O-17)(1-3). Here I show that elements with distinct affinities for metal can be used to decipher the isotopic nature of the Earth's accreting material through time. I find that the mantle signatures of lithophile O, Ca, Ti and Nd, moderately siderophile Cr, Ni and Mo, and highly siderophile Ru record different stages of the Earth's accretion; yet all those elements point to material that was isotopically most similar to enstatite meteorites. This isotopic similarity indicates that the material accreted by the Earth always comprised a large fraction of enstatite-type impactors (about half were E-type in the first 60 per cent of the accretion and all of the impactors were E-type after that). Accordingly, the giant impactor that formed the Moon probably had an isotopic composition similar to that of the Earth, hence relaxing the constraints on models of lunar formation. Enstatite meteorites and the Earth were formed from the same isotopic reservoir but they diverged in their chemical evolution owing to subsequent fractionation by nebular and planetary processes(13).	[Dauphas, Nicolas] Univ Chicago, Origins Lab, Dept Geophys Sci, 5734 South Ellis Ave, Chicago, IL 60637 USA; [Dauphas, Nicolas] Univ Chicago, Enrico Fermi Inst, 5734 South Ellis Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Dauphas, N (corresponding author), Univ Chicago, Origins Lab, Dept Geophys Sci, 5734 South Ellis Ave, Chicago, IL 60637 USA.; Dauphas, N (corresponding author), Univ Chicago, Enrico Fermi Inst, 5734 South Ellis Ave, Chicago, IL 60637 USA.	dauphas@uchicago.edu			NSF (CSEDI) [EAR1502591]; NSF (Petrology and Geochemistry) [EAR1444951]; NASA (LARS) [NNX14AK09G]	NSF (CSEDI)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NSF (Petrology and Geochemistry)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NASA (LARS)	S. Jacobson provided the PDFs for the Rubie et al. model<SUP>15</SUP> and J. Siebert and J. Badro provided assistance during development of the code to reproduce their model<SUP>19</SUP>. Discussions with A. Morbidelli, D. Rubie, A. Campbell, F. Ciesla, R. Yokochi, M. Roskosz, N. Greber and C. Burkhardt were greatly appreciated. J. Hu double-checked all the derivations and codes used in this contribution. This work was supported by NSF (CSEDI, grant EAR1502591; Petrology and Geochemistry, grant EAR1444951) and NASA (LARS, grant NNX14AK09G).	Badro J, 2015, P NATL ACAD SCI USA, V112, P12310, DOI 10.1073/pnas.1505672112; Bottke WF, 2010, SCIENCE, V330, P1527, DOI 10.1126/science.1196874; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Burkhardt C, 2016, NATURE, V537, P394, DOI 10.1038/nature18956; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Dauphas N, 2015, LUNAR PLANET SCI C A, V46, P2436; Dauphas N, 2016, ANNU REV EARTH PL SC, V44, P709, DOI 10.1146/annurev-earth-060115-012157; Dauphas N, 2015, EARTH PLANET SC LETT, V427, P236, DOI 10.1016/j.epsl.2015.07.008; Javoy M, 2010, EARTH PLANET SC LETT, V293, P259, DOI 10.1016/j.epsl.2010.02.033; Kaib NA, 2015, ICARUS, V252, P161, DOI 10.1016/j.icarus.2015.01.013; Kruijer TS, 2015, NATURE, V520, P534, DOI 10.1038/nature14360; Nimmo F, 2010, EARTH PLANET SC LETT, V292, P363, DOI 10.1016/j.epsl.2010.02.003; Nittler LR, 2011, SCIENCE, V333, P1847, DOI 10.1126/science.1211567; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Qin LP, 2010, GEOCHIM COSMOCHIM AC, V74, P1122, DOI 10.1016/j.gca.2009.11.005; Render J., 2016, LUNAR PLANET SCI C, VXXXXVII, P2639; Rubie DC, 2015, ICARUS, V248, P89, DOI 10.1016/j.icarus.2014.10.015; Rubie DC, 2016, SCIENCE, V353, P1141, DOI 10.1126/science.aaf6919; Rudge JF, 2010, NAT GEOSCI, V3, P439, DOI 10.1038/NGEO872; Schonbachler M, 2010, SCIENCE, V328, P884, DOI 10.1126/science.1186239; Siebert J, 2011, GEOCHIM COSMOCHIM AC, V75, P1451, DOI 10.1016/j.gca.2010.12.013; Tang H, 2014, EARTH PLANET SC LETT, V390, P264, DOI 10.1016/j.epsl.2014.01.005; Warren PH, 2011, EARTH PLANET SC LETT, V311, P93, DOI 10.1016/j.epsl.2011.08.047; Young ED, 2016, SCIENCE, V351, P493, DOI 10.1126/science.aad0525; Zhang JJ, 2012, NAT GEOSCI, V5, P251, DOI [10.1038/NGEO1429, 10.1038/ngeo1429]	32	216	220	4	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2017	541	7638					521	524		10.1038/nature20830	http://dx.doi.org/10.1038/nature20830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6LX	28128239				2022-12-28	WOS:000396116600048
J	Batty, GD; Russ, TC; Stamatakis, E; Kivimaki, M				Batty, G. David; Russ, Tom C.; Stamatakis, Emmanuel; Kivimaki, Mika			Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; SELF-REPORTED CANCERS; FOLLOW-UP; RISK-FACTOR; CARDIOVASCULAR MORTALITY; POOLED ANALYSIS; ALL-CAUSE; DEPRESSION; METAANALYSIS; ASSOCIATION	OBJECTIVE To examine the role of psychological distress (anxiety and depression) as a potential predictor of site specific cancer mortality. DESIGN Pooling of individual participant data from 16 prospective cohort studies initiated 1994-2008. SETTING Nationally representative samples drawn from the health survey for England (13 studies) and the Scottish health survey (three studies). PARTICIPANTS 163 363 men and women aged 16 or older at study induction, who were initially free of a cancer diagnosis, provided self reported psychological distress scores (based on the general health questionnaire, GHQ-12) and consented to health record linkage. MAIN OUTCOME MEASURE Vital status records used to ascertain death from 16 site specific malignancies; the three Scottish studies also had information on cancer registration (incidence). RESULTS The studies collectively contributed an average of 9.5 years of mortality surveillance during which there were 16 267 deaths (4353 from cancer). After adjustment for age, sex, education, socioeconomic status, body mass index (BMI), and smoking and alcohol intake, and with reverse causality (by left censoring) and missing data (by imputation) taken into account, relative to people in the least distressed group (GHQ-12 score 0-6), death rates in the most distressed group (score 7-12) were consistently raised for cancer of all sites combined (multivariable adjusted hazard ratio 1.32, 95% confidence interval 1.18 to 1.48) and cancers not related to smoking (1.45, 1.23 to 1.71), as well as carcinoma of the colorectum (1.84, 1.21 to 2.78), prostate (2.42, 1.29 to 4.54), pancreas (2.76, 1.47 to 5.19), oesophagus (2.59, 1.34 to 5.00), and for leukaemia (3.86, 1.42 to 10.5). Stepwise associations across the full range of distress scores were observed for colorectal and prostate cancer. CONCLUSION This study contributes to the growing evidence that psychological distress might have some predictive capacity for selected cancer presentations, in addition to other somatic diseases.	[Batty, G. David; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Russ, Tom C.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Russ, Tom C.] Univ Edinburgh, Div Psychiat, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Stamatakis, Emmanuel] Univ Sydney, Charles Perkins Ctr, Fac Hlth Sci, Sydney, NSW, Australia	University of London; University College London; University of Edinburgh; University of Edinburgh; University of Sydney	Batty, GD (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	david.batty@ucl.ac.uk	Batty, GD/Y-4401-2018; Russ, Tom/J-7114-2015; Stamatakis, Emmanuel/C-4958-2009	Batty, GD/0000-0003-1822-5753; Russ, Tom/0000-0001-9797-2188; Stamatakis, Emmanuel/0000-0001-7323-3225; Kivimaki, Mika/0000-0002-4699-5627	Alzheimer Scotland through the Marjorie MacBeath bequest; Medical Research Council [K013351]; NordForsk (the Nordic Programme on Health and Welfare); ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL12-Russ] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1, MR/K026992/1] Funding Source: researchfish	Alzheimer Scotland through the Marjorie MacBeath bequest; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NordForsk (the Nordic Programme on Health and Welfare); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. TCR is supported by Alzheimer Scotland through the Marjorie MacBeath bequest. MK is supported by the Medical Research Council (K013351) and NordForsk (the Nordic Programme on Health and Welfare). The views expressed herein by the authors are independent of all funding agencies.	American Cancer Society, 2016, CANC FACTS FIGURES 2; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 1977, MANUAL INT STAT CLAS; [Anonymous], 1992, INT STAT CLASSIFICAT; Batty D, 2000, BRIT MED J, V321, P1424, DOI 10.1136/bmj.321.7274.1424; Batty GD, 2008, ANN ONCOL, V19, P996, DOI 10.1093/annonc/mdm578; Batty GD, 2016, JAMA PSYCHIAT, V73, P993, DOI 10.1001/jamapsychiatry.2016.1805; Batty GD, 2016, AM J EPIDEMIOL, V183, P183, DOI 10.1093/aje/kwv139; Batty GD, 2014, ATHEROSCLEROSIS, V236, P385, DOI 10.1016/j.atherosclerosis.2014.06.025; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P556; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Chang CK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004295; Chang HY, 2015, J AFFECT DISORDERS, V173, P1, DOI 10.1016/j.jad.2014.10.064; Chen YH, 2011, J AFFECT DISORDERS, V131, P200, DOI 10.1016/j.jad.2010.12.006; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Colditz GA, 2000, CANCER CAUSE CONTROL, V11, P477, DOI 10.1023/A:1008984432272; COX DR, 1972, J R STAT SOC B, V34, P187; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Fedeles BI, 2015, P NATL ACAD SCI USA, V112, pE4571, DOI 10.1073/pnas.1507709112; Gallo JJ, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f2570; Goldacre MJ, 2007, SOC PSYCH PSYCH EPID, V42, P683, DOI 10.1007/s00127-007-0211-2; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Gray L, 2010, INT J EPIDEMIOL, V39, P345, DOI 10.1093/ije/dyp155; Gross AL, 2010, CANCER CAUSE CONTROL, V21, P191, DOI 10.1007/s10552-009-9449-1; Haapakoski R, 2016, PROG NEURO-PSYCHOPH, V66, P63, DOI 10.1016/j.pnpbp.2015.11.012; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hotopf M, 2002, PALLIATIVE MED, V16, P81, DOI 10.1191/02169216302pm507oa; Hung YN, 2014, BRIT J PSYCHIAT, V205, P183, DOI 10.1192/bjp.bp.114.144741; International Agency for Research on Cancer, 2002, IARC MON EV CARC RIS, V38; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jokela M, 2014, J BEHAV MED, V37, P881, DOI 10.1007/s10865-013-9548-z; KANNEL WB, 1987, HEALTH SERV RES, V22, P499; Kengne AP, 2012, J HEPATOL, V57, P1083, DOI 10.1016/j.jhep.2012.06.034; Kiecolt-Glaser JK, 2002, ANN ONCOL, V13, P165, DOI 10.1093/annonc/mdf655; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Lemogne C, 2013, AM J EPIDEMIOL, V178, P1712, DOI 10.1093/aje/kwt217; Lerman C, 1994, J Natl Cancer Inst Monogr, P171; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McCartney G, 2015, J EPIDEMIOL COMMUN H, V69, P20, DOI 10.1136/jech-2014-204185; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Mettler CC, 1947, HIST MED; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Oerlemans Marjolein Ej, 2007, Clin Pract Epidemiol Ment Health, V3, P29, DOI 10.1186/1745-0179-3-29; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Pan A, 2011, STROKE, V42, P2770, DOI 10.1161/STROKEAHA.111.617043; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Parikh-Patel A, 2003, AM J EPIDEMIOL, V157, P539, DOI 10.1093/aje/kwg006; Pelucchi C, 2011, NUTR CANCER, V63, P983, DOI 10.1080/01635581.2011.596642; Phillips AC, 2009, PSYCHOSOM MED, V71, P395, DOI 10.1097/PSY.0b013e31819e6706; Pirl WF, 1999, ONCOLOGY-NY, V13, P1293; Pirl WF, 1999, ONCOLOGY, V13, P1305; Rubin DB, 1987, MULTIPLE IMPUTATION; Russ TC, 2015, GASTROENTEROLOGY, V148, P958, DOI 10.1053/j.gastro.2015.02.004; Russ Tom C, 2012, BMJ, V345, pe4933, DOI 10.1136/bmj.e4933; Russ TC, 2011, ARCH INTERN MED, V171, P1858, DOI 10.1001/archinternmed.2011.521; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2016, INT J EPIDEMIOL, V45, P605, DOI 10.1093/ije/dyw224; Spiegel D, 2003, BIOL PSYCHIAT, V54, P269, DOI 10.1016/S0006-3223(03)00566-3; Stamatakis E, 2013, EUR HEART J, V34, P750, DOI 10.1093/eurheartj/ehs097; STANSFELD SA, 1992, PSYCHOL MED, V22, P939, DOI 10.1017/S0033291700038514; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; UK Chief Medical Officers, 2015, UK CHIEF MED OFF ALC; World Health Organization, 1995, WHO TECH REP SER, V854, P1; Yang EV, 2002, INT IMMUNOPHARMACOL, V2, P315, DOI 10.1016/S1567-5769(01)00182-5; ZIEGLER RG, 1993, JNCI-J NATL CANCER I, V85, P1819, DOI 10.1093/jnci/85.22.1819	71	168	170	2	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2017	356								j108	10.1136/bmj.j108	http://dx.doi.org/10.1136/bmj.j108			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ4HO	28122812	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000393177700004
J	Lind, M; Polonsky, W; Hirsch, IB; Heise, T; Bolinder, J; Dahlqvist, S; Schwarz, E; Olafsdottir, AF; Frid, A; Wedel, H; Ahlen, E; Nystrom, T; Hellman, J				Lind, Marcus; Polonsky, William; Hirsch, Irl B.; Heise, Tim; Bolinder, Jan; Dahlqvist, Sofia; Schwarz, Erik; Olafsdottir, Arndis Finna; Frid, Anders; Wedel, Hans; Ahlen, Elsa; Nystrom, Thomas; Hellman, Jarl			Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-GLUCOSE; TREATMENT SATISFACTION; SEVERE HYPOGLYCEMIA; SWEDISH VERSION; PUMP THERAPY; ASSOCIATION; REDUCTION; FREQUENCY	IMPORTANCE The majority of individuals with type 1 diabetes do not meet recommended glycemic targets. OBJECTIVE To evaluate the effects of continuous glucose monitoring in adults with type 1 diabetes treated with multiple daily insulin injections. DESIGN, SETTING, AND PARTICIPANTS Open-label crossover randomized clinical trial conducted in 15 diabetes outpatient clinics in Sweden between February 24, 2014, and June 1, 2016 that included 161 individuals with type 1 diabetes and hemoglobin A(1c) (HbA(1c)) of at least 7.5%(58 mmol/mol) treated with multiple daily insulin injections. INTERVENTIONS Participants were randomized to receive treatment using a continuous glucose monitoring system or conventional treatment for 26 weeks, separated by a washout period of 17 weeks. MAIN OUTCOMES AND MEASURES Difference in HbA(1c) between weeks 26 and 69 for the 2 treatments. Adverse events including severe hypoglycemia were also studied. RESULTS Among 161 randomized participants, mean age was 43.7 years, 45.3% were women, and mean HbA(1c) was 8.6%(70 mmol/mol). A total of 142 participants had follow-up data in both treatment periods. Mean HbA(1c) was 7.92%(63 mmol/mol) during continuous glucose monitoring use and 8.35%(68 mmol/mol) during conventional treatment (mean difference, -0.43% [95% CI, -0.57% to -0.29%] or -4.7 [-6.3 to -3.1 mmol/mol]; P < .001). Of 19 secondary end points comprising psychosocial and various glycemic measures, 6 met the hierarchical testing criteria of statistical significance, favoring continuous glucose monitoring compared with conventional treatment. Five patients in the conventional treatment group and 1 patient in the continuous glucose monitoring group had severe hypoglycemia. During washout when patients used conventional therapy, 7 patients had severe hypoglycemia. CONCLUSIONS AND RELEVANCE Among patients with inadequately controlled type 1 diabetes treated with multiple daily insulin injections, the use of continuous glucose monitoring compared with conventional treatment for 26 weeks resulted in lower HbA(1c). Further research is needed to assess clinical outcomes and longer-term adverse effects.	[Lind, Marcus; Ahlen, Elsa] Univ Gothenburg, Dept Mol & Clin Med, Gothenburg, Sweden; [Lind, Marcus; Dahlqvist, Sofia; Olafsdottir, Arndis Finna; Ahlen, Elsa] NU Hosp Grp, Dept Med, Uddevalla, Sweden; [Polonsky, William] Univ Calif San Diego, La Jolla, CA 92093 USA; [Hirsch, Irl B.] Univ Washington, Sch Med, Seattle, WA USA; [Heise, Tim] Profil, Neuss, Germany; [Bolinder, Jan] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Stockholm, Sweden; [Schwarz, Erik] Univ Orebro, Fac Med & Hlth, Dept Internal Med, Orebro, Sweden; [Frid, Anders] Skane Univ Hosp, Dept Clin Sci, Div Endocrinol, Malmo, Sweden; [Frid, Anders] Lund Univ, Lund, Sweden; [Wedel, Hans] Univ Gothenburg, Hlth Metr Sahlgrenska Acad, Gothenburg, Sweden; [Nystrom, Thomas] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden; [Hellman, Jarl] Uppsala Univ, Dept Med Sci Clin Diabet & Metab, Uppsala, Sweden	University of Gothenburg; NU Hospital Group; Voestalpine AG; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; Profil; Karolinska Institutet; Karolinska University Hospital; Orebro University; Lund University; Skane University Hospital; Lund University; University of Gothenburg; Karolinska Institutet; Sodersjukhuset Hospital; Uppsala University	Lind, M (corresponding author), Uddevalla Cent Hosp, Diabet Outpatient Clin, S-45180 Uddevalla, Sweden.	lind.marcus@telia.com	Lind, Marcus/GRJ-4946-2022; Lind, Marcus/AAI-6733-2021	Bolinder, Jan/0000-0003-0035-0142; Lind, Marcus/0000-0002-3796-9283; Olafsdottir, Arndis Finna/0000-0002-2083-2512	NU Hospital Group, Trollhattan and Uddevalla, Sweden	NU Hospital Group, Trollhattan and Uddevalla, Sweden	The trial was sponsored by the NU Hospital Group, Trollhattan and Uddevalla, Sweden.	Ahlen Elsa, 2016, J Diabetes Sci Technol, V10, P1006, DOI 10.1177/1932296816652901; Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010; Anderbro T, 2008, PATIENT EDUC COUNS, V73, P127, DOI 10.1016/j.pec.2008.03.022; Baghurst PA, 2011, DIABETES TECHNOL THE, V13, P296, DOI 10.1089/dia.2010.0090; Battelino T, 2012, DIABETOLOGIA, V55, P3155, DOI 10.1007/s00125-012-2708-9; Beck RW, 2010, DIABETES CARE, V33, P2175, DOI 10.2337/dc10-0331; Bergenstal RM, 2013, NEW ENGL J MED, V369, P224, DOI 10.1056/NEJMoa1303576; Bergenstal RM, 2011, DIABETES CARE, V34, P2403, DOI 10.2337/dc11-1248; Bradley C, 1999, DIABETES CARE, V22, P530, DOI 10.2337/diacare.22.3.530; Bradley C, 2008, DIABETES OBES METAB, V10, P50, DOI 10.1111/j.1463-1326.2008.00871.x; Bradley C., 1994, HDB PSYCHOL DIABETES, V1; Evans JMM, 1999, BMJ-BRIT MED J, V319, P83, DOI 10.1136/bmj.319.7202.83; Fiallo-Scharer R, 2011, DIABETES CARE, V34, P586, DOI 10.2337/dc10-1111; Gonder-Frederick, 1997, Semin Clin Neuropsychiatry, V2, P57; Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343; Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040; Hajos TRS, 2012, QUAL LIFE RES, V21, P1359, DOI 10.1007/s11136-011-0051-0; Hansen MV, 2009, DIABETES RES CLIN PR, V85, P183, DOI 10.1016/j.diabres.2009.04.022; Herman WH, 2016, DIABETES CARE, V39, pS3, DOI 10.2337/dc16-S002; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Hirsch IB, 2009, J CLIN ENDOCR METAB, V94, P2232, DOI 10.1210/jc.2008-2625; Irvine A, 1994, HDB PSYCHOL DIABETES; Kovatchev BP, 2000, J CLIN ENDOCR METAB, V85, P4287, DOI 10.1210/jc.85.11.4287; Lind M, 2010, DIABETOLOGIA, V53, P1093, DOI 10.1007/s00125-010-1706-z; Lind Marcus, 2016, J Diabetes Sci Technol, V10, P754, DOI 10.1177/1932296816642578; Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214; Lind M, 2008, DIABETES METAB SYND, V2, P282, DOI 10.1016/j.dsx.2008.04.006; Matthews JNS, 2014, STAT METHODS MED RES, V23, P60, DOI 10.1177/0962280212445838; Miller KM, 2013, DIABETES CARE, V36, P2009, DOI 10.2337/dc12-1770; Misso ML, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005103.pub2; Pickup JC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3805; POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754; Riveline JP, 2012, DIABETES CARE, V35, P965, DOI 10.2337/dc11-2021; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Zhang Y., 2010, JCOM, V17, P547	36	338	341	2	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					379	387		10.1001/jama.2016.19976	http://dx.doi.org/10.1001/jama.2016.19976			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118454				2022-12-28	WOS:000392509600020
J	Leslie, WD; Majumdar, SR; Morin, SN; Lix, LM				Leslie, William D.; Majumdar, Sumit R.; Morin, Suzanne N.; Lix, Lisa M.			Change in Bone Mineral Density Is an Indicator of Treatment-Related Antifracture Effect RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							DENSITOMETRY		[Leslie, William D.; Lix, Lisa M.] Univ Manitoba, Winnipeg, MB, Canada; [Majumdar, Sumit R.] Univ Alberta, Edmonton, AB, Canada; [Morin, Suzanne N.] McGill Univ, Montreal, PQ, Canada	University of Manitoba; University of Alberta; McGill University	Leslie, WD (corresponding author), Univ Manitoba, Winnipeg, MB, Canada.							Cummings SR, 2000, JAMA-J AM MED ASSOC, V283, P1318, DOI 10.1001/jama.283.10.1318; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Leslie WD, 2015, J CLIN ENDOCR METAB, V100, P679, DOI 10.1210/jc.2014-3777; Shepherd JA, 2006, J CLIN DENSITOM, V9, P31, DOI 10.1016/j.jocd.2006.05.005	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					152	153		10.7326/L16-0529	http://dx.doi.org/10.7326/L16-0529			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	28114471				2022-12-28	WOS:000391842600026
J	Pignone, M; Viera, AJ				Pignone, Michael; Viera, Anthony J.			Blood Pressure Treatment Targets in Adults Aged 60 Years or Older	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HYPERTENSION		[Pignone, Michael] Univ Texas Austin, Dell Med Sch, 1912 Speedway D2000, Austin, TX 78712 USA; [Viera, Anthony J.] Univ North Carolina Chapel Hill, Dept Family Med, 590 Manning Dr,CB 7595, Chapel Hill, NC 27599 USA	University of Texas System; University of Texas Austin; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Pignone, M (corresponding author), Univ Texas Austin, Dell Med Sch, 1912 Speedway D2000, Austin, TX 78712 USA.	pignone@austin.utexas.edu						Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; Navar AM, 2016, JAMA CARDIOL, V1, P864, DOI 10.1001/jamacardio.2016.2861; Qaseem A, 2017, ANN INTERN MED, V166, P430, DOI 10.7326/M16-1785; Richman IB, 2016, JAMA CARDIOL, V1, P872, DOI 10.1001/jamacardio.2016.3517; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Weiss J, 2017, ANN INTERN MED, V166, P419, DOI 10.7326/M16-1754	9	3	4	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					445	+		10.7326/M17-0034	http://dx.doi.org/10.7326/M17-0034			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28114514				2022-12-28	WOS:000397025800022
J	Soria, JC; Tan, DSW; Chiari, R; Wu, YL; Paz-Ares, L; Wolf, J; Geater, SL; Orlov, S; Cortinovis, D; Yu, CJ; Hochmair, M; Cortot, AB; Tsai, CM; Moro-Sibilot, D; Campelo, RG; McCulloch, T; Sen, P; Dugan, M; Pantano, S; Branle, F; Massacesi, C; de Castro, G				Soria, Jean-Charles; Tan, Daniel S. W.; Chiari, Rita; Wu, Yi-Long; Paz-Ares, Luis; Wolf, Juergen; Geater, Sarayut L.; Orlov, Sergey; Cortinovis, Diego; Yu, Chong-Jen; Hochmair, Maximillian; Cortot, Alexis B.; Tsai, Chun-Ming; Moro-Sibilot, Denis; Campelo, Rosario G.; McCulloch, Tracey; Sen, Paramita; Dugan, Margaret; Pantano, Serafino; Branle, Fabrice; Massacesi, Cristian; de Castro, Gilberto, Jr.			First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study	LANCET			English	Article							PEMETREXED PLUS CISPLATIN; CRIZOTINIB; PARAMOUNT	Background The efficacy of ceritinib in patients with untreated anaplastic lymphoma kinase (ALK)-rearranged non-small-cell lung cancer (NSCLC) is not known. We assessed the efficacy and safety of ceritinib versus platinum-based chemotherapy in these patients. Methods This randomised, open-label, phase 3 study in untreated patients with stage IIIB/IV ALK-rearranged non-squamous NSCLC was done in 134 centres across 28 countries. Eligible patients were assigned via interactive response technology to oral ceritinib 750 mg/day or platinum-based chemotherapy ([cisplatin 75 mg/m(2) or carboplatin AUC 5-6 plus pemetrexed 500 mg/m(2)] every 3 weeks for four cycles followed by maintenance pemetrexed); randomisation was stratified by World Health Organization performance status (0 vs 1-2), previous neoadjuvant or adjuvant chemotherapy, and presence of brain metastases as per investigator's assessment at screening. Investigators and patients were not masked to treatment assignment. The primary endpoint was blinded independent review committee assessed progression-free survival, based on all randomly assigned patients (the full analysis set). Efficacy analyses were done based on the full analysis set. All safety analyses were done based on the safety set, which included all patients who received at least one dose of study drug. This trial is registered with ClinicalTrials.gov, number NCT01828099. Findings Between Aug 19, 2013, and May 11, 2015, 376 patients were randomly assigned to ceritinib (n=189) or chemotherapy (n=187). Median progression-free survival (as assessed by blinded independent review committee) was 16.6 months (95% CI 12.6-27.2) in the ceritinib group and 8.1 months (5.8-11.1) in the chemotherapy group (hazard ratio 0.55 [95% CI 0.42-0.73]; p<0.00001). The most common adverse events were diarrhoea (in 160 [85%] of 189 patients), nausea (130 [69%]), vomiting (125 [66%]), and an increase in alanine aminotransferase (114 [60%]) in the ceritinib group and nausea (in 97 [55%] of 175 patients), vomiting (63 [36%]), and anaemia (62 [35%]) in the chemotherapy group. Interpretation First-line ceritinib showed a statistically significant and clinically meaningful improvement in progression-free survival versus chemotherapy in patients with advanced ALK-rearranged NSCLC.	[Soria, Jean-Charles] Univ Paris Sud, Orsay, France; [Soria, Jean-Charles] Inst Gustave Roussy, 114 Rue Edouard Vaillant, F-94800 Villejuif, France; [Tan, Daniel S. W.] Natl Canc Ctr Singapore, Singapore, Singapore; [Tan, Daniel S. W.] Genome Inst Singapore, Singapore, Singapore; [Chiari, Rita] Azienda Osped Perugia, Perugia, Italy; [Wu, Yi-Long] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; [Wu, Yi-Long] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Paz-Ares, Luis] Univ Complutense, Univ Hosp Virgen del Rocio Doce Octubre, Madrid, Spain; [Paz-Ares, Luis] CNIO, Madrid, Spain; [Wolf, Juergen] Univ Hosp Cologne, Cologne, Germany; [Geater, Sarayut L.] Songklanagarind Hosp, Songkhla, Thailand; [Orlov, Sergey] State Pavlov Med Univ, St Petersburg, Russia; [Cortinovis, Diego] Osped San Gerardo, Monza, Italy; [Yu, Chong-Jen] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Hochmair, Maximillian] Otto Wagner Spital, Resp Oncol Unit, Dept Resp & Crit Care Med, Vienna, Austria; [Cortot, Alexis B.] CHU Lille, Lille, France; [Tsai, Chun-Ming] Taipei Vet Gen Hosp, Taipei, Taiwan; [Moro-Sibilot, Denis] Hop Albert Michallon, Grenoble, France; [Campelo, Rosario G.] Univ Hosp A Coruna, La Coruna, Spain; [McCulloch, Tracey; Sen, Paramita; Dugan, Margaret] Novartis Pharmaceut, E Hanover, NJ USA; [Pantano, Serafino; Branle, Fabrice; Massacesi, Cristian] Novartis Pharma AG, Basel, Switzerland; [de Castro, Gilberto, Jr.] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil	UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; National Cancer Centre Singapore (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Perugia; Azienda Ospedaliera di Perugia; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Complutense University of Madrid; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Cologne; Prince of Songkla University; San Gerardo Hospital; National Taiwan University; National Taiwan University Hospital; Universite de Lille - ISITE; CHU Lille; Taipei Veterans General Hospital; CHU Grenoble Alpes; Complejo Hospitalario Universitario A Coruna; Novartis; Novartis	Soria, JC (corresponding author), Inst Gustave Roussy, 114 Rue Edouard Vaillant, F-94800 Villejuif, France.	Jean-Charles.Soria@gustaveroussy.fr	Wu, Yi-Long/C-3396-2008; Cortot, Alexis B/F-7006-2019; Wu, Yi-Long/AAW-9832-2020; Soria, Jean-Charles/F-3619-2014; Cortinovis, Diego/AAC-2076-2022; de Castro, Gilberto/C-1627-2013; Orlov, Sergey/AAC-8379-2022; Wu, Yi-Long/GRJ-9238-2022; Paz-Ares, Luis/AAH-2750-2019; Wu, Yi-Long/AAB-9137-2022	Wu, Yi-Long/0000-0002-3611-0258; Cortot, Alexis B/0000-0003-0098-2238; de Castro, Gilberto/0000-0001-8765-3044; Wu, Yi-Long/0000-0002-3611-0258; cortinovis, diego/0000-0001-7611-7369; Yu, Chong-Jen/0000-0001-5664-9392; Orlov, Sergey/0000-0001-6080-8042; chiari, rita/0000-0002-7649-273X; MORO-SIBILOT, Denis/0000-0001-6776-8610	Novartis Pharmaceuticals Corporation	Novartis Pharmaceuticals Corporation(Novartis)	Novartis Pharmaceuticals Corporation.	Camidge DR, 2011, J THORAC ONCOL, V6, P774, DOI 10.1097/JTO.0b013e31820cf053; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Dziadziuszko R, 2016, WORLD C LUNG CANC VI; Felip E, 2016, ANN ONCOL S, V27; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Gettinger SN, 2016, LANCET ONCOL, V17, P1683, DOI 10.1016/S1470-2045(16)30392-8; Hida T, LANCET IN PRESS; Hong Y, 2017, J CLIN PHARMACOL, V57, P652, DOI 10.1002/jcph.849; Kang D, 2016, INT J PRECIS ENG MAN, V17, P5, DOI 10.1007/s12541-016-0001-4; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Kim Y, 2016, WORLD C LUNG CANC VI; Lee JO, 2011, J THORAC ONCOL, V6, P1474, DOI 10.1097/JTO.0b013e3182208fc2; Otterson GA, 2012, J CLIN ONCOL, V30; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Paz-Ares LG, 2013, J CLIN ONCOL, V31, P2895, DOI 10.1200/JCO.2012.47.1102; Peters S, 2014, ANN ONCOL, V25; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Scagliotti GV, 2005, CLIN CANCER RES, V11, P690; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solomon BJ, 2016, J CLIN ONCOL, V34, P2858, DOI 10.1200/JCO.2015.63.5888; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Zhang I, 2015, LANCET ONCOL, V16, pE510, DOI 10.1016/S1470-2045(15)00013-3; Zykadia prescribing information, 2014, ZYK PRESCR INF	25	654	696	0	84	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					917	929		10.1016/S0140-6736(17)30123-X	http://dx.doi.org/10.1016/S0140-6736(17)30123-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM4DL	28126333				2022-12-28	WOS:000395263400031
J	Lacy, ME; Wellenius, GA; Sumner, AE; Correa, A; Carnethon, MR; Liem, RI; Wilson, JG; Sacks, DB; Jacobs, DR; Carson, AP; Luo, X; Gjelsvik, A; Reiner, AP; Naik, RP; Liu, SM; Musani, SK; Eaton, CB; Wu, WC				Lacy, Mary E.; Wellenius, Gregory A.; Sumner, Anne E.; Correa, Adolfo; Carnethon, Mercedes R.; Liem, Robert I.; Wilson, James G.; Sacks, David B.; Jacobs, David R., Jr.; Carson, April P.; Luo, Xi; Gjelsvik, Annie; Reiner, Alexander P.; Naik, Rakhi P.; Liu, Simin; Musani, Solomon K.; Eaton, Charles B.; Wu, Wen-Chih			Association of Sickle Cell Trait With Hemoglobin A(1c) in African Americans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; LIFE-SPAN; A1C; GLUCOSE; ADULTS; PREVALENCE; DISPARITIES; HBA(1C)	IMPORTANCE Hemoglobin A(1c) (HbA(1c)) reflects past glucose concentrations, but this relationship may differ between those with sickle cell trait (SCT) and those without it. OBJECTIVE To evaluate the association between SCT and HbA(1c) for given levels of fasting or 2-hour glucose levels among African Americans. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study using data collected from 7938 participants in 2 community-based cohorts, the Coronary Artery Risk Development in Young Adults (CARDIA) study and the Jackson Heart Study (JHS). From the CARDIA study, 2637 patients contributed a maximum of 2 visits (2005-2011); from the JHS, 5301 participants contributed a maximum of 3 visits (2000-2013). All visits were scheduled at approximately 5-year intervals. Participants without SCT data, those without any concurrent HbA(1c) and glucose measurements, and those with hemoglobin variants HbSS, HbCC, or HbAC were excluded. Analysis of the primary outcome was conducted using generalized estimating equations (GEE) to examine the association of SCT with HbA(1c) levels, controlling for fasting or 2-hour glucose measures. EXPOSURES Presence of SCT. MAIN OUTCOMES AND MEASURES Hemoglobin A(1c) stratified by the presence or absence of SCT was the primary outcome measure. RESULTS The analytic sample included 4620 participants (mean age, 52.3 [SD, 11.8] years; 2835 women [61.3%]; 367 [7.9%] with SCT) with 9062 concurrent measures of fasting glucose and HbA(1c) levels. In unadjusted GEE analyses, for a given fasting glucose, HbA(1c) values were statistically significantly lower in those with (5.72%) vs those without (6.01%) SCT (mean HbA(1c) difference, -0.29%; 95% CI, -0.35% to -0.23%). Findings were similar in models adjusted for key risk factors and in analyses using 2001 concurrent measures of 2-hour glucose and HbA(1c) concentration for those with SCT (mean, 5.35%) vs those without SCT (mean, 5.65%) for a mean HbA(1c) difference of -0.30% (95% CI, -0.39% to -0.21%). The HbA(1c) difference by SCT was greater at higher fasting (P=.02 for interaction) and 2-hour (P=.03) glucose concentrations. The prevalence of prediabetes and diabetes was statistically significantly lower among participants with SCT when defined using HbA(1c) values (29.2% vs 48.6% for prediabetes and 3.8% vs 7.3% for diabetes in 572 observations from participants with SCT and 6877 observations from participants without SCT; P<. 001 for both comparisons). CONCLUSIONS AND RELEVANCE Among African Americans from 2 large, well-established cohorts, participants with SCT had lower levels of HbA(1c) at any given concentration of fasting or 2-hour glucose compared with participants without SCT. These findings suggest that HbA(1c) may systematically underestimate past glycemia in black patients with SCT and may require further evaluation.	[Lacy, Mary E.; Wellenius, Gregory A.; Gjelsvik, Annie; Liu, Simin; Eaton, Charles B.; Wu, Wen-Chih] Brown Univ, Sch Publ Hlth, Dept Epidemiol, 121 S Main St,POB G, Providence, RI 02906 USA; [Sumner, Anne E.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Sumner, Anne E.] Natl Inst Minor Hlth & Hlth Dispar, NIH, Bethesda, MD USA; [Correa, Adolfo; Musani, Solomon K.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Carnethon, Mercedes R.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Liem, Robert I.] Ann & Robert H Lurie Childrens Hosp, Div Hematol Oncol & SCT, Chicago, IL USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Sacks, David B.] NIH, Dept Lab Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Carson, April P.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Luo, Xi] Brown Univ, Sch Publ Hlth, Dept Biostat, Providence, RI 02912 USA; [Reiner, Alexander P.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Naik, Rakhi P.] Johns Hopkins Univ, Dept Med, Div Hematol, Baltimore, MD USA; [Wu, Wen-Chih] Providence Vet Affairs Med Ctr, Ctr Innovat Long Term Serv & Support, Providence, RI USA; [Wu, Wen-Chih] Providence Vet Affairs Med Ctr, Div Cardiol, Providence, RI USA; [Liu, Simin; Wu, Wen-Chih] Brown Univ, Alpert Med Sch, Dept Med, Providence, RI 02912 USA	Brown University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute on Minority Health & Health Disparities (NIMHD); University of Mississippi; University of Mississippi Medical Center; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; University of Mississippi; University of Mississippi Medical Center; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; Brown University; University of Washington; University of Washington Seattle; Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University	Lacy, ME (corresponding author), Brown Univ, Sch Publ Hlth, Dept Epidemiol, 121 S Main St,POB G, Providence, RI 02906 USA.	mary_lacy@brown.edu	Wellenius, Gregory/AAR-1691-2020; Liu, Simin/I-3689-2014; Liu, Simin/GSN-4159-2022; Wellenius, Gregory A/A-7105-2012; Gjelsvik, Annie/I-1011-2014	Wellenius, Gregory/0000-0003-0427-7376; Liu, Simin/0000-0003-2098-3844; Wellenius, Gregory A/0000-0003-0427-7376; Gjelsvik, Annie/0000-0002-5632-6435; Eaton, Charles/0000-0002-7723-9461; Carnethon, Mercedes/0000-0001-7035-0848; Jacobs, David/0000-0002-7232-0543; Sacks, David/0000-0003-3100-0735; Carson, April/0000-0002-7970-6756	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, HHSN26820090004]; Intramural Research Program of the National Institute on Aging (NIA); NIA [AG0005]; NHLBI [AG0005, HHSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, HHSN268201300050C, K08HL125100]; National Institute on Minority Health and Health Disparities; Center of Innovation in Long-Term Services and Support, Providence VA Medical Center; NIDDK; NIMHD; NIH;  [F31DK105791];  [K01DK095928];  [R01HL107816]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107816, K08HL125100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK047023, K01DK095928, F31DK105791] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program of the National Institute on Aging (NIA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Center of Innovation in Long-Term Services and Support, Providence VA Medical Center; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMHD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	CARDIA is supported by contracts HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, and HHSN26820090004 from the National Heart, Lung, and Blood Institute (NHLBI), the Intramural Research Program of the National Institute on Aging (NIA), and an intra-agency agreement between NIA and NHLBI (AG0005). The JHS is supported by contracts HHSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, and HHSN268201300050C from the NHLBI and the National Institute on Minority Health and Health Disparities. Dr Lacy was supported by F31DK105791 (Drs Wu and Wellenius are cosponsors of this grant). Dr Wu was supported by the Center of Innovation in Long-Term Services and Support, Providence VA Medical Center. Dr Carson was supported by K01DK095928. Dr Sumner is supported by the intramural program of NIDDK and NIMHD. Dr Sacks is supported by the Intramural Research Program of the NIH. Dr Naik was supported by NHLBI grant K08HL125100. Joint calling of exome sequence data in JHS was supported by R01HL107816 to S. Kathiresan, who was the principal investigator of the ancillary study that obtained the SCT data on JHS participants.	Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS86, DOI 10.2337/dc16-S014; BARBEDO MMR, 1974, ACTA HAEMATOL-BASEL, V51, P339, DOI 10.1159/000208316; Bleyer AJ, 2010, DIABETIC MED, V27, P1012, DOI 10.1111/j.1464-5491.2010.03050.x; Bonora E, 2011, DIABETES CARE, V34, pS184, DOI 10.2337/dc11-s216; Carpenter MA, 2004, AM J MED SCI, V328, P131, DOI 10.1097/00000441-200409000-00001; Fonseca VA, 2009, DIABETES CARE, V32, P1, DOI [10.2337/dc09-9033, 10.2337/dc09-S301]; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Gonen M, 2007, ANAL RECEIVER OPERAT; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hardin J.W., 2005, ENCY STAT BEHAV SCI, DOI 10.1002/0470013192.bsa250; Kang SH, 2015, PLOS ONE, V10; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Kim C, 2010, DIABETES CARE, V33, P780, DOI 10.2337/dc09-0836; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin CN, 2012, CLIN CHIM ACTA, V413, P819, DOI 10.1016/j.cca.2011.12.019; Lorey FW, 1996, GENET EPIDEMIOL, V13, P501, DOI 10.1002/(SICI)1098-2272(1996)13:5<501::AID-GEPI6>3.0.CO;2-4; MCCLISH DK, 1987, MED DECIS MAKING, V7, P149, DOI 10.1177/0272989X8700700305; MCCURDY PR, 1969, BLOOD-J HEMATOL, V33, P214, DOI 10.1182/blood.V33.2.214.214; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Miller WG, 2008, ARCH PATHOL LAB MED, V132, P838, DOI 10.1043/1543-2165(2008)132[838:SOTAIT]2.0.CO;2; Naik RP, 2014, JAMA-J AM MED ASSOC, V312, P2115, DOI 10.1001/jama.2014.15063; Nathan DM, 2008, DIABETES CARE, V31, P173, DOI [10.2337/dc08-9016, 10.2337/dc08-0545]; Sacks David B, 2011, Diabetes Care, V34, pe61, DOI 10.2337/dc11-9998; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; Selvin E, 2009, DIABETES CARE, V32, P828, DOI 10.2337/dc08-1699; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; SUAREZ RM, 1959, BLOOD, V14, P255, DOI 10.1182/blood.V14.3.255.255; Sumner AE, 2015, DIABETES CARE, V38, P213, DOI 10.2337/dc14-1179; Taylor HA, 2005, ETHNIC DIS, V15, pS4; WEINSTEIN IM, 1954, BLOOD, V9, P1155, DOI 10.1182/blood.V9.12.1155.1155; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	35	76	77	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					507	515		10.1001/jama.2016.21035	http://dx.doi.org/10.1001/jama.2016.21035			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28170479	Green Accepted			2022-12-28	WOS:000393564200019
J	Rimmer, A				Rimmer, Abi			GMC fires warning shot to protect doctors' training	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												arimmer@bmj.com						Gulland A., GMC PROPOSES SINGLE; Rimmer A., 2016, BMJ CAREERS; RIMMER A, 2016, BMJ-BRIT MED J, V355, DOI DOI 10.1136/BMJ.I5905	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2017	356								j532	10.1136/bmj.j532	http://dx.doi.org/10.1136/bmj.j532			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BQ	28148481				2022-12-28	WOS:000393449800007
J	Welin, ER; Le, C; Arias-Rotondo, DM; McCusker, JK; MacMillan, DWC				Welin, Eric R.; Le, Chip; Arias-Rotondo, Daniela M.; McCusker, James K.; MacMillan, David W. C.			PHOTOCHEMISTRY Photosensitized, energy transfer-mediated organometallic catalysis through electronically excited nickel(II)	SCIENCE			English	Article							VISIBLE-LIGHT; COORDINATION-COMPOUNDS; PHOTOREDOX; LUMINESCENCE; TRIS(2,2-BIPYRIDINE)RUTHENIUM(II); MECHANISMS; ARYLATION; STATE	Transition metal catalysis has traditionally relied on organometallic complexes that can cycle through a series of ground-state oxidation levels to achieve a series of discrete yet fundamental fragment-coupling steps. The viability of excited-state organometallic catalysis via direct photoexcitation has been demonstrated. Although the utility of triplet sensitization by energy transfer has long been known as a powerful activation mode in organic photochemistry, it is surprising to recognize that photosensitization mechanisms to access excited-state organometallic catalysts have lagged far behind. Here, we demonstrate excited-state organometallic catalysis via such an activation pathway: Energy transfer from an iridium sensitizer produces an excited-state nickel complex that couples aryl halides with carboxylic acids. Detailed mechanistic studies confirm the role of photosensitization via energy transfer.	[Welin, Eric R.; Le, Chip; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA; [Arias-Rotondo, Daniela M.; McCusker, James K.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Princeton University; Michigan State University	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.; McCusker, JK (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	jkm@chemistry.msu.edu; dmacmill@princeton.edu	Arias-Rotondo, Daniela M./R-8693-2018	Arias-Rotondo, Daniela M./0000-0002-6427-898X; Welin, Eric/0000-0002-1760-4121; Le, Chi/0000-0002-9614-365X	National Institute of General Medical Sciences (NIGMS), NIH [R01 GM078201-05]; NSF [CHE-1300096]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078201] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1300096] Funding Source: National Science Foundation	National Institute of General Medical Sciences (NIGMS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Research reported in this publication was supported by the National Institute of General Medical Sciences (NIGMS), NIH, under award number R01 GM078201-05 (D.W.C.M., E.R.W., and C.C.L.) and the NSF under the award number CHE-1300096 (J.K.M. and D.A.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIGMS or NSF. Additional data supporting the conclusions are available in supplementary material.	Arias-Rotondo DM, 2016, CHEM SOC REV, V45, P5803, DOI 10.1039/c6cs00526h; Bhattarai B, 2015, CHEM COMMUN, V51, P5398, DOI 10.1039/c4cc08604j; Biswas S, 2013, J AM CHEM SOC, V135, P16192, DOI 10.1021/ja407589e; Bitterwolf TE, 2004, J ORGANOMET CHEM, V689, P3939, DOI 10.1016/j.jorganchem.2004.06.023; Breitenfeld J, 2014, ORGANOMETALLICS, V33, P5708, DOI 10.1021/om500506y; Corcoran EB, 2016, SCIENCE, V353, P279, DOI 10.1126/science.aag0209; Creutz SE, 2012, SCIENCE, V338, P647, DOI 10.1126/science.1226458; DEMAS JN, 1976, J AM CHEM SOC, V98, P5800, DOI 10.1021/ja00435a010; Dixon IM, 2000, CHEM SOC REV, V29, P385, DOI 10.1039/b000704h; Flamigni L, 2007, TOP CURR CHEM, V281, P143, DOI 10.1007/128_2007_131; Hegedus L. S., 2010, TRANSITION METALS SY; Heitz DR, 2016, J AM CHEM SOC, V138, P12715, DOI 10.1021/jacs.6b04789; Hwang SJ, 2015, J AM CHEM SOC, V137, P6472, DOI 10.1021/jacs.5b03192; IKEZAWA H, 1986, J AM CHEM SOC, V108, P1589, DOI 10.1021/ja00267a032; Islangulov RR, 2006, ANGEW CHEM INT EDIT, V45, P5957, DOI 10.1002/anie.200601615; JURIS A, 1976, J AM CHEM SOC, V98, P1047, DOI 10.1021/ja00420a046; JURIS A, 1978, INORG CHEM, V17, P2258, DOI 10.1021/ic50186a049; Kainz QM, 2016, SCIENCE, V351, P681, DOI 10.1126/science.aad8313; Kalyani D, 2011, J AM CHEM SOC, V133, P18566, DOI 10.1021/ja208068w; Lakowicz J. R., 2006, SPRINGER SCI BUSINES; LEERMAKERS PA, 1963, J AM CHEM SOC, V85, P2670, DOI 10.1021/ja00900a036; Lu Z, 2012, ANGEW CHEM INT EDIT, V51, P10329, DOI 10.1002/anie.201204835; Macgregor SA, 2003, FARADAY DISCUSS, V124, P111, DOI 10.1039/b212309f; MARCINIAK B, 1990, SPECTROSC LETT, V23, P149, DOI 10.1080/00387019008054043; Muci AR, 2002, TOP CURR CHEM, V219, P131, DOI 10.1007/3-540-45313-X_5; Muller C, 2009, ANGEW CHEM INT EDIT, V48, P6640, DOI 10.1002/anie.200901603; REHM D, 1970, ISRAEL J CHEM, V8, P259; SCHENCK GO, 1952, ANGEW CHEM-GER EDIT, V64, P12, DOI 10.1002/ange.19520640105; SCHENCK GO, 1962, CHEM BER-RECL, V95, P1642, DOI 10.1002/cber.19620950711; Schley ND, 2014, J AM CHEM SOC, V136, P16588, DOI 10.1021/ja508718m; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; Shaw MH, 2016, J ORG CHEM, V81, P6898, DOI 10.1021/acs.joc.6b01449; Shields BJ, 2016, J AM CHEM SOC, V138, P12719, DOI 10.1021/jacs.6b08397; Singh K, 2014, J AM CHEM SOC, V136, P5275, DOI 10.1021/ja5019749; Standley EA, 2014, ORGANOMETALLICS, V33, P2012, DOI 10.1021/om500156q; Tellis JC, 2014, SCIENCE, V345, P433, DOI 10.1126/science.1253647; Terrett JA, 2015, NATURE, V524, P330, DOI 10.1038/nature14875; Thasana N, 2007, J ORG CHEM, V72, P9379, DOI 10.1021/jo701599g; TURRO NJ, 1966, J CHEM EDUC, V43, P13, DOI 10.1021/ed043p13; Yoo K, 2016, TETRAHEDRON LETT, V57, P781, DOI 10.1016/j.tetlet.2016.01.022; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525	41	289	288	17	478	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					380	384		10.1126/science.aal2490	http://dx.doi.org/10.1126/science.aal2490			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126814	Green Accepted			2022-12-28	WOS:000393172800035
J	Kasza, KA; Ambrose, BK; Conway, KP; Borek, N; Taylor, K; Goniewicz, ML; Cummings, KM; Sharma, E; Pearson, JL; Green, VR; Kaufman, AR; Bansal-Travers, M; Travers, MJ; Kwan, J; Tworek, C; Cheng, YC; Yang, L; Pharris-Ciurej, N; van Bemmel, DM; Backinger, CL; Compton, WM; Hyland, AJ				Kasza, Karin A.; Ambrose, Bridget K.; Conway, Kevin P.; Borek, Nicolette; Taylor, Kristie; Goniewicz, Maciej L.; Cummings, K. Michael; Sharma, Eva; Pearson, Jennifer L.; Green, Victoria R.; Kaufman, Annette R.; Bansal-Travers, Maansi; Travers, Mark J.; Kwan, Jonathan; Tworek, Cindy; Cheng, Yu-Ching; Yang, Ling; Pharris-Ciurej, Nikolas; van Bemmel, Dana M.; Backinger, Cathy L.; Compton, Wilson M.; Hyland, Andrew J.			Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CIGARETTE SMOKERS; POLYTOBACCO USE; TRENDS; PREVALENCE; CIGARILLO; AWARENESS; SMOKING	BACKGROUND Noncigarette tobacco products are evolving rapidly, with increasing popularity in the United States. METHODS We present prevalence estimates for 12 types of tobacco products, using data from 45,971 adult and youth participants (>= 12 years of age) from Wave 1 (September 2013 through December 2014) of the Population Assessment of Tobacco and Health (PATH) Study, a large, nationally representative, longitudinal study of tobacco use and health in the United States. Participants were asked about their use of cigarettes, e-cigarettes, traditional cigars, cigarillos, filtered cigars, pipe tobacco, hookah, snus pouches, other smokeless tobacco, dissolvable tobacco, bidis, and kreteks. Estimates of the prevalence of use for each product were determined according to use category (e.g., current use or use in the previous 30 days) and demographic subgroup, and the prevalence of multiple-product use was explored. RESULTS More than a quarter (27.6%) of adults were current users of at least one type of tobacco product in 2013 and 2014, although the prevalence varied depending on use category. A total of 8.9% of youths had used a tobacco product in the previous 30 days; 1.6% of youths were daily users. Approximately 40% of tobacco users, adults and youths alike, used multiple tobacco products; cigarettes plus e-cigarettes was the most common combination. Young adults (18 to 24 years of age), male adults and youths, members of racial minorities, and members of sexual minorities generally had higher use of tobacco than their counterparts. CONCLUSIONS During this study, 28% of U.S. adults were current users of tobacco, and 9% of youths had used tobacco in the previous 30 days. Use of multiple products was common among tobacco users. These findings will serve as baseline data to examine between-person differences and within-person changes over time in the use of tobacco products. (Funded by the National Institute on Drug Abuse and the Food and Drug Administration.)	[Kasza, Karin A.; Goniewicz, Maciej L.; Bansal-Travers, Maansi; Travers, Mark J.; Hyland, Andrew J.] Roswell Pk Canc Inst, Dept Hlth Behav, Elm & Carlton Sts, Buffalo, NY 14263 USA; [Ambrose, Bridget K.; Borek, Nicolette; Kwan, Jonathan; Tworek, Cindy; Cheng, Yu-Ching; Yang, Ling; Pharris-Ciurej, Nikolas; van Bemmel, Dana M.; Backinger, Cathy L.] US FDA, Off Sci, Ctr Tobacco Prod, Silver Spring, MD USA; [Conway, Kevin P.; Green, Victoria R.; Compton, Wilson M.] NIDA, NIH, Bethesda, MD 20892 USA; [Kaufman, Annette R.] NCI, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA; [Taylor, Kristie; Sharma, Eva] Westat Corp, Rockville, MD USA; [Green, Victoria R.] Kelly Govt Solut, Rockville, MD USA; [Cummings, K. Michael] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC USA; [Pearson, Jennifer L.] Truth Initiat, Schroeder Inst Tobacco Res & Policy Studies, Washington, DC USA	Roswell Park Cancer Institute; US Food & Drug Administration (FDA); FDA Center for Tobacco Products (CTP); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Westat; Medical University of South Carolina	Kasza, KA (corresponding author), Roswell Pk Canc Inst, Dept Hlth Behav, Elm & Carlton Sts, Buffalo, NY 14263 USA.	karin.kasza@roswellpark.org	Goniewicz, Maciej Lukasz/Z-1604-2019; Bansal-Travers, Maansi/AFM-0150-2022; Goniewicz, Maciej L/D-8986-2012; Bansal-Travers, Maansi/AAH-2486-2022; Kaufman, Annette/GSD-7193-2022; Hyland, Andrew/ABE-6249-2020; Pearson, Jennifer L/AAZ-9398-2020	Goniewicz, Maciej Lukasz/0000-0001-6748-3068; Bansal-Travers, Maansi/0000-0002-7944-3570; Bansal-Travers, Maansi/0000-0002-7944-3570; Pearson, Jennifer L/0000-0002-1400-5932; Conway, Kevin/0000-0002-7638-339X	National Institute on Drug Abuse, National Institutes of Health; Food and Drug Administration, Department of Health and Human Services [HHSN271201100027C]; Pfizer; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Food and Drug Administration, Department of Health and Human Services; Pfizer(Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by federal funds from the National Institute on Drug Abuse, National Institutes of Health, and the Food and Drug Administration, Department of Health and Human Services, under a contract (Contract No. HHSN271201100027C) to Westat.; Dr. Cummings reports receiving grant support from Pfizer and fees as a paid expert witness in litigation filed against the tobacco industry; Dr. Goniewicz, receiving fees for serving on an advisory board from Johnson & Johnson and grant support from Pfizer; and Dr. Compton, holding stock in General Electric, the 3M Companies, and Pfizer. No other potential conflict of interest relevant to this article was reported.	Abrams DB, 2014, JAMA-J AM MED ASSOC, V311, P135, DOI 10.1001/jama.2013.285347; Agaku IT, 2014, MMWR-MORBID MORTAL W, V63, P542; [Anonymous], 1994, PREV TOB US YOUNG PE; [Anonymous], 2012, POP ASS TOB HLTH PAT; [Anonymous], 2014, MON FUT CONT STUD MA; Ashley DL, 2012, AM J PREV MED, V43, pS255, DOI 10.1016/j.amepre.2012.08.004; Backinger CL, 2008, ADDICT BEHAV, V33, P472, DOI 10.1016/j.addbeh.2007.10.009; Biglan M, 2004, NICOTINE TOB RES, V6, P427, DOI 10.1080/14622200410001696592; Bombard JM, 2007, ADDICT BEHAV, V32, P2411, DOI 10.1016/j.addbeh.2007.04.001; Callahan-Lyon P, 2014, TOB CONTROL, V23, P36, DOI 10.1136/tobaccocontrol-2013-051470; Carter BD, 2015, NEW ENGL J MED, V372, P2170, DOI 10.1056/NEJMc1503675; Centers for Disease Control and Prevention, 2014, NAT YOUTH TOB SURV N; Centers for Disease Control and Prevention, YOUTH RISK BEH SURV; Cobb NK, 2010, AM J PUBLIC HEALTH, V100, P2340, DOI 10.2105/AJPH.2010.199281; Cohn A, 2015, NICOTINE TOB RES, V17, P1473, DOI 10.1093/ntr/ntv022; Colditz GA, 2015, NEW ENGL J MED, V372, P665, DOI 10.1056/NEJMe1414318; Corey CG, 2014, MMWR-MORBID MORTAL W, V63, P650; Delnevo CD, 2014, TOB CONTROL, V23, P107, DOI 10.1136/tobaccocontrol-2012-050739; Delnevo Cristine D, 2009, Prev Med, V48, pS16, DOI 10.1016/j.ypmed.2008.09.008; Department of Health and Human Services, 2014, HLTH CONSMOK 50 YE; Dolcini MM, 1996, J RES ADOLESCENCE, V6, P515; Fix BV, 2014, ADDICT BEHAV, V39, P768, DOI 10.1016/j.addbeh.2013.12.015; Giovino GA, 2002, ONCOGENE, V21, P7326, DOI 10.1038/sj.onc.1205808; Giovino Gary A, 2009, Prev Med, V48, pS4, DOI 10.1016/j.ypmed.2008.08.007; Hyland A., 2016, TOB CONTROL; Judkins D. R., 1990, J OFF STAT, V6, P223, DOI DOI 10.1016/J.AMJMED.2017.09.025.(ADVANCE; Kasza KA, 2014, NICOTINE TOB RES, V16, P672, DOI 10.1093/ntr/ntt212; Kaufman AR, 2014, NICOTINE TOB RES, V16, P1404, DOI 10.1093/ntr/ntu116; King BA, 2015, NICOTINE TOB RES, V17, P219, DOI 10.1093/ntr/ntu191; Kozlowski LT, 2008, AM J PREV MED, V34, P424, DOI 10.1016/j.amepre.2007.12.025; Lee JGL, 2009, TOB CONTROL, V18, P275, DOI 10.1136/tc.2008.028241; Lee YO, 2014, PREV MED, V62, P14, DOI 10.1016/j.ypmed.2014.01.014; McCarthy P J, 1969, Vital Health Stat 2, P1; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Rath JM, 2013, NICOTINE TOB RES, V15, P1822, DOI 10.1093/ntr/ntt062; Richardson A, 2013, NICOTINE TOB RES, V15, P1729, DOI 10.1093/ntr/ntt053; StataCorp, 2011, STAT STAT SOFTW REL, P173; Substance Abuse and Mental Health Services Administration, NAT SURV DRUG US HLT	38	469	473	1	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2017	376	4					342	353		10.1056/NEJMsa1607538	http://dx.doi.org/10.1056/NEJMsa1607538			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ3KR	28121512	Green Accepted			2022-12-28	WOS:000393111600009
J	Litton, JE				Litton, Jan-Eric			We must urgently clarify data-sharing rules	NATURE			English	Editorial Material									[Litton, Jan-Eric] BBMRI ERIC Graz, Graz, Austria		Litton, JE (corresponding author), BBMRI ERIC Graz, Graz, Austria.	contact@bbmri-eric.eu							0	12	14	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2017	541	7638					437	437		10.1038/541437a	http://dx.doi.org/10.1038/541437a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6LX	28128265	Bronze			2022-12-28	WOS:000396116600016
J	Lodahl, P; Mahmoodian, S; Stobbe, S; Rauschenbeutel, A; Schneeweiss, P; Volz, J; Pichler, H; Zoller, P				Lodahl, Peter; Mahmoodian, Sahand; Stobbe, Soren; Rauschenbeutel, Arno; Schneeweiss, Philipp; Volz, Juergen; Pichler, Hannes; Zoller, Peter			Chiral quantum optics	NATURE			English	Review							NANOPHOTONIC WAVE-GUIDE; SPIN-ORBIT INTERACTION; N-ATOM SYSTEM; SINGLE-PHOTON; SPONTANEOUS EMISSION; EVANESCENT WAVES; NONLINEAR OPTICS; NEUTRAL ATOMS; LIGHT; CAVITY		[Lodahl, Peter; Mahmoodian, Sahand; Stobbe, Soren] Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark; [Rauschenbeutel, Arno; Schneeweiss, Philipp; Volz, Juergen] TU Wien, Vienna Ctr Quantum Sci & Technol, Stad Allee 2, A-1020 Vienna, Austria; [Pichler, Hannes; Zoller, Peter] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Pichler, Hannes; Zoller, Peter] Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, A-6020 Innsbruck, Austria	University of Copenhagen; Niels Bohr Institute; Technische Universitat Wien; University of Innsbruck; Austrian Academy of Sciences	Lodahl, P (corresponding author), Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.; Rauschenbeutel, A (corresponding author), TU Wien, Vienna Ctr Quantum Sci & Technol, Stad Allee 2, A-1020 Vienna, Austria.; Zoller, P (corresponding author), Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria.; Zoller, P (corresponding author), Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, A-6020 Innsbruck, Austria.	lodahl@nbi.ku.dk; arno.rauschenbeutel@ati.ac.at; Peter.Zoller@uibk.ac.at	Zoller, Peter/O-1639-2014; Pichler, Hannes/AAC-9665-2022; Schneeweiss, Philipp/N-6469-2016; Rauschenbeutel, Arno/C-1472-2013; Stobbe, Søren/F-6782-2010; Volz, Jürgen/N-6457-2016	Zoller, Peter/0000-0003-4014-1505; Pichler, Hannes/0000-0003-2144-536X; Schneeweiss, Philipp/0000-0002-1485-7502; Rauschenbeutel, Arno/0000-0003-2467-4029; Stobbe, Søren/0000-0002-0991-041X; Volz, Jürgen/0000-0002-3174-2141; Mahmoodian, Sahand/0000-0003-1483-5482	Lundbeck Foundation; Villum Foundation; Carlsberg Foundation; European Research Council (ERC); Innovation Fund Denmark; Danish Council for Independent Research; Austrian Science Fund (SFB) [F 4908-N23, F 4017, W 1210-N16]; European Commission [600645, 300392]; SFB FOQUS of the Austrian Science Fund FWF; ERC Synergy Grant UQUAM; Villum Fonden [00013170] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Villum Foundation(Villum Fonden); Carlsberg Foundation(Carlsberg Foundation); European Research Council (ERC)(European Research Council (ERC)European Commission); Innovation Fund Denmark; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Austrian Science Fund (SFB)(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre); SFB FOQUS of the Austrian Science Fund FWF(Austrian Science Fund (FWF)); ERC Synergy Grant UQUAM; Villum Fonden(Villum Fonden)	We acknowledge I. Sollner and A. S. Sorensen for discussions. P.L., S.M. and S. S. acknowledge financial support from the following funding agencies: the Lundbeck Foundation, the Villum Foundation, the Carlsberg Foundation, the European Research Council (ERC Consolidator Grant 'ALLQUANTUM' and ERC Advanced Grant 'SCALE'), Innovation Fund Denmark (Quantum Innovation Center 'Qubiz') and the Danish Council for Independent Research. A.R., P.S. and J.V. acknowledge financial support from the following funding agencies: the Austrian Science Fund (SFB NextLite Project No. F 4908-N23, SFB FoQuS Project No. F 4017 and DK CoQuS Project No. W 1210-N16), the European Commission (IP SIQS No. 600645 and Marie Curie IEF Grant No. 300392) and the European Research Council (ERC Consolidator Grant 'NanoQuaNt'). H.P. and P.Z. are supported by the SFB FOQUS of the Austrian Science Fund FWF, and ERC Synergy Grant UQUAM.	Aiello A, 2015, NAT PHOTONICS, V9, P789, DOI 10.1038/nphoton.2015.203; Bliokh KY, 2015, NAT PHOTONICS, V9, P796, DOI 10.1038/nphoton.2015.201; Bliokh KY, 2015, PHYS REP, V592, P1, DOI 10.1016/j.physrep.2015.06.003; Bliokh KY, 2015, SCIENCE, V348, P1448, DOI 10.1126/science.aaa9519; Bliokh KY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4300; Bliokh KY, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.061801; Chang DE, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.113606; Chang DE, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063003; Chang DE, 2014, NAT PHOTONICS, V8, P685, DOI [10.1038/NPHOTON.2014.192, 10.1038/nphoton.2014.192]; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; COHENTANNOUDJI C, 1972, PHYS REV A-GEN PHYS, V5, P968, DOI 10.1103/PhysRevA.5.968; Coles RJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11183; Coles RJ, 2014, OPT EXPRESS, V22, P2376, DOI 10.1364/OE.22.002376; Corzo NV, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.133603; DICKE RH, 1954, PHYS REV, V93, P99, DOI 10.1103/PhysRev.93.99; Douglas JS, 2015, NAT PHOTONICS, V9, P326, DOI 10.1038/NPHOTON.2015.57; Duan LM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.127902; Gardiner C., 2015, QUANTUM WORLD ULTRAC, VII; Gardiner C., 2014, QUANTUM WORLD ULTRAC, VI; Goban A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4808; Gonzalez-Ballestero C, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.155304; Griesser T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.055702; Grimm R, 2000, ADV ATOM MOL OPT PHY, V42, P95, DOI 10.1016/S1049-250X(08)60186-X; Hafezi M, 2011, NAT PHYS, V7, P907, DOI [10.1038/NPHYS2063, 10.1038/nphys2063]; Haroche S., 2006, EXPLORING QUANTUM; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Holzmann D, 2014, EUR PHYS J D, V68, DOI 10.1140/epjd/e2014-50692-2; Hung CL, 2016, P NATL ACAD SCI USA, V113, pE4946, DOI 10.1073/pnas.1603777113; Jalas D, 2013, NAT PHOTONICS, V7, P579, DOI 10.1038/nphoton.2013.185; Javadi A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9655; Junge C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.213604; Kalhor F, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4941539; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Kimble HJ, 1998, PHYS SCRIPTA, VT76, P127, DOI 10.1238/Physica.Topical.076a00127; Koshino K, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.043805; Koshino K, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.010301; Laakso M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.183601; Lang B, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.063819; LAX M, 1975, PHYS REV A, V11, P1365, DOI 10.1103/PhysRevA.11.1365; Le Kien F, 2004, OPT COMMUN, V242, P445, DOI 10.1016/j.optcom.2004.08.044; Lee SY, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.213907; LEHMBERG RH, 1970, PHYS REV A-GEN PHYS, V2, P889, DOI 10.1103/PhysRevA.2.889; Lembessis VE, 2014, J OPT SOC AM B, V31, P1322, DOI 10.1364/JOSAB.31.001322; Lin J, 2013, SCIENCE, V340, P331, DOI 10.1126/science.1233746; Lodahl P, 2015, REV MOD PHYS, V87, P347, DOI 10.1103/RevModPhys.87.347; Lu L, 2014, NAT PHOTONICS, V8, P821, DOI [10.1038/nphoton.2014.248, 10.1038/NPHOTON.2014.248]; Luxmoore IJ, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4845975; Mitsch R, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.063829; Mochol M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07672; Neugebauer M, 2014, NANO LETT, V14, P2546, DOI 10.1021/nl5003526; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Novotny L., 2012, PRINCIPLES NANOOPTIC; O'Connor D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6327; Pinotsi D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093603; Raghu S, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.033834; Ralph TC, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.173603; Rechtsman MC, 2013, NAT PHOTONICS, V7, P153, DOI [10.1038/NPHOTON.2012.302, 10.1038/nphoton.2012.302]; Reiserer A, 2015, REV MOD PHYS, V87, DOI 10.1103/RevModPhys.87.1379; Reitz D, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.031804; Ringel M, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/11/113030; Rodriguez-Fortuno FJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9799; Rodriguez-Fortuno FJ, 2014, ACS PHOTONICS, V1, P762, DOI 10.1021/ph500084b; Rodriguez-Fortuno FJ, 2013, SCIENCE, V340, P328, DOI 10.1126/science.1233739; Rosenblum S, 2016, NAT PHOTONICS, V10, P19, DOI [10.1038/nphoton.2015.227, 10.1038/NPHOTON.2015.227]; Sapienza L, 2010, SCIENCE, V327, P1352, DOI 10.1126/science.1185080; Sayrin C, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041036; Scheucher M, 2016, SCIENCE, V354, P1577, DOI 10.1126/science.aaj2118; Schine N, 2016, NATURE, V534, P671, DOI 10.1038/nature17943; Schneeweiss P, 2017, OPT LETT, V42, P85, DOI 10.1364/OL.42.000085; Schneeweiss P, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/1/013014; Shen JT, 2005, OPT LETT, V30, P2001, DOI 10.1364/OL.30.002001; Shomroni I, 2014, SCIENCE, V345, P903, DOI 10.1126/science.1254699; Sollner I, 2015, NAT NANOTECHNOL, V10, P775, DOI [10.1038/NNANO.2015.159, 10.1038/nnano.2015.159]; Stannigel K, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.042341; Sukhov S, 2015, NAT PHOTONICS, V9, P809, DOI [10.1038/NPHOTON.2015.200, 10.1038/nphoton.2015.200]; Tighineanu P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.043601; Van Mechelen T, 2016, OPTICA, V3, P118, DOI 10.1364/OPTICA.3.000118; Volz J, 2014, NAT PHOTONICS, V8, P965, DOI [10.1038/nphoton.2014.253, 10.1038/NPHOTON.2014.253]; Volz T, 2012, NAT PHOTONICS, V6, P605, DOI [10.1038/nphoton.2012.181, 10.1038/NPHOTON.2012.181]; Xia KY, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.043802; Young AB, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.153901	96	730	737	26	417	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2017	541	7638					473	480		10.1038/nature21037	http://dx.doi.org/10.1038/nature21037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6LX	28128249	Green Submitted			2022-12-28	WOS:000396116600040
J	Parker, CG; Galmozzi, A; Wang, YJ; Correia, BE; Sasaki, K; Joslyn, CM; Kim, AS; Cavallaro, CL; Lawrence, RM; Johnson, SR; Narvaiza, I; Saez, E; Cravatt, BF				Parker, Christopher G.; Galmozzi, Andrea; Wang, Yujia; Correia, Bruno E.; Sasaki, Kenji; Joslyn, Christopher M.; Kim, Arthur S.; Cavallaro, Cullen L.; Lawrence, R. Michael; Johnson, Stephen R.; Narvaiza, Inigo; Saez, Enrique; Cravatt, Benjamin F.			Ligand and Target Discovery by Fragment-Based Screening in Human Cells	CELL			English	Article							REV-ERB-ALPHA; SMALL-MOLECULE PROBES; STRUCTURAL BASIS; DRUG DISCOVERY; PROTEIN; IDENTIFICATION; HEME; REGULATOR; DIFFERENTIATION; BIOLOGY	Advances in the synthesis and screening of small-molecule libraries have accelerated the discovery of chemical probes for studying biological processes. Still, only a small fraction of the human proteome has chemical ligands. Here, we describe a platform that marries fragment-based ligand discovery with quantitative chemical proteomics to map thousands of reversible small molecule-protein interactions directly in human cells, many of which can be site-specifically determined. We show that fragment hits can be advanced to furnish selective ligands that affect the activity of proteins heretofore lacking chemical probes. We further combine fragment-based chemical proteomics with phenotypic screening to identify small molecules that promote adipocyte differentiation by engaging the poorly characterized membrane protein PGRMC2. Fragmentbased screening in human cells thus provides an extensive proteome-widemap of protein ligandability and facilitates the coordinated discovery of bioactive small molecules and their molecular targets.	[Parker, Christopher G.; Galmozzi, Andrea; Wang, Yujia; Sasaki, Kenji; Joslyn, Christopher M.; Kim, Arthur S.; Saez, Enrique; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Physiol Chem, La Jolla, CA 92037 USA; [Correia, Bruno E.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Cavallaro, Cullen L.; Lawrence, R. Michael; Johnson, Stephen R.] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ 08648 USA; [Narvaiza, Inigo] Salk Inst Biol Studies, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA	Scripps Research Institute; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Bristol-Myers Squibb; Salk Institute	Parker, CG; Saez, E; Cravatt, BF (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, Dept Physiol Chem, La Jolla, CA 92037 USA.	cparker@scripps.edu; esaez@scripps.edu; cravatt@scripps.edu	Parker, Christopher/AAT-1744-2020	Parker, Christopher/0000-0001-8509-9289; Wang, Yujia/0000-0002-7099-6283; Kim, Arthur/0000-0003-4101-6642; Cavallaro, Cullen/0000-0001-9498-2612	American Cancer Society [PF-14-100-01-CDD]; American Heart Association [14POST18200019]; NIH [DK099810, CA132630, 1S10OD16357]; NATIONAL CANCER INSTITUTE [R01CA132630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK099810] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016357] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Thompson, J. Shi, A. Roy, D. Vytla, S. Bhaskaran, K. Srinivasarao, R. Velayuthaperumal, K. Gurubaran, and M. Asiff for their contributions to the synthesis and purification of the FFF probe library, and M. M. Dix, D. J. Hermanson, K. M. Lum, S. Forli, U. Garaigorta, and S. Lee for additional technical assistance. C.G.P. was supported by a Postdoctoral Fellowship PF-14-100-01-CDD from the American Cancer Society. A.G. was supported by fellowship 14POST18200019 from the American Heart Association. This work was supported by NIH (DK099810, CA132630, 1S10OD16357).	Backus KM, 2016, NATURE, V534, P570, DOI 10.1038/nature18002; Bembenek SD, 2009, DRUG DISCOV TODAY, V14, P278, DOI 10.1016/j.drudis.2008.11.007; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; CHEN JJ, 1981, CELL, V26, P117, DOI 10.1016/0092-8674(81)90039-8; Chou WL, 2007, J BIOL CHEM, V282, P18162, DOI 10.1074/jbc.M702289200; Cisar JS, 2012, J AM CHEM SOC, V134, P10385, DOI 10.1021/ja304213w; Dai HX, 2011, J AM CHEM SOC, V133, P7222, DOI 10.1021/ja201708f; Dominguez E, 2014, NAT CHEM BIOL, V10, P113, DOI 10.1038/nchembio.1429; Edfeldt FNB, 2011, DRUG DISCOV TODAY, V16, P284, DOI 10.1016/j.drudis.2011.02.002; Edwards AM, 2009, NAT CHEM BIOL, V5, P436, DOI 10.1038/nchembio0709-436; Effenberger KA, 2015, J BIOL CHEM, V290, P27524, DOI 10.1074/jbc.M115.673210; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gerdes D, 1998, BIOL CHEM, V379, P907; Grant D, 2010, ACS CHEM BIOL, V5, P925, DOI 10.1021/cb100141y; Guce AI, 2011, CHEM BIOL, V18, P1521, DOI 10.1016/j.chembiol.2011.10.012; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008; Kabe Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11030; Kambe T, 2014, J AM CHEM SOC, V136, P10777, DOI 10.1021/ja505517t; Kim YG, 2011, MOL BIOSYST, V7, P1046, DOI 10.1039/c0mb00324g; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Kolb P, 2009, CURR OPIN BIOTECH, V20, P429, DOI 10.1016/j.copbio.2009.08.003; Kozakov D, 2015, P NATL ACAD SCI USA, V112, pE2585, DOI 10.1073/pnas.1501567112; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Lee J, 2013, CURR OPIN CHEM BIOL, V17, P118, DOI 10.1016/j.cbpa.2012.12.022; Li ZQ, 2013, ANGEW CHEM INT EDIT, V52, P8551, DOI 10.1002/anie.201300683; Moreno-Navarrete JM, 2014, DIABETOLOGIA, V57, P1957, DOI 10.1007/s00125-014-3298-5; Mifsud W, 2002, GENOME BIOL, V3; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Molzan M, 2012, FEBS J, V279, P563, DOI 10.1111/j.1742-4658.2011.08445.x; Niphakis MJ, 2015, CELL, V161, P1668, DOI 10.1016/j.cell.2015.05.045; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Piel RB, 2016, BIOCHEMISTRY-US, V55, P5204, DOI 10.1021/acs.biochem.6b00756; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Robin AY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.141; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Schenone M, 2013, NAT CHEM BIOL, V9, P232, DOI [10.1038/NCHEMBIO.1199, 10.1038/nchembio.1199]; Scott DE, 2012, BIOCHEMISTRY-US, V51, P4990, DOI 10.1021/bi3005126; Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336; Sumranjit J, 2013, MOLECULES, V18, P10425, DOI 10.3390/molecules180910425; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tan S, 2008, PROTEOMICS, V8, P3924, DOI 10.1002/pmic.200800597; Violante S, 2013, FASEB J, V27, P2039, DOI 10.1096/fj.12-216689; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weerapana E, 2007, NAT PROTOC, V2, P1414, DOI 10.1038/nprot.2007.194; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Welsch ME, 2010, CURR OPIN CHEM BIOL, V14, P347, DOI 10.1016/j.cbpa.2010.02.018; Wendler A, 2013, STEROIDS, V78, P555, DOI 10.1016/j.steroids.2012.12.002; Wu YH, 2008, STRUCTURE, V16, P1714, DOI 10.1016/j.str.2008.09.007; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	56	230	233	7	183	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					527	+		10.1016/j.cell.2016.12.029	http://dx.doi.org/10.1016/j.cell.2016.12.029			44	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28111073	Green Accepted, Bronze			2022-12-28	WOS:000396249600018
J	Scudellari, M				Scudellari, Megan			Buzzwords and big dreams	NATURE			English	News Item																			0	8	8	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2017	541	7638					450	453		10.1038/541450a	http://dx.doi.org/10.1038/541450a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6LX	28128261	Bronze			2022-12-28	WOS:000396116600021
J	Wacker, D; Wang, S; McCorvy, JD; Betz, RM; Venkatakrishnan, AJ; Levit, A; Lansu, K; Schools, ZL; Che, T; Nichols, DE; Shoichet, BK; Dror, RO; Roth, BL				Wacker, Daniel; Wang, Sheng; McCorvy, John D.; Betz, Robin M.; Venkatakrishnan, A. J.; Levit, Anat; Lansu, Katherine; Schools, Zachary L.; Che, Tao; Nichols, David E.; Shoichet, Brian K.; Dror, Ron O.; Roth, Bryan L.			Crystal Structure of an LSD-Bound Human Serotonin Receptor	CELL			English	Article							GENERAL FORCE-FIELD; LYSERGIC-ACID DIETHYLAMIDE; FUNCTIONAL SELECTIVITY; MOLECULAR-DYNAMICS; ASSISTED PSYCHOTHERAPY; PROTEIN; BINDING; MODEL; LIGANDS; SURFACE	The prototypical hallucinogen LSD acts via serotonin receptors, and here we describe the crystal structure of LSD in complex with the human serotonin receptor 5-HT2B. The complex reveals conformational rearrangements to accommodate LSD, providing a structural explanation for the conformational selectivity of LSD's key diethylamide moiety. LSD dissociates exceptionally slow from both 5-HT2BR and 5-HT2AR-a major target for its psychoactivity. Molecular dynamics (MD) simulations suggest that LSD's slow binding kinetics may be due to a "lid'' formed by extracellular loop 2 (EL2) at the entrance to the binding pocket. A mutation predicted to increase the mobility of this lid greatly accelerates LSD's binding kinetics and selectively dampens LSD-mediated beta-arrestin2 recruitment. This study thus reveals an unexpected binding mode of LSD; illuminates key features of its kinetics, stereochemistry, and signaling; and provides a molecular explanation for LSD's actions at human serotonin receptors.	[Wacker, Daniel; Wang, Sheng; McCorvy, John D.; Lansu, Katherine; Schools, Zachary L.; Che, Tao; Roth, Bryan L.] Univ North Carolina Chapel Hill, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Betz, Robin M.; Venkatakrishnan, A. J.; Dror, Ron O.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Betz, Robin M.; Venkatakrishnan, A. J.; Dror, Ron O.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Betz, Robin M.; Venkatakrishnan, A. J.; Dror, Ron O.] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA; [Betz, Robin M.; Dror, Ron O.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Levit, Anat; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Nichols, David E.; Roth, Bryan L.] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ North Carolina Chapel Hill, Sch Med, NIMH, PDSP, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Stanford University; Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Wacker, D; Roth, BL (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.; Dror, RO (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.; Dror, RO (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Dror, RO (corresponding author), Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA.; Dror, RO (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.; Roth, BL (corresponding author), Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA.; Roth, BL (corresponding author), Univ North Carolina Chapel Hill, Sch Med, NIMH, PDSP, Chapel Hill, NC 27599 USA.	dwacker@email.unc.edu; ron.dror@stanford.edu; bryan_roth@med.unc.edu	Roth, Bryan/ABE-7032-2020; Roth, Bryan L/F-3928-2010; , PEP-MX Core/AGV-4051-2022	Roth, Bryan/0000-0002-0561-6520; Dror, Ron/0000-0002-6418-2793	NIH [RO1MH61887, U19MH82441]; NIMH Psychoactive Drug Screening Program Contract [GM59957]; Terman Faculty Fellowship; Michael Hooker Distinguished Chair of Pharmacology; National Cancer Institute [P30CA016086]; federal funds from the National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059957, T32GM008294, T32GM007040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH112205, R01MH099993, U19MH082441, R01MH061887] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH Psychoactive Drug Screening Program Contract; Terman Faculty Fellowship; Michael Hooker Distinguished Chair of Pharmacology; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); federal funds from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants RO1MH61887 and U19MH82441, the NIMH Psychoactive Drug Screening Program Contract (all to B.L.R.), GM59957 (to B.K.S.), a Terman Faculty Fellowship (R.O.D.), and the Michael Hooker Distinguished Chair of Pharmacology (B.L.R.). The CRISPR-generated knockout HEK293 cells were a generous gift from A. Inoue (Tohoku University). We also gratefully acknowledge J. Sondek and S. Endo-Streeter for providing independent structure quality control analysis; M.J. Miley and the UNC macromolecular crystallization core for advice and use of their equipment for crystal harvesting and transport, which is supported by the National Cancer Institute under award number P30CA016086; J. Smith, R. Fischetti, and the staff of GM/CA@APS, which has been funded with federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BENNETT JP, 1975, BRAIN RES, V94, P523, DOI 10.1016/0006-8993(75)90234-6; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Best RB, 2012, BIOPHYS J, V103, P1045, DOI 10.1016/j.bpj.2012.07.042; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bogenschutz MP, 2016, PROG NEURO-PSYCHOPH, V64, P250, DOI 10.1016/j.pnpbp.2015.03.002; Bourdon DM, 2006, METHOD ENZYMOL, V406, P489, DOI 10.1016/S0076-6879(06)06037-X; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Carhart-Harris RL, 2016, P NATL ACAD SCI USA, V113, P4853, DOI 10.1073/pnas.1518377113; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Chambers CC, 1996, J PHYS CHEM-US, V100, P16385, DOI 10.1021/jp9610776; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; CHOUDHARY MS, 1995, MOL PHARMACOL, V47, P450; Chu R, 2002, J MOL BIOL, V323, P253, DOI 10.1016/S0022-2836(02)00884-7; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Coleman RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075992; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Dolder PC, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv072; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gallagher K, 1998, BIOPHYS J, V75, P769, DOI 10.1016/S0006-3495(98)77566-6; Gasser P, 2015, J PSYCHOPHARMACOL, V29, P57, DOI 10.1177/0269881114555249; Ghanouni P, 2000, J BIOL CHEM, V275, P3121, DOI 10.1074/jbc.275.5.3121; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Hamdan FF, 2005, J BIOMOL SCREEN, V10, P463, DOI 10.1177/1087057105275344; Hanson MA, 2007, PROTEIN EXPRES PURIF, V56, P85, DOI 10.1016/j.pep.2007.06.003; HOFMANN A, 1979, J PSYCHEDEL DRUG, V11, P53, DOI 10.1080/02791072.1979.10472092; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Huang XP, 2015, NATURE, V527, P477, DOI 10.1038/nature15699; Huang XP, 2009, MOL PHARMACOL, V76, P710, DOI 10.1124/mol.109.058057; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jakab RL, 1998, P NATL ACAD SCI USA, V95, P735, DOI 10.1073/pnas.95.2.735; JOHNSON FN, 1973, J MED CHEM, V16, P532, DOI 10.1021/jm00263a028; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Li JB, 1998, J PHYS CHEM A, V102, P1820, DOI 10.1021/jp972682r; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Manglik A, 2016, NATURE, V537, P185, DOI 10.1038/nature19112; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MOTULSKY HJ, 1984, MOL PHARMACOL, V25, P1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Nichols DE, 2016, PHARMACOL REV, V68, P264, DOI 10.1124/pr.115.011478; Nichols DE, 1995, BEHAV BRAIN RES, V73, P117; Nichols DE, 2002, J MED CHEM, V45, P4344, DOI 10.1021/jm020153s; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Passie T, 2008, CNS NEUROSCI THER, V14, P295, DOI 10.1111/j.1755-5949.2008.00059.x; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Perez-Aguilar JM, 2014, J AM CHEM SOC, V136, P16044, DOI 10.1021/ja508394x; Ranganathan A, 2014, BIOCHEMISTRY-US, V53, P7283, DOI 10.1021/bi5008723; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Roth CB, 2008, J MOL BIOL, V376, P1305, DOI 10.1016/j.jmb.2007.12.028; SADOWSKI J, 1994, J CHEM INF COMP SCI, V34, P1000, DOI 10.1021/ci00020a039; Schmid Y, 2015, BIOL PSYCHIAT, V78, P544, DOI 10.1016/j.biopsych.2014.11.015; Sewell RA, 2006, NEUROLOGY, V66, P1920, DOI 10.1212/01.wnl.0000219761.05466.43; SHARP KA, 1995, BIOPOLYMERS, V36, P227, DOI 10.1002/bip.360360210; SHAW E, 1956, SCIENCE, V124, P121, DOI 10.1126/science.124.3212.121; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; STOLL A, 1955, HELV CHIM ACTA, V38, P421, DOI 10.1002/hlca.19550380207; TITELER M, 1988, PSYCHOPHARMACOLOGY, V94, P213; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; VANE JR, 1957, BRIT J PHARM CHEMOTH, V12, P344, DOI 10.1111/j.1476-5381.1957.tb00146.x; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; WOOLLEY DW, 1954, P NATL ACAD SCI USA, V40, P228, DOI 10.1073/pnas.40.4.228; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F	87	210	212	4	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					377	+		10.1016/j.cell.2016.12.033	http://dx.doi.org/10.1016/j.cell.2016.12.033			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28129538	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000396249600008
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: When are hospital doctors right to challenge patients' families?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						General Medical Council, DUT OF A DOCT; Oliver D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4959; Parliamentary and Health Service Ombudsman, REP INV UNS DISCH HO; Parliamentary and Health Service Ombudsman, COMPL HLTH ORG YEAR	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2017	356								j344	10.1136/bmj.j344	http://dx.doi.org/10.1136/bmj.j344			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HO	28122707	Green Published, Bronze			2022-12-28	WOS:000393177700009
J	Stringhini, S; Carmeli, C; Jokela, M; Avendano, M; Muennig, P; Guida, F; Ricceri, F; d'Errico, A; Barros, H; Bochud, M; Chadeau-Hyam, M; Clavel-Chapelon, F; Costa, G; Delpierre, C; Fraga, S; Goldberg, M; Giles, GG; Krogh, V; Kelly-Irving, M; Layte, R; Lasserre, AM; Marmot, MG; Preisig, M; Shipley, MJ; Vollenweider, P; Zins, M; Kawachi, I; Steptoe, A; Mackenbach, JP; Vineis, P; Kivimaki, M				Stringhini, Silvia; Carmeli, Cristian; Jokela, Markus; Avendano, Mauricio; Muennig, Peter; Guida, Florence; Ricceri, Fulvio; d'Errico, Angelo; Barros, Henrique; Bochud, Murielle; Chadeau-Hyam, Marc; Clavel-Chapelon, Francoise; Costa, Giuseppe; Delpierre, Cyrille; Fraga, Silvia; Goldberg, Marcel; Giles, Graham G.; Krogh, Vittorio; Kelly-Irving, Michelle; Layte, Richard; Lasserre, Aurelie M.; Marmot, Michael G.; Preisig, Martin; Shipley, Martin J.; Vollenweider, Peter; Zins, Marie; Kawachi, Ichiro; Steptoe, Andrew; Mackenbach, Johan P.; Vineis, Paolo; Kivimaki, Mika		LIFEPATH Consortium	Socioeconomic status and the 25 x 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1.7 million men and women	LANCET			English	Article							NONCOMMUNICABLE DISEASES; LIFE EXPECTANCY; UNITED-STATES; HEALTH; INCOME; INEQUALITIES; BURDEN; ASSOCIATION; COUNTRIES	Background In 2011, WHO member states signed up to the 25 x 25 initiative, a plan to cut mortality due to noncommunicable diseases by 25% by 2025. However, socioeconomic factors influencing non-communicable diseases have not been included in the plan. In this study, we aimed to compare the contribution of socioeconomic status to mortality and years-of-life-lost with that of the 25 x 25 conventional risk factors. Methods We did a multicohort study and meta-analysis with individual-level data from 48 independent prospective cohort studies with information about socioeconomic status, indexed by occupational position, 25 x 25 risk factors (high alcohol intake, physical inactivity, current smoking, hypertension, diabetes, and obesity), and mortality, for a total population of 1 751 479 (54% women) from seven high-income WHO member countries. We estimated the association of socioeconomic status and the 25 x 25 risk factors with all-cause mortality and cause-specific mortality by calculating minimally adjusted and mutually adjusted hazard ratios [HR] and 95% CIs. We also estimated the population attributable fraction and the years of life lost due to suboptimal risk factors. Findings During 26.6 million person-years at risk (mean follow-up 13.3 years [SD 6.4 years]), 310 277 participants died. HR for the 25 x 25 risk factors and mortality varied between 1.04 (95% CI 0.98-1.11) for obesity in men and 2.17 (2.06-2.29) for current smoking in men. Participants with low socioeconomic status had greater mortality compared with those with high socioeconomic status (HR 1.42, 95% CI 1.38-1.45 for men; 1.34, 1.28-1.39 for women); this association remained significant in mutually adjusted models that included the 25 x 25 factors (HR 1.26, 1.21-1.32, men and women combined). The population attributable fraction was highest for smoking, followed by physical inactivity then socioeconomic status. Low socioeconomic status was associated with a 2.1-year reduction in life expectancy between ages 40 and 85 years, the corresponding years-of-life-lost were 0.5 years for high alcohol intake, 0.7 years for obesity, 3.9 years for diabetes, 1.6 years for hypertension, 2.4 years for physical inactivity, and 4.8 years for current smoking. Interpretation Socioeconomic circumstances, in addition to the 25 x 25 factors, should be targeted by local and global health strategies and health risk surveillance to reduce mortality.	[Stringhini, Silvia; Carmeli, Cristian; Bochud, Murielle; Lasserre, Aurelie M.; Preisig, Martin; Vollenweider, Peter] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Stringhini, Silvia; Carmeli, Cristian; Bochud, Murielle; Lasserre, Aurelie M.; Preisig, Martin; Vollenweider, Peter] Univ Lausanne Hosp, Dept Psychiat, Lausanne, Switzerland; [Stringhini, Silvia; Carmeli, Cristian; Bochud, Murielle; Lasserre, Aurelie M.; Preisig, Martin; Vollenweider, Peter] Univ Lausanne Hosp, Dept Internal Med, Lausanne, Switzerland; [Jokela, Markus] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Avendano, Mauricio] Kings Coll London, Dept Global Hlth & Social Med, London, England; [Avendano, Mauricio; Kawachi, Ichiro] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Muennig, Peter] Columbia Univ, Global Res Analyt Populat Hlth, Hlth Policy & Management, New York, NY USA; [Guida, Florence; Chadeau-Hyam, Marc; Vineis, Paolo] Imperial Coll London, MRC PHE Ctr Environm & Hlth, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Ricceri, Fulvio; d'Errico, Angelo] ASL TO3 Piedmont Reg, Epidemiol Unit, Grugliasco, Italy; [Bochud, Murielle; Fraga, Silvia] Univ Porto, EPIUnit, Inst Publ Hlth, Oporto, Portugal; [Barros, Henrique] Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, Oporto, Portugal; [Clavel-Chapelon, Francoise] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Costa, Giuseppe] Univ Turin, Dept Biol & Clin Sci, Turin, Italy; [Delpierre, Cyrille; Kelly-Irving, Michelle] INSERM, UMR1027, Toulouse, France; [Delpierre, Cyrille; Kelly-Irving, Michelle] Univ Toulouse III Paul Sabatier, UMR1027, Toulouse, France; [Goldberg, Marcel; Zins, Marie] INSERM, UMS 11, Populat Based Epidemiol Cohorts Unit, Villejuif, France; [Goldberg, Marcel; Zins, Marie] Paris Descartes Univ, Paris, France; [Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Krogh, Vittorio] Fdn IRCCS Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy; [Layte, Richard] Trinity Coll Dublin, Dept Sociol, Dublin, Ireland; [Marmot, Michael G.; Shipley, Martin J.; Steptoe, Andrew; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Mackenbach, Johan P.] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Kivimaki, Mika] Univ Helsinki, Clinicum, Fac Med, Helsinki, Finland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Helsinki; University of London; King's College London; Harvard University; Harvard T.H. Chan School of Public Health; Columbia University; Imperial College London; Universidade do Porto; Universidade do Porto; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Turin; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cancer Council Victoria; Fondazione IRCCS Istituto Nazionale Tumori Milan; Trinity College Dublin; University of London; University College London; Erasmus University Rotterdam; Erasmus MC; University of Helsinki	Stringhini, S (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, 10 Route Corniche, CH-1010 Lausanne, Switzerland.	silvia.stringhini@chuv.ch	Jokela, Markus/A-4669-2009; Chadeau, Marc/AAN-7586-2021; Greco, Dario/T-7113-2019; Lasserre, Aurélie M/AEA-0456-2022; Krogh, Vittorio/AAA-9171-2019; Marmot, M G/Y-3920-2019; Zins, Marie/AAX-6551-2021; Lang, Thierry/C-1686-2009; Ribeiro, Ana Isabel/AAH-8373-2019; costa, giuseppe/K-2526-2016; Barros, Henrique/Q-8609-2019; Kelly-Irving, Michelle/G-3151-2010; Colaus, PsyColaus/K-6607-2013; LANG, THIERRY/ABC-4576-2021; Kelly Irving, Michelle/AAA-5052-2022; Goldberg, Marcel/I-7834-2012; d'Errico, Angelo/AAB-8993-2019; Krogh, Vittorio/K-2628-2016; d'Errico, Angelo/K-5547-2018; Barros, Henrique/A-5488-2008; Guida, Florence/AAD-1839-2019; Ricceri, Fulvio/I-9910-2018; Steptoe, Andrew/Y-2440-2019; LEPAGE, Benoit/C-1228-2011; Avendano, Mauricio/C-9658-2018	Jokela, Markus/0000-0003-0117-0012; Chadeau, Marc/0000-0001-8341-5436; Greco, Dario/0000-0001-9195-9003; Lasserre, Aurélie M/0000-0003-3925-6663; Krogh, Vittorio/0000-0003-0122-8624; Marmot, M G/0000-0002-2431-6419; Ribeiro, Ana Isabel/0000-0001-8880-6962; Barros, Henrique/0000-0003-4699-6571; Kelly-Irving, Michelle/0000-0001-5749-4791; LANG, THIERRY/0000-0003-3406-8970; Kelly Irving, Michelle/0000-0001-5749-4791; Goldberg, Marcel/0000-0002-6161-5880; Krogh, Vittorio/0000-0003-0122-8624; Guida, Florence/0000-0002-9652-2430; Ricceri, Fulvio/0000-0001-8749-9737; Kivimaki, Mika/0000-0002-4699-5627; Sacerdote, Carlotta/0000-0002-8008-5096; d'Errico, Angelo/0000-0003-3171-413X; Carmeli, Cristian/0000-0002-1463-4587; Polidoro, Silvia/0000-0003-2968-0575; LEPAGE, Benoit/0000-0002-1586-2055; Fraga, Silvia/0000-0002-5268-7751; COSTA, Giuseppe/0000-0003-3187-4889; Hodge, Allison/0000-0001-5464-2197; Alenius, Harri/0000-0003-0106-8923; Preisig, Martin/0000-0001-5689-4259; Elliott, Paul/0000-0002-7511-5684; Avendano, Mauricio/0000-0002-7295-2911; tumino, rosario/0000-0003-2666-414X; Muennig, Peter/0000-0002-4234-0498; delpierre, cyrille/0000-0002-0831-080X; Courtin, Emilie/0000-0001-5073-7279	European Commission; Swiss State Secretariat for Education; Swiss National Science Foundation; Medical Research Council; NordForsk; Portuguese Foundation for Science and Technology; European Commission; Swiss State Secretariat for Education; Swiss National Science Foundation; Medical Research Council; NordForsk; Portuguese Foundation for Science and Technology; ESRC [ES/M001660/1, ES/J023299/1] Funding Source: UKRI; MRC [MR/M501669/1, MR/K013351/1, MR/L01341X/1] Funding Source: UKRI; Economic and Social Research Council [ES/M001660/1, ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1, MR/M501669/1, MR/L01341X/1] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss State Secretariat for Education; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NordForsk; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss State Secretariat for Education; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NordForsk; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	European Commission, Swiss State Secretariat for Education, Swiss National Science Foundation, the Medical Research Council, NordForsk, Portuguese Foundation for Science and Technology.	[Anonymous], 2008, CLOS GAP GEN HLTH EQ; Black D., 1982, INEQUALITIES HLTH BL; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; ELESH D, 1977, J HEALTH SOC BEHAV, V18, P391, DOI 10.2307/2955347; Gellert C, 2012, ARCH INTERN MED, V172, P837, DOI 10.1001/archinternmed.2012.1397; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-474; IntHout J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010247; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Levin H, COSTS BENEFITS EXCEL; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lleras-Muney A, 2005, REV ECON STUD, V72, P189, DOI 10.1111/0034-6527.00329; Lopez- Arana S, 2016, PUBLIC HEALTH NUTR, V19, P1; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1732; Maki NE, 2014, J EPIDEMIOL COMMUN H, V68, P635, DOI 10.1136/jech-2013-203501; Marmot M, 2010, FAIR SOC HLTH LIVES; MARMOT MG, 1984, LANCET, V1, P1003; Mayhew L, 2016, INVESTIGATION INEQUA; Muennig P, 2005, SOC SCI MED, V61, P2018, DOI 10.1016/j.socscimed.2005.04.005; Muennig P, 2010, AM J PUBLIC HEALTH, V100, P1758, DOI 10.2105/AJPH.2009.165019; Muennig PA, 2016, AM J PREV MED, V51, P874, DOI 10.1016/j.amepre.2016.07.001; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Stringhini S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102858; Stringhini S, 2013, INT J CARDIOL, V168, P1201, DOI 10.1016/j.ijcard.2012.11.064; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2016, METR POP ATTR FRACT; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2011, RIO POL DECL SOC DET	38	535	552	10	130	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2017	389	10075					1229	1237		10.1016/S0140-6736(16)32380-7	http://dx.doi.org/10.1016/S0140-6736(16)32380-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP1KL	28159391	Green Published, hybrid			2022-12-28	WOS:000397143700035
J	Dentzer, S				Dentzer, Susan			The Affordable Care Act: Do No Harm	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Dentzer, Susan] Network Excellence Hlth Innovat, One Broadway,15th Floor, Cambridge, MA 02142 USA		Dentzer, S (corresponding author), Network Excellence Hlth Innovat, One Broadway,15th Floor, Cambridge, MA 02142 USA.	sdentzer@nehi.net						[Anonymous], 2016, HLTH CARE; [Anonymous], 2015, COMMUNICATION; Blue Cross Blue Shield Association, 2016, NEWL ENR MEMB IND HL; Dobson A, 2016, ESTIMATING IMPACT RE; *I MED, 2003, HIDD COSTS VAL LOST; Kaufman HW, 2015, DIABETES CARE, V38, P833, DOI 10.2337/dc14-2334; Varney S, 2016, NY TIMES; Ward B.W., 2016, EARLY RELEASE SELECT	8	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					441	+		10.7326/M16-2935	http://dx.doi.org/10.7326/M16-2935			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28114663				2022-12-28	WOS:000397025800020
J	Garabato, ACN; Forryan, A; Dutrieux, P; Brannigan, L; Biddle, LC; Heywood, KJ; Jenkins, A; Firing, YL; Kimura, S				Garabato, Alberto C. Naveira; Forryan, Alexander; Dutrieux, Pierre; Brannigan, Liam; Biddle, Louise C.; Heywood, Karen J.; Jenkins, Adrian; Firing, Yvonne L.; Kimura, Satoshi			Vigorous lateral export of the meltwater outflow from beneath an Antarctic ice shelf	NATURE			English	Article							GLACIAL MELTWATER; SEA-ICE; SHEET; INSTABILITY; AMUNDSEN; OCEAN; WATER; HELIUM; NEON; MELT	The instability and accelerated melting of the Antarctic Ice Sheet are among the foremost elements of contemporary global climate change la. The increased freshwater output from Antarctica is important in determining sea level rise(1,3), the fate of Antarctic sea ice and its effect on the Earth's albedo(4,5), ongoing changes in global deep-ocean ventilation(3,6), and the evolution of Southern Ocean ecosystems and carbon cycling(7,8). A key uncertainty in assessing and predicting the impacts of Antarctic Ice Sheet melting concerns the vertical distribution of the exported meltwater. This is usually represented by climate-scale models(3-5,9) as a near-surface freshwater input to the ocean, yet measurements around Antarctica reveal the meltwater to be concentrated at deeper levels(10-14). Here we use observations of the turbulent properties of the meltwater outflows from beneath a rapidly melting Antarctic ice shelf to identify the mechanism responsible for the depth of the meltwater. We show that the initial ascent of the meltwater outflow from the ice shelf cavity triggers a centrifugal overturning instability that grows by extracting kinetic energy from the lateral shear of the background oceanic flow. The instability promotes vigorous lateral export, rapid dilution by turbulent mixing, and finally settling of meltwater at depth. We use an idealized ocean circulation model to show that this mechanism is relevant to a broad spectrum of Antarctic ice shelves. Our findings demonstrate that the mechanism producing meltwater at depth is a dynamically robust feature of Antarctic melting that should be incorporated into climate-scale models.	[Garabato, Alberto C. Naveira; Forryan, Alexander] Univ Southampton, Ocean & Earth Sci, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Dutrieux, Pierre; Jenkins, Adrian; Kimura, Satoshi] British Antarctic Survey, Cambridge CB3 0ET, England; [Dutrieux, Pierre] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Brannigan, Liam] Stockholm Univ, Dept Meteorol, SE-10691 Stockholm, Sweden; [Biddle, Louise C.; Heywood, Karen J.] Univ East Anglia, Sch Environm Sci, Ctr Ocean & Atmospher Sci, Norwich NR4 7TJ, Norfolk, England; [Firing, Yvonne L.] Natl Inst Oceanog, Southampton SO14 3ZH, Hants, England	NERC National Oceanography Centre; University of Southampton; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Columbia University; Stockholm University; University of East Anglia; NERC National Oceanography Centre	Garabato, ACN (corresponding author), Univ Southampton, Ocean & Earth Sci, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England.	acng@noc.soton.ac.uk	Garabato, Alberto Naveira/AAQ-1114-2020; Heywood, Karen J/L-1757-2016; Dutrieux, Pierre/B-7568-2012; Kimura, Satoshi/AAT-3036-2021	Garabato, Alberto Naveira/0000-0001-6071-605X; Heywood, Karen J/0000-0001-9859-0026; Dutrieux, Pierre/0000-0002-8066-934X; Kimura, Satoshi/0000-0003-1689-1605; Firing, Yvonne/0000-0002-3640-3974; Jenkins, Adrian/0000-0002-9117-0616; Biddle, Louise/0000-0002-4785-1959	Natural Environment Research Council of the UK [NE/J005703/1, NE/J005746/1, NE/J005770/1]; Philip Leverhulme Prize; Royal Society; Wolfson Foundation; NERC [NE/J005770/1, NE/J005711/1, NE/J005746/1, bas0100033, NE/J005703/1] Funding Source: UKRI; Natural Environment Research Council [NE/J005711/1, 1210192, bas0100033, NE/J005746/1, NE/J005703/1, NE/J005770/1, noc010012] Funding Source: researchfish	Natural Environment Research Council of the UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Philip Leverhulme Prize; Royal Society(Royal Society of London); Wolfson Foundation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The iSTAR programme is supported by the Natural Environment Research Council of the UK (grants NE/J005703/1, NE/J005746/1 and NE/J005770/1). A.C.N.G. acknowledges the support of a Philip Leverhulme Prize, the Royal Society and the Wolfson Foundation. We are grateful to the scientific party, crew and technicians on the RRS James Clark Ross for their hard work during data collection.	Arrigo KR, 2015, J GEOPHYS RES-OCEANS, V120, P5545, DOI 10.1002/2015JC010888; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035624; Bintanja R, 2013, NAT GEOSCI, V6, P376, DOI [10.1038/NGEO1767, 10.1038/ngeo1767]; Dutrieux P, 2014, SCIENCE, V343, P174, DOI 10.1126/science.1244341; Feldmann J, 2015, P NATL ACAD SCI USA, V112, P14191, DOI 10.1073/pnas.1512482112; Haine TWN, 1998, J PHYS OCEANOGR, V28, P634, DOI 10.1175/1520-0485(1998)028<0634:GSABIO>2.0.CO;2; Hohmann R, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000378; HOSKINS BJ, 1974, Q J ROY METEOR SOC, V100, P480, DOI 10.1256/smsqj.42519; Joughin I, 2012, SCIENCE, V338, P1172, DOI 10.1126/science.1226481; Kim I, 2016, J GEOPHYS RES-OCEANS, V121, P1654, DOI 10.1002/2015JC011211; Loose B, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005048; Nakayama Y, 2014, GEOPHYS RES LETT, V41, P7942, DOI 10.1002/2014GL061600; Nicholls KW, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000250; Paolo FS, 2015, SCIENCE, V348, P327, DOI 10.1126/science.aaa0940; Pauling AG, 2016, J CLIMATE, V29, P1655, DOI 10.1175/JCLI-D-15-0501.1; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Purkey SG, 2012, J CLIMATE, V25, P5830, DOI 10.1175/JCLI-D-11-00612.1; Richardson G, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021586; Rye CD, 2014, NAT GEOSCI, V7, P732, DOI [10.1038/ngeo2230, 10.1038/NGEO2230]; Schmidtko S, 2014, SCIENCE, V346, P1227, DOI 10.1126/science.1256117; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; St-Laurent P, 2015, J GEOPHYS RES-OCEANS, V120, P6718, DOI 10.1002/2015JC010709; Stewart AL, 2015, GEOPHYS RES LETT, V42, P432, DOI 10.1002/2014GL062281; Stocker T. F., 2014, CLIM CHANG 2013 PHYS; Swart NC, 2013, GEOPHYS RES LETT, V40, P4328, DOI 10.1002/grl.50820; Thoma M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034939; Thomas LN, 2013, DEEP-SEA RES PT II, V91, P96, DOI 10.1016/j.dsr2.2013.02.025; Thurnherr AM, 2014, J GEOPHYS RES-OCEANS, V119, P1754, DOI 10.1002/2013JC009307	28	39	39	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					219	222		10.1038/nature20825	http://dx.doi.org/10.1038/nature20825			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28135723	Green Accepted			2022-12-28	WOS:000393737500038
J	Watts, G				Watts, Geoff			Richard Lilford: finding a new challenge in slum health	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					496	496		10.1016/S0140-6736(17)30206-4	http://dx.doi.org/10.1016/S0140-6736(17)30206-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ5UH	28170326				2022-12-28	WOS:000393283400020
J	Bahcall, NA				Bahcall, Neta A.			Vera Rubin (1928-2016) OBITUARY	NATURE			English	Biographical-Item									[Bahcall, Neta A.] Princeton Univ, Astrophys, Princeton, NJ 08544 USA; [Bahcall, Neta A.] US Natl Acad Sci, Washington, DC 20418 USA	Princeton University; National Academies of Sciences, Engineering & Medicine	Bahcall, NA (corresponding author), Princeton Univ, Astrophys, Princeton, NJ 08544 USA.; Bahcall, NA (corresponding author), US Natl Acad Sci, Washington, DC 20418 USA.	neta@astro.princeton.edu						RUBIN VC, PUBLICATION LIST	1	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					32	32		10.1038/542032a	http://dx.doi.org/10.1038/542032a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28150763				2022-12-28	WOS:000396119300021
J	Esteva, A; Kuprel, B; Novoa, RA; Ko, J; Swetter, SM; Blau, HM; Thrun, S				Esteva, Andre; Kuprel, Brett; Novoa, Roberto A.; Ko, Justin; Swetter, Susan M.; Blau, Helen M.; Thrun, Sebastian			Dermatologist-level classification of skin cancer with deep neural networks	NATURE			English	Article							MELANOMA; DIAGNOSIS; ACCURACY; LESIONS	Skin cancer, the most common human malignancy(1-3), is primarily diagnosed visually, beginning with an initial clinical screening and followed potentially by dermoscopic analysis, a biopsy and histopathological examination. Automated classification of skin lesions using images is a challenging task owing to the fine-grained variability in the appearance of skin lesions. Deep convolutional neural networks (CNNs)(4,5) show potential for general and highly variable tasks across many fine-grained object categories(6-11). Here we demonstrate classification of skin lesions using a single CNN, trained end-to-end from images directly, using only pixels and disease labels as inputs. We train a CNN using a dataset of 129,450 clinical images-two orders of magnitude larger than previous datasets(12)-consisting of 2,032 different diseases. We test its performance against 21 board-certified dermatologists on biopsy-proven clinical images with two critical binary classification use cases: keratinocyte carcinomas versus benign seborrheic keratoses; and malignant melanomas versus benign nevi. The first case represents the identification of the most common cancers, the second represents the identification of the deadliest skin cancer. The CNN achieves performance on par with all tested experts across both tasks, demonstrating an artificial intelligence capable of classifying skin cancer with a level of competence comparable to dermatologists. Outfitted with deep neural networks, mobile devices can potentially extend the reach of dermatologists outside of the clinic. It is projected that 6.3 billion smartphone subscriptions will exist by the year 2021 (ref. 13) and can therefore potentially provide low-cost universal access to vital diagnostic care.	[Esteva, Andre; Kuprel, Brett] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Novoa, Roberto A.; Ko, Justin; Swetter, Susan M.] Stanford Univ, Dept Dermatol, Stanford, CA 94305 USA; [Novoa, Roberto A.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Swetter, Susan M.] Vet Affairs Palo Alto Hlth Care Syst, Dept Serv, Palo Alto, CA USA; [Blau, Helen M.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Thrun, Sebastian] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Esteva, A; Kuprel, B (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.; Novoa, RA (corresponding author), Stanford Univ, Dept Dermatol, Stanford, CA 94305 USA.; Novoa, RA (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Thrun, S (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	esteva@cs.stanford.edu; kuprel@stanford.edu; rnovoa@stanford.edu; thrun@stanford.edu	Ko, Justin/Y-7233-2019		Baxter Foundation; California Institute for Regenerative Medicine (CIRM) [TT3-05501, RB5-07469]; US National Institutes of Health (NIH) [AG044815, AG009521, NS089533, AR063963, AG020961]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009521, R21AG044815] Funding Source: NIH RePORTER	Baxter Foundation; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Thrun laboratory for their support and ideas. We thank members of the dermatology departments at Stanford University, University of Pennsylvania, Massachusetts General Hospital and University of Iowa for completing our tests. This study was supported by the Baxter Foundation, California Institute for Regenerative Medicine (CIRM) grants TT3-05501 and RB5-07469 and US National Institutes of Health (NIH) grants AG044815, AG009521, NS089533, AR063963 and AG020961 (H.M.B.).	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; American Cancer Society, 2016, CANC FACTS FIGURES 2; Ballerini Lucia, 2013, COLOR MED IMAGE ANAL, P63; Binder M, 1998, MELANOMA RES, V8, P261, DOI 10.1097/00008390-199806000-00009; Burroni M, 2004, CLIN CANCER RES, V10, P1881, DOI 10.1158/1078-0432.CCR-03-0039; Cerwall, 2016, REP ER MOB REP; CLARK WH, 1989, JNCI-J NATL CANCER I, V81, P1893, DOI 10.1093/jnci/81.24.1893; Codella Noel, 2015, Machine Learning in Medical Imaging. 6th International Workshop, MLMI 2015, held in conjunction with MICCAI 2015. Proceedings: LNCS 9352, P118, DOI 10.1007/978-3-319-24888-2_15; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Gutman D, 2016, INT S BIOM IM ISBI I; He K., 2015, DEEP RESIDUAL LEARNI, DOI DOI 10.1109/CVPR.2016.90; IOFFE S, 2015, ARXIV 1502 03167, V1502, P3167, DOI DOI 10.1007/S13398-014-0173-7.2; Kittler H, 2002, LANCET ONCOL, V3, P159, DOI 10.1016/S1470-2045(02)00679-4; Krizhevsky A., P 25 INT C NEUR INF, P1097; LeCun Y., 1995, HDB BRAIN THEORY NEU, V3361, DOI DOI 10.1109/IJCNN.2004.1381049; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Masood A, 2013, INT J BIOMED IMAGING, V2013, DOI 10.1155/2013/323268; Menzies SW, 1997, SKIN CANCER AND UV RADIATION, P1064; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Ramlakhan K, 2011, PROC INT C TOOLS ART, P138, DOI 10.1109/ICTAI.2011.29; Rogers HW, 2015, JAMA DERMATOL, V151, P1081, DOI 10.1001/jamadermatol.2015.1187; Rosado B, 2003, ARCH DERMATOL, V139, P361, DOI 10.1001/archderm.139.3.361; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; SCHINDEWOLF T, 1993, ANAL QUANT CYTOL, V15, P1; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Stern RS, 2010, ARCH DERMATOL, V146, P279, DOI 10.1001/archdermatol.2010.4; Szegedy C., 2015, P IEEE C COMPUTER VI, P1; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Van Der Maaten L. J. P., 2008, J MACH LEARN RES, V9, P2579	30	5023	5280	129	2103	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					115	+		10.1038/nature21056	http://dx.doi.org/10.1038/nature21056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28117445	Green Accepted			2022-12-28	WOS:000396119300042
J	Kimmelman, J; Federico, C				Kimmelman, Jonathan; Federico, Carole			Consider drug efficacy before first-in-human trials	NATURE			English	Editorial Material							CLINICAL-TRIALS; STANDARDS		[Kimmelman, Jonathan] McGill Univ, Biomed Eth, Montreal, PQ, Canada; [Federico, Carole] McGill Univ, Montreal, PQ, Canada	McGill University; McGill University	Kimmelman, J (corresponding author), McGill Univ, Biomed Eth, Montreal, PQ, Canada.	jonathan.kimmelman@mcgill.ca						Bonini S, 2016, NEW ENGL J MED, V375, P1788, DOI 10.1056/NEJMe1609006; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; Henderson VC, 2015, ELIFE, V4, DOI 10.7554/eLife.08351; Johnson RA, 2016, CLIN TRIALS, V13, P149, DOI 10.1177/1740774515602868; Kimmelman J, 2016, NATURE, V533, P311, DOI 10.1038/533311a; Kimmelman J, 2016, J MED ETHICS, V42, P50, DOI 10.1136/medethics-2015-102882; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Rice ASC, 2008, PAIN, V139, P243, DOI 10.1016/j.pain.2008.08.017; Steward O, 2012, EXP NEUROL, V233, P597, DOI 10.1016/j.expneurol.2011.06.017; Wagner TH, 2010, J CLIN ONCOL, V28, P662, DOI 10.1200/JCO.2009.23.2470	10	34	34	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					25	27		10.1038/542025a	http://dx.doi.org/10.1038/542025a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6MY	28150789	Bronze			2022-12-28	WOS:000396119300013
J	Milburn, A				Milburn, Alan			Commentary: Five changes to future proof the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Milburn, Alan] PricewaterhouseCoopers Hlth Ind Oversight Board, London, England		Milburn, A (corresponding author), PricewaterhouseCoopers Hlth Ind Oversight Board, London, England.	newhealth@uk.pwc.com						PricewaterhouseCoopers, 2016, REDR HLTH SOC CAR AR	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2017	356								j508	10.1136/bmj.j508	http://dx.doi.org/10.1136/bmj.j508			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BT	28153958				2022-12-28	WOS:000393450100007
J	Rochmyaningsih, D				Rochmyaningsih, Dyna			The developing world needs more than numbers	NATURE			English	Editorial Material												drochmya87@gmail.com						Singh SC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601689; Supali T, 2008, CLIN INFECT DIS, V46, P1385, DOI 10.1086/586753	2	6	6	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					7	7		10.1038/542007a	http://dx.doi.org/10.1038/542007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6MY	28150793	Bronze			2022-12-28	WOS:000396119300005
J	Schuster, MA; Fuentes-Afflick, E				Schuster, Mark A.; Fuentes-Afflick, Elena			Caring for Children by Supporting Parents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		[Schuster, Mark A.] Boston Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA; [Schuster, Mark A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Fuentes-Afflick, Elena] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco	Schuster, MA (corresponding author), Boston Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA.; Schuster, MA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.							[Anonymous], 2016, PAR MATT SUPP PAR CH; Coker TR, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3013; Piotrowski CC, 2009, J DEV BEHAV PEDIATR, V30, P91, DOI 10.1097/DBP.0b013e3181976a95; Schuster MA, 2014, NEW ENGL J MED, V371, P493, DOI 10.1056/NEJMp1404860; Zuckerman B, 2010, CURR OPIN PEDIATR, V22, P539, DOI 10.1097/MOP.0b013e32833a4673	5	10	10	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 2	2017	376	5					410	413		10.1056/NEJMp1611499	http://dx.doi.org/10.1056/NEJMp1611499			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8WH	28146653				2022-12-28	WOS:000393507200003
J	Loewenberg, S				Loewenberg, Sam			Famine fears in northeast Nigeria as Boko Haram fight rages	LANCET			English	Editorial Material																			0	4	4	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					352	352						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	28137685				2022-12-28	WOS:000392804700016
J	Sheldon, MP				Sheldon, Myrna Perez			The Book That Changed America	SCIENCE			English	Book Review									[Sheldon, Myrna Perez] Ohio Univ, Dept Class & World Relig, Athens, OH 45701 USA	Ohio University	Sheldon, MP (corresponding author), Ohio Univ, Dept Class & World Relig, Athens, OH 45701 USA.	sheldonm@ohio.edu						FULLER R, 2017, BOOK CHANGED AM	1	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					356	356		10.1126/science.aal4355	http://dx.doi.org/10.1126/science.aal4355			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4FR	28126775				2022-12-28	WOS:000393172800024
J	Landhuis, E				Landhuis, Esther			BIG BRAIN, BIG DATA	NATURE			English	Editorial Material																		Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107	3	34	35	4	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2017	541	7638					559	561		10.1038/541559a	http://dx.doi.org/10.1038/541559a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4NI	28128250	Bronze			2022-12-28	WOS:000426801100001
J	Gulland, A				Gulland, Anne			Halfdan Mahler OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												annecgulland@yahoo.co.uk						MAHLER H, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2017	356								j333	10.1136/bmj.j333	http://dx.doi.org/10.1136/bmj.j333			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HL	28119337				2022-12-28	WOS:000393177400006
J	Bai, G; Anderson, GF				Bai, Ge; Anderson, Gerard F.			Variation in the Ratio of Physician Charges to Medicare Payments by Specialty and Region	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Bai, Ge] Johns Hopkins Carey Business Sch, Baltimore, MD USA; [Anderson, Gerard F.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bai, G (corresponding author), Johns Hopkins Carey Business Sch, 100 Int Dr, Baltimore, MD 21202 USA.	gbai@jhu.edu						Centers for Medicare and Medicaid Services, MED PROV UT PAYM DAT; Haeder SF, 2015, JAMA-J AM MED ASSOC, V314, P669, DOI 10.1001/jama.2015.6807; Kaiser Family Foundation, BURD MED DEBT; Kyanko KA, 2013, HEALTH SERV RES, V48, P1704, DOI 10.1111/1475-6773.12071; New York State Department of Financial Services, UNW SURPR NEW YORK A; New York State Department of Financial Services, PROT SURPR BILLS EM	6	31	31	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					315	317		10.1001/jama.2016.16230	http://dx.doi.org/10.1001/jama.2016.16230			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114540				2022-12-28	WOS:000392089200021
J	Burk, RD; Chen, ZG; Saller, C; Tarvin, K; Carvalho, AL; Scapulatempo-Neto, C; Silveira, HC; Fregnani, JH; Creighton, CJ; Anderson, ML; Castro, P; Wang, SS; Yau, C; Benz, C; Robertson, AG; Mungall, K; Lim, L; Bowlby, R; Sadeghi, S; Brooks, D; Sipahimalani, P; Mar, R; Ally, A; Clarke, A; Mungall, AJ; Tam, A; Lee, D; Chuah, E; Schein, JE; Tse, K; Kasaian, K; Ma, Y; Marra, MA; Mayo, M; Balasundaram, M; Thiessen, N; Dhalla, N; Carlsen, R; Moore, RA; Holt, RA; Jones, SJM; Wong, TN; Pantazi, A; Parfenov, M; Kucherlapati, R; Hadjipanayis, A; Seidman, J; Kucherlapati, M; Ren, XJ; Xu, AW; Yang, LX; Park, PJ; Lee, S; Rabeno, B; Huelsenbeck-Dill, L; Borowsky, M; Cadungog, M; Iacocca, M; Petrelli, N; Swanson, P; Ojesina, AI; Le, X; Sandusky, G; Adebamowo, SN; Akeredolu, T; Adebamowo, C; Reynolds, SM; Shmulevich, I; Shelton, C; Crain, D; Mallery, D; Curley, E; Gardner, J; Penny, R; Morris, S; Shelton, T; Liu, J; Lolla, L; Chudamani, S; Wu, Y; Birrer, M; McLellan, MD; Bailey, MH; Miller, CA; Wyczalkowski, MA; Fulton, RS; Fronick, CC; Lu, C; Mardis, ER; Appelbaum, EL; Schmidt, HK; Fulton, LA; Cordes, MG; Li, TD; Ding, L; Wilson, RK; Rader, JS; Behmaram, B; Uyar, D; Bradley, W; Wrangle, J; Pastore, A; Levine, DA; Dao, F; Gao, JJ; Schultz, N; Sander, C; Ladanyi, M; Einstein, M; Teeter, R; Benz, S; Wentzensen, N; Felau, I; Zenklusen, JC; Bodelon, C; Demchok, JA; Yang, LM; Sheth, M; Ferguson, ML; Tarnuzzer, R; Yang, HN; Schiffman, M; Zhang, JS; Wang, ZN; Davidsen, T; Olaniyan, O; Hutter, CM; Sofia, HJ; Gordenin, DA; Chan, K; Roberts, SA; Klimczak, LJ; Van Waes, C; Chen, Z; Saleh, AD; Cheng, H; Parfitt, J; Bartlett, J; Albert, M; Arnaout, A; Sekhon, H; Gilbert, S; Peto, M; Myers, J; Harr, J; Eckman, J; Bergsten, J; Tucker, K; Zach, LA; Karlan, BY; Lester, J; Orsulic, S; Sun, Q; Naresh, R; Pihl, T; Wan, YH; Zaren, H; Sapp, J; Miller, J; Drwiega, P; Ojesina, AI; Murray, BA; Zhang, HL; Cherniack, AD; Sougnez, C; Pedamallu, CS; Lichtenstein, L; Meyerson, M; Noble, MS; Heiman, DI; Voet, D; Getz, G; Saksena, G; Kim, J; Shih, J; Cho, J; Lawrence, MS; Gehlenborg, N; Lin, P; Beroukhim, R; Frazer, S; Gabriel, SB; Schumacher, SE; Leraas, KM; Lichtenberg, TM; Zmuda, E; Bowen, J; Frick, J; Gastier-Foster, JM; Wise, L; Gerken, M; Ramirez, NC; Danilova, L; Cope, L; Baylin, SB; Salvesen, HB; Vellano, CP; Ju, ZL; Diao, LX; Zhao, H; Chong, ZC; Ryan, MC; Martinez-Ledesma, E; Verhaak, RG; Byers, LA; Yuan, Y; Chen, K; Ling, SY; Mills, GB; Lu, YL; Akbani, R; Seth, S; Liang, H; Wang, J; Han, L; Weinstein, JN; Bristow, CA; Zhang, W; Mahadeshwar, HS; Sun, HD; Tang, JB; Zhang, JH; Song, XZ; Protopopov, A; Shaw, KRM; Chin, L; Olabode, O; Ojesina, AI; DiSaia, P; Radenbaugh, A; Haussler, D; Zhu, JC; Stuart, J; Chalise, P; Koestler, D; Fridley, BL; Godwin, AK; Madan, R; Ciriello, G; Martinez, C; Higgins, K; Bocklage, T; Auman, JT; Perou, CM; Tan, DH; Parker, JS; Hoadley, KA; Wilkerson, MD; Mieczkowski, PA; Skelly, T; Veluvolu, U; Hayes, DN; Rathmell, WK; Hoyle, AP; Simons, JV; Wu, JY; Mose, LE; Soloway, MG; Balu, S; Meng, SW; Jefferys, SR; Bodenheimer, T; Shi, Y; Roach, J; Thorne, LB; Boice, L; Huang, M; Jones, CD; Zuna, R; Walker, J; Gunderson, C; Snowbarger, C; Brown, D; Moxley, K; Moore, K; Andrade, K; Landrum, L; Mannel, R; McMeekin, S; Johnson, S; Nelson, T; Elishaev, E; Dhir, R; Edwards, R; Bhargava, R; Tiezzi, DG; Andrade, JM; Noushmehr, H; Carlotti, CG; Tirapelli, DPD; Weisenberger, DJ; Van Den Berg, DJ; Maglinte, DT; Bootwalla, MS; Lai, PH; Triche, T; Swisher, EM; Agnew, KJ; Shelley, CS; Laird, PW; Schwarz, J; Grigsby, P; Mutch, D				Burk, Robert D.; Chen, Zigui; Saller, Charles; Tarvin, Katherine; Carvalho, Andre L.; Scapulatempo-Neto, Cristovam; Silveira, Henrique C.; Fregnani, Jose H.; Creighton, Chad J.; Anderson, Matthew L.; Castro, Patricia; Wang, Sophia S.; Yau, Christina; Benz, Christopher; Robertson, A. Gordon; Mungall, Karen; Lim, Lynette; Bowlby, Reanne; Sadeghi, Sara; Brooks, Denise; Sipahimalani, Payal; Mar, Richard; Ally, Adrian; Clarke, Amanda; Mungall, Andrew J.; Tam, Angela; Lee, Darlene; Chuah, Eric; Schein, Jacqueline E.; Tse, Kane; Kasaian, Katayoon; Ma, Yussanne; Marra, Marco A.; Mayo, Michael; Balasundaram, Miruna; Thiessen, Nina; Dhalla, Noreen; Carlsen, Rebecca; Moore, Richard A.; Holt, Robert A.; Jones, Steven J. M.; Wong, Tina; Pantazi, Angeliki; Parfenov, Michael; Kucherlapati, Raju; Hadjipanayis, Angela; Seidman, Jonathan; Kucherlapati, Melanie; Ren, Xiaojia; Xu, Andrew W.; Yang, Lixing; Park, Peter J.; Lee, Semin; Rabeno, Brenda; Huelsenbeck-Dill, Lori; Borowsky, Mark; Cadungog, Mark; Iacocca, Mary; Petrelli, Nicholas; Swanson, Patricia; Ojesina, Akinyemi I.; Le, Xuan; Sandusky, George; Adebamowo, Sally N.; Akeredolu, Teniola; Adebamowo, Clement; Reynolds, Sheila M.; Shmulevich, Ilya; Shelton, Candace; Crain, Daniel; Mallery, David; Curley, Erin; Gardner, Johanna; Penny, Robert; Morris, Scott; Shelton, Troy; Liu, Jia; Lolla, Laxmi; Chudamani, Sudha; Wu, Ye; Birrer, Michael; McLellan, Michael D.; Bailey, Matthew H.; Miller, Christopher A.; Wyczalkowski, Matthew A.; Fulton, Robert S.; Fronick, Catrina C.; Lu, Charles; Mardis, Elaine R.; Appelbaum, Elizabeth L.; Schmidt, Heather K.; Fulton, Lucinda A.; Cordes, Matthew G.; Li, Tiandao; Ding, Li; Wilson, Richard K.; Rader, Janet S.; Behmaram, Behnaz; Uyar, Denise; Bradley, William; Wrangle, John; Pastore, Alessandro; Levine, Douglas A.; Dao, Fanny; Gao, Jianjiong; Schultz, Nikolaus; Sander, Chris; Ladanyi, Marc; Einstein, Mark; Teeter, Randall; Benz, Stephen; Wentzensen, Nicolas; Felau, Ina; Zenklusen, Jean C.; Bodelon, Clara; Demchok, John A.; Yang, Liming; Sheth, Margi; Ferguson, Martin L.; Tarnuzzer, Roy; Yang, Hannah; Schiffman, Mark; Zhang, Jiashan; Wang, Zhining; Davidsen, Tanja; Olaniyan, Olayinka; Hutter, Carolyn M.; Sofia, Heidi J.; Gordenin, Dmitry A.; Chan, Kin; Roberts, Steven A.; Klimczak, Leszek J.; Van Waes, Carter; Chen, Zhong; Saleh, Anthony D.; Cheng, Hui; Parfitt, Jeremy; Bartlett, John; Albert, Monique; Arnaout, Angel; Sekhon, Harman; Gilbert, Sebastien; Peto, Myron; Myers, Jerome; Harr, Jodi; Eckman, John; Bergsten, Julie; Tucker, Kelinda; Zach, Leigh Anne; Karlan, Beth Y.; Lester, Jenny; Orsulic, Sandra; Sun, Qiang; Naresh, Rashi; Pihl, Todd; Wan, Yunhu; Zaren, Howard; Sapp, Jennifer; Miller, Judy; Drwiega, Paul; Ojesina, Akinyemi I.; Murray, Bradley A.; Zhang, Hailei; Cherniack, Andrew D.; Sougnez, Carrie; Pedamallu, Chandra Sekhar; Lichtenstein, Lee; Meyerson, Matthew; Noble, Michael S.; Heiman, David I.; Voet, Doug; Getz, Gad; Saksena, Gordon; Kim, Jaegil; Shih, Juliann; Cho, Juok; Lawrence, Michael S.; Gehlenborg, Nils; Lin, Pei; Beroukhim, Rameen; Frazer, Scott; Gabriel, Stacey B.; Schumacher, Steven E.; Leraas, Kristen M.; Lichtenberg, Tara M.; Zmuda, Erik; Bowen, Jay; Frick, Jessica; Gastier-Foster, Julie M.; Wise, Lisa; Gerken, Mark; Ramirez, Nilsa C.; Danilova, Ludmila; Cope, Leslie; Baylin, Stephen B.; Salvesen, Helga B.; Vellano, Christopher P.; Ju, Zhenlin; Diao, Lixia; Zhao, Hao; Chong, Zechen; Ryan, Michael C.; Martinez-Ledesma, Emmanuel; Verhaak, Roeland G.; Byers, Lauren Averett; Yuan, Yuan; Chen, Ken; Ling, Shiyun; Mills, Gordon B.; Lu, Yiling; Akbani, Rehan; Seth, Sahil; Liang, Han; Wang, Jing; Han, Leng; Weinstein, John N.; Bristow, Christopher A.; Zhang, Wei; Mahadeshwar, Harshad S.; Sun, Huandong; Tang, Jiabin; Zhang, Jianhua; Song, Xingzhi; Protopopov, Alexei; Shaw, Kenna R. Mills; Chin, Lynda; Olabode, Oluwole; Ojesina, Akinyemi I.; DiSaia, Philip; Radenbaugh, Amie; Haussler, David; Zhu, Jingchun; Stuart, Josh; Chalise, Prabhakar; Koestler, Devin; Fridley, Brooke L.; Godwin, Andrew K.; Madan, Rashna; Ciriello, Giovanni; Martinez, Cathleen; Higgins, Kelly; Bocklage, Therese; Auman, J. Todd; Perou, Charles M.; Tan, Donghui; Parker, Joel S.; Hoadley, Katherine A.; Wilkerson, Matthew D.; Mieczkowski, Piotr A.; Skelly, Tara; Veluvolu, Umadevi; Hayes, D. Neil; Rathmell, W. Kimryn; Hoyle, Alan P.; Simons, Janae V.; Wu, Junyuan; Mose, Lisle E.; Soloway, Matthew G.; Balu, Saianand; Meng, Shaowu; Jefferys, Stuart R.; Bodenheimer, Tom; Shi, Yan; Roach, Jeffrey; Thorne, Leigh B.; Boice, Lori; Huang, Mei; Jones, Corbin D.; Zuna, Rosemary; Walker, Joan; Gunderson, Camille; Snowbarger, Carie; Brown, David; Moxley, Katherine; Moore, Kathleen; Andrade, Kelsi; Landrum, Lisa; Mannel, Robert; McMeekin, Scott; Johnson, Starla; Nelson, Tina; Elishaev, Esther; Dhir, Rajiv; Edwards, Robert; Bhargava, Rohit; Tiezzi, Daniel G.; Andrade, Jurandyr M.; Noushmehr, Houtan; Carlotti, Carlos Gilberto, Jr.; Tirapelli, Daniela Pretti da Cunha; Weisenberger, Daniel J.; Van Den Berg, David J.; Maglinte, Dennis T.; Bootwalla, Moiz S.; Lai, Phillip H.; Triche, Timothy, Jr.; Swisher, Elizabeth M.; Agnew, Kathy J.; Shelley, Carl Simon; Laird, Peter W.; Schwarz, Julie; Grigsby, Perry; Mutch, David		Canc Genome Atlas Res Network	Integrated genomic and molecular characterization of cervical cancer	NATURE			English	Article							EPITHELIAL-MESENCHYMAL-TRANSITION; TRANSCRIPTION FACTORS; DNA METHYLATION; BREAST-CANCER; 14-3-3-SIGMA; RESISTANCE; EXPRESSION; SIGNATURE; ACCURATE; QUANTIFICATION		[Burk, Robert D.; Chen, Zigui] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Saller, Charles; Tarvin, Katherine] Analyt Biol Serv Inc, Wilmington, DE 19801 USA; [Carvalho, Andre L.; Scapulatempo-Neto, Cristovam; Silveira, Henrique C.; Fregnani, Jose H.] Barretos Canc Hosp, Barretos, SP, Brazil; [Wang, Sophia S.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Yau, Christina; Benz, Christopher] Buck Inst Res Aging, Novato, CA 94945 USA; [Robertson, A. Gordon; Mungall, Karen; Lim, Lynette; Bowlby, Reanne; Sadeghi, Sara; Brooks, Denise; Sipahimalani, Payal; Mar, Richard; Ally, Adrian; Clarke, Amanda; Mungall, Andrew J.; Tam, Angela; Lee, Darlene; Chuah, Eric; Schein, Jacqueline E.; Tse, Kane; Kasaian, Katayoon; Ma, Yussanne; Marra, Marco A.; Mayo, Michael; Balasundaram, Miruna; Thiessen, Nina; Dhalla, Noreen; Carlsen, Rebecca; Moore, Richard A.; Holt, Robert A.; Jones, Steven J. M.; Wong, Tina] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Pantazi, Angeliki; Parfenov, Michael; Kucherlapati, Raju; Hadjipanayis, Angela; Seidman, Jonathan; Kucherlapati, Melanie; Ren, Xiaojia; Xu, Andrew W.; Yang, Lixing; Park, Peter J.; Lee, Semin] Harvard Med Sch, Boston, MA 02115 USA; [Rabeno, Brenda; Huelsenbeck-Dill, Lori; Borowsky, Mark; Cadungog, Mark; Iacocca, Mary; Petrelli, Nicholas; Swanson, Patricia] Christiana Care Hlth Serv Inc, Helen F Graham Canc Ctr, Newark, DE 19713 USA; [Rabeno, Brenda; Huelsenbeck-Dill, Lori; Borowsky, Mark; Cadungog, Mark; Iacocca, Mary; Petrelli, Nicholas; Swanson, Patricia] Christiana Care Hlth Serv Inc, Res Inst, Newark, DE 19713 USA; [Ojesina, Akinyemi I.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Ojesina, Akinyemi I.; Murray, Bradley A.; Zhang, Hailei; Cherniack, Andrew D.; Sougnez, Carrie; Pedamallu, Chandra Sekhar; Lichtenstein, Lee; Meyerson, Matthew; Noble, Michael S.; Heiman, David I.; Voet, Doug; Getz, Gad; Saksena, Gordon; Kim, Jaegil; Shih, Juliann; Cho, Juok; Lawrence, Michael S.; Gehlenborg, Nils; Lin, Pei; Beroukhim, Rameen; Frazer, Scott; Gabriel, Stacey B.; Schumacher, Steven E.; Protopopov, Alexei] Eli & Edythe L Broad Inst Massachusetts Inst Tech, Cambridge, MA 02142 USA; [Ojesina, Akinyemi I.] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Le, Xuan] ILSbio LLC, Chestertown, MD 21620 USA; [Sandusky, George] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Adebamowo, Sally N.; Akeredolu, Teniola; Adebamowo, Clement] Inst Human Virol, Abuja, Nigeria; [Reynolds, Sheila M.; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA 98109 USA; [Shelton, Candace; Crain, Daniel; Mallery, David; Curley, Erin; Gardner, Johanna; Penny, Robert; Morris, Scott; Shelton, Troy] Int Genom Consortium, Phoenix, AZ 85004 USA; [Liu, Jia; Lolla, Laxmi; Chudamani, Sudha; Wu, Ye] Leidos Biomed, Rockville, MD 20850 USA; [Birrer, Michael] Massachusetts Gen Hosp, Boston, MA 02114 USA; [McLellan, Michael D.; Bailey, Matthew H.; Miller, Christopher A.; Wyczalkowski, Matthew A.; Fulton, Robert S.; Fronick, Catrina C.; Lu, Charles; Mardis, Elaine R.; Appelbaum, Elizabeth L.; Schmidt, Heather K.; Fulton, Lucinda A.; Cordes, Matthew G.; Li, Tiandao; Ding, Li; Wilson, Richard K.] Washington Univ, McDonnell Genome Inst, St Louis, MO 63108 USA; [Rader, Janet S.; Behmaram, Behnaz; Uyar, Denise; Bradley, William] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Wrangle, John] Med Univ South Carolina, Charleston, SC 29425 USA; [Pastore, Alessandro; Levine, Douglas A.; Dao, Fanny; Gao, Jianjiong; Schultz, Nikolaus; Sander, Chris; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Einstein, Mark; Teeter, Randall] Montefiore Med Ctr, Bronx, NY 10461 USA; [Benz, Stephen] NantOmics, Santa Cruz, CA 95060 USA; [Wentzensen, Nicolas; Felau, Ina; Zenklusen, Jean C.; Bodelon, Clara; Demchok, John A.; Yang, Liming; Sheth, Margi; Ferguson, Martin L.; Tarnuzzer, Roy; Yang, Hannah; Schiffman, Mark; Zhang, Jiashan; Wang, Zhining; Davidsen, Tanja] NCI, Bethesda, MD 20892 USA; [Olaniyan, Olayinka] Natl Hosp, Abuja, Nigeria; [Hutter, Carolyn M.; Sofia, Heidi J.] NHGRI, Bethesda, MD 20892 USA; [Gordenin, Dmitry A.; Chan, Kin; Roberts, Steven A.; Klimczak, Leszek J.] NIEHS, POB 12233, Durham, NC 27709 USA; [Van Waes, Carter; Chen, Zhong; Saleh, Anthony D.; Cheng, Hui] NIDCD, Bethesda, MD 20892 USA; [Parfitt, Jeremy] London Hlth Sci Ctr, Ontario Tumour Bank, London, ON N6A 5A5, Canada; [Bartlett, John; Albert, Monique] Ontario Inst Canc Res, Ontario Tumour Bank, Toronto, ON M5G 0A3, Canada; [Arnaout, Angel; Sekhon, Harman; Gilbert, Sebastien] Ottawa Hosp, Ontario Tumour Bank, Ottawa, ON K1H 8L6, Canada; [Peto, Myron] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Myers, Jerome; Harr, Jodi; Eckman, John; Bergsten, Julie; Tucker, Kelinda; Zach, Leigh Anne] Penrose St Francis Hlth Serv, Colorado Springs, CO 80906 USA; [Karlan, Beth Y.; Lester, Jenny; Orsulic, Sandra] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Sun, Qiang; Naresh, Rashi; Pihl, Todd; Wan, Yunhu] SRA Int, Fairfax, VA 22033 USA; [Zaren, Howard; Sapp, Jennifer; Miller, Judy; Drwiega, Paul] St Josephs Candler Hlth Syst, Savannah, GA 31406 USA; [Leraas, Kristen M.; Lichtenberg, Tara M.; Zmuda, Erik; Bowen, Jay; Frick, Jessica; Gastier-Foster, Julie M.; Wise, Lisa; Gerken, Mark; Ramirez, Nilsa C.] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Danilova, Ludmila; Cope, Leslie; Baylin, Stephen B.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Salvesen, Helga B.] Univ Bergen, Bergen, Norway; [Vellano, Christopher P.; Ju, Zhenlin; Diao, Lixia; Zhao, Hao; Chong, Zechen; Ryan, Michael C.; Martinez-Ledesma, Emmanuel; Verhaak, Roeland G.; Byers, Lauren Averett; Yuan, Yuan; Chen, Ken; Ling, Shiyun; Mills, Gordon B.; Lu, Yiling; Akbani, Rehan; Seth, Sahil; Liang, Han; Wang, Jing; Han, Leng; Weinstein, John N.; Bristow, Christopher A.; Zhang, Wei; Mahadeshwar, Harshad S.; Sun, Huandong; Tang, Jiabin; Zhang, Jianhua; Song, Xingzhi; Protopopov, Alexei; Shaw, Kenna R. Mills; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Olabode, Oluwole] Univ Abuja, Teaching Hosp, Gwagwalada, Abuja, Nigeria; [DiSaia, Philip] Univ Calif Irvine, Orange, CA 92668 USA; [Radenbaugh, Amie; Haussler, David; Zhu, Jingchun; Stuart, Josh] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Chalise, Prabhakar; Koestler, Devin; Fridley, Brooke L.; Godwin, Andrew K.; Madan, Rashna] Univ Kansas, Med Ctr, Kansas City, KS 66160 USA; [Ciriello, Giovanni] Univ Lausanne, Lausanne, Switzerland; [Martinez, Cathleen; Higgins, Kelly; Bocklage, Therese] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Auman, J. Todd; Perou, Charles M.; Tan, Donghui; Parker, Joel S.; Hoadley, Katherine A.; Wilkerson, Matthew D.; Mieczkowski, Piotr A.; Skelly, Tara; Veluvolu, Umadevi; Hayes, D. Neil; Rathmell, W. Kimryn; Hoyle, Alan P.; Simons, Janae V.; Wu, Junyuan; Mose, Lisle E.; Soloway, Matthew G.; Balu, Saianand; Meng, Shaowu; Jefferys, Stuart R.; Bodenheimer, Tom; Shi, Yan; Roach, Jeffrey; Thorne, Leigh B.; Boice, Lori; Huang, Mei; Jones, Corbin D.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Zuna, Rosemary; Walker, Joan; Gunderson, Camille; Snowbarger, Carie; Brown, David; Moxley, Katherine; Moore, Kathleen; Andrade, Kelsi; Landrum, Lisa; Mannel, Robert; McMeekin, Scott; Johnson, Starla; Nelson, Tina] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Elishaev, Esther; Dhir, Rajiv; Edwards, Robert; Bhargava, Rohit] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Tiezzi, Daniel G.; Andrade, Jurandyr M.; Noushmehr, Houtan; Carlotti, Carlos Gilberto, Jr.; Tirapelli, Daniela Pretti da Cunha] Univ Sao Paulo, Ribeirao Preto Med Sch, BR-14049900 Ribeirao Preto, SP, Brazil; [Weisenberger, Daniel J.; Van Den Berg, David J.; Maglinte, Dennis T.; Bootwalla, Moiz S.; Lai, Phillip H.; Triche, Timothy, Jr.] Univ Southern Calif, Los Angeles, CA 90033 USA; [Swisher, Elizabeth M.; Agnew, Kathy J.] Univ Washington, Seattle, WA 98109 USA; [Shelley, Carl Simon] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Laird, Peter W.] Van Andel Res Inst, Grand Rapids, MI 49503 USA; [Schwarz, Julie; Grigsby, Perry; Mutch, David] Washington Univ, St Louis, MO 63110 USA	Yeshiva University; Albert Einstein College of Medicine; Hospital de Cancer de Barretos; City of Hope; Beckman Research Institute of City of Hope; Buck Institute for Research on Aging; British Columbia Cancer Agency; Harvard University; Harvard Medical School; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; Christiana Care Health System; HudsonAlpha Institute for Biotechnology; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Alabama System; University of Alabama Birmingham; Indiana University System; Indiana University Bloomington; Institute for Systems Biology (ISB); International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; Washington University (WUSTL); Medical College of Wisconsin; Medical University of South Carolina; Memorial Sloan Kettering Cancer Center; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); London Health Sciences Centre; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Ottawa; Ottawa Hospital Research Institute; Oregon Health & Science University; Cedars Sinai Medical Center; SRA International; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Johns Hopkins University; Johns Hopkins Medicine; University of Bergen; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Irvine; University of California System; University of California Santa Cruz; University of Kansas; University of Kansas Medical Center; University of Lausanne; University of New Mexico; University of New Mexico's Health Sciences Center; University of North Carolina; University of North Carolina Chapel Hill; University of Oklahoma System; University of Oklahoma Health Sciences Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidade de Sao Paulo; University of Southern California; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison; Van Andel Institute; Washington University (WUSTL)	Ojesina, AI (corresponding author), HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA.; Ojesina, AI (corresponding author), Eli & Edythe L Broad Inst Massachusetts Inst Tech, Cambridge, MA 02142 USA.; Ojesina, AI (corresponding author), Univ Alabama Birmingham, Birmingham, AL 35294 USA.; Rader, JS (corresponding author), Med Coll Wisconsin, Milwaukee, WI 53226 USA.; Rader, JS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53705 USA.	ojesina@uab.edu; jrader@mcw.edu; wentzenn@mail.nih.gov; vellcp2@gmail.com	Jones, Steven J/C-3621-2009; Tiezzi, Daniel/AAE-6790-2019; Dmitry, Gordenin/C-3907-2018; Andrade, Jurandyr M/B-2025-2013; Akbani, Rehan/AAG-1490-2019; Cherniack, Andrew D./AAY-8132-2020; Carvalho, Andre Lopes/S-7053-2016; Fregnani, José H/H-4238-2012; Ladanyi, Marc/AAG-8585-2019; Schein, Jacquie E/G-3674-2015; Han, Leng/HCH-3491-2022; Li, Tiandao/F-4039-2012; Wentzensen, Nicolas/AAG-8522-2019; Pedamallu, Chandra Sekhar/AAV-6745-2020; Chen, Ken/AAU-1432-2021; Weisenberger, Daniel/AAA-8314-2020; Mungall, Andrew J./U-7067-2018; Kucherlapati, Raju/ABC-8807-2021; Marra, Marco A/B-5987-2008; Cherniack, Andrew/AAC-5310-2019; Adebamowo, Clement/C-8778-2011; Verhaak, Roel/ABE-7058-2020; Perou, Charles M/H-9934-2014; Santos, José Sebastião/A-2179-2008; Pedamallu, Chandra Sekhar/AAV-6723-2020; Lawrence, Michael/AAC-8202-2020; Mardis, Elaine/W-2202-2019; N, Houtan/C-9692-2013; Parker, Joel/AAG-1108-2019; Laird, Peter W/G-8683-2012; Silveira, Henrique C S/J-1730-2014; Schultz, Nikolaus/ABE-6347-2020; Wilson, Richard K./AAF-4139-2019; Kucherlapati, Melanie/GXN-1132-2022; Van Den Berg, David J/G-8598-2017; Tirapelli, Daniela PC/F-9230-2012; Gao, JianJiong/B-5673-2016; Carlotti, Carlos G/C-1608-2012; Holt, Robert A/C-3303-2009; Tiezzi, Daniel Guimarães/V-4168-2019; Seth, Sahil/I-5809-2019; Chen, Zigui/E-8490-2017; Schiffman, Mark/B-9766-2015; Anderson, Matthew/C-4755-2019	Jones, Steven J/0000-0003-3394-2208; Tiezzi, Daniel/0000-0002-2660-0093; Dmitry, Gordenin/0000-0002-8399-1836; Andrade, Jurandyr M/0000-0003-3619-0582; Cherniack, Andrew D./0000-0003-0470-0111; Carvalho, Andre Lopes/0000-0001-7214-6402; Fregnani, José H/0000-0002-5235-6469; Han, Leng/0000-0002-7380-2640; Li, Tiandao/0000-0003-1650-0555; Chen, Ken/0000-0003-4013-5279; Weisenberger, Daniel/0000-0001-8303-2603; Mungall, Andrew J./0000-0002-0905-2742; Marra, Marco A/0000-0001-7146-7175; Adebamowo, Clement/0000-0002-6571-2880; Perou, Charles M/0000-0001-9827-2247; Santos, José Sebastião/0000-0001-5118-0361; N, Houtan/0000-0003-4051-8114; Laird, Peter W/0000-0001-9117-3641; Silveira, Henrique C S/0000-0001-8607-6206; Wilson, Richard K./0000-0002-1992-1358; Van Den Berg, David J/0000-0002-5404-5218; Tirapelli, Daniela PC/0000-0002-1886-4988; Gao, JianJiong/0000-0002-5739-1781; Carlotti, Carlos G/0000-0002-7055-0564; Holt, Robert A/0000-0002-7259-1247; Seth, Sahil/0000-0003-4579-3959; Chen, Zigui/0000-0002-8577-1298; Levine, Douglas/0000-0003-1038-8232; Weinstein, John/0000-0001-9401-6908; Auman, James/0000-0002-9328-8829; Stuart, Joshua/0000-0002-2171-565X; MCLELLAN, MICHAEL/0000-0002-2703-8784; Heiman, David/0000-0001-7895-4259; Meyerson, Matthew/0000-0002-9133-8108; WANG, SOPHIA/0000-0003-2597-9393; Scapulatempo-Neto, Cristovam/0000-0002-8920-6579; Mills, Gordon/0000-0002-0144-9614; Anderson, Matthew/0000-0002-2081-4672; Mieczkowski, Piotr/0000-0003-2418-0096; Benz, Stephen/0000-0002-4067-0602; Hoadley, Katherine/0000-0002-1216-477X; Martinez Ledesma, Juan Emmanuel/0000-0003-1191-7917; Tarnuzzer, Roy/0000-0002-3725-4173; Bailey, Matthew H./0000-0003-4526-9727; Triche, Tim/0000-0001-5665-946X; Chan, Kin/0000-0002-5827-3154; Bowen, Jay/0000-0001-6861-9043; Ciriello, Giovanni/0000-0003-2021-8683	NATIONAL CANCER INSTITUTE [ZIACP010124, U24CA210974, U24CA143848, U24CA143858, U24CA210949, U24CA143799, U24CA144025, P30CA016672, U24CA199461, U24CA143843, U24CA143840, U24CA180951, U24CA143883, U24CA143835, U24CA210950, U24CA143845, U24CA143882, U24CA211006, U24CA143866, U24CA143867] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG003273, U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000074] Funding Source: NIH RePORTER; NCI NIH HHS [U24 CA143799, U24 CA210950, U24 CA210974, U24 CA143882, U24 CA143840, U24 CA143845, U24 CA180951, U24 CA144025, U24 CA143835, U24 CA143858, U24 CA143848, U24 CA143843, U24 CA143866, P30 CA016672, U24 CA199461, U24 CA143867, U24 CA211006, U24 CA143883, U24 CA210949] Funding Source: Medline; NHGRI NIH HHS [U54 HG003067, U54 HG003079, U54 HG003273] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Carstens JL, 2014, J CLIN INVEST, V124, P1458, DOI 10.1172/JCI75239; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Ceppi P, 2014, ONCOGENE, V33, P269, DOI 10.1038/onc.2013.55; Chang TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040193; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chu J, 2014, BIOINFORMATICS, V30, P3402, DOI 10.1093/bioinformatics/btu558; Chung TKH, 2015, INT J CANCER, V137, P776, DOI 10.1002/ijc.29456; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Dellambra E, 2000, J CELL BIOL, V149, P1117, DOI 10.1083/jcb.149.5.1117; den Boon JA, 2015, P NATL ACAD SCI USA, V112, pE3255, DOI 10.1073/pnas.1509322112; Diaz-Martin J, 2014, J PATHOL, V232, P319, DOI 10.1002/path.4289; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Godinho MFE, 2012, BRIT J CANCER, V107, P947, DOI 10.1038/bjc.2012.351; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Jiao YM, 2014, BIOINFORMATICS, V30, P2360, DOI 10.1093/bioinformatics/btu316; Kiesslich T, 2013, MOL CLIN ONCOL, V1, P3, DOI 10.3892/mco.2012.28; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Moreira JMA, 2004, MOL CELL PROTEOMICS, V3, P410, DOI 10.1074/mcp.M300134-MCP200; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Roman A, 2013, VIROLOGY, V445, P138, DOI 10.1016/j.virol.2013.04.013; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Sedgewick AJ, 2013, BIOINFORMATICS, V29, P62, DOI 10.1093/bioinformatics/btt229; Seton-Rogers S, 2014, NAT REV CANCER, V14, DOI 10.1038/nrc3791; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tang AL, 2012, HEAD NECK-J SCI SPEC, V34, P1480, DOI 10.1002/hed.21962; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uyar D, 2014, CLIN CHEM, V60, P144, DOI 10.1373/clinchem.2013.212985; Vande Pol SB, 2013, VIROLOGY, V445, P115, DOI 10.1016/j.virol.2013.04.026; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; Yang LX, 2013, CELL, V153, P919, DOI 10.1016/j.cell.2013.04.010; Zwiener I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085150	67	746	759	21	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					378	+		10.1038/nature21386	http://dx.doi.org/10.1038/nature21386			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28112728	hybrid, Green Accepted			2022-12-28	WOS:000396337400042
J	Lopez-Rivera, E; Liu, YP; Verbitsky, M; Anderson, BR; Capone, VP; Otto, EA; Yan, Z; Mitrotti, A; Martino, J; Steers, NJ; Fasel, DA; Vukojevic, K; Deng, R; Racedo, SE; Liu, Q; Werth, M; Westland, R; Vivante, A; Makar, GS; Bodria, M; Sampson, MG; Gillies, CE; Vega-Warner, V; Maiorana, M; Petrey, DS; Honig, B; Lozanovski, VJ; Salomon, R; Heidet, L; Carpentier, W; Gaillard, D; Carrea, A; Gesualdo, L; Cusi, D; Izzi, C; Scolari, F; van Wijk, JAE; Arapovic, A; Saraga-Babic, M; Saraga, M; Kunac, N; Samii, A; McDonald-McGinn, DM; Crowley, TB; Zackai, EH; Drozdz, D; Miklaszewska, M; Tkaczyk, M; Sikora, P; Szczepanska, M; Mizerska-Wasiak, M; Krzemien, G; Szmigielska, A; Zaniew, M; Darlow, JM; Puri, P; Barton, D; Casolari, E; Furth, SL; Warady, BA; Gucev, Z; Hakonarson, H; Flogelova, H; Tasic, V; Latos-Bielenska, A; Materna-Kiryluk, A; Allegri, L; Wong, CS; Drummond, IA; D'Agati, V; Imamoto, A; Barasch, JM; Hildebrandt, F; Kiryluk, K; Lifton, RP; Morrow, BE; Jeanpierre, C; Papaioannou, VE; Ghiggeri, GM; Gharavi, AG; Katsanis, N; Sanna-Cherchi, S				Lopez-Rivera, E.; Liu, Y. P.; Verbitsky, M.; Anderson, B. R.; Capone, V. P.; Otto, E. A.; Yan, Z.; Mitrotti, A.; Martino, J.; Steers, N. J.; Fasel, D. A.; Vukojevic, K.; Deng, R.; Racedo, S. E.; Liu, Q.; Werth, M.; Westland, R.; Vivante, A.; Makar, G. S.; Bodria, M.; Sampson, M. G.; Gillies, C. E.; Vega-Warner, V.; Maiorana, M.; Petrey, D. S.; Honig, B.; Lozanovski, V. J.; Salomon, R.; Heidet, L.; Carpentier, W.; Gaillard, D.; Carrea, A.; Gesualdo, L.; Cusi, D.; Izzi, C.; Scolari, F.; van Wijk, J. A. E.; Arapovic, A.; Saraga-Babic, M.; Saraga, M.; Kunac, N.; Samii, A.; McDonald-McGinn, D. M.; Crowley, T. B.; Zackai, E. H.; Drozdz, D.; Miklaszewska, M.; Tkaczyk, M.; Sikora, P.; Szczepanska, M.; Mizerska-Wasiak, M.; Krzemien, G.; Szmigielska, A.; Zaniew, M.; Darlow, J. M.; Puri, P.; Barton, D.; Casolari, E.; Furth, S. L.; Warady, B. A.; Gucev, Z.; Hakonarson, H.; Flogelova, H.; Tasic, V.; Latos-Bielenska, A.; Materna-Kiryluk, A.; Allegri, L.; Wong, C. S.; Drummond, I. A.; D'Agati, V.; Imamoto, A.; Barasch, J. M.; Hildebrandt, F.; Kiryluk, K.; Lifton, R. P.; Morrow, B. E.; Jeanpierre, C.; Papaioannou, V. E.; Ghiggeri, G. M.; Gharavi, A. G.; Katsanis, N.; Sanna-Cherchi, S.			Genetic Drivers of Kidney Defects in the DiGeorge Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							22Q11.2 DELETION SYNDROME; LOW COPY REPEATS; TBX1 HAPLOINSUFFICIENCY; MICE LACKING; MUTATIONS; DISORDERS; MOUSE; CRKL; MALFORMATIONS; MORPHOGENESIS	BACKGROUND The DiGeorge syndrome, the most common of the microdeletion syndromes, affects multiple organs, including the heart, the nervous system, and the kidney. It is caused by deletions on chromosome 22q11.2; the genetic driver of the kidney defects is unknown. METHODS We conducted a genomewide search for structural variants in two cohorts: 2080 patients with congenital kidney and urinary tract anomalies and 22,094 controls. We performed exome and targeted resequencing in samples obtained from 586 additional patients with congenital kidney anomalies. We also carried out functional studies using zebrafish and mice. RESULTS We identified heterozygous deletions of 22q11.2 in 1.1% of the patients with congenital kidney anomalies and in 0.01% of population controls (odds ratio, 81.5; P = 4.5x10-14). We localized the main drivers of renal disease in the DiGeorge syndrome to a 370-kb region containing nine genes. In zebrafish embryos, an induced loss of function in snap29, aifm3, and crkl resulted in renal defects; the loss of crkl alone was sufficient to induce defects. Five of 586 patients with congenital urinary anomalies had newly identified, heterozygous protein-altering variants, including a premature termination codon, in CRKL. The inactivation of Crkl in the mouse model induced developmental defects similar to those observed in patients with congenital urinary anomalies. CONCLUSIONS We identified a recurrent 370-kb deletion at the 22q11.2 locus as a driver of kidney defects in the DiGeorge syndrome and in sporadic congenital kidney and urinary tract anomalies. Of the nine genes at this locus, SNAP29, AIFM3, and CRKL appear to be critical to the phenotype, with haploinsufficiency of CRKL emerging as the main genetic driver.	[Sanna-Cherchi, S.] Columbia Univ, Div Nephrol, Coll Physicians & Surg, New York, NY 10032 USA; [Katsanis, N.] Duke Univ, Med Ctr, Ctr Dis Modeling, 466A Nanaline Duke Bldg,Box 3709, Durham, NC 27710 USA	Columbia University; Duke University	Sanna-Cherchi, S (corresponding author), Columbia Univ, Div Nephrol, Coll Physicians & Surg, New York, NY 10032 USA.; Katsanis, N (corresponding author), Duke Univ, Med Ctr, Ctr Dis Modeling, 466A Nanaline Duke Bldg,Box 3709, Durham, NC 27710 USA.	katsanis@cellbio.duke.edu; ss2517@cumc.columbia.edu	Yan, Zhonghai/B-9228-2017; scolari, francesco/AAC-5957-2022; Arapovic, Adela/D-7022-2017; Jeanpierre, cecile/H-3770-2017; Barton, David E/B-9460-2008; Wang, Guilin/G-8794-2018; Lozanovski, Vladimir J/AAP-9781-2020; McDonald-McGinn, Donna/L-8643-2019; Vukojevic, Katarina/AAU-1906-2020; bodria, monica/K-2115-2016; Izzi, Claudia/GZG-8769-2022; Saraga, Marijan/E-7647-2017; Barton, David E/I-1795-2019; Saraga-Babic, Mirna/D-6362-2017; Sikora, Przemyslaw/ABE-1814-2021; Izzi, Claudia/AAB-7004-2022; Vukojevic, Katarina/D-5246-2017; Tasic, Velibor/H-8714-2019; Maiorana, Mariarosa/AGI-3423-2022; Krzemien, Grazyna/M-8980-2018; Tkaczyk, Marcin/S-9468-2016; Szmigielska, Agnieszka/M-9075-2018; Sampson, Matthew/U-4501-2017	Yan, Zhonghai/0000-0003-2456-4284; Jeanpierre, cecile/0000-0002-3463-5907; Lozanovski, Vladimir J/0000-0002-7332-3973; Vukojevic, Katarina/0000-0003-2182-2890; bodria, monica/0000-0001-9690-9945; Barton, David E/0000-0002-2031-9719; Saraga-Babic, Mirna/0000-0002-9776-2532; Sikora, Przemyslaw/0000-0002-5698-6863; Vukojevic, Katarina/0000-0003-2182-2890; Tasic, Velibor/0000-0002-3377-1245; Maiorana, Mariarosa/0000-0003-2426-3262; Arapovic, Adela/0000-0002-2462-039X; Scolari, Francesco/0000-0003-0233-9705; Heidet, Laurence/0000-0002-1362-5515; Krzemien, Grazyna/0000-0002-5964-8536; Westland, Rik/0000-0003-4960-4078; Honig, Barry/0000-0002-1835-1031; Morrow, Bernice/0000-0002-8076-4726; Szczepanska, Maria/0000-0002-6772-1983; McDonald-McGinn, Donna/0000-0003-4077-250X; Izzi, Claudia/0000-0001-6253-3185; Tkaczyk, Marcin/0000-0003-1753-7560; Makar, Gabriel/0000-0002-0402-5577; Ghiggeri, Gian Marco/0000-0003-3659-9062; Szmigielska, Agnieszka/0000-0002-1085-4160; Sampson, Matthew/0000-0001-9560-076X	National Institutes of Health (NIH) [1R01DK103184, 1R21DK098531, UL1 TR000040, P50DK096415, P30DK096493, 2R01DK080099, 3U54DK104309, P01HD070454, 4R01GM030518, R37HD033082, 1R01DK105124]; American Heart Association [13GRNT14680075]; Joint Italian Ministry of Health and NIH Young Investigators Finalized Research [2010-2307403]; National Human Genome Research Institute Centers for Mendelian Genomics [HG006504]; Fondazione Malattie Renali nel Bambino; GIS-Institut des Maladies Rares [AAE07007KSA]; Programme Hospitalier de la Recherche Clinique Assistance Publique [AOM07129]; Polish Ministry of Health; Polish Kidney Genetics Network (POLYGENES); Polish Registry of Congenital Malformations (PRCM); NZOZ Center for Medical Genetics (GENESIS); National Institute of Diabetes and Digestive and Kidney Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute [U01DK66143, U01DK66174, U01DK082194, U01DK66116, RO1DK082394]; Paul Marks Scholar Award; Dutch Kidney Foundation [15OKK95]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079123, P01HD070454, R37HD033082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006504, U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493, U54DK104309, P30DK079310, P50DK096415, U01DK066116, R01DK080099, U01DK066143, P30DK081943, R21DK098531, R01DK105124, U01DK082194, R01DK082394, R01DK103184, R01DK053093, U01DK066174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030518] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Joint Italian Ministry of Health and NIH Young Investigators Finalized Research; National Human Genome Research Institute Centers for Mendelian Genomics; Fondazione Malattie Renali nel Bambino; GIS-Institut des Maladies Rares; Programme Hospitalier de la Recherche Clinique Assistance Publique; Polish Ministry of Health; Polish Kidney Genetics Network (POLYGENES); Polish Registry of Congenital Malformations (PRCM); NZOZ Center for Medical Genetics (GENESIS); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Paul Marks Scholar Award; Dutch Kidney Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants (1R01DK103184, 1R21DK098531, and UL1 TR000040, to Dr. Sanna-Cherchi; P50DK096415 and P30DK096493, to Dr. Katsanis; 2R01DK080099, to Dr. Gharavi; 3U54DK104309, to Drs. Gharavi and Barasch; P01HD070454, to Ms. McDonald-McGinn and Dr. Morrow; 4R01GM030518, to Dr. Honig; R37HD033082, to Dr. Papaioannou; and 1R01DK105124, to Dr. Kiryluk) from the National Institutes of Health (NIH); a grant-in-aid (13GRNT14680075, to Dr. Sanna-Cherchi) from the American Heart Association; a grant (RF-2010-2307403, to Drs. Sanna-Cherchi and Ghiggeri) from the Joint Italian Ministry of Health and NIH Young Investigators Finalized Research; a grant (HG006504, to Dr. Lifton) from the National Human Genome Research Institute Centers for Mendelian Genomics; a grant (to Dr. Ghiggeri) from the Fondazione Malattie Renali nel Bambino; a grant (AAE07007KSA, to Drs. Salomon and Jeanpierre) from the GIS-Institut des Maladies Rares; and a grant (AOM07129, to Drs. Salomon and Jeanpierre) from the Programme Hospitalier de la Recherche Clinique Assistance Publique; by the Polish Ministry of Health (to Drs. Materna-Kiryluk and Latos-Bielenska); by the Polish Kidney Genetics Network (POLYGENES), the Polish Registry of Congenital Malformations (PRCM), and the NZOZ Center for Medical Genetics (GENESIS); by grants (to the Chronic Kidney Disease in Children Study) from the National Institute of Diabetes and Digestive and Kidney Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development; by grants (U01DK66143, U01DK66174, U01DK082194, U01DK66116, and RO1DK082394) from the National Heart, Lung, and Blood Institute; and by the Paul Marks Scholar Award (to Dr. Sanna-Cherchi); and a Kolff Postdoc Fellowship Abroad grant (15OKK95, to Dr. Westland) from the Dutch Kidney Foundation.	Bassett AS, 2005, AM J MED GENET A, V138A, P307, DOI 10.1002/ajmg.a.30984; Bates CM, 2011, AM J PHYSIOL-RENAL, V301, pF245, DOI 10.1152/ajprenal.00186.2011; Besseau-Ayasse J, 2014, PRENATAL DIAG, V34, P424, DOI 10.1002/pd.4321; Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114; Burnside RD, 2015, CYTOGENET GENOME RES, V146, P89, DOI 10.1159/000438708; Carvalho CMB, 2014, AM J HUM GENET, V95, P565, DOI 10.1016/j.ajhg.2014.10.006; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chatterjee R, 2012, HUM GENET, V131, P1725, DOI 10.1007/s00439-012-1181-3; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Dauber A, 2013, AM J HUM GENET, V93, P798, DOI 10.1016/j.ajhg.2013.09.010; de Pontual L, 2009, P NATL ACAD SCI USA, V106, P13921, DOI 10.1073/pnas.0901219106; Devriendt K, 1998, J MED GENET, V35, P789, DOI 10.1136/jmg.35.9.789-a; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Guris DL, 2001, NAT GENET, V27, P293, DOI 10.1038/85855; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Hwang DY, 2014, KIDNEY INT, V85, P1429, DOI 10.1038/ki.2013.508; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Kondo S, 1996, BLOOD, V87, P1006, DOI 10.1182/blood.V87.3.1006.bloodjournal8731006; Kujat A, 2006, AM J MED GENET A, V140A, P1601, DOI 10.1002/ajmg.a.31289; Lindsay EA, 2001, NAT REV GENET, V2, P858, DOI 10.1038/35098574; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; McDonald-McGinn DM, 2011, MEDICINE, V90, P1, DOI 10.1097/MD.0b013e3182060469; Mefford HC, 2007, AM J HUM GENET, V81, P1057, DOI 10.1086/522591; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Migliavacca E, 2015, AM J HUM GENET, V96, P784, DOI 10.1016/j.ajhg.2015.04.002; Moon AM, 2006, DEV CELL, V10, P71, DOI 10.1016/j.devcel.2005.12.003; Noel AC, 2014, AM J MED GENET A, V164, P2724, DOI 10.1002/ajmg.a.36720; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; Racedo SE, 2015, AM J HUM GENET, V96, P235, DOI 10.1016/j.ajhg.2014.12.025; Rump P, 2014, AM J MED GENET A, V164, P2707, DOI 10.1002/ajmg.a.36711; Saitta SC, 2004, HUM MOL GENET, V13, P417, DOI 10.1093/hmg/ddh041; Sanna-Cherchi S, 2013, NEW ENGL J MED, V369, P621, DOI 10.1056/NEJMoa1214479; Sanna-Cherchi S, 2012, AM J HUM GENET, V91, P987, DOI 10.1016/j.ajhg.2012.10.007; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Shaikh TH, 2007, GENOME RES, V17, P482, DOI 10.1101/gr.5986507; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009; Verbitsky M, 2015, J CLIN INVEST, V125, P2171, DOI 10.1172/JCI80877; Westland R, 2015, KIDNEY INT, V88, P1402, DOI 10.1038/ki.2015.239; Westland R, 2014, J AM SOC NEPHROL, V25, P1408, DOI 10.1681/ASN.2013080886; Wu HY, 2002, J UROLOGY, V168, P2564, DOI 10.1016/S0022-5347(05)64215-2; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6	48	77	83	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2017	376	8					742	754		10.1056/NEJMoa1609009	http://dx.doi.org/10.1056/NEJMoa1609009			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JO	28121514	Green Accepted, Green Published			2022-12-28	WOS:000395627900007
J	Sommers, BD; Epstein, AM				Sommers, Benjamin D.; Epstein, Arnold M.			Red-State Medicaid Expansions - Achilles' Heel of ACA Repeal?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sommers, Benjamin D.; Epstein, Arnold M.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Sommers, BD (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							[Anonymous], 2016, EC REC OB AD REF HLT; Bachrach D., 2016, STATES EXPANDING MED; Blavin F, 2016, JAMA-J AM MED ASSOC, V316, P1475, DOI 10.1001/jama.2016.14765; Collins SR., 2021, PANDEMIC EASES WHAT; Sommers BD, 2016, JAMA INTERN MED, V176, P1501, DOI 10.1001/jamainternmed.2016.4419	5	15	15	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2017	376	6							e7	10.1056/NEJMp1700156	http://dx.doi.org/10.1056/NEJMp1700156			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8XL	28122189	Green Published			2022-12-28	WOS:000393510500004
J	Yamaguchi, T; Sato, H; Kato-Itoh, M; Goto, T; Hara, H; Sanbo, M; Mizuno, N; Kobayashi, T; Yanagida, A; Umino, A; Ota, Y; Hamanaka, S; Masaki, H; Rashid, ST; Hirabayashi, M; Nakauchi, H				Yamaguchi, Tomoyuki; Sato, Hideyuki; Kato-Itoh, Megumi; Goto, Teppei; Hara, Hiromasa; Sanbo, Makoto; Mizuno, Naoaki; Kobayashi, Toshihiro; Yanagida, Ayaka; Umino, Ayumi; Ota, Yasunori; Hamanaka, Sanae; Masaki, Hideki; Rashid, Sheikh Tamir; Hirabayashi, Masumi; Nakauchi, Hiromitsu			Interspecies organogenesis generates autologous functional islets	NATURE			English	Article							PLURIPOTENT STEM-CELLS; PROGENITOR CELLS; IN-VITRO; ORGAN SIZE; BETA-CELLS; LIVER; TRANSPLANTATION; PANCREAS; SIGNAL; MOUSE	Islet transplantation is an established therapy for diabetes. We have previously shown that rat pancreata can be created from rat pluripotent stem cells (PSCs) in mice through interspecies blastocyst complementation. Although they were functional and composed of rat-derived cells, the resulting pancreata were of mouse size, rendering them insufficient for isolating the numbers of islets required to treat diabetes in a rat model. Here, by performing the reverse experiment, injecting mouse PSCs into Pdx-1-deficient rat blastocysts, we generated rat-sized pancreata composed of mouse-PSC-derived cells. Islets subsequently prepared from these mouse-rat chimaeric pancreata were transplanted into mice with streptozotocin-induced diabetes. The transplanted islets successfully normalized and maintained host blood glucose levels for over 370 days in the absence of immunosuppression (excluding the first 5 days after transplant). These data provide proof-of-principle evidence for the therapeutic potential of PSC-derived islets generated by blastocyst complementation in a xenogeneic host.	[Yamaguchi, Tomoyuki; Sato, Hideyuki; Kato-Itoh, Megumi; Mizuno, Naoaki; Kobayashi, Toshihiro; Yanagida, Ayaka; Umino, Ayumi; Hamanaka, Sanae; Masaki, Hideki; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, Tokyo, Japan; [Goto, Teppei; Hara, Hiromasa; Sanbo, Makoto; Hirabayashi, Masumi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Okazaki, Aichi, Japan; [Ota, Yasunori] Univ Tokyo, Inst Med Sci, Res Hosp, Dept Pathol,Minato Ku, Tokyo, Japan; [Rashid, Sheikh Tamir] Kings Coll London, Ctr Stem Cells & Regenerat Med, London WC2R 2LS, England; [Rashid, Sheikh Tamir] Kings Coll London, Inst Liver Studies, London WC2R 2LS, England; [Rashid, Sheikh Tamir; Nakauchi, Hiromitsu] Stanford Univ, Dept Genet, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Kobayashi, Toshihiro] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University of Tokyo; University of London; King's College London; University of London; King's College London; Stanford University; University of Cambridge	Nakauchi, H (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, Tokyo, Japan.; Nakauchi, H (corresponding author), Stanford Univ, Dept Genet, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	nakauchi@stanford.edu	Hirabayashi, Masumi/C-8935-2019	Hirabayashi, Masumi/0000-0002-1059-5883; Rashid, Sheikh Tamir/0000-0001-6779-2506; Goto, Teppei/0000-0002-0081-3357; Kobayashi, Toshihiro/0000-0001-8019-0008; Yanagida, Roh/0000-0002-4474-8075	Japan Insulin-Dependent Diabetes Mellitus (IDDM) Network; Japan Science and Technology Agency; Exploratory Research for Advanced Technology, Leading Advanced Projects for medical innovation; Japan Agency for Medical Research and Development; Japan Society for the Promotion of Science; KAKENHI [26460358]; MRC [MR/L006537/1] Funding Source: UKRI; Medical Research Council [MR/L006537/1] Funding Source: researchfish	Japan Insulin-Dependent Diabetes Mellitus (IDDM) Network; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Exploratory Research for Advanced Technology, Leading Advanced Projects for medical innovation(Japan Science & Technology Agency (JST)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Oshima and H. Tsukui for technical support, K. Okada for secretarial support, H. Nagashima and M. Watanabe for advice in preparing the manuscript, A. S. Knisely for reading of the manuscript and Japan Insulin-Dependent Diabetes Mellitus (IDDM) Network for continuous support. This work was supported by grants from Japan Science and Technology Agency, Exploratory Research for Advanced Technology, Leading Advanced Projects for medical innovation, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, KAKENHI Grant Number 26460358, research grant for type 1 diabetes, Japan IDDM Network and California Institute for Regenerative Medicine.	Agulnick AD, 2015, STEM CELL TRANSL MED, V4, P1214, DOI 10.5966/sctm.2015-0079; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Balboa D, 2015, BEST PRACT RES CL EN, V29, P899, DOI 10.1016/j.beem.2015.10.012; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Moede T, 1999, FEBS LETT, V461, P229, DOI 10.1016/S0014-5793(99)01446-5; Nakamura S, 2014, CELL STEM CELL, V14, P535, DOI 10.1016/j.stem.2014.01.011; Oliver-Krasinski JM, 2009, J CLIN INVEST, V119, P1888, DOI 10.1172/JCI37028; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Rashid T, 2014, CELL STEM CELL, V15, P406, DOI 10.1016/j.stem.2014.09.013; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Sutherland DER, 2008, TRANSPLANTATION, V86, P1799, DOI 10.1097/TP.0b013e31819143ec; Takahashi R, 1999, TRANSGENIC RES, V8, P397, DOI 10.1023/A:1008910629235; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030; Volkner M, 2016, STEM CELL REP, V6, P525, DOI 10.1016/j.stemcr.2016.03.001; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	30	162	166	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					191	196		10.1038/nature21070	http://dx.doi.org/10.1038/nature21070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28117444				2022-12-28	WOS:000393737500032
J	Sutton, S				Sutton, Stuart			Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis Responses	ANNALS OF INTERNAL MEDICINE			English	Letter							BLADDER-CANCER RISK		[Sutton, Stuart] Eastern Virginia Med Sch, Norfolk, VA 23501 USA	Eastern Virginia Medical School	Sutton, S (corresponding author), Eastern Virginia Med Sch, Norfolk, VA 23501 USA.							Cusi K, 2016, ANN INTERN MED, V165, P305, DOI 10.7326/M15-1774; Davidson MB, 2016, J DIABETES COMPLICAT, V30, P981, DOI 10.1016/j.jdiacomp.2016.04.004; Levin D, 2015, DIABETOLOGIA, V58, P493, DOI 10.1007/s00125-014-3456-9; Lewis JD, 2015, JAMA-J AM MED ASSOC, V314, P265, DOI 10.1001/jama.2015.7996; Ryder REJ, 2015, DIABETIC MED, V32, P305, DOI 10.1111/dme.12627	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2017	166	3					229	229		10.7326/L16-0627	http://dx.doi.org/10.7326/L16-0627			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7DL	28166554				2022-12-28	WOS:000394781200014
J	Vaughn, V; Saint, S; Chopra, V				Vaughn, Valerie; Saint, Sanjay; Chopra, Vineet			Mentee Missteps Tales From the Academic Trenches	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Vaughn, Valerie; Saint, Sanjay; Chopra, Vineet] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Saint, Sanjay; Chopra, Vineet] VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Vaughn, V (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA.	valmv@med.umich.edu	Saint, Sanjay/AAF-5126-2019; Vaughn, Valerie M/L-3649-2018	Chopra, Vineet/0000-0001-8670-9376; Vaughn, Valerie/0000-0003-4362-7842				[Anonymous], 2014, ED MANAG, V26, P65; Borhart J., 2015, EMERGENCY MED NEWS, V37, P24; Borhart J., 2015, EMERGENCY MED NEWS, V37, P1; Chopra V, 2016, JAMA-J AM MED ASSOC, V315, P1453, DOI 10.1001/jama.2015.18884; Dweck CS., 2008, MINDSETTHE NEW PSYCH; LANGFORD J, 1993, PSYCHOTHER, V30, P495, DOI 10.1037/0033-3204.30.3.495; Ury W., 2007, POWER POSITIVE NO	7	20	20	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					475	476		10.1001/jama.2016.12384	http://dx.doi.org/10.1001/jama.2016.12384			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28170482				2022-12-28	WOS:000393564200013
J	Starrs, AM				Starrs, Ann M.			The Trump global gag rule: an attack on US family planning and global health aid	LANCET			English	Editorial Material									[Starrs, Ann M.] Guttmacher Inst, New York, NY 10038 USA		Starrs, AM (corresponding author), Guttmacher Inst, New York, NY 10038 USA.	astarrs@guttmacher.org						Barot S., 2015, GLOBAL GAG RULE FIGH; Bendavid E, 2011, B WORLD HEALTH ORGAN, V89, P873, DOI 10.2471/BLT.11.091660; Hasstedt K., 2017, WHY WE CANNOT AFFORD; Hasstedt K., 2017, UNDERSTANDING PLANNE; Jones KM, 2015, ECON DEV CULT CHANGE, V64, P31, DOI 10.1086/682981; Kaiser Family Foundation, 2016, US FUND INT FAM PLAN; Kaiser Family Foundation, 2016, US GOV GLOB HLTH; Kaiser Family Foundation, 2017, US GOV ENG GLOB HLTH; PAI, 2017, TRUMPS GLOB GAG RUL; USAID, 2017, USAIDS FAM PLANN GUI	10	27	27	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					485	486		10.1016/S0140-6736(17)30270-2	http://dx.doi.org/10.1016/S0140-6736(17)30270-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ5UH	28170321	Bronze			2022-12-28	WOS:000393283400014
J	Acsady, L; Harris, KD				Acsady, Laszlo; Harris, Kenneth D.			Synaptic scaling in sleep	SCIENCE			English	Editorial Material									[Acsady, Laszlo] Hungarian Acad Sci, Inst Expt Med, Szigony U 43, H-1083 Budapest, Hungary; [Harris, Kenneth D.] UCL, Inst Neurol, London WC1N 3BG, England; [Harris, Kenneth D.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6DE, England	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of London; University College London; University of London; University College London	Acsady, L (corresponding author), Hungarian Acad Sci, Inst Expt Med, Szigony U 43, H-1083 Budapest, Hungary.	acsady@koki.hu		Harris, Kenneth/0000-0002-5930-6456	Engineering and Physical Sciences Research Council [EP/I005102/1] Funding Source: researchfish; EPSRC [EP/I005102/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; de Vivo L, 2017, SCIENCE, V355, P507, DOI 10.1126/science.aah5982; Diering GH, 2017, SCIENCE, V355, P511, DOI 10.1126/science.aai8355; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Grosmark AD, 2012, NEURON, V75, P1001, DOI 10.1016/j.neuron.2012.08.015; Hayashi-Takagi A, 2015, NATURE, V525, P333, DOI 10.1038/nature15257; Hinton G. E., 1983, Proceedings of the IEEE Computer Society Conference on Computer Vision and Pattern Recognition, P448; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2013, NAT REV NEUROSCI, V14, P445, DOI 10.1038/nrn3494; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	13	4	4	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					457	457		10.1126/science.aam7917	http://dx.doi.org/10.1126/science.aam7917			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154034				2022-12-28	WOS:000393183100018
J	Baum, P				Baum, Peter			Laser-driven nanoparticle motion in liquids	SCIENCE			English	Editorial Material							ELECTRON-MICROSCOPY; BUNCHES		[Baum, Peter] Ludwig Maximilians Univ Munchen, D-85748 Garching, Germany	University of Munich	Baum, P (corresponding author), Ludwig Maximilians Univ Munchen, D-85748 Garching, Germany.	peter.baum@lmu.de	Baum, Peter/B-7637-2008	Baum, Peter/0000-0002-1521-8729				Engelen WJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2700; Fu XW, 2017, SCIENCE, V355, P494, DOI 10.1126/science.aah3582; Hekstra DR, 2016, NATURE, V540, P400, DOI 10.1038/nature20571; Kealhofer C, 2016, SCIENCE, V352, P429, DOI 10.1126/science.aae0003; LaGrange T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2236263; LaGrange T, 2015, MRS BULL, V40, P22, DOI 10.1557/mrs.2014.282; McCulloch AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2699; Miller RJD, 2014, SCIENCE, V343, P1108, DOI 10.1126/science.1248488; Ryabov A, 2016, SCIENCE, V353, P374, DOI 10.1126/science.aaf8589; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135	10	2	2	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					458	459		10.1126/science.aam6381	http://dx.doi.org/10.1126/science.aam6381			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154035				2022-12-28	WOS:000393183100019
J	Fadok, JP; Krabbe, S; Markovic, M; Courtin, J; Xu, C; Massi, L; Botta, P; Bylund, K; Muller, C; Kovacevic, A; Tovote, P; Luthi, A				Fadok, Jonathan P.; Krabbe, Sabine; Markovic, Milica; Courtin, Julien; Xu, Chun; Massi, Lema; Botta, Paolo; Bylund, Kristine; Mueller, Christian; Kovacevic, Aleksandar; Tovote, Philip; Luthi, Andreas			A competitive inhibitory circuit for selection of active and passive fear responses	NATURE			English	Article							CENTRAL AMYGDALA; DEFENSIVE BEHAVIORS; PERIAQUEDUCTAL GRAY; PROJECTION NEURONS; CONDITIONED FEAR; ORGANIZATION; ANXIETY; CELLS; RAT; INFORMATION	When faced with threat, the survival of an organism is contingent upon the selection of appropriate active or passive behavioural responses(1-3). Freezing is an evolutionarily conserved passive fear response that has been used extensively to study the neuronal mechanisms of fear and fear conditioning in rodents(4). However, rodents also exhibit active responses such as flight under natural conditions(2). The central amygdala (CEA) is a forebrain structure vital for the acquisition and expression of conditioned fear responses, and the role of specific neuronal sub-populations of the CEA in freezing behaviour is well-established(1,5-7). Whether the CEA is also involved in flight behaviour, and how neuronal circuits for active and passive fear behaviour interact within the CEA, are not yet understood. Here, using in vivo optogenetics and extracellular recordings of identified cell types in a behavioural model in which mice switch between conditioned freezing and flight, we show that active and passive fear responses are mediated by distinct and mutually inhibitory CEA neurons. Cells expressing corticotropin-releasing factor (CRF+) mediate conditioned flight, and activation of somatostatin-positive (SOM+) neurons initiates passive freezing behaviour. Moreover, we find that the balance between conditioned flight and freezing behaviour is regulated by means of local inhibitory connections between CRF+ and SOM+ neurons, indicating that the selection of appropriate behavioural responses to threat is based on competitive interactions between two defined populations of inhibitory neurons, a circuit motif allowing for rapid and flexible action selection.	[Fadok, Jonathan P.; Krabbe, Sabine; Markovic, Milica; Courtin, Julien; Xu, Chun; Massi, Lema; Botta, Paolo; Bylund, Kristine; Mueller, Christian; Kovacevic, Aleksandar; Tovote, Philip; Luthi, Andreas] Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland; [Markovic, Milica; Botta, Paolo; Luthi, Andreas] Univ Basel, CH-4000 Basel, Switzerland; [Botta, Paolo] Champalimaud Ctr Unknown, P-1400038 Lisbon, Portugal	Friedrich Miescher Institute for Biomedical Research; University of Basel; Fundacao Champalimaud	Tovote, P; Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.; Luthi, A (corresponding author), Univ Basel, CH-4000 Basel, Switzerland.	philip.tovote@fmi.ch; andreas.luthi@fmi.ch	Xu, Chun/AAL-3376-2021; Fadok, Jonathan/AAX-2999-2020; courtin, julien/AAH-2380-2022; Tovote, Philip/AAC-5668-2019; courtin, julien/AEN-1402-2022; Luthi, Andreas/D-7940-2016	courtin, julien/0000-0002-6454-3245; courtin, julien/0000-0002-6454-3245; Markovic, Milica/0000-0002-6973-6679; Tovote, Philip/0000-0002-4598-722X; Botta, Paolo/0000-0003-0570-5774; Fadok, Jonathan/0000-0002-0608-5151; Xu, Chun/0000-0001-5149-8257; Luthi, Andreas/0000-0002-1859-4252; Krabbe, Sabine/0000-0002-5735-469X	EMBO LTF [952-2011]; NARSAD Young Investigator Fellowship; EMBO ALTF [1579-2010]; National Center of Competences in Research: 'SYNAPSY - The Synaptic Bases of Mental Diseases' - Swiss National Science Foundation; SNSF; ERC; Novartis Research Foundation	EMBO LTF(European Molecular Biology Organization (EMBO)); NARSAD Young Investigator Fellowship(NARSAD); EMBO ALTF; National Center of Competences in Research: 'SYNAPSY - The Synaptic Bases of Mental Diseases' - Swiss National Science Foundation; SNSF(Swiss National Science Foundation (SNSF)); ERC(European Research Council (ERC)European Commission); Novartis Research Foundation	We thank N. Whittle for comments on the manuscript. C. Ramakrishnan and K. Deisseroth provided intersectional viral vectors. M. S. Esposito and S. Arber provided flex-synaptophysin-GFP viral vectors. Z. Josh Huang provided the SOM-Flp mouse line. We thank J. Eglinger for providing overlap analysis scripts and S. Bourke for imaging advice. J.P.F. was funded by an EMBO LTF (952-2011) and a NARSAD Young Investigator Fellowship. C.X. was funded by EMBO ALTF (1579-2010). S.K., L.M. and P.T. were funded by a NARSAD Young Investigator Fellowship. All authors were supported by the National Center of Competences in Research: 'SYNAPSY - The Synaptic Bases of Mental Diseases' (financed by the Swiss National Science Foundation), a SNSF core grant (to A.L.), an ERC Advanced Grant (to A.L.), and the Novartis Research Foundation.	Anderson DJ, 2014, CELL, V157, P187, DOI 10.1016/j.cell.2014.03.003; Beyeler A, 2016, NEURON, V90, P348, DOI 10.1016/j.neuron.2016.03.004; Bittencourt AS, 2004, NEUROSCIENCE, V125, P71, DOI 10.1016/j.neuroscience.2004.01.026; Blanchard DC, 2008, HBK BEHAV NEUROSCI, V17, P63, DOI 10.1016/S1569-7339(07)00005-7; Canteras NS, 2014, NEUROSCI BIOBEHAV R, V46, P352, DOI 10.1016/j.neubiorev.2014.03.020; Ciocchi S, 2015, SCIENCE, V348, P560, DOI 10.1126/science.aaa3245; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Davis M., 2000, AMYGDALA, P213; De Oca BM, 1998, J NEUROSCI, V18, P3426; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Gozzi A, 2010, NEURON, V67, P656, DOI 10.1016/j.neuron.2010.07.008; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Isosaka T, 2015, CELL, V163, P1153, DOI 10.1016/j.cell.2015.10.047; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Nelson AB, 2014, ANNU REV NEUROSCI, V37, P117, DOI 10.1146/annurev-neuro-071013-013916; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Penzo MA, 2015, NATURE, V519, P455, DOI 10.1038/nature13978; Penzo MA, 2014, J NEUROSCI, V34, P2432, DOI 10.1523/JNEUROSCI.4166-13.2014; Perusini JN, 2015, LEARN MEMORY, V22, P417, DOI 10.1101/lm.039180.115; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; ROBERTS GW, 1982, NEUROSCIENCE, V7, P99, DOI 10.1016/0306-4522(82)90156-7; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tovote P, 2016, NATURE, V534, P206, DOI 10.1038/nature17996; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Tsetsenis T, 2007, NAT NEUROSCI, V10, P896, DOI 10.1038/nn1919; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Xu C, 2016, CELL, V167, P961, DOI 10.1016/j.cell.2016.09.051; Yu K, 2016, J NEUROSCI, V36, P6488, DOI 10.1523/JNEUROSCI.4419-15.2016	38	203	206	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					96	+		10.1038/nature21047	http://dx.doi.org/10.1038/nature21047			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28117439				2022-12-28	WOS:000396119300038
J	Norby, RJ; De Kauwe, MG; Walker, AP; Werner, C; Zaehle, S; Zak, DR				Norby, R. J.; De Kauwe, M. G.; Walker, A. P.; Werner, C.; Zaehle, S.; Zak, D. R.			Comment on "Mycorrhizal association as a primary control of the CO2 fertilization effect"	SCIENCE			English	Editorial Material							FOREST; CARBON; ENHANCEMENT	Terrer et al. (Reports, 1 July 2016, p. 72) used meta-analysis of carbon dioxide (CO2) enrichment experiments as evidence of an interaction between mycorrhizal symbiosis and soil nitrogen availability. We challenge their database and biomass as the response metric and, hence, their recommendation that incorporation of mycorrhizae in models will improve predictions of terrestrial ecosystem responses to increasing atmospheric CO2.	[Norby, R. J.; Walker, A. P.] Oak Ridge Natl Lab, Environm Sci Div, Oak Ridge, TN 37831 USA; [Norby, R. J.; Walker, A. P.] Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN 37831 USA; [De Kauwe, M. G.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [Werner, C.] Senckenberg Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Zaehle, S.] Max Planck Inst Biogeochem, Biogeochem Integrat Dept, D-07701 Jena, Germany; [Zak, D. R.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Macquarie University; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Max Planck Society; University of Michigan System; University of Michigan	Norby, RJ (corresponding author), Oak Ridge Natl Lab, Environm Sci Div, Oak Ridge, TN 37831 USA.; Norby, RJ (corresponding author), Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN 37831 USA.	rjn@ornl.gov	Zaehle, Sönke/C-9528-2017; De Kauwe, Martin/AAH-1304-2019; Walker, Anthony P/G-2931-2016	Zaehle, Sönke/0000-0001-5602-7956; De Kauwe, Martin/0000-0002-3399-9098; Walker, Anthony P/0000-0003-0557-5594; Walker, Alexander P/0000-0002-9650-382X; Zak, Donald/0000-0002-9730-7337	U.S. Department of Energy, Office of Science at the Oak Ridge National Laboratory; U.S. Department of Energy [DE-AC05-00OR22725]; Division Of Environmental Biology [1242531] Funding Source: National Science Foundation	U.S. Department of Energy, Office of Science at the Oak Ridge National Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by U.S. Department of Energy, Office of Science at the Oak Ridge National Laboratory. Oak Ridge National Laboratory is operated by UT-Battelle, LLC, under contract DE-AC05-00OR22725 with the U.S. Department of Energy.	Dickie IA, 2014, BOTANY, V92, P149, DOI 10.1139/cjb-2013-0091; Evans RD, 2014, NAT CLIM CHANGE, V4, P394, DOI [10.1038/nclimate2184, 10.1038/NCLIMATE2184]; Hibbett DS, 2000, NATURE, V407, P506, DOI 10.1038/35035065; Iversen CM, 2012, GLOBAL CHANGE BIOL, V18, P1684, DOI 10.1111/j.1365-2486.2012.02643.x; Kohler A, 2015, NAT GENET, V47, P410, DOI 10.1038/ng.3223; MCCONNAUGHAY KDM, 1993, OECOLOGIA, V94, P550, DOI 10.1007/BF00566971; Norby R. J., 1996, Carbon dioxide and terrestrial ecosystems., P1, DOI 10.1016/B978-012505295-5/50002-1; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Norby RJ, 1996, NATURE, V381, P564, DOI 10.1038/381564a0; Norby RJ, 1999, PLANT CELL ENVIRON, V22, P683, DOI 10.1046/j.1365-3040.1999.00391.x; Phillips RP, 2013, NEW PHYTOL, V199, P41, DOI 10.1111/nph.12221; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Terrer C, 2016, SCIENCE, V353, P72, DOI 10.1126/science.aaf4610	13	13	14	7	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323								10.1126/science.aai7976	http://dx.doi.org/10.1126/science.aai7976			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4FR	28126781				2022-12-28	WOS:000393172800028
J	Baker, CJ				Baker, Carol J.			Evaluating Precision Medicine's Ability to Improve Population Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Baker, Carol J.] Baylor Coll Med, Dept Pediat, 1102 Bates St,Ste1120, Houston, TX 77030 USA	Baylor College of Medicine	Baker, CJ (corresponding author), Baylor Coll Med, Dept Pediat, 1102 Bates St,Ste1120, Houston, TX 77030 USA.	cbaker@bcm.edu						[Anonymous], 2016, JAMA-J AM MED ASSOC, V316, P1820, DOI 10.1001/jama.2016.10899; Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633	2	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					441	442		10.1001/jama.2016.19244	http://dx.doi.org/10.1001/jama.2016.19244			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118445				2022-12-28	WOS:000392509600031
J	Lenzer, J				Lenzer, Jeanne			Commentary: The real problem is that electronic health records focus too much on billing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jlenzer@bmj.com						Billings E., 2014, HLTH CARE BLOG  0610; Essin D., 2012, IMPROVE EHR SYSTEMS; Himmelstein DU, 2014, HEALTH AFFAIR, V33, DOI 10.1377/hlthaff.2014.1097; Jiwani A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0556-7; Kaushal R, 2010, J GEN INTERN MED, V25, P530, DOI 10.1007/s11606-009-1238-8; Ohno-Machado L, 2011, J AM MED INFORM ASSN, V18, P729, DOI 10.1136/amiajnl-2011-000577; Poses R., 2017, HLTH CARE RENEW 0109; Ross M K, 2014, Yearb Med Inform, V9, P97, DOI 10.15265/IY-2014-0003; Sinsky C, 2016, ANN INTERN MED, V165, P753, DOI 10.7326/M16-0961; Stack SJ, 2015, AMA NEWS        0721	10	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2017	356								j326	10.1136/bmj.j326	http://dx.doi.org/10.1136/bmj.j326			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HL	28119294				2022-12-28	WOS:000393177400004
J	Chen, C; Liu, S; Shi, XQ; Chate, H; Wu, YL				Chen, Chong; Liu, Song; Shi, Xia-qing; Chate, Hugues; Wu, Yilin			Weak synchronization and large-scale collective oscillation in dense bacterial suspensions	NATURE			English	Article							SELF-ORGANIZATION; ACTIVE MATTER; DYNAMICS; MICROTUBULES; MOTION; QUORUM; SYSTEM; SWARM	Collective oscillatory behaviour is ubiquitous in nature(1), having a vital role in many biological processes from embryogenesis(2) and organ development(3) to pace-making in neuron networks(4). Elucidating the mechanisms that give rise to synchronization is essential to the understanding of biological self-organization. Collective oscillations in biological multicellular systems often arise from long-range coupling mediated by diffusive chemicals(2,5-9), by electrochemical mechanisms(4,10), or by biomechanical interaction between cells and their physical environment(11). In these examples, the phase of some oscillatory intracellular degree of freedom is synchronized. Here, in contrast, we report the discovery of a weak synchronization mechanism that does not require long-range coupling or inherent oscillation of individual cells. We find that millions of motile cells in dense bacterial suspensions can self organize into highly robust collective oscillatory motion, while individual cells move in an erratic manner, without obvious periodic motion but with frequent, abrupt and random directional changes. So erratic are individual trajectories that uncovering the collective oscillations of our micrometre-sized cells requires individual velocities to be averaged over tens or hundreds of micrometres. On such large scales, the oscillations appear to be in phase and the mean position of cells typically describes a regular elliptic trajectory. We found that the phase of the oscillations is organized into a centimetre-scale travelling wave. We present a model of noisy self-propelled particles with strictly local interactions that accounts faithfully for our observations, suggesting that self-organized collective oscillatory motion results from spontaneous chiral and rotational symmetry breaking. These findings reveal a previously unseen type of long-range order in active matter systems (those in which energy is spent locally to produce non-random motion)(12,13). This mechanism of collective oscillation may inspire new strategies to control the self-organization of active matter(14-18) and swarming robots.	[Chen, Chong; Liu, Song; Wu, Yilin] Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China; [Chen, Chong; Liu, Song; Wu, Yilin] Chinese Univ Hong Kong, Shenzhen Res Inst, Shatin, Hong Kong, Peoples R China; [Shi, Xia-qing] Soochow Univ, Ctr Soft Condensed Matter Phys, Suzhou 215006, Peoples R China; [Chate, Hugues] Univ Paris Saclay, CNRS, CEA, Serv Phys Etat Condense,CEA Saclay, F-91191 Gif Sur Yvette, France; [Chate, Hugues] Beijing Computat Sci Res Ctr, Beijing 100094, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Soochow University - China; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Chinese Academy of Engineering Physics; Beijing Computational Science Research Center (CSRC)	Wu, YL (corresponding author), Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China.; Wu, YL (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shatin, Hong Kong, Peoples R China.; Shi, XQ (corresponding author), Soochow Univ, Ctr Soft Condensed Matter Phys, Suzhou 215006, Peoples R China.; Chate, H (corresponding author), Univ Paris Saclay, CNRS, CEA, Serv Phys Etat Condense,CEA Saclay, F-91191 Gif Sur Yvette, France.; Chate, H (corresponding author), Beijing Computat Sci Res Ctr, Beijing 100094, Peoples R China.	xqshi@suda.edu.cn; hugues.chate@cea.fr; ylwu@phy.cuhk.edu.hk	Chaté, Hugues/D-2156-2015; SHI, Xia-qing/P-6744-2018; Wu, Yilin/C-3526-2013	Chaté, Hugues/0000-0002-6098-4094; SHI, Xia-qing/0000-0003-2180-3497; Wu, Yilin/0000-0002-0392-2137; Chen, Chong/0000-0002-7153-2181	Research Grants Council of Hong Kong SAR (RGC) [2191031, 2130439]; Research Grants Council of Hong Kong SAR (CUHK) [3132738, 3132739]; National Natural Science Foundation of China (NSFC) [21473152, 11635002, 11474210, 11674236, 91427302]; Agence Nationale de la Recherche	Research Grants Council of Hong Kong SAR (RGC); Research Grants Council of Hong Kong SAR (CUHK); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank Y. Li and W. Zuo from our laboratory for building the microscope stage temperature control system, L. Xu (The Chinese University of Hong Kong) for providing silicone oil, H. C. Berg (Harvard University) for providing the bacterial strains, and J. Nasvall and J. Bergman (Uppsala University) for providing the mRFP plasmid. This work was supported by the Research Grants Council of Hong Kong SAR (RGC numbers 2191031 and 2130439 and CUHK Direct Grant numbers 3132738 and 3132739 to Y.W.), the National Natural Science Foundation of China (NSFC number 21473152, to Y.W.; NSFC number 11635002 to H.C. and X.S.; NSFC numbers 11474210, 11674236 and 91427302 to X.S.), and the Agence Nationale de la Recherche (project Bactterns, to H.C.).	Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Bricard A, 2013, NATURE, V503, P95, DOI 10.1038/nature12673; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; De Monte S, 2007, P NATL ACAD SCI USA, V104, P18377, DOI 10.1073/pnas.0706089104; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Koride S, 2014, MOL BIOL CELL, V25, P3709, DOI 10.1091/mbc.E14-04-0875; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Liu JT, 2015, NATURE, V523, P550, DOI 10.1038/nature14660; Lopez HM, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.028301; Lushi E, 2014, P NATL ACAD SCI USA, V111, P9733, DOI 10.1073/pnas.1405698111; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Muller P, 2012, SCIENCE, V336, P721, DOI 10.1126/science.1221920; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Pushkin DO, 2013, J FLUID MECH, V726, P5, DOI 10.1017/jfm.2013.208; Ramaswamy S., 2010, ANNU REV CONDEN MA P, V1, P1; Rubenstein M, 2014, SCIENCE, V345, P795, DOI 10.1126/science.1254295; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Schaller V, 2010, NATURE, V467, P73, DOI 10.1038/nature09312; Sokolov A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248109; Sumino Y, 2012, NATURE, V483, P448, DOI 10.1038/nature10874; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Wensink HH, 2012, P NATL ACAD SCI USA, V109, P14308, DOI 10.1073/pnas.1202032109; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; Wu YL, 2012, P NATL ACAD SCI USA, V109, P4128, DOI 10.1073/pnas.1118238109; Zhang HP, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48011	30	114	114	8	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					210	214		10.1038/nature20817	http://dx.doi.org/10.1038/nature20817			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28114301	Green Published			2022-12-28	WOS:000393737500036
J	Bril, F; Cusi, K				Bril, Fernando; Cusi, Kenneth			Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis Response	ANNALS OF INTERNAL MEDICINE			English	Letter									[Bril, Fernando; Cusi, Kenneth] Univ Florida, Gainesville, FL 32611 USA; [Cusi, Kenneth] Malcom Randall Vet Affairs Med Ctr, Gainesville, FL USA	State University System of Florida; University of Florida	Bril, F (corresponding author), Univ Florida, Gainesville, FL 32611 USA.		Bril, Fernando/E-3430-2017	Bril, Fernando/0000-0001-5570-4396				Bril F, 2017, DIABETES CARE, V40, P419, DOI 10.2337/dc16-1787; Bril F, 2016, ENDOCRIN METAB CLIN, V45, P765, DOI 10.1016/j.ecl.2016.06.005; Einhorn D, 2016, ENDOCR PRACT, V22, P1343, DOI 10.4158/EP161409.CO; Kernan WN, 2016, NEW ENGL J MED, V374, P1321, DOI 10.1056/NEJMoa1506930; Soccio RE, 2014, CELL METAB, V20, P573, DOI 10.1016/j.cmet.2014.08.005	5	3	3	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2017	166	3					230	230		10.7326/L16-0629	http://dx.doi.org/10.7326/L16-0629			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7DL	28166556				2022-12-28	WOS:000394781200016
J	Fischer, S; Rose, A				Fischer, Shira; Rose, Adam			Responsible e-Prescribing Needs e-Discontinuation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fischer, Shira; Rose, Adam] RAND Corp, 20 Pk Plaza,Ste 920, Boston, MA 02116 USA	RAND Corporation	Fischer, S (corresponding author), RAND Corp, 20 Pk Plaza,Ste 920, Boston, MA 02116 USA.	sfischer@rand.org	Rose, Adam/HHY-9078-2022; Fischer, Shira/ABC-4293-2021	Fischer, Shira/0000-0002-1124-4962; Rose, Adam/0000-0001-8681-6155				Allen AS, 2012, ANN INTERN MED, V157, P700, DOI 10.7326/0003-4819-157-10-201211200-00006; Department of Health and Human Services-Office of the National Coordinator for Health Information Technology, 2015, 2015 ED HLTH INF TEC; Kaushal R, 2010, J GEN INTERN MED, V25, P530, DOI 10.1007/s11606-009-1238-8; Lourenco LM, 2016, J GEN INTERN MED, V31, P808, DOI 10.1007/s11606-016-3606-5	4	13	13	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					469	470		10.1001/jama.2016.19908	http://dx.doi.org/10.1001/jama.2016.19908			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28170486				2022-12-28	WOS:000393564200010
J	Service, RF				Service, Robert F.			PALEONTOLOGY Researchers close in on ancient dinosaur proteins	SCIENCE			English	News Item																			0	1	1	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					441	442		10.1126/science.355.6324.441	http://dx.doi.org/10.1126/science.355.6324.441			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154027				2022-12-28	WOS:000393183100011
J	Servick, K				Servick, Kelly			ON MESSAGE	SCIENCE			English	Editorial Material																			0	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					446	450		10.1126/science.355.6324.446	http://dx.doi.org/10.1126/science.355.6324.446			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154031				2022-12-28	WOS:000393183100015
J	Tsugawa, Y; Jena, AB; Orav, EJ; Jha, AK				Tsugawa, Yusuke; Jena, Anupam B.; Orav, E. John; Jha, Ashish K.			Quality of care delivered by general internists in US hospitals who graduated from foreign versus US medical schools: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-STATES; PHYSICIAN-CHARACTERISTICS; SEX-DIFFERENCES; CERTIFICATION; ASSOCIATIONS; EDUCATION; CITIZENS	OBJECTIVE To determine whether patient outcomes differ between general internists who graduated from a medical school outside the United States and those who graduated from a US medical school. DESIGN Observational study. SETTING Medicare, USA. PARTICIPANTS 20% national sample of data for Medicare fee-for-service beneficiaries aged 65 years or older admitted to hospital with a medical condition in 2011-14 and treated by international or US medical graduates who were general internists. The study sample for mortality analysis included 1 215 490 admissions to the hospital treated by 44 227 general internists. MAIN OUTCOME MEASURES Patients' 30 day mortality and readmission rates, and costs of care per hospital admission, with adjustment for patient and physician characteristics and hospital fixed effects (effectively comparing physicians within the same hospital). As a sensitivity analysis, we focused on physicians who specialize in the care of patients admitted to hospital ("hospitalists"), who typically work in shifts and whose patients are plausibly quasi-randomized based on the physicians' work schedules. RESULTS Compared with patients treated by US graduates, patients treated by international graduates had slightly more chronic conditions. After adjustment for patient and physician characteristics and hospital fixed effects, patients treated by international graduates had lower mortality (adjusted mortality 11.2% v 11.6%; adjusted odds ratio 0.95, 95% confidence interval 0.93 to 0.96; P<0.001) and slightly higher costs of care per admission (adjusted costs $1145 (950; pound (sic)1080) v $1098; adjusted difference $47, 95% confidence interval $39 to $55, P<0.001). Readmission rates did not differ between the two types of graduates. Similar differences in patient outcomes were observed among hospitalists. Differences in patient mortality were not explained by differences in length of stay, spending level, or discharge location. CONCLUSIONS Data on older Medicare patients admitted to hospital in the US showed that patients treated by international graduates had lower mortality than patients cared for by US graduates.	[Tsugawa, Yusuke; Jha, Ashish K.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Tsugawa, Yusuke; Orav, E. John; Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Tsugawa, Yusuke; Jha, Ashish K.] Harvard Global Hlth Inst, Cambridge, MA 02138 USA; [Jena, Anupam B.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Orav, E. John] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Tsugawa, Y (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.; Tsugawa, Y (corresponding author), Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA.; Tsugawa, Y (corresponding author), Harvard Global Hlth Inst, Cambridge, MA 02138 USA.	ytsugawa@hsph.harvard.edu		Tsugawa, Yusuke/0000-0002-1937-4833	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Allison P.D., 2005, FIXED EFFECTS REGRES; American Medical Association, INT MED GRAD; [Anonymous], 2013, NY TIMES; ARELLANO M, 1987, OXFORD B ECON STAT, V49, P431; BALDWIN DC, 1994, ACAD MED, V69, pS19, DOI 10.1097/00001888-199410000-00029; Brotherton Sarah E, 2015, JAMA, V314, P2436, DOI 10.1001/jama.2015.10473; Coates Ta-Nehisi, 2014, ATLANTIC; Covinsky KE, 2000, J AM GERIATR SOC, V48, pS187, DOI 10.1111/j.1532-5415.2000.tb03131.x; Delamothe T, 2014, BMJ-BRIT MED J, V348, pg2894, DOI [10.1136/bmj.g2894, DOI 10.1136/BMJ.G2894]; Desbiens NA, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-5; ECFMG, 2010, MED SCH ACCR REQ ECF; Eckhert NL, 2015, NEW ENGL J MED, V372, P1686, DOI 10.1056/NEJMp1415239; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Esmail A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5662; Garibaldi RA, 2002, ANN INTERN MED, V137, P505, DOI 10.7326/0003-4819-137-6-200209170-00011; General Medical Council, 2015, STAT MED ED PRACT UK; General Medical Council, APPL REG INT MED GRA; Gunasekara FI, 2014, INT J EPIDEMIOL, V43, P264, DOI 10.1093/ije/dyt221; Hall Margaret Jean, 2013, NCHS Data Brief, P1; Hinami K, 2012, J HOSP MED, V7, P402, DOI 10.1002/jhm.1907; Jena AB, 2016, JAMA INTERN MED, V176, P1294, DOI 10.1001/jamainternmed.2016.3284; Jena AB, 2015, JAMA-J AM MED ASSOC, V314, P1149, DOI 10.1001/jama.2015.10680; Kaufman JS, 2008, INT J EPIDEMIOL, V37, P624, DOI 10.1093/ije/dyn035; Ko DT, 2005, ARCH INTERN MED, V165, P458, DOI 10.1001/archinte.165.4.458; McAvinue MB, 2005, ACAD MED, V80, P473, DOI 10.1097/00001888-200505000-00015; McManus IC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2621; McWilliams JM, 2016, NEW ENGL J MED, V374, P2357, DOI 10.1056/NEJMsa1600142; McWilliams JM, 2014, NEW ENGL J MED, V371, P1715, DOI 10.1056/NEJMsa1406552; Mehrotra A, 2010, ANN INTERN MED, V152, P649, DOI 10.7326/0003-4819-152-10-201005180-00005; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; National Resident Matching Program, 2015, RES DAT 2015 MAIN RE; Norcini J, 2006, SURGERY, V140, P338, DOI 10.1016/j.surg.2006.06.001; Norcini JJ, 2013, MED CARE, V51, P1034, DOI 10.1097/MLR.0b013e3182a048af; Norcini JJ, 2010, HEALTH AFFAIR, V29, P1461, DOI 10.1377/hlthaff.2009.0222; Reid RO, 2010, ARCH INTERN MED, V170, P1442, DOI 10.1001/archinternmed.2010.307; Thompson MJ, 2009, J RURAL HEALTH, V25, P124, DOI 10.1111/j.1748-0361.2009.00208.x; Tiffin PA, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2622; Tsugawa Y, 2017, JAMA INTERN MED, V177, P206, DOI 10.1001/jamainternmed.2016.7875; Whelan GP, 2002, JAMA-J AM MED ASSOC, V288, P1079, DOI 10.1001/jama.288.9.1079; Zaheer S, 2017, ANN SURG, V265, P916, DOI 10.1097/SLA.0000000000001878	40	45	45	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2017	356								j273	10.1136/bmj.j273	http://dx.doi.org/10.1136/bmj.j273			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BX	28153977	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000393450500001
J	Tracy, DK; Wood, DM; Baumeister, D				Tracy, Derek K.; Wood, David M.; Baumeister, David			PRACTICE POINTER Novel psychoactive substances: identifying and managing acute and chronic harmful use	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEPHEDRONE TOXICITY		[Tracy, Derek K.] Oxleas NHS Fdn Trust, London, England; [Tracy, Derek K.] Kings Coll London, Cognit Schizophrenia & Imaging Lab, Dept Psychosis Studies, Inst Psychiat Psychol & Neurosci, London, England; [Wood, David M.] Guys & St Thomas NHS Fdn Trust, Clin Toxicol, London, England; [Wood, David M.] Kings Hlth Partners, London, England; [Wood, David M.] Kings Coll London, Sch Life Sci & Med, London, England; [Baumeister, David] Kings Coll London, Dept Psychol, Inst Psychiat Psychol & Neurosci, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of London; King's College London	Tracy, DK (corresponding author), Oxleas NHS Fdn Trust, London, England.; Tracy, DK (corresponding author), Kings Coll London, Cognit Schizophrenia & Imaging Lab, Dept Psychosis Studies, Inst Psychiat Psychol & Neurosci, London, England.	derek.tracy@nhs.net	Tracy, Derek/AAE-1155-2021	Tracy, Derek/0000-0002-3609-9407				Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Dargan PI, 2010, QJM-INT J MED, V103, P875, DOI 10.1093/qjmed/hcq134; Dargan PI, 2011, DRUG TEST ANAL, V3, P454, DOI 10.1002/dta.312; EMCDDA. Europol, 2016, EUR EU DRUG MARK REP; Hester RK, 1995, HDB ALCOHOLISM TREAT; Hockenhull J, 2016, LANCET, V387, P1719, DOI 10.1016/S0140-6736(16)30258-6; James D, 2011, EMERG MED J, V28, P686, DOI 10.1136/emj.2010.096636; National Poisons Information Service Public Health England, 2015, NAT POIS INF SERV RE; Public Health England, 2015, AD SUBST MIS STAT NA; Regan L, 2011, EMERG MED J, V28, P1055, DOI 10.1136/emj.2010.103093; Tracy DK, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6848; Wood DM, 2012, J MED TOXICOL, V8, P300, DOI 10.1007/s13181-012-0241-3; Wood DM, 2011, EMERG MED J, V28, P280, DOI 10.1136/emj.2010.092288; Wood DM, 2012, PROG NEURO-PSYCHOPH, V39, P227, DOI 10.1016/j.pnpbp.2012.04.020; Wood DM, 2012, J SUBST USE, V17, P91, DOI 10.3109/14659891.2012.661025; Wood DM, 2010, CLIN TOXICOL, V48, P924, DOI 10.3109/15563650.2010.531021; World Health Organization, 2016, INT CLASS DIS	17	5	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2017	356								i6814	10.1136/bmj.i6814	http://dx.doi.org/10.1136/bmj.i6814			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HO	28122703	Green Published			2022-12-28	WOS:000393177700001
J	Freund, Y; Lemachatti, N; Krastinova, E; Van Laer, M; Claessens, YE; Avondo, A; Occelli, C; Feral-Pierssens, AL; Truchot, J; Ortega, M; Carneiro, B; Pernet, J; Claret, PG; Dami, F; Bloom, B; Riou, B; Beaune, S				Freund, Yonathan; Lemachatti, Najla; Krastinova, Evguenia; Van Laer, Marie; Claessens, Yann-Erick; Avondo, Aurelie; Occelli, Celine; Feral-Pierssens, Anne-Laure; Truchot, Jennifer; Ortega, Mar; Carneiro, Bruno; Pernet, Julie; Claret, Pierre-Geraud; Dami, Fabrice; Bloom, Ben; Riou, Bruno; Beaune, Sebastien		French Soc Emergency Med	Prognostic Accuracy of Sepsis-3 Criteria for In-Hospital Mortality Among Patients With Suspected Infection Presenting to the Emergency Department	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; GOAL-DIRECTED RESUSCITATION; ORGAN FAILURE ASSESSMENT; SEPTIC SHOCK; SERUM LACTATE; SURVIVING SEPSIS; PERFORMANCE; SIRS	IMPORTANCE An international task force recently redefined the concept of sepsis. This task force recommended the use of the quick Sequential Organ Failure Assessment (qSOFA) score instead of systemic inflammatory response syndrome (SIRS) criteria to identify patients at high risk of mortality. However, these new criteria have not been prospectively validated in some settings, and their added value in the emergency department remains unknown. OBJECTIVE To prospectively validate qSOFA as a mortality predictor and compare the performances of the new sepsis criteria to the previous ones. DESIGN, SETTINGS, AND PARTICIPANTS International prospective cohort study, conducted in France, Spain, Belgium, and Switzerland between May and June 2016. In the 30 participating emergency departments, for a 4-week period, consecutive patients who visited the emergency departments with suspected infection were included. All variables from previous and new definitions of sepsis were collected. Patients were followed up until hospital discharge or death. EXPOSURES Measurement of qSOFA, SOFA, and SIRS. MAIN OUTCOMES AND MEASURES In-hospital mortality. RESULTS Of 1088 patients screened, 879 were included in the analysis. Median age was 67 years (interquartile range, 47-81 years), 414 (47%) were women, and 379 (43%) had respiratory tract infection. Overall in-hospital mortality was 8%: 3% for patients with a qSOFA score lower than 2 vs 24% for those with qSOFA score of 2 or higher (absolute difference, 21%; 95% CI, 15%-26%). The qSOFA performed better than both SIRS and severe sepsis in predicting in-hospital mortality, with an area under the receiver operating curve (AUROC) of 0.80 (95% CI, 0.74-0.85) vs 0.65 (95% CI, 0.59-0.70) for both SIRS and severe sepsis (P < .001; incremental AUROC, 0.15; 95% CI, 0.09-0.22). The hazard ratio of qSOFA score for death was 6.2 (95% CI, 3.8-10.3) vs 3.5 (95% CI, 2.2-5.5) for severe sepsis. CONCLUSIONS AND RELEVANCE Among patients presenting to the emergency department with suspected infection, the use of qSOFA resulted in greater prognostic accuracy for in-hospital mortality than did either SIRS or severe sepsis. These findings provide support for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) criteria in the emergency department setting.	[Freund, Yonathan; Riou, Bruno] UPMC Paris Univ 06, Sorbonne Univ, Paris, France; [Freund, Yonathan; Lemachatti, Najla; Riou, Bruno] APHP, Hop Pitie Salpetriere, Emergency Dept, Paris, France; [Krastinova, Evguenia] Hop St Antoine, APHP, Plateforme Rech Clin Est Parisien URCEST CRCEST, Paris, France; [Van Laer, Marie] Clin Univ St Luc, Emergency Dept, Brussels, Belgium; [Claessens, Yann-Erick] Princess Grace Hosp, Emergency Dept, Monte Carlo, Monaco; [Avondo, Aurelie] Ctr Hosp Univ, Emergency Dept, Dijon, France; [Occelli, Celine] Hop Louis Pasteur, Emergency Dept, Nice, France; [Feral-Pierssens, Anne-Laure] Hop Europeen Georges Pompidou, Emergency Dept, Paris, France; [Truchot, Jennifer] Hop Lariboisiere, Emergency Dept, Paris, France; [Ortega, Mar] Hosp Clin Barcelona, Emergency Dept, Barcelona, Spain; [Carneiro, Bruno] Ctr Hosp Univ, Emergency Dept, Angers, France; [Pernet, Julie] Hop Tenon, APHP, Emergency Dept, Paris, France; [Claret, Pierre-Geraud] Ctr Hosp Univ, Emergency Dept, Nimes, France; [Dami, Fabrice] CHU Vaudois, Emergency Dept, Lausanne, Switzerland; [Bloom, Ben] Barts Hlth NHS Trust, Emergency Dept, London, England; [Beaune, Sebastien] Hop Ambroise Pare, Emergency Dept, Boulogne, France; [Beaune, Sebastien] Paris Diderot Univ, INSERM, UMRS 1144, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; CHU Dijon Bourgogne; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Barcelona; Hospital Clinic de Barcelona; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; CHU de Nimes; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Barts Health NHS Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Freund, Y (corresponding author), Hop La Pitie Salpetriere, Serv Accueil Urgences, 83 Blvd Hop, F-75013 Paris, France.	yonathan.freund@aphp.fr	beaune, sebastien/L-6527-2017	beaune, sebastien/0000-0001-9299-6703; Bloom, Ben/0000-0002-3016-4925; Van Laer, Marie/0000-0002-1900-6117	Daichi-Sankyo; ThermoFisher Brahms; CrossJect; Sanofi; LFB; Daichi-Sankyo; ThermoFisher Brahms; CrossJect; Sanofi; LFB	Daichi-Sankyo; ThermoFisher Brahms; CrossJect; Sanofi; LFB; Daichi-Sankyo; ThermoFisher Brahms; CrossJect; Sanofi; LFB	Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Freund reported receiving lecturer fees from Daichi-Sankyo. Dr Riou reported receiving personal fees from ThermoFisher Brahms, CrossJect, Sanofi, and LFB. No other disclosures were reported.	Abraham E, 2016, JAMA-J AM MED ASSOC, V315, P757, DOI 10.1001/jama.2016.0290; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bernardin G, 1996, INTENS CARE MED, V22, P17; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Chen YX, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1351-0; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dulhunty JM, 2008, INTENS CARE MED, V34, P1654, DOI 10.1007/s00134-008-1160-2; Freund Y, 2012, BIOMARKERS, V17, P590, DOI 10.3109/1354750X.2012.704645; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sprung CL, 2006, INTENS CARE MED, V32, P421, DOI 10.1007/s00134-005-0039-8; Trzeciak S, 2007, INTENS CARE MED, V33, P970, DOI 10.1007/s00134-007-0563-9; Vincent JL, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1389-z; Wang JY, 2016, AM J EMERG MED, V34, P1788, DOI 10.1016/j.ajem.2016.06.015; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	21	406	431	1	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					301	308		10.1001/jama.2016.20329	http://dx.doi.org/10.1001/jama.2016.20329			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114554	Green Submitted, Green Published			2022-12-28	WOS:000392089200017
J	Kepreotes, E; Whitehead, B; Attia, J; Oldmeadow, C; Collison, A; Searles, A; Goddard, B; Hilton, J; Lee, M; Mattes, J				Kepreotes, Elizabeth; Whitehead, Bruce; Attia, John; Oldmeadow, Christopher; Collison, Adam; Searles, Andrew; Goddard, Bernadette; Hilton, Jodi; Lee, Mark; Mattes, Joerg			High-flow warm humidified oxygen versus standard low-flow nasal cannula oxygen for moderate bronchiolitis (HFWHO RCT): an open, phase 4, randomised controlled trial	LANCET			English	Article							POSITIVE AIRWAY PRESSURE; PRETERM INFANTS; THERAPY	Background Bronchiolitis is the most common lung infection in infants and treatment focuses on management of respiratory distress and hypoxia. High-flow warm humidified oxygen (HFWHO) is increasingly used, but has not been rigorously studied in randomised trials. We aimed to examine whether HFWHO provided enhanced respiratory support, thereby shortening time to weaning off oxygen. Methods In this open, phase 4, randomised controlled trial, we recruited children aged less than 24 months with moderate bronchiolitis attending the emergency department of the John Hunter Hospital or the medical unit of the John Hunter Children's Hospital in New South Wales, Australia. Patients were randomly allocated (1:1) via opaque sealed envelopes to HFWHO (maximum flow of 1 L/kg per min to a limit of 20 L/min using 1:1 air-oxygen ratio, resulting in a maximum FiO(2) of 0.6) or standard therapy (cold wall oxygen 100% via infant nasal cannulae at low flow to a maximum of 2 L/min) using a block size of four and stratifying for gestational age at birth. The primary outcome was time from randomisation to last use of oxygen therapy. All randomised children were included in the primary and secondary safety analyses. This trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12612000685819. Findings From July 16, 2012, to May 1, 2015, we randomly assigned 202 children to either HFWHO (101 children) or standard therapy (101 children). Median time to weaning was 24 h (95% CI 18-28) for standard therapy and 20 h (95% CI 17-34) for HFWHO (hazard ratio [HR] for difference in survival distributions 0.9 [95% CI 0.7-1.2]; log rank p=0.61). Fewer children experienced treatment failure on HFWHO (14 [14%]) compared with standard therapy (33 [33%]; p=0.0016); of these children, those on HFWHO were supported for longer than were those on standard therapy before treatment failure (HR 0.3; 95% CI 0.2-0.6; p<0.0001). 20 (61%) of 33 children who experienced treatment failure on standard therapy were rescued with HFWHO. 12 (12%) of children on standard therapy required transfer to the intensive care unit compared with 14 (14%) of those on HFWHO (difference -1%; 95% CI-7 to 16; p=0.41). Four adverse events occurred (oxygen desaturation and condensation inhalation in the HFWHO group, and two incidences of oxygen tubing disconnection in the standard therapy group); none resulted in withdrawal from the trial. No oxygen-related serious adverse events occurred. Secondary effectiveness outcomes are reported in the Results section. Interpretation HFWHO did not significantly reduce time on oxygen compared with standard therapy, suggesting that early use of HFWHO does not modify the underlying disease process in moderately severe bronchiolitis. HFWHO might have a role as a rescue therapy to reduce the proportion of children requiring high-cost intensive care.	[Kepreotes, Elizabeth; Whitehead, Bruce; Goddard, Bernadette; Hilton, Jodi; Lee, Mark; Mattes, Joerg] John Hunter Childrens Hosp, Newcastle, NSW 2310, Australia; [Kepreotes, Elizabeth; Collison, Adam; Mattes, Joerg] Univ Newcastle, Prior Res Ctr GrowUpWell, Newcastle, NSW, Australia; [Kepreotes, Elizabeth; Whitehead, Bruce; Attia, John] Univ Newcastle, Fac Hlth, Newcastle, NSW, Australia; [Attia, John; Oldmeadow, Christopher; Lee, Mark] John Hunter Hosp, Newcastle, NSW, Australia; [Kepreotes, Elizabeth; Attia, John; Oldmeadow, Christopher; Collison, Adam; Searles, Andrew; Mattes, Joerg] Hunter Med Res Inst, Newcastle, NSW, Australia	University of Newcastle; University of Newcastle; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle	Kepreotes, E (corresponding author), John Hunter Childrens Hosp, Newcastle, NSW 2310, Australia.	Elizabeth.Kepreotes@hnehealth.nsw.gov.au	MATTES, JOERG/M-5179-2019; Attia, John R/F-5376-2013; Collison, Adam/G-7718-2013	Attia, John R/0000-0001-9800-1308; Collison, Adam/0000-0002-3074-3046; Oldmeadow, Christopher/0000-0001-6104-1322; Searles, Andrew/0000-0002-9452-9735	Hunter Children's Research Foundation; John Hunter Hospital Charitable Trust; University of Newcastle Priority Research Centre GrowUpWell	Hunter Children's Research Foundation; John Hunter Hospital Charitable Trust; University of Newcastle Priority Research Centre GrowUpWell	Hunter Children's Research Foundation, John Hunter Hospital Charitable Trust, and the University of Newcastle Priority Research Centre GrowUpWell.	Beggs S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009609.pub2; Chisti MJ, 2015, LANCET, V386, P1057, DOI 10.1016/S0140-6736(15)60249-5; Clinical Excellence Commission, 2011, FLAGS KEEP PAT SAF; Collins CL, 2013, J PEDIATR-US, V162, P949, DOI 10.1016/j.jpeds.2012.11.016; Cunningham S, 2016, THORAX, V71, P679, DOI 10.1136/thoraxjnl-2016-209012; Cunningham S, 2015, LANCET, V386, P1041, DOI 10.1016/S0140-6736(15)00163-4; Duarte-Dorado DM, 2013, J ASTHMA, V50, P1056, DOI 10.3109/02770903.2013.834504; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Haq I, 2014, PAEDIATR RESPIR REV, V15, P124, DOI 10.1016/j.prrv.2013.12.002; Hough JL, 2012, J PAEDIATR CHILD H, V48, P106, DOI 10.1111/j.1440-1754.2011.02070.x; Independent Hospital Pricing Authority, 2015, NAT EFF PRIC DET 201; Jubran A, 1999, CRIT CARE, V3, pR11, DOI 10.1186/cc341; Manley BJ, 2013, NEW ENGL J MED, V369, P1425, DOI 10.1056/NEJMoa1300071; Manley BJ, 2012, NEONATOLOGY, V102, P300, DOI 10.1159/000341754; Mayfield S, 2014, J PAEDIATR CHILD H, V50, P373, DOI 10.1111/jpc.12509; Mayfield S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009850.pub2; McKiernan C, 2010, J PEDIATR-US, V156, P634, DOI 10.1016/j.jpeds.2009.10.039; Meissner HC, 2016, NEW ENGL J MED, V374, P62, DOI 10.1056/NEJMra1413456; NSW Health, 2011, PD2011077 NSW HLTH; NSW Health, 2012, PD2012004 NSW HLTH; Piedra P, 2016, BRONCHIOLITIS INFANT; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Schibler A, 2011, INTENS CARE MED, V37, P847, DOI 10.1007/s00134-011-2177-5; Schuh S, EFFECT OXIMETRY HOSP; SIGN, BRONCH CHILDR NAT CL; STEPHAN F, 2015, JAMA-J AM MED ASSOC, V313, P2331, DOI [DOI 10.1001/JAMA.2015.5213, 10.1001/jama.2015.5213]; Suiter DM, 2007, ARCH PHYS MED REHAB, V88, P1681, DOI 10.1016/j.apmr.2007.07.042; Welliver RC, 2003, J PEDIATR-US, V143, pS112, DOI 10.1067/S0022-3476(03)00508-0; Wettstein Richard B, 2005, Respir Care, V50, P604; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	30	154	157	1	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					930	939		10.1016/S0140-6736(17)30061-2	http://dx.doi.org/10.1016/S0140-6736(17)30061-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM4DL	28161016				2022-12-28	WOS:000395263400032
J	Han, J; Morris, SC; Ou, Q; Shu, DG; Huang, H				Han, Jian; Morris, Simon Conway; Ou, Qiang; Shu, Degan; Huang, Hai			Meiofaunal deuterostomes from the basal Cambrian of Shaanxi (China)	NATURE			English	Article							CHORDATE ORIGINS; EARLY EVOLUTION; LAGERSTATTE; ANIMALS; HISTORY	Deuterostomes(1) include the group we belong to (vertebrates) as well as an array of disparate forms that include echinoderms(2), hemichordates(3) and more problematic groups such as vetulicolians(4) and vetulocystids(5). The Cambrian fossil record is well-populated with representative examples, but possible intermediates(6,7) are controversial and the nature of the original deuterostome remains idealized. Here we report millimetric fossils, Saccorhytus coronarius nov. gen., nov. sp., from an Orsten-like Lagerstatte from the earliest Cambrian period of South China, which stratigraphically are amongst the earliest of deuterostomes. The bag-like body bears a prominent mouth and associated folds, and behind them up to four conical openings on either side of the body as well as possible sensory structures. An anus may have been absent, and correspondingly the lateral openings probably served to expel water and waste material. This new form has similarities to both the vetulicolians4 and vetulocystids5 and collectively these findings suggest that a key step in deuterostome evolution was the development of lateral openings that subsequently were co-opted as pharyngeal gills(2-4,8). Depending on its exact phylogenetic position, the meiofaunal habit of Saccorhytus may help to explain the major gap between divergence times seen in the fossil record and estimates based on molecular clocks(9).	[Han, Jian; Shu, Degan] Northwest Univ Xian, Dept Geol, State Key Lab Continental Dynam, Xian 710069, Peoples R China; [Morris, Simon Conway] Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England; [Ou, Qiang] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing 100083, Peoples R China; [Ou, Qiang] Univ Kassel, Dept Zool, D-34132 Kassel, Germany; [Huang, Hai] Xian Shiyou Univ, Coll Petr Engn, Xian 710065, Peoples R China	Northwest University Xi'an; University of Cambridge; China University of Geosciences; Universitat Kassel; Xi'an Shiyou University	Shu, DG (corresponding author), Northwest Univ Xian, Dept Geol, State Key Lab Continental Dynam, Xian 710069, Peoples R China.; Morris, SC (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.	sc113@cam.ac.uk; elidgshu@nwu.edu.cn	Han, Jian/AAU-4500-2021	Han, Jian/0000-0002-2134-4078; Ou, Qiang/0000-0002-1142-5114	Natural Science Foundation of China [41621003, 41272019, 41572017, 41672009]; Ministry of Science and Technology of China [2013CB835002]; Alexander von Humboldt Foundation; Program for New Century Excellent Talents; Ministry of Education of China; Department of Earth Sciences, University of Cambridge; St. John's College, Cambridge	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET)); Ministry of Education of China(Ministry of Education, China); Department of Earth Sciences, University of Cambridge(University of Cambridge); St. John's College, Cambridge	Supported by Natural Science Foundation of China (nos 41621003, 41272019, 41572017, 41672009), Ministry of Science and Technology of China (D.S., J.H.) (no. 2013CB835002), Alexander von Humboldt Foundation (Q.O.), Program for New Century Excellent Talents, Ministry of Education of China (Q.O.), Department of Earth Sciences, University of Cambridge and St. John's College, Cambridge (S.C.M.). We thank V. Brown, J. Luo, J. Sun, M. Cheng, and H. Gong for technical assistance and D.-H. Yang for the reconstruction.	BOADEN PJS, 1989, ZOOL J LINN SOC-LOND, V96, P217, DOI 10.1111/j.1096-3642.1989.tb02257.x; Brown FD, 2008, GENESIS, V46, P605, DOI 10.1002/dvg.20471; Caron JB, 2005, T ROY SOC EDIN-EARTH, V96, P95, DOI 10.1017/S0263593300001255; Caron JB, 2010, PLOS ONE, V5, pA189, DOI 10.1371/journal.pone.0009586; Dong XP, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0071; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Giere O, 2019, PERSPECTIVES MEIOBEN; Gillis JA, 2012, P ROY SOC B-BIOL SCI, V279, P237, DOI 10.1098/rspb.2011.0599; Han J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070741; Hejnol A, 2016, CURR OPIN GENET DEV, V39, P48, DOI 10.1016/j.gde.2016.05.019; Hejnol A, 2015, ZOOL ANZ, V256, P61, DOI 10.1016/j.jcz.2015.02.006; Liu YH, 2014, EVOL DEV, V16, P155, DOI 10.1111/ede.12076; Lowe CJ, 2015, NATURE, V520, P456, DOI 10.1038/nature14434; Morris SC, 2015, J PALEONTOL, V89, P631, DOI 10.1017/jpa.2015.40; Morris SC, 2014, NATURE, V512, P419, DOI 10.1038/nature13414; Nanglu K, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0271-4; Ou Q, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-81; Peterson KJ, 2016, ORG DIVERS EVOL, V16, P401, DOI 10.1007/s13127-016-0270-x; Shu DG, 2010, P ROY SOC B-BIOL SCI, V277, P165, DOI 10.1098/rspb.2009.0646; Shu DG, 2004, NATURE, V430, P422, DOI 10.1038/nature02648; Shu DG, 2003, SCIENCE, V299, P1380, DOI 10.1126/science.1079846; Shu DG, 2001, NATURE, V411, P472, DOI 10.1038/35078069; Shu DG, 2001, NATURE, V414, P419, DOI 10.1038/35106514; Simakov O, 2015, NATURE, V527, P459, DOI 10.1038/nature16150; Sly BJ, 2003, INT J DEV BIOL, V47, P623; Smith AB, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-79; Wray GA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0046; Young C, 2002, IRELANDS MARINE ATLA; Zamora S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038296; Zhang HQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16521	30	40	58	10	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					228	231		10.1038/nature21072	http://dx.doi.org/10.1038/nature21072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28135722				2022-12-28	WOS:000393737500040
J	Hampton, T				Hampton, Tracy			Father's Age May Be a Factor in Neurodevelopmental Disorders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					465	465		10.1001/jama.2017.0113	http://dx.doi.org/10.1001/jama.2017.0113			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28170471				2022-12-28	WOS:000393564200005
J	Thongnoi, P; Praphasiri, P; Dawood, FS; Lindblade, KA				Thongnoi, Pipat; Praphasiri, Prabda; Dawood, Fatimah S.; Lindblade, Kim A.			Maternal death from influenza in tropical Thailand	LANCET			English	Editorial Material									[Thongnoi, Pipat] Phon Thong Hosp, Sa Nok Kaeo, Roi Et Province, Thailand; [Praphasiri, Prabda; Lindblade, Kim A.] US Ctr Dis Control & Prevent, Thailand Minist Publ Hlth, Influenza Program, Nonthaburi, Thailand; [Dawood, Fatimah S.; Lindblade, Kim A.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA	Praphasiri, P (corresponding author), Minist Publ Hlth, Thailand MOPH US CDC Collaborat, Nonthaburi 11000, Thailand.	hpu3@cdc.gov		Praphasiri, Prabda/0000-0003-4593-0247; Lindblade, Kim/0000-0002-5593-0470	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Newsome Kimberly, 2011, Morbidity and Mortality Weekly Report, V60, P1193; Owusu JT, 2015, VACCINE, V33, P742, DOI 10.1016/j.vaccine.2014.10.029; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089	4	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					571	572		10.1016/S0140-6736(16)31334-4	http://dx.doi.org/10.1016/S0140-6736(16)31334-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ5UH	28170335	Green Accepted			2022-12-28	WOS:000393283400039
J	Yang, YS; Chen, CC; Scott, MC; Ophus, C; Xu, R; Pryor, A; Wu, L; Sun, F; Theis, W; Zhou, JH; Eisenbach, M; Kent, PRC; Sabirianov, RF; Zeng, H; Ercius, P; Miao, JW				Yang, Yongsoo; Chen, Chien-Chun; Scott, M. C.; Ophus, Colin; Xu, Rui; Pryor, Alan, Jr.; Wu, Li; Sun, Fan; Theis, Wolfgang; Zhou, Jihan; Eisenbach, Markus; Kent, Paul R. C.; Sabirianov, Renat F.; Zeng, Hao; Ercius, Peter; Miao, Jianwei			Deciphering chemical order/disorder and material properties at the single-atom level	NATURE			English	Article							FEPT NANOPARTICLES; ELECTRON TOMOGRAPHY; STATE; CRYSTALLOGRAPHY; RECONSTRUCTION; SEGREGATION; SCALE	Perfect crystals are rare in nature. Real materials often contain crystal defects and chemical order/disorder such as grain boundaries, dislocations, interfaces, surface reconstructions and point defects(1-3). Such disruption in periodicity strongly affects material properties and functionality(1-3). Despite rapid development of quantitative material characterization methods(1,4-18), correlating three-dimensional (3D) atomic arrangements of chemical order/disorder and crystal defects with material properties remains a challenge. On a parallel front, quantum mechanics calculations such as density functional theory (DFT) have progressed from the modelling of ideal bulk systems to modelling 'real' materials with dopants, dislocations, grain boundaries and interfaces(19,20); but these calculations rely heavily on average atomic models extracted from crystallography. To improve the predictive power of first-principles calculations, there is a pressing need to use atomic coordinates of real systems beyond average crystallographic measurements. Here we determine the 3D coordinates of 6,569 iron and 16,627 platinum atoms in an iron-platinum nanoparticle, and correlate chemical order/disorder and crystal defects with material properties at the single-atom level. We identify rich structural variety with unprecedented 3D detail including atomic composition, grain boundaries, anti-phase boundaries, anti-site point defects and swap defects. We show that the experimentally measured coordinates and chemical species with 22 picometre precision can be used as direct input for DFT calculations of material properties such as atomic spin and orbital magnetic moments and local magnetocrystalline anisotropy. This work combines 3D atomic structure determination of crystal defects with DFT calculations, which is expected to advance our understanding of structure-property relationships at the fundamental level.	[Yang, Yongsoo; Chen, Chien-Chun; Scott, M. C.; Xu, Rui; Pryor, Alan, Jr.; Wu, Li; Zhou, Jihan; Miao, Jianwei] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Yang, Yongsoo; Chen, Chien-Chun; Scott, M. C.; Xu, Rui; Pryor, Alan, Jr.; Wu, Li; Zhou, Jihan; Miao, Jianwei] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Chen, Chien-Chun] Natl Sun Yat Sen Univ, Dept Phys, Kaohsiung 80424, Taiwan; [Scott, M. C.; Ophus, Colin; Ercius, Peter] Lawrence Berkeley Natl Lab, Natl Ctr Electro Microscopy, Mol Foundry, Berkeley, CA 94720 USA; [Sun, Fan; Zeng, Hao] SUNY Buffalo, Univ Buffalo, Dept Phys, Buffalo, NY 14260 USA; [Theis, Wolfgang] Univ Birmingham, Sch Phys & Astron, Nanoscale Phys Res Lab, Birmingham B15 2TT, W Midlands, England; [Eisenbach, Markus] Oak Ridge Natl Lab, Natl Ctr Computat Sci, Oak Ridge, TN 37831 USA; [Kent, Paul R. C.] Oak Ridge Natl Lab, Comp Sci & Math Div, Oak Ridge, TN 37831 USA; [Kent, Paul R. C.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Sabirianov, Renat F.] Univ Nebraska, Dept Phys, Omaha, NE 68182 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Sun Yat Sen University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Birmingham; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of Nebraska System	Miao, JW (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.; Miao, JW (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.	miao@physics.ucla.edu	Kent, Paul R C/A-6756-2008; McCoy, Tina/P-3402-2019; Ophus, Colin/H-2350-2013; Zeng, Hao/AAD-8060-2021; Eisenbach, Markus/AGO-7284-2022; Yang, Yongsoo/P-7716-2014; Ercius, Peter/AAN-2870-2020; Theis, Wolfgang/AAA-3195-2022; Eisenbach, Markus/AAQ-7943-2021; Ophus, Colin/P-5390-2019	Kent, Paul R C/0000-0001-5539-4017; Yang, Yongsoo/0000-0001-8654-302X; Ercius, Peter/0000-0002-6762-9976; Eisenbach, Markus/0000-0001-8805-8327; Ophus, Colin/0000-0003-2348-8558; Theis, Wolfgang/0000-0002-4074-8318	Office of Basic Energy Sciences of the US DOE [DE-SC0010378]; Division of Materials Research of the US NSF [DMR-1548924, DMR-1437263]; DARPA [DARPA-BAA-12-63]; Direct For Mathematical & Physical Scien [1623947] Funding Source: National Science Foundation	Office of Basic Energy Sciences of the US DOE(United States Department of Energy (DOE)); Division of Materials Research of the US NSF; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank J. Shan, J. A. Rodriguez, M. Gallagher-Jones and J. Ma for help with this project. This work was primarily supported by the Office of Basic Energy Sciences of the US DOE (DE-SC0010378). This work was also supported by the Division of Materials Research of the US NSF (DMR-1548924 and DMR-1437263) and DARPA (DARPA-BAA-12-63). The chemical ordering analysis and ADF-STEM imaging with TEAM I were performed at the Molecular Foundry, Lawrence Berkeley National Laboratory, which is supported by the Office of Science, Office of Basic Energy Sciences of the US DOE (DE-AC02-05CH11231). M.E. (DFT calculations) was supported by the US DOE, Office of Science, Basic Energy Sciences, Material Sciences and Engineering Division. DFT calculations by P.K. were conducted at the Center for Nanophase Materials Sciences, which is a DOE Office of Science User Facility. This research used resources of the Oak Ridge Leadership Computing Facility, which is supported by the Office of Science of the US DOE (DE-AC05-00OR22725).	Albrecht TR, 2015, IEEE T MAGN, V51, DOI 10.1109/TMAG.2015.2397880; ANDERSEN AH, 1984, ULTRASONIC IMAGING, V6, P81, DOI 10.1016/0161-7346(84)90008-7; Antoniak C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.117201; Antoniak C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1538; Bacon D.H.D.J, 2011, INTRO DISLOCATIONS; Bals S, 2011, NANO LETT, V11, P3420, DOI 10.1021/nl201826e; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; Chen CC, 2013, NATURE, V496, P74, DOI 10.1038/nature12009; Cullity B.D., 2011, INTRO MAGNETIC MAT; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Dmitrieva O, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064414; Eisenbach M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144424; Ercius P, 2012, MICROSC MICROANAL, V18, P676, DOI 10.1017/S1431927612001225; Fidler J, 2000, J PHYS D APPL PHYS, V33, pR135, DOI 10.1088/0022-3727/33/15/201; FINEL A, 1990, PHYS REV LETT, V65, P1016, DOI 10.1103/PhysRevLett.65.1016; Frank J., 2010, ELECT TOMOGRAPHY MET; GILBERT P, 1972, J THEOR BIOL, V36, P105, DOI 10.1016/0022-5193(72)90180-4; Goris B, 2015, NANO LETT, V15, P6996, DOI 10.1021/acs.nanolett.5b03008; Goris B, 2013, NANO LETT, V13, P4236, DOI 10.1021/nl401945b; Gruner ME, 2012, INT J QUANTUM CHEM, V112, P277, DOI 10.1002/qua.23254; Gruner ME, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.087203; Haberfehlner G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9779; Jones RO, 2015, REV MOD PHYS, V87, P897, DOI 10.1103/RevModPhys.87.897; Ju GP, 2015, IEEE T MAGN, V51, DOI 10.1109/TMAG.2015.2439690; Kak A. C., 2001, PRINCIPLES COMPUTERI; Kelly A, 2012, CRYSTALLOGRAPHY AND CRYSTAL DEFECTS, 2ND EDITION, P1, DOI 10.1002/9781119961468; Kelly TF, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2709758; Kirkland E.J., 2010, ADV COMPUTING ELECT, V2nd; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; KRAUSS U, 1991, J MAGN MAGN MATER, V98, pL1, DOI 10.1016/0304-8853(91)90416-8; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Krivanek OL, 2010, NATURE, V464, P571, DOI 10.1038/nature08879; Larkin KG, 1997, OPT COMMUN, V139, P99, DOI 10.1016/S0030-4018(97)00097-7; Makitalo M, 2011, IEEE T IMAGE PROCESS, V20, P2697, DOI 10.1109/TIP.2011.2121085; Miao J, 1998, J OPT SOC AM A, V15, P1662, DOI 10.1364/JOSAA.15.001662; Miao J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf2157; Miao JW, 2015, SCIENCE, V348, P530, DOI 10.1126/science.aaa1394; Miao JW, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.052103; Midgley PA, 2009, NAT MATER, V8, P271, DOI 10.1038/nmat2406; Muller DA, 2009, NAT MATER, V8, P263, DOI [10.1038/nmat2380, 10.1038/NMAT2380]; Muller M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.094203; Parr R.G., 1994, DENSITY FUNCTIONAL T; Pennycook S. J., 2011, SCANNING TRANSMISSIO; Ratke L., 2002, GROWTH COARSENING OS, DOI [10.1007/978-3-662-04884-9, DOI 10.1007/978-3-662-04884-9]; Saita S, 2005, CHEM MATER, V17, P6624, DOI 10.1021/cm051760h; Stocks GM, 2007, PROG MATER SCI, V52, P371, DOI 10.1016/j.pmatsci.2006.10.015; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Van Aert S, 2011, NATURE, V470, P374, DOI 10.1038/nature09741; WANG Y, 1995, PHYS REV LETT, V75, P2867, DOI 10.1103/PhysRevLett.75.2867; Xu CJ, 2009, J AM CHEM SOC, V131, P15346, DOI 10.1021/ja905938a; Xu R, 2015, NAT MATER, V14, P1099, DOI [10.1038/nmat4426, 10.1038/NMAT4426]; Yang H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7129	56	156	158	29	509	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					75	+		10.1038/nature21042	http://dx.doi.org/10.1038/nature21042			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28150758	Green Published, Green Submitted			2022-12-28	WOS:000396119300034
J	Zhang, C; Sun, CG; Hu, BC; Yu, CM; Lu, M				Zhang, Chong; Sun, Chengguo; Hu, Bingcheng; Yu, Chuanming; Lu, Ming			INORGANIC CHEMISTRY Synthesis and characterization of the pentazolate anion cyclo-N-5(-) in (N-5)(6)(H3O)(3)(NH4)(4)Cl	SCIENCE			English	Article							P-DIMETHYLAMINOPHENYLPENTAZOLE; STABILITY; NITROGEN; ARYLPENTAZOLES; GENERATION; SYSTEMS; RINGS; N-4	Pentazole (HN5), an unstable molecular ring comprising five nitrogen atoms, has been of great interest to researchers for the better part of a century. We report the synthesis and characterization of the pentazolate anion stabilized in a (N-5)(6)(H3O)(3)(NH4)(4)Cl salt. The anion was generated by direct cleavage of the C-N bond in a multisubstituted arylpentazole using m-chloroperbenzoic acid and ferrous bisglycinate. The structure was confirmed by single-crystal x-ray diffraction analysis, which highlighted stabilization of the cyclo-N-5(-) ring by chloride, ammonium, and hydronium. Thermal analysis indicated the stability of the salt below 117 degrees C on the basis of thermogravimetry-measured onset decomposition temperature.	[Zhang, Chong; Hu, Bingcheng; Yu, Chuanming; Lu, Ming] Nanjing Univ Sci & Technol, Sch Chem Engn, Nanjing 210094, Jiangsu, Peoples R China; [Sun, Chengguo] Univ Sci & Technol Liaoning, Sch Chem Engn, Anshan 114051, Liaoning, Peoples R China	Nanjing University of Science & Technology; University of Science & Technology Liaoning	Hu, BC; Lu, M (corresponding author), Nanjing Univ Sci & Technol, Sch Chem Engn, Nanjing 210094, Jiangsu, Peoples R China.	hubc@njust.edu.cn; luming@mail.njust.edu			Priority Academic Program Development of Jiangsu Higher Education Institutions	Priority Academic Program Development of Jiangsu Higher Education Institutions	Supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions. We thank L. Yi [Analysis and Testing Center, Nanjing University of Science and Technology (NJUST)] for testing of NMR spectra; X. L. Bao (Shanghai Jiaotong University) for testing of crystal structure; F. F. Wang (Institute of Materia Medica, Chinese Academy of Medical Science, and Peking Union Medical College) for expert crystallographic analysis; and C. Jiang, H. W. Yang, L. D. Lu, and X. D. Wu (NJUST) for comments on the manuscript. Additional data are in the supplementary materials. Crystallographic parameters are available free of charge from FIZ Karlsruhe under reference CSD-431382.	Bazanov B, 2016, ANGEW CHEM INT EDIT, V55, P13233, DOI 10.1002/anie.201605400; Benin V, 2002, J ORG CHEM, V67, P1354, DOI 10.1021/jo0110754; Butler R. N., 1998, J CHEM SOC P2, V10, P2243; Butler RN, 2008, J ORG CHEM, V73, P1354, DOI 10.1021/jo702423z; Butler RN, 2003, CHEM COMMUN, P1016, DOI 10.1039/b301491f; Cacace F, 2002, SCIENCE, V295, P480, DOI 10.1126/science.1067681; Carlqvist P, 2004, J PHYS CHEM A, V108, P7463, DOI 10.1021/jp0484480; DOWS DA, 1955, J CHEM PHYS, V23, P1258, DOI 10.1063/1.1742253; DOWS DA, 1955, J CHEM PHYS, V23, P1475, DOI 10.1063/1.1742333; Fau S, 2002, J PHYS CHEM A, V106, P4639, DOI 10.1021/jp015564j; JANOSCHEK R, 1993, ANGEW CHEM INT EDIT, V32, P230, DOI 10.1002/anie.199302301; Marnellos G, 1998, SCIENCE, V282, P98, DOI 10.1126/science.282.5386.98; Nagai A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1542; Nguyen MT, 2003, COORDIN CHEM REV, V244, P93, DOI 10.1016/S0010-8545(03)00101-2; Ostmark H, 2003, CHEM PHYS LETT, V379, P539, DOI 10.1016/j.cplett.2003.08.081; Perera SA, 2009, J PHYS CHEM A, V113, P3197, DOI 10.1021/jp809267y; Perera SA, 1999, CHEM PHYS LETT, V314, P381, DOI 10.1016/S0009-2614(99)01186-0; Rao C. N. R., 1972, WATER COMPREHENSIVE, V1, P93; Schroer T, 2005, CHEM COMMUN, P1607, DOI 10.1039/b417010e; Shan H, 1997, SCIENCE, V275, P1460, DOI 10.1126/science.275.5305.1460; Steele BA, 2016, CHEM PHYS LETT, V643, P21, DOI 10.1016/j.cplett.2015.11.008; Straka M, 2003, INORG CHEM, V42, P8241, DOI 10.1021/ic034702b; Ugi I., 1961, ANGEW CHEM, V73, P172; Velian A, 2015, SCIENCE, V348, P1001, DOI 10.1126/science.aab0204; Vij A, 2002, ANGEW CHEM INT EDIT, V41, P3051, DOI 10.1002/1521-3773(20020816)41:16<3051::AID-ANIE3051>3.0.CO;2-T; WALLIS JD, 1983, J CHEM SOC CHEM COMM, P910, DOI 10.1039/c39830000910; Yang YZ, 2014, RSC ADV, V4, P57629, DOI 10.1039/c4ra08454c; Zhang C, 2016, J ENERG MATER, V34, P103, DOI 10.1080/07370652.2014.1001918	28	288	319	19	334	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					374	376		10.1126/science.aah3840	http://dx.doi.org/10.1126/science.aah3840			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	28126812				2022-12-28	WOS:000393172800033
J	Warren, P				Warren, Penny			Una Kroll OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												penny.warren@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2017	356								j409	10.1136/bmj.j409	http://dx.doi.org/10.1136/bmj.j409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HO	28122806				2022-12-28	WOS:000393177700015
J	Webster, PC				Webster, Paul C.			Calls for medically safe heroin mount in Canada	LANCET			English	Editorial Material								Canada is rapidly scaling up supervised injection facilities to tackle a surge in heroin overdoses. The move is welcomed by experts but several are calling for further measures. Paul C Webster reports.											0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					239	239		10.1016/S0140-6736(17)30135-6	http://dx.doi.org/10.1016/S0140-6736(17)30135-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9BC	28118904				2022-12-28	WOS:000392801200012
J	Tan, HR; Jain, A; Voznyy, O; Lan, XZ; de Arquer, FPG; Fan, JZ; Quintero-Bermudez, R; Yuan, MJ; Zhang, B; Zhao, YC; Fan, FJ; Li, PC; Quan, LN; Zhao, YB; Lu, ZH; Yang, ZY; Hoogland, S; Sargent, EH				Tan, Hairen; Jain, Ankit; Voznyy, Oleksandr; Lan, Xinzheng; de Arquer, F. Pelayo Garcia; Fan, James Z.; Quintero-Bermudez, Rafael; Yuan, Mingjian; Zhang, Bo; Zhao, Yicheng; Fan, Fengjia; Li, Peicheng; Quan, Li Na; Zhao, Yongbiao; Lu, Zheng-Hong; Yang, Zhenyu; Hoogland, Sjoerd; Sargent, Edward H.			Efficient and stable solution-processed planar perovskite solar cells via contact passivation	SCIENCE			English	Article							HALIDE PEROVSKITES; DEGRADATION; INTERFACE; STABILITY; AREA; REDISTRIBUTION; CRYSTALLINE; MIGRATION; CHLORINE; IMPACT	Planar perovskite solar cells (PSCs) made entirely via solution processing at low temperatures (<150 degrees C) offer promise for simple manufacturing, compatibility with flexible substrates, and perovskite-based tandem devices. However, these PSCs require an electron-selective layer that performs well with similar processing. We report a contact-passivation strategy using chlorine-capped TiO2 colloidal nanocrystal film that mitigates interfacial recombination and improves interface binding in low-temperature planar solar cells. We fabricated solar cells with certified efficiencies of 20.1 and 19.5% for active areas of 0.049 and 1.1 square centimeters, respectively, achieved via low-temperature solution processing. Solar cells with efficiency greater than 20% retained 90% (97% after dark recovery) of their initial performance after 500 hours of continuous room-temperature operation at their maximum power point under 1-sun illumination (where 1 sun is defined as the standard illumination at AM1.5, or 1 kilowatt/square meter).	[Tan, Hairen; Jain, Ankit; Voznyy, Oleksandr; Lan, Xinzheng; de Arquer, F. Pelayo Garcia; Fan, James Z.; Quintero-Bermudez, Rafael; Yuan, Mingjian; Zhang, Bo; Zhao, Yicheng; Fan, Fengjia; Quan, Li Na; Yang, Zhenyu; Hoogland, Sjoerd; Sargent, Edward H.] Univ Toronto, Dept Elect & Comp Engn, 35 St George St, Toronto, ON M5S 1A4, Canada; [Li, Peicheng; Zhao, Yongbiao; Lu, Zheng-Hong] Univ Toronto, Dept Mat Sci & Engn, 184 Coll St, Toronto, ON M5S 3E4, Canada	University of Toronto; University of Toronto	Sargent, EH (corresponding author), Univ Toronto, Dept Elect & Comp Engn, 35 St George St, Toronto, ON M5S 1A4, Canada.	ted.sargent@utoronto.ca	Garcia de Arquer, F. Pelayo/AAF-1803-2019; Zhang, Bo/AAX-9762-2020; Yang, Zhenyu/AAV-6749-2021; Quan, Li Na/AAN-3248-2021; Quintero-Bermudez, Rafael/ABE-7388-2021; Quan, Lina/R-3981-2018; Lan, Xinzheng/S-6960-2018; Tan, Hairen/C-9478-2012; Fan, Fengjia/A-7173-2018; Zhao, Yong-Biao/U-9878-2017; Tan, Hairen/AAY-1657-2021; Zhao, Yong-Biao/F-6864-2012; Sargent, Edward H./O-9520-2014; Zhao, Yongbiao/AAE-4288-2020; Quan, Lina/AAE-7649-2019; Jain, Ankit/P-8371-2017	Garcia de Arquer, F. Pelayo/0000-0003-2422-6234; Zhang, Bo/0000-0002-7853-979X; Yang, Zhenyu/0000-0002-6403-8679; Quan, Lina/0000-0001-9301-3764; Tan, Hairen/0000-0003-0821-476X; Fan, Fengjia/0000-0002-5447-6296; Zhao, Yong-Biao/0000-0002-4090-9185; Tan, Hairen/0000-0003-0821-476X; Sargent, Edward H./0000-0003-0396-6495; Zhao, Yongbiao/0000-0001-9548-0614; Quan, Lina/0000-0001-9301-3764; Jain, Ankit/0000-0002-8963-7774	King Abdullah University of Science and Technology [KUS-11-009-21]; Ontario Research Fund Research Excellence Program; Ontario Research Fund; Natal Sciences and Engineering Research Council of Canada; Netherlands Organisation for Scientific Research (NWO) at the University of Toronto [680-50-1511]; IBM Canada Research and Development Center through the Southern Ontario Smart Computing Innovation Platform (SOSCIP); Connaught program; SOSCIP	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Ontario Research Fund Research Excellence Program; Ontario Research Fund; Natal Sciences and Engineering Research Council of Canada; Netherlands Organisation for Scientific Research (NWO) at the University of Toronto; IBM Canada Research and Development Center through the Southern Ontario Smart Computing Innovation Platform (SOSCIP); Connaught program; SOSCIP	This publication is based, in part, on work supported by an award (KUS-11-009-21) from the King Abdullah University of Science and Technology, by the Ontario Research Fund Research Excellence Program, by the Ontario Research Fund, and by the Natal Sciences and Engineering Research Council of Canada. H.T. acknowledges the Netherlands Organisation for Scientific Research (NWO) for a Rubicon grant (680-50-1511) to support his postdoctoral research at the University of Toronto. The work of A.J. is supported by the IBM Canada Research and Development Center through the Southern Ontario Smart Computing Innovation Platform (SOSCIP) postdoctoral fellowship. F.P.G.A. acknowledges funding from the Connaught program. OFT calculations were performed on the IBM BlueGene Q supercomputer with support from the SOSCIP. We thank R. Wolowiec E. Palmiano, D. Kopilovic, and J. Li for they help during the course of study. All data are reported in the main text and supplementary materials.	Ahn N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13422; Anaraki EH, 2016, ENERG ENVIRON SCI, V9, P3128, DOI 10.1039/c6ee02390h; Berhe TA, 2016, ENERG ENVIRON SCI, V9, P323, DOI 10.1039/c5ee02733k; Bi DQ, 2016, NAT ENERGY, V1, DOI [10.1038/NENERGY.2016.142, 10.1038/nenergy.2016.142]; Bi DQ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501170; Buin A, 2014, NANO LETT, V14, P6281, DOI 10.1021/nl502612m; Chae J, 2015, NANO LETT, V15, P8114, DOI 10.1021/acs.nanolett.5b03556; Chen Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8269; Chen W, 2015, SCIENCE, V350, P944, DOI 10.1126/science.aad1015; Dequilettes DW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11683; deQuilettes DW, 2015, SCIENCE, V348, P683, DOI 10.1126/science.aaa5333; Domanski K, 2016, ACS NANO, V10, P6306, DOI 10.1021/acsnano.6b02613; Giordano F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10379; Green MA, 2016, PROG PHOTOVOLTAICS, V24, P905, DOI 10.1002/pip.2788; Green MA, 2014, NAT PHOTONICS, V8, P506, DOI [10.1038/nphoton.2014.134, 10.1038/NPHOTON.2014.134]; Guerrero A, 2016, ACS NANO, V10, P218, DOI 10.1021/acsnano.5b03687; Hawash Z, 2015, CHEM MATER, V27, P562, DOI 10.1021/cm504022q; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/NMAT4014, 10.1038/nmat4014]; Jiang Q, 2017, NAT ENERGY, V2, P1, DOI [10.1038/nenergy.2016.177, 10.1038/NENERGY.2016.177]; Kim H, 2016, ENERG ENVIRON SCI, V9, P12, DOI 10.1039/c5ee02194d; Lee JW, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201501310; Li X, 2016, SCIENCE, V353, P58, DOI 10.1126/science.aaf8060; Li YW, 2015, J AM CHEM SOC, V137, P15540, DOI 10.1021/jacs.5b10614; Li Z, 2016, CHEM MATER, V28, P284, DOI 10.1021/acs.chemmater.5b04107; Liu DY, 2014, NAT PHOTONICS, V8, P133, DOI 10.1038/nphoton.2013.342; Liu X, 2016, ADV MATER INTERFACES, V3, DOI 10.1002/admi.201600122; Mei AY, 2014, SCIENCE, V345, P295, DOI 10.1126/science.1254763; Mosconi E, 2016, ENERG ENVIRON SCI, V9, P3180, DOI 10.1039/c6ee01504b; Mosconi E, 2014, J PHYS CHEM LETT, V5, P2619, DOI 10.1021/jz501127k; Nie W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11574; Niederberger M, 2002, CHEM MATER, V14, P4364, DOI 10.1021/cm021203k; Park NG, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2016.152; Saliba M, 2016, SCIENCE, V354, P206, DOI 10.1126/science.aah5557; Saliba M, 2016, ENERG ENVIRON SCI, V9, P1989, DOI 10.1039/c5ee03874j; Shao YC, 2016, NAT ENERGY, V1, DOI [10.1038/nenergy.2015.1, 10.1038/NENERGY.2015.1]; Shin SS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8410; Singh T, 2016, CHEMSUSCHEM, V9, P2559, DOI 10.1002/cssc.201601004; Son DY, 2016, NAT ENERGY, V1, DOI [10.1038/nenergy.2016.81, 10.1038/NENERGY.2016.81]; Starr DE, 2015, ENERG ENVIRON SCI, V8, P1609, DOI 10.1039/c5ee00403a; Stranks SD, 2015, NAT NANOTECHNOL, V10, P391, DOI [10.1038/NNANO.2015.90, 10.1038/nnano.2015.90]; Tress W, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201600396; Tsai HH, 2016, NATURE, V536, P312, DOI 10.1038/nature18306; Wang J, 2007, J PHYS CHEM C, V111, P14925, DOI 10.1021/jp074464w; Wang Q, 2016, ADV MATER, V28, P6734, DOI 10.1002/adma.201600969; Werner J, 2016, ACS ENERGY LETT, V1, P474, DOI 10.1021/acsenergylett.6b00254; Wojciechowski K, 2014, ENERG ENVIRON SCI, V7, P1142, DOI 10.1039/c3ee43707h; Wu YZ, 2016, NAT ENERGY, V1, DOI [10.1038/nenergy.2016.148, 10.1038/NENERGY.2016.148]; Yang WS, 2015, SCIENCE, V348, P1234, DOI 10.1126/science.aaa9272; Yin WJ, 2015, J MATER CHEM A, V3, P8926, DOI 10.1039/c4ta05033a; Yin WJ, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4864778; You JB, 2016, NAT NANOTECHNOL, V11, P75, DOI [10.1038/nnano.2015.230, 10.1038/NNANO.2015.230]; Yuan YB, 2016, ACCOUNTS CHEM RES, V49, P286, DOI 10.1021/acs.accounts.5b00420; Zhao YX, 2016, CHEM SOC REV, V45, P655, DOI 10.1039/c4cs00458b; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050; Zhu ZL, 2016, ADV MATER, V28, P6478, DOI 10.1002/adma.201600619	55	1716	1739	96	2128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					722	726		10.1126/science.aai9081	http://dx.doi.org/10.1126/science.aai9081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28154242				2022-12-28	WOS:000395117700036
J	Chobanian, AV				Chobanian, Aram V.			Hypertension in 2017-What Is the Right Target?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-PRESSURE; GUIDELINES; MANAGEMENT; SOCIETY		[Chobanian, Aram V.] Boston Univ, Med Ctr, 72 E Concord St, Boston, MA 02118 USA	Boston University	Chobanian, AV (corresponding author), Boston Univ, Med Ctr, 72 E Concord St, Boston, MA 02118 USA.	achob@bu.edu						Chobanian AV, 2016, JAMA-J AM MED ASSOC, V315, P2669, DOI 10.1001/jama.2016.7070; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050; Yusuf S, 2016, NEW ENGL J MED, V374, P2032, DOI 10.1056/NEJMoa1600177	9	22	26	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					579	580		10.1001/jama.2017.0105	http://dx.doi.org/10.1001/jama.2017.0105			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8LI	28135357				2022-12-28	WOS:000394870900006
J	Burci, GL; Gostin, LO				Burci, Gian Luca; Gostin, Lawrence O.			Privatized Pharmaceutical Innovation vs Access to Essential Medicines A Global Framework for Equitable Sharing of Benefits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Burci, Gian Luca] Grad Inst Int & Dev Studies, Geneva, Switzerland; [Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Burci, Gian Luca/0000-0002-7650-2192				Gostin LO, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002042	1	4	4	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					473	474		10.1001/jama.2016.17994	http://dx.doi.org/10.1001/jama.2016.17994			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28170485				2022-12-28	WOS:000393564200012
J	Kim, DK; Riley, LE; Harriman, KH; Hunter, P; Bridges, CB				Kim, David K.; Riley, Laura E.; Harriman, Kathleen H.; Hunter, Paul; Bridges, Carolyn B.		Advisory Comm Immunization Practic	Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2017	ANNALS OF INTERNAL MEDICINE			English	Article							ADVISORY-COMMITTEE; VACCINATION COVERAGE; VACCINES; POPULATIONS		[Kim, David K.; Bridges, Carolyn B.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Riley, Laura E.] Harvard Univ, Cambridge, MA USA; [Harriman, Kathleen H.] Calif Dept Publ Hlth, Richmond, CA USA; [Hunter, Paul] Univ Wisconsin, Madison, WI USA	Centers for Disease Control & Prevention - USA; Harvard University; California Department of Public Health; University of Wisconsin System; University of Wisconsin Madison	Kim, DK (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Immunizat Serv Div, 1600 Clifton Rd NE,Mailstop A-19, Atlanta, GA 30329 USA.	dkim@cdc.gov			U.S. Department of Health and Human Services	U.S. Department of Health and Human Services	To assure the integrity of the ACIP, the U.S. Department of Health and Human Services has taken steps to ensure technical adherence to ethics statutes and regulations regarding financial conflicts of interest. Concerns regarding the potential for the appearance of a conflict are addressed, or avoided altogether, through pre- and postappointment considerations. Individuals with particular vaccine- related interests will not be considered for appointment to the committee. Potential nominees are screened for conflicts of interest, and if any are found, they are asked to divest or forgo certain vaccine- related activities. In addition, at the beginning of each ACIP meeting, each member is asked to declare his or her conflicts. Members with conflicts are not permitted to vote if the conflict involves the vaccine or biological being voted on. Details can be found at www.cdc.gov/vaccines/acip/committee/structure-role.html. Conflict of interest disclosures of members of the ACIP are available at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M16-2936.	Bhatt A, 2014, PUBLIC HEALTH REP, V129, P115; Cullen KA, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6502a1; Hurley LP, 2016, PUBLIC HEALTH REP, V131, P320, DOI 10.1177/003335491613100216; Hurley LP, 2014, ANN INTERN MED, V160, P161, DOI 10.7326/M13-2332; Lu PJ, 2015, VACCINE, V33, pD83, DOI 10.1016/j.vaccine.2015.09.031; MacNeil JR, 2016, MMWR-MORBID MORTAL W, V65, P1189, DOI 10.15585/mmwr.mm6543a3; Meites E, 2016, MMWR-MORBID MORTAL W, V65, P1405, DOI 10.15585/mmwr.mm6549a5; Smith JC, 2010, VACCINE, V28, pA68, DOI 10.1016/j.vaccine.2010.02.037; U. S. Government Accountability Office, 2011, GAO1261; U. S. Preventive Services Task Force, 2014, AHRQ PUBLICATION, V14-05158; Williams WW, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6501a1	11	39	43	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2017	166	3					209	+		10.7326/M16-2936	http://dx.doi.org/10.7326/M16-2936			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7DL	28166560				2022-12-28	WOS:000394781200010
J	Voelker, R				Voelker, Rebecca			Autologous Cells Treat Knee Damage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					466	466		10.1001/jama.2016.21397	http://dx.doi.org/10.1001/jama.2016.21397			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28170463				2022-12-28	WOS:000393564200006
J	Danovaro, R; Aguzzi, J; Fanelli, E; Billett, D; Gjerde, K; Jamieson, A; Ramirez-Llodra, E; Smith, CR; Snelgrove, PVR; Thomsen, L; Van Dover, CL				Danovaro, R.; Aguzzi, J.; Fanelli, E.; Billett, D.; Gjerde, K.; Jamieson, A.; Ramirez-Llodra, E.; Smith, C. R.; Snelgrove, P. V. R.; Thomsen, L.; Van Dover, C. L.			An ecosystem-based deep-ocean strategy	SCIENCE			English	Editorial Material							SEA; CLIMATE		[Danovaro, R.] Polytech Univ Marche, I-60121 Ancona, Italy; [Danovaro, R.] Stn Zool Anton Dohrn, I-80121 Naples, Italy; [Aguzzi, J.] CSIC, Inst Ciencias Mar, E-08003 Barcelona, Spain; [Fanelli, E.] Italian Natl Agcy New Technol Energy & Sustainabl, Marine Environm Res Ctr, I-19100 Pozzuolo Di Lerici, Italy; [Billett, D.] Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Gjerde, K.] Wycliffe Management, PL-02123 Warsaw, Poland; [Gjerde, K.] IUCN, CH-1196 Gland, Switzerland; [Jamieson, A.] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ramirez-Llodra, E.] Norwegian Inst Water Res NIVA, N-0349 Oslo, Norway; [Smith, C. R.] Univ Hawaii Manoa, Honolulu, HI 96822 USA; [Snelgrove, P. V. R.] Mem Univ Newfoundland, St John, NF A1C 5S7, Canada; [Thomsen, L.] Jacobs Univ, D-28759 Bremen, Germany; [Van Dover, C. L.] Duke Univ, Raleigh, NC 28516 USA	Marche Polytechnic University; Stazione Zoologica Anton Dohrn di Napoli; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Italian National Agency New Technical Energy & Sustainable Economics Development; NERC National Oceanography Centre; Newcastle University - UK; Norwegian Institute for Water Research (NIVA); University of Hawaii System; University of Hawaii Manoa; Memorial University Newfoundland; Jacobs University; Duke University	Danovaro, R (corresponding author), Polytech Univ Marche, I-60121 Ancona, Italy.; Danovaro, R (corresponding author), Stn Zool Anton Dohrn, I-80121 Naples, Italy.	r.danovaro@univpm.it	; Aguzzi, Jacopo/D-6574-2012; Fanelli, Emanuela/H-4412-2014	Van Dover, Cindy/0000-0001-9845-8391; Ramirez-Llodra, Eva/0000-0003-0137-1906; Aguzzi, Jacopo/0000-0002-1484-8219; Fanelli, Emanuela/0000-0002-5358-5159; Jamieson, Alan/0000-0001-9835-2909	European Union (EU) project MERCES [689518]; EU project MIDAS [603418]; NIVA; NSERC, Canada; ONC; ROBEX; NSF [1031050]; Duke University; NERC [noc010009] Funding Source: UKRI; Natural Environment Research Council [noc010009] Funding Source: researchfish	European Union (EU) project MERCES; EU project MIDAS; NIVA; NSERC, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); ONC; ROBEX; NSF(National Science Foundation (NSF)); Duke University; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	R.D. was supported by European Union (EU) project MERCES (689518); R.D, K.G., and D.B. by EU project MIDAS (603418); E.R.-L. by NIVA; P.V.R.S. by NSERC, Canada; L.T. by ONC and ROBEX; and C.L.V.D. by NSF 1031050 and Duke University.	Block Barbara, 2010, P291, DOI 10.1002/9781444325508.ch15; Collins PC, 2013, MAR POLICY, V42, P198, DOI 10.1016/j.marpol.2013.01.020; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Kintisch E, 2013, SCIENCE, V339, P1138, DOI 10.1126/science.339.6124.1138; Levin LA, 2015, SCIENCE, V350, P766, DOI 10.1126/science.aad0126; Lodge M, 2014, MAR POLICY, V49, P66, DOI 10.1016/j.marpol.2014.04.006; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Rogers A. D., 2015, DELVING DEEPER CRITI; Smith KL, 2013, P NATL ACAD SCI USA, V110, P19838, DOI 10.1073/pnas.1315447110; Snelgrove P, 1997, AMBIO, V26, P578; Thurber AR, 2014, BIOGEOSCIENCES, V11, P3941, DOI 10.5194/bg-11-3941-2014; Wedding LM, 2015, SCIENCE, V349, P144, DOI 10.1126/science.aac6647; Wedding LM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1684	13	105	107	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					452	454		10.1126/science.aah7178	http://dx.doi.org/10.1126/science.aah7178			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154032	Green Published			2022-12-28	WOS:000393183100016
J	Jasny, BR; Stone, R				Jasny, Barbara R.; Stone, Richard			PREDICTION AND ITS LIMITS	SCIENCE			English	Editorial Material																			0	15	16	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					469	469		10.1126/science.355.6324.468	http://dx.doi.org/10.1126/science.355.6324.468			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4JO	28154045				2022-12-28	WOS:000393183100029
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Are hospitals heading the same way as prisons?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Allen G, 2016, PRISON POPULATION ST; [Anonymous], 2016, ANN REP 2015 16; Hall M, 2016, EXPRESS; House of Commons Justice Committee, 2015, PRIS PLANN POL; House of Commons Justice Committee, 2016, PRIS SAF 6 REP SESS; James E, 2016, GUARDIAN; Maddox D, 2016, EXPRESS; Prison Reform Trust, 2016, PRIS FACTS BROML BRI; Rutter T, 2016, GUARDIAN; Stone J., 2016, INDEPENDENT; TRAVIS ALAN, 2016, GUARDIAN; Weaver M, 2016, GUARDIAN; Willgress L, 2016, TELEGRAPH	13	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2017	356								j514	10.1136/bmj.j514	http://dx.doi.org/10.1136/bmj.j514			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BX	28159746	Green Published, Bronze			2022-12-28	WOS:000393450500003
J	Voosen, P				Voosen, Paul			PLANETARY SCIENCE Mars rover steps up hunt for molecular signs of life	SCIENCE			English	News Item																			0	7	7	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					444	444		10.1126/science.355.6324.444	http://dx.doi.org/10.1126/science.355.6324.444			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154030				2022-12-28	WOS:000393183100014
J	Rutledge, GG; Bohme, U; Sanders, M; Rrid, AJ; Cotton, JA; Maiga-Ascofare, O; Djimde, AA; Apinjoh, TO; Amenga-Etego, L; Manske, M; Barnwell, JW; Renaud, F; Ollomo, B; Prugnolle, F; Anstey, NM; Auburn, S; Price, RN; McCarthy, JS; Kwiatkowski, DP; Newbold, CI; Berriman, M; Otto, TD				Rutledge, Gavin G.; Bohme, Ulrike; Sanders, Mandy; Rrid, Adam J.; Cotton, James A.; Maiga-Ascofare, Oumou; Djimde, Abdoulaye A.; Apinjoh, Tobias O.; Amenga-Etego, Lucas; Manske, Magnus; Barnwell, John W.; Renaud, Francois; Ollomo, Benjamin; Prugnolle, Franck; Anstey, Nicholas M.; Auburn, Sarah; Price, Ric N.; McCarthy, James S.; Kwiatkowski, Dominic P.; Newbold, Chris I.; Berriman, Matthew; Otto, Thomas D.			Plasmodium malariae and P. ovale genomes provide insights into malaria parasite evolution	NATURE			English	Article							GENE-EXPRESSION; I-TASSER; SEQUENCE; ALGORITHM; ALIGNMENT; FAMILIES; BRASILIANUM; PHYLOGENIES; GENERATION; ASSEMBLIES	Elucidation of the evolutionary history and interrelatedness of Plasmodium species that infect humans has been hampered by a lack of genetic information for three human-infective species: P. malariae and two P. ovale species (P. o. curtisi and P. o. wallikeri)(1). These species are prevalent across most regions in which malaria is endemic(2,3) and are often undetectable by light microscopy(4), rendering their study in human populations difficult(5). The exact evolutionary relationship of these species to the other human-infective species has been contested(6,7). Using a new reference genome for P. malariae and a manually curated draft P. o. curtisi genome, we are now able to accurately place these species within the Plasmodium phylogeny. Sequencing of a P. malariae relative that infects chimpanzees reveals similar signatures of selection in the P. malariae lineage to another Plasmodium lineage shown to be capable of colonization of both human and chimpanzee hosts. Molecular dating suggests that these host adaptations occurred over similar evolutionary timescales. In addition to the core genome that is conserved between species, differences in gene content can be linked to their specific biology. The genome suggests that P. malariae expresses a family of heterodimeric proteins on its surface that have structural similarities to a protein crucial for invasion of red blood cells. The data presented here provide insight into the evolution of the Plasmodium genus as a whole.	[Rutledge, Gavin G.; Bohme, Ulrike; Sanders, Mandy; Rrid, Adam J.; Cotton, James A.; Djimde, Abdoulaye A.; Manske, Magnus; Berriman, Matthew; Otto, Thomas D.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Maiga-Ascofare, Oumou; Amenga-Etego, Lucas; Barnwell, John W.] Univ Sci Techn & Technol Bamako, Malaria Res & Training Ctr, BP E 2528, Bamako, Mali; [Sanders, Mandy; Apinjoh, Tobias O.; Auburn, Sarah] German Ctr Infect Res, D-20359 Hamburg, Germany; [Cotton, James A.; Manske, Magnus; Auburn, Sarah; Price, Ric N.] Univ Buea, Post Off Box 63, Buea, South West Regi, Cameroon; [Sanders, Mandy; Apinjoh, Tobias O.; McCarthy, James S.] Navrongo Hlth Res Ctr, Post Off Box 114, Navrongo, Upper East Regi, Ghana; [Cotton, James A.; Amenga-Etego, Lucas; Ollomo, Benjamin; Anstey, Nicholas M.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Rrid, Adam J.; Barnwell, John W.; Renaud, Francois; Ollomo, Benjamin; Prugnolle, Franck; Auburn, Sarah] UM1 CNRS IRD, Lab MIVEGEC, F-34394 Montpellier, France; [Sanders, Mandy; Djimde, Abdoulaye A.; Manske, Magnus; Prugnolle, Franck; Price, Ric N.] Ctr Int Recherches Med Franceville, BP 709 Franceville, Franceville, Gabon; [Sanders, Mandy; Apinjoh, Tobias O.; Anstey, Nicholas M.] Menzies Sch Hlth Res & Charles Darwin Univ, Global & Trop Hlth Div, Darwin, NT, Australia; [Sanders, Mandy; Djimde, Abdoulaye A.; Barnwell, John W.; Prugnolle, Franck] Univ Oxford, Nuffield Dept Clin Med, Ctr Top Med & Global Hlth, Oxford OX3 7LJ, England; [Bohme, Ulrike; Berriman, Matthew] Univ Queensland, QIMR Berghofer Med Res Inst, Clin Trop Med Lab, Brisbane, Qld, Australia; [Rrid, Adam J.; Djimde, Abdoulaye A.; Barnwell, John W.; McCarthy, James S.; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Sanders, Mandy; Renaud, Francois; McCarthy, James S.; Newbold, Chris I.] Univ Oxford, Inst Mol Med, John Radcliffe Hosp, Oxford OX3 9DS, England	Wellcome Trust Sanger Institute; University of Science & Technology of Bamako; German Center for Infection Research; Navrongo Health Research Center; Centers for Disease Control & Prevention - USA; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Charles Darwin University; Menzies School of Health Research; University of Oxford; QIMR Berghofer Medical Research Institute; University of Queensland; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Berriman, M; Otto, TD (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	mb4@sanger.ac.uk; tdo@sanger.ac.uk	Otto, Thomas/ABE-7632-2020; Berriman, Matthew/A-7618-2011; Auburn, Sarah/N-2266-2013	Berriman, Matthew/0000-0002-9581-0377; Kwiatkowski, Dominic/0000-0002-5023-0176; Rutledge, Gavin/0000-0003-0468-0528; Otto, Thomas/0000-0002-1246-7404; Bohme, Ulrike/0000-0002-0248-5924; Prugnolle, Franck/0000-0001-8519-1253; Cotton, James/0000-0001-5475-3583; Manske, Magnus/0000-0001-5916-0947; Newbold, Chris/0000-0002-9274-3789; Auburn, Sarah/0000-0002-4638-536X; Reid, Adam/0000-0002-5926-7768; McCarthy, James/0000-0001-6596-9718; Maiga Ascofare, Oumou/0000-0003-2947-5651; Price, Richard/0000-0003-2000-2874; Apinjoh, Tobias/0000-0001-9889-7271	Medical Research Council [MR/J004111/1, MR/L008661/1]; Wellcome Trust [098051, 091625, 104792/Z/14/Z]; ANR JCJC ORIGIN; LMI Zofac; CNRS; IRD; CIRMF; NHMRC [1041802, 1042072]; MRC [MR/M006212/1, G0600718] Funding Source: UKRI; Medical Research Council [MR/M006212/1, 1500002, G0600718, G0600718B] Funding Source: researchfish; Wellcome Trust [204911/Z/16/Z] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); ANR JCJC ORIGIN(French National Research Agency (ANR)); LMI Zofac; CNRS(Centre National de la Recherche Scientifique (CNRS)); IRD; CIRMF; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Medical Research Council (MR/J004111/1; MR/L008661/1) and the Wellcome Trust (098051). S.A. and R.N.P. are funded by the Wellcome Trust (091625). F.R., B.O. and F.P. are financed by the ANR JCJC 2012 ORIGIN, the LMI Zofac, as well as by CNRS, IRD, and CIRMF. C.I.N. is funded by a Wellcome Trust Investigator Award (104792/Z/14/Z). A.A.D. is funded as a Sanger International Fellow. J.S.M. and N.M.A. are supported by NHMRC Practitioner Fellowships (1041802; 1042072). The authors thank E. Willaume from the Park of La Lekedi and the people involved in the sanitary controls of the chimpanzees. The authors also thank P. Griffin and S. Sekuloski for assistance in collection of P. malariae isolate PmGN01.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ansari HR, 2016, INT J PARASITOL, V46, P685, DOI 10.1016/j.ijpara.2016.05.009; Arisue N, 2012, MOL BIOL EVOL, V29, P2095, DOI 10.1093/molbev/mss082; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Auburn S., 2016, WELLCOME OPEN RES; Auburn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022213; Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; Boehme U., 2016, PREPRINT; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Bronner I. F., 2014, CURR PROTOC HUM GENE, V80, P11, DOI [10.1002/0471142905.hg1802s80, DOI 10.1002/0471142905.HG1802S80]; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Claessens A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004812; Collins WE, 2005, CLIN MICROBIOL REV, V18, P570, DOI 10.1128/CMR.18.3.570-581.2005; Collins WE, 2007, CLIN MICROBIOL REV, V20, P579, DOI 10.1128/CMR.00027-07; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Daniels RF, 2015, P NATL ACAD SCI USA, V112, P7067, DOI 10.1073/pnas.1505691112; Doderer-Lang C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-240; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fougere A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005917; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Gruszczyk J, 2016, P NATL ACAD SCI USA, V113, pE191, DOI 10.1073/pnas.1516512113; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Holloway AK, 2007, PLOS GENET, V3, P2007, DOI 10.1371/journal.pgen.0030187; Innan H, 2006, GENETICS, V173, P1725, DOI 10.1534/genetics.106.056242; Kamau E, 2015, J INFECT DIS, V211, P1352, DOI 10.1093/infdis/jiu608; KREITMAN M, 1991, GENETICS, V127, P565; Lalremruata A, 2015, EBIOMEDICINE, V2, P1186, DOI 10.1016/j.ebiom.2015.07.033; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lopez-Barragan MJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-587; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Nadalin F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S8; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Nolder D, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002711; Ochoa D, 2010, BIOINFORMATICS, V26, P1370, DOI 10.1093/bioinformatics/btq137; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Otto TD, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0086-0; Otto TD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5754; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Oyola SO, 2014, DNA RES, V21, P661, DOI 10.1093/dnares/dsu028; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Rahnenfuhrer J, 2016, TOPGO ENRICHMENT ANA; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schaer J, 2013, P NATL ACAD SCI USA, V110, P17415, DOI 10.1073/pnas.1311016110; Silva JC, 2015, MOL BIOL EVOL, V32, P1354, DOI 10.1093/molbev/msv005; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Steinbiss S, 2016, NUCLEIC ACIDS RES, V44, pW29, DOI 10.1093/nar/gkw292; Sundararaman SA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11078; Sutherland CJ, 2010, J INFECT DIS, V201, P1544, DOI 10.1086/652240; Tachibana SI, 2012, NAT GENET, V44, P1051, DOI 10.1038/ng.2375; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tsai IJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r41; WEDDERBURN N, 1985, PARASITOLOGY, V90, P573, DOI 10.1017/S0031182000055566; Worley KC, 2014, NAT GENET, V46, P850, DOI 10.1038/ng.3042; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	77	101	102	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					101	+		10.1038/nature21038	http://dx.doi.org/10.1038/nature21038			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28117441	Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000396119300039
J	Brooks, M				Brooks, Michael			Stem cell research: time for a dose of realism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mb@michaelbrooks.org						Burt RK, 2015, JAMA-J AM MED ASSOC, V313, P275, DOI 10.1001/jama.2014.17986; International Society for Stem Cell Research, 2016, PHYT ROADM RES TRANS; Kamenova K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010496; King A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007700; Macare F, 2015, DAILY MAIL; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007	6	4	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2017	356								j443	10.1136/bmj.j443	http://dx.doi.org/10.1136/bmj.j443			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BP	28143810				2022-12-28	WOS:000393449700003
J	Davison, K; McClelland, H; Kerr, A; Schapira, M				Davison, Kenneth; McClelland, Hamish; Kerr, Alan; Schapira, Martin			Kurt Schapira OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		SCHAPIRA K, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2017	356								j499	10.1136/bmj.j499	http://dx.doi.org/10.1136/bmj.j499			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BO	28137770				2022-12-28	WOS:000393449600011
J	Toseland, M				Toseland, Michael			Leonard Irving Liebling OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		TOSELAND M, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2017	356								j466	10.1136/bmj.j466	http://dx.doi.org/10.1136/bmj.j466			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BO	28138094				2022-12-28	WOS:000393449600003
J	Fazzari, P; Horre, K; Arranz, AM; Frigerio, CS; Saito, T; Saido, TC; De Strooper, B				Fazzari, Pietro; Horre, Katrien; Arranz, Amaia M.; Frigerio, Carlo Sala; Saito, Takashi; Saido, Takaomi C.; De Strooper, Bart			PLD3 gene and processing of APP	NATURE			English	Letter									[Fazzari, Pietro; Horre, Katrien; Arranz, Amaia M.; Frigerio, Carlo Sala; De Strooper, Bart] VIB, Ctr Biol Dis, Leuven, Belgium; [Fazzari, Pietro; Horre, Katrien; Arranz, Amaia M.; Frigerio, Carlo Sala; De Strooper, Bart] Univ Hosp Leuven, LIND, Ctr Human Genet, KULeuven, O&N4 Herestr, Leuven, Belgium; [Fazzari, Pietro; Horre, Katrien; Arranz, Amaia M.; Frigerio, Carlo Sala; De Strooper, Bart] Univ Leuven, O&N4 Herestr, Leuven, Belgium; [Saito, Takashi; Saido, Takaomi C.] RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama, Japan; [Saito, Takashi] Japan Sci & Technol Agcy, Saitama, Japan; [De Strooper, Bart] UCL, Inst Neurol, Queen Sq, London, England	Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven; RIKEN; Japan Science & Technology Agency (JST); University of London; University College London	De Strooper, B (corresponding author), VIB, Ctr Biol Dis, Leuven, Belgium.; De Strooper, B (corresponding author), Univ Hosp Leuven, LIND, Ctr Human Genet, KULeuven, O&N4 Herestr, Leuven, Belgium.; De Strooper, B (corresponding author), Univ Leuven, O&N4 Herestr, Leuven, Belgium.; De Strooper, B (corresponding author), UCL, Inst Neurol, Queen Sq, London, England.	bart.destrooper@cme.vib-kuleuven.be	Arranz, Amaia/ACV-3437-2022; Arranz, Amaia M/C-3776-2017; Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015; de+Strooper, Bart/Z-1638-2019; Fazzari, Pietro/ABE-9368-2020; Saito, Takashi/G-2563-2015	Arranz, Amaia M/0000-0002-8314-7870; Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; Fazzari, Pietro/0000-0003-3457-9201; Sala Frigerio, Carlo/0000-0003-4038-6449; Horre, Katrien/0000-0002-6801-3137; Saito, Takashi/0000-0002-9659-9251	Medical Research Council [MC_PC_17116] Funding Source: Medline; MRC [MC_PC_17116] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	28	28	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2017	541	7638					E1	U354		10.1038/nature21030	http://dx.doi.org/10.1038/nature21030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6LX	28128235	Green Submitted			2022-12-28	WOS:000396116600001
J	Gulland, A				Gulland, Anne			Trump expands antiabortion rule to include all global health funding	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2017	356								j476	10.1136/bmj.j476	http://dx.doi.org/10.1136/bmj.j476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HS	28126756				2022-12-28	WOS:000393178100017
J	Shapiro, A				Shapiro, Aaron			Reform predictive policing	NATURE			English	Editorial Material									[Shapiro, Aaron] Univ Penn, Annenberg Sch Commun, Philadelphia, PA 19104 USA	University of Pennsylvania	Shapiro, A (corresponding author), Univ Penn, Annenberg Sch Commun, Philadelphia, PA 19104 USA.	ashapiro@asc.upenn.edu						Benbouzid B., 2016, WHO BENEFITS CRIME; Brayne Sarah, 2015, WORKSH PRIM DAT CIV; Gutierrez C. M., 2015, CRIME DELINQUENCY; Hunt P, 2014, EVALUATION SHREVEPOR; Lum K., 2016, SIGNIFICANCE, V13, P14, DOI [10.1111/j.1740-9713.2016.00960.x, DOI 10.1111/J.1740-9713.2016.00960.X]; Manning P.K., 2014, ENCY CRIMINOLOGY CRI, P2501; Muhammad K.G., 2011, CONDEMNATION BLACKNE; Paoline EA, 2007, CRIM JUSTICE BEHAV, V34, P179, DOI 10.1177/0093854806290239; Robinson D., 2016, STUCK PATTERN EARLY	9	50	51	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2017	541	7638					458	460		10.1038/541458a	http://dx.doi.org/10.1038/541458a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6LX	28128275	hybrid			2022-12-28	WOS:000396116600024
J	Abramowicz, M; Zuccotti, G; Pflomm, JM				Abramowicz, Mark; Zuccotti, Gianna; Pflomm, Jean-Marie			Epinephrine Auto-Injectors for Anaphylaxis (Reprinted from The Medical Letter on Drugs and Therapeutics, vol 58, issue 1503, 2016)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint													Pflomm, Jean-Marie/HDO-0765-2022					2016, MED LETT DRUGS THERA, V58	1	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					313	313		10.1001/jama.2016.14505	http://dx.doi.org/10.1001/jama.2016.14505			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114550				2022-12-28	WOS:000392089200020
J	Friedrich, MJ				Friedrich, M. J.			UNICEF Reports on the Impact of Air Pollution on Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					246	246		10.1001/jama.2016.19034	http://dx.doi.org/10.1001/jama.2016.19034			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	28114563				2022-12-28	WOS:000392089200004
J	Merli, GJ; Weitz, HH				Merli, G. J.; Weitz, H. H.			Annals Consult Guys-Measuring Lipids: To Fast or Not to Fast (vol 166, pg CG1, 2017)	ANNALS OF INTERNAL MEDICINE			English	Correction																		Merli GJ, 2017, ANN INTERN MED, V166, P764, DOI 10.7326/W17-0001	1	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					764	764		10.7326/W17-0001	http://dx.doi.org/10.7326/W17-0001			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28114475				2022-12-28	WOS:000401240200035
J	Califf, RM				Califf, Robert M.			Benefit-Risk Assessments at the US Food and Drug Administration Finding the Balance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Califf, Robert M.] US FDA, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Califf, RM (corresponding author), US FDA, Silver Spring, MD 20993 USA.	Robert.Califf@duke.edu			Patient-Centered Outcomes Research Institute; National Institutes of Health; US Food and Drug Administration; Amylin; Eli Lilly and Company; Bristol-Myers Squibb; Janssen Research and Development; Merck; Novartis; Amgen; Bayer Healthcare; BMEB Services; Genentech; GlaxoSmithKline; Heart. org-Daiichi Sankyo; Kowa; Les Laboratoires Servier; Medscape/Heart.org, Regado; Roche	Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Food and Drug Administration; Amylin; Eli Lilly and Company(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Janssen Research and Development; Merck(Merck & Company); Novartis(Novartis); Amgen(Amgen); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); BMEB Services; Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Heart. org-Daiichi Sankyo; Kowa; Les Laboratoires Servier; Medscape/Heart.org, Regado; Roche(Roche Holding)	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Califf was the Commissioner of Food and Drugs of the FDA from February 2016 through January 20,2017. Prior to his appointment to the FDA, Dr Califf received research grant funding from the Patient-Centered Outcomes Research Institute, the National Institutes of Health, the US Food and Drug Administration, Amylin, and Eli Lilly and Company; research grants and consulting payments from Bristol-Myers Squibb, Janssen Research and Development, Merck, and Novartis; consulting payments from Amgen, Bayer Healthcare, BMEB Services, Genentech, GlaxoSmithKline, Heart. org-Daiichi Sankyo, Kowa, Les Laboratoires Servier, Medscape/Heart.org, Regado, and Roche; he also held equity in N30 Pharma and Portola.	[Anonymous], 2016, CONSUMER REPORTS; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Schwartz JL, 2016, NEW ENGL J MED, V375, P2015, DOI 10.1056/NEJMp1609763	3	18	18	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2017	317	7					693	694		10.1001/jama.2017.0410	http://dx.doi.org/10.1001/jama.2017.0410			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8WR	28114599				2022-12-28	WOS:000394901600012
J	Scheele, CLGJ; Hannezo, E; Muraro, MJ; Zomer, A; Langedijk, NSM; van Oudenaarden, A; Simons, BD; van Rheenen, J				Scheele, Colinda L. G. J.; Hannezo, Edouard; Muraro, Mauro J.; Zomer, Anoek; Langedijk, Nathalia S. M.; van Oudenaarden, Alexander; Simons, Benjamin D.; van Rheenen, Jacco			Identity and dynamics of mammary stem cells during branching morphogenesis	NATURE			English	Article							GLAND DEVELOPMENT; BASAL LAMINA; DIFFERENTIATION; ORGANOGENESIS; HOMEOSTASIS; HIERARCHY; TISSUE	During puberty, the mouse mammary gland develops into a highly branched epithelial network. Owing to the absence of exclusive stem cell markers, the location, multiplicity, dynamics and fate of mammary stem cells (MaSCs), which drive branching morphogenesis, are unknown. Here we show that morphogenesis is driven by proliferative terminal end buds that terminate or bifurcate with near equal probability, in a stochastic and time-invariant manner, leading to a heterogeneous epithelial network. We show that the majority of terminal end bud cells function as highly proliferative, lineage-committed MaSCs that are heterogeneous in their expression profile and short-term contribution to ductal extension. Yet, through cell rearrangements during terminal end bud bifurcation, each MaSC is able to contribute actively to long-term growth. Our study shows that the behaviour of MaSCs is not directly linked to a single expression profile. Instead, morphogenesis relies upon lineage-restricted heterogeneous MaSC populations that function as single equipotent pools in the long term.	[Scheele, Colinda L. G. J.; Muraro, Mauro J.; Zomer, Anoek; Langedijk, Nathalia S. M.; van Oudenaarden, Alexander; van Rheenen, Jacco] Hubrecht Inst KNAW, Canc Genom Netherlands, Utrecht, Netherlands; [Scheele, Colinda L. G. J.; Muraro, Mauro J.; Zomer, Anoek; Langedijk, Nathalia S. M.; van Oudenaarden, Alexander; van Rheenen, Jacco] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Hannezo, Edouard; Simons, Benjamin D.] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge, England; [Hannezo, Edouard; Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England; [Hannezo, Edouard; Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1TN, England	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Cambridge; University of Cambridge; University of Cambridge	van Rheenen, J (corresponding author), Hubrecht Inst KNAW, Canc Genom Netherlands, Utrecht, Netherlands.; van Rheenen, J (corresponding author), Univ Med Ctr Utrecht, Utrecht, Netherlands.; Simons, BD (corresponding author), Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge, England.; Simons, BD (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England.; Simons, BD (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1TN, England.	bds10@cam.ac.uk; j.vanrheenen@hubrecht.eu	van Oudenaarden, Alexander/AAA-1705-2019; Simons, Benjamin/AAY-8920-2020; Scheele, Colinda/AAZ-9118-2021	Simons, Benjamin/0000-0002-3875-7071; Scheele, Colinda/0000-0001-8999-5451; Hannezo, Edouard/0000-0001-6005-1561	European Research Council [648804]; Worldwide Cancer Research [13-0297]; Wellcome Trust [098357/Z/12/Z, 110326/Z/15/Z]; Trinity College, Cambridge; Wellcome Trust; Bettencourt-Schueller Young Researcher Prize; Boehringer Ingelheim Fonds PhD Fellowship; Medical Research Council [MC_PC_12009] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Worldwide Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); Trinity College, Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission); Bettencourt-Schueller Young Researcher Prize; Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors would like to thank members of the van Rheenen group for critically reading this manuscript, and Anko de Graaff of the Hubrecht Imaging Centre and the Hubrecht Institute animal caretakers for technical support This work was supported by the European Research Council (consolidator grant 648804 to J.v.R.), the Worldwide Cancer Research (grant 13-0297 to J.v.R), and the Wellcome Trust (grant 098357/Z/12/Z to B.D.S. and 110326/Z/15/Z to E.H.). E.H. is funded by a Junior Research Fellowship from Trinity College, Cambridge, and a Sir Henry Wellcome Fellowship from the Wellcome Trust and acknowledges the Bettencourt-Schueller Young Researcher Prize for support C.L.G.J.S. is funded by a Boehringer Ingelheim Fonds PhD Fellowship.	Alieva Maria, 2014, Intravital, V3, pe29917, DOI 10.4161/intv.29917; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bai LX, 2010, GENE DEV, V24, P1882, DOI 10.1101/gad.1932810; de Visser KE, 2012, J PATHOL, V228, P300, DOI 10.1002/path.4096; dos Santos CO, 2013, P NATL ACAD SCI USA, V110, P7123, DOI 10.1073/pnas.1303919110; Giraddi RR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9487; Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168; Grun D, 2016, CELL STEM CELL, V19, P266, DOI 10.1016/j.stem.2016.05.010; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Inman JL, 2015, DEVELOPMENT, V142, P1028, DOI 10.1242/dev.087643; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Plaks V, 2015, DEV CELL, V34, P493, DOI 10.1016/j.devcel.2015.07.015; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Prater MD, 2014, NAT CELL BIOL, V16, P942, DOI 10.1038/ncb3025; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shehata M, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0411-0; SILBERSTEIN GB, 1984, MECH AGEING DEV, V24, P151, DOI 10.1016/0047-6374(84)90067-8; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851; WILLIAMS JM, 1983, DEV BIOL, V97, P274, DOI 10.1016/0012-1606(83)90086-6; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zomer A, 2013, STEM CELLS, V31, P602, DOI 10.1002/stem.1296	35	115	115	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					313	+		10.1038/nature21046	http://dx.doi.org/10.1038/nature21046			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2LQ	28135720	Green Accepted, Green Submitted			2022-12-28	WOS:000394451600029
J	Lascarrou, JB; Boisrame-Helms, J; Bailly, A; Le Thuaut, A; Kamel, T; Mercier, E; Ricard, JD; Lemiale, V; Colin, G; Mira, JP; Meziani, F; Messika, J; Dequin, PF; Boulain, T; Azoulay, E; Champigneulle, B; Reignier, J				Lascarrou, Jean Baptiste; Boisrame-Helms, Julie; Bailly, Arthur; Le Thuaut, Aurelie; Kamel, Toufik; Mercier, Emmanuelle; Ricard, Jean-Damien; Lemiale, Virginie; Colin, Gwenhael; Mira, Jean Paul; Meziani, Ferhat; Messika, Jonathan; Dequin, Pierre Francois; Boulain, Thierry; Azoulay, Elie; Champigneulle, Benoit; Reignier, Jean		Clinical Res In Intensive Care	Video Laryngoscopy vs Direct Laryngoscopy on Successful First-Pass Orotracheal Intubation Among ICU Patients A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; URGENT ENDOTRACHEAL INTUBATION; CRITICALLY-ILL PATIENTS; TRACHEAL INTUBATION; DIFFICULT AIRWAY; 1ST-ATTEMPT SUCCESS; RISK-FACTORS; COMPLICATIONS; VIDEOLARYNGOSCOPE; GUIDELINES	IMPORTANCE In the intensive care unit (ICU), orotracheal intubation can be associated with increased risk of complications because the patient may be acutely unstable, requiring prompt intervention, often by a practitioner with nonexpert skills. Video laryngoscopymay decrease this risk by improving glottis visualization. OBJECTIVE To determine whether video laryngoscopy increases the frequency of successful first-pass orotracheal intubation compared with direct laryngoscopy in ICU patients. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial of 371 adults requiring intubation while being treated at 7 ICUs in France between May 2015 and January 2016; there was 28 days of follow-up. INTERVENTIONS Intubation using a video laryngoscope (n = 186) or direct laryngoscopy (n = 185). All patients received general anesthesia. MAIN OUTCOMES AND MEASURES The primary outcome was the proportion of patients with successful first-pass intubation. The secondary outcomes included time to successful intubation and mild to moderate and severe life-threatening complications. RESULTS Among 371 randomized patients (mean [SD] age, 62.8 [15.8] years; 136 [36.7%] women), 371 completed the trial. The proportion of patients with successful first-pass intubation did not differ significantly between the video laryngoscopy and direct laryngoscopy groups (67.7% vs 70.3%; absolute difference, -2.5%[95% CI, -11.9% to 6.9%]; P=.60). The proportion of first-attempt intubations performed by nonexperts (primarily residents, n = 290) did not differ between the groups (84.4% with video laryngoscopy vs 83.2% with direct laryngoscopy; absolute difference 1.2%[95% CI, -6.3% to 8.6%]; P=.76). The median time to successful intubationwas 3 minutes (range, 2 to 4 minutes) for both video laryngoscopy and direct laryngoscopy (absolute difference, 0 [95% CI, 0 to 0]; P=.95). Video laryngoscopywas not associated with life-threatening complications (24/180 [13.3%] vs 17/179 [9.5%] for direct laryngoscopy; absolute difference, 3.8% [95% CI, -2.7% to 10.4%]; P=.25). In post hoc analysis, video laryngoscopywas associated with severe life-threatening complications (17/179 [9.5%] vs 5/179 [2.8%] for direct laryngoscopy; absolute difference, 6.7%[95% CI, 1.8% to 11.6%]; P=.01) but not with mild to moderate life-threatening complications (10/181 [5.4%] vs 14/181 [7.7%]; absolute difference, -2.3%[95% CI, -7.4% to 2.8%]; P=.37). CONCLUSIONS AND RELEVANCE Among patients in the ICU requiring intubation, video laryngoscopy compared with direct laryngoscopy did not improve first-pass orotracheal intubation rates and was associated with higher rates of severe life-threatening complications. Further studies are needed to assess the comparative effectiveness of these 2 strategies in different clinical settings and among operators with diverse skill levels.	[Lascarrou, Jean Baptiste; Bailly, Arthur; Colin, Gwenhael] Dist Hosp Ctr, Med Surg Intens Care Unit, La Roche Sur Yon, France; [Boisrame-Helms, Julie; Meziani, Ferhat] Hop Univ Strasbourg, Nouvel Hop Civil, Serv Reanimat Med, Strasbourg, France; [Boisrame-Helms, Julie; Meziani, Ferhat] Univ Strasbourg, EA 7293, Fac Med, Federat Med Translat Strasbourg, Strasbourg, France; [Le Thuaut, Aurelie] Dist Hosp Ctr, Clin Res Unit, La Roche Sur Yon, France; [Le Thuaut, Aurelie] CHU Hotel Dieu, Delegat Rech Clin & Innovat, Nantes, France; [Kamel, Toufik; Boulain, Thierry] Reg Hosp Ctr, Med Intens Care Unit, Orleans, France; [Mercier, Emmanuelle; Dequin, Pierre Francois] Univ Hosp Ctr, Med Intens Care Unit, Tours, France; [Ricard, Jean-Damien; Messika, Jonathan] Hop Louis Mourier, AP HP, F-92700 Colombes, France; [Ricard, Jean-Damien; Messika, Jonathan] Sorbonne Paris Cite, INSERM, IAME 1137, F-75018 Paris, France; [Lemiale, Virginie; Azoulay, Elie] Hop St Louis, AP HP, Serv Reanimat Med, Paris, France; [Mira, Jean Paul; Champigneulle, Benoit] Cochin Univ, Med Intens Care Unit, Ctr Hosp, Paris, France; [Reignier, Jean] Univ Hosp Ctr, Med Intens Care Unit, Nantes, France; [Reignier, Jean] Univ Med, Clin & Expt Treatments Infect, EA 3826, Nantes, France	CHD Vendee; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHD Vendee; Nantes Universite; CHU de Nantes; Centre Hospitalier Regional d'Orleans; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes	Lascarrou, JB (corresponding author), Ctr Hosp Dept Vendee, Serv Reanimat, F-85000 La Roche Sur Yon, France.	jean-baptiste.lascarrou@chd-vendee.fr	Lascarrou, Jean Baptiste/I-4079-2014; Boulain, Thierry/M-3309-2019; Colin, Gwenhael/AAL-1780-2021	Lascarrou, Jean Baptiste/0000-0003-3706-078X; Boulain, Thierry/0000-0003-4664-3661; Colin, Gwenhael/0000-0001-7607-9913; KAMEL, Toufik/0000-0001-6788-2544	nonprofit health care institution Centre Hospitalier Departement de la Vendee	nonprofit health care institution Centre Hospitalier Departement de la Vendee	The nonprofit health care institution Centre Hospitalier Departement de la Vendee was the study funder and sponsor.	Baillard C, 2006, AM J RESP CRIT CARE, V174, P171, DOI 10.1164/rccm.200509-1507OC; Bailly A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009855; Batuwitage B, 2015, EUR J ANAESTH, V32, P400, DOI 10.1097/EJA.0000000000000070; Buis ML, 2016, RESUSCITATION, V99, P63, DOI 10.1016/j.resuscitation.2015.11.005; De Jong A, 2014, INTENS CARE MED, V40, P629, DOI 10.1007/s00134-014-3236-5; De Jong A, 2013, INTENS CARE MED, V39, P2144, DOI 10.1007/s00134-013-3099-1; Frerk C, 2015, BRIT J ANAESTH, V115, P827, DOI 10.1093/bja/aev371; Griesdale DEG, 2008, INTENS CARE MED, V34, P1835, DOI 10.1007/s00134-008-1205-6; Griesdale DEG, 2012, CAN J ANESTH, V59, P1032, DOI 10.1007/s12630-012-9775-8; Griesdale DEG, 2012, CAN J ANESTH, V59, P41, DOI 10.1007/s12630-011-9620-5; Hirabayashi Y, 2010, J ANESTH, V24, P366, DOI 10.1007/s00540-010-0927-0; Hypes CD, 2016, ANN AM THORAC SOC, V13, P382, DOI 10.1513/AnnalsATS.201508-505OC; Jaber S, 2006, CRIT CARE MED, V34, P2355, DOI 10.1097/01.CCM.0000233879.58720.87; Jaber S, 2010, INTENS CARE MED, V36, P248, DOI 10.1007/s00134-009-1717-8; Janz DR, 2016, CRIT CARE MED, V44, P1980, DOI 10.1097/CCM.0000000000001841; Kleine-Brueggeney M, 2016, BRIT J ANAESTH, V116, P670, DOI 10.1093/bja/aew058; Kory P, 2013, ANESTH ANALG, V117, P144, DOI 10.1213/ANE.0b013e3182917f2a; Lakticova V, 2015, J INTENSIVE CARE MED, V30, P44, DOI 10.1177/0885066613492641; Langeron O, 2008, ANN FR ANESTH, V27, P41, DOI 10.1016/j.annfar.2007.10.025; Levitan RM, 1998, ACAD EMERG MED, V5, P919, DOI 10.1111/j.1553-2712.1998.tb02823.x; Michailidou M, 2015, WORLD J SURG, V39, P782, DOI 10.1007/s00268-014-2845-z; Miguel-Montanes R, 2015, CRIT CARE MED, V43, P574, DOI 10.1097/CCM.0000000000000743; Mort TC, 2004, J CLIN ANESTH, V16, P508, DOI 10.1016/j.jclinane.2004.01.007; Mosier JM, 2015, ANN AM THORAC SOC, V12, P734, DOI 10.1513/AnnalsATS.201411-517OC; Mosier JM, 2013, CRIT CARE, V17, DOI 10.1186/cc13061; Noguchi T, 2003, CAN J ANAESTH, V50, P712, DOI 10.1007/BF03018715; Noppens RR, 2012, CRIT CARE, V16, DOI 10.1186/cc11384; Platts-Mills TF, 2009, ACAD EMERG MED, V16, P866, DOI 10.1111/j.1553-2712.2009.00492.x; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Roux D, 2014, CRIT CARE MED, V42, P886, DOI 10.1097/CCM.0000000000000049; Sakles JC, 2013, ACAD EMERG MED, V20, P71, DOI 10.1111/acem.12055; Silverberg MJ, 2015, CRIT CARE MED, V43, P636, DOI 10.1097/CCM.0000000000000751; Silverberg Michael J, 2014, Ann Am Thorac Soc, V11, P1225, DOI 10.1513/AnnalsATS.201405-189OC; Simpson GD, 2012, BRIT J ANAESTH, V108, P792, DOI 10.1093/bja/aer504; Sinclair RCF, 2005, BJA EDUC, V5, P45, DOI 10.1093/bjaceaccp/mki016; Ural K, 2011, CRIT CARE RESUSC, V13, P89; Walker L, 2009, BRIT J ANAESTH, V103, P440, DOI 10.1093/bja/aep191; Wallace CD, 2015, ANAESTHESIA, V70, P1281, DOI 10.1111/anae.13209; Wang Henry E, 2005, Prehosp Emerg Care, V9, P156; Yeatts DJ, 2013, J TRAUMA ACUTE CARE, V75, P212, DOI 10.1097/TA.0b013e318293103d	40	117	118	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2017	317	5					483	493		10.1001/jama.2016.20603	http://dx.doi.org/10.1001/jama.2016.20603			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ9RN	28118659				2022-12-28	WOS:000393564200017
J	Desai, N; Brown, A; Amunts, A; Ramakrishnan, V				Desai, Nirupa; Brown, Alan; Amunts, Alexey; Ramakrishnan, V.			The structure of the yeast mitochondrial ribosome	SCIENCE			English	Article							MESSENGER-RNA; TRANSLATIONAL ACTIVATOR; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL INTERACTIONS; PROTEIN-SYNTHESIS; SUBUNIT; IDENTIFICATION; ORGANIZATION; EVOLUTION; HOMOLOGS	Mitochondria have specialized ribosomes (mitoribosomes) dedicated to the expression of the genetic information encoded by their genomes. Here, using electron cryomicroscopy, we have determined the structure of the 75-component yeast mitoribosome to an overall resolution of 3.3 angstroms. The mitoribosomal small subunit has been built de novo and includes 15S ribosomal RNA (rRNA) and 34 proteins, including 14 without homologs in the evolutionarily related bacterial ribosome. Yeast-specific rRNA and protein elements, including the acquisition of a putatively active enzyme, give the mitoribosome a distinct architecture compared to the mammalian mitoribosome. At an expanded messenger RNA channel exit, there is a binding platform for translational activators that regulate translation in yeast but not mammalian mitochondria. The structure provides insights into the evolution and species-specific specialization of mitochondrial translation.	[Desai, Nirupa; Brown, Alan; Amunts, Alexey; Ramakrishnan, V.] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [Amunts, Alexey] Stockholm Univ, SciLifeLab, SE-10691 Stockholm, Sweden	MRC Laboratory Molecular Biology; SciLifeLab; Stockholm University	Ramakrishnan, V (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk	Amunts, A./AAZ-2279-2020	Amunts, A./0000-0002-5302-1740; Ramakrishnan, V/0000-0002-4699-2194; Brown, Alan/0000-0002-0021-0476	UK Medical Research Council [MC_U105184332]; Wellcome Trust [WT096570, 110301/Z/15/Z]; Agouron Institute; Louis-Jeantet Foundation; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332] Funding Source: researchfish; Wellcome Trust [096570/Z/11/Z] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank C. Savva and J. Murray for assistance with the electron microscopes; J. L. Llacer for help with model building and analysis; S. Tan for help with figure presentation; J. Grimmett and T. Darling for computing support; and M. Skehel for mass spectrometry. This work was funded by grants to V.R. from the UK Medical Research Council (MC_U105184332.); a Wellcome Trust Senior Investigator award (WT096570); the Agouron Institute; and the Louis-Jeantet Foundation. N.D. is funded by the Wellcome Trust Clinical PhD Fellowship (110301/Z/15/Z). The maps nave been deposited with the Electron Microscopy Data Bank under the accession codes EMD-3551, EMD-3552, EMD-3553, EMD-3554, EMD-3555, and EMD-3556. Atomic coordinates have been deposited with the Protein Data Bank under IDs 5MRC, 5MRE, and 5MRF.	Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Barros MH, 2006, J BIOL CHEM, V281, P3743, DOI 10.1074/jbc.M510778200; BROWN GK, 1982, PEDIATRICS, V70, P532; Bullerwell CE, 2000, TRENDS BIOCHEM SCI, V25, P363, DOI 10.1016/S0968-0004(00)01612-1; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Couvillion MT, 2016, NATURE, V533, P499, DOI 10.1038/nature18015; DENSLOW ND, 1991, J BIOL CHEM, V266, P9586; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Greber BJ, 2016, ANNU REV BIOCHEM, V85, P103, DOI 10.1146/annurev-biochem-060815-014343; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Green-Willms NS, 1998, MOL CELL BIOL, V18, P1826, DOI 10.1128/MCB.18.4.1826; GROOT GSP, 1979, MOL GEN GENET, V174, P339, DOI 10.1007/BF00267808; HAFFTER P, 1991, GENETICS, V127, P319; HAFFTER P, 1992, MOL GEN GENET, V235, P64, DOI 10.1007/BF00286182; Hajnsdorf E, 2012, BIOCHIMIE, V94, P1544, DOI 10.1016/j.biochi.2012.02.010; Herrmann JM, 2013, BBA-MOL CELL RES, V1833, P286, DOI 10.1016/j.bbamcr.2012.03.007; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Kitakawa M, 1997, EUR J BIOCHEM, V245, P449, DOI 10.1111/j.1432-1033.1997.t01-2-00449.x; MCMULLIN TW, 1990, MOL CELL BIOL, V10, P4590, DOI 10.1128/MCB.10.9.4590; Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334; Park Y, 2012, BIOINFORMATICS, V28, pI40, DOI 10.1093/bioinformatics/bts211; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Pfeffer S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7019; Saveanu C, 2001, J BIOL CHEM, V276, P15861, DOI 10.1074/jbc.M010864200; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; van der Sluis EO, 2015, GENOME BIOL EVOL, V7, P1235, DOI 10.1093/gbe/evv061; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	30	110	134	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					528	531		10.1126/science.aal2415	http://dx.doi.org/10.1126/science.aal2415			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154081	Green Accepted			2022-12-28	WOS:000393183100046
J	Pennington, RT; Banda, K; Delgado-Salinas, A; Dexter, KG; Galetti, L; Linares-Palomino, R; Maturo, HM; Mogni, V; Oakley, L; Olivera, A; Prado, D; Quintana, C; Riina, R; Sarkinen, T				Pennington, R. Toby; Banda-R, Karina; Delgado-Salinas, Alfonso; Dexter, Kyle G.; Galetti, Luciano; Linares-Palomino, Reynaldo; Maturo, Hernan M.; Mogni, Virginia; Oakley, Luis; Olivera-Filho, Ary; Prado, Darien; Quintana, Catalina; Riina, Ricarda; Sarkinen, Tiina		DRYFLOR	Forest conservation: Remember Gran Chaco Response	SCIENCE			English	Letter							DRY TROPICAL FORESTS		[DRYFLOR] Royal Bot Garden Edinburgh, Latin Amer & Caribbean Seasonally Dry Trop Forest, Edinburgh EH3 5LR, Midlothian, Scotland; [Pennington, R. Toby; Banda-R, Karina; Dexter, Kyle G.; Sarkinen, Tiina] Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland; [Banda-R, Karina] Fdn Ecosistemas Secos Colombia, Bogota, Colombia; [Delgado-Salinas, Alfonso] Univ Nacl Autonoma Mexico, Dept Bot, Mexico City, DF, Mexico; [Dexter, Kyle G.] Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland; [Galetti, Luciano; Maturo, Hernan M.; Mogni, Virginia; Oakley, Luis; Prado, Darien] Univ Nacl Rosario, Fac Ciencias Agr, IICAR CONICET, Catedra Bot, S2125ZAA, Zavalla, Argentina; [Linares-Palomino, Reynaldo] Univ Nacl Agr La Molina, Ave La Molina, Lima, Peru; [Linares-Palomino, Reynaldo] Smithsonian Conservat Biol Inst, Lima, Peru; [Olivera-Filho, Ary] Univ Fed Minas Gerais, ICB, Dept Bot, Belo Horizonte, MG, Brazil; [Quintana, Catalina] Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas, Escuela Biol, Quito, Ecuador; [Riina, Ricarda] CSIC, RJB, E-28014 Madrid, Spain	Universidad Nacional Autonoma de Mexico; University of Edinburgh; National University of Rosario; University Nacional Agraria La Molina; Universidade Federal de Minas Gerais; Pontificia Universidad Catolica del Ecuador; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Pennington, RT (corresponding author), Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland.	t.pennington@rbge.ac.uk	Dexter, Kyle G/D-5589-2018; Linares-Palomino, Reynaldo/AAI-1023-2020; Riina, Ricarda/J-1032-2014; Prado, Darien/K-6360-2019; Quintana, Catalina/AAX-7492-2020	Dexter, Kyle G/0000-0001-9232-5221; Linares-Palomino, Reynaldo/0000-0002-7631-5549; Riina, Ricarda/0000-0002-7423-899X; Prado, Darien/0000-0001-5112-7077; Banda, Karina/0000-0001-5789-0110; Pennington, Toby/0000-0002-8196-288X; Quintana, Catalina/0000-0003-4115-1705	NERC [NE/I027797/1] Funding Source: UKRI; Natural Environment Research Council [NE/I027797/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Conti H., 2009, FLORA CHAQUENA ASTER, P9; Huber O, 1997, GLOSARIO FITOECOLOGI, V1; Huber O., 2003, GLOSARIO FITOECOLOGI, V2; Hughes CE, 2013, BOT J LINN SOC, V171, P1, DOI 10.1111/boj.12006; Murphy P., 1995, SEASONALLY DRY TROPI, P146; Pennington RT, 2009, ANNU REV ECOL EVOL S, V40, P437, DOI 10.1146/annurev.ecolsys.110308.120327; Prado Darien E., 1993, Candollea, V48, P145; Prado Dariene E., 1993, Candollea, V48, P615; Saerkinen Tiina, 2011, BMC Ecology, V11, P27, DOI 10.1186/1472-6785-11-27	9	5	5	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					465	466		10.1126/science.aal5010	http://dx.doi.org/10.1126/science.aal5010			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154042	Green Accepted, Green Submitted			2022-12-28	WOS:000393183100026
J	Wade, L				Wade, Lizzie			SCIENTIFIC COMMUNITY Mexican scientists feel the Trump effect	SCIENCE			English	News Item																			0	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2017	355	6324					440	441		10.1126/science.355.6324.440	http://dx.doi.org/10.1126/science.355.6324.440			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4JO	28154026				2022-12-28	WOS:000393183100010
J	Castelvecchi, D				Castelvecchi, Davide			Hydrogen yet to prove it's metal	NATURE			English	News Item																		Dias RP, 2017, SCIENCE, V357; Wigner E, 1935, J CHEM PHYS, V3, P764, DOI 10.1063/1.1749590	2	11	11	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					17	17		10.1038/nature.2017.21379	http://dx.doi.org/10.1038/nature.2017.21379			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28150796	Bronze			2022-12-28	WOS:000396119300009
J	Samuels, MA; Gonzalez, RG; Makadzange, AT; Hedley-Whyte, ET				Samuels, Martin A.; Gonzalez, R. Gilberto; Makadzange, Azure T.; Hedley-Whyte, E. Tessa			Case 3-2017: A 62-Year-Old Man with Cardiac Sarcoidosis and New Diplopia and Weakness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GRANULOMATOUS AMEBIC ENCEPHALITIS; ACANTHAMOEBA; PATIENT; INFECTION; MILTEFOSINE		[Samuels, Martin A.] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Makadzange, Azure T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Hedley-Whyte, E. Tessa] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Samuels, Martin A.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Gonzalez, R. Gilberto] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Makadzange, Azure T.] Harvard Med Sch, Dept Med, Boston, MA USA; [Hedley-Whyte, E. Tessa] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Samuels, MA (corresponding author), Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.; Samuels, MA (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.		Hedley-Whyte, E Tessa/AAJ-9975-2021	Hedley-Whyte, E Tessa/0000-0002-1687-8905; Makadzange, Azure Tariro/0000-0001-5330-1470	GlaxoSmithKline; Janssen Pharmaceuticals; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI104348] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Hedley-Whyte reports holding stock in Becton Dickinson; and Dr. Makadzange, receiving consulting fees from GlaxoSmithKline and lecture fees from Janssen Pharmaceuticals, as well as nonfinancial support from Roche Diagnostics and Becton Dickinson. No other potential conflict of interest relevant to this article was reported.	Aichelburg AC, 2008, EMERG INFECT DIS, V14, P1743, DOI 10.3201/eid1411.070854; [Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P666; Barete S, 2007, EMERG INFECT DIS, V13, P736, DOI 10.3201/eid1305.061347; Bloch KC, 2005, J CLIN MICROBIOL, V43, P3003, DOI 10.1128/JCM.43.6.3003-3006.2005; Centers for Disease Control and Prevention, PAR AC GRAN AM ENC G; Centers for Disease Control and Prevention, NAEGL FOWL PRIM AM M; D'Auria A, 2012, J NEUROPARASITOLOGY, V3, P1, DOI [DOI 10.4303/JNP/N120801, 10.4303/jnp/N120801]; Hassan Azza, 2012, J Infect Public Health, V5, P304, DOI 10.1016/j.jiph.2012.06.001; Hikal W, 2015, IRAN J PARASITOL, V10, P410; Lackner P, 2010, NEUROCRIT CARE, V12, P91, DOI 10.1007/s12028-009-9291-z; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Maritschnegg P, 2011, J CLIN MICROBIOL, V49, P446, DOI 10.1128/JCM.01456-10; Martinez MS, 2000, J CLIN MICROBIOL, V38, P3892, DOI 10.1128/JCM.38.10.3892-3895.2000; SLATER CA, 1994, NEW ENGL J MED, V331, P85, DOI 10.1056/NEJM199407143310204; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747; Visvesvara G. S., 2010, Journal of Neuroparasitology, V1, pN100802, DOI 10.4303/jnp/N100802; Webster D, 2012, AM J TROP MED HYG, V87, P715, DOI 10.4269/ajtmh.2012.12-0100	18	2	2	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2017	376	4					368	379		10.1056/NEJMcpc1610713	http://dx.doi.org/10.1056/NEJMcpc1610713			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ3KR	28121502				2022-12-28	WOS:000393111600012
J	Velzel, J; Vlemmix, F; Opmeer, BC; Molkenboer, JFM; Verhoeven, CJ; van Pampus, MG; Papatsonis, DNM; Bais, JMJ; Vollebregt, KC; van der Esch, L; Van der Post, JAM; Mol, B; Kok, M				Velzel, Joost; Vlemmix, Floortje; Opmeer, Brent C.; Molkenboer, Jan F. M.; Verhoeven, Corine J.; van Pampus, Marielle G.; Papatsonis, Dimitri N. M.; Bais, Joke M. J.; Vollebregt, Karlijn C.; van der Esch, Liesbeth; Van der Post, Joris A. M.; Mol, Ben Willem; Kok, Marjolein			Atosiban versus fenoterol as a uterine relaxant for external cephalic version: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BREECH PRESENTATION; CESAREAN-SECTION; VAGINAL BIRTH; COMPLICATIONS; TERM	OBJECTIVE To compare the effectiveness of the oxytocin receptor antagonist atosiban with the beta mimetic fenoterol as uterine relaxants in women undergoing external cephalic version (ECV) for breech presentation. DESIGN Multicentre, open label, randomised controlled trial. SETTING Eight hospitals in the Netherlands, August 2009 to May 2014. PARTICIPANTS 830 women with a singleton fetus in breech presentation and a gestational age of more than 34 weeks were randomly allocated in a 1: 1 ratio to either 6.75 mg atosiban (n = 416) or 40 g fenoterol (n = 414) intravenously for uterine relaxation before ECV. MAIN OUTCOME MEASURES The primary outcome measures were a fetus in cephalic position 30 minutes after the procedure and cephalic presentation at delivery. Secondary outcome measures were mode of delivery, incidence of fetal and maternal complications, and drug related adverse events. All analyses were done on an intention-to-treat basis. RESULTS Cephalic position 30 minutes after ECV occurred significantly less in the atosiban group than in the fenoterol group (34% v 40%, relative risk 0.73, 95% confidence interval 0.55 to 0.93). Presentation at birth was cephalic in 35% (n = 139) of the atosiban group and 40% (n = 166) of the fenoterol group (0.86, 0.72 to 1.03), and caesarean delivery was performed in 60% (n = 240) of women in the atosiban group and 55% (n = 218) in the fenoterol group (1.09, 0.96 to 1.20). No significant differences were found in neonatal outcomes or drug related adverse events. CONCLUSIONS In women undergoing ECV for breech presentation, uterine relaxation with fenoterol increases the rate of cephalic presentation 30 minutes after the procedure. No statistically significant difference was found for cephalic presentation at delivery.	[Velzel, Joost; Vlemmix, Floortje; Van der Post, Joris A. M.; Kok, Marjolein] Acad Med Ctr, Dept Obstet & Gynaecol, Amsterdam, Netherlands; [Opmeer, Brent C.] Acad Med Ctr, Clin Res Unit, Amsterdam, Netherlands; [Molkenboer, Jan F. M.] Spaarne Gasthuis, Dept Obstet & Gynaecol, Hoofddorp, Netherlands; [Verhoeven, Corine J.] Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands; [van Pampus, Marielle G.] Onze Lieve Vrouw Hosp, Dept Obstet & Gynaecol, Amsterdam, Netherlands; [Papatsonis, Dimitri N. M.] Amphia Hosp, Dept Obstet & Gynaecol, Breda, Netherlands; [Bais, Joke M. J.] Med Ctr Alkmaar, Dept Obstet & Gynaecol, Alkmaar, Netherlands; [Vollebregt, Karlijn C.] Spaarne Gasthuis, Dept Obstet & Gynaecol, Haarlem, Netherlands; [van der Esch, Liesbeth] St Antonius Hosp, Dept Obstet & Gynaecol, Nieuwegein, Netherlands; [Mol, Ben Willem] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Inst, Adelaide, SA 5005, Australia; [Mol, Ben Willem] South Australian Hlth, Adelaide, SA, Australia; [Mol, Ben Willem] Med Res Inst, Adelaide, SA, Australia	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Spaarne Hospital; Maxima Medical Center; Onze Lieve Vrouwe Gasthuis Hospital; Amphia Hospital; Medical Center Of Alkmaar; Spaarne Hospital; St. Antonius Hospital Utrecht; Robinson Research Institute; University of Adelaide	Velzel, J (corresponding author), Acad Med Ctr, Dept Obstet & Gynaecol, Amsterdam, Netherlands.	j.velzel@amc.nl	Verhoeven, Corine/N-8354-2019; Verhoeven, C.J.M./E-8128-2018; van der Post, Joris A M/A-8991-2008	Verhoeven, Corine/0000-0002-0001-0888; Kok, Marjolein/0000-0001-9420-2313; van Pampus, Maria/0000-0002-3020-8908; van der Post, Joris/0000-0003-3311-2116	Dutch Obstetric Consortium	Dutch Obstetric Consortium	This study was supported by the Dutch Obstetric Consortium.	ACOG Committee on Obstetric Practice, 2006, Obstet Gynecol, V108, P235; AKERLUND M, 1986, BRIT J OBSTET GYNAEC, V93, P22, DOI 10.1111/j.1471-0528.1986.tb07807.x; [Anonymous], 2014, OBSTET GYNECOL, V123, P693; Barber EL, 2011, OBSTET GYNECOL, V118, P29, DOI 10.1097/AOG.0b013e31821e5f65; Betran AP, 2016, BJOG-INT J OBSTET GY, V123, P667, DOI 10.1111/1471-0528.13526; Beuckens A, 2016, BJOG-INT J OBSTET GY, V123, P415, DOI 10.1111/1471-0528.13234; Cluver C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000184.pub3; Collaris RJ, 2004, ACTA OBSTET GYN SCAN, V83, P511, DOI 10.1111/j.0001-6349.2004.00347.x; Collins S, 2007, BJOG-INT J OBSTET GY, V114, P636, DOI 10.1111/j.1471-0528.2007.01271.x; Gibbons L, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.026; Gregory Kimberly D, 2012, Am J Perinatol, V29, P7, DOI 10.1055/s-0031-1285829; Grootscholten K, 2008, OBSTET GYNECOL, V112, P1143, DOI 10.1097/AOG.0b013e31818b4ade; Hamilton BE, 2013, PEDIATRICS, V131, P548, DOI 10.1542/peds.2012-3769; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; HICKOK DE, 1992, AM J OBSTET GYNECOL, V166, P851, DOI 10.1016/0002-9378(92)91347-D; Hofmeyr GJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000184.PUB2; Hofmeyr GJ, 2015, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000083.PUB3; Kok M, 2008, OBSTET GYNECOL, V112, P271, DOI 10.1097/AOG.0b013e31817f1f2e; LIPPERT TH, 1980, GYNECOL OBSTET INVES, V11, P219, DOI 10.1159/000299840; LUNDIN S, 1993, CLIN ENDOCRINOL, V39, P369, DOI 10.1111/j.1365-2265.1993.tb02379.x; MacDorman M, 2011, CLIN PERINATOL, V38, P179, DOI 10.1016/j.clp.2011.03.007; Mishra M, 2011, J OBSTET GYNAECOL, V31, P495, DOI 10.3109/01443615.2011.578226; Obstetrische Werkgroep, 2008, STUITL; Rasmussen BB, 2005, BJOG-INT J OBSTET GY, V112, P1492, DOI 10.1111/j.1471-0528.2005.00735.x; Reinheimer TM, 2005, J CLIN ENDOCR METAB, V90, P2275, DOI 10.1210/jc.2004-2120; Rietberg CCT, 2005, BJOG-INT J OBSTET GY, V112, P205, DOI 10.1111/j.1471-0528.2004.00317.x; Vlemmix F, 2015, ACTA OBSTET GYN SCAN, V94, P518, DOI 10.1111/aogs.12609; Vlemmix F, 2013, J PSYCHOSOM OBST GYN, V34, P15, DOI 10.3109/0167482X.2012.760540	28	9	10	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2017	356								i6773	10.1136/bmj.i6773	http://dx.doi.org/10.1136/bmj.i6773			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HS	28126898	Green Published, Green Submitted			2022-12-28	WOS:000393178100001
J	Nurok, M; Makkar, R; Gewertz, B				Nurok, Michael; Makkar, Raj; Gewertz, Bruce			The Ethics of Interventional Procedures for Patients Too Ill for Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTOPERATIVE LIFE-SUPPORT; GUIDELINES		[Nurok, Michael] Cedars Sinai Heart Inst, Cardiac Surg Intens Care Unit, Los Angeles, CA USA; [Makkar, Raj] Cedars Sinai Heart Inst, Cardiac Catheterizat Lab, Los Angeles, CA USA; [Gewertz, Bruce] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Nurok, M (corresponding author), Cedars Sinai Heart Inst, Div Cardiothorac Surg, Cardiac Surg Intens Care Unit, 127 San Vicente Blvd,Ste 3100, Los Angeles, CA 90048 USA.	michael.nurok@cshs.org			Edwards Lifesciences and St Jude Medical	Edwards Lifesciences and St Jude Medical	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Makkar reported receiving grants from Edwards Lifesciences and St Jude Medical and serving as a consultant for Abbott Vascular, Cordis, and Medtronic. No other disclosures were reported.	Bosk CL, 2003, FORGIVE REMEMBER MAN; Burkle CM, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-2; Fins J, 2006, PALLIATIVE ETHIC CAR; Holmes DR, 2015, J AM COLL CARDIOL, V66, P2813, DOI 10.1016/j.jacc.2015.10.021; Nurok M, 2014, J CLIN ANESTH, V26, P174, DOI 10.1016/j.jclinane.2013.11.011; Schwarze ML, 2013, CRIT CARE MED, V41, P1, DOI 10.1097/CCM.0b013e31826a4650; Schwarze ML, 2012, ANN SURG, V256, P10, DOI 10.1097/SLA.0b013e3182580de5; Waisel DB, 2002, J CLIN ANESTH, V14, P467, DOI 10.1016/S0952-8180(02)00401-4	8	2	2	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					359	360		10.1001/jama.2016.20288	http://dx.doi.org/10.1001/jama.2016.20288			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118464				2022-12-28	WOS:000392509600014
J	Slomski, A				Slomski, Anita			Physiotherapy Offers No Benefit in Treating Ankle Sprains	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					351	351		10.1001/jama.2016.20780	http://dx.doi.org/10.1001/jama.2016.20780			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118452				2022-12-28	WOS:000392509600008
J	Torjesen, I				Torjesen, Ingrid			Joe Smith OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												itorjesen@bmj.com						SMITH J, PUBLICATION LIST	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2017	356								j397	10.1136/bmj.j397	http://dx.doi.org/10.1136/bmj.j397			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HL	28119339				2022-12-28	WOS:000393177400013
J	Cunningham, S; Fernandes, RM				Cunningham, Steve; Fernandes, Ricardo M.			High-flow oxygen therapy in acute bronchiolitis	LANCET			English	Editorial Material							INFANTS; SATURATION; CHILDREN		[Cunningham, Steve] Univ Edinburgh, Dept Child Life & Hlth, Edinburgh, Midlothian, Scotland; [Cunningham, Steve] Royal Hosp Sick Children, Dept Resp & Sleep Med, Edinburgh EH9 1LF, Midlothian, Scotland; [Fernandes, Ricardo M.] Hosp Santa Maria, Ctr Hosp, Dept Pediat, Lisbon, Portugal; [Fernandes, Ricardo M.] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal	University of Edinburgh; Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa	Cunningham, S (corresponding author), Univ Edinburgh, Dept Child Life & Hlth, Edinburgh, Midlothian, Scotland.; Cunningham, S (corresponding author), Royal Hosp Sick Children, Dept Resp & Sleep Med, Edinburgh EH9 1LF, Midlothian, Scotland.	steve.cunningham@nhs.net	Fernandes, Ricardo M/C-7501-2015	Fernandes, Ricardo M/0000-0002-7253-6475; Cunningham, Steve/0000-0001-7342-251X	LFB Paris; Ablynx [ALX-0171]	LFB Paris; Ablynx(Ablynx)	SC reports consultancy fees paid to NHS Lothian from Ablynx for development of the phase I/IIa trial of ALX-0171 in bronchiolitis and personal fees from LFB Paris outside the submitted work. RMF was a member of the Independent Data Monitoring Committee for the Ablynx phase I/IIa trial of ALX-0171 in bronchiolitis.	Alam N, 2014, RESUSCITATION, V85, P587, DOI 10.1016/j.resuscitation.2014.01.013; Beggs S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009609.pub2; Cunningham S, 2015, JAMA PEDIATR, V169, P891, DOI 10.1001/jamapediatrics.2015.1971; Cunningham S, 2015, LANCET, V386, P1041, DOI 10.1016/S0140-6736(15)00163-4; Dumas O, 2016, THORAX, V71, P712, DOI 10.1136/thoraxjnl-2016-208535; Franklin D, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0501-x; Kepreotes E, 2016, LANCET; Mason BW, 2016, ARCH DIS CHILD, V101, P552, DOI 10.1136/archdischild-2015-308465; Milesi C, 2013, INTENS CARE MED, V39, P1088, DOI 10.1007/s00134-013-2879-y; Ricci V, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2305; Sinha IP, 2015, CHEST, V148, P810, DOI 10.1378/chest.14-1589; Unger S, 2008, PEDIATRICS, V121, P470, DOI 10.1542/peds.2007-1135	12	5	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2017	389	10072					886	887		10.1016/S0140-6736(17)30192-7	http://dx.doi.org/10.1016/S0140-6736(17)30192-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM4DL	28161017	Green Submitted			2022-12-28	WOS:000395263400007
J	Zerkle, AL; Poulton, SW; Newton, RJ; Mettam, C; Claire, MW; Bekker, A; Junium, CK				Zerkle, Aubrey L.; Poulton, Simon W.; Newton, Robert J.; Mettam, Colin; Claire, Mark W.; Bekker, Andrey; Junium, Christopher K.			Onset of the aerobic nitrogen cycle during the Great Oxidation Event	NATURE			English	Article							ISOTOPIC COMPOSITION; NATURAL GASES; FRACTIONATION; TRANSVAAL; OXYGEN; EVOLUTION; SEDIMENTS; ANAMMOX; RATIOS; CARBON	The rise of oxygen on the early Earth (about 2.4 billion years ago)(1) caused a reorganization of marine nutrient cycles(2,3), including that of nitrogen, which is important for controlling global primary productivity. However, current geochemical records(4) lack the temporal resolution to address the nature and timing of the biogeochemical response to oxygenation directly. Here we couple records of ocean redox chemistry with nitrogen isotope (N-15/N-14) values from approximately 2.31-billion-year-old shales(5) of the Rooihoogte and Timeball Hill formations in South Africa, deposited during the early stages of the first rise in atmospheric oxygen on the Earth (the Great Oxidation Event)(6). Our data fill a gap of about 400 million years in the temporal N-15/N-14 record(4) and provide evidence for the emergence of a pervasive aerobic marine nitrogen cycle. The interpretation of our nitrogen isotope data in the context of iron speciation and carbon isotope data suggests biogeochemical cycling across a dynamic redox boundary, with primary productivity fuelled by chemoautotrophic production and a nitrogen cycle dominated by nitrogen loss processes using newly available marine oxidants. This chemostratigraphic trend constrains the onset of widespread nitrate availability associated with ocean oxygenation. The rise of marine nitrate could have allowed for the rapid diversification and proliferation of nitrate-using cyanobacteria and, potentially, eukaryotic phytoplankton.	[Zerkle, Aubrey L.; Mettam, Colin; Claire, Mark W.] Univ St Andrews, Sch Earth & Environm Sci, St Andrews KY16 9AL, Fife, Scotland; [Zerkle, Aubrey L.; Mettam, Colin; Claire, Mark W.] Univ St Andrews, Ctr Exoplanet Sci, St Andrews KY16 9AL, Fife, Scotland; [Poulton, Simon W.; Newton, Robert J.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Claire, Mark W.] Blue Marble Space Inst Sci, POB 88561, Seattle, WA 98145 USA; [Bekker, Andrey] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Junium, Christopher K.] Syracuse Univ, Dept Earth Sci, Syracuse, NY 13244 USA	University of St Andrews; University of St Andrews; University of Leeds; University of California System; University of California Riverside; Syracuse University	Zerkle, AL (corresponding author), Univ St Andrews, Sch Earth & Environm Sci, St Andrews KY16 9AL, Fife, Scotland.; Zerkle, AL (corresponding author), Univ St Andrews, Ctr Exoplanet Sci, St Andrews KY16 9AL, Fife, Scotland.	az29@st-andrews.ac.uk	Newton, Robert/B-2599-2009; Claire, Mark/G-4989-2017	Newton, Robert/0000-0003-0144-6867; Claire, Mark/0000-0001-9518-089X; Bekker, Andrey/0000-0002-1154-0585; Zerkle, Aubrey/0000-0003-2324-1619; Poulton, Simon/0000-0001-7621-189X; Mettam, Colin/0000-0002-3639-6399	Natural Environment Research Council [NE/H016805]; Directorate For Geosciences [1455258] Funding Source: National Science Foundation; Natural Environment Research Council [NE/H016805/1, NE/H016805/2] Funding Source: researchfish; NERC [NE/H016805/2, NE/H016805/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported financially by a Natural Environment Research Council Fellowship (number NE/H016805 to A.L.Z.). We thank the Council for Geoscience in South Africa and the staff at the National Core Library in Donkerhoek for facilitating access to the core materials, and M. Yun for assistance with stable isotope analyses at the University of Manitoba.	Ader M, 1998, ORG GEOCHEM, V29, P315, DOI 10.1016/S0146-6380(98)00072-2; Ader M, 2016, CHEM GEOL, V429, P93, DOI 10.1016/j.chemgeo.2016.02.010; Beaumont V, 1999, PRECAMBRIAN RES, V96, P63, DOI 10.1016/S0301-9268(99)00005-4; BEBOUT GE, 1992, GEOCHIM COSMOCHIM AC, V56, P2839, DOI 10.1016/0016-7037(92)90363-N; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Bekker A, 2012, EARTH PLANET SC LETT, V317, P295, DOI 10.1016/j.epsl.2011.12.012; Boyd SR, 1998, CHEM GEOL, V144, P257, DOI 10.1016/S0009-2541(97)00135-6; Brunner B, 2013, P NATL ACAD SCI USA, V110, P18994, DOI 10.1073/pnas.1310488110; Busigny V, 2013, CHEM GEOL, V362, P115, DOI 10.1016/j.chemgeo.2013.06.023; Coetzee LL, 2006, S AFR J GEOL, V109, P109, DOI 10.2113/gssajg.109.1-2.109; Coplen TB, 2006, ANAL CHEM, V78, P2439, DOI 10.1021/ac052027c; Dalsgaard T, 2012, LIMNOL OCEANOGR, V57, P1331, DOI 10.4319/lo.2012.57.5.1331; De Pol-Holz R, 2009, DEEP-SEA RES PT II, V56, P1100, DOI 10.1016/j.dsr2.2008.09.014; Farquhar J., 2014, TREATISE GEOCHEMISTR, P91; Farquhar J, 2011, PHOTOSYNTH RES, V107, P11, DOI 10.1007/s11120-010-9594-0; Garvin J, 2009, SCIENCE, V323, P1045, DOI 10.1126/science.1165675; Godfrey LV, 2013, GEOLOGY, V41, P655, DOI 10.1130/G33930.1; Godfrey LV, 2009, NAT GEOSCI, V2, P725, DOI 10.1038/NGEO633; HOCH MP, 1992, LIMNOL OCEANOGR, V37, P1447, DOI 10.4319/lo.1992.37.7.1447; HOERING TC, 1958, GEOCHIM COSMOCHIM AC, V13, P225, DOI 10.1016/0016-7037(58)90024-3; Kump LR, 2011, SCIENCE, V334, P1694, DOI 10.1126/science.1213999; Luo GM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600134; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; MCCREADY RGL, 1983, CAN J MICROBIOL, V29, P231, DOI 10.1139/m83-038; McKirdy D.M., 1974, GEOLOGY, V2, P591, DOI [591, DOI 10.1130/0091-7613(1974)2<591:MAOCIC>2.0.CO;2]; MURTY SVS, 1992, CHEM GEOL, V94, P229, DOI 10.1016/0168-9622(92)90015-3; Papineau D, 2009, PRECAMBRIAN RES, V171, P37, DOI 10.1016/j.precamres.2009.03.005; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; PETERS KE, 1978, LIMNOL OCEANOGR, V23, P598, DOI 10.4319/lo.1978.23.4.0598; Polissar PJ, 2009, ANAL CHEM, V81, P755, DOI 10.1021/ac801370c; Poulton SW, 2005, CHEM GEOL, V214, P209, DOI 10.1016/j.chemgeo.2004.09.003; Rasmussen B, 2013, EARTH PLANET SC LETT, V382, P173, DOI 10.1016/j.epsl.2013.08.037; Reinhard CT, 2009, SCIENCE, V326, P713, DOI 10.1126/science.1176711; Robinson RS, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002321; Schimmelmann A, 2010, ORG GEOCHEM, V41, P63, DOI 10.1016/j.orggeochem.2009.01.005; Stueken EE, 2015, EARTH PLANET SC LETT, V411, P1, DOI 10.1016/j.epsl.2014.11.037; Stueken EE, 2013, GEOCHIM COSMOCHIM AC, V120, P121, DOI 10.1016/j.gca.2013.06.002; Stueken EE, 2016, EARTH-SCI REV, V160, P220, DOI 10.1016/j.earscirev.2016.07.007; Sumner DY, 2006, S AFR J GEOL, V109, P11, DOI 10.2113/gssajg.109.1-2.11; Thomazo C, 2011, GEOBIOLOGY, V9, P107, DOI 10.1111/j.1472-4669.2011.00271.x; Thomazo C, 2013, ELEMENTS, V9, P345, DOI 10.2113/gselements.9.5.345; Wada E., 1980, ISOTOPE MARINE CHEM, P375; Zerkle AL, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000651	43	76	77	11	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					465	+		10.1038/nature20826	http://dx.doi.org/10.1038/nature20826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28166535	Green Submitted, Green Accepted			2022-12-28	WOS:000395094100033
J	Spelsberg, A; Prugger, C; Doshi, P; Ostrowski, K; Witte, T; Husgen, D; Keil, U				Spelsberg, Angela; Prugger, Christof; Doshi, Peter; Ostrowski, Kerstin; Witte, Thomas; Huesgen, Dieter; Keil, Ulrich			Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRESCRIBING PATTERNS; TRIAL; ASSOCIATION; PHYSICIANS; PAYMENTS	OBJECTIVES To investigate the practice of post-marketing studies in Germany during a three year period and to evaluate whether these trials meet the aims specified in the German Medicinal Products Act. DESIGN Survey of notifications submitted to German regulatory agencies before post-marketing studies were carried out, 2008-10. SETTING Notifications obtained through freedom of information requests to the three authorities responsible for registering post-marketing studies in Germany. Main outcome measures Descriptive statistics of post-marketing studies, including the products under study, intended number of patients, intended number of participating physicians, proposed remunerations, study plan and protocol, and availability of associated scientific publications and reports on adverse drug reactions. RESULTS Information was obtained from 558 studies, with a median of 600 (mean 2331, range 2-75 000) patients and 63 (270, 0-7000) participating physicians per study. The median remuneration to physicians per patient was (sic)200 ((sic)441, (sic)0-(sic)7280) (170 pound, 0- pound 6200; pound $215, $0-$7820), with a total remuneration cost of more than (sic)217m for 558 studies registered over the three year period. The median remuneration per participating physician per study was (sic)2000 (mean (sic)19 424), ranging from (sic)0 to (sic)2 080 000. There was a broad range of drugs and non-drug products, of which only a third represented recently approved drugs. In many notifications, data, information, and results were, by contract, strictly confidential and the sole property of the respective sponsor. No single adverse drug reaction report could be identified from any of the 558 post-marketing studies. Less than 1% of studies could be verified as published in scientific journals. CONCLUSIONS Post-marketing studies are not improving drug safety surveillance. Sample sizes are generally too small to allow the detection of rare adverse drug reactions, and many participating physicians are strictly obliged to maintain confidentiality towards the sponsor. High remuneration and strict confidentiality clauses in these studies could influence the physicians' reporting behaviours of adverse drug reactions.	[Spelsberg, Angela; Huesgen, Dieter; Keil, Ulrich] Transparency Int Deutschland eV, Working Grp Hlth, Alte Schonhauser Str 44, D-10119 Berlin, Germany; [Spelsberg, Angela; Huesgen, Dieter; Keil, Ulrich] Transparency Int Deutschland eV, Working Grp Freedom Informat, Alte Schonhauser Str 44, D-10119 Berlin, Germany; [Spelsberg, Angela; Ostrowski, Kerstin; Witte, Thomas] Comprehens Canc Ctr Aachen, Pauwelsstr 30, D-52074 Aachen, Germany; [Prugger, Christof] Charite, Inst Publ Hlth, Seestr 73, D-13347 Berlin, Germany; [Doshi, Peter] Univ Maryland, Sch Pharm, Pharmaceut Hlth Serv Res Dept, Baltimore, MD 21201 USA; [Keil, Ulrich] Univ Munster, Inst Epidemiol & Social Med, Albert Schweitzer Campus, D-48149 Munster, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University System of Maryland; University of Maryland Baltimore; University of Munster	Spelsberg, A (corresponding author), Transparency Int Deutschland eV, Working Grp Hlth, Alte Schonhauser Str 44, D-10119 Berlin, Germany.; Spelsberg, A (corresponding author), Transparency Int Deutschland eV, Working Grp Freedom Informat, Alte Schonhauser Str 44, D-10119 Berlin, Germany.; Spelsberg, A (corresponding author), Comprehens Canc Ctr Aachen, Pauwelsstr 30, D-52074 Aachen, Germany.	spelsberg@tuzac.de		Prugger, Christof/0000-0003-1845-0950	Board of Transparency International Germany	Board of Transparency International Germany	The Board of Transparency International Germany provided financial resources for legal advice and fees related to assertion of freedom of information rights. The board had no influence on study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.	Angell M., 2004, TRUTH DRUG CO THEY D, P156; [Anonymous], 2015, NATURE, V526, P5, DOI 10.1038/526005a; Barbour V, 2016, TRIALS, V17, DOI 10.1186/s13063-015-1107-1; Charlton B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4681; Cohen D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4670; Council for International Organizations of Medical Sciences (CIOMS), 1999, REP ADV DRUG REACT D; Cox AR, 2010, BRIT J CLIN PHARMACO, V69, P529, DOI 10.1111/j.1365-2125.2010.03637.x; DeJong C, 2016, JAMA INTERN MED, V176, P1114, DOI 10.1001/jamainternmed.2016.2765; Dietrich ES, EVALUATION WISSENSCH; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; FLEISCHMAN W, 2016, BMJ-BRIT MED J, V354, DOI DOI 10.1136/BMJ.I4189; Hasford J, 1998, EUR J CLIN PHARMACOL, V53, P369, DOI 10.1007/s002280050395; Hill KP, 2008, ANN INTERN MED, V149, P251, DOI 10.7326/0003-4819-149-4-200808190-00006; Hochberg AM, 2009, J CLIN PHARMACOL, V49, P626, DOI 10.1177/0091270009333484; KESSLER DA, 1994, NEW ENGL J MED, V331, P1350, DOI 10.1056/NEJM199411173312007; Krumholz SD, 2011, ARCH INTERN MED, V171, P1100, DOI 10.1001/archinternmed.2011.241; London AJ, 2012, SCIENCE, V336, P544, DOI 10.1126/science.1216086; Lopez-Gonzalez E, 2009, DRUG SAFETY, V32, P19, DOI 10.2165/00002018-200932010-00002; McCully S, CONDUCTING NONINTERV; Muller CH, 2009, DTSCH ARZTEBL, V106, pA2042; Pirmohamed M, 1998, BRIT MED J, V316, P1295, DOI 10.1136/bmj.316.7140.1295; Porta M., 2008, DICT EPIDEMIOLOGY, P33; Psaty BM, 2006, JAMA-J AM MED ASSOC, V295, P2787, DOI 10.1001/jama.295.23.2787; RAWLINS MD, 1995, J ROY COLL PHYS LOND, V29, P41; von Jeinsen BKJG, 2013, EUR J CLIN PHARMACOL, V69, P1453, DOI 10.1007/s00228-013-1482-z; Wink K, 2010, POSTMARKETING NONINT; Yeh JS, 2016, JAMA INTERN MED, V176, P763, DOI 10.1001/jamainternmed.2016.1709; Zhang F, 2016, PHARMACOEPIDEM DR S, V25, P628, DOI 10.1002/pds.3947	29	20	21	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2017	356								j337	10.1136/bmj.j337	http://dx.doi.org/10.1136/bmj.j337			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FV	28174182	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000394578000001
J	Garcia-Moreno, C; Zimmerman, C; Watts, C				Garcia-Moreno, Claudia; Zimmerman, Cathy; Watts, Charlotte			Calling for action on violence against women: is anyone listening?	LANCET			English	Editorial Material							INTIMATE PARTNER VIOLENCE; GIRLS; CONFLICT		[Garcia-Moreno, Claudia] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland; [Zimmerman, Cathy; Watts, Charlotte] London Sch Hyg & Trop Med, Violence & Hlth Ctr, London, England; [Watts, Charlotte] Dept Int Dev, London, England	World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Garcia-Moreno, C (corresponding author), WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland.	garciamorenoc@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Carlson M., 2017, HILL; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Ellsberg M, 2015, LANCET, V385, P1555, DOI 10.1016/S0140-6736(14)61703-7; Garcia-Moreno C, 2015, LANCET, V385, P1685, DOI 10.1016/S0140-6736(14)61830-4; Garcia-Moreno C, 2014, LANCET, V383, P2023, DOI 10.1016/S0140-6736(14)60963-6; Guedes A., 2016, Global Health Action, V9, P31516; Heise LL, 2015, LANCET GLOB HEALTH, V3, pE332, DOI 10.1016/S2214-109X(15)00013-3; Hossain M, 2014, LANCET, V383, P2021, DOI 10.1016/S0140-6736(14)60964-8; International Labour Organization, 2012, GLOB EST FORC LAB RE; McAlpine A, 2016, BMC INT HEALTH HUM R, V16, DOI 10.1186/s12914-016-0107-x; Millett LS, 2013, CHILD MALTREATMENT, V18, P71, DOI 10.1177/1077559513484821; Seddon M, 2017, FINANC TIMES; UK Department for International Development, 2017, WHAT WORKS PREV VIOL; UK Department of International Development, 2014, WHAT WORKS PREV VIOL; United Nations, SUST DEV GOALS; WHO, 2014, A CLIN HDB; World Health Organisation, 2013, RESPONDING INTIMATE; World Health Organization, 2016, GLOB PLAN ACT STRENG	18	4	5	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					486	488		10.1016/S0140-6736(17)30271-4	http://dx.doi.org/10.1016/S0140-6736(17)30271-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ5UH	28170322	Green Published			2022-12-28	WOS:000393283400015
J	Wang, R; Kim, BV; van Wely, M; Johnson, NP; Costello, MF; Zhang, HW; Ng, EHY; Legro, RS; Bhattacharya, S; Norman, RJ; Mol, BJ				Wang, Rui; Kim, Bobae V.; van Wely, Madelon; Johnson, Neil P.; Costello, Michael F.; Zhang, Hanwang; Ng, Ernest Hung Yu; Legro, Richard S.; Bhattacharya, Siladitya; Norman, Robert J.; Mol, Ben Willem J.			Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							POLYCYSTIC-OVARY-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; COMPARING CLOMIPHENE CITRATE; RECEIVE LAPAROSCOPIC ELECTROCAUTERY; LABEL DRUG-USE; OVULATION INDUCTION; DOUBLE-BLIND; INFERTILE WOMEN; 1ST-LINE TREATMENT; PREGNANCY COMPLICATIONS	OBJECTIVE To compare the effectiveness of alternative first line treatment options for women with WHO group II anovulation wishing to conceive. DESIGN Systematic review and network meta-analysis. DATA SOURCES Cochrane Central Register of Controlled Trials, Medline, and Embase, up to 11 April 2016. STUDY SELECTION Randomised controlled trials comparing eight ovulation induction treatments in women with WHO group II anovulation: clomiphene, letrozole, metformin, clomiphene and metformin combined, tamoxifen, gonadotropins, laparoscopic ovarian drilling, and placebo or no treatment. Study quality was measured on the basis of the methodology and categories described in the Cochrane Collaboration Handbook. Pregnancy, defined preferably as clinical pregnancy, was the primary outcome; live birth, ovulation, miscarriage, and multiple pregnancy were secondary outcomes. RESULTS Of 2631 titles and abstracts initially identified, 57 trials reporting on 8082 women were included. All pharmacological treatments were superior to placebo or no intervention in terms of pregnancy and ovulation. Compared with clomiphene alone, both letrozole and the combination of clomiphene and metformin showed higher pregnancy rates (odds ratio 1.58, 95% confidence interval 1.25 to 2.00; 1.81, 1.35 to 2.42; respectively) and ovulation rates (1.99, 1.38 to 2.87; 1.55, 1.02 to 2.36; respectively). Letrozole led to higher live birth rates when compared with clomiphene alone (1.67, 1.11 to 2.49). Both letrozole and metformin led to lower multiple pregnancy rates compared with clomiphene alone (0.46, 0.23 to 0.92; 0.22, 0.05 to 0.92; respectively). CONCLUSIONS In women with WHO group II anovulation, letrozole and the combination of clomiphene and metformin are superior to clomiphene alone in terms of ovulation and pregnancy. Compared with clomiphene alone, letrozole is the only treatment showing a significantly higher rate of live birth. SYSTEMATIC REVIEW REGISTRATION PROSPERO CRD42015027579.	[Wang, Rui; Kim, Bobae V.; Johnson, Neil P.; Norman, Robert J.; Mol, Ben Willem J.] Univ Adelaide, Robinson Res Inst, Sch Med, Discipline Obstet & Gynaecol, North Adelaide, SA, Australia; [Wang, Rui; Zhang, Hanwang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Reprod Med Ctr, Wuhan, Peoples R China; [van Wely, Madelon] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, Ctr Reprod Med, Amsterdam, Netherlands; [Johnson, Neil P.] Univ Auckland, Dept Obstet & Gynaecol, Auckland, New Zealand; [Costello, Michael F.] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Ng, Ernest Hung Yu] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Legro, Richard S.] Penn State Coll Med, Dept Obstet & Gynecol, Hershey, PA USA; [Bhattacharya, Siladitya] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [Norman, Robert J.] FertilitySA, Adelaide, SA, Australia; [Norman, Robert J.] NHMRC, Ctr Res Excellence Polycyst Ovary Syndrome, Adelaide, SA, Australia; [Mol, Ben Willem J.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide; Huazhong University of Science & Technology; University of Amsterdam; Academic Medical Center Amsterdam; University of Auckland; University of New South Wales Sydney; University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Aberdeen; South Australian Health & Medical Research Institute (SAHMRI)	Wang, R (corresponding author), Univ Adelaide, North Adelaide, SA, Australia.	r.wang@adelaide.edu.au	Norman, Robert J/A-1155-2007; Wang, Rui/AAC-8543-2019; Wang, Rui/ABB-5615-2020; van Wely, Madelon/GXV-1757-2022	Norman, Robert J/0000-0002-3118-3896; Wang, Rui/0000-0002-6622-8134; Legro, Richard/0000-0001-9927-7584; Ng, Ernest/0000-0002-7688-4557; van Wely, Madelon/0000-0001-8263-213X; Bhattacharya, Siladitya/0000-0002-4588-356X	Australian government; Australian National Health and Medical Research Council [APP1078444]	Australian government(Australian GovernmentCGIAR); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by an Australian government research training programme scholarship (held by RW) and the Australian National Health and Medical Research Council funded Centre for Research Excellence in Polycystic Ovary Syndrome (APP1078444).	Abu Hashim H, 2013, ARCH GYNECOL OBSTET, V288, P409, DOI 10.1007/s00404-013-2808-x; Abuelghar WM, 2013, MIDDLE EAST FERTIL S, V18, P135, DOI 10.1016/j.mefs.2013.05.002; Amer S, 2015, HUM REPROD, V30, P96; Amer SA, 2009, HUM REPROD, V24, P219, DOI 10.1093/humrep/den325; Atay V, 2006, J INT MED RES, V34, P73, DOI 10.1177/147323000603400109; Ayaz Aqueela, 2013, J Hum Reprod Sci, V6, P15, DOI 10.4103/0974-1208.112372; Aygen EM, 2007, ERCIYES MED J, V29, P195; Badawy A, 2009, FERTIL STERIL, V92, P849, DOI 10.1016/j.fertnstert.2007.02.062; Badawy A, 2011, EUR J OBSTET GYN R B, V159, P151, DOI 10.1016/j.ejogrb.2011.07.015; Baird DT, 2012, HUM REPROD UPDATE, V18, P586, DOI 10.1093/humupd/dms019; Balen AH, 2016, HUM REPROD UPDATE, V22, P687, DOI 10.1093/humupd/dmw025; Basirat Z, 2012, INT J FERTIL STERIL, V6, P31; Bayar U, 2006, FERTIL STERIL, V86, P1447, DOI 10.1016/j.fertnstert.2006.04.026; Bayram N, 2004, BMJ-BRIT MED J, V328, P192, DOI 10.1136/bmj.328.7433.192; Beigi A, 2006, HUM REPROD, V21, pI129; Biljan MM, 2005, FERTIL STERIL, V84, pS95, DOI 10.1016/j.fertnstert.2005.07.230; Boomsma CM, 2006, HUM REPROD UPDATE, V12, P673, DOI 10.1093/humupd/dml036; Boostanfar R, 2001, FERTIL STERIL, V75, P1024, DOI 10.1016/S0015-0282(01)01749-6; Boudhraa Khaled, 2010, Tunis Med, V88, P335; Brown J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002249.pub4; Chaimani A, 2015, STATA J, V15, P905, DOI 10.1177/1536867X1501500402; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen ZJ, 2016, NEW ENGL J MED, V375, P523, DOI 10.1056/NEJMoa1513873; Clarke JF, 2010, FERTIL STERIL, V94, P1647, DOI 10.1016/j.fertnstert.2009.11.018; Conway G, 2014, EUR J ENDOCRINOL, V171, pP1, DOI 10.1530/EJE-14-0253; CUDMORE DW, 1966, FERTIL STERIL, V17, P363; Dasari Papa, 2009, J Hum Reprod Sci, V2, P18, DOI 10.4103/0974-1208.51337; Dehbashi S, 2009, IRAN J MED SCI, V34, P23; Diamond MP, 2015, NEW ENGL J MED, V373, P1230, DOI 10.1056/NEJMoa1414827; El-Biely MM, 2001, MIDDLE E FERTIL SOC, V6, P43; Elsedeek MSE, 2011, MIDDLE EAST FERTIL S, V16, P125, DOI 10.1016/j.mefs.2010.11.004; Farquhar C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001122.pub4; Fauser BCJM, 2012, HUM REPROD, V27, P14, DOI 10.1093/humrep/der396; Fauser BCJM, 2012, FERTIL STERIL, V97, P28, DOI 10.1016/j.fertnstert.2011.09.024; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Fleming R, 2002, J CLIN ENDOCR METAB, V87, P569, DOI 10.1210/jc.87.2.569; Forman R, 2007, J OBSTET GYNAECOL CA, V29, P668, DOI 10.1016/S1701-2163(16)32551-8; Franik S, 2014, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD010287.PUB2; GARCIA CR, 1985, FERTIL STERIL, V44, P478; Goodman NF, 2015, ENDOCR PRACT, V21, P1415, DOI 10.4158/EP15748.DSCPT2; Hansen M, 2013, HUM REPROD UPDATE, V19, P330, DOI 10.1093/humupd/dmt006; Hart R, 2013, HUM REPROD UPDATE, V19, P232, DOI 10.1093/humupd/dms062; Homburg R, 2012, HUM REPROD, V27, P468, DOI 10.1093/humrep/der401; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Jahan S., 2015, INT J GYNECOL OBSTET, V131, pE503; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; JOHNSON JE, 1966, INT J FERTIL, V11, P265; Johnson NP, 2010, HUM REPROD, V25, P1675, DOI 10.1093/humrep/deq100; Kar Sujata, 2015, J Hum Reprod Sci, V8, P197, DOI 10.4103/0974-1208.170373; Kar Sujata, 2012, J Hum Reprod Sci, V5, P262, DOI 10.4103/0974-1208.106338; Karimzadeh MA., 2007, MIDDLE EAST FERTIL S, V12, P174; Karimzadeh MA, 2010, FERTIL STERIL, V94, P216, DOI 10.1016/j.fertnstert.2009.02.078; Keikha F, 2011, IRAN J REPROD MED, V9, P46; Khan K, 2014, BJOG-INT J OBSTET GY, V121, P1181, DOI 10.1111/1471-0528.12929; Khorram O, 2006, FERTIL STERIL, V85, P1448, DOI 10.1016/j.fertnstert.2005.10.042; Leanza V, MINERVA GINECOL; Legro RS, 2007, NEW ENGL J MED, V356, P551, DOI 10.1056/NEJMoa063971; Legro RS, 2016, J CLIN ENDOCR METAB, V101, P2658, DOI 10.1210/jc.2016-1659; Legro RS, 2015, J CLIN ENDOCR METAB, V100, P4048, DOI 10.1210/jc.2015-2778; Legro RS, 2014, HUM REPROD, V29, P2075, DOI 10.1093/humrep/deu218; Legro RS, 2014, FERTIL STERIL, V102, P952, DOI 10.1016/j.fertnstert.2014.08.002; Legro RS, 2014, NEW ENGL J MED, V371, P119, DOI 10.1056/NEJMoa1313517; Legro RS, 2013, J CLIN ENDOCR METAB, V98, P4565, DOI 10.1210/jc.2013-2350; Liu C, 2015, INT J GYNECOL OBSTET, V131, pE231; Lopez E, 2004, REPROD BIOMED ONLINE, V9, P382, DOI 10.1016/S1472-6483(10)61273-4; Lord J, 2006, BJOG-INT J OBSTET GY, V113, P817, DOI 10.1111/j.1471-0528.2006.00966.x; Lorzadeh N., 2011, Iranian Journal of Obstetrics, Gynecology and Infertility, V14, P13; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Maged AM, 2015, GYNECOL ENDOCRINOL, V31, P635, DOI 10.3109/09513590.2015.1037269; McCartney CR, 2016, NEW ENGL J MED, V375, P54, DOI 10.1056/NEJMcp1514916; Mills EJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2914; Misso ML, 2013, HUM REPROD UPDATE, V19, P2, DOI 10.1093/humupd/dms036; Misso ML, 2012, HUM REPROD UPDATE, V18, P301, DOI 10.1093/humupd/dms003; Mobusher I, 2014, PAK J MED HEALTH SCI, V8, P905; Moghetti P, 2015, J ENDOCRINOL INVEST, V38, P1025, DOI 10.1007/s40618-015-0274-y; Moll E, 2006, BRIT MED J, V332, P1485, DOI 10.1136/bmj.38867.631551.55; Moll E, 2007, HUM REPROD UPDATE, V13, P527, DOI 10.1093/humupd/dmm026; Mutsaerts MAQ, 2016, NEW ENGL J MED, V374, P1942, DOI 10.1056/NEJMoa1505297; Nahuis MJ, 2012, HUM REPROD, V27, P3577, DOI 10.1093/humrep/des336; Nahuis MJ, 2011, HUM REPROD, V26, P1899, DOI 10.1093/humrep/der141; Nahuis MJ, 2014, FERTIL STERIL, V101, P270, DOI 10.1016/j.fertnstert.2013.09.004; National Health and Medical Research Council, 2015, EV BAS GUID ASS MAN; National Institute for Health and Care Excellence, 2013, FERT ASS TREATM PEOP; Nazik H, 2012, HEALTHMED, V6, P879; Palomba S, 2005, J CLIN ENDOCR METAB, V90, P4068, DOI 10.1210/jc.2005-0110; Palomba S, 2015, HUM REPROD UPDATE, V21, P575, DOI 10.1093/humupd/dmv029; Palomba S, 2015, J CLIN ENDOCR METAB, V100, P1742, DOI 10.1210/jc.2014-4235; Pandey S, 2012, HUM REPROD UPDATE, V18, P485, DOI 10.1093/humupd/dms018; Petersen KB, 2016, REPROD BIOMED ONLINE, V32, P563, DOI 10.1016/j.rbmo.2016.03.006; Pinborg A, 2013, HUM REPROD UPDATE, V19, P87, DOI 10.1093/humupd/dms044; Raja Ayisha, 2005, J Ayub Med Coll Abbottabad, V17, P50; Ray PB, 2012, ARCH GYNECOL OBSTET, V285, P873, DOI 10.1007/s00404-011-2091-7; Robinson RD, 2003, FERTIL STERIL, V80, pS273; Roque M, GYNECOL ENDOCRINOL; Roy Kallol Kumar, 2012, J Hum Reprod Sci, V5, P20, DOI 10.4103/0974-1208.97789; Sahin Y, 2004, EUR J OBSTET GYN R B, V113, P214, DOI 10.1016/j.ejogrb.2003.09.036; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Santonocito V, 2009, G ITAL OSTET GINECOL, V31, P455; Selim MF, 2012, J GYNECOL SURG, V28, P405, DOI 10.1089/gyn.2012.0033; Seyedoshohadaei F, 2012, IRAN J REPROD MED, V10, P531; Sharief M, 2015, J PAK MED ASSOC, V65, P1149; Sharma Sunita, 2014, PLoS One, V9, pe108219, DOI 10.1371/journal.pone.0108219; Sirmans SM, 2014, CLIN EPIDEMIOL, V6, P1, DOI 10.2147/CLEP.S37559; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Stein IF, 1935, AM J OBSTET GYNECOL, V29, P181, DOI 10.1016/S0002-9378(15)30642-6; Tang T, 2006, HUM REPROD, V21, P80, DOI 10.1093/humrep/dei311; Tang T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003053.pub5; Tarlatzis BC, 2008, HUM REPROD, V23, P462, DOI 10.1093/humrep/dem426; Tatsumi T, 2017, HUM REPROD, V32, P125, DOI 10.1093/humrep/dew280; Tulandi T, 2006, FERTIL STERIL, V85, P1761, DOI 10.1016/j.fertnstert.2006.03.014; Usadi RS, 2015, FERTIL STERIL, V103, P583, DOI 10.1016/j.fertnstert.2015.01.011; Vause TDR, 2010, J OBSTET GYNAECOL CA, V32, P1027; Vegetti W, 1999, FERTIL STERIL S1, V72, pS234; Vitek W, 2015, FERTIL STERIL, V103, P605, DOI 10.1016/j.fertnstert.2015.01.019; Williams CD, 2009, FERTIL STERIL, V92, pS105, DOI DOI 10.1016/j.fertnstert.2009.07.1076.; Wu XK, 2016, FERTIL STERIL, V106, P757, DOI 10.1016/j.fertnstert.2016.05.022; Zain MM, 2009, FERTIL STERIL, V91, P514, DOI 10.1016/j.fertnstert.2007.12.002; Zeinalzadeh M, 2010, J REPROD MED, V55, P36	120	60	62	1	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2017	356								j138	10.1136/bmj.j138	http://dx.doi.org/10.1136/bmj.j138			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8BP	28143834	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000393449700002
J	Zetka, M				Zetka, Monique			CHROMOSOME DYNAMICS When degradation spurs segregation A proteasome controls chromosome pairing and recombination during gamete formation	SCIENCE			English	Editorial Material							LIGASE HEI10; PATHWAY; ROLES		[Zetka, Monique] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Zetka, M (corresponding author), McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada.	monique.zetka@mcgill.ca						Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Ahuja JS, 2017, SCIENCE, V355, P408, DOI 10.1126/science.aaf4778; Chelysheva L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002799; Da Ines O, 2015, ANNU REV GENET, V49, P95, DOI 10.1146/annurev-genet-112414-055107; De Muyt A, 2014, GENE DEV, V28, P1111, DOI 10.1101/gad.240408.114; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Lake CM, 2016, SEMIN CELL DEV BIOL, V54, P117, DOI 10.1016/j.semcdb.2016.01.008; Murakami H, 2008, GENE DEV, V22, P286, DOI 10.1101/gad.1642308; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Qiao H, 2014, NAT GENET, V46, P194, DOI 10.1038/ng.2858; Rao HBDP, 2017, SCIENCE, V355, P403, DOI 10.1126/science.aaf6407; Scherthan H, 2007, CELL MOL LIFE SCI, V64, P117, DOI 10.1007/s00018-006-6463-2; Wang KJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002809	15	2	2	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					349	350		10.1126/science.aam5904	http://dx.doi.org/10.1126/science.aam5904			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EJ4FR	28126771				2022-12-28	WOS:000393172800020
J	Guo, CJ; Chang, FY; Wyche, TP; Backus, KM; Acker, TM; Funabashi, M; Taketani, M; Donia, MS; Nayfach, S; Pollard, KS; Craik, CS; Cravatt, BF; Clardy, J; Voigt, CA; Fischbach, MA				Guo, Chun-Jun; Chang, Fang-Yuan; Wyche, Thomas P.; Backus, Keriann M.; Acker, Timothy M.; Funabashi, Masanori; Taketani, Mao; Donia, Mohamed S.; Nayfach, Stephen; Pollard, Katherine S.; Craik, Charles S.; Cravatt, Benjamin F.; Clardy, Jon; Voigt, Christopher A.; Fischbach, Michael A.			Discovery of Reactive Microbiota-Derived Metabolites that Inhibit Host Proteases	CELL			English	Article							SELECTIVE INHIBITORS; CYSTEINE PROTEASES; SYNTHETASE; CATHEPSINS; ALDEHYDES; BACTERIA; FAMILY; POTENT; GENES	The gut microbiota modulate host biology in numerous ways, but little is known about the molecular mediators of these interactions. Previously, we found a widely distributed family of nonribosomal peptide synthetase gene clusters in gut bacteria. Here, by expressing a subset of these clusters in Escherichia coli or Bacillus subtilis, we show that they encode pyrazinones and dihydropyrazinones. At least one of the 47 clusters is present in 88% of the National Institutes of Health Human Microbiome Project (NIH HMP) stool samples, and they are transcribed under conditions of host colonization. We present evidence that the active form of these molecules is the initially released peptide aldehyde, which bears potent protease inhibitory activity and selectively targets a subset of cathepsins in human cell proteomes. Our findings show that an approach combining bioinformatics, synthetic biology, and heterologous gene cluster expression can rapidly expand our knowledge of the metabolic potential of the microbiota while avoiding the challenges of cultivating fastidious commensals.	[Guo, Chun-Jun; Funabashi, Masanori; Taketani, Mao; Fischbach, Michael A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Guo, Chun-Jun; Funabashi, Masanori; Taketani, Mao; Fischbach, Michael A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Chang, Fang-Yuan; Voigt, Christopher A.] MIT, Dept Biol Engn, Boston, MA 02115 USA; [Chang, Fang-Yuan; Voigt, Christopher A.] MIT, Synthet Biol Ctr, Boston, MA 02115 USA; [Wyche, Thomas P.; Clardy, Jon] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Backus, Keriann M.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92307 USA; [Acker, Timothy M.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Donia, Mohamed S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Nayfach, Stephen; Pollard, Katherine S.] Univ Calif San Francisco, Integrat Program Quantitat Biol, Gladstone Inst, San Francisco, CA 94143 USA; [Nayfach, Stephen; Pollard, Katherine S.] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Scripps Research Institute; University of California System; University of California San Francisco; Princeton University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Fischbach, MA (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.; Fischbach, MA (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA.	fischbach@fischbachgroup.org	Funabashi, Masanori/GQZ-8735-2022	Fischbach, Michael/0000-0003-3079-8247; Chang, Fang-Yuan/0000-0001-5819-6454	BASF California Research Alliance; NIH [R01 DK101674, R01 DK110174, DP1 DK113598, R01 CA087660, DP2 AI124441, R01 GM104659]; David and Lucile Packard Foundation; HHMI-Simons Faculty Scholars Award; Novartis; U.S. Defense Advanced Research Projects Agency's Living Foundries program [HR0011-12-C-0067, HR0011-13-1-001, HR0011-15-C-0084]; Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship [5F32GM111012-03]; Burroughs Welcome Fund Investigators in the Pathogenesis of Infectious Disease award; NATIONAL CANCER INSTITUTE [R37CA087660] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT009874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101674, R01DK110174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547, R01GM104659, F32GM111012] Funding Source: NIH RePORTER	BASF California Research Alliance(BASF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); HHMI-Simons Faculty Scholars Award; Novartis(Novartis); U.S. Defense Advanced Research Projects Agency's Living Foundries program; Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Welcome Fund Investigators in the Pathogenesis of Infectious Disease award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are deeply grateful to Piro Siuti and Horst Hemmerle at Novartis for their many constructive discussions and support of this research program, Emma Allen-Vercoe for sending us Lachnospiraceae sp. 3_1_57FAA and Ruminococcus sp. 5_1_39BFAA, Kim Lewis and Phil Strandwitz for providing us with Clostridium sp. KLE 1755, Jeff Johnson and Nevan Krogan for help with MS/MS experiments, Hiroki Shimizu and Adam Renslo for help with the chemical synthesis of peptide aldehydes, three anonymous reviewers for constructive suggestions, and members of the Fischbach Group for helpful comments. This work was supported by the BASF California Research Alliance (M.A.F.) grants from the NIH (R01 DK101674, R01 DK110174, and DP1 DK113598 [M.A.F.], R01 CA087660 [B.F.C.], DP2 AI124441 [M.S.D.], and R01 GM104659 [C.S.C.]), a fellowship from the David and Lucile Packard Foundation (M.A.F.), an HHMI-Simons Faculty Scholars Award (M.A.F.), a research award from Novartis (M.A.F., C.A.V., and J.C.); research awards from the U.S. Defense Advanced Research Projects Agency's Living Foundries program (HR0011-12-C-0067, HR0011-13-1-001, and HR0011-15-C-0084 [C.A.V. and M.A.F.]), a Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (5F32GM111012-03 [T.M.A.]), and a Burroughs Welcome Fund Investigators in the Pathogenesis of Infectious Disease award (M.A.F.). M.A.F. is a member of the board of directors of Achaogen and the scientific advisory boards of NGM Biopharmaceuticals and Cell Design Labs and is a co-founder of Revolution Medicines. C.A.V. is a cofounder and scientific advisory board member of Pivot Bio, and on the scientific advisory boards of DSM, Twist Bio, SynLogic, Biomilenia, Senti Bio, Bolt Threads, and Zymergen. K.S.P. is a consultant for Phylagen Biosciences.	Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; AOYAGI T, 1969, J ANTIBIOT, V22, P558, DOI 10.7164/antibiotics.22.558; AOYAGI T, 1969, J ANTIBIOT, V22, P283, DOI 10.7164/antibiotics.22.283; Backus KM, 2016, NATURE, V534, P570, DOI 10.1038/nature18002; Blattner S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005857; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; Fung TC, 2014, IMMUNOL REV, V260, P35, DOI 10.1111/imr.12186; Hershberg RM, 1997, J CLIN INVEST, V100, P204, DOI 10.1172/JCI119514; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Katunuma N, 2011, P JPN ACAD B-PHYS, V87, P29, DOI 10.2183/pjab.87.29; Laine DI, 2010, EXPERT OPIN THER PAT, V20, P497, DOI 10.1517/13543771003657172; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; MACDONALD JC, 1976, TETRAHEDRON, V32, P655, DOI 10.1016/S0040-4020(01)93786-X; Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130; Medema MH, 2013, MOL BIOL EVOL, V30, P1218, DOI 10.1093/molbev/mst025; MEHDI S, 1988, BIOCHEM BIOPH RES CO, V157, P1117, DOI 10.1016/S0006-291X(88)80989-6; Nayfach S, 2015, BIOINFORMATICS, V31, P3368, DOI 10.1093/bioinformatics/btv382; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Otto HH, 1997, CHEM REV, V97, P133, DOI 10.1021/cr950025u; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Reuter K, 1999, EMBO J, V18, P6823, DOI 10.1093/emboj/18.23.6823; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Siklos M, 2015, ACTA PHARM SIN B, V5, P506, DOI 10.1016/j.apsb.2015.08.001; THOMPSON RC, 1973, BIOCHEMISTRY-US, V12, P47, DOI 10.1021/bi00725a009; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; WESTERIK JO, 1972, J BIOL CHEM, V247, P8195; WOO JT, 1995, BIOORG MED CHEM LETT, V5, P1501, DOI 10.1016/0960-894X(95)00236-M; Wyatt MA, 2013, BIOCHEM CELL BIOL, V91, P203, DOI 10.1139/bcb-2012-0097; Wyatt MA, 2012, CHEMBIOCHEM, V13, P2408, DOI 10.1002/cbic.201200340; Zimmermann M, 2010, CHEM BIOL, V17, P925, DOI 10.1016/j.chembiol.2010.08.006	37	138	145	4	100	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					517	+		10.1016/j.cell.2016.12.021	http://dx.doi.org/10.1016/j.cell.2016.12.021			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28111075	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000396249600017
J	Hite, RK; MacKinnon, R				Hite, Richard K.; MacKinnon, Roderick			Structural Titration of Slo2.2, a Na+-Dependent K+ Channel	CELL			English	Article							MIGRATING PARTIAL SEIZURES; ACTIVATED POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; KCNT1 MUTATION; PURIFICATION; SENSITIVITY; PARTICLES; REVEALS; SHAKER; DOMAIN	The stable structural conformations that occur along the complete reaction coordinate for ion channel opening have never been observed. In this study, we describe the equilibrium ensemble of structures of Slo2.2, a neuronal Na+-activated K+ channel, as a function of the Na+ concentration. We find that Slo2.2 exists in multiple closed conformations whose relative occupancies are independent of Na+ concentration. An open conformation emerges from an ensemble of closed conformations in a highly Na+-dependent manner, without evidence of Na+-dependent intermediates. In other words, channel opening is a highly concerted, switch-like process. The midpoint of the structural titration matches that of the functional titration. A maximum open conformation probability approaching 1.0 and maximum functional open probability approaching 0.7 imply that, within the class of open channels, there is a subclass that is not permeable to ions.	[Hite, Richard K.; MacKinnon, Roderick] Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA; [MacKinnon, Roderick] Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute	MacKinnon, R (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.; MacKinnon, R (corresponding author), Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu			 [GM43949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Ebrahim at the Evelyn Gruss Lipper Cryo-electron resource center and Rockefeller University and Z. Yu and C. Hong at the Howard Hughes Medical Institute Janelia Cryo-EM facility for assistance in data collection, Sjors Scheres for advice on classification, and J. Chen at Rockefeller University for advice on the manuscript. This work was supported in part by GM43949. R.K.H. is a Howard Hughes Medical Institute postdoctoral fellow of the Helen Hay Whitney Foundation and R.M. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; BADER CR, 1985, NATURE, V317, P540, DOI 10.1038/317540a0; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DRYER SE, 1989, J PHYSIOL-LONDON, V410, P283, DOI 10.1113/jphysiol.1989.sp017533; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grant T, 2015, J STRUCT BIOL, V192, P204, DOI 10.1016/j.jsb.2015.08.006; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; HAIMANN C, 1989, CELL BIOL INT REP, V13, P1133, DOI 10.1016/0309-1651(89)90027-1; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hite R. K., 2016, NATURE; Hite RK, 2015, NATURE, V527, P198, DOI 10.1038/nature14958; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Ishii A, 2013, GENE, V531, P467, DOI 10.1016/j.gene.2013.08.096; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; KAMEYAMA M, 1984, NATURE, V309, P354, DOI 10.1038/309354a0; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; MAK DOD, 1994, J BIOL CHEM, V269, P29375; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MCMANUS OB, 1988, J PHYSIOL-LONDON, V402, P79, DOI 10.1113/jphysiol.1988.sp017195; McTague A, 2013, BRAIN, V136, P1578, DOI 10.1093/brain/awt073; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rubinstein JL, 2015, J STRUCT BIOL, V192, P188, DOI 10.1016/j.jsb.2015.08.007; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SCHWINDT PC, 1989, J NEUROPHYSIOL, V61, P233, DOI 10.1152/jn.1989.61.2.233; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Tao X., 2016, NATURE; Vanderver A, 2014, PEDIATR NEUROL, V50, P112, DOI 10.1016/j.pediatrneurol.2013.06.024; Wang W, 2016, ELIFE, V5, DOI [10.7754/eLife.15751, 10.7554/eLife.15751]; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wong JP, 2009, J PROTEOME RES, V8, P2388, DOI 10.1021/pr801008c; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Yan YY, 2012, J MEMBRANE BIOL, V245, P667, DOI 10.1007/s00232-012-9425-7; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Zhang Z, 2010, J NEUROSCI, V30, P7554, DOI 10.1523/JNEUROSCI.0525-10.2010	53	71	75	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2017	168	3					390	+		10.1016/j.cell.2016.12.030	http://dx.doi.org/10.1016/j.cell.2016.12.030			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8KP	28111072	Green Accepted, Bronze			2022-12-28	WOS:000396249600009
J	Landhuis, E				Landhuis, Esther			Big brain, big data Neuroscientists are starting to share and integrate data-but shifting to a team approach isn't easy	NATURE			English	Editorial Material									[Landhuis, Esther] San Francisco Bay Area Calif, San Francisco, CA 94115 USA		Landhuis, E (corresponding author), San Francisco Bay Area Calif, San Francisco, CA 94115 USA.							Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107	3	34	35	4	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2017	541	7638								10.1038/541559a	http://dx.doi.org/10.1038/541559a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6LX	28128250	Bronze			2022-12-28	WOS:000396116600058
J	Butt, CA				Butt, Carrie A.			"Move Your Arm Like a Swan" Dance for PD Demedicalizes Parkinson Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Butt, Carrie A.] JAMA Network, Digital Content Operat, Chicago, IL 60654 USA		Butt, CA (corresponding author), JAMA Network, Digital Content Operat, Chicago, IL 60654 USA.	carrie.butt@jamanetwork.org							0	9	9	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					342	343		10.1001/jama.2016.21033	http://dx.doi.org/10.1001/jama.2016.21033			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118430				2022-12-28	WOS:000392509600001
J	[Anonymous]				[Anonymous]			Five minutes with ... Kate Lampard	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2017	356								i6846	10.1136/bmj.i6846	http://dx.doi.org/10.1136/bmj.i6846			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ4HL	28119300				2022-12-28	WOS:000393177400001
J	[Anonymous]				[Anonymous]			Compulsory Health Insurance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 1916, J AMA           0617, P1951	1	0	0	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					444	444		10.1001/jama.2016.19840	http://dx.doi.org/10.1001/jama.2016.19840			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28118442				2022-12-28	WOS:000392509600034
J	Voelker, R				Voelker, Rebecca			Relief for Ureteral Obstruction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					247	247		10.1001/jama.2016.19759	http://dx.doi.org/10.1001/jama.2016.19759			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NP	28114535				2022-12-28	WOS:000426802000003
J	Zahn, LM; Riddihough, G				Zahn, Laura M.; Riddihough, Guy			BUILDING ON NATURE'S DESIGN	SCIENCE			English	Editorial Material												guy.riddihough@lifescienceeditors.com							0	23	24	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1038	1039		10.1126/science.355.6329.1038	http://dx.doi.org/10.1126/science.355.6329.1038			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5HQ	28280198				2022-12-28	WOS:000426858300001
